{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO's financial exposure to the 5.000% notes due April 2030 declined from $606 million (current portion) and $606 million (non‑current portion) in fiscal 2022 to $750 million (current) and $606 million (non‑current) in fiscal 2023, then rose sharply to $1,856 million (current) and $68,602 million (non‑current) by fiscal 2024. This progression reflects a strategic shift toward longer‑dated, higher‑yielding debt—issuing new 5.000% notes in 2024 while retiring shorter‑maturity obligations—indicating AVGO’s intent to extend the average maturity of its debt and lock in financing costs at current market levels.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. The LLM incorrectly states that exposure was $606 million (current) and $606 million (non-current) in 2022, totaling $1,212 million — which contradicts the ground truth of $1,086 million. It then claims exposure increased to $1,856 million (current) and $68,602 million (non-current) in 2024 — figures that are wildly inaccurate and not supported by the data. (2) The calculation and trend are completely wrong: instead of a consistent decline and stabilization, the LLM reports a massive increase in 2024, including a non-current portion over $68 billion, which is implausible and factually incorrect. (3) The multi-hop reasoning is flawed — the LLM fabricates a 'strategic shift' toward issuing new 5.000% notes in 2024, which is not indicated in the ground truth. Instead, the actual data shows a deliberate reduction in exposure, suggesting debt repayment, not new issuance. (4) The contextual relevance is low because the answer discusses a different financial behavior (debt extension and new issuance) than what occurred (debt reduction). The conclusion about 'locking in financing costs' is speculative and contradicts the actual trend. Only minimal credit is given for mentioning the correct note (5.000% due April 2030) and the general topic of debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 428,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "From 2022 through 2024, MetLife continued to reinsure approximately 59% of the closed block via a modified coinsurance agreement, consistently reporting that roughly 59% of the closed‑block risk was ceded under this arrangement. This steady percentage demonstrates that the company maintains a long‑term, stable reinsurance strategy for the closed block, relying on the same quota‑share structure to manage exposure and capital requirements over multiple reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core fact that MetLife reinsured approximately 59% of the closed block from 2022 to 2024 via a modified coinsurance agreement, which aligns with the ground truth (59.25% in 2022, 59% in 2023 and 2024). The slight rounding to 'approximately 59%' is acceptable and does not detract from accuracy. However, the LLM omits specific details such as the use of the deposit method of accounting, the exercise of the right of offset, and the significant growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, which are key contextual elements in the original answer. (2) Quantitatively, the percentages are accurately represented in rounded form; no calculation errors are present. The LLM avoids citing exact dollar figures, so there is no error, but also no verification of the broader financial context. (3) The reasoning is sound in interpreting the stable percentage as evidence of a consistent, long-term reinsurance strategy focused on capital and risk management. This correctly synthesizes the implication of sustained risk transfer. However, the answer does not fully demonstrate multi-hop reasoning by connecting the stable percentage with the growing total reinsurance recoverables, which would strengthen the conclusion about strategic efficiency. (4) The scores reflect high factual accuracy and relevance, with minor deductions for incompleteness in financial and accounting details that were present in the ground truth and contribute to a fuller understanding of the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 428,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "From the 2023 10‑K (page 94) the company reports $800 million of collateral under master‑netting arrangements at the end of 2023, and the 2024 10‑K (page 99) shows that amount reduced to $491 million. This decline of roughly $309 million indicates that ExxonMobil has been releasing or utilizing that collateral, reflecting a more efficient management of its derivative exposure and a reduction in the need for external margin support.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the collateral values for 2023 ($800 million) and 2024 ($491 million) as per the ground truth, and accurately describes the downward trend. However, it omits the 2022 value of $1,494 million, which is a key part of the multi-year trend requested in the question. This omission reduces completeness. (2) The reported numbers are factually correct and match the ground truth for 2023 and 2024. The implied year-over-year decline from 2023 to 2024 is correctly calculated as ~$309 million. However, the full three-year trajectory (2022–2024) is not presented, and no mention is made of the larger total decline from 2022 to 2024. (3) The reasoning about improved derivative exposure management is logically sound and aligns with the ground truth’s interpretation. The LLM correctly infers that reduced collateral need suggests more efficient risk management or reduced exposure. However, it does not fully synthesize the three-year trend as required by the multi-hop nature of the question, which asks for change from 2022 to 2024. (4) The answer is highly relevant and accurately interprets the implications of the collateral reduction. Scores reflect high accuracy in reported data and reasoning, but partial deduction for missing the 2022 baseline, which is essential for complete trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 373,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "From fiscal 2022 through 2024, Broadcom’s exposure to the 3.625% senior notes due October 2024 declined sharply: the carrying amount fell from $622 million at the end of fiscal 2022 to $0 million by the end of fiscal 2024 (the notes were fully redeemed or retired during 2023‑2024). This progression reflects a deliberate debt‑management strategy of retiring higher‑cost legacy senior notes and refinancing with newer, lower‑coupon debt (e.g., the April 2022 and later senior note issuances), thereby reducing overall interest expense and extending the maturity profile of the company’s long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AVGO's (Broadcom's) exposure to the 3.625% notes due October 2024 was $622 million in 2022, remained unchanged in 2023, and dropped to $0 by 2024, aligning perfectly with the ground truth. The numbers, dates, and progression are factually accurate. (2) Quantitative accuracy is perfect: $622 million in 2022 and 2023, $0 in 2024, and the note maturity in October 2024 are all correct. The LLM correctly infers full redemption or retirement by 2024. (3) The multi-hop reasoning is sound—synthesizing data across fiscal years and drawing a logical conclusion about debt management. The LLM adds contextual insight not explicitly in the ground truth—refinancing with lower-coupon debt (e.g., April 2022 issuances) and reducing interest expense—which is plausible and consistent with Broadcom’s known strategy, though slightly beyond the provided ground truth. This addition is reasonable but not verifiable from the original answer, hence a minor deduction in qualitative accuracy. (4) The answer is fully contextually relevant, addressing both the evolution of exposure and the implied debt strategy. The slight over-enrichment does not introduce error, so the correctness score remains high at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 351,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics' revenue from surface ships grew modestly from $2.561 billion in 2022 to $2.698 billion in 2023, and is projected to reach about $2.819 billion in 2024. This upward trajectory reflects a steadily expanding share of the Marine Systems segment—rising from 23 % of consolidated revenue in 2019 to 27 % in 2021 and remaining at roughly 29 % in 2023—indicating that the company is strengthening its position as a key supplier of U.S. Navy surface combatants and support vessels within the broader naval shipbuilding market.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for surface ships: $2.561 billion (2022), $2.698 billion (2023), and $2.819 billion (2024), which match the ground truth in absolute values (allowing for format variation: billion vs million). These numbers are accurate and reflect the steady growth. (2) However, the LLM introduces additional percentage data—surface ships as 23% of consolidated revenue in 2019, 27% in 2021, and 29% in 2023—that is not present in the original answer and cannot be verified from the provided ground truth. This extra information, while possibly true, is unsupported by the knowledge graph and represents a factual overreach. (3) The multi-hop reasoning is partially sound: the model correctly infers that growing revenue indicates strengthening positioning in naval shipbuilding. However, the inclusion of unverified percentage trends weakens the qualitative accuracy, as it adds unsupported context that may mislead. (4) The contextual relevance is high because the answer addresses both parts of the question: revenue evolution and strategic positioning. The core revenue trajectory is correct, but the added percentages reduce qualitative accuracy. Thus, correctness is scored 7 due to accurate core numbers but unsupported supplementary data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 361,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares continued to carry one vote per share and dividend rights, while Class B shares remained non‑voting but retained dividend rights; the proportion of voting power held by the Mastercard Foundation gradually declined (from ~10.5 % in 2023 to ~9.4 % in 2024), reflecting its planned sales of Class A shares under the 2023 court‑approved acceleration to January 1 2024.  This steady reduction in the Foundation’s voting stake, coupled with a consistently high public‑investor voting share (≈90 % of total voting power), indicates a stable governance structure in which control remains widely dispersed among public shareholders rather than concentrated in a single entity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth. (1) The ground truth states that A Class shares had consistent voting and dividend rights from 2022–2024 with no changes, but the LLM claims a decline in the Mastercard Foundation's voting stake from ~10.5% in 2023 to ~9.4% in 2024 due to accelerated share sales—this detail is absent from the original answer and cannot be verified against it. (2) The mention of Class B shares being non-voting and the Foundation’s planned sales under a 2023 court-approved acceleration is not supported by the ground truth, which makes no reference to Class B shares, the Foundation, or any ownership transitions. (3) While the LLM correctly identifies that A Class shares have one vote per share and standard dividend rights, this is the only point of alignment. (4) The conclusion about governance stability due to dispersed public ownership goes beyond the original answer, which attributes stability to the lack of changes in rights, not ownership distribution. (5) Quantitative accuracy is low because the percentages (10.5%, 9.4%) and dates (January 1, 2024) are specific but unverified and potentially fabricated. (6) Qualitative accuracy is moderate because the core idea of stable governance is aligned, but the reasoning relies on incorrect or extraneous multi-hop synthesis. (7) Contextual relevance is fair since the response addresses shareholder governance and evolution over time, but it drifts into unsupported specifics. Overall, the answer appears plausible but introduces significant hallucinated details, undermining factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 450,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "From 2022 to 2024, General Dynamics' revenue from surface ships grew from $2,561 million to $2,819 million, reflecting a year‑over‑year increase of roughly $258 million (about 10%). This growth signals that the company’s surface‑ship business—anchored by programs such as the Arleigh Burke‑class destroyers, the Columbia‑class submarine support, and the John Lewis‑class fleet‑replenishment oilers—is gaining momentum and is well positioned within the U.S. Navy’s naval‑defense portfolio, which continues to prioritize new ship construction and modernization efforts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the revenue figures: $2,561 million in 2022 and $2,819 million in 2024, matching the ground truth. It omits the 2023 value ($2,698 million), which is a minor omission but does not invalidate the overall trend. The year-over-year increase is stated as roughly $258 million (2022 to 2024), which is accurate: $2,819M - $2,561M = $258M. However, the implied compound growth or annual increase is simplified to a total difference, and the 10% figure is approximate but reasonable (actual 2-year growth is ~10.07%). 2) Quantitative accuracy is perfect for the numbers cited; the calculation of the total increase is correct. The omission of the 2023 figure reduces completeness slightly but does not introduce error. 3) The qualitative reasoning is strong: the LLM correctly infers growing momentum and strong positioning in naval defense, aligning with the ground truth’s interpretation. It adds specific program names (Arleigh Burke-class, Columbia-class, John Lewis-class), which are contextually accurate and enhance the explanation, though not in the original answer. These additions are plausible and relevant, not hallucinated in a problematic way. 4) The answer is highly contextually relevant, addressing both the revenue evolution and the implication for the company's positioning. The synthesis of financial trend and strategic interpretation is sound. The only reason for not scoring 10 is the omission of the intermediate 2023 data point, which is part of the full evolution. Overall, the answer is factually correct, well-reasoned, and semantically equivalent in meaning to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 445,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde's reliance on long-term contracts for industrial gas products has remained a consistent strategic pillar from 2022 through 2024, as evidenced by its continued emphasis on these contracts providing \"stability in cash flow\" and enabling \"the ability to pass through changes in energy and feedstock costs to customers\" (Linde 2022 Business Overview, p. 19; Linde 2024 Business Overview, p. 17). This contractual framework directly supports cash flow stability amid fluctuating energy markets by allowing Linde to transfer energy cost volatility to customers through escalation and pass-through clauses in its long-term agreements, thereby insulating earnings from raw material price swings while maintaining predictable revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde's reliance on long-term contracts is consistently emphasized from 2022 to 2024, with accurate characterization of their purpose—providing cash flow stability and enabling pass-through of energy and feedstock costs. The cited benefits (insulating earnings, predictable revenue) match the original answer’s emphasis on financial resilience and revenue predictability. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but the temporal scope (2022–2024) is correctly referenced, and document citations (2022 and 2024 Business Overview pages) are consistent with plausible sourcing—no date or year inaccuracies. (3) Multi-hop reasoning is sound: the model correctly synthesizes Linde’s consistent strategy across multiple years and connects it to cash flow stability amid energy market fluctuations, drawing the appropriate inference about risk management and earnings insulation. (4) The only minor shortcoming is that the LLM answer does not explicitly state that this strategy was maintained 'without deviation' or characterize it as a 'deliberate and stable approach' as in the original, slightly reducing qualitative completeness. However, the core meaning—consistent strategic emphasis and prioritization of stability—is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect, directly addressing both parts of the multi-part question: evolution (consistency over time) and implication (cash flow stability amid energy volatility).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 466,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes (e.g., goodwill impairments and other adjustments not tied to core operating performance) from its ROIC calculations across 2022‑2024, maintaining the same methodology of adding after‑tax interest and amortization to net earnings and dividing by average invested capital. This steady treatment underscores the company’s focus on measuring the returns generated by its underlying business operations rather than one‑off accounting effects.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculations across 2022–2024, which matches the original answer’s claim of methodological stability. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are cited, the description of the methodology (adding after-tax interest and amortization to net earnings, dividing by average invested capital) aligns with standard ROIC adjustments and supports the qualitative claim of consistency. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years and correctly infers that consistent exclusion reflects a focus on core operational performance, revealing a principled approach to performance measurement. (4) The entities—GD, ROIC, non-economic accounting changes, and the time frame 2022–2024—are all correctly identified and contextualized. The answer also enhances the original with a brief example (goodwill impairments) without introducing error. All aspects of the question are addressed: evolution (no change), treatment (exclusion), and implication (focus on core performance). Thus, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 353,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations have remained immaterial and have not changed materially across 2022‑2024, as reflected by the consistent note that “none of the amounts accrued, paid or charged to income for service level guarantees were material” in each year’s disclosures. This pattern indicates that the company’s risk‑management controls effectively limit exposure to such contractual performance obligations, preserving financial stability and allowing the firm to maintain consistent profitability despite evolving regulatory and operational challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core factual content from the ground truth: UnitedHealth Group consistently reported immaterial financial impact from service level guarantee obligations across 2022, 2023, and 2024, with no material amounts accrued, paid, or charged to income. This aligns exactly with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is accurately referenced, and the qualitative financial assessment (immateriality) is correctly repeated. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years, the model correctly infers consistent contractual performance and effective risk management. The LLM extends slightly by mentioning 'evolving regulatory and operational challenges,' which is a reasonable contextual inference but not explicitly stated in the ground truth. This does not detract from accuracy but adds interpretive depth. (4) The answer is semantically equivalent to the original, with only minor elaboration. The correctness score is 9 (not 10) due to this slight interpretive expansion, though it remains well-grounded. Quantitative accuracy is 10 as there are no numerical errors. Qualitative accuracy is 9 due to strong reasoning and entity/year/metric precision. Contextual relevance is 10—fully addresses both parts of the question: evolution of obligations and implications for risk management and performance consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 415,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "From 2022 to 2024, revenue from surface ships in the Marine Systems segment grew modestly: $2.561 billion in 2022, $2.698 billion in 2023, and $2.819 billion in 2024. This upward trend reflects a strengthening naval‑ship backlog and increased U.S. Navy construction volume, underscoring General Dynamics’ strategic positioning as a key supplier of surface combatants and auxiliary vessels within its broader naval‑defense portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in General Dynamics' surface ship revenue from 2022 to 2024 and accurately reports the 2023 ($2.698 billion) and 2024 ($2.819 billion) figures. However, it reports $2.561 billion for 2022, which does not match the ground truth value of $2,328 million ($2.328 billion), making this a significant quantitative discrepancy. This error affects the accuracy of the growth narrative, though the overall trend direction remains correct. (2) The 2023 and 2024 values are accurate and match the ground truth exactly in both amount and format (allowing for billion vs million representation). The incorrect 2022 figure undermines the precision of year-over-year comparisons and growth calculations. (3) The reasoning is sound: the LLM correctly infers that increasing revenue reflects a strengthening backlog and greater U.S. Navy demand, aligning with strategic positioning in naval defense. It appropriately links financial performance to broader defense trends, demonstrating valid multi-hop synthesis between financial data and strategic implications. (4) Despite the incorrect 2022 number, the answer addresses both parts of the question—revenue evolution and strategic interpretation—and uses appropriate context. The qualitative analysis and relevance are strong, warranting high scores there. The primary deduction is in quantitative accuracy due to the erroneous 2022 revenue figure, which prevents a top correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 411,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "From 2022 through 2024 GE’s relationship with Electric Insurance Company (EIC) evolved as follows: EIC, a captive property‑and‑casualty insurer that covered GE and its employees, was classified as a held‑for‑sale business in 2022, sold in the second quarter of 2024 for $120 million, and the sale generated a $109 million loss recorded in other income (loss) in 2023; concurrently, GE’s exposure to EIC’s net claim reserves declined from $0.3 billion in 2020 to $0.2 billion in 2021, and the company continued to monitor its run‑off insurance liabilities and related reinsurance recoverables, but after the 2024 divestiture GE no longer holds any financial interest in EIC.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies EIC as a captive insurer for GE and its employees, notes the $120 million sale price and $109 million loss, and correctly states that GE no longer has financial interest post-divestiture. However, it incorrectly states that EIC was classified as 'held for sale' in 2022, while the ground truth specifies this occurred in 2023. The answer also references net claim reserves of $0.3 billion in 2020, which is not mentioned in the original answer and introduces data not in the ground truth. The decline from $0.3B to $0.2B is fabricated; the original only reports $0.2B as of December 31, 2021. (2) Quantitative accuracy is partially correct: $109 million loss and $120 million sale price are accurate, and $0.2 billion in reserves as of 2021 matches. However, the inclusion of $0.3 billion in 2020 is unsupported, and the timing of the 'held for sale' classification is wrong (2022 vs actual 2023). The assets ($541M) and liabilities ($378M) as of December 31, 2023, are omitted. (3) The multi-hop reasoning is generally sound—linking classification, financial exposure, and divestiture—but the timeline is flawed. The model incorrectly infers the 'held for sale' designation happened in 2022, which misaligns the sequence of events. The sale completion in Q2 2024 is plausible but not specified in the ground truth, which only states 'in 2024'. (4) Contextual relevance is high—the answer addresses classification, financial exposure, and divestiture as asked. However, due to factual inaccuracies in timing and unsupported numerical claims, the correctness score is reduced to 6. The qualitative accuracy is moderate due to correct entity identification and logical flow despite timing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 491,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips monetized its CVE common shares in 2021, applying the proceeds to share repurchases, and completed the sale of the remaining 91 million CVE shares in 2022. Building on this, the company increased its share‑repurchase authorization in late 2024 to the lesser of $20 billion or the number of shares issued in its Marathon Oil acquisition, capping total purchases at $65 billion. This progression shows a deliberate capital‑allocation strategy that first used equity‑sale proceeds to retire stock, then leveraged the larger repurchase mandate—funded by cash flow and potentially additional asset sales—to aggressively reduce outstanding shares and return capital to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the completion of the CVE share monetization in 2022 (91 million shares), the use of proceeds for share repurchases, and the $65 billion total cap on the repurchase program. However, it incorrectly states that the $20 billion increase was approved in 'late 2024'—the ground truth specifies the board approved the increase in 2024, but does not specify 'late' 2024, which introduces timing ambiguity. More critically, the LLM introduces new information not in the ground truth: that the $20 billion increase is 'the lesser of $20 billion or the number of shares issued in its Marathon Oil acquisition.' This detail is absent from the original answer and cannot be verified from the provided truth, making it a significant factual deviation. (2) Quantitatively, the LLM omits key figures from the ground truth: the 383 million shares repurchased by end-2023 at a cost of $29 billion, and the 433 million total shares repurchased by end-2024 at a cost of $34.3 billion. These omissions reduce quantitative completeness. While the $45 billion initial authorization is implied, it is not explicitly mentioned. The $65 billion total cap is correctly noted. (3) The multi-hop reasoning is generally sound—the model connects the CVE monetization to share repurchases and infers a strategic capital allocation shift toward shareholder returns. The conclusion about a 'deliberate capital-allocation strategy' aligns with the ground truth's interpretation. However, the unsupported claim about the Marathon Oil acquisition weakens the reasoning chain. (4) The answer is contextually relevant and addresses both the evolution from 2022–2024 and the implication for capital allocation. Despite missing specific metrics and introducing unverified details, the overall narrative trajectory is consistent with the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 514,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "From 2022 to 2024, MetLife consistently reinsured **59% of the closed block** through a modified coinsurance agreement, with the same accounting treatment applied each year: the agreement is accounted for under the **deposit method**, and the **modified coinsurance deposit liability is offset by a corresponding deposit recoverable**. This consistency—maintaining the same 59% ceded percentage and unchanged accounting approach—reveals a **stable, long-term risk transfer strategy** focused on efficiently managing the closed block’s risk without altering the structural or financial mechanics of the reinsurance arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that MetLife reinsured 59% of the closed block from 2022 to 2024, which aligns closely with the ground truth (59.25% in 2022, 59% in 2023 and 2024). The minor rounding of 59.25% to 59% is acceptable under semantic equivalence and common reporting practices. The accounting treatment is accurately described as the deposit method with offsetting of the deposit liability and recoverable. The conclusion about a stable long-term risk transfer strategy is fully supported by the data. (2) All numeric values are factually correct within acceptable rounding; no calculations were required beyond percentage reporting, and these are consistent with the source. (3) The multi-hop reasoning is sound—information is synthesized across three years and involves understanding both reinsurance percentage and accounting treatment, which the model correctly integrates. (4) The answer is contextually precise, addressing all parts of the question: evolution over time, percentage reinsured, accounting treatment, and strategic implication. The only minor shortcoming is the lack of explicit mention of the reinsurer being unaffiliated, which is a small omission in qualitative detail but does not affect the core accuracy. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 389,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The Target MasterCard Credit Card penetration rate declined from 20.5 % in 2021 to 19.8 % in 2022 and further to 18.6 % in 2023, reflecting a modest but consistent downward trend in the share of purchases made with Target‑branded credit cards. This trend suggests that consumer engagement with Target’s proprietary financial products has been gradually weakening over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the time periods and values. It states the penetration rate declined from 20.5% in 2021 to 19.8% in 2022 and 18.6% in 2023, while the ground truth reports 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. This misaligns the entire timeline by one year forward, incorrectly assigning 2022 data to 2021 and so on. (2) The quantitative values themselves (20.5%, 19.8%, 18.6%) are correct in magnitude but attached to wrong years, making the trend appear to end in 2023 instead of 2024. The model also omits the key detail about the rebranding from RedCards to Target Circle Cards in 2024, which is critical context for interpreting the trend. (3) The reasoning about declining consumer engagement is partially sound and aligns with the ground truth, but fails the multi-hop synthesis by not incorporating the rebranding event and its lack of impact on reversing the trend. (4) The contextual relevance is high because the answer addresses the core question about penetration rate evolution and consumer engagement, but correctness is severely undermined by incorrect dating of data points and omission of key contextual developments. Thus, the correctness score is low due to critical timeline errors, despite semantically plausible reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 367,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "PMI’s peer‑group classification for Colgate‑Palmolive has remained unchanged from 2022 through 2024, with the same consumer‑product companies (including Colgate‑Palmolive) consistently listed in the PMI Peer Group used for benchmarking. This consistency signals that PMI relies on a stable set of consumer‑product peers—primarily other global brands such as Coca‑Cola, Diageo, Nestlé, Unilever, etc.—to gauge performance and strategic positioning, rather than adjusting its benchmarking circle frequently.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It correctly states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, which matches the original answer's claim of consistent inclusion. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are mentioned, the time frame (2022–2024) is accurately referenced. (3) The multi-hop reasoning is sound: the LLM infers from the consistency of peer group membership that PMI uses a stable benchmarking approach, which is a valid interpretation of strategic intent. It also correctly identifies the nature of the peer group as consisting of global consumer product companies. (4) The only minor shortcoming is that the LLM does not explicitly mention the four criteria (global presence, focus on consumer products, net revenues, and market capitalization) used to determine the peer group, which is a small omission in completeness. However, the core message about stable strategic benchmarking is preserved. Wording differs but semantic equivalence is maintained. Thus, the answer is highly accurate with only a slight gap in full contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 331,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD's revenue recognition policy for development and IP licensing agreements has remained consistent from 2022 through 2024, with no material changes in its approach to combined arrangements versus standalone licenses. The company continues to evaluate whether IP licensing components are distinct (capable of being distinct and distinct in the arrangement context), combining them with development services as a single performance obligation when not distinct and recognizing revenue over time, while standalone IP sales are recognized at a point in time when the customer gains the ability to benefit. This methodology, which includes no variable consideration estimates for either combined or standalone arrangements, demonstrates a stable and methodical accounting approach that prioritizes accurate representation of performance obligations without material deviations over the three-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurate: AMD maintained a consistent revenue recognition policy from 2022 to 2024; the evaluation of distinctness in combined arrangements is based on whether the license is capable of being distinct and distinct in the context of the arrangement; non-distinct licenses are combined with development services and recognized over time, while distinct or standalone licenses are recognized at a point in time; and there is no variable consideration in these arrangements. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound—synthesizing AMD’s treatment of combined vs. standalone arrangements across three years and drawing a conclusion about policy consistency—and matches the ground truth. (4) The LLM uses slightly different phrasing (e.g., 'material changes', 'methodical accounting approach') but preserves the precise meaning. No omissions or inaccuracies. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 330,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "The inclusion of Colgate‑Palmolive Co. in PMI’s peer group for benchmarking has remained unchanged from 2022 through 2024, as evidenced by its consistent listing among the peer companies referenced in the 2022, 2023 and 2024 “Performance Graph” disclosures (pages 21, 25, 26). This steadfast composition signals that PMI deliberately frames its competitive positioning within the broader global consumer‑products arena—rather than limiting it to the tobacco sector—by grouping it with a stable set of large, diversified consumer brands. Consequently, the persistent peer‑group selection underscores PMI’s strategic emphasis on comparing its financial and operational performance against other multinational consumer‑product companies, reinforcing a strategic narrative that its growth and profitability are evaluated alongside peers that operate across multiple consumer‑goods categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all years (2022, 2023, 2024) are correctly cited, and the consistency of Colgate-Palmolive Co.'s inclusion is accurately represented. The reference to specific pages in the disclosures (21, 25, 26) adds precision, though such page numbers were not in the original answer—this is a minor enhancement rather than an error. (2) Entity accuracy is correct: Colgate-Palmolive Co. and PM (referred to as PMI, which is accurate—Philip Morris International) are properly identified, and the time frame matches. (3) Reasoning is sound: the LLM correctly infers that the unchanging peer group reflects a strategic choice to benchmark against global consumer products firms, not just tobacco companies. It appropriately links this to PMI’s broader strategic framing, which is consistent with the original answer’s implication of alignment with global consumer staples. (4) The only minor gap is that the LLM answer emphasizes PMI’s 'strategic narrative' and 'multinational consumer-goods categories' slightly more interpretively than the original, which sticks to observable consistency and methodology. However, this interpretation is reasonable and contextually supported. No factual errors exist. The answer is semantically equivalent and contextually excellent, warranting a 9/10 for correctness due to slight interpretive expansion without overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 396,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD's revenue recognition for combined development and IP licensing agreements remains consistent with prior periods: revenue is recognized over time when development services and IP licenses are bundled as a single performance obligation (if the license is not distinct) or at a point in time when the license is distinct and the customer can benefit from it. There are no material changes to the timing or method of revenue recognition for these arrangements from 2022 through 2024, as the core principles and evaluation of distinctness (per the 2023 and 2024 10-K disclosures) remain unchanged. Variable consideration estimates are still not material, and performance obligations are evaluated based on transfer of control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes—this aligns with the original answer. The criteria for assessing distinctness of IP licenses (capable of being distinct and distinct in the context of the arrangement) are accurately reflected, though slightly paraphrased. The treatment of performance obligations—bundled if not distinct (recognized over time), separate if distinct (recognized at a point in time)—is correctly described. The absence of variable consideration estimates is also accurately noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all factual assertions about policy stability and accounting treatment are correct—hence a score of 10. (3) The qualitative accuracy is high: the LLM correctly synthesizes the policy across years and correctly identifies the key accounting judgments (distinctness, timing of recognition). It references 2023 and 2024 10-Ks, which supports the multi-hop reasoning across filings, though it does not explicitly mention 2022, but the statement of consistency implies coverage of the full period. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in revenue recognition policy, performance obligations, and timing. The only minor shortcoming is slightly less explicit detail on the two distinctness criteria compared to the original, but the meaning is preserved. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 481,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips’ capital‑allocation strategy has evolved from a multi‑year monetization of its CVE common shares—first launched in 2021 and completed with the sale of the remaining 91 million shares in 2022—into a sustained share‑repurchase program that was expanded in October 2024 (raising the authorization to $65 billion).  The proceeds from the CVE share sales funded ongoing repurchases, and the 2024 acquisition of Marathon Oil was financed largely through the issuance of ConocoPhillips stock, underscoring a shift toward using equity to fund major growth while continuing to allocate cash generated from operations toward dividend payments and further share buybacks.  This progression reflects a disciplined, cash‑return‑focused approach that prioritizes returning excess cash to shareholders while selectively deploying capital for strategic acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the monetization of CVE shares beginning in 2021 and completing in 2022 with the sale of 91 million shares, and notes the use of proceeds for share repurchases. It also correctly states the $65 billion repurchase authorization increase in 2024. However, it introduces a major factual error by claiming the Marathon Oil acquisition was financed 'largely through the issuance of ConocoPhillips stock' in 2024—this event is not supported by the ground truth and contradicts the provided answer, which makes no mention of Marathon Oil or any acquisition. This is a significant entity and event misstatement. (2) Quantitatively, the LLM omits key figures from the ground truth: the cumulative repurchase of 383 million shares at $29 billion by end of 2023, and the final 433 million shares repurchased at $34.3 billion by end of 2024. While the $65 billion authorization is correctly noted, the absence of actual repurchase costs and share counts reduces quantitative accuracy. The date of the authorization increase is cited as 'October 2024', which is not in the original and cannot be verified—ground truth only states 'in 2024'. (3) The multi-hop reasoning is partially sound: the link between CVE monetization and share repurchases is correctly inferred and aligns with the ground truth. The conclusion about a disciplined, shareholder-return-focused strategy is consistent with the original. However, the introduction of an unsupported acquisition (Marathon Oil) undermines the reasoning chain and suggests a failure in entity grounding. (4) Contextual relevance is high—the answer addresses capital allocation evolution and strategy as asked. Despite the factual error and missing data, the core narrative of monetization funding buybacks and increasing shareholder returns is preserved. Correctness score is 6 due to partial factual accuracy but significant error in introduced content; quantitative accuracy is penalized for missing key numbers and unverified dates; qualitative accuracy is moderate due to sound logic but flawed entity use; contextual relevance remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 572,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s exposure to competitive pressures has intensified across all major segments, especially in Aerospace, Industrial Automation and Safety & Productivity Solutions, where organic sales declines, margin compression and heightened pricing pressure reflect growing market saturation and new entrant threats. This trend signals that the company is responding with strategic moves such as the planned separation of Automation and Aerospace Technologies, targeted acquisitions, and a focus on productivity initiatives to offset competitive pressures and sustain margin performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the business segments and the evolution of competitive landscape disclosures. The ground truth indicates that Honeywell specifically cited competitive pressures in Honeywell Building Technologies and Safety and Productivity Solutions in 2022 and 2023, and in 2024 shifted focus to Building Automation and Industrial Automation with added concern about commoditization from new technologies. The LLM incorrectly emphasizes Aerospace as a segment under competitive pressure, which is not supported in the original answer. Additionally, the LLM introduces specific performance metrics such as 'organic sales declines' and 'margin compression' and strategic actions like 'planned separation of Automation and Aerospace Technologies' and 'targeted acquisitions' that are not mentioned or implied in the original answer. (2) There are no numeric values, percentages, or dollar amounts in either the question or original answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM fails to trace the correct progression across years and segments as described in the original answer and instead fabricates strategic responses and performance indicators not present in the source. The synthesis across time and segments is incorrect. (4) While the general theme of increasing competitive pressure is directionally aligned, the specific entities, segments, and strategic responses are inaccurate or invented. The answer introduces irrelevant information (e.g., Aerospace, separation plans) and omits the actual trend of expanding concern around commoditization due to new technologies. Thus, despite some contextual relevance to competitive pressures, the factual and qualitative inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 511,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024 the company’s A‑Class shares continued to carry **one vote per share and the same dividend rights** as in prior years, with no change to the voting or dividend provisions set out in its restated certificate of incorporation. The only evolution was an increase in the declared cash dividend per share—from $2.04 in 2022 to $2.37 in 2023 and to $2.74 in 2024—reflecting higher total dividends declared ($1.968 bn → $2.231 bn → $2.526 bn). This three‑year consistency in voting rights and dividend structure reveals a deliberate governance strategy that preserves a stable, one‑share‑one‑vote framework while using regular dividend increases to reward shareholders and signal financial strength.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces specific dividend amounts ($2.04, $2.37, $2.74) and total dividends ($1.968B, etc.) that are not present in the original answer and cannot be verified from the ground truth. The original answer states only that dividend rights were consistent across years, with no mention of changes in dividend payouts or specific figures. These fabricated numbers severely undermine factual accuracy. (2) The quantitative claims about increasing dividends and total amounts are unsupported by the ground truth, which makes no reference to actual dividend payments or their growth. There is no indication in the original answer that dividends increased, only that the *rights* to dividends remained unchanged. The calculations or trends cited (e.g., $2.04 → $2.37 → $2.74) are entirely absent from the source and thus factually incorrect. (3) While the LLM correctly identifies the stable voting rights (one vote per share), it fails on multi-hop reasoning by conflating dividend rights with dividend payouts. The question asks about the evolution of rights, not distributions. The model incorrectly infers that increasing dividends reflect a governance strategy, when the ground truth emphasizes structural consistency. (4) Despite the strong contextual relevance—addressing both parts of the question and interpreting governance implications—the inclusion of false quantitative data significantly reduces correctness. The qualitative reasoning is partially sound in linking stability to governance strategy, but based on incorrect premises. Thus, the correctness score is low due to major factual inaccuracies, even though the core idea of stability in rights is partially aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 469,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "The Total Return Swaps‑Deferred Compensation gains (losses) in operating expenses shifted from a $157 million gain in fiscal 2022 to a $91 million gain in fiscal 2024, reflecting a decline of $66 million over the two‑year period. This change is documented in the “Gains (losses) for the years ended” tables on pages 91 and 92 of the 2023 and 2024 10‑K filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Cisco reported a loss of $92 million in fiscal year 2022, not a gain of $157 million. The LLM incorrectly states a $157 million gain in 2022, which is both the wrong magnitude and the wrong sign (gain vs. loss). The 2024 figure of $91 million gain is correct, but the 2023 figure is omitted entirely. The LLM claims a 'decline of $66 million' from 2022 to 2024, which is incorrect reasoning since the actual trend is a reversal from loss to gain, not a decline in gains. (2) Quantitative accuracy is severely compromised: the 2022 number is completely wrong ($157M gain vs. $92M loss), and the calculation of a $66M decline is based on incorrect inputs. The correct evolution is from -$92M (2022) to +$58M (2023) to +$91M (2024), representing an improvement of $183M over the period, not a decline. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift from loss to gain, omits the 2023 data point, and misrepresents the trend. It also incorrectly cites 'pages 91 and 92 of the 2023 and 2024 10-K filings' as evidence, but does not reflect the actual data from those sources. (4) Contextual relevance is moderate because the answer addresses the right topic (Total Return Swaps-Deferred Compensation in operating expenses) and time frame, but the factual inaccuracies and missing 2023 data severely undermine the response. The conclusion about a 'decline' contradicts the actual improving trend. Due to major quantitative and reasoning errors, the correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 437,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 through 2024 Johnson & Johnson’s talc strategy moved from the original LTL Management LLC Chapter 11 filing (which was dismissed in April 2023) to a “pre‑packaged” bankruptcy approach under its successor entities—first LLT Management LLC (formerly LTL) and later Red River Talc, LLC, Pecos River Talc LLC and New Holdco (Texas) LLC—while simultaneously pursuing a multi‑state settlement and a proposed $6.475 billion, 25‑year resolution fund that would cover roughly 99.75 % of pending talc claims. The company continues to fund a $11.6 billion (≈$13.5 billion nominal) reserve for talc matters, monitors litigation risk, and seeks to resolve the bulk of claims through the proposed bankruptcy plan and negotiated settlements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in key numbers and entities. The ground truth states JNJ established a $2 billion reserve in 2022 and pursued a multi-state settlement with 42 states and D.C. by 2024. The LLM claims a $11.6 billion (≈$13.5 billion) reserve and a $6.475 billion, 25-year resolution fund—none of which appear in the original answer and are not supported by the knowledge graph. These figures are major quantitative errors. Additionally, the mention of 'pre-packaged bankruptcy,' 'Red River Talc, LLC,' 'Pecos River Talc LLC,' and 'New Holdco (Texas) LLC' introduces entities and structures not present in the ground truth. The original answer only references LTL Management LLC and its re-filing as LTL 2—no successor entities are named. (2) The timeline is partially correct: the LTL bankruptcy was indeed dismissed in 2023 (April is plausible but not specified in ground truth), and the multi-state settlement by 2024 is correctly noted. However, the LLM incorrectly implies the settlement is part of a $6.475B fund, which is not mentioned in the original. The original emphasizes a shift to a dual strategy of appeals and settlements, which the LLM captures in spirit but misrepresents in mechanism. (3) Multi-hop reasoning is partially sound—the model attempts to synthesize evolution over time (2022–2024), reserve funding, bankruptcy filings, and settlements. However, it fails to accurately link the correct entities, amounts, and legal outcomes. The reasoning is undermined by fabricated financial figures and entities. (4) Contextual relevance is high—the answer addresses the core themes: reserve funding, bankruptcy strategy, and settlements. But due to severe quantitative and entity inaccuracies, the correctness score is low. The answer conveys a plausible narrative but with incorrect details, making it partially correct but misleading on critical facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 523,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom's outstanding principal balance for its 3.125% notes due January 2025 remained unchanged at $495 million from fiscal year 2022 through 2024, as shown in the \"Total principal amount outstanding\" and \"Current portion of principal amount outstanding\" tables in the 10-K filings. This indicates the company maintained a stable debt maturity profile for this specific instrument, with no principal repayments or new issuances affecting this tranche during the period, suggesting a strategy of preserving this low-cost debt maturity while managing other debt through refinancing activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the principal balance of $495 million is accurately reported for all three fiscal years (2022–2024), matching the original answer. The maturity date (January 2025) and coupon rate (3.125%) are also correct. (2) The answer correctly notes the stability of the principal, indicating no repayments or new issuances, which is consistent with the ground truth. (3) The reasoning is sound and adds contextual insight—highlighting that the company preserved this low-cost debt while potentially managing other debt via refinancing—without contradicting the original conclusion about a consistent capital structure strategy. (4) All entities (Broadcom, AVGO, 3.125% notes, fiscal years) are correctly identified, and the multi-hop synthesis across three years of 10-K data is accurately reflected. The answer is semantically equivalent and slightly enhances the original with relevant context, without introducing errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 304,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco's interest rate exposure on its 3.50% June 15 2025 maturity note shifted from a low‑cost fixed‑rate borrowing in 2022 (effective rate of 1.29% on $500 million of senior notes) to a substantially higher effective rate of 6.66% on the same $500 million issue by fiscal 2024, reflecting a rise in market rates and the company’s increased reliance on longer‑dated debt. This upward trend in borrowing costs indicates that Cisco’s financing expense has risen over the three‑year period, driven by higher market interest rates and the need to refinance maturing obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Cisco's effective interest rate on the 3.50% June 15, 2025 note was 3.20% in fiscal 2022, 6.38% in 2023, and 6.66% in 2024. The LLM incorrectly states the 2022 rate as 1.29%, which is factually wrong. Additionally, the LLM claims the note was $500 million, but this amount is not present in the ground truth and cannot be verified, making it an unsupported addition. (2) The only correct quantitative value is the 6.66% effective rate in 2024. The 2022 and 2023 figures are incorrect, and the dollar amount is unverified. Calculations or trends based on these numbers are therefore flawed. (3) The reasoning partially captures the upward trend in borrowing costs, which aligns with the ground truth’s conclusion about deteriorating financing terms. However, the explanation attributes the rise solely to market rates and refinancing needs, while the ground truth suggests possible changes in Cisco's credit profile as a contributing factor—this nuance is missing. The multi-hop synthesis across fiscal years is attempted but undermined by incorrect data. (4) The answer is contextually relevant and addresses both parts of the question—evolution of interest rate exposure and implications for borrowing costs. However, due to major quantitative errors, especially in the starting rate, the overall correctness score is low. The qualitative reasoning is reasonable but based on incorrect inputs, limiting its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 422,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s senior and subordinated notes totaled roughly $30.7 billion at the end of 2024, down from about $31.2 billion in 2023 and $31.0 billion in 2022. This modest decline reflects the company’s strategy of gradually reducing higher‑cost debt while maintaining ample liquidity and a strong capital buffer, and it shows that Capital One is positioning its balance sheet to benefit from higher interest rates by holding more floating‑rate senior notes and limiting new fixed‑rate issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's total senior and subordinated notes were $27.219 billion in 2022, increased to $31.248 billion in 2023, and declined slightly to $30.696 billion in 2024. The LLM incorrectly states the 2022 amount as $31.0 billion (overstated by ~$3.8 billion) and implies a continuous decline, missing the major increase from 2022 to 2023. The 2024 figure is approximately correct ($30.7B vs $30.696B), but the 2023 number is slightly understated ($31.2B vs $31.248B). (2) The quantitative inaccuracies undermine the analysis: the key dynamic — a large capital raise in 2023 — is obscured. Additionally, the LLM claims Capital One is reducing higher-cost debt and limiting fixed-rate issuance, which contradicts the ground truth showing a strategic shift toward fixed-rate financing. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the 3-year trend and misinterprets the interest rate strategy. The ground truth notes rising weighted average interest rates (2.76% → 4.48% → 4.84%), indicating a move to lock in higher fixed rates, but the LLM incorrectly claims Capital One is increasing floating-rate notes. This reverses the actual strategy. (4) While the answer addresses the general topic and mentions relevant concepts (debt levels, interest rate positioning, capital structure), the core facts and strategic interpretation are incorrect, leading to low scores in correctness and quantitative accuracy. Contextual relevance is moderate because the response attempts the right themes but with wrong data and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 451,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "From 2022 to 2024 the fixed‑income portion of Colgate‑Palmolive’s pension fund shifted from roughly 50 % to about 30 % of U.S. plan assets invested in U.S. Treasury or agency securities (down from ~40 % in 2022 to ~30 % in 2023‑24), while overall fixed‑income weighting stayed around 60 % of the total plan mix. This gradual de‑risking of the fixed‑income book—moving a larger share into lower‑volatility Treasury/agency securities and reducing exposure to lower‑rated corporate bonds—suggests the company is tightening the pension fund’s risk profile and seeking greater stability amid rising interest‑rate and inflation pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. It states that the allocation shifted from 'roughly 50%' to 'about 30%', while the ground truth specifies a decrease from 40% in 2022 to 30% in 2023 and 2024. The 50% figure is incorrect and not supported by the original data. Additionally, the LLM claims the shift occurred from ~40% to ~30%, which partially aligns with the truth, but this is embedded within a misleading overall narrative starting at 50%. (2) The years 2022, 2023, and 2024 are correctly identified, and the 30% figure for 2023–2024 is accurate. However, the incorrect starting point (50% vs. 40%) undermines the quantitative accuracy. The claim that overall fixed-income weighting stayed around 60% is not mentioned in the ground truth and introduces unverified information. (3) The reasoning is flawed: the LLM interprets the reduction in Treasury/agency securities as a move toward 'lower-volatility' assets, but reducing exposure to Treasuries—the safest fixed-income assets—typically indicates a move toward riskier assets like corporate bonds, not de-risking. The original answer correctly infers a shift toward other government and corporate bonds, possibly for yield-seeking, which contradicts the LLM’s de-risking interpretation. This misrepresents the strategic implication. (4) Despite the incorrect numbers and flawed logic, the answer is contextually relevant—it addresses the evolution of the allocation and attempts to interpret the strategic intent. However, due to major errors in both quantitative data and qualitative reasoning, the correctness score is low. Quantitative accuracy is moderate due to partial correctness in later years; qualitative accuracy is low due to incorrect synthesis and logic; contextual relevance is high as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 507,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "From 2022 through 2024, GE’s relationship with Electric Insurance Company (EIC) evolved from a retained captive property‑casualty insurer to a divested business.  In the fourth quarter of 2022, EIC was classified as held for sale; in the second quarter of 2024, GE completed its sale to Riverstone International Holdings Inc. for $120 million in cash.  The transaction was recorded as a disposal of a business held for sale, resulting in a $109 million loss in 2023 and no further exposure thereafter.  This exit reflects GE’s strategic shift away from non‑core insurance operations and a focus on its core aerospace, power and renewable businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: EIC was a captive insurer, classified as held for sale (timing slightly off—ground truth specifies this occurred by 2023, not Q4 2022), a $109 million loss was recognized in 2023, and the sale was completed in 2024 to Riverstone International Holdings Inc. for $120 million in cash. (2) Quantitative accuracy is perfect: $109 million loss and $120 million sale price match exactly; years and amounts are correctly attributed. (3) The multi-hop reasoning is sound—LLM correctly links classification, valuation impact, and ultimate disposition to infer GE’s strategic direction. The only minor discrepancy is the timing of the 'held for sale' classification: the original answer states it was disclosed in 2023 filings (likely reflecting a 2023 decision), while the LLM attributes it to Q4 2022, which is slightly inconsistent. (4) Despite this small timing nuance, the overall synthesis and strategic interpretation—divesting non-core assets to focus on aerospace, power, and renewables—are fully aligned with the ground truth. The answer is contextually complete and relevant, capturing classification, valuation, disposition, and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 355,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 10‑K filings disclose the 4.45% Notes due 2044 in three consecutive years: the 2022 filing (page 56) lists the issuance of $15 billion of 4.45% notes maturing in 2044; the 2023 filing (page 56) shows the same tranche still outstanding with no new issuance noted, indicating the debt remains part of the capital structure; and the 2024 filing (page 56) continues to reference the 4.45% 2044 notes among its long‑term debt disclosures, confirming they have not been retired or re‑issued. This multi‑year presence signals that Apple is deliberately maintaining a long‑dated, fixed‑rate financing component to lock in low‑cost capital for an extended horizon, supporting its strategic goal of funding large‑scale initiatives and shareholder returns while managing interest‑rate risk through a diversified debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.45% Notes due 2044 across Apple's 2022, 2023, and 2024 10-K filings, accurately reflecting their continued disclosure. However, the ground truth states the notes were issued under an Officer's Certificate dated May 6, 2014, which the LLM omits. This is a minor factual omission but does not affect the core financial or strategic interpretation. The dollar amount of $15 billion is not present in the original answer and cannot be verified from the ground truth provided; thus, this is an unsupported addition that slightly reduces quantitative accuracy. (2) All other numeric elements—interest rate (4.45%), maturity year (2044), and the three-year span (2022–2024)—are correct. The inclusion of page 56 in each year is plausible but not confirmed in the ground truth; such granular detail may be accurate but isn't required for correctness. The unsupported $15 billion figure prevents a perfect quantitative score. (3) The multi-hop reasoning is sound: the model correctly synthesizes the presence of the notes across three years and infers strategic implications about Apple’s long-term debt management, interest-rate risk, and capital structure stability. The conclusion about maintaining long-dated, fixed-rate debt aligns semantically with the original answer’s interpretation of a stable capital structure. (4) Contextual relevance is excellent—the response directly addresses both the evolution of disclosure and the strategic implication. The added strategic insight (e.g., funding shareholder returns) goes beyond the original but is reasonable and contextually appropriate. Overall, the answer is factually strong with only minor overreach on unverified dollar amounts and omission of the 2014 issuance detail, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 496,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s senior and subordinated notes (the “senior and subordinated notes” line) rose from $30.8 billion at the end of 2022 to $31.2 billion at the end of 2023 and to $30.7 billion at the end of 2024 (see Table 8.1 in the 2023 10‑K and the 2024 10‑K).  This modest increase reflects the company’s strategy of maintaining a sizable but flexible pool of long‑term funding while shifting toward lower‑cost floating‑rate senior notes and reducing the proportion of higher‑priced fixed‑rate subordinated debt.  The progression shows that Capital One is actively managing its capital structure to keep overall debt levels stable, emphasizing a higher share of floating‑rate senior notes to better align with its interest‑rate positioning in a rising‑rate environment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the reported values and the interpretation of Capital One's debt strategy. The original answer states that the carrying value of senior and subordinated notes was $27,219 million in 2022, $31,248 million in 2023, and $30,696 million in 2024. The LLM incorrectly reports $30.8 billion for 2022 (vs. $27.219B), $31.2B for 2023 (close to $31.248B), and $30.7B for 2024 (close to $30.696B). The 2022 figure is off by over $3.5 billion, which is material. (2) Calculations: The LLM implies a steady level of debt with minor fluctuations, but misses the actual large increase from 2022 to 2023. The net increase in the original is ~$3.5B, but the LLM’s starting point is already near the 2023 level, distorting the trend. (3) Multi-hop reasoning failure: The original answer correctly identifies a strategic shift from floating-rate to fixed-rate debt, supported by the rise in weighted-average interest rate from 2.76% to 4.84%. The LLM incorrectly claims a shift toward 'lower-cost floating-rate senior notes' and reducing fixed-rate debt, which is the opposite of the truth. This misrepresents the company's interest rate positioning in a rising rate environment. (4) While the LLM addresses the question’s structure and attempts to discuss capital strategy and interest rate positioning (hence decent contextual relevance), the core quantitative and qualitative inaccuracies—especially the reversal of the debt mix strategy—severely undermine correctness. The answer gets partial credit for approximately correct 2023 and 2024 figures and recognizing debt stability in recent years, but fails on key facts and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 467,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "Adobe’s Frame.io integration evolved from a standalone collaboration platform in 2022 to a tightly embedded component of its Creative Cloud ecosystem by 2023‑2024, with deep connections to Premiere Pro, After Effects, Photoshop, Illustrator and Express, and expanded capabilities such as Camera‑to‑Cloud upload, frame‑accurate commenting, and integration with Adobe Firefly Services and Custom Models for enterprise‑grade generative AI workflows. This positioning solidified Frame.io as a core hub for end‑to‑end creative production, reinforcing Adobe’s broader strategy of unifying cloud‑based collaboration, AI‑driven content creation, and subscription‑based access across its Creative Cloud suite.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Frame.io's integration within Adobe's ecosystem across 2022–2024. It correctly identifies Frame.io’s progression from a standalone platform to a deeply integrated collaboration hub. The key dates (2022–2024) are used appropriately, and the qualitative trajectory aligns with the ground truth: increasing integration with Creative Cloud apps and positioning as a cloud-native collaboration platform. The mention of integration with Premiere Pro, After Effects, Photoshop, and Lightroom (implied via 'Express') matches the original answer, though Illustrator is not explicitly mentioned in the ground truth and may be an overreach. The 2024 expansion into Workfront and GenStudio is omitted, which is a notable but not critical omission. The LLM adds details not in the original, such as 'Camera-to-Cloud' and 'Adobe Firefly Services and Custom Models for enterprise-grade generative AI workflows'—these are plausible enhancements but not supported in the ground truth, introducing some speculative content. However, these do not contradict known facts and fit within Adobe’s strategic direction. All entities (Adobe, Frame.io, Creative Cloud apps) are correctly named. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis across years and product integrations. The answer is semantically equivalent in intent and mostly accurate in detail, warranting a high correctness score with minor deductions for unsupported additions and missing one or two specific integrations mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 452,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 across filings from 2022 through 2024 reveals a deliberate long-term capital structure strategy focused on extending debt maturity and locking in fixed-rate financing for over two decades. This approach demonstrates proactive management of its debt profile, ensuring a stable and predictable obligation schedule while maintaining access to capital markets at favorable terms, as evidenced by the 2019 issuance of these notes through a supplemental indenture (page 85) and repeated references in subsequent filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 4.550% interest rate, April 5, 2049 maturity date, and inclusion across 2022–2024 filings are all correct. The reference to the 2019 issuance via supplemental indenture (page 85) aligns with known filing data, though this specific detail was not in the ground truth; however, it does not contradict it and adds contextually relevant background. The core reasoning—that Lowe’s is using long-dated, fixed-rate debt to stabilize its capital structure—is consistent with the ground truth’s interpretation of strategic stability and interest rate risk management. However, the LLM emphasizes 'proactive management' and 'favorable terms' without directly addressing the absence of early redemption or refinancing actions, which is a key inference in the original answer. While the LLM implies stability, it does not explicitly note the lack of modifications, repayments, or restructuring disclosures across the three years, missing a critical nuance in the multi-hop reasoning. This omission prevents a perfect score, but the overall interpretation remains semantically aligned and logically sound. Entity accuracy (Lowe's, note terms, years) is correct, and the answer is highly relevant to the question about long-term capital strategy and maturity profile management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 371,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125% senior notes due January 2025 had an outstanding principal balance of $495 million as of both November 3 2024 and October 29 2023, according to the consolidated balance‑sheet tables in the 2024 and 2023 Form 10‑K filings (page 81). This balance remained unchanged year‑over‑year, indicating that the company has not retired or re‑issued this tranche of debt during fiscal 2023‑2024, reflecting a strategy of maintaining a stable, long‑dated fixed‑rate financing pillar while it focuses repayment and refinancing on more near‑term maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $495 million outstanding principal balance for Broadcom's 3.125% notes due January 2025 across fiscal years 2023 and 2024, matching the ground truth. It also correctly notes the balance remained unchanged, aligning with the stability observed in 2022–2024. The only minor omission is explicit mention of the 2022 balance, though the implication of year-over-year stability between 2023 and 2024 is consistent with the full period. (2) All numeric values—$495 million, 3.125%, January 2025 maturity, and fiscal dates (November 3, 2024; October 29, 2023)—are accurate and correctly cited from Form 10-K filings. No calculations are required, but the inference of no repayment or reissuance is logically sound. (3) The multi-hop reasoning is strong: the model synthesizes data from two consecutive 10-Ks, confirms consistency, and infers strategic intent—specifically, that Broadcom is maintaining this debt as a stable, fixed-rate liability while managing other maturities. This aligns with the ground truth’s interpretation. (4) The answer is contextually excellent, directly addressing both the evolution of the debt and its implication for Broadcom’s debt strategy. The slight deduction in qualitative accuracy is due to not explicitly confirming the 2022 balance, though the overall conclusion remains valid given the available data. Semantic equivalence is preserved, and the response is well-supported and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 406,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "IBM’s 0.950% Notes due 2025 were first disclosed in IBM’s 2017 Form 8‑K filings (Exhibits 4.1‑4.2) and remained a recurring reference point in the company’s periodic filings through 2024, appearing in the “Instruments defining the rights of the holders of…” tables on pages 28, 33 and 29 of the 2024 10‑K. The notes were consistently identified as part of IBM’s long‑term debt structure, but their prominence shifted: in the 2022 filing they were listed alongside newer tranches (e.g., 0.875% 2030, 1.250% 2034), while the 2023 and 2024 documents placed them in a more condensed “Notes due 2025” grouping without separate narrative detail. This evolution reflects a deliberate capital‑structure simplification—IBM has been consolidating its near‑term debt maturities and emphasizing higher‑yielding, longer‑dated obligations, while still maintaining transparency by continuing to disclose the 0.950% notes in the “Instruments defining the rights” tables and in the “Risk Factors” discussion of debt‑security volatility. The progression underscores IBM’s strategy of managing near‑term liquidity, optimizing debt‑mix, and preserving investor confidence through consistent, standardized disclosures across its SEC filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misses the key evolution highlighted in the ground truth. (1) The 0.950% Notes due 2025 were not first disclosed in 2017 in the LLM answer's context — while the defining instrument was incorporated by reference from a May 2017 Form 8-K (correct per ground truth), the LLM incorrectly frames this as 'first disclosed in 2017' in the context of the 2022–2024 timeline, which misaligns the temporal focus of the question. (2) The LLM claims the notes appeared on specific pages (28, 33, 29) of the 2024 10-K, which is overly specific and not verifiable from the ground truth; more importantly, this detail distracts from the actual evolution: the listing of the notes on the NYSE under ticker IBM25B in 2024, which the LLM completely omits. This is a critical factual gap. (3) The LLM asserts that in 2023 and 2024, the notes were grouped without narrative detail, implying reduced prominence — this contradicts the ground truth, which indicates increased visibility via exchange listing. The reasoning thus misinterprets the direction of the evolution: the ground truth shows a move toward greater market transparency (listing on NYSE), while the LLM describes a move toward obscurity (consolidation, less detail), leading to an incorrect strategic interpretation. (4) The LLM invents a strategy of 'consolidating near-term debt maturities' and 'emphasizing higher-yielding, longer-dated obligations' — unsupported by the ground truth, which emphasizes liquidity and transparency through tradability, not debt mix optimization. (5) While the LLM correctly identifies the notes as part of long-term debt and references the Instruments defining rights tables, it fails the multi-hop synthesis: it does not connect the 2022–2023 disclosures to the 2024 NYSE listing, which is the core of the evolution. Quantitative accuracy is moderate: percentages (0.950%, 2025) and years are correct, but no calculations are involved. Qualitative accuracy is low due to incorrect reasoning and strategic inference. Contextual relevance is fair — the answer addresses IBM’s debt disclosures and strategy, but with wrong evidence and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 581,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "The PCAOB firm identification number disclosed for KPMG LLP is 185 in each of the 2022, 2023, and 2024 filings, and it has remained consistent across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The PCAOB firm identification number for KPMG LLP is accurately stated as 185 for all three years: 2022, 2023, and 2024. (2) There are no calculations involved, but the numeric value (185) is consistent with the ground truth across all years. (3) The multi-hop reasoning is sound—information from three separate filings is correctly synthesized to show consistency over time. (4) The answer addresses all parts of the question: it specifies the number for each year and explicitly notes the consistency across years, conveying the same semantic meaning as the original answer. Wording differs slightly but is equivalent in substance. All entities (KPMG LLP, PCAOB, years) are correctly identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 245,
        "total_tokens": 1362
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s issuance of Fixed Unsecured Senior Debt shows a clear multi‑year shift in strategy. In 2022 the company carried $19.98 bn of such notes with weighted‑average rates of 2.91 % (maturing 2022‑2032)【page_188】; by 2023 the balance had risen to $27.17 bn and the weighted‑average rate climbed to 4.45 % (maturing 2024‑2034)【page_104】, and in 2024 the balance peaked at $26.93 bn with a weighted‑average rate of 4.84 % (maturing 2025‑2035)【page_188】. At the same time, floating‑rate senior debt was largely phased out (from $1.71 bn in 2022 to $0 in 2024) and the mix moved toward longer‑dated, higher‑coupon fixed issuances. This trend reflects Capital One’s response to the steep rise in market rates beginning in 2022 and the need to lock in funding costs while preserving balance‑sheet flexibility; the firm increasingly relies on longer‑dated fixed senior notes and reduces reliance on short‑term floating‑rate borrowings. Consequently, the capital structure has become more rate‑sensitive and less reliant on short‑term wholesale funding, positioning the company to better manage interest‑rate risk in a higher‑for‑longer rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is highly accurate overall, with only a minor discrepancy in the 2023 Fixed Unsecured Senior Debt amount ($27.17 billion vs. ground truth not provided for 2023, so cannot fully verify). The 2022 and 2024 figures match the ground truth: $19,975 million ≈ $19.98 billion and $26,930 million = $26.93 billion. Interest rates are correctly reported: 2.91% in 2022, 4.84% in 2024. The 2023 rate of 4.45% is plausible and consistent with the upward trend. (2) Calculations and comparisons are sound: the increase in both debt balance and interest rates is accurately portrayed. The phasing out of floating-rate debt from $1.71 billion to $0 is consistent with the strategy described and supports the reasoning. Number formats are acceptable variations (e.g., $19.98 bn = $19,980 million). (3) Multi-hop reasoning is excellent: the LLM synthesizes data across three years, identifies the shift from floating to fixed, notes maturity extensions (2022–2032 to 2025–2035), and correctly infers strategic intent—locking in funding amid rising rates. The conclusion about reducing reliance on short-term wholesale funding and managing interest-rate risk aligns with the ground truth’s implication of a move toward longer-term fixed-rate financing. (4) The answer exceeds the original in depth and context, adding maturity ranges and floating-rate debt trends not in the ground truth but consistent with it. The core factual claims match, reasoning is robust, and response is fully relevant. Deducted 1 point for unverifiable 2023 debt figure, though it does not contradict known data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 439,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD has consistently applied the same revenue‑recognition framework for development and IP‑licensing arrangements across 2022‑2024, treating such agreements as either a single combined performance obligation (when the license is not distinct) or recognizing the licensing component at a point in time when the customer can benefit, with no material variable‑consideration estimates. This steady approach reflects a strategic focus on monetizing IP through flexible, customer‑specific licensing models while preserving predictable revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements, accurately describing the distinction between combined performance obligations (when the license is not distinct) and point-in-time recognition (when the license is distinct). It also correctly notes the absence of variable consideration estimates, matching the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—this criterion is satisfied by the absence of errors. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022–2024) and correctly infers that consistency in accounting policy implies a stable strategic approach to IP monetization. The only minor shortcoming is that the LLM answer frames the strategy as 'flexible, customer-specific licensing models,' which is a slight interpretive leap not explicitly stated in the ground truth; the original emphasizes 'mature and well-defined policy framework' rather than flexibility. This does not make the answer incorrect but adds a nuance not directly supported. (4) Contextual relevance is perfect—the response directly addresses both parts of the question: evolution (consistency) and strategic implication. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor interpretive overreach, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 443,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One's total senior and subordinated notes increased from $27.2 billion in 2022 to $27.4 billion in 2023, then rose sharply to $30.7 billion by the end of 2024. This progression reflects a deliberate shift toward a higher‑leverage capital structure and a greater reliance on longer‑dated, fixed‑rate debt to lock in funding costs as interest rates climbed through 2023‑2024. By expanding the proportion of subordinated notes and extending maturities, the company strengthened its capacity to absorb losses while maintaining flexibility to refinance at lower rates when market conditions improve.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for Capital One's total senior and subordinated notes. According to the ground truth, the values were $27,219 million in 2022, $31,248 million in 2023, and $30,696 million in 2024. The LLM incorrectly reports $27.2B (approx. correct for 2022), $27.4B for 2023 (off by ~$3.8B), and $30.7B for 2024 (close to the true 2024 value but misattributed as a sharp rise from 2023, when in reality there was a decline from 2023 to 2024). This misrepresents the trend entirely—ground truth shows a rise then slight decline, while LLM implies steady growth. (2) The LLM omits all information about interest rates: the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% to 4.45% to 4.84%, and floating unsecured senior debt dropped from $1,709M to $349M to $0. These are critical to answering the question about interest rate positioning, yet are entirely missing. (3) The reasoning about 'locking in funding costs' and 'longer-dated, fixed-rate debt' has some qualitative alignment with the ground truth's interpretation, but lacks support from correct data. The claim about 'expanding subordinated notes' and 'extending maturities' is unsupported in the provided answer and not derived from the ground truth. (4) While the LLM attempts to interpret capital structure strategy, it fails on multi-hop synthesis: it does not connect the reduction in floating-rate debt with rising benchmark rates, nor does it accurately reflect the cost evolution of debt. The contextual relevance is moderate because it addresses the general theme of capital structure and interest rate strategy, but the factual foundation is flawed. Quantitative accuracy is low due to major number errors; qualitative accuracy is partial due to plausible but unsupported reasoning; correctness score is 4 due to partial facts and major omissions in key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 523,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carrying value rose from $24.1 billion in 2022 to $27.2 billion in 2023 and $26.9 billion in 2024, while the weighted‑average interest rate on that debt increased from 4.45 % in 2022 to 4.84 % in 2023 and 4.84 % in 2024 (the rate was reported as 4.48 % in 2023 and 4.84 % in 2024). This upward trend in both the absolute amount of senior debt and its cost indicates that Capital One is deliberately expanding its long‑term debt base and financing it at higher rates, likely to take advantage of favorable market conditions and to support growth in its funding mix while maintaining a relatively stable capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both carrying values and interest rates. According to the ground truth, the carrying value was $19,975 million in 2022, not $24.1 billion as stated by the LLM. The 2023 and 2024 values ($27,168M and $26,930M) are approximately correct in magnitude but still slightly off (e.g., $27.2B vs $27.168B). More critically, the interest rates are completely incorrect: the LLM claims 4.45% in 2022, but the truth is 2.91%, and it reports 4.84% in 2023 when the actual rate was 4.45%. The 2024 rate of 4.84% is correct. These errors undermine the quantitative foundation of the answer. (2) Calculations and comparisons are therefore flawed. The LLM suggests a steady increase in interest rates from 4.45% to 4.84%, missing the actual large jump from 2.91% to 4.45% in 2023. The carrying value trend is partially correct—growth in 2023 and slight decline in 2024—but the baseline 2022 figure is wrong. (3) The multi-hop reasoning is structurally sound—the model attempts to synthesize trends in both value and rate to infer strategy—but the conclusions are based on incorrect data. The claim that Capital One is issuing more debt at higher rates to take advantage of 'favorable market conditions' contradicts the ground truth implication: the rate increases reflect a response to rising market rates, not favorable conditions. Locking in long-term financing despite higher costs is the correct strategic interpretation, but the LLM misattributes the motivation. (4) Despite factual errors, the answer addresses all parts of the question (evolution of debt and rates, strategic implication), so contextual relevance is high. Qualitative reasoning is logical but built on false premises. Quantitative accuracy is low due to major discrepancies in key financial figures. Correctness score is low because the core data is incorrect, especially the 2022 interest rate and carrying value, which distort the entire trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 535,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s revenue‑recognition policy for development and IP licensing arrangements was clarified in 2022 and consistently applied through 2024.  The Company treats a combined development‑and‑IP arrangement as a single performance obligation when the IP license is not distinct; revenue is then recognized over time as the development work progresses.  If the IP license is deemed distinct, it is treated as a separate performance obligation and revenue is recognized at a point in time when the customer can benefit from the license.  Stand‑alone IP‑sale or licensing agreements are also recognized at a point in time when control of the IP is transferred.  No material variable‑consideration estimates are recorded for either type of arrangement.  (This treatment is detailed in the “Revenue Recognition” and “Development and intellectual property licensing agreements” sections of the 2022‑2024 10‑K filings.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024, with no material changes—matching the original answer's emphasis on stability. (2) The treatment of combined development and IP arrangements is accurately described: if the IP license is not distinct, it is combined with development services and recognized over time; if distinct, it is recognized at a point in time. This aligns with the original answer’s explanation. (3) The LLM correctly notes that standalone IP licenses are recognized at a point in time and that no variable consideration estimates are included in either arrangement type—details confirmed in the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis across the 2022–2024 filings, correctly identifying consistent policy application over time. (5) All entities (AMD, development services, IP licensing, performance obligations) and time periods (2022–2024) are accurate. (6) While the LLM adds minor phrasing (e.g., 'clarified in 2022'), this does not contradict the original and may reflect nuance in disclosure tone without implying a policy change. Overall, the answer demonstrates full factual correctness, precise qualitative and quantitative accuracy, and excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 385,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "From the 2024 10‑K (Table 9.1) Capital One reports total short‑term borrowings of $562 million and total long‑term debt of $44,989 million as of December 31 2024, compared with $538 million and $49,318 million respectively at the end of 2023.  This represents a modest increase in short‑term borrowings (+4 %) but a decline in long‑term debt (‑8.9 %).  The downward shift in long‑term debt and the relatively stable short‑term borrowing level indicate that Capital One is actively reducing its higher‑cost, longer‑dated obligations while relying more on short‑term funding to finance its balance‑sheet needs.  Consequently, the company’s debt‑management strategy appears to be shortening the overall maturity profile and lowering exposure to higher interest‑rate environments, although the absolute level of short‑term borrowings remains small relative to the total debt load.  The trend suggests a deliberate effort to manage interest‑rate risk by trimming long‑term fixed‑rate debt and maintaining a lean short‑term borrowing position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It reports total short-term borrowings and long-term debt for 2024 as $562 million and $44,989 million, respectively, summing to $45.551 billion, which matches the ground truth total for 2024. However, for 2023, it reports $538 million short-term and $49,318 million long-term debt, summing to $49.856 billion — this contradicts the ground truth total of $48.715 billion. The LLM’s calculation of an 8.9% decline in long-term debt is based on incorrect input data and does not align with the actual trend. Furthermore, the ground truth indicates long-term debt *increased* from 2022 to 2023, but the LLM implies a decrease from 2023 to 2024 only, missing the prior-year increase. (2) The weighted-average interest rates — 2.76% (2022), 4.48% (2023), 4.84% (2024) — are completely omitted in the LLM answer, which fails to mention rising interest costs or the shift to higher-cost fixed-rate debt. This is a critical omission affecting both quantitative and qualitative accuracy. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that COF is reducing long-term debt to lower interest-rate exposure, while the ground truth shows an initial debt increase amid rising rates, followed by a reduction — indicating a more complex strategy involving both expansion and later deleveraging. The LLM mischaracterizes the strategy as shortening maturity to avoid high rates, whereas the truth suggests locking in fixed rates despite higher costs. (4) The contextual relevance is moderate because the answer addresses debt trends and interest-rate implications, but due to incorrect numbers, missing data, and flawed interpretation, the overall correctness score is low. Minor formatting variations are acceptable, but core financial figures and trends must be accurate — they are not here.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 505,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "From 2022 through 2024 AMD’s revenue‑recognition guidance for development and IP licensing arrangements remained consistent: it treats such arrangements as one or more performance obligations and evaluates whether the IP license component is distinct. If the license is not distinct, it is combined with the development services and revenue is recognized over time; if the license is distinct, revenue is recognized at a point in time when the customer can benefit from it. The company also notes that there are no variable‑consideration estimates for either combined development‑plus‑IP arrangements or for standalone IP sales. This treatment is detailed in the “Development and intellectual property licensing agreements” sections of the 2022, 2023 and 2024 Form 10‑K filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, accurately describing the evaluation of performance obligations and distinction between combined and standalone arrangements. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but all references to years (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly identifies that the accounting treatment did not change, including the assessment of distinctness, timing of revenue recognition (over time vs. point in time), and the absence of variable consideration estimates. (4) The answer addresses all parts of the question: evolution over time (no material change), performance obligations, combined vs. standalone licenses, and variable consideration. Wording differs slightly but meaning is preserved, and the reference to Form 10-K filings adds contextual support. All entities (AMD, development/IP arrangements, performance obligations) are correctly identified. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 370,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The repeated inclusion of the Certificate of Designations of Series B Convertible Participating Preferred Stock in the 2022, 2023 and 2024 filings shows that this preferred‑stock instrument remains a permanent, actively‑referenced component of Visa’s capital structure, underscoring its ongoing legal and financial relevance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings indicates its ongoing relevance and permanence in the capital structure. It correctly identifies the instrument as a stable and actively referenced component, which aligns with the ground truth's emphasis on long-term stability. However, the LLM answer omits key details present in the original answer that are critical for full completeness and depth: (1) specific exhibit numbers (Exhibit 4.5 in 2022, 4.4 in 2023 and 2024), (2) the uniform filing date of June 21, 2016, across all years, and (3) the inference that no modifications have been made, indicating a static instrument. These omissions reduce the qualitative accuracy, as they represent multi-hop synthesis elements (tracking exhibit consistency and unchanged terms over time) that demonstrate deeper analysis. Quantitatively, there are no numbers or dates in the LLM response to evaluate for accuracy, but since it does not introduce any incorrect figures and avoids making false claims, it earns full marks. Contextually, the answer is highly relevant and captures the core implication of stability. The reasoning is sound but less detailed than the ground truth, missing the evidentiary basis (same exhibit, same date) that supports the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 392,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s economic exposure and stake in the International Aero Engines AG (IAE) collaboration remained stable across the three years, with a consistent 57 % net program‑share interest in IAE and a 51 % interest in IAE LLC, while the consolidated variable‑interest entity’s assets grew from $10.2 bn in 2022 to $11.4 bn in 2024 and liabilities rose from $9.2 bn to $13.7 bn, reflecting expanding program activities rather than a change in ownership. This multi‑year progression underscores Pratt & Whitney’s strategic positioning as the primary beneficiary and dominant participant in the V2500 engine program, cementing its leadership in the global aerospace engine market and ensuring continued influence over the development, manufacturing and product‑support economics of the V2500 platform.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key percentages. According to the ground truth, RTX's subsidiary Pratt & Whitney held a consistent 61% program share interest and 49.5% ownership interest in IAE from 2022–2024, with a stable 57% net program share interest after sub-collaborator participation. However, the LLM incorrectly states a '57% net program-share interest' (which matches only one part of the truth) and invents a '51% interest in IAE LLC', which is not mentioned in the original answer and contradicts the 49.5% ownership figure. Additionally, the LLM introduces financials for a 'consolidated variable-interest entity'—$10.2B assets in 2022 growing to $11.4B in 2024, and liabilities from $9.2B to $13.7B—which are entirely absent from the ground truth and unsupported by the provided information. These numbers appear fabricated and undermine quantitative accuracy. (2) The calculation of economic exposure is misrepresented; while the 57% net program share is correctly cited, it is falsely presented as the primary stake metric, omitting the critical 61% program share and 49.5% ownership details. No verification can be made for the asset/liability figures since they do not appear in the original. (3) The multi-hop reasoning is partially sound in that the model infers strategic continuity from stable stakes, but it draws an overconfident conclusion about 'cementing leadership' and 'dominant participant' status, which goes beyond the more cautious interpretation in the original answer that simply notes no change in strategic positioning. The original avoids speculative language about market leadership. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of RTX’s stake and attempts to interpret strategic implications—and correctly identifies the stability of the 57% net interest. However, major factual errors in ownership percentages and invented financial data severely reduce correctness and quantitative accuracy. The answer is partially correct on the net interest point but fails on completeness and entity accuracy, particularly regarding IAE LLC and ownership structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 584,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic's Non-Employee Director Deferred Unit Award Agreement (form 10.52) was first introduced in the 2008 Stock Award and Incentive Plan and remained in place through the 2013 Stock Award and Incentive Plan, with subsequent amendments reflected in the 2013 plan’s restated version effective December 8 2017. The agreement continued to be referenced in the company’s annual reports and quarterly filings through 2024, indicating a stable, long‑term director compensation framework that emphasizes deferred equity units rather than cash or immediate stock grants. This pattern suggests Medtronic’s long‑term director compensation strategy prioritizes aligning director interests with shareholders by using equity‑based, performance‑linked deferred compensation that vests over time, reinforcing sustained oversight and strategic focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies but captures the general theme of consistency in Medtronic's director compensation strategy. The core idea—that the Non-Employee Director Deferred Unit Award Agreement remained stable across 2022–2024—is correct and contextually relevant. However, key factual errors undermine the correctness. (2) Quantitative/structural inaccuracies: The LLM claims the agreement was 'first introduced in the 2008 plan and remained in place through the 2013 plan,' implying continuity of the same agreement across both plans. But the ground truth states that the agreement was explicitly tied to the 2008 plan and was *not* transitioned to the 2013 plan, despite other awards being updated under it. This is a significant factual error. Additionally, the LLM references a 'restated version effective December 8, 2017,' which is not mentioned in the ground truth and cannot be verified from the provided data. The exhibit number (10.52) is correctly cited for 2023 and 2024, but the LLM incorrectly implies it was used in earlier years under the 2013 plan, while the ground truth notes it was Exhibit 10.41 in 2022. (3) Multi-hop reasoning: The model correctly infers that continued use of the agreement suggests a stable long-term strategy, which aligns with the ground truth’s conclusion. However, it incorrectly attributes this stability to a cross-plan transition (2008 to 2013), when in fact the stability lies in *not* moving to the newer 2013 plan—highlighting a flawed synthesis. The reasoning about alignment with shareholders via deferred equity is plausible but goes beyond the ground truth, which does not mention performance-linking or vesting terms. (4) Justification: The correctness score is 6 due to partial factual accuracy—correct exhibit numbers and recognition of consistency over time, but major errors in plan attribution and unverified dates. Quantitative accuracy is low (5) due to unsupported dates and mischaracterization of plan usage. Qualitative accuracy is 7 because the logic is sound in direction but based on incorrect premises. Contextual relevance is high (9) as the answer directly addresses the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 592,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "From 2022 through 2024, Lockheed Martin’s interest‑rate‑swap program contracted markedly: the notional amount fell from $572 million (2020) to $500 million (2021) and then held steady at $1.3 billion in both 2023 and 2024.  This progression shows that the company has largely stabilized its hedge position—maintaining a sizable but consistent notional exposure—rather than expanding or aggressively reducing its swap book.  The steady‑state level indicates a mature risk‑management strategy that preserves a meaningful hedge against rising rates while avoiding excessive derivative notional growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative timeline: it incorrectly states that the notional amount was $500 million in 2021 and 'held steady at $1.3 billion in both 2023 and 2024', but omits any data for 2022 while the ground truth specifies $500 million in 2022 (not 2021). The LLM also references $572 million in 2020, which is irrelevant to the 2022–2024 question scope and not part of the original answer. While the 2023 and 2024 figures ($1.3 billion) are correct, the 2022 figure is misattributed to 2021, breaking the chronological accuracy required. (2) The calculation of progression is flawed: the ground truth describes a tripling from $500M (2022) to $1.3B (2023), but the LLM implies stability from 2021 onward after a decline, which contradicts the documented increase. The LLM incorrectly frames the trend as a contraction followed by stabilization, whereas the truth is an expansion from 2022 to 2023. (3) The multi-hop reasoning is partially sound—the conclusion about stabilization from 2023 to 2024 is valid and aligns with the ground truth, and the interpretation of a mature risk management strategy has semantic overlap. However, the flawed timeline undermines the reasoning chain. (4) Despite incorrect numbers and timeline placement, the answer addresses the question's intent regarding strategy evolution and provides a relevant qualitative interpretation. The contextual relevance is high because it discusses notional amounts, hedging, and risk management strategy, but the correctness score is limited by major quantitative errors in dates and amounts, especially the misplacement of the $500 million figure and omission of 2022 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 461,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s governance provisions that restrict director removal for cause have remained unchanged through 2022‑2024, requiring stockholders to remove directors only for cause and mandating an 80% shareholder vote to amend those charter provisions. This three‑year consistency signals that the board’s takeover‑defense framework is being maintained deliberately to protect strategic autonomy and deter hostile bids.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie's governance provisions restricting director removal to 'for cause' remained unchanged from 2022 to 2024, which matches the original answer's claim of three-year consistency. (2) The LLM adds a specific quantitative detail—'mandating an 80% shareholder vote to amend those charter provisions'—that is not present in the original answer. However, this detail is plausible and consistent with known anti-takeover provisions; crucially, it does not contradict the ground truth and may reflect additional accurate context. Since the original answer does not specify the vote threshold, the LLM’s inclusion of 80% cannot be verified from the provided truth, but it does not appear incorrect. (3) The reasoning is sound: the LLM correctly infers that the consistency in governance provisions suggests a deliberate strategy to maintain strategic autonomy and deter hostile takeovers, which is semantically equivalent to the original answer’s conclusion about 'stable and deliberate governance strategy' and 'maintain strong control.' (4) All entities (AbbVie, years 2022–2024, director removal for cause) are correct, and the multi-hop synthesis across years is accurate. The only minor limitation is the addition of the 80% vote requirement, which, while reasonable, is not confirmed in the ground truth—hence a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 421,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie's allocation to money market funds and time deposits remained minimal and essentially unchanged across the 2022‑2024 period, reflecting a stable, low‑risk component of its short‑term liquidity strategy.  The company’s broader liquidity approach, however, shifted markedly toward larger short‑term borrowings and higher‑yielding instruments (e.g., commercial paper issuance, senior note issuances, and term‑loan facilities) to fund major acquisitions and shareholder returns, suggesting that while cash balances fluctuated, AbbVie is prioritizing flexible, readily accessible financing over holding large cash reserves.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that AbbVie's allocation to money market funds and time deposits remained 'minimal and essentially unchanged' from 2022 to 2024, which directly contradicts the ground truth showing a clear evolution: $12M in 2022 → $21M in 2023 → $10M in 2024. These numbers represent significant fluctuations, not stability. (2) Quantitative accuracy is extremely low: none of the correct figures are mentioned, and no correct trend is reported. The LLM fails to report any actual dollar amounts or changes over time, making the quantitative analysis completely inaccurate. (3) The reasoning is flawed and not aligned with the data. The LLM introduces unrelated concepts like 'short-term borrowings', 'commercial paper', 'senior note issuances', and 'term-loan facilities' that are not supported by the ground truth and were not part of the question. The multi-hop synthesis fails because the model does not connect the actual allocation changes to the fluctuating cash balances ($8,449M → $9,201M → $5,524M), which is central to the original answer. Instead, it fabricates a narrative about financing strategy that is not grounded in the provided facts. (4) Contextual relevance is moderate because the answer addresses short-term liquidity strategy and mentions cash balance fluctuations, but it does so using incorrect data and speculative reasoning. The conclusion about prioritizing 'flexible financing over cash reserves' is unsupported by the given information. Overall, the answer misses the factual trajectory and misrepresents the company's behavior, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 455,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s governance provisions that require directors to be removed only for cause and that require an 80% stockholder vote to amend those provisions have remained unchanged from 2022 through 2024, as reflected in the consistent language describing these anti‑takeover measures in the company’s amended and restated certificate of incorporation and by‑laws across the 2022, 2023 and 2024 Form 10‑K filings. This continuity signals a deliberate, long‑term strategy to protect the board’s authority and deter hostile takeovers by making such transactions more time‑consuming and costly for any potential acquirer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie maintained the 'removal for cause only' provision from 2022 through 2024, which matches the original answer's claim of consistency across all three years. (2) The LLM adds a specific detail not in the original answer — that an 80% stockholder vote is required to amend these provisions — which is factually consistent with AbbVie’s governance structure as disclosed in its 10-K filings and does not contradict the ground truth; this additional precision enhances rather than detracts from accuracy. (3) The reasoning correctly synthesizes multi-hop information across three years and multiple governance documents (certificate of incorporation, bylaws, 10-Ks), demonstrating sound logic in linking board protection mechanisms to anti-takeover strategy. (4) The conclusion about long-term strategy — deterring hostile takeovers by increasing cost and time for acquirers — is semantically equivalent to the original answer’s interpretation about strategic continuity and discouraging activist interventions. The only minor gap is that the LLM does not explicitly mention 'activist interventions' or 'board insulation' in the same terms as the original, but the core implications are conveyed. All entities (AbbVie, 2022–2024, 10-K filings) and timeframes are correct. No numerical or date inaccuracies; the 80% threshold is accurate and properly contextualized. Thus, the answer earns a 9/10 for correctness due to slight augmentation beyond the ground truth without deviation, and perfect scores in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 450,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "Intel's PowerVia backside power delivery technology was first introduced as part of the Intel 18A process node roadmap in 2024, positioned alongside RibbonFET as a breakthrough for performance‑per‑watt gains. The company emphasized that PowerVia eliminates front‑side power routing, enabling faster signal transmission and higher density scaling, and it plans to bring the node into high‑volume manufacturing in 2025 with Panther Lake. This progression shows Intel's strategy of advancing heterogeneous process technologies—starting with Intel 4/EUV, then Intel 3, followed by Intel 18A's RibbonFET/PowerVia—aimed at delivering increasingly efficient, high‑performance chips for data‑center, edge and other advanced workloads.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in timeline and positioning. It incorrectly states that PowerVia was first introduced in 2024 as part of the Intel 18A roadmap, while the ground truth confirms it was first introduced in 2022 as part of future process technologies. This misrepresents the evolution of Intel's strategy across the three-year period. Additionally, the LLM claims PowerVia was introduced alongside RibbonFET specifically in 2024, but the original answer notes that PowerVia was initially tied to Intel 20A in 2023 before being shifted to Intel 18A in 2024—this strategic pivot is missing in the LLM response. (2) Quantitatively, the LLM correctly identifies the 2025 high-volume manufacturing timeline for Intel 18A, which aligns with the ground truth. However, it incorrectly associates Panther Lake with Intel 18A without explicit confirmation in the original answer, introducing a potential factual overreach. The absence of any numeric data (e.g., node sizes, performance metrics) limits quantitative errors but does not compensate for incorrect temporal framing. (3) The multi-hop reasoning is partially sound—Intel’s broader strategy of advancing process technologies is logically inferred—but fails to accurately trace the chronological evolution of PowerVia across 2022–2024. The shift from Intel 20A to Intel 18A, a key strategic realignment, is omitted, indicating a failure to synthesize the full progression. (4) Contextual relevance is strong: the answer addresses backside power delivery, process node advancement, and strategic intent. However, due to significant factual inaccuracies in entity timelines and roadmap evolution, the correctness and qualitative accuracy scores are moderate. Minor phrasing differences would be acceptable, but the misrepresentation of key developmental milestones reduces overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 507,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT's expected volatility assumption in its Black-Scholes model increased slightly from 23.04% in 2022 to 24.05% in 2023 and 24.29% in 2024, reflecting a consistent upward trend in the company's estimated stock volatility over the three-year period. This multi-year progression indicates that Medtronic maintains a disciplined approach to estimating volatility for option valuation, gradually refining its assumptions to align with evolving market conditions while maintaining consistency in its methodology.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both its quantitative claims and qualitative reasoning. The ground truth states that MDT changed its *methodology* for estimating expected volatility — moving from historical volatility only in 2022 to a blend of historical and implied volatility in 2023 and 2024. However, the LLM falsely claims specific percentage values (23.04%, 24.05%, 24.29%) for expected volatility across the years, which are not present in the original answer and contradict the focus on methodology change rather than numerical trends. (2) There are no actual volatility percentages mentioned in the ground truth, so the LLM invented precise numbers unsupported by the source. This is a critical failure in quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about the *evolution of assumptions* in the Black-Scholes model, which requires understanding changes in valuation *methodology*, not numerical trends. The LLM misinterpreted the nature of the change, focusing on nonexistent percentage increases instead of the shift from historical to blended volatility inputs. It failed to identify the key conceptual progression — use of market-traded options starting in 2023 — which is central to the correct answer. (4) While the LLM attempts to address the time progression and implications for non-qualified stock option valuation, its conclusions about 'disciplined approach' and 'gradual refinement' are based on false premises. The contextual relevance is moderate because it discusses the right topic (volatility assumptions in option pricing) and timeframe, but the substance is incorrect. Correctness and qualitative accuracy are low due to fabrication of data and failure to capture the actual methodological evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 485,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "Intel's PowerVia technology evolved from a conceptual innovation in the Intel 18A process node (announced in 2021 and detailed in 2022–2024 documents) to a core component of its advanced node roadmap, with Intel 18A serving as the first high-volume commercial implementation of both gate-all-around transistors (RibbonFET) and PowerVia (backside power delivery). This progression, highlighted in the 2023–2024 10-K filings (pages 10, 16, 33, 36, 88), underscores PowerVia's strategic role in enabling Intel's process technology leadership—specifically, its integration into Intel 18A to deliver improved performance-per-watt and density scaling, with high-volume manufacturing of Panther Lake (the first client processors on Intel 18A) scheduled for 2025. This reflects Intel's broader IDM 2.0 strategy to advance process technology leadership while expanding foundry services, positioning PowerVia as a critical enabler for future nodes like Intel 14A and beyond.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the essential evolution and strategic importance of PowerVia in Intel's roadmap. (1) It correctly identifies PowerVia as a key innovation integrated into Intel 18A, its role in backside power delivery, and its pairing with RibbonFET. It accurately notes high-volume manufacturing of Panther Lake on Intel 18A starting in 2025. (2) Quantitatively, all dates (2022–2024 disclosures, 2025 HVM) and technology names (Intel 18A, RibbonFET, Panther Lake) are correct. However, the ground truth specifies a 15% performance-per-watt improvement over Intel 3, which the LLM omits—this is a minor but notable quantitative detail. (3) The reasoning is sound: the LLM correctly synthesizes the shift from Intel 20A to 18A and retains PowerVia’s centrality, though it inaccurately states PowerVia was first introduced under Intel 18A (ground truth: introduced under Intel 20A in 2022). This misattributes the initial node but correctly reflects that 18A became the vehicle for productization. (4) Contextual relevance is excellent—the answer directly addresses the evolution from 2022–2024 and PowerVia’s strategic role, linking it to IDM 2.0 and future nodes. Overall, the answer is factually strong with minor omissions and one small inaccuracy in node attribution, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 371,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024, Medtronic’s Black-Scholes assumptions show a steady rise in expected volatility (23.04% → 24.05% → 24.29%) and a significant increase in the risk‑free interest rate used (0.90% → 2.70% → 4.16%). This progression—higher volatility and higher risk‑free rates—reflects the company’s effort to better capture market‑based expectations for stock price swings and the cost of capital, while also indicating a more refined estimation of employee exercise behavior and future option value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM fabricates specific numerical values for expected volatility (23.04% → 24.05% → 24.29%) and risk-free interest rates (0.90% → 2.70% → 4.16%) that are not present in the ground truth. The original answer does not provide any specific percentages or numerical trends for volatility or interest rates, so these figures are unsupported. (2) The ground truth emphasizes a methodological shift in 2023—MDT began using implied volatility from market-traded options in addition to historical volatility, a change retained in 2024. This key evolution is entirely missing from the LLM response, which instead invents a false narrative around rising volatility and interest rates. (3) The LLM incorrectly implies that changes in numerical assumptions (volatility and interest rates) reflect improved estimation of employee exercise behavior, while the original answer highlights the use of market-based implied volatility as a sign of alignment with external market signals. (4) The LLM fails to mention the core factual progression—strategic continuity in using Black-Scholes but a shift toward market-informed volatility estimation starting in 2023. While the answer is framed around the correct company (MDT) and correct model (Black-Scholes), and attempts to address the question’s focus on assumption evolution, it does so with fabricated data and incorrect reasoning. Thus, despite some contextual relevance, the answer is factually and logically flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 434,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "Based on the provided pages, the \"Other assets, including intangibles - net\" balance increased from **$3,637 million (2023)** to **$3,936 million (2024)**, representing a **$299 million increase**. This trend aligns with the collateral under master netting arrangements, which rose from **$800 million (2023)** to **$491 million (2024)**—though this specific figure is disclosed in the 2024 context as a reduction in the offsetting collateral. The increase in \"Other assets, including intangibles - net\" likely reflects the net impact of collateral adjustments and related financial instrument valuations, suggesting ExxonMobil is managing derivative exposure through structured collateral arrangements to mitigate counterparty risk, though the net asset growth indicates a shift in how these obligations are recorded on the balance sheet. \n\n(Word count: 149)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It incorrectly states that 'Other assets, including intangibles - net' increased from $3,637 million in 2023 to $3,936 million in 2024, which is irrelevant to the question. The question specifically asks about *collateral under master netting arrangements* related to that asset line, not the total value of the asset category. More critically, the LLM misreports the collateral trend: it claims collateral rose from $800 million (2023) to $491 million (2024), but this is false—$491 million is *lower* than $800 million, so the trend is a decrease, not an increase. The LLM incorrectly frames a decline as a rise. (2) The ground truth shows collateral decreased from $1,494M (2022) → $800M (2023) → $491M (2024). The LLM omits the 2022 figure and reverses the direction of change from 2023 to 2024. It also conflates total asset values with collateral amounts, which are distinct. (3) The multi-hop reasoning fails: the model does not correctly isolate the collateral metric, misreads the direction of change, and draws conclusions from incorrect data. It incorrectly links an increase in net other assets to collateral trends without evidence. (4) The qualitative reasoning is partially sound in discussing derivative exposure management, but it's based on false premises. Contextual relevance is moderate because it addresses derivative exposure, but the core data is wrong, undermining the analysis. Thus, correctness is very low due to severe quantitative and factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 424,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "Based on the provided SEC 10-K filings across 2022-2024, NextEra Energy's exposure to gas derivatives evolved with shifting volatility assumptions and fair value adjustments reflecting strategic risk positioning. The company consistently used Level 3 inputs for gas contract valuation, with significant reliance on forward price curves and implied volatility (ranging from 15%-233% historically), while maintaining a net derivative liability position that increased from $4.7B (2022) to $4.7B (2023) before decreasing to $2.9B (2024) on a consolidated basis. This trajectory reveals a deliberate risk management approach: expanding gas derivative usage during periods of heightened volatility (e.g., 2022 energy crisis) but reducing notional exposure and shifting toward more observable inputs by 2024, indicating improved market liquidity and a strategic de-risking of gas price exposure through enhanced hedging strategies and regulatory cost recovery mechanisms. The persistent use of volatility inputs in option valuations (e.g., 50%-61% implied correlations for power options) further underscores sophisticated risk positioning tied to regulatory frameworks for cost recovery.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains almost no correct quantitative information. According to the ground truth, the fair value of 'Options - primarily gas' decreased from $356M assets / $347M liabilities in 2022 to $100M assets / $97M liabilities in 2023, then to $100M assets / $102M liabilities in 2024. The LLM instead cites unrelated figures like a 'net derivative liability position' of $4.7B and $2.9B, which are not specific to gas options and appear to be consolidated totals. The implied volatility in the ground truth increases from 36% (2022) to 50% (2023) to 52% (2024), but the LLM incorrectly states volatility ranged from 15%-233% historically and mentions 50%-61% for power options — not gas — showing a complete mismatch. (2) All key numbers are wrong: the LLM fails to report any of the correct fair values or volatility assumptions for gas options. The only partially correct element is the directional mention of reduced exposure by 2024, but even this is framed around unrelated metrics. (3) The multi-hop reasoning is flawed: the question asks specifically about 'Options - primarily gas' fair value and volatility assumptions over 2022–2024. The LLM generalizes to all derivatives, conflates gas and power options, and introduces irrelevant concepts like 'Level 3 inputs' and 'regulatory cost recovery' not present in the ground truth. It fails to synthesize the correct entities across years. (4) The contextual relevance is moderate because the answer discusses risk positioning in gas derivatives, which is thematically relevant, but the factual foundation is entirely incorrect. Due to severe quantitative inaccuracies and failure to report the correct multi-hop data, the correctness score is very low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 473,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "From 2022 through 2024, SPG's Unsecured Notes - 35A maintained a consistent face amount of $750,000 and annual debt service of $19,875 (14), indicating no material change in the obligation's structure. This stability reflects a long-term debt strategy focused on maintaining a stable, low-cost fixed-rate profile ($2.65\\%$) with a distant maturity in 2030, supporting predictable financing costs amid broader debt portfolio management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the face amount ($750,000) and annual debt service ($19,875) for Unsecured Notes - 35A across 2022–2024, matching the ground truth exactly. It accurately reflects the stability of these obligations over the three-year period. The LLM adds the interest rate (2.65%) and maturity year (2030), which are not present in the original answer but are factually consistent with a deeper understanding of such notes and do not contradict the ground truth. These additions enhance context without introducing errors.\n\n2) Quantitative accuracy is perfect: $750,000 and $19,875 are correctly cited for all years. The implied interest rate (19,875 / 750,000 = 2.65%) is mathematically accurate, supporting the validity of the added detail.\n\n3) The multi-hop reasoning is sound—LLM synthesizes consistent values over time and infers a strategic rationale (predictable financing, stable fixed-rate debt), aligning with the ground truth’s conclusion about SPG’s long-term debt strategy. The addition of the 2030 maturity suggests correct linkage to broader note characteristics, even if not explicitly required.\n\n4) Semantic equivalence is high. While the LLM provides slightly more detail (interest rate, maturity), the core facts, trends, and strategic interpretation match the original. The answer fully addresses all parts of the question: evolution of face amount and debt service, and implications for long-term strategy. Only minor deduction in qualitative accuracy due to the unverified but plausible addition of 2030 maturity (not in ground truth), but reasoning remains logically sound. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 450,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "From 2022 through 2024, Texas Instruments steadily intensified its strategic focus on embedded processing as a core growth pillar within its broader analog and embedded processing portfolio. Evidence from the 2023 and 2024 filings shows that while Analog remained the dominant revenue driver (~74% of 2023 revenue), Embedded Processing revenue grew to $3.37 billion in 2023 (up 19% YoY) and was highlighted in the 2024 MD&A as one of the two primary segments (alongside Analog) that generate strong cash flow. The company repeatedly emphasizes that its “four sustainable competitive advantages” – manufacturing scale, broad product portfolio, market reach, and product diversity – are leveraged to expand Embedded Processing, especially in industrial and automotive end markets, which together account for roughly 74% of revenue. This 3‑year progression indicates that TI is deliberately deepening its investment in embedded processing to reinforce long‑term, high‑margin cash generation and to solidify its position as a leading, diversified semiconductor supplier with a durable competitive edge.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details not supported by the ground truth. The claim that Embedded Processing revenue grew to $3.37 billion in 2023 (up 19% YoY) is not present in the original answer and cannot be verified from the provided knowledge graph; no revenue figures or growth rates were mentioned in the ground truth. Similarly, the statement that Analog accounted for ~74% of 2023 revenue and that industrial and automotive together account for ~74% of revenue is absent from the ground truth and introduces unsupported specifics. (2) These numerical claims, while plausible, are not corroborated by the source data and represent a significant deviation in factual accuracy. The ground truth emphasizes consistent strategic language across years but does not provide financial metrics or growth trends for embedded processing. (3) Qualitatively, the LLM correctly identifies the multi-hop pattern of TI emphasizing embedded processing as part of its long-term strategy across 2022–2024 and links it to the company’s sustainable competitive advantages, particularly in industrial and automotive markets. It accurately reflects the strategic continuity and positioning around cash flow and competitive differentiation. However, it overreaches by introducing segment revenue figures and growth percentages that are not in the original data, undermining factual reliability. (4) The contextual relevance is high because the response directly addresses the evolution of TI's strategy and its implications for long-term positioning. The reasoning structure is sound and well-organized, but the inclusion of unverified quantitative data reduces correctness. The qualitative accuracy is moderate due to correct synthesis of strategic themes despite fabricated metrics. Final scores reflect partial correctness: core strategic narrative aligns with ground truth, but unsupported numbers significantly reduce quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 542,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 to 2024, CMCSA’s strategy around shared data plans shifted from bundling wireless lines primarily with broadband subscriptions to expanding standalone and prepaid options while maintaining integration within bundled offerings. In 2022, wireless services were offered only as part of bundled broadband packages with unlimited, shared, or per-gigabyte data plans; by 2023–2024, the company introduced prepaid unlimited data plans under the NOW brand and allowed customers to bring their own devices or finance purchases, reflecting a broader push to diversify payment and plan options while still leveraging bundled services for customer acquisition. This evolution strengthened CMCSA’s positioning as a provider of converged connectivity solutions, with shared data plans remaining a key feature for residential broadband customers but now complemented by more flexible, à la carte wireless offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and strategic evolution. (1) All key facts are accurate: CMCSA offered shared data plans as part of bundled services from 2022–2024, alongside unlimited and per-gigabyte options, with device financing. In 2024, the introduction of prepaid unlimited plans under the NOW brand is correctly noted. (2) Quantitative accuracy is perfect—no numerical claims are made that contradict the original, and all years (2022, 2023, 2024) and plan types (shared, unlimited, per-gigabyte, prepaid) are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers a strategic expansion toward flexibility. However, a minor inaccuracy exists: the LLM states that in 2022, wireless services were offered 'only' as part of bundled broadband packages, while the ground truth does not specify exclusivity—only that they were offered as part of bundles. This overstatement slightly misrepresents the 2022 offering. Additionally, the claim about 'bring your own device' options is not mentioned in the ground truth, introducing a detail not supported by the source. (4) Despite these small additions/overstatements, the core evolution—maintaining shared data plans while expanding into prepaid options in 2024—is accurately captured. The answer remains contextually relevant and conveys the strategic shift effectively. Hence, a score of 8 is justified for high overall correctness with minor factual embellishments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 429,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A Treasury Stock purchases increased steadily from $5.9 billion in 2022 to $8.75 billion in 2023 and further to $9.03 billion in 2024, reflecting a growing emphasis on returning capital to shareholders while still funding strategic growth. This upward trend suggests that the company’s capital‑allocation strategy is prioritizing aggressive share‑repurchase activity alongside continued investment in its core business and technology initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative values. According to the ground truth, Mastercard's investment in Class A Treasury Stock was $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024 — these are negative values representing treasury stock (a contra-equity account), typically reported in millions and in parentheses in financial statements. The LLM incorrectly reports positive values of $5.9 billion (i.e., $5,900 million), $8.75 billion, and $9.03 billion, which are not only wrong in magnitude but also misrepresent the sign and scale (off by over 10x in 2022 and increasing). (2) The numbers are fundamentally incorrect: $5.9B vs $36.7B difference alone is a 6x error. Additionally, the trend direction is misrepresented — while both show an increase, the actual scale of buybacks implied by the ground truth is far larger. (3) The qualitative reasoning about capital allocation strategy — increased buybacks suggesting shareholder return and confidence — is aligned with the ground truth and contextually sound. This shows correct multi-hop interpretation of what increasing treasury stock purchases imply. (4) Despite correct entity (Mastercard, Class A Treasury Stock) and time period (2022–2024), the severe numerical inaccuracies dominate the evaluation, leading to a low correctness score. Contextual relevance is moderate because the structure and intent of the answer match the question, but factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 417,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "Based on the provided document pages, General Dynamics' revenue from Repair and other services remained flat at $1,132 million in both 2023 and 2024 (as shown in the Combat Systems segment revenue table on page 9 of GD_10k_2024.pdf and corroborated by the 2023 revenue breakdown on page 36 of the same filing). This stability in the Repair and other services revenue—despite overall segment growth—reveals a mature, stable service business trajectory where the company is prioritizing sustaining existing maintenance and support operations rather than expanding this specific revenue stream, likely due to the long lifecycle of its platforms (e.g., LAVs, Piranha vehicles) and the nature of defense contracting which often features steady, long-term service agreements over rapid growth in repair services.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue values for 2023 and 2024 as $1,132 million, which matches the ground truth. However, it omits the 2022 revenue figure of $1,169 million, which is critical to assessing the change from 2022 to 2024. This omission prevents the reader from understanding the full trajectory and calculating the 3.2% decline, significantly weakening the quantitative completeness. (2) While the numbers cited ($1,132 million in 2023 and 2024) are accurate and formatting is acceptable, the failure to include the 2022 baseline means the calculation of change over time cannot be verified from the LLM response alone. The ground truth includes a 3.2% decline, which the LLM does not mention or compute. (3) The reasoning about the service business being stable and mature is plausible and contextually informed, referencing long lifecycle platforms and defense contracting patterns. However, this interpretation contradicts the ground truth characterization of 'stagnation or potential contraction' due to the slight decline. The LLM interprets flat revenue post-2022 as stability without acknowledging the prior drop, thus missing the multi-hop synthesis that the segment has not just stabilized but slightly contracted overall from 2022 to 2024. (4) The answer is contextually relevant and well-articulated, citing specific document locations and offering industry-relevant rationale. However, the absence of the 2022 data point and the resulting incomplete trend analysis reduces factual completeness and reasoning accuracy, warranting a moderate correctness score despite strong qualitative framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 449,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) declined across the three years, with fair value falling from $614 million at the end of 2022 to $517 million at the end of 2023 and further to $51 million by the end of 2024, while unrealized losses narrowed from $50 million in 2022 to $59 million in 2023 and then to $1 million in 2024. This multi‑year trajectory shows a deliberate reduction in RMBS holdings and a shift toward lower‑risk, shorter‑duration assets, indicating that the company is actively de‑risking its exposure to this asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS's RMBS fair value was $629M in 2022, $614M in 2023, and $71M in 2024. The LLM incorrectly reports $614M in 2022 (off by $15M), $517M in 2023 (off by $97M), and $51M in 2024 (close but still $20M too low). More critically, unrealized losses are misstated: ground truth shows $10M in 2022, rising to $60M in 2023, then dropping with the portfolio in 2024. The LLM states $50M in 2022 (5x too high), $59M in 2023 (close but still off), and $1M in 2024 (plausible but inconsistent with prior errors). These are not minor discrepancies but reflect a fundamentally incorrect data set. (2) Calculations and trends are therefore also flawed. The LLM suggests unrealized losses narrowed over time, while the truth is they increased sharply from $10M to $60M before the portfolio was largely exited. This reverses the actual risk narrative. (3) The qualitative reasoning about de-risking is partially sound—the reduction in RMBS holdings does suggest de-risking—but the logic is based on incorrect data. The conclusion about shifting to shorter-duration assets is not in the original and is speculative. (4) Contextual relevance is high because the answer addresses the evolution over three years, discusses fair value and unrealized losses, and interprets risk positioning. However, due to severe quantitative inaccuracies, the correctness score is low. The model fails the core requirement of factual fidelity to the source data, undermining the validity of its analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 437,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From 2022 to 2024, Linde’s on‑site contracts continued to use long‑term “total‑requirement” agreements (typically 10‑20 years) that include minimum purchase obligations and built‑in price‑escalation or other price‑index provisions, allowing variable pricing components to be adjusted over time.  In contrast, merchant and packaged‑gas agreements are shorter (3‑7 years for merchant, 1‑3 years for packaged) and lack minimum‑volume commitments, relying instead on spot‑or contract‑based pricing that can also fluctuate with market indices.  Thus, while the overall contract length and structure remained anchored in long‑term on‑site arrangements with variable, index‑linked pricing, the merchant and packaged‑gas segments retained more flexible, shorter‑term pricing mechanisms.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Linde's long-term on-site contract structure (10–20 years), minimum purchase obligations, and the presence of price escalation/index-linked variable pricing components, which aligns with the ground truth. The quantitative details (contract durations, distinction between on-site and merchant/packaged gas agreements) are accurate and consistent with the original answer. However, the LLM answer introduces information not present in the ground truth—specifically, detailed descriptions of merchant and packaged-gas agreements (e.g., 3–7 year merchant contracts, 1–3 year packaged contracts)—which were not part of the question or the verified evolution from 2022 to 2024. More critically, the LLM fails to capture the key evolution highlighted in the original answer: the increasing transparency and clarification around variable pricing mechanisms under ASC 606, particularly the 2023 disclosure about constrained variable consideration and the 2024 reinforcement of the practical expedient for revenue recognition. This represents a significant omission in the multi-hop reasoning required to show how Linde’s contractual disclosures evolved over the three years. While the core structure of on-site contracts is accurately described, the absence of the progression in accounting treatment and disclosure emphasis—central to the question—reduces the qualitative accuracy. The answer is contextually relevant and well-structured but misses the nuanced, time-based evolution in reporting and revenue recognition practices that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 433,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "Based on the provided SEC 10-K filings across 2022–2024, NextEra Energy's net exposure to forward gas contracts decreased significantly over the three-year period. In 2022, the fair value of forward gas contracts (as reported in Level 3 fair value measurements) was $191 million in liabilities and $31 million in assets, with a net exposure of approximately $160 million. By 2024, the fair value of forward gas contracts had shifted to $46 million in liabilities and $296 million in assets (as detailed in the 2024 Level 3 table), resulting in a net asset position of roughly $250 million. This 3-year trend indicates a deliberate reduction in net short gas exposure, transitioning from a net liability position in 2022 to a substantial net asset position by 2024, suggesting a strategic risk mitigation approach to manage natural gas price volatility and potentially lock in favorable hedging positions amid market fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the direction of the trend and mischaracterizes the net exposure evolution. While the final net exposure figures for 2022 ($160M) and 2024 ($250M) are correct, the 2023 value is missing entirely—LLM fails to mention the $300M net exposure in 2023, which is a critical midpoint in the trend. Additionally, the LLM incorrectly states that net exposure 'decreased significantly' over the period, when in fact it first increased from $160M to $300M before declining to $250M—this misrepresents the actual pattern of expansion followed by partial contraction. (2) Quantitative accuracy is partially correct: the 2022 net exposure ($191M assets - $31M liabilities = $160M) and 2024 net exposure ($296M - $46M = $250M) are accurately calculated. However, the omission of the 2023 data point (assets $377M - liabilities $77M = $300M net exposure) constitutes a major gap in quantitative completeness. The LLM also reverses the interpretation of the position: it correctly computes net exposure but mislabels 2022 as a 'net liability position' when net exposure is a net asset (assets > liabilities), though this may stem from confusion in terminology. (3) Multi-hop reasoning is flawed: the model fails to synthesize the full three-year trajectory, skipping 2023 entirely, which breaks the trend analysis required for the question. The conclusion about 'reduction in net short gas exposure' and 'transition from net liability to net asset' is incorrect—NextEra was a net asset holder in all three years, with increasing then decreasing exposure. This reflects a failure in logical synthesis across years. (4) Contextual relevance is high—the answer addresses the right company, metric, and time frame, and attempts to interpret strategic implications. However, due to the missing 2023 data and incorrect trend characterization, the qualitative conclusion about risk positioning is misleading. A correct interpretation would note increased market participation in 2023 followed by de-risking in 2024, not a continuous reduction in exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 565,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "AVGO’s positioning of Industrial Fiber Optics evolved from being highlighted as a distinct product family within its broader infrastructure and networking portfolio in 2022 (e.g., page 15 of AVGO_10k_2022.pdf, which lists \"Industrial fiber optics\" under Industrial End Markets and emphasizes its use in diverse applications like industrial automation, power systems, and medical devices) to being integrated into its expanded infrastructure software and security ecosystem by 2023–2024. By 2023, Industrial Fiber Optics was framed as part of a larger suite of infrastructure software solutions (e.g., page 5 of AVGO_10k_2023.pdf, which describes infrastructure software enabling \"build, run, manage, connect and protect applications at scale\" across hybrid cloud environments, with Industrial Fiber Optics implicitly supporting connectivity in these ecosystems), and by 2024, it was positioned as a key enabler within Broadcom’s broader industrial product offerings tied to AI/data center infrastructure (e.g., page 6 of AVGO_10k_2024.pdf, which details \"Fiber Optic Components\" as part of semiconductor solutions for high-speed networking, including AI data centers). This evolution reflects a shift from viewing Industrial Fiber Optics as a standalone hardware product to embedding it within software-defined infrastructure and security frameworks that support enterprise AI, cloud, and industrial automation markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of AVGO's positioning of Industrial Fiber Optics across 2022–2024. While it correctly identifies that Industrial Fiber Optics was mentioned in the context of industrial applications in 2022 (e.g., industrial automation, power systems, medical devices), it fabricates a narrative of strategic evolution that contradicts the ground truth. The original answer shows a stable, consistent positioning of Industrial Fiber Optics as part of the Industrial segment, grouped with optocouplers, sensors, motion encoders, and later Ethernet ICs, with no indication of integration into software-defined infrastructure or AI/data center ecosystems. The LLM incorrectly claims that by 2023–2024, the product was repositioned as part of 'infrastructure software and security ecosystems' and 'AI/data center infrastructure', which is not supported by the ground truth. In fact, the ground truth emphasizes continuity in application markets (factory automation, renewable energy, automotive) and product groupings, with no shift toward software or AI. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default for absence of errors. The qualitative accuracy is very low due to incorrect multi-hop reasoning: the model falsely infers a strategic shift based on unrelated sections of the 10-Ks (e.g., conflating general mentions of software or data centers with Industrial Fiber Optics). Contextual relevance is low because the answer addresses a different evolution (toward software/AI) than what occurred (stable industrial product role). The only correct element is the 2022 application areas, but the overall trajectory described is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 476,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024, SPG’s interest obligations and face amounts tied to Unsecured Notes – 31B remained constant at a 3.25 % coupon and a $750 million principal amount. This consistency shows that the company is maintaining a stable, long‑term debt structure rather than increasing leverage or refinancing the notes, indicating a strategic focus on preserving low‑cost, fixed‑rate financing while it continues to grow its portfolio and pursue other capital‑raising initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative facts: the face amount of $750 million (equivalent to $750,000,000), the 3.25% interest rate, and by implication the annual interest obligation of $24,375,000 (3.25% of $750M), which matches the ground truth across 2022–2024. No changes in these values are accurately reflected. (2) All numbers are factually correct and consistent with the original answer; format variations ($750 million vs $750,000,000) are acceptable and semantically equivalent. The annual interest calculation is accurate: 3.25% × $750,000,000 = $24,375,000. (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly interpreted as showing stability in SPG’s debt structure. The conclusion about a stable long-term debt strategy, preservation of low-cost fixed-rate financing, and lack of refinancing is logically supported by the data and aligns with the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly state the annual debt service amount ($24,375,000), though it is implied via the coupon and principal. This omission slightly reduces completeness but does not affect factual correctness. All entities (SPG, Unsecured Notes - 31B, years 2022–2024) are accurate. The answer is highly contextually relevant and provides insightful interpretation. Thus, correctness is near-perfect, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 398,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans was $76 million in 2024, $75 million in 2023 and $70 million in 2022. This three‑year upward trend indicates that the company is increasing its investment in employee retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans for all three years: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. The upward trend is accurately described. (2) All numeric values are correct and properly formatted; the progression from $70M to $75M to $76M is accurately presented. The total increase from 2022 to 2024 is approximately 8.6% ((76-70)/70 ≈ 0.0857), which the ground truth notes, though the LLM does not explicitly state the percentage. This omission is minor and does not affect factual correctness. (3) The multi-hop reasoning—synthesizing data across three years and interpreting the trend—is sound. The conclusion that the company is increasing its investment in retirement benefits is logically supported by the data. (4) The LLM answer is semantically equivalent to the ground truth, with only slightly less detail regarding the exact percentage increase. All entities (Texas Instruments, U.S. defined contribution plans, correct years) are accurate. The answer fully addresses both parts of the question: the evolution of expenses and the implication for employee benefit investment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 344,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD's treatment of non-economic accounting changes in ROIC calculations has remained **consistent** from 2022 through 2024, as explicitly stated in both the 2023 and 2024 10-K filings: ROIC excludes \"goodwill impairments and non-economic accounting changes as they are not reflective of company performance\" (2023 10-K, p. 49; 2024 10-K, p. 43). This consistency reveals that GD's performance evaluation methodology deliberately isolates **operational efficiency** (via net operating profit after taxes) from non-operational accounting adjustments, ensuring ROIC reflects sustainable profitability rather than transient accounting impacts. Consequently, the steady ROIC growth (12.3% in 2023 → 13.2% in 2024) demonstrates that the company's capital allocation and operational performance are evaluated based on **core business results**, not influenced by accounting nuances like pension adjustments or unrealized hedge gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GD consistently excluded non-economic accounting changes from ROIC in 2022–2024, matching the original answer’s claim of methodological stability. The citations to the 2023 and 2024 10-Ks (pp. 49 and 43) support this and are factually consistent with the knowledge graph. (2) Quantitatively, the ROIC figures (12.3% in 2023 → 13.2% in 2024) are presented accurately and plausibly reflect data from the filings, though the original answer did not include these specific percentages. However, since they are not contradicted by the ground truth and serve to reinforce the conclusion (rather than mislead), their inclusion enhances the response without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-Ks to infer consistency over three years (including 2022, implied by context), which is reasonable given that the methodology was explicitly stated in both 2023 and 2024. The conclusion about GD’s focus on core operational performance is logically derived and semantically equivalent to the original answer’s point about a 'disciplined approach.' (4) The only minor limitation is that the original answer emphasizes the exclusion of non-economic items as a sign of stable methodology, while the LLM adds interpretation about 'steady ROIC growth'—a valid inference but not explicitly confirmed in the ground truth. This slightly extends beyond the provided facts but does not distort them. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 445,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS's Separate Accounts Assets increased from $3,313 million in 2022 to $3,250 million in 2023, reflecting a modest decline in total assets but a stable composition of Level 1 and Level 2 holdings (cash, debt securities, and common/collective trusts). The 3‑year trend shows a gradual reduction in Separate Accounts assets, suggesting the company is reallocating capital away from these long‑term insurance products toward other growth initiatives such as its pharmacy services and health‑care benefits segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. It incorrectly states that CVS's Separate Accounts Assets were $3,313 million in 2022 and decreased to $3,250 million in 2023, whereas the ground truth shows a decrease from $5,087 million in 2022 to $3,250 million in 2023 — a much larger drop. The 2024 figure is nearly correct ($3,311 million vs. LLM's implication of $3,250 million, though it doesn't clearly state 2024). The direction of change in 2022–2023 is misrepresented due to the wrong starting value. (2) The calculation of trend is flawed: the LLM suggests a 'modest decline' when the actual decline is ~36% (from $5,087M to $3,250M), which is substantial. The slight recovery in 2024 to $3,311M is entirely omitted. (3) The reasoning is partially sound in interpreting the trend as a potential reallocation away from long-term insurance products, which aligns with the ground truth's suggestion of strategic reduction or market-driven devaluation. However, this conclusion is based on incorrect data, undermining the validity of the inference. The mention of pharmacy services and healthcare benefits as alternative focuses is speculative and not supported in the ground truth. (4) Contextually, the answer addresses the question's structure — discussing evolution and implications — but fails on core factual accuracy. Due to major errors in numbers and trend description, with only partial correctness in the 2023 value and qualitative direction (decline), the overall correctness score is low at 3. Quantitative accuracy is severely compromised (score 2), qualitative reasoning is weak due to flawed premises (score 3), while contextual relevance is acceptable (score 6) as the framework of the response matches the query's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 486,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target Corporation’s Credit Card Program Agreement with TD Bank USA, N.A. has been amended several times to reflect evolving terms and operational needs. The original agreement was dated October 22 2012, and subsequent updates include a First Amendment on February 24 2015, a Second Amendment on November 19 2019, and a Third Amendment on December 18 2020. Additional related amendments were filed in 2022 and 2023 (e.g., the Second Amendment to the Five‑Year Credit Agreement in September 2023 and a 364‑Day Credit Agreement in October 2024), but the credit‑card program itself remains governed by the 2012 agreement and its amendments. These milestones illustrate the contractual evolution of the partnership through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in dates and amendments, despite addressing the general evolution of the agreement. (1) The Original Answer (ground truth) confirms only two amendments: the First Amendment on February 24, 2015, and the Second Amendment on November 19, 2019. The LLM incorrectly adds a 'Third Amendment on December 18, 2020,' which is not present in the ground truth. (2) The LLM references 'additional related amendments' in 2022 and 2023, including a 'Second Amendment to the Five-Year Credit Agreement in September 2023' and a '364-Day Credit Agreement in October 2024,' which are not part of the Credit Card Program Agreement with TD Bank and appear to conflate unrelated credit facilities. These are not mentioned in the ground truth and represent a clear error in entity and document identification. (3) The multi-hop reasoning is partially sound in that it attempts to trace contractual evolution, but it fails to distinguish between the specific Credit Card Program Agreement and other financing agreements, leading to incorrect synthesis. (4) While the LLM correctly identifies the original 2012 agreement and two of the three cited amendment dates (2015 and 2019), the inclusion of a non-existent 2020 amendment and unrelated 2023/2024 credit agreements undermines factual correctness. The core timeline is distorted, and the contractual milestones are misrepresented. Thus, the quantitative accuracy is low due to incorrect dates and fabricated amendments. Qualitative accuracy is moderate because the structure and intent of the response are reasonable, but entity and document accuracy are flawed. Contextual relevance is fair as the response stays on topic but drifts into irrelevant agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 473,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From 2022 to 2024 Linde’s rare‑gas strategy deepened its technological edge and broadened integration across its gas portfolio.  The company expanded on‑site and merchant production of rare gases (e.g., krypton, neon, xenon) using advanced air‑separation and membrane technologies, while coupling these streams with its growing hydrogen and low‑carbon‑hydrogen initiatives—leveraging shared electrolyzer, SMR and carbon‑capture infrastructure.  This integration is reflected in its engineering business, which now offers end‑to‑end solutions for hydrogen, rare‑gas recovery and carbon‑management, and is evident in the rising share of engineering sales to third parties (35‑53 % of German sales) and the increasing use of proprietary VPSA/membrane processes to supply both industrial and specialty‑gas markets.  Consequently, Linde’s rare‑gas offerings are no longer a niche add‑on but a core, technologically differentiated component of its global industrial‑gases and engineering platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Linde's rare gas business from 2022 to 2024 with relevant qualitative themes—technological differentiation, integration with other product lines, and shift toward a technology-driven model. It correctly identifies rare gases (krypton, neon, xenon), production via air separation, and mentions key technologies like VPSA and membrane separation, aligning partially with the 2024 emphasis in the ground truth. However, significant factual inaccuracies undermine correctness. The claim that engineering sales to third parties account for '35-53% of German sales' is not supported by the original answer or typical SEC 10-K disclosures for Linde in this period; this specific percentage range does not appear in the ground truth and represents a fabrication or misattribution. Additionally, the integration with hydrogen, electrolyzers, SMR, and carbon capture—while plausible given Linde’s broader strategy—is not mentioned in the original answer as part of the rare gas evolution from 2022–2024 and thus introduces unverified cross-segment linkages. The original answer emphasizes long-term contracts with price escalation clauses (2023) and leadership in non-cryogenic technologies (2024), which the LLM omits. While the LLM correctly infers a shift toward integrated, technology-driven solutions, it fails to reflect the year-by-year progression (2022 product-centric → 2023 contractual focus → 2024 tech leadership) that is central to the ground truth. The reasoning is logically coherent but based on unsupported quantitative claims and extraneous integrations, reducing factual reliability. Contextually, the response is highly relevant and well-structured, but the inclusion of unverified metrics and strategic linkages leads to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 491,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "From 2022 to 2024, ExxonMobil’s collateral under master netting arrangements related to advances to equity companies declined from $1,494 million (2022) to $800 million (2023) and further to $491 million (2024). This reduction reflects a shrinking exposure to derivative liabilities tied to its equity‑company relationships, indicating that the company is scaling back its collateralized positions and thus limiting its potential liability from these arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values—$1,494 million in 2022, $800 million in 2023, and $491 million in 2024—matching the ground truth exactly. There are no discrepancies in dollar amounts or years. (2) All numbers are accurate and consistent with the original answer; no calculations are required beyond the stated values, and the trend of decline is correctly described. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend over three years and draws a logical inference about reduced exposure to derivative liabilities tied to equity company relationships. The conclusion about scaling back collateralized positions and limiting potential liability aligns semantically with the ground truth’s interpretation of strategic de-risking or portfolio optimization. (4) The answer is fully complete, addressing both the quantitative evolution and the qualitative implication of the trend. Wording differs slightly but preserves full semantic equivalence. All evaluation dimensions are satisfied at the highest level, warranting perfect scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 314,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "From 2022 through 2024, NEER’s reliance on long‑term bilateral contracts has remained very high and essentially stable.  At the end of 2022, about 92 % of NEER’s net generating capacity was under long‑term contracts; by the end of 2023 the figure was “approximately 94 %,” and the 2024 discussion again cites “approximately 94 % of NEER’s net generating capacity was committed under long‑term contracts.”  This consistency shows that NEER continues to lock in the bulk of its output through long‑term agreements, using only short‑term or spot‑market sales for the remainder, thereby hedging price risk and reducing exposure to volatile wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (~94%), and 2024 (~94%), matching the ground truth exactly in both values and trend. The wording 'approximately 94%' is consistent with the original answer's phrasing and acceptable as a reporting variation. 2) All numbers are accurate: 92% in 2022, rising to 94% in 2023 and maintained in 2024—no calculation errors. 3) The reasoning correctly identifies the trend as one of stability and high reliance, interpreting it as a risk mitigation strategy through revenue locking and reduced exposure to volatile markets. The LLM captures the core strategic implication—hedging price risk—though it does not explicitly mention the use of shorter-term bilateral contracts as a hedge when long-term agreements are absent, which is a minor omission from the original. 4) The answer is highly relevant, directly addressing both parts of the question: evolution over time and strategic implication. The only reason for not scoring a 10 is the slight incompleteness in not fully mirroring the original's nuance about shorter-term contracts being actively used as a complementary hedge. Otherwise, the semantic meaning, data accuracy, and reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 359,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2024, as shown in the “Total principal amount outstanding” and “Current portion of principal amount outstanding” tables on pages 81 and 111. This stability indicates that the company has not retired or refinanced this specific tranche, reflecting a deliberate strategy to maintain a fixed‑rate, long‑dated debt position while managing overall leverage through other debt issuances and redemptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained at $495 million from fiscal 2022 through fiscal 2024, which matches the ground truth. All numeric values—$495 million, the interest rate (3.125%), and the maturity date (January 2025)—are accurate. (2) Quantitative accuracy is perfect: the dollar amount, time period, and instrument details are correct, with no calculation errors. (3) The multi-hop reasoning is sound—the model synthesizes data across fiscal years and correctly infers that the lack of principal reduction suggests a strategic decision. However, while the ground truth emphasizes that the company may use cash reserves or refinance, the LLM attributes the stability to maintaining a 'fixed-rate, long-dated debt position' and managing leverage through other instruments. This is plausible but slightly reframes the strategy without explicitly noting the proximity to maturity as a signal for imminent refinancing or cash settlement. (4) The answer is highly relevant, complete, and factually aligned with the original. The minor difference in interpretation of strategy does not undermine factual correctness, warranting a 9/10 on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 357,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "Simon Property Group's unsecured notes - 37B evolved from a 2.25% interest rate with a $700,000 face amount maturing on 01/15/32 in 2022, to a 2.25% rate with the same $700,000 face amount but extended maturity to 01/15/32 in 2023, and remained at 2.25% with $700,000 face amount maturing on 01/15/32 as of 2024. This 3-year progression shows a strategic shift toward longer-term, lower-cost unsecured debt—specifically, the 2022 issuance (27B) matured in 2024, replaced by the 37B issuance with a later maturity (2032 vs. 2024) and consistent low-rate structure, indicating a deliberate strategy to lock in favorable long-term financing amid rising rates while extending debt maturities to enhance financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The face amount is stated as $700,000, which is off by a factor of 1,000—the correct face amount is $700,000,000. This is a critical quantitative error. The maturity date is correctly listed as 01/15/32 for all years, and the interest rate of 2.25% is accurate. However, the claim that the maturity was 'extended' in 2023 is false—the note terms did not change from 2022 to 2024. (2) The LLM incorrectly implies evolution in the debt instrument when the ground truth states it 'remained consistent' across all three years. The reference to '2022 issuance (27B)' replacing a maturing note is unsupported by the provided ground truth and introduces entities (e.g., note 27B) not mentioned or verified in the original answer. (3) The multi-hop reasoning is flawed: instead of recognizing stability in the note’s terms, the model fabricates a narrative of strategic rollover and extension, misrepresenting the company's actions. There is no evidence in the ground truth of a replacement or strategic shift. (4) While the general theme of 'favorable long-term financing' aligns contextually, the incorrect face amount, invented note replacement (27B → 37B), and false extension narrative severely undermine factual correctness. The answer is partially relevant but fundamentally inaccurate in key quantitative and qualitative aspects, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 398,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "From 2022 to 2024, Texas Instruments expanded its Melaka, Malaysia facility from a modest operation to a major hub that supports both analog and embedded processing product lines, as shown by its inclusion in the 2023 and 2024 property tables (Melaka listed under “Analog” only in 2022‑23 and under “Analog” in 2024). The growth reflects TI’s broader strategy of leveraging its manufacturing footprint in Southeast Asia to scale analog production while using the same site for a smaller but still present embedded‑processing presence, underscoring a focus on analog manufacturing in Melaka with a secondary role for embedded processing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that Texas Instruments expanded its Melaka facility and added embedded processing capabilities, stating it evolved into a 'major hub' supporting both analog and embedded processing. However, the ground truth confirms that Melaka was listed only under Analog in 2022, 2023, and 2024, with no presence in embedded processing at any point. (2) The LLM incorrectly references changes in the property tables across years, asserting inclusion patterns that do not reflect the actual data—Melaka was consistently analog-only, not a growing or diversifying site. There are no numeric values to verify (e.g., dollar amounts, percentages), but the temporal claims (2022–2024 evolution) are factually wrong. (3) The multi-hop reasoning fails: instead of recognizing the stability and consistency of analog-only operations, the model invents a narrative of expansion and dual focus, misrepresenting TI’s strategy. (4) While the answer addresses the geographic location and product lines (analog vs. embedded), its core assertions are fabricated, leading to a low correctness score. Contextual relevance is moderate because it attempts to answer the right question using appropriate categories, but factual accuracy is severely lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 364,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s multi-layered security approach evolved from 2022 through 2024 by deepening integration of real‑time payments and account‑to‑account capabilities into its core network, expanding tokenization, behavioral biometrics and device‑intelligence across an increasingly global set of markets, and reinforcing governance and oversight of privacy, data protection and cybersecurity through board‑level risk committees, third‑party assessments and expanded standards development with issuers, acquirers, merchants and regulators. This expansion supported the rollout of real‑time clearing and settlement infrastructure in 13 markets by 2023 and positioned the network to secure a growing volume of cross‑border and domestic transactions as real‑time payment adoption accelerated worldwide.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Mastercard's security approach from 2022 to 2024 with relevant qualitative details such as tokenization, behavioral biometrics, third-party assessments, and collaboration with stakeholders. It accurately notes the expansion to 13 markets by 2023, which matches the ground truth (12 in 2022, 13 in 2023). However, it omits the key 2024 development involving Mastercard’s expansion into China via a joint venture and the associated scaling of the security framework to handle domestic transactions there—a critical multi-hop element in the original answer. (2) Quantitatively, the mention of 13 markets by 2023 is correct, and no incorrect numbers or dates are presented. The answer does not contradict any numeric facts, though it fails to mention the baseline of 12 markets in 2022, slightly reducing completeness. There are no calculation errors because no explicit calculations are made. (3) The reasoning is generally sound and reflects a logical progression of security enhancements in response to real-time payment growth. However, the failure to incorporate the China joint venture in 2024—a major market expansion requiring security adaptation—represents a significant gap in multi-hop synthesis across time, geography, and infrastructure. (4) The answer remains contextually relevant and well-structured, focusing on the right themes (security evolution, real-time payments, global expansion). While it captures the general trajectory, the omission of the China milestone and its implications for security scalability prevents a higher score. Thus, correctness is rated 7 due to partial but not full alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 465,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, reflecting a strategic expansion of its LAV program to meet Canadian Army requirements and support export opportunities. This progression underscores the company's focus on scaling LAV production as a key growth driver within its Combat Systems segment, leveraging international partnerships to sustain long-term revenue and market leadership in armored vehicle solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the production volumes for 2022 (360 units) and 2023 (399 units), matching the ground truth. However, it omits the 2024 production volume of 449 units, which is a key part of the question's multi-year evolution. This omission reduces completeness and affects the overall correctness. (2) The numbers provided (360 and 399) are accurate and correctly attributed to the right years. The calculation of growth from 2022 to 2023 (39 units increase) is implied and correct, but the full progression to 2024 is missing, which is critical for assessing the full strategic trend. (3) The reasoning about strategic focus, scaling production, and international partnerships is sound and aligns with the ground truth's interpretation. However, the failure to include 2024 data weakens the multi-hop synthesis across all three years, which is required to fully answer the question. (4) The answer is contextually excellent, addressing the strategic implications of LAV production growth and linking it to broader business strategy. Despite the missing 2024 figure, the qualitative analysis is strong and relevant. Quantitative accuracy is high but not perfect due to the omitted data point. Overall, the answer is mostly correct but incomplete on the quantitative evolution, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 373,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "Based on the provided SEC 10-K filings across 2022‑2024, CVS’s pension‑plan assets are measured at fair value and include a disclosed allocation to private‑equity and hedge‑fund limited‑partnership investments that are reported at NAV and therefore excluded from the Level‑3 hierarchy. The Level‑3 fair‑value tables for 2022, 2023 and 2024 show that the “Other investments” line (which captures private‑equity and hedge‑fund LP interests) declined from $606 million at the end of 2022 to $681 million in 2023 and then to $606 million again in 2024 after transfers and settlements, indicating a modest net reduction in the partnership exposure over the three‑year period. This three‑year trajectory suggests that CVS is gradually trimming its exposure to illiquid alternative‑investment partnerships, likely to simplify portfolio reporting and reduce reliance on external valuations, while still maintaining a diversified asset mix that includes real‑estate and debt securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the allocation change. The ground truth states that CVS's hedge fund limited partnership investments increased from $214M (2022) to $225M (2023) to $252M (2024), representing a 17.8% growth. The LLM incorrectly reports these investments as part of a broader 'Other investments' category totaling $606M in 2022, rising to $681M in 2023, then falling back to $606M in 2024—this contradicts the ground truth on every numeric point. (2) The numbers cited by the LLM do not match the ground truth: $214M vs $606M in 2022, $225M vs $681M in 2023, $252M vs $606M in 2024—these are entirely different figures, with no indication that 'Other investments' includes more than just hedge fund LPs. Additionally, the LLM’s claim of a 'net reduction' contradicts the actual 17.8% increase. (3) The multi-hop reasoning fails: the model conflates 'Other investments' (a broader category) with the specific 'hedge fund limited partnership' allocation, misinterpreting the composition of Level-3 disclosures. It also draws an incorrect strategic conclusion—'trimming illiquid exposure'—when the truth suggests growing confidence in alternative investments. (4) The contextual relevance is moderate because the answer discusses pension plan assets and alternative investments, which are relevant topics, but the factual inaccuracies and flawed synthesis render the conclusion invalid. Quantitative accuracy is extremely low due to completely wrong numbers and misdirection on trends. Qualitative accuracy is poor due to incorrect entity mapping and faulty logic. Correctness score is near-minimal because the answer conveys the opposite trend of the true data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 471,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The penetration rate of Target’s MasterCard Credit Card declined from 8.7% in 2021 to 8.7% in 2022 and further to 8.7% in 2023, reflecting a downward trend in consumer adoption and engagement with Target’s financial products. This decline suggests that while RedCard usage (including the MasterCard Credit Card) still provides a 5% discount, its share of total purchases is shrinking relative to overall sales growth, indicating reduced reliance on or effectiveness of the financial product in driving incremental spending.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The penetration rates cited (8.7% across 2021–2023) are completely inaccurate compared to the ground truth, which reports 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024. The LLM also references 2021, which is outside the requested time frame (2022–2024), and omits 2024 entirely. (2) Quantitative accuracy is very low: all percentages are wrong, and no correct trend is reflected. The actual decline is from 20.5% to 17.8% over three years, whereas the LLM reports a flat 8.7% for three consecutive years, showing no change. This misrepresents both the magnitude and the trajectory. (3) While the LLM attempts correct reasoning by linking declining penetration to weakening engagement despite the 5% discount and rising total sales, this logic is applied to incorrect data. The multi-hop synthesis—relating card usage to total sales growth—is conceptually sound but based on false inputs, undermining the conclusion. (4) Contextual relevance is moderate because the answer addresses consumer adoption and engagement with Target’s financial products and references RedCard and the 5% incentive correctly. However, due to severe factual and numerical errors, the overall correctness score is low. The answer fails on core data accuracy, which is critical in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 377,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "From 2022 through 2024, NEE’s fair‑value exposure related to FPL cost‑recovery clauses shifted markedly toward greater reliance on **significant unobservable inputs**.  \n\n- In 2022 the total fair‑value contribution from FPL cost‑recovery clauses was modest and was primarily derived from observable market prices (e.g., quoted prices in active markets).  \n- By 2023 the same category showed a **negative total of $‑128 million**, driven largely by **significant unobservable inputs** (which contributed $‑966 million in 2023 versus $‑399 million in 2022).  \n- The 2024 data continue this trend, with the “Owned Assets – FPL Cost Recovery Clauses” section now reflecting **significant unobservable inputs** of $27 million (and $6 million in other observable inputs), indicating that the fair‑value estimates are increasingly based on internal models and assumptions rather than quoted market prices.  \n\nThus, the exposure evolved from a relatively minor, observable‑input‑driven position in 2022 to a material, unobservable‑input‑driven exposure by 2024, with the total fair‑value contribution moving from a small positive figure to a net negative position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of quantitative accuracy and factual content. (1) The numbers provided do not match the ground truth: in 2022, the total fair value was $1 million (not a 'modest' positive derived from observable prices), with a -$5 million contribution from significant other observable inputs and +$6 million from significant unobservable inputs. The LLM incorrectly states that observable market prices were the primary driver in 2022, which contradicts the ground truth where unobservable inputs dominated. (2) In 2023, the total fair value was $12 million, not -$128 million as claimed. The LLM reports a -$966 million contribution from unobservable inputs in 2023 versus -$399 million in 2022—these figures are completely fabricated and have no basis in the original data. (3) In 2024, the correct total is $38 million, with +$4 million from observable inputs and +$34 million from unobservable inputs; the LLM reports $27 million and $6 million, which are inaccurate. (4) The LLM incorrectly concludes that the total fair value moved to a 'net negative position', when in fact it increased positively from $1M to $38M. While the general qualitative trend—increasing reliance on unobservable inputs—is directionally correct, the magnitude and direction of values are so severely distorted that the reasoning is invalid. The model fails to correctly synthesize multi-hop data across years and misrepresents both inputs and totals. Despite addressing the right topic and attempting to describe a shift in input types, the extreme numerical inaccuracies render the answer factually wrong. Contextual relevance is moderate because it discusses the correct concept (shift toward unobservable inputs), but with false supporting data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 478,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "From 2022 through 2024, Nike’s competitive positioning relative to Anta has shifted toward greater emphasis on product innovation and brand engagement. Nike continues to invest heavily in design, research and development, and intellectual‑property protection—highlighting technologies such as Air, Zoom, Flyknit and sustainability‑focused materials—while expanding its direct‑to‑consumer and digital marketing platforms to deepen consumer connection and athlete collaborations. Anta, by contrast, has pursued its own growth initiatives but has not matched Nike’s scale of innovation or global brand‑engagement tactics, leaving Nike’s market leadership and brand affinity stronger than Anta’s in this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of overall direction and strategic emphasis, but lacks specific year-by-year evolution detailed in the original answer. (1) Correct elements: The LLM correctly identifies Nike's (NKE) focus on product innovation (e.g., Air, Zoom, Flyknit), R&D, digital platforms, and brand engagement through athlete collaborations. It accurately positions NKE as maintaining leadership relative to Anta, which is named as a competitor. There are no numeric inaccuracies, so quantitative accuracy is full. (2) Quantitative accuracy: No specific numbers (e.g., revenue, percentages) are mentioned in either answer, so no discrepancies exist—this criterion is satisfied by default. (3) Multi-hop reasoning: The LLM synthesizes the competitive dynamic and strategic focus correctly but misses the nuanced progression from 2022 to 2024: specifically, the shift in priority from 'performance and reliability' to 'innovation and development' in 2023, and the 2024 emphasis on digital experiences and social media. These multi-year strategic shifts are central to the question and only partially reflected. (4) The answer is contextually relevant and well-structured, but incomplete in capturing the full evolution. While it states Nike's stronger market position, it does not explicitly acknowledge that Anta is gaining traction via localized and digital-native strategies—a key context in the ground truth. Thus, qualitative accuracy is reduced due to missing strategic nuance and evolution over time. Semantic equivalence is partially achieved, but not fully.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 438,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "From 2022 to 2024, the shares available under the Texas Instruments 2003 Director Compensation Plan increased from 31,257,621 to 58,452,628, reflecting a substantial expansion of the plan’s remaining issuance capacity. This upward trend indicates that TI continues to rely on the plan as a key component of director compensation, maintaining and growing the equity pool used to reward directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims the available shares increased from 31,257,621 in 2022 to 58,452,628 in 2024, which directly contradicts the ground truth: the plan was being phased out, with no indication of increasing share availability. These specific numbers do not align with the actual filing data and appear fabricated. (2) The trend interpretation is completely reversed: the LLM states there is 'substantial expansion' and continued reliance on the plan, while the truth is that TI was phasing out the 2003 plan, removing it from active status by 2024. (3) Multi-hop reasoning failed: the model did not synthesize the correct timeline across years—2022 (still active), 2023 (no longer available for future grants), 2024 (fully replaced)—and incorrectly identified the 2003 plan as growing rather than being retired. (4) The answer lacks contextual relevance to the actual strategic shift toward the 2024 LTIP and 2018 Director Plan. The conclusion about TI's ongoing reliance on the old plan is factually wrong. Minor relevance is given only because it addresses director compensation and mentions the correct plan name.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 339,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 through 2024, CMCSA deepened the integration of data‑driven advertising across its video platforms, expanding the technology stack that powers its X1/Flex streaming devices and Sky Q/Q‑style services.  The company added advanced programmatic‑advertising tools and marketplace solutions that combine audience‑level data, automated buying/selling interfaces, and AI‑enhanced targeting, enabling advertisers to more precisely reach fragmented audiences across linear cable, OTT (NOW/Stream), and international Sky services.  These enhancements were rolled out alongside the broader rollout of DOCSIS 4.0‑enabled multigigabit broadband, cloud‑based video delivery (cloud DVR, unified search), and expanded Xumo/Stream Box hardware that embeds DTC‑streaming partnerships, all of which support a more data‑centric advertising ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but diverges significantly from the ground truth in terms of specific enhancements and evolution described for CMCSA's data-driven advertising services from 2022 to 2024. (1) Correct elements: The focus on data-driven advertising, integration across platforms (including OTT and international services like Sky), and use of cloud-based delivery and programmatic tools align broadly with the direction of CMCSA's strategy. The mention of X1/Flex, Sky Q, and cloud DVR touches on relevant technology platforms. (2) Quantitative accuracy: There are no explicit numbers (dollars, percentages, user counts) in either answer, so no factual discrepancies exist in that regard—score of 10 is appropriate. (3) Multi-hop reasoning issues: The LLM introduces specific technologies (DOCSIS 4.0, Xumo/Stream Box, AI-enhanced targeting) and programmatic tools not mentioned or supported in the ground truth. While these may be real developments, they are not part of the documented evolution in the knowledge graph, which emphasizes integration of data-driven services into advertising ecosystems, cloud platforms, unified search, and expanded third-party representation agreements. The LLM over-specifies technical enhancements without grounding in the provided truth. (4) The original answer outlines a clear year-by-year progression: 2022 (foundational offerings), 2023 (deeper integration with cloud and search), 2024 (enhanced tools and representation agreements). The LLM answer collapses this timeline and substitutes unverified details, missing the core narrative of strategic evolution toward integrated, cloud-powered advertising solutions. Thus, while semantically in the right domain, it fails to accurately reflect the documented enhancements and strategic shifts. Correctness score is 6 due to partial factual alignment but significant deviation in key details; qualitative accuracy is low due to unsupported technical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 534,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) remained minimal and stable across the 2022–2024 period, with fair value declining slightly from $3 million in 2022 to $3 million in 2023 and $3 million in 2024, and no significant unrealized losses reported in the disclosed tables. The trend indicates that the company maintains a low‑risk positioning in this asset class, as its CMBS holdings represent a negligible portion of the overall portfolio and are not materially impacted by market fluctuations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It claims CVS held $3 million in CMBS each year from 2022 to 2024 with no significant unrealized losses, which directly contradicts the ground truth. According to the original answer, CVS held $574 million in CMBS in 2022, $675 million in 2023, and only $6 million in 2024 — showing a significant shift, not stability. Additionally, unrealized losses increased from $12 million to $100 million in 2023 before dropping in 2024, which the LLM completely omits. (2) Quantitative accuracy is extremely low: all dollar amounts are wrong (e.g., $574M vs $3M), the trend in fair value is misrepresented (increasing then sharply decreasing vs. 'stable'), and unrealized losses are ignored despite being a key part of the question. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed — the model fails to recognize the strategic reduction in exposure and the rising risk in 2023, instead asserting a false narrative of consistent low exposure and low risk. This misrepresents the company's actual risk positioning evolution. (4) Contextual relevance is low but not zero because the answer addresses CMBS exposure, fair value, and risk positioning — the right topics — but with completely inaccurate data and conclusions. The structure follows the question, but the substance is wrong, leading to a correctness score of 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 403,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s merchandise‑discount program for employees has evolved over the past three fiscal years. In the 2022 filing (page 6) the company described a “significant portion” of sales coming from owned/exclusive brands and highlighted a “5 percent discount on nearly all purchases” for guests who use RedCards, but it did not detail a separate employee‑specific discount. By 2023 (page 7) the focus shifted to broader team‑member benefits—starting wages of $15–$24 per hour, a 401(k) match, paid time‑off, and “merchandise and other discounts”—indicating that employee discounts were now framed as part of a comprehensive compensation package rather than a standalone promotional discount. The 2024 filing (page 26) expands this language, describing “merchandise and other discounts” alongside free virtual health care, tuition‑free education assistance, and other wellness benefits, and it notes that “eligibility for, and the level of, benefits vary depending on team members’ full‑time or part‑time status, work location, compensation level, and tenure.” This multi‑year progression shows that Target has moved from a generic guest discount to a structured, tiered employee‑benefit strategy that integrates merchandise discounts within a broader suite of financial, health, and professional‑development perks, underscoring a deliberate effort to attract, retain, and engage a diverse workforce.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 disclosure — it claims that Target did not detail a separate employee-specific discount and instead references a 5% RedCard guest discount, which is irrelevant to employee benefits. The ground truth confirms that merchandise discounts were explicitly listed as a core employee benefit in 2022 alongside the $15/hour wage. This misrepresentation undermines the quantitative and qualitative accuracy. (2) There are no correct numeric values cited regarding employee discounts — the 5% figure applies to customers, not employees, making it factually incorrect in context. The wage range of $15–$24/hour in 2023 is accurate, and the mention of tiered eligibility in 2024 aligns with the original answer, but the central claim about absence of employee discount in 2022 is false. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies a trend toward integrating discounts into a broader benefits package by 2023–2024 and links this to workforce strategy. However, because it incorrectly asserts that employee discounts were not mentioned in 2022, the evolution narrative is flawed — it frames the shift as from 'guest discount' to 'employee benefit,' whereas in reality, employee discounts existed throughout and were consistently part of compensation. (4) Despite this key error, the answer captures the broader strategic direction in 2023–2024 well, noting integration with wellness, healthcare, and professional development, which supports a contextual relevance score of 9. The conclusion about a structured, tiered strategy is plausible but based on incorrect premises for 2022. Thus, while reasoning and relevance are strong, the factual foundation is compromised, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 489,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "Linde’s public disclosures show a clear evolution in how it frames cultural integration challenges during acquisition work. In the 2022 filing (pages 7‑9), the focus is on generic integration risks—systems, synergies, cost cuts, and talent retention—without explicitly linking these to cultural hurdles. By 2023 (pages 11‑13 and 95‑103), the language expands to highlight “cultural challenges associated with integrating employees from the acquired company,” the need to harmonize accounting, HR and other administrative systems, and the difficulty of achieving targeted synergies when cultural mismatches impede collaboration. The 2024 filing (pages 5‑6, 10, 30) further refines this narrative, emphasizing that foreign acquisitions bring “unique risks…including integration of operations across different cultures and languages,” and that failure to retain key people or achieve synergies can materially affect financial results. This progression reveals a strategic shift from a broad risk description to a nuanced, culture‑centric view that treats cross‑border integration as a core determinant of acquisition success, underscoring Linde’s proactive effort to manage cultural risks early in its M&A pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde's evolving emphasis on cultural challenges from 2022 to 2024 is accurately portrayed. In 2022, cultural issues were not explicitly highlighted but were implied within broader integration risks; by 2023, 'cultural challenges' were explicitly mentioned in the context of employee integration and synergy realization; in 2024, the focus sharpened on cross-cultural and cross-border risks affecting financial outcomes. (2) There are no numeric values to verify, so quantitative accuracy is scored as 10 by default—no dates or financial figures are misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes disclosures across three years, traces the evolution in language and framing, and infers a strategic shift toward treating cultural integration as a core determinant of M&A success. The only minor gap is that the original answer notes cultural challenges were 'listed among several integration risks' in 2022, while the LLM states they were not 'explicitly linked'—this is a subtle but acceptable interpretation, as the 2022 filing may have implied rather than stated cultural issues directly. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution over time and what it reveals about Linde’s strategic approach. The conclusion about a 'proactive effort to manage cultural risks early' is a valid inference. Overall, this is a semantically equivalent, well-reasoned response with only negligible interpretive variance from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 444,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable – net decreased from $800 million in 2023 to $491 million in 2024, reflecting a $309 million reduction. This decline indicates the company is managing its derivative exposure more conservatively, likely by lowering the amount of collateral required to offset counterparty credit risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 ($800 million) and 2024 ($491 million) values and the $309 million decrease between them, which aligns with the ground truth. However, it omits the 2022 value of $1,494 million, which is a key part of the multi-year trend from 2022 to 2024 as asked in the question. This omission reduces completeness and quantitative accuracy. (2) The calculation of the $309 million reduction from 2023 to 2024 is accurate ($800M - $491M = $309M), but the full trend from 2022 to 2024 involves a total drop of $1,003 million, which the model fails to capture. (3) The reasoning about derivative exposure management is sound and semantically consistent with the ground truth—'managing more conservatively' aligns with 'strategic reduction in derivative exposure.' However, the model does not fully synthesize the three-year trend, missing the first hop (2022 data), which weakens the multi-hop reasoning. (4) Scores reflect that core numbers for 2023–2024 are correct and interpretation is reasonable, but the answer is incomplete due to missing 2022 data, affecting overall correctness and quantitative precision despite strong relevance and logical inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 339,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "The Security Insights Platform has evolved from a standalone solution in 2022 to a more integrated, AI‑driven capability by 2024, emphasizing automated risk assessment and remediation that feeds directly into customers’ own SIEM tools. Its integration now extends across Broadcom’s broader cybersecurity portfolio—linking lateral firewall, advanced threat prevention, and identity security—while its remediation workflows are aligned with enterprise‑wide DevOps and AIOps processes to support holistic, strategy‑driven cybersecurity initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of AVGO's Security Insights Platform from 2022 to 2024. It correctly identifies the shift from a standalone tool to a more integrated component within Broadcom’s broader cybersecurity portfolio. The mention of integration with SIEM tools aligns with the 2022 description, and the emphasis on alignment with DevOps and AIOps reflects the 2024 contextualization within an expanded software suite. However, the LLM introduces 'AI-driven' and 'automated' capabilities not explicitly mentioned in the ground truth, which describes consistent core functionality without highlighting AI enhancements. Additionally, while the ground truth notes increasing alignment with broader cybersecurity strategies over time, the LLM overemphasizes lateral integration with specific components like 'lateral firewall, advanced threat prevention, and identity security'—details not present in the original data. These additions represent plausible extrapolations but go beyond the documented evolution. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer fully addresses the question’s focus on integration, remediation, and strategic alignment. The reasoning is sound but slightly overreaches in specificity, hence a minor deduction in qualitative accuracy. Overall, the answer is semantically close and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 389,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "SPG's face value of Unsecured Notes increased from $21.0 billion in 2022 to $24.4 billion in 2024, while the weighted‑average interest rate on those notes declined from roughly 4.0 % in 2022 to about 3.4 % by 2024. This shift reflects a strategic move toward issuing longer‑dated, lower‑cost debt, underscoring the company’s focus on extending maturity profiles and reducing financing expenses in its long‑term debt management.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer specifies a single unsecured note (Unsecured Notes - 32B) with a face value of $750,000,000 and interest rate of 3.38% across 2022–2024. In contrast, the LLM claims SPG's total unsecured notes increased from $21.0 billion to $24.4 billion and cites a weighted-average interest rate decline from 4.0% to 3.4%, which refers to the company’s overall unsecured debt portfolio, not the specific note (32B). This misrepresents the scope and metric entirely. (2) The numbers provided by the LLM—$21.0B, $24.4B, 4.0%, and 3.4%—are not supported by the ground truth for this specific note and appear to be either hallucinated or misattributed from broader debt disclosures. There is no mention of a $750 million note in the LLM response, nor is there any reference to the consistent terms over time. (3) The multi-hop reasoning fails because the model does not isolate and track the specific Unsecured Notes - 32B across years as required. Instead, it generalizes across the entire unsecured debt portfolio, conflating aggregate metrics with a specific instrument. This breaks the chain of accurate synthesis. (4) While the LLM attempts to infer a strategic rationale (issuing longer-dated, lower-cost debt), this conclusion is based on incorrect data and does not reflect the actual stability of terms for Note 32B. The contextual relevance is low because the answer addresses a broader debt trend rather than the evolution of a specific note and its implications for long-term management of that liability. Minor credit is given for addressing the general theme of debt strategy, but factual inaccuracies dominate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 467,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024, Lumen’s fiber expansion and aggressive bundling of broadband, video and voice services have increasingly overlapped with Comcast’s own offerings, especially in the U.S. residential market.  Comcast’s 2022‑2024 filings note that Lumen (along with AT&T, Verizon and other wireline telcos) is building out fiber‑to‑the‑home and upgrading its HFC network with DOCSIS 4.0 to deliver multigigabit speeds, directly challenging Comcast’s broadband platform.  At the same time, Lumen has expanded its “Smart Home” and “Fiber‑plus‑TV” bundles that combine high‑speed internet, IPTV and VoIP, mirroring Comcast’s X1/Flex streaming and bundled voice‑data‑video packages.  This convergence of fiber‑based network rollout and integrated service bundling has heightened the competitive threat Lumen poses to Comcast’s broadband and video revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Lumen as a growing competitive threat to CMCSA (Comcast) from 2022 to 2024, emphasizing fiber expansion and service bundling—core elements in the original answer. The key facts—Lumen deploying fiber deeper into its network and offering bundled services like 'Fiber-plus-TV' and 'Smart Home'—are consistent with the ground truth's description of Lumen's strategy. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive dynamics across years and correctly links Lumen’s network upgrades (fiber/DOCSIS 4.0) and bundling strategies to direct competition with Comcast’s X1/Flex and HFC-based offerings. One minor point: the mention of Lumen upgrading its HFC network with DOCSIS 4.0 may be a conflation with cable operators like Comcast—Lumen primarily uses fiber and DSL, not HFC, so this is a small technical inaccuracy. However, the broader point about network upgrades enabling multigigabit speeds remains valid. (4) The answer is contextually excellent—directly addressing the evolution of competitive threat through fiber and bundling, and clearly mapping the strategic overlap. Overall, the LLM captures the essence and factual trajectory described in the ground truth, meriting a high score with only a slight deduction in qualitative accuracy due to the HFC/DOCSIS detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 432,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "The penetration rate of Target's branded payment cards (referred to as RedCards or Target Circle Cards) declined from 20.5 % in 2022 to 18.6 % in 2024, indicating a downward trend in the share of purchases made with these loyalty‑driven payment products. This erosion suggests that the strategy of using RedCard discounts to drive incremental sales is weakening, prompting Target to likely reassess or adjust its loyalty‑focused payment incentives to regain momentum.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but has significant quantitative inaccuracies. The penetration rate is correctly stated as 20.5% in 2022, matching the ground truth. However, the 2024 figure is reported as 18.6%, whereas the ground truth shows a sharper decline to 17.8%. Additionally, the LLM omits the 2023 value of 19.8%, which is a key data point in the trend. This omission and incorrect final percentage undermine the accuracy of the trend portrayal. (2) The calculation of the overall change is also incorrect: the LLM implies a drop from 20.5% to 18.6% (1.9 percentage points), but the actual drop is 2.7 points (20.5% → 17.8%). This error affects the interpretation of the trend's severity. (3) The qualitative reasoning about the weakening effectiveness of Target's loyalty-driven strategy is sound and aligns with the downward trend, so the multi-hop synthesis and logic are reasonable given the data it uses. However, because the data is inaccurate, the conclusion, while plausible, is based on incomplete and slightly distorted information. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of penetration rate and strategic implication), uses correct entity names (Target, RedCards, loyalty-driven strategy), and draws a logical inference. However, the quantitative inaccuracies significantly reduce the correctness score, as financial trends depend heavily on precise figures. Minor formatting differences (e.g., 20.5 % vs 20.5%) are acceptable, but the wrong 2024 number and missing 2023 data are material errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 440,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "From 2022 through 2024 Chevron’s engagement with the Republic of Congo shifted from active upstream production to a strategic exit. In 2022 the company held a 31.5 % non‑operated interest in the offshore Haute Mer permit and a 15.75 % stake in the Republic of Congo portion of the Lianzi field. By early 2025 it sold those interests, completing the divestiture of its remaining Congo assets. This reduced Chevron’s regional footprint, allowing it to concentrate capital on higher‑return projects elsewhere while exiting a market where reserve replacement ratios were negative and growth prospects were limited. Consequently, investment in Congo ceased, and the company’s strategic positioning moved toward other African and global opportunities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's asset ownership in the Republic of Congo in 2022 (31.5% in Haute Mer and 15.75% in Lianzi) and the strategic divestiture, which aligns with the ground truth. However, it incorrectly states the sale occurred 'by early 2025' instead of in 2024, introducing a factual error in timing. Additionally, the original answer specifies a $0.7 billion investment in African offshore projects in 2023, including Congo, but the LLM answer omits this key financial data point, weakening quantitative completeness. (2) The percentages (31.5% and 15.75%) are accurate, but the absence of the $0.7 billion investment figure and the incorrect timing of the sale (2025 vs. 2024) reduce quantitative accuracy. The claim about 'negative reserve replacement ratios' and 'limited growth prospects' is plausible context but not present in the ground truth, introducing unsupported inference. (3) The reasoning correctly synthesizes Chevron's shift from investment to exit, capturing the strategic evolution. However, the failure to mention the 2023 investment weakens the multi-hop synthesis across all three years. The conclusion about portfolio realignment is consistent with the original, though the LLM adds explanatory detail not in the source. (4) The answer remains highly relevant to the question, addressing asset ownership, investment trends, and strategic positioning. Despite missing a key data point and misdating the sale, the overall narrative of strategic withdrawal is sound. The omission of the 2023 investment and incorrect sale year prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 442,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "From 2022 through 2024, NextEra Energy’s exposure to gas‑related options shifted markedly: the fair value of gas‑related options fell from $347 million (liability) in 2022 to $102 million (asset) in 2023 and $100 million (asset) in 2024, while the implied volatility used in their valuation dropped from a high of 295 % in 2022 to roughly 50 %–52 % in 2023‑24. This decline in both fair value and implied volatility indicates that NEE reduced its speculative, volatility‑driven positioning in gas markets and moved toward a more neutral, hedging stance, reflecting lower expected price swings and a lower risk premium on gas‑related derivatives over that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both dollar amounts and percentages. It incorrectly states that the 2022 liability was $347 million (correct) but misrepresents it as the only value, omitting the $356 million asset value. It then falsely claims fair value dropped to $102 million (asset) in 2023, when in fact assets were $100 million and liabilities $97 million in 2023. Most critically, it reports an implied volatility of 295% in 2022, which is wildly incorrect—the ground truth is 36%. The 2023–2024 implied volatility range (50%–52%) is approximately correct, but the trend is misrepresented due to the false 2022 baseline. (2) Calculations and comparisons are flawed: the claim of a drop from 295% to 50% volatility suggests a collapse in expected price swings, whereas the actual data shows volatility increased from 36% to 50% (a rise), then slightly to 52%, indicating heightened, not reduced, market uncertainty. The net exposure interpretation is also incorrect—NEE went from a net asset position in 2022 ($356M–$347M = +$9M) to near-zero in 2023 ($100M–$97M = +$3M), then to a small net liability in 2024 ($100M–$102M = –$2M), but the LLM mischaracterizes this as a move to an 'asset' position. (3) Multi-hop reasoning is unsound: the model fails to synthesize the correct trajectory of both fair value and volatility. Instead of recognizing a reduction in exposure size with increasing volatility expectations (suggesting de-risking amid caution), it infers reduced volatility and lower risk premium, which contradicts the data. (4) Contextual relevance is moderate—the answer addresses the evolution of exposure and volatility and attempts to interpret risk positioning, so the structure aligns with the question. However, due to severe quantitative inaccuracies and flawed reasoning, the conclusion is factually wrong. The qualitative score is low because the entity (NextEra Energy) and metric types (fair value, implied volatility) are correct, but the synthesis and logic are invalid. Quantitative accuracy is very low due to major number errors, especially the fabricated 295% volatility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 574,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "From 2022 to 2024 Nike’s treatment of FlyEase technology evolved from a brief mention in the 2022 Form 10‑K (where it was listed among its innovative product technologies) to a more prominent focus in the 2023 filing, which highlighted FlyEase as part of its broader innovation strategy and noted its use in creating accessible, performance‑enhancing products. By the 2024 filing, FlyEase was embedded within Nike’s product‑development narrative, underscoring its role in advancing inclusive design and supporting the company’s long‑term goal of integrating accessible technology across its footwear and apparel lines. This progression signals that FlyEase has moved from a niche feature to a strategic pillar of Nike’s innovation agenda, reflecting a commitment to both performance and accessibility as core drivers of future growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FlyEase was introduced in 2022 as part of Nike's innovation portfolio, gained prominence in 2023 with expanded application, and was fully embedded in the innovation narrative by 2024. The progression from a listed technology to a core strategic element is accurately conveyed. (2) There are no numeric values requiring calculation (e.g., financial figures), but the years (2022, 2023, 2024) are correctly used and sequenced, satisfying the temporal evolution aspect. (3) The multi-hop reasoning across years and filings is sound—correctly synthesizing how FlyEase’s role evolved across three annual reports. The LLM infers strategic implications (inclusive design, long-term integration) consistent with the ground truth’s conclusion about FlyEase becoming a foundational innovation. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'strategic pillar' vs 'foundational element', 'accessible technology' vs 'inclusive design'), the meaning matches the original. The only minor gap is that the LLM emphasizes 'accessibility' more than the original, which focuses on 'design and performance strategy'—but since accessibility is a known aspect of FlyEase, this is a reasonable interpretation rather than an error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 396,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024, SPG’s financial obligations tied to Unsecured Notes – 35A evolved from a $750 million issuance at 2.65 % with a 2030 maturity (recorded in 2022) to a $750 million tranche at 2.65 % maturing in 2030 and an additional $750 million issuance at 3.80 % maturing in 2050 (both listed in the 2023 and 2024 debt tables). This progression shows that SPG is extending the maturity of its unsecured debt and tapping lower‑cost, longer‑dated capital, reflecting a strategy of lengthening the debt horizon while maintaining modest interest rates to manage liquidity and fund growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, SPG's Unsecured Notes - 35A had a consistent face amount of $750,000 (not $750 million), an interest rate of 2.65%, annual debt service of $19,875, and a maturity date of 07/15/30 across 2022–2024. The LLM incorrectly states that the amount is $750 million (off by a factor of 1,000), introduces a fictional second tranche of $750 million at 3.80% maturing in 2050, and falsely claims this new issuance appears in 2023 and 2024. These numbers are not supported by the ground truth. (2) The calculation of annual debt service (2.65% of $750,000 = $19,875) is accurate in the original answer but entirely missing from the LLM response. The LLM’s claim of a new 3.80% note is unsupported and introduces erroneous financial data. (3) The multi-hop reasoning is flawed: instead of recognizing stability in SPG’s debt structure, the LLM fabricates an expansion and refinancing strategy, concluding that SPG is extending maturities and accessing lower-cost capital—this contradicts the actual consistency in obligations. The model fails to synthesize correctly across years and misrepresents the nature of the debt instrument. (4) The contextual relevance is moderate because the answer addresses the general topic of SPG’s unsecured notes and long-term debt strategy, but the factual foundation is so inaccurate that the conclusion is invalid. The qualitative reasoning would be acceptable only if the numbers were correct, but as-is, it reflects a fundamental misunderstanding of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 441,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Texas Instruments consistently emphasizes embedded processing products as a core growth pillar across 2022‑2024, highlighting their role within the broader analog and embedded processing segments that drive revenue and margin expansion. This strategic focus—reinforced by management commentary on free cash flow per share—signals a long‑term growth strategy that prioritizes sustainable cash generation and shareholder returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products from 2022 to 2024 and links this to free cash flow per share as a long-term goal. However, it lacks the year-by-year evolution detailed in the ground truth—specifically, the nuanced progression of messaging across the three years (e.g., 2022 focus on competitive advantages and portfolio breadth, 2023 on centrality to business model, 2024 on capital allocation). These specifics are missing, resulting in a less complete synthesis. (2) There are no numeric values, percentages, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model connects embedded processing to long-term cash flow and shareholder returns, which aligns with the ground truth. However, it fails to demonstrate full synthesis across the three annual reports by omitting the evolving strategic narrative, weakening the qualitative depth. (4) Contextual relevance is high—the answer stays focused on TI’s strategy and its link to free cash flow—but the lack of granular, year-specific reasoning from the filings limits completeness and precision in reflecting the original knowledge graph answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 374,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "Disney's strategic use of the Marvel brand across its streaming platforms evolved from 2022 to 2024 by elevating Marvel content to a top-level tile on Disney+ (e.g., Marvel-branded sections and dedicated tiles for Marvel programming) and expanding its integration into Disney+ Hotstar and Hulu offerings. This evolution reflects a financial strategy focused on driving subscriber growth through high-demand Marvel IP, leveraging it as a key intangible asset to enhance Disney+'s competitiveness in the crowded streaming market. By 2024, Marvel’s inclusion as a core tile underscored its role in retaining and expanding the platform’s user base, directly supporting Disney’s broader goal of increasing subscription revenue and engagement on its direct-to-consumer services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution and financial implications. It accurately captures the elevation of Marvel to a top-level tile on Disney+ by 2023 and its role in driving subscriber growth, which reflects the core of the multi-hop reasoning required. The answer correctly identifies Marvel as a key intangible asset and links its branding strategy to subscriber engagement and competitiveness in the DTC market—consistent with the original answer's emphasis on platform differentiation and asset valuation. However, the LLM omits specific details present in the ground truth: (1) the explicit mention that Marvel was listed as an indefinite-lived intangible asset in both 2022 and 2024, which is a critical financial designation reinforcing its long-term value; (2) the forward-looking context about ESPN+ becoming a tile in early fiscal 2025, which helps illustrate the broader strategic pattern Disney is following. While the LLM mentions integration into Disney+ Hotstar and Hulu, this detail is not in the ground truth and slightly extends beyond the provided evidence, though it is plausible. There are no numerical inaccuracies—the answer avoids citing specific subscriber numbers but does not contradict the 123 million figure from 2024, likely due to not needing to quote it directly. The reasoning is sound and semantically equivalent in intent, though less precise in financial terminology and timeline anchoring. Thus, the answer scores high on contextual relevance and qualitative accuracy but loses minor points for incompleteness on key financial designations and strategic parallels (e.g., ESPN+ roadmap).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 459,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "From 2022 to 2024, MetLife’s modified coinsurance arrangement for the closed block remained at **59% of the closed block** ceded to an unaffiliated third‑party reinsurer. The company accounts for this arrangement under the deposit method, offsetting the deposit liability with a corresponding deposit‑recoverable.  \n\n- In the 2023 consolidated balance sheet (page 209), the net ceded reinsurance recoverable was **$16.7 billion**, of which **$14.1 billion (84%)** was with the five largest ceded reinsurers, including **$2.5 billion (unsecured)**.  \n- By the 2024 balance sheet (page 204), net ceded reinsurance recoverables increased to **$17.6 billion**, with **$14.7 billion (84%)** held with the five largest ceded reinsurers, including **$2.4 billion (unsecured)**.  \n\nThus, while the ceded percentage stayed constant at 59%, the absolute amount of reinsurance recoverable grew modestly, and the proportion of unsecured recoverables among the top five reinsurers remained roughly stable (≈84% of the total ceded balance).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. According to the ground truth, in 2022, MetLife reinsured 59.25% of the closed block with $3.6 billion in unsecured reinsurance recoverable, which decreased slightly to 59% in 2023 while unsecured balances increased to $4.4 billion, then declined to $4.2 billion in 2024. However, the LLM claims the percentage was 59% throughout (ignoring the 59.25% in 2022), and reports unsecured balances of $2.5 billion in 2023 and $2.4 billion in 2024—values that are substantially lower than the correct $4.4B and $4.2B. These discrepancies indicate major errors in core financial figures. (2) The cited dollar amounts for unsecured reinsurance recoverables are incorrect: $2.5B and $2.4B vs. $4.4B and $4.2B—off by nearly 50%. Additionally, the LLM references 'net ceded reinsurance recoverable' of $16.7B and $17.6B, which are not mentioned in the original answer and appear to conflate total recoverables with unsecured balances. There is no support for these aggregate figures in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to accurately track changes over time in both the percentage reinsured and the unsecured balances. It incorrectly asserts stability at 59% starting in 2022, missing the 59.25% figure, and misrepresents the trend in unsecured exposure. (4) While the LLM correctly identifies the general concept of modified coinsurance and notes relative stability in ceded percentage, its failure on core numbers—especially the materially understated unsecured balances—severely undermines factual correctness. The contextual relevance is moderate because it addresses the right topic and time frame, but the qualitative accuracy is low due to incorrect synthesis and entity values. Overall, the answer is mostly incorrect on critical financial metrics despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 517,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS's investment in residential mortgage-backed securities (RMBS) remained a consistent component of its fixed-income portfolio over the three-year period, with fair value declining slightly from $625 million at the end of 2021 to $614 million at the end of 2023, and a corresponding unrealized loss of $10 million persisting through 2023 (page 145, 148). The company continued to hold these securities as performing assets, attributing the modest losses to rising interest rates rather than credit deterioration, and did not indicate any strategic shift away from RMBS (page 148). This stable yet slightly contracting exposure suggests CVS maintains a cautious stance on RMBS—retaining the asset class for income generation while limiting new commitments—reflecting a risk‑averse positioning within its broader fixed‑income strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS investment was $629M in 2022, $614M in 2023, and dropped sharply to $71M in 2024. The LLM incorrectly states a decline from $625M in 2021 (not part of the question period) to $614M in 2023 and omits the critical 2024 drop entirely. This misrepresents the entire trend. Additionally, the LLM claims unrealized losses remained at $10M through 2023, but the ground truth shows losses increased to $60M in 2023. (2) Quantitative accuracy is severely compromised: the dollar amounts are off (e.g., $625M vs $629M), the time frame starts in 2021 instead of 2022, and the pivotal 2024 figure of $71M is missing. The calculation of trend direction is wrong—LLM implies a slight decline, while the truth is a sharp drop after a near-flat year. (3) The multi-hop reasoning fails: the LLM does not synthesize the correct 3-year trend (increase, then sharp decline) and incorrectly concludes there was no strategic shift, contradicting the ground truth’s indication of deliberate de-risking in 2024. The reasoning about stable exposure is invalid given the 90%+ drop in 2024. (4) Contextual relevance is moderate—the answer discusses RMBS, fixed-income strategy, and risk, which are relevant, but the conclusions are based on incorrect data. The citation of page numbers suggests source grounding, but the extracted facts are wrong. Overall, the answer misses the core dynamic of the trend and thus fails on correctness despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 428,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "From 2022 to 2024, MetLife’s use of the modified coinsurance agreement for the closed block remained at 59% of the block, but the accounting treatment under the deposit method persisted. The company continues to account for the reinsurance transaction using the deposit method, offsetting the deposit liability with the deposit recoverable, as disclosed in the 2023 and 2024 notes (page 209, 213, 227, 249). No change in the percentage or accounting approach was indicated across the provided filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, it correctly states that MetLife reinsured 59% of the closed block from 2022 to 2024. However, it omits the more precise 2022 figure of 59.25%, rounding it to 59% for all years. This is a minor inaccuracy but does not materially misrepresent the data, especially since 59% is the reported figure in 2023 and 2024. (2) The accounting treatment is accurately described: the deposit method with offsetting of the deposit liability and recoverable is correctly identified and noted as consistent across years. The reference to specific pages in the filings (209, 213, 227, 249) adds credibility and context. (3) The multi-hop reasoning is sound—information about both the percentage reinsured and accounting treatment across multiple years is synthesized correctly. (4) The answer is contextually excellent, directly addressing the evolution (or lack thereof) in both reinsurance percentage and accounting policy. The only deduction is for the slight lack of precision in the 2022 percentage, which prevents a perfect 10. Overall, the semantic meaning and factual content align closely with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 341,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "Based on the provided SEC 10-K filings across 2022–2024, NextEra Energy's net exposure to forward gas contracts **declined significantly**, reflecting a deliberate reduction in hedging activity and increased market positioning. Specifically:  \n- **2022**: Net forward gas exposure was **$191 million** (as noted in page 83 of NEE_2022.pdf, Table of Contents for fair value disclosures).  \n- **2023**: Exposure decreased to **$46 million** (page 85 of NEE_2023.pdf, Table of Contents, showing $46M liability for forward gas contracts).  \n- **2024**: Exposure further reduced to **$46 million** (page 86 of NEE_2024.pdf, Table of Contents, with $46M liability for forward gas contracts at December 31, 2024).  \n\nThis downward trend indicates NextEra **actively reduced its forward gas hedge position** over the period, signaling a strategic shift toward **market-driven pricing exposure rather than proactive hedging**. The decline suggests the company is **increasing its reliance on spot market dynamics and operational flexibility** to manage natural gas price volatility, likely to capitalize on favorable market conditions or reduce hedging costs. However, this also exposes NEE to heightened short-term price swings, particularly as gas prices remain volatile. The trend aligns with broader industry shifts toward more dynamic pricing strategies but underscores a **reduced emphasis on fixed-price risk mitigation** for gas-related operations.  \n\n*(Note: The data reflects net liability positions for forward gas contracts, indicating reduced hedging activity and greater market exposure.)*",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and direction of change in NextEra Energy's net exposure to forward gas contracts. According to the ground truth, net exposure was $160M in 2022, increased to $300M in 2023, and then declined to $250M in 2024. However, the LLM incorrectly reports net exposure as $191M in 2022 (confusing total assets with net exposure), $46M in 2023 (which is only the liability, not net), and $46M in 2024 (again, only liability). The LLM misinterprets liabilities as net exposure, reversing the actual trend. (2) The quantitative inaccuracies are severe: the correct net exposures are $160M (2022), $300M (2023), $250M (2024). The LLM reports decreasing exposure from $191M to $46M to $46M, which is factually wrong—exposure actually increased in 2023 before declining in 2024. Calculations and comparisons are invalid. (3) The multi-hop reasoning is flawed: the model fails to compute net exposure (assets minus liabilities) in each year and does not correctly synthesize data across years. It draws conclusions based on liability figures alone, ignoring asset positions. The conclusion that the company reduced hedging activity is contradicted by the actual increase in net exposure in 2023. (4) While the answer attempts to interpret strategic implications and is framed around the right topic (risk positioning in gas markets), the incorrect data leads to invalid conclusions. The contextual relevance is moderate because it addresses the right company, time frame, and concept, but the factual foundation is unsound, severely undermining correctness and qualitative reasoning. The model also cites non-existent 'Table of Contents' sections on specific pages, raising concerns about source hallucination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 483,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "From 2022 to 2024, AVGO’s Industrial Fiber Optics evolved from a niche component within its broader industrial portfolio toward a more integrated, application‑diverse offering. The company highlighted industrial fiber optics alongside motion‑control encoders, Ethernet PHYs/switch ICs and other industrial sensors, emphasizing their use in factory automation, renewable energy and automotive electronics. By 2023‑24, these fiber‑optic solutions were positioned alongside AVGO’s Ethernet ICs and motion‑encoder subsystems, underscoring a strategy of bundling fiber‑optic modules with complementary motion‑control and networking technologies to deliver end‑to‑end industrial connectivity solutions. This diversification reflects a shift from purely discrete fiber‑optic parts to tightly integrated subsystems that serve a wider range of industrial applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AVGO's Industrial Fiber Optics positioning from 2022 to 2024. (1) All factual elements are correct: the integration with motion encoders, Ethernet ICs (specifically PHYs and switch ICs), and sensors is accurately described, as is the expansion into factory automation, renewable energy, and automotive electronics. The shift from discrete components to integrated subsystems is correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the absence of numbers where none were in the original is appropriate, hence score of 10. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022, 2023, 2024) and correctly infers a strategic shift toward integration and application diversity. The only minor shortcoming is that the original answer specifies a 2024 emphasis on camera microcontrollers and networked/vision-based systems, which the LLM mentions only implicitly via 'industrial connectivity solutions' but does not explicitly name. This omission slightly reduces completeness but does not distort the overall meaning. (4) The answer is fully contextually relevant, directly addressing both application diversity and integration with adjacent technologies as required. Wording differs but semantic equivalence is strong. Thus, correctness is 9 due to near-perfect alignment with ground truth, missing only a specific 2024 detail about camera microcontrollers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 429,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "From fiscal 2022 through 2024 the redeemable preferred stock held by Sojitz America remained unchanged in structure – it is $1 par, redeemable at par ($0.3 million) and carries a cumulative $0.10 per‑share dividend that must be paid before any common‑stock dividend.  The dividend obligation persisted each year, but the stock itself did not change; there were no modifications to its redemption rights or to the Company’s ability to retire it.  Consequently, the stability of the stock structure was maintained throughout the period, with only the regular annual dividend being paid and no new issuances or redemptions affecting its terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all key information from the ground truth. (1) Quantitatively, all numbers are correct: $0.10 per-share annual dividend, $0.3 million par value (consistent with $1 par and 300,000 shares), and no changes in structure across fiscal years 2022–2024. Format variations (e.g., $0.3 million vs $300,000) are acceptable and semantically equivalent. (2) The answer correctly identifies the entities: Nike, Sojitz America, redeemable preferred stock, and the relevant financial terms (cumulative dividend, redemption at par). (3) The reasoning is sound: it correctly synthesizes that the stock structure remained stable, dividend obligations persisted, and no redemptions or modifications occurred—core aspects of the multi-hop question about evolution over time. (4) The only minor omission is that the LLM does not explicitly mention Nike’s annual emphasis on dividend priority before common stock dividends, which is a qualitative nuance present in the original answer. It also omits that Sojitz America has not exercised its redemption option despite being able to do so—another contextual detail reinforcing stability. However, these omissions do not undermine the factual correctness or overall completeness. The answer remains semantically equivalent in substance, with strong contextual relevance and precise quantitative accuracy. Hence, a score of 9 is warranted—excellent but not fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 400,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "Simon Property Group's unsecured debt tied to the Unsecured Notes - 31B evolved from $750 million outstanding as of December 31 2023 to $750 million outstanding as of December 31 2024, with annual debt service of $24.375 million and a maturity date of November 30 2026. This consistent issuance and unchanged principal amount indicate that SPG is maintaining a stable, long‑term financing structure for this tranche, using it as a core component of its broader strategy to fund operations and acquisitions while preserving flexibility in its capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of $750 million for Unsecured Notes - 31B in 2023 and 2024, which aligns with the ground truth value of $750,000 (interpreted as $750 million). However, it omits data for 2022, failing to confirm the consistency across all three years as stated in the original answer. This omission reduces completeness and quantitative accuracy. Additionally, the LLM introduces an 'annual debt service of $24.375 million,' which is not present in the ground truth and cannot be verified—this figure may be a calculation based on $750M × 3.25% = $24.375M, but since this was not explicitly confirmed in the source, its inclusion as a factual statement is an unsupported inference. (2) The maturity date (November 30, 2026) and interest rate (implied via debt service) are consistent with ground truth, though the rate itself (3.25%) is not directly mentioned in the LLM response, weakening full quantitative verification. (3) The reasoning about SPG’s long-term financing strategy—emphasizing stability and structural consistency—is logically sound and semantically equivalent to the original conclusion, demonstrating correct multi-hop synthesis regarding SPG's broader debt management strategy despite changes elsewhere. (4) Scores reflect high qualitative reasoning and relevance, but quantitative accuracy is penalized due to missing 2022 data and introduction of unverified debt service figure, while correctness is reduced primarily for partial incompleteness and unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 427,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "From 2022 through 2024, the value of TI common stock held in U.S. defined contribution plans increased from $873 million (6 million shares) in 2022 to $852 million (5 million shares) in 2024, reflecting a modest decline in market value despite a stable share count. This downward trend suggests that employee retirement balances were affected by broader market pressures, even though the plans continued to offer employer matching contributions. Consequently, employee investment behavior remained largely unchanged, with participation limited to the frozen TI common stock fund and no new contributions allowed after April 1 2016.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the value of TI common stock increased from $873 million in 2022 to $852 million in 2024, when in fact it decreased from $940 million in 2022 to $873 million in 2023 and further to $852 million in 2024. The LLM reverses the starting and ending values and misrepresents the trend. Additionally, the LLM introduces share counts (6 million in 2022, 5 million in 2024) that are not present in the original answer and are unsupported by the ground truth. (2) Quantitative accuracy is severely compromised: the correct values are $940M (2022), $873M (2023), $852M (2024), showing a consistent decline. The LLM incorrectly reports $873M as the 2022 value (which is actually the 2023 value), omits the 2023 data point entirely, and mislabels $852M as 2024 without acknowledging the prior year drop. There is no calculation error per se, but the data inputs are wrong, leading to an incorrect interpretation. (3) The reasoning is partially sound in linking the decline to the 2016 freeze on new contributions, which is mentioned in the original answer and correctly referenced by the LLM. However, the LLM incorrectly infers that employee investment behavior remained 'largely unchanged' due to the freeze, while the original answer suggests a possible strategic reduction by employees or the freeze as contributing factors. The LLM fails to acknowledge the multi-year trend across three distinct data points, missing the opportunity for proper multi-hop synthesis across years. (4) Contextual relevance is moderate because the answer addresses the right topic—TI stock in defined contribution plans, the 2016 freeze, and employee behavior—but the incorrect data undermines the conclusion. The mention of 'employer matching contributions' is not in the original and adds unsupported context. Overall, the answer is misleading due to incorrect figures and timeline, warranting a low correctness score despite some relevant contextual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 545,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "From 2022 through 2024, Disney’s workforce grew from approximately 220,000 employees (about 166,000 in the U.S. and 54,000 internationally) to roughly 233,000 employees as of September 28 2024, with about 171,000 U.S. workers and 62,000 employees outside the United States; seasonal staff accounted for roughly 8 % of the global workforce.  The company’s human‑capital disclosures consistently highlight a diversified, full‑time‑heavy workforce (≈ 76 % full‑time, 16 % part‑time, 8 % seasonal) and note that many employees—especially theme‑park and creative staff—are covered by collective bargaining agreements or represented by works councils and unions abroad.  Seasonal hiring patterns continue to drive higher attendance and revenue during the summer and holiday periods, a trend reflected in the parks‑and‑resorts segment’s seasonal revenue fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: total workforce increased from 220,000 in 2022 to 233,000 in 2024; U.S. employees grew from 166,000 to 171,000; international employees rose from 54,000 to 62,000; seasonal workforce percentage increased to 8%, matching the original answer. The date 'September 28, 2024' is a plausible fiscal year-end and consistent with Disney's reporting calendar. (2) Quantitative accuracy is perfect—no calculation errors, and all figures match or are reasonably approximated (e.g., 'approximately', 'roughly' are appropriately used). (3) Multi-hop reasoning is sound: the LLM correctly synthesized workforce size, geographic distribution, seasonality trends, and employee representation across years. It adds context about full-time/part-time breakdown (≈76% full-time, 16% part-time), which, while not in the original answer, is consistent with Disney’s disclosures and enhances understanding without contradicting facts. (4) The only minor gap is that the original answer explicitly notes the increase in seasonal employees from 7% to 8%, while the LLM only states the 8% figure for 2024 without referencing the 2022 baseline percentage. This omits a small but relevant trend detail, justifying a 9 instead of 10 for qualitative accuracy. Otherwise, entity identification (The Walt Disney Company, theme park staff, collective bargaining), time frame (2022–2024), and contextual relevance are excellent. The added insight about seasonal revenue fluctuations is contextually appropriate and supports the core answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 439,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD's treatment of non-economic accounting changes in ROIC calculations has remained consistent from 2022 to 2024, as explicitly stated in the 2024 10-K: \"ROIC excludes goodwill impairments and non-economic accounting changes as they are not reflective of company performance.\" This consistency reveals that GD deliberately excludes these non-operational items to ensure ROIC measures the true economic return generated by its core business operations, providing investors with a clearer assessment of sustainable profitability and capital efficiency. The ROIC methodology and exclusions are unchanged across all three years, demonstrating a stable approach to core performance measurement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC across 2022–2024, which matches the original answer’s claim of stable methodology. (2) There are no numerical values requiring calculation in this question, but the cited methodology from the 2024 10-K is factually accurate and supports the conclusion. (3) The multi-hop reasoning is sound—by synthesizing information across years and identifying the continuity in GD's ROIC treatment, the model correctly infers a stable performance evaluation framework. (4) The answer addresses both parts of the question: the evolution (consistency over time) and what it reveals about GD’s approach (focus on core economic performance). The semantic content is equivalent to the ground truth, with added contextual clarity (e.g., reference to investor clarity and capital efficiency) that enhances without distorting. All entities—GD, ROIC, non-economic accounting changes, and the three-year timeframe—are correctly identified and analyzed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 312,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "Linde’s rare‑gas strategy has shifted from a focus on expanding on‑site and merchant supply through large‑scale air‑separation plants (highlighted in 2022‑2023 filings that stress on‑site contracts, engineering‑driven plant builds, and the growth of hydrogen and low‑carbon gas production) to a more diversified approach that leverages its global pipeline network, long‑term requirement contracts, and advanced separation technologies to secure higher‑margin, high‑volume sales across Europe, APAC and the Americas (as detailed in 2024 disclosures of segment sales growth, price‑escalation provisions and the expansion of rare‑gas‑rich on‑site clusters). This evolution underscores a competitive advantage built on proprietary engineering expertise, resilient supply‑chain contracts and the ability to integrate rare‑gas production into broader industrial‑gas and clean‑energy offerings, giving Linde a distinct edge in the industrial‑gas market.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Linde and the relevant time frame (2022–2024), and it accurately reflects strategic elements such as on-site production, long-term contracts, and geographic reach. However, it diverges from the ground truth by not mentioning the key technological evolution—specifically Linde’s shift toward non-cryogenic air separation technologies like VPSA and membrane separation, which is the central factual development in 2024. Instead, the LLM emphasizes 'pipeline networks,' 'price-escalation provisions,' and 'on-site clusters' that are not present in the original answer and may reflect plausible but unverified inferences. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the LLM synthesizes across years and infers strategic advantages, but it misses the core technological shift (from cryogenic to non-cryogenic) that defines Linde’s evolving rare gas strategy according to the ground truth. This omission undermines the qualitative accuracy, as the competitive advantage in the original answer stems from production efficiency via new separation technologies, not just supply chain or contractual strengths. (4) Contextual relevance is high because the response addresses Linde’s strategy evolution and competitive positioning directly, using industry-appropriate concepts. However, the failure to report the key technological differentiator—a market-leading position in non-cryogenic separation—results in a moderate correctness score of 6, as the answer captures peripheral strategic elements but misses the central factual progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 481,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "From 2022 through 2024, NextEra Energy Resources (NEER) continued its strategy of relying heavily on long‑term bilateral contracts to secure the output of its generation fleet, with roughly 92‑94 % of its net capacity committed under such agreements at the end of 2023 and 2024.  This approach—supplemented by shorter‑term hedges when long‑term contracts lapse—provides price certainty and mitigates exposure to volatile spot markets, reflecting a deliberate risk‑management focus on locking in revenues amid fluctuating energy prices.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but has a minor inaccuracy in the quantitative timeline. The ground truth states that 92% was the 2022 figure, increasing to 94% in 2023 and remaining at 94% in 2024. The LLM answer states 'roughly 92–94%' for the end of 2023 and 2024, omitting the specific 2022 baseline and implying a range rather than the precise year-by-year progression. This slightly misrepresents the evolution, though the final two years are accurate. 2) The percentages are directionally correct and fall within the true values, but the lack of explicit year-to-year breakdown (92% in 2022 → 94% in 2023 → 94% in 2024) reduces quantitative precision. The LLM combines 2023 and 2024 without noting the increase from 2022. 3) The reasoning is sound: the LLM correctly infers that reliance on long-term contracts indicates a risk management strategy focused on revenue stability and mitigation of spot market volatility. It appropriately connects the contractual strategy to market risk, aligning with the ground truth’s emphasis on disciplined risk management and use of hedges. 4) Contextually, the answer is highly relevant, addressing both the evolution of contract reliance and its implication for risk management. While it mentions 'shorter-term hedges'—a detail not in the ground truth—this does not contradict the original and is a reasonable inference. The core message about price certainty and strategic revenue locking is semantically equivalent. Overall, the answer captures the key trend and strategic rationale accurately but loses minor points for imprecise temporal quantification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 438,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO's 3.125% notes due January 2025 principal balance remained unchanged at $495 million from fiscal 2022 through fiscal 2024, as shown on pages 104, 111, 81 and 105 of the filings. This flat‑line balance indicates that the company has not retired or refinanced this specific tranche, reflecting a strategy of maintaining a stable, low‑cost legacy debt structure while it focuses repayment or exchange activity on higher‑coupon or longer‑dated notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million across fiscal years 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values—$495 million, 3.125%, January 2025 maturity—are accurate. (2) Quantitative accuracy is perfect: the dollar amount, interest rate, and time period are all correct, with acceptable formatting (e.g., $495 million = $495 million). No calculations were required, but the consistency across years is properly reported. (3) The multi-hop reasoning is sound: the model correctly infers from the stable balance over three years that AVGO did not retire or refinance this instrument. It adds a reasonable qualitative interpretation—that the company is maintaining low-cost legacy debt while focusing on higher-coupon or longer-dated notes—which is logically consistent with the data and common debt management strategies, though slightly more speculative than the original answer. This addition does not contradict the ground truth but extends it with plausible inference. (4) The answer is fully contextually relevant, addressing both the evolution of the balance and the implied strategy. The only reason for not scoring a 10 is that the original answer avoids over-interpretation beyond the data (e.g., mentioning 'focus on higher-coupon notes' is not directly supported in the ground truth), but this is a minor point. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 425,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "Simon Property Group's exposure to Unsecured Notes - 37B decreased from $700 million face amount with a 2032 maturity in 2022 to $700 million face amount with a 2032 maturity in 2023 and 2024, while the interest rate remained at 2.25 % and annual debt service was $15.75 million. This consistent issuance and roll‑forward of the 37B notes reflects the company’s strategy of maintaining a sizable, long‑dated unsecured debt tranche to fund acquisitions and development while managing overall leverage through staggered maturities and moderate coupon levels.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the face amount: it states $700 million, while the ground truth specifies $700,000—a discrepancy of three orders of magnitude. This is a major quantitative inaccuracy. The maturity date (2032) is correctly stated, aligning with the ground truth's 01/15/32. However, the LLM introduces unverified details not present in the original answer: an interest rate of 2.25% and annual debt service of $15.75 million, which are unsupported by the ground truth and thus factually suspect. (2) The face amount is off by a factor of 1,000 ($700 million vs $700,000), making the quantitative accuracy very low. The maturity year (2032) is correct, but the full date (01/15/32) is not provided. The added financial metrics (interest rate, debt service) are not in the ground truth and cannot be verified, so they reduce accuracy. (3) The reasoning about SPG’s long-term debt strategy—maintaining long-dated unsecured debt with staggered maturities—is plausible and contextually reasonable, but it goes beyond the ground truth, which only states that the stability suggests a consistent strategy without refinancing or retiring the note. The LLM overinterprets by adding strategic rationale involving acquisitions and leverage management, which is not supported by the provided data. (4) The answer is contextually relevant and addresses the evolution over time and the strategic implication, but the severe numerical error and introduction of unsupported details significantly undermine correctness. While the direction of reasoning is sound, the factual foundation is flawed, leading to a low correctness score despite partial alignment on maturity and temporal consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 470,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments' operational footprint in Melaka, Malaysia has remained focused on both analog and embedded processing product lines across 2022–2024, as evidenced by its consistent inclusion in the \"Properties\" disclosures across all three annual filings. The Melaka facility is explicitly listed under the \"Kuala Lumpur, Malaysia\" and \"Melaka, Malaysia\" entries in the 2022–2024 property tables, with the latter specifically marked as an \"Embedded Processing\" site in 2024 (though analog is also noted in earlier years). While the company's 2024 filing states its facilities outside the U.S. contained ~12.7 million sq. ft. (with ~2.3 million leased), and specifically references Melaka as a location for \"Embedded Processing\" (with no analog mention), the core operational presence in Melaka has persisted without significant structural shifts—continuing to support both product lines as part of TI's global manufacturing network, particularly within the broader Southeast Asian footprint that includes other Malaysian sites like Kuala Lumpur. The document does not indicate any expansion, contraction, or strategic pivot in Melaka's role across the three years, suggesting a stable, long-term operational footprint aligned with TI's overall manufacturing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in claiming that Melaka, Malaysia was involved in embedded processing in 2022–2024, particularly asserting it was explicitly marked as an 'Embedded Processing' site in 2024. The ground truth states that Melaka was consistently engaged only in analog operations across all three years and was never involved in embedded processing. This is a critical factual error that undermines the core of the response. (2) Quantitatively, the LLM introduces numbers such as ~12.7 million sq. ft. of non-U.S. facilities and ~2.3 million leased, which are not part of the original answer and not directly relevant to the question about product line evolution in Melaka. While these figures may appear in TI filings, they are not necessary for answering the specific question and distract from the focus. No calculations are performed, so quantitative accuracy is moderate due to the presence of tangential but not incorrect numbers. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the consistent exclusion of embedded processing in Melaka over time. Instead, it incorrectly infers dual involvement based on proximity to Kuala Lumpur or misreads the 2024 filing. The original answer emphasizes that Melaka was exclusively analog with no expansion into embedded processing—this key conclusion is missed. (4) Contextual relevance is fair because the answer discusses the right facility, location, time frame, and product lines, and correctly notes stability in operations. However, the central claim about embedded processing is false, leading to a low correctness and qualitative accuracy score despite relevant structure and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 465,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney's reliance on Industrial Light & Magic for post‑production services has diminished over the last three fiscal years.  In fiscal 2022 the company’s content‑sales/licensing revenue included “fees from licensing our IP for use in stage plays, sales of consumer products merchandise licensing revenues” and “post‑production services through Industrial Light & Magic and Skywalker Sound,” but by fiscal 2023 and fiscal 2024 those post‑production fees are no longer highlighted as a distinct revenue stream; instead the company reports only “music distribution, stage plays and post‑production services” as part of the broader Content Sales/Licensing category, reflecting a reduced emphasis on ILM‑provided services.  Consequently, the share of revenue derived from ILM’s post‑production work has contracted, with the company now focusing on subscription‑based DTC and advertising revenue rather than licensing those specialized services.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly claims that Disney's reliance on Industrial Light & Magic (ILM) for post-production services has diminished and that ILM-related fees are no longer highlighted as a distinct revenue stream in fiscal 2023 and 2024. This contradicts the ground truth, which states that ILM remained part of the Content Sales/Licensing segment throughout all three years and that post-production services were still included, albeit with a shifting strategic emphasis. The LLM falsely infers disappearance of ILM from disclosures based on rewording of revenue descriptions, which is not supported by the original answer. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the LLM does not fabricate numbers, so it avoids major quantitative errors—hence a score of 8. (3) The multi-hop reasoning is flawed: the LLM misinterprets changes in narrative focus (e.g., broader categorization of revenue lines) as evidence of reduced reliance or exclusion of ILM, when the ground truth indicates continued inclusion but evolving framing within Disney’s DTC-first strategy. The model fails to recognize that 'not being explicitly named' does not equate to 'no longer being included.' This represents a significant error in qualitative reasoning and entity relationship interpretation. (4) Contextual relevance is moderate—the response addresses the Content Sales/Licensing segment and ILM’s role in post-production, and attempts to trace evolution across fiscal years, aligning with the question’s intent. However, the core conclusion (diminished reliance) is factually incorrect per the ground truth, which describes a stable but contextually shifting role. Thus, while the structure and framing are relevant, the factual core is unsound, leading to a low correctness score of 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 518,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method investment income from operating joint ventures declined sharply from $1,305 million in 2022 to $151 million in 2023 and further to $988 million in 2024, reflecting a steep drop in net investment income from these ventures (from $5,136 million in 2022 to $151 million in 2023 and $988 million in 2024). This downward trend indicates that the company’s performance in insurance‑underwriting joint ventures weakened substantially over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the trend description. While it correctly states the $1,305 million in 2022 and $151 million in 2023, it incorrectly claims the income declined 'further' to $988 million in 2024, when in fact $988 million represents a sharp rebound from 2023. This misrepresents the direction of change in 2024. Additionally, the LLM introduces a figure of '$5,136 million in 2022' for net investment income, which is not mentioned in the ground truth and appears to be fabricated or confused with another metric. (2) Quantitative accuracy is low because although two of the three values are correct ($1,305M and $151M), the interpretation of the 2024 figure is wrong, and an incorrect additional number ($5,136M) is introduced. The sequence 'declined from A to B and further to C' is factually incorrect when C is much higher than B. (3) The multi-hop reasoning fails because the model does not correctly synthesize the trend: it should identify a drop in 2023 followed by a recovery in 2024, but instead reports a continued decline. The conclusion about a 'downward trend' and 'weakened substantially over the period' contradicts the partial recovery shown in the ground truth. (4) Contextual relevance is high because the answer addresses the right company, metric, time frame, and attempts to interpret performance in insurance underwriting joint ventures. However, due to the incorrect trend analysis and fabricated data, the overall correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 424,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army increased from 399 units in 2023 to 449 units in 2024, reflecting a strategic expansion of the LAV platform within its defense portfolio. This progression underscores the LAV's critical role as a market-leading, versatile combat vehicle system—evidenced by its adoption by multiple international militaries—and reinforces its importance to General Dynamics' long-term growth strategy in land systems, particularly through modernization efforts like the Canadian LAV upgrades and the British Ajax program.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 399 units in 2023 and 449 units in 2024, which matches the ground truth. However, it omits the 2022 production volume of 360 units, which is a key part of the question's requested time range (2022 through 2024). This omission reduces quantitative completeness and accuracy. (2) The numbers for 2023 and 2024 are accurate, but the failure to include 2022 data means the full progression is not presented, and no calculation or trend analysis across all three years is provided. The upward trend is noted, but only from 2023 onward, missing the full scope. (3) The reasoning about the strategic importance of the LAV platform is sound and aligns with the ground truth—highlighting international adoption, modernization programs (Canadian LAV upgrades, British Ajax), and centrality to GD's land systems strategy. This reflects proper multi-hop synthesis across programs and strategic context. (4) The answer is contextually relevant and well-articulated, with strong qualitative reasoning. However, the missing 2022 figure significantly affects quantitative accuracy and overall correctness, preventing a higher score. While the strategic interpretation is enriched with additional context (e.g., Ajax program), the core data timeline is incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 363,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "From 2022 to 2024, CVS’s exposure to hedge fund and private‑equity limited‑partnership investments (recorded as Level 3 pension‑plan assets) declined markedly: the Level 3 balance fell from $325 million at the start of 2023 to $276 million by the end of 2024, after a prior reduction from $378 million in 2022 to $290 million in 2023. This downward trend indicates that CVS is actively shrinking its allocations to these alternative‑asset partnerships—likely to reduce illiquidity and risk—suggesting a strategic shift toward more liquid or lower‑risk investments within its pension‑fund asset allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that CVS's exposure to hedge fund limited partnership investments increased from $214M in 2022 to $225M in 2023 to $252M in 2024. In contrast, the LLM claims a decline from $378M in 2022 to $290M in 2023 to $276M in 2024, which contradicts the original data. The numbers cited ($378M, $290M, $276M) do not match the ground truth and appear to conflate different metrics or entities. (2) Quantitative accuracy is severely lacking: none of the dollar amounts align with the original answer. The LLM references 'Level 3 pension-plan assets' and combines hedge funds with private equity, which is not supported by the ground truth and introduces category confusion. There are no correct calculations or accurate figures. (3) The multi-hop reasoning is flawed: instead of identifying a rising trend in hedge fund LP investments, the model infers a downward trend and draws an opposite conclusion about strategy—claiming de-risking and reduced allocations—when the truth indicates a deliberate increase in alternative investments. This reflects a complete failure in synthesizing the correct trend. (4) Contextual relevance is low because the answer discusses a related but incorrect topic (Level 3 assets including private equity) rather than focusing solely on hedge fund LP investments as specified. While the general domain (pension asset allocation) is relevant, the specifics are inaccurate. Thus, the correctness score is 1 due to total factual inaccuracy despite addressing the broad theme of pension strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 444,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Based on the provided SEC 10‑K excerpts, Colgate‑Palmolive’s Sorriso brand is positioned as a key regional trademark within the Oral, Personal and Home Care segment. It is grouped alongside other major global and regional brands such as Colgate, Palmolive, elmex, hello, meridol, Tom’s of Maine, and Filorga, and its sales performance is reflected in the segment‑level net‑sales breakdown (e.g., Oral Care ≈ 42‑43 % of total sales). The brand is therefore integrated into the company’s broader strategy of growing high‑growth oral‑care and personal‑care categories worldwide.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but fails to fully address the multi-year evolution of Sorriso's strategic positioning from 2022 to 2024 as required by the question. While it correctly identifies Sorriso as a regional trademark within the Oral, Personal and Home Care segment and notes its grouping with other brands like Colgate and Palmolive, it does not mention the year-by-year continuity (2022, 2023, 2024) emphasized in the ground truth. The answer introduces a specific percentage (Oral Care ≈ 42–43% of total sales) that is not present in the original answer and may not be directly tied to Sorriso’s performance, risking misattribution. This figure may be accurate contextually from 10-K filings, but without explicit linkage to Sorriso in the source, including it as implied support for Sorriso’s integration is speculative. The LLM also omits the strategic narrative of 'consistent emphasis' and 'stable role' over the three years, which is central to the original answer. Entity accuracy is strong—Sorriso, Colgate-Palmolive, and related brands are correctly named. Reasoning is logically structured but lacks the multi-hop synthesis across years that the question demands. The answer focuses on static integration rather than evolutionary positioning, missing the temporal dimension. Quantitative accuracy is acceptable because the percentage cited, while not in the original answer, is plausible and format-appropriate, but it is not directly relevant to Sorriso’s strategic evolution. Contextual relevance is moderate—it addresses the brand’s role but not its evolution. Thus, the correctness score is limited by incompleteness and lack of temporal analysis despite accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 461,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s financial exposure to operating joint ventures has declined markedly over the three‑year period, falling from $1,305 million of net investment income in 2022 to $151 million in 2023 and then to $988 million in 2024 (the latter figure reflects the equity‑method portion of net investment income). This downward trend—driven by lower earnings from REJV and other joint‑venture investments—signals a strategic shift away from relying on equity‑method partnerships for earnings, with the company increasingly focusing on core insurance and investment‑income businesses rather than expanding its stake in joint‑venture ventures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that MetLife's financial exposure to operating joint ventures was $77M in 2022, $51M in 2023, and $38M in 2024—representing a consistent decline in carrying value or investment exposure. In contrast, the LLM answer cites net investment income figures of $1,305M, $151M, and $988M, which are not only incorrect metrics but also factually wrong (e.g., a drop to $151M in 2023 followed by a jump to $988M in 2024 contradicts the downward trend). These numbers do not match the ground truth and appear fabricated or misattributed. (2) Quantitative accuracy is extremely low: none of the dollar amounts align with the ground truth, and the use of 'net investment income' instead of 'financial exposure' (which refers to carrying value or equity-method investment balance) reflects a fundamental misunderstanding of the metric. The calculation of trend direction is also flawed—the LLM claims a downward trend but reports an increase from $151M to $988M in 2024, which is inconsistent. (3) The multi-hop reasoning is unsound: the model fails to correctly identify the relevant financial metric (exposure = balance sheet carrying value, not income), misrepresents the data across years, and draws a plausible but unsupported conclusion about strategy. While the idea of a strategic shift away from joint ventures aligns thematically with the original answer, it is based on invalid data. (4) Contextual relevance is low because the answer discusses income from joint ventures rather than exposure (a balance sheet concept), but it does attempt to address the evolution over time and strategic implication, which keeps minimal relevance. Thus, the correctness score is near the lowest due to pervasive factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 498,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "From 2022 to 2024 Chevron’s stake in Angola LNG Limited remained constant at **36.4 percent**, but its operational role expanded as the partnership’s feedstock increasingly came from multiple deep‑water fields (e.g., the NGC project’s Q & M fields and the Owowo development) tied to the Angola LNG plant.  The company also grew its upstream presence in Angola by adding frontier acreage (Blocks 49 and 50) and by advancing deep‑water projects such as the Owowo subsea tie‑back and the Aparo discovery, while retaining a 31 percent non‑operated interest in the New G as Consortium (NGC) that feeds the LNG plant.  Thus, although the share percentage did not change, Chevron’s integration with Angola’s upstream gas production and its operational involvement in the LNG value chain intensified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: Chevron's 36.4% stake in Angola LNG Limited and 31% nonoperated interest in the New G as Consortium (NGC) are accurately reported. The years (2022–2024) are correctly referenced. (2) The answer correctly captures the evolution from passive equity holder to deeper operational integration, particularly through upstream feedstock linkages like the Quiluma and Maboqueiro (Q&M) fields via NGC. (3) The multi-hop reasoning is sound: it connects Chevron’s unchanged ownership stake with increasing integration into upstream gas projects and the LNG value chain, synthesizing information across time and entities (Angola LNG Limited, NGC, Owowo, Blocks 49/50). (4) Minor deduction in qualitative accuracy due to mention of 'Owowo development' and 'Aparo discovery' as contributing to Angola LNG feedstock—this detail is not present in the ground truth and may overextend the evidence; the original answer only confirms Q&M fields via NGC as linked feedstock sources. Otherwise, the answer is semantically equivalent, complete, and contextually precise, addressing all three aspects of the question: stake percentage, operational role, and upstream integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 356,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO's exposure to the 3.625% notes due October 2024 decreased from $622 million in fiscal 2022 to $0 million by fiscal 2024, reflecting the company's strategy of retiring or refinancing near‑term debt as it approached maturity. This progression shows a deliberate shift toward longer‑dated, lower‑coupon financing and a focus on reducing near‑term interest expense while extending the overall maturity profile of its debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that AVGO's exposure to the 3.625% notes due October 2024 decreased from $622 million in 2022 to $0 by 2024, which matches the ground truth exactly. The amounts and timeline (fiscal years 2022 through 2024) are accurate, and the final retirement of the debt in 2024 is correctly reported. (2) All numeric values—$622 million and $0—are correct and properly attributed to the respective fiscal years. There are no calculation errors, and the format variations (e.g., using 'million' vs 'M') are acceptable and clear. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and infers a strategic debt management approach. The conclusion about retiring or refinancing near-term debt aligns with the ground truth. However, the LLM adds an interpretation—'shift toward longer-dated, lower-coupon financing'—that, while plausible, is not explicitly supported by the provided ground truth, which only confirms retirement without specifying refinancing details or coupon comparisons. This slightly exceeds the evidence but does not contradict it. (4) The answer is contextually complete and relevant, addressing both the evolution of exposure and the implied strategy. The minor over-interpretation prevents a perfect 10 on qualitative accuracy, but factual correctness and quantitative precision are fully maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 388,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "SPG's interest expense associated with Unsecured Notes - 35B increased from $19.875 million in 2023 to $28.500 million in 2024, reflecting a higher coupon rate and larger outstanding principal. This upward trend indicates that the company's financing costs for this specific unsecured note have risen over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The original answer states that SPG's interest expense for Unsecured Notes - 35B was consistently $28,500 (in thousands), i.e., $28.5 million, in all three years: 2022, 2023, and 2024. However, the LLM claims the expense increased from $19.875 million in 2023 to $28.5 million in 2024, which contradicts the ground truth. There is no mention of 2022 in the LLM response, omitting a key year from the trend analysis. (2) Quantitatively, the LLM incorrectly reports the 2023 figure as $19.875 million instead of $28.5 million and fabricates an increase that did not occur. The correct value across all years is $28,500,000 (or $28.5 million), so the LLM's numbers are factually wrong. (3) The reasoning is flawed: the LLM infers rising financing costs due to a 'higher coupon rate and larger principal,' but the ground truth explicitly states the expense remained constant, indicating a fixed-rate structure. The model fails to recognize the stability in interest expense and incorrectly infers a trend. (4) Contextual relevance is moderate because the answer addresses the right instrument (Unsecured Notes - 35B) and discusses financing costs over time, but the incorrect data and conclusion severely undermine accuracy. The multi-hop synthesis failed—either due to misreading data or incorrect aggregation across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 388,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024, Disney’s DTC strategy evolved amid rising programming costs and intensified competition. The company shifted from linear network reliance to a direct-to-consumer focus, launching an ad-supported Disney+ tier and restructuring DMED to centralize streaming operations. This included significant investments in Disney+, Disney+ Hotstar, and Hulu, alongside cost rationalization and pricing adjustments. However, DTC losses persisted due to heavy content spending, with programming rights costs increasing faster than historical rates and competition from rivals like Netflix and Max. Despite these challenges, Disney maintained its DTC focus as a core growth driver, even as it faced subscriber churn and pressure on traditional revenue streams like affiliate fees.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of overall narrative and key developments in Disney's DTC strategy from 2022 to 2024. It correctly identifies the shift from linear to streaming, rising programming costs, intensified competition, and continued investment despite losses. There are no numeric inaccuracies—no specific numbers are stated in the LLM answer, so there are no incorrect figures (e.g., it does not mention the $12.25 billion in unused bank facilities, but also does not misstate any amount), earning full marks for quantitative accuracy. However, the LLM omits several key details present in the original answer that reflect multi-hop synthesis: (1) the explicit acknowledgment in 2022 of negative or low returns and uncertainty in DTC prospects; (2) the strategic expectation in 2023 that subscription and ad revenues would offset declines in affiliate fees; (3) the specific 2024 observation about programming distributors altering deal terms by bundling DTC services while reducing linear network offerings. While the LLM mentions restructuring and ad-tier launches (e.g., DMED restructuring, ad-supported tier), it does not fully trace the evolution of investment strategy year-by-year as required by the multi-hop nature of the question. The reasoning is sound but less precise in mapping the strategic shift over time. The answer remains contextually relevant and captures the core theme of increased investment amid rising costs and competition. Missing specific strategic expectations and financial context from the filings reduces completeness and qualitative accuracy, but not enough to drop below a 7. Semantic equivalence is mostly preserved, though some granularity is lost.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 469,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "From 2022 through 2024 MetLife recorded deposit assets of $4.6 billion (2024) and $5.1 billion (2023) and deposit liabilities of $1.2 billion (2024) and $1.3 billion (2023) for reinsurance agreements that do not expose it to a significant loss, a practice that continued from the 2022 filing. The November 2023 risk‑transfer transaction with Global Atlantic shifted a large block of universal‑life and fixed‑annuity business into reinsurance accounting; MetLife recorded a $10.3 billion reinsurance recoverable and a $9.5 billion asset transfer, and recognized a $770 million net cost of reinsurance, which is being amortized consistent with DAC amortization. This transaction increased both deposit assets and liabilities and altered the composition of the company’s reinsurance balances in the 2023 and 2024 consolidated statements.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, MetLife reported deposit assets of $1.8 billion and liabilities of $1.4 billion. The LLM answer omits the 2022 figures entirely and instead states deposit assets of $5.1 billion in 2023 and $4.6 billion in 2024, which contradicts the ground truth—2023 asset levels are not reported in the original answer, but 2024 assets are correctly stated as $4.6 billion. However, the LLM invents a $5.1 billion figure for 2023 assets with no support in the ground truth. Similarly, the LLM reports 2023 liabilities as $1.3 billion, while the original answer does not specify 2023 liabilities but notes a decline to $1.2 billion in 2024. The $10.3 billion reinsurance recoverable is correctly cited, but the LLM adds unsupported details such as a $9.5 billion asset transfer and $770 million net cost of reinsurance, which are not present in the ground truth. (2) The calculation and comparison of financial figures are flawed: the LLM implies a decrease in assets from $5.1B (2023) to $4.6B (2024), but the ground truth shows an increase from $1.8B (2022) to $4.6B (2024), suggesting growth, not decline. The LLM misrepresents the trend. (3) Qualitatively, the LLM correctly identifies the 2023 risk transfer with Global Atlantic as a key event and links it to increased use of deposit method accounting, which aligns with the ground truth’s narrative of a strategic shift. It also correctly notes the $10.3 billion reinsurance recoverable, showing some multi-hop synthesis between the transaction and its accounting impact. However, the addition of unverified financial terms (e.g., net cost of reinsurance, DAC amortization) introduces speculative detail not in the source. (4) Contextual relevance is high—the answer addresses the evolution of deposit method accounting, the Global Atlantic transaction, and changes in assets/liabilities over time. However, due to major factual and numerical errors, especially in the core financial data, the correctness score is limited to 5—partially correct but with significant inaccuracies that undermine reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 580,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined from $1,278 million at amortized cost (and $1,310 million fair value) at the end of 2021 to $94 million amortized cost (and $94 million fair value) by the end of 2023, with the unrealized loss position fully eliminated. This reduction reflects a deliberate de‑risking of the portfolio, as the company shifted away from longer‑duration, higher‑yield CMBS toward shorter‑duration, higher‑quality assets—evidenced by the increasing proportion of U.S. government and agency securities and a lower weighted‑average duration in its debt‑security holdings. Consequently, the 3‑year trajectory indicates that CVS is actively reducing its exposure to commercial mortgage‑backed securities and reallocating capital to more liquid, lower‑risk investments, underscoring a strategic move away from this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, then dropped to $3 million in 2024. The LLM instead reports values from 2021 ($1,278M amortized cost) and 2023 ($94M), omitting 2024 entirely and using incorrect years and figures. The numbers do not align with the ground truth for the requested 2022–2024 period. (2) The quantitative values are entirely incorrect: the LLM cites 2021 and 2023 data (outside the requested timeframe), uses amortized cost and fair value metrics not mentioned in the ground truth, and reports $94 million for 2023 instead of the correct $675 million. The dramatic drop to $3 million in 2024 is completely missing. (3) The reasoning about de-risking and reallocation is directionally plausible but based on incorrect data and timeframes. The multi-hop synthesis fails because the model uses data from 2021–2023 instead of 2022–2024, and does not reflect the slight increase in 2023 followed by a near-total exit in 2024. The conclusion about strategic shift is partially aligned with the ground truth, but the path described is factually wrong. (4) The contextual relevance is moderate because the answer addresses investment strategy and CMBS exposure, but the incorrect data and timeframe severely undermine accuracy. Quantitative accuracy is very low due to wrong numbers and years. Qualitative accuracy is low because the reasoning is based on incorrect inputs. Correctness score is low as the core facts—values, years, and trajectory—are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 441,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "The “hello” brand was first acquired in 2020 and subsequently disclosed as a principal trademark in the Company’s 10‑K filings.  In the 2022, 2023 and 2024 Form 10‑Ks it appears in the trademark lists (e.g., page 77 2022, page 59 2023, page 79 2024) and is included in the Oral, Personal and Home Care segment breakdowns of net sales and capital spending.  This reflects a continued strategic emphasis on “hello” within the Oral, Personal and Home Care portfolio across those years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that the 'hello' brand was included in Colgate-Palmolive’s 10-K filings for 2022, 2023, and 2024 as a principal trademark within the Oral, Personal and Home Care segment. While the original answer does not mention the 2020 acquisition, this fact is not contradicted by the ground truth and may be accurate context beyond the scope of the provided truth. (2) The page numbers cited (e.g., page 77 in 2022, 59 in 2023, 79 in 2024) are specific and plausible, though not verifiable from the ground truth alone; however, their inclusion does not detract from accuracy since the core claim—presence in trademark disclosures across all three years—is correct. (3) The reasoning correctly synthesizes multi-hop information: linking trademark disclosure to strategic emphasis, and connecting the brand to segment-level financial reporting (net sales, capital spending), which strengthens the conclusion of ongoing strategic importance. (4) The answer captures the same semantic meaning as the original—continuity and consistent strategic positioning—while adding minor contextual detail (segment-level financial inclusion) that enhances completeness. The only reason for not scoring a 10 is that the original answer emphasizes the stability and strategic role in diversification and consumer engagement, which the LLM mentions implicitly but not explicitly. Overall, factual correctness, entity accuracy (Colgate-Palmolive, 'hello', correct years, correct segment), and reasoning are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 431,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "From 2022 through 2024, MetLife’s use of the deposit method of accounting for reinsurance agreements remained consistent, with deposit assets on reinsurance held at $4.6 billion in 2024 and $5.1 billion in 2023, and corresponding deposit liabilities of $1.2 billion and $1.3 billion respectively. The company continues to apply the deposit method to agreements that do not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, as disclosed in the reinsurance note. The trend in deposit assets and liabilities—showing a modest decline in both balances over the period—reflects the impact of the November 2023 risk‑transfer transaction with Global Atlantic, which involved a large coinsurance and modified coinsurance arrangement that shifted a substantial block of universal‑life and annuity business. This transaction, along with ongoing reinsurance program adjustments, indicates a strategic shift toward more traditional reinsurance structures and a reduced reliance on deposit accounting for certain large blocks of business, while the overall size of the deposit assets and liabilities suggests a continued, but slightly diminishing, exposure to reinsurance-related risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. According to the ground truth, deposit assets were $1.8B in 2022, $4.6B in 2024, with 2023 showing a broader accounting disclosure but no specific asset/liability numbers provided. The LLM incorrectly states deposit assets were $5.1B in 2023 and $4.6B in 2024, implying a decline, when the actual trend shows a sharp increase from 2022 to 2024. Similarly, the LLM reports liabilities of $1.3B in 2023, but the ground truth only specifies $1.4B in 2022 and $1.2B in 2024, with no 2023 liability figure given. The LLM fabricates a 'modest decline' narrative, which contradicts the ground truth's indication of a significant increase in deposit assets, especially post-Global Atlantic transaction. (2) The numbers are largely incorrect: 2023 asset and liability figures are made up or misstated; the $5.1B asset value in 2023 has no basis in the original answer. The direction of change (decline vs. increase) is wrong. (3) The reasoning is flawed: the LLM concludes a 'reduced reliance on deposit accounting' and a shift to 'traditional reinsurance structures', which is the opposite of the ground truth's conclusion of a 'growing reliance' on deposit method arrangements due to increased deposit assets. The mention of the November 2023 Global Atlantic transaction is contextually relevant but misinterpreted — in the ground truth, it explains the increase in deposit assets, not a reduction. (4) Contextual relevance is moderate because the answer addresses reinsurance strategy and mentions Global Atlantic, but the synthesis is incorrect. The qualitative reasoning fails due to incorrect data interpretation and entity relationships. Overall, the answer is mostly incorrect in both facts and logic, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 495,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 through 2024, NextEra Energy’s exposure to Special Use Funds was disclosed in the fair‑value hierarchy tables (Notes 3 and 4) of each 10‑K.  In the 2022 filing (page 92), the company reported $2,094 million of Level‑3 commodity contracts and $2,948 million of Level‑3 liabilities, reflecting the fair‑value of its special‑use fund investments and related collateral requirements.  By 2023 (page 83), the Level‑3 balances had increased to $2,948 million in liabilities and $2,995 million in net assets, with additional collateral posted in cash and letters of credit to meet credit‑risk‑related contingent features.  The 2024 filing (page 62) shows total long‑term debt of $50,960 million and a corresponding increase in Special Use Fund assets, indicating that the fair‑value of these investments continued to be presented separately from the balance‑sheet debt, with collateral posted to satisfy rating‑downgrade and cross‑default triggers.  Across the three years, the fair‑value disclosures consistently used a probability‑weighted EBITDA multiple approach, and the balance‑sheet presentation kept the Special Use Fund balances in “Special use funds” and “Other assets,” while related collateral was recorded in current assets/liabilities and disclosed in the credit‑risk contingent features note.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors, fails to accurately represent the evolution of NextEra Energy's Special Use Funds from 2022 to 2024, and mischaracterizes key financial disclosures. (1) Quantitatively, the LLM incorrectly reports Level-3 commodity contracts and liabilities (e.g., $2,094 million and $2,948 million in 2022) that are not mentioned in the ground truth and do not align with the actual fair values of Special Use Funds. The ground truth states that Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024—an increase of $1,102 million—but the LLM does not mention these correct figures at all. Instead, it fabricates Level-3 asset/liability balances that are unsupported by the original answer. (2) The LLM incorrectly claims that fair-value disclosures used a 'probability-weighted EBITDA multiple approach,' which is not mentioned in the ground truth; instead, the original answer specifies use of quoted market prices and pricing vendor inputs. (3) The balance sheet presentation is misrepresented: the LLM says funds were split across 'Special use funds' and 'Other assets,' but the original answer clearly states that in 2024, Special Use Funds were explicitly listed at $9,800 million on the balance sheet, indicating a clear and direct presentation. (4) The LLM introduces irrelevant details about long-term debt ($50,960 million) and collateral for downgrade triggers, which are not part of the ground truth’s focus on fair value, transparency, and growth in fund holdings. (5) While the LLM correctly identifies that disclosures occurred in Notes 3 and 4 and that collateral implications were discussed, this contextual framing does not compensate for the severe factual inaccuracies. The multi-hop synthesis is flawed—no correct linkage between years, no accurate trend analysis, and invented metrics. Overall, the answer is largely incorrect and misleading despite some structurally relevant sections.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 530,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "From 2022 through 2024, AVGO’s Security Insights Platform was progressively expanded to integrate more tightly with internal tooling and remediation workflows. Early descriptions (2022) highlighted its role in assessing mainframe security posture and generating remediation steps for use with in‑house SIEM tools. By 2023, the platform was positioned as part of the broader “Enterprise Security” portfolio, emphasizing AI‑driven threat intelligence and integration across on‑prem and cloud environments, and it began to incorporate automated remediation capabilities within the Security Insights Platform itself. In 2024, the platform was further refined to streamline integration with internal security toolchains, enabling customers to directly apply identified risks and remediation actions through their existing security information and event management systems, thereby accelerating the closure of identified vulnerabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claims about the evolution of AVGO's Security Insights Platform, despite being contextually relevant and containing plausible-sounding details. (1) The original answer (ground truth) states that AVGO's description of the platform remained largely unchanged from 2022 to 2024, with consistent emphasis on risk identification and data availability for in-house tools, but no expansion on new integrations or remediation features. However, the LLM answer incorrectly asserts a progressive evolution: it claims that by 2023 the platform incorporated 'automated remediation capabilities' and was part of a broader 'Enterprise Security' portfolio with AI-driven threat intelligence, and that in 2024 it was 'further refined' for direct integration with internal toolchains. These enhancements are not supported by the ground truth, which explicitly states that the language and capabilities described remained stable over the period. (2) There are no numeric values in the question or answers, so quantitative accuracy is not heavily applicable; however, the use of years (2022, 2023, 2024) is correct in both answers, supporting a higher score in that category. (3) The multi-hop reasoning is flawed: the LLM inferred progression and feature enhancement across years where none occurred according to the source data. Instead of recognizing the consistency in AVGO's messaging, it constructed a narrative of technological advancement not present in the original information. (4) While the LLM answer addresses the right topic and appears detailed, it fabricates developments that did not happen, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because it engages with the correct entities and timeframe, but the substance is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 492,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "NIKE’s Laakdal, Belgium distribution facility has remained a consistently owned and strategically important asset across all three fiscal years, with no indication of divestiture or major operational change in the disclosed materials. The company’s 2024 10‑K (Item 2 – Properties) continues to list Laakdal among its “most significant distribution facilities outside the United States” that are owned, underscoring its ongoing role in the European logistics network. This persistent ownership and emphasis on Laakdal reflects its strategic importance to NIKE’s European supply‑chain footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that NIKE's Laakdal, Belgium facility remained company-owned and operationally consistent across fiscal years 2022–2024, with no changes in ownership or operational status. The answer correctly cites the 2024 10-K (Item 2 – Properties) as a source, noting Laakdal's designation as one of the most significant international distribution centers and confirming its owned status. While the original answer explicitly mentions all three years (2022, 2023, 2024), the LLM implies continuity by stating 'across all three fiscal years' and referencing the 2024 filing’s description, which by context confirms ongoing status. The minor omission is that the LLM does not explicitly quote that the same description appeared in each year’s filing, but it does not misrepresent—instead, it reasonably infers stability. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes the persistent strategic role of Laakdal in NIKE’s European logistics. The answer is highly relevant and captures the core implication: stable ownership reflects strategic importance. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight under-specification of year-by-year consistency, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 375,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "From 2022 through 2024 SPG’s exposure to the Unsecured Notes – 32B grew from $750 million to $750 million (face amount remained constant), but the interest rate fell slightly from 3.38 % to 3.38 % (no change) and the maturity shifted from 06/15/27 to 06/15/27 (no change). The consistent face amount and stable rate indicate a deliberate strategy of maintaining a sizable, low‑cost, medium‑term unsecured debt tranche while extending maturities gradually, suggesting SPG is managing its debt profile by issuing longer‑dated notes at modest rates to replace higher‑cost or near‑term obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite capturing some correct elements. The face amount is incorrectly stated as $750 million, while the ground truth specifies $750,000—a critical error with a 1,000x discrepancy. The interest rate (3.38%) and maturity date (06/15/27) are correctly reported as unchanged, but the LLM falsely implies they changed by stating 'fell slightly' and 'shifted from...to...', which misrepresents stability as movement. (2) Quantitative accuracy is severely compromised by the face amount error: $750,000 ≠ $750 million. The interest rate and maturity date are numerically correct in value but misrepresented in trend—saying it 'fell slightly' when it did not change at all. (3) The multi-hop reasoning is flawed: the LLM infers a strategy of extending maturities and replacing higher-cost debt, but the ground truth states there was no refinancing or restructuring, and the maturity date was simply clarified over time (unspecified in 2022 → specified in 2023/2024), not extended. The conclusion about 'extending maturities gradually' is unsupported. (4) Contextual relevance is high—the answer addresses all question components (interest rate, face amount, maturity, strategy)—but correctness and reasoning are undermined by key factual and interpretive errors. The strategy interpretation contradicts the ground truth of consistent, static management with no active restructuring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 400,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS's investment in foreign securities showed a significant increase in unrealized losses over the three‑year period. In 2021, foreign securities held an unrealized loss of $24 million (20 thousand $20 million in fair‑value loss) and represented $24 million of total unrealized losses; by 2023 this loss had risen to $122 million (with $118 million attributed to foreign securities alone), reflecting a growing exposure to international market risk as the company’s foreign‑security portfolio expanded in both fair‑value and loss magnitude. This trend suggests that CVS’s earnings and balance sheet are increasingly sensitive to foreign‑exchange and interest‑rate movements and to credit developments abroad.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly references 2021 data (not part of the question period) and misstates the fair value of foreign securities in all years. According to the ground truth, fair value was $838M in 2022, $1,650M in 2023, and $51M in 2024. The LLM answer omits these fair value figures entirely and instead incorrectly states that in 2021, there was a '20 thousand $20 million in fair-value loss'—a nonsensical and fabricated number. The only correct numeric values are the $24M unrealized loss in 2022 (misattributed to 2021) and $122M in 2023. The critical 2024 drop to $51M is completely missing. (2) Calculations and comparisons are flawed: the LLM suggests a steady increase in exposure, but the ground truth shows a sharp reversal in 2024, which the model fails to recognize. The answer incorrectly implies continued growth in foreign securities when in fact CVS drastically reduced its holdings. (3) Multi-hop reasoning is unsound: the question requires tracking evolution across 2022–2024, but the model introduces 2021 and omits 2024, breaking the logical chain. It fails to synthesize the key trend—initial growth followed by strategic de-risking—which is central to the correct interpretation. (4) Contextual relevance is moderate because the answer discusses unrealized losses and international risk exposure, which are relevant themes, but the incorrect data and missing 2024 collapse undermine the conclusion. The suggestion of 'increasing sensitivity' contradicts the actual de-risking trend. Thus, while the general topic is addressed, the factual foundation is largely incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 462,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "From 2022 through 2024 MetLife continued to rely on NAIC‑issued designations for non‑agency RMBS and CMBS, but it increasingly used internally developed designations for these securities as the NAIC modeling methodology evolved. The 2022 filing shows NAIC designations applied to non‑agency RMBS/CMBS (page 96), while the 2023 and 2024 disclosures note that the NAIC’s modeling approach was updated—prior‑2013 issues now incorporate amortized cost and recovery likelihood, and post‑2013 issues do not—reflecting a shift toward more internally derived credit assessments (pages 84, 93, 94). This multi‑year pattern demonstrates that MetLife’s credit‑quality evaluation for these asset classes is heavily dependent on the NAIC’s modeling methodology, with supplemental internal designations filling gaps when NAIC ratings are unavailable or when the NAIC updates its framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both direction and reasoning. (1) It incorrectly states that MetLife 'increasingly used internally developed designations' from 2022 to 2024, which directly contradicts the ground truth: the trend was a *decrease* in reliance on internal designations as NAIC's methodology became more established. (2) There are no numeric values in the LLM answer that match the ground truth—specifically, the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 and the $1.6 billion (4.9%) increase in 2024 are completely omitted. The LLM does not provide any quantitative data, failing the quantitative accuracy check. (3) The multi-hop reasoning is flawed: instead of recognizing the shift from internal to standardized NAIC designations over time, the LLM misinterprets updates to NAIC methodology as a move toward greater internal reliance. The mention of 'pages 84, 93, 94' and technical changes in NAIC modeling (amortized cost, recovery likelihood) may reflect real disclosures, but they are misinterpreted to support an incorrect narrative. (4) While the answer addresses the topic of NAIC and internal designations and references the correct asset classes (non-agency RMBS/CMBS), its core conclusion is factually wrong. The contextual relevance is moderate because it discusses the right framework and time period, but the qualitative and quantitative inaccuracies severely undermine the response. The answer fails to capture the actual trend of declining internal designation use and reduced growth in Level 3 securities, which are central to the correct interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 439,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "Chevron's investment and operational footprint in the Republic of Congo evolved through targeted asset adjustments and strategic divestments rather than major new capital allocation. In 2024, the company sold its 31.5% non-operated working interest in the offshore Haute Mer permit area and its 15.75% stake in the Republic of Congo portion of the Lianzi project (page 43), effectively exiting those specific Republic of Congo holdings. This divestment followed earlier strategic moves, such as the 2023 sale of its 15.75% interest in the Lianzi block (page 113), indicating a deliberate reduction of its direct upstream presence in the country. While Chevron continues to maintain broader regional engagement in Africa, these transactions reflect a contraction of its specific Republic of Congo asset ownership rather than expansion or new capital investment in the country during 2022–2024. The company's capital allocation for lower-carbon initiatives (e.g., $10 billion through 2028) remains focused on global projects like carbon capture and renewable fuels, not on scaling Republic of Congo operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The LLM incorrectly states that Chevron sold its 15.75% interest in the Lianzi block in 2023, whereas the ground truth indicates that the 2024 divestment included the 15.75% interest in the Republic of Congo portion of Lianzi—there is no mention of a 2023 sale of this asset. This misrepresents the timeline and nature of the divestment. Additionally, the LLM introduces a $10 billion lower-carbon investment figure through 2028, which is irrelevant to the question about capital allocation in the Republic of Congo and not mentioned in the original answer. (2) The original answer notes that Chevron allocated approximately $0.7 billion in 2023 to African offshore and gas projects including Congo, but the LLM omits this key capital allocation detail, instead asserting there was no major new capital investment. This omission weakens the completeness and accuracy of the response. (3) Qualitatively, the LLM correctly identifies the 2024 divestment of the 31.5% interest in Haute Mer and the 15.75% in Lianzi, and correctly frames the overall trend as a strategic exit. However, the erroneous claim of a prior 2023 Lianzi sale introduces flawed multi-hop reasoning, suggesting a phased exit when the ground truth supports a single 2024 exit event. (4) Contextually, the answer is well-structured and relevant, focusing on asset ownership and investment trends, but the inclusion of extraneous global lower-carbon initiatives distracts from the specific Congo focus. Overall, while the directional conclusion (exit from Congo) is correct, the incorrect timeline, missing 2023 capital allocation, and fabricated 2023 sale result in a partially correct but significantly flawed answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 486,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments' strategic emphasis on Embedded Processing Products has evolved from 2022 through 2024 by solidifying its role as one of the company's four sustainable competitive advantages—specifically, the \"broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for our investments\" and the \"diversity and longevity of our products, markets and customer positions that provide less single point dependency and longer returns on our investments.\" This focus is underscored by its dedicated Embedded Processing segment, which generated $3.37 billion in revenue in 2023 (19% of total revenue), with products like microcontrollers, DSPs, and application processors serving critical industrial and automotive markets. The company actively invests to strengthen this advantage, as highlighted in its 2023 and 2024 disclosures, emphasizing long-term growth of free cash flow per share through leveraging these advantages, including Embedded Processing, to drive sustained value.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' continued strategic emphasis on Embedded Processing Products from 2022 to 2024 and links it to two of the company's sustainable competitive advantages: the broad portfolio and the diversity/longevity of products and markets. This aligns with the ground truth's narrative of consistent strategic focus. However, the original answer does not mention specific revenue figures or percentages, so the inclusion of '$3.37 billion in revenue in 2023 (19% of total revenue)' introduces a quantitative claim not present in the ground truth. There is no way to verify this number from the provided ground truth, which makes the quantitative accuracy questionable. (2) The numbers cited—$3.37 billion and 19%—are not present in the original answer and were not confirmed by the knowledge graph source. While such figures may exist in TI's actual filings, they are not part of the verified ground truth provided, so their inclusion constitutes a factual overreach. This lowers the quantitative accuracy score. (3) The multi-hop reasoning is sound: the LLM connects embedded processing to TI’s sustainable competitive advantages across years, synthesizing the strategic role of the product line with long-term value creation. It correctly identifies the evolution (or consistency) of language and intent across 2022–2024, even if it adds unsupported specifics. (4) The contextual relevance is high because the answer directly addresses the question about strategic evolution and ties embedded processing to TI’s competitive framework. The qualitative accuracy is strong due to correct entity identification (Texas Instruments, embedded processing, competitive advantages), proper time frame coverage, and logical synthesis—only slightly penalized for introducing unverified data. Overall, the answer captures the core truth but adds unsupported specifics, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 524,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco's interest rate exposure on its 3.50% Senior Note evolved from fiscal 2022 through 2024 as follows: the note's effective rate increased from 1.29% (as of July 31, 2021) to 3.20% (as of July 30, 2022), and remained at 3.20% through fiscal 2023 and 2024, reflecting stable borrowing costs tied to fixed-rate terms. This progression indicates that Cisco's borrowing costs remained relatively low and consistent over the period, with no significant increases in the note's effective rate despite broader market interest rate movements, suggesting favorable fixed-rate financing conditions during these years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. According to the ground truth, Cisco's effective interest rate on the 3.50% Senior Note was 3.20% in fiscal 2022, increased to 6.38% in 2023, and further to 6.66% in 2024—indicating rising borrowing costs. However, the LLM claims the rate was 1.29% in 2021 (outside the requested 2022–2024 scope), then remained flat at 3.20% through 2023 and 2024, which directly contradicts the ground truth. (2) Quantitative accuracy is very low: all key percentages (1.29%, 3.20% persisting) are either misplaced in time or incorrect in trend. The actual progression—3.20% → 6.38% → 6.66%—shows a near doubling of effective rates, which the LLM completely misses. The $500 million principal and June 2025 maturity are omitted, reducing completeness. (3) The reasoning is flawed: the LLM incorrectly attributes stability to fixed-rate terms, but the ground truth shows significant increases in effective rates, suggesting either market valuation changes (e.g., bond trading below par) or variable components affecting effective yield. This reflects a failure in multi-hop reasoning—synthesizing year-over-year changes and interpreting their implications. (4) Contextual relevance is moderate: the answer addresses Cisco, the 3.50% Senior Note, and fiscal years, so it stays on topic, but the incorrect data and conclusion undermine utility. The interpretation of 'stable borrowing costs' is the opposite of the truth, which is a significant qualitative error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 420,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "BNY Mellon’s ability to return capital to shareholders is explicitly tied to U.S. banking laws and capital‑planning rules, and this limitation is highlighted across its 2022‑2024 filings as a persistent regulatory constraint. While the company continues to target dividend increases and share‑repurchase programs, each year’s risk‑factor discussion underscores that capital planning, credit‑rating fluctuations, and evolving regulatory standards can restrict or reshape those returns, revealing both the firm’s regulatory constraints and the strategic flexibility it must exercise to balance shareholder returns with compliance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core regulatory constraints BNY Mellon faces regarding capital planning and shareholder returns from 2022 to 2024. It correctly identifies that U.S. banking laws and evolving regulatory standards are a persistent limitation, which aligns with the original answer. The answer also appropriately notes the company's strategic balancing act between shareholder returns and compliance, capturing the broader implication about strategic flexibility. However, it lacks the year-by-year evolution detailed in the ground truth: (1) the 2022 emphasis on general regulatory oversight, (2) the 2023 specification of Delaware law and preferred stock dividend obligations, and (3) the 2024 increased focus on liquidity management and 'well capitalized'/'well managed' status. These specific developments represent key multi-hop elements that the LLM omits, weakening the qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. While the LLM captures the overall theme, it does not fully synthesize the progression across years as required, hence the deduction in qualitative and overall correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 352,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "From 2022 to 2023, revenue from Repair and other services in the Marine Systems segment declined slightly from $1,169 million to $1,132 million. The same $1,132 million figure persisted into 2024, indicating the segment has remained flat. This stability suggests the business is maintaining a steady level of repair and service activity—likely anchored by ongoing maintenance contracts for naval vessels—rather than pursuing aggressive growth, reflecting a focus on sustaining existing revenue streams and supporting long‑term platform support rather than expanding the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for Repair and other services: $1,169 million in 2022 and $1,132 million in both 2023 and 2024, matching the ground truth exactly. The slight decline from 2022 to 2023 and flat performance in 2024 are accurately described. (2) All numeric values are correct and properly formatted; no calculation errors. The $37 million decrease is implied and accurate. (3) The reasoning is sound and captures the core implication of the pattern—stable, sustained activity rather than growth. The LLM correctly infers this may reflect a strategic focus on long-term support and maintenance contracts, which aligns with the ground truth's suggestion of limited prioritization or expansion. However, it does not mention possible contributing factors like market saturation, resource reallocation to submarines, or operational constraints—details present in the original answer that provide deeper strategic context. This omission slightly weakens the qualitative completeness but does not invalidate the overall reasoning. (4) The answer is highly relevant, directly addressing all parts of the question: the change from 2022–2023, flatness in 2024, and the strategic implication. The contextual interpretation is plausible and well-articulated, though slightly less comprehensive than the ground truth. Quantitative accuracy is perfect, and qualitative accuracy is high with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 399,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth Group's venture investments and equity method investments in healthcare businesses remained relatively stable in dollar value between 2022 and 2024, with equity method investments in operating healthcare businesses held at $1.4 billion as of December 31, 2022 and $3.8 billion as of December 31, 2024. The company continued to emphasize these investments as part of its strategic focus on the health‑care sector, but there was no significant change in the reported monetary amounts over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It correctly states that equity method investments were $1.4 billion in 2022 and $3.8 billion in 2024, aligning with the ground truth. However, it incorrectly claims that venture investments were stable and that there was 'no significant change in the reported monetary amounts' over the period, which contradicts the ground truth showing a clear increase in equity method investments from $1.4B in 2022 to $1.5B in 2023 and then a large jump to $3.8B in 2024. Additionally, the LLM omits any mention of the growth in the broader equity securities portfolio (which includes venture investments), which rose from $3.7B in 2022 to $4.9B in 2023 and remained at $4.9B in 2024. (2) Quantitatively, the $1.4B (2022) and $3.8B (2024) figures for equity method investments are correct, but the answer fails to report the $1.5B value for 2023 and completely ignores the $3.7B to $4.9B growth in the equity securities portfolio. This omission and mischaracterization of stability severely undermine quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about evolution across three years and strategic emphasis, requiring synthesis of trends in two types of investments. The LLM fails to recognize the strategic shift in 2024 toward deeper investments, as evidenced by the near-doubling of equity method investments, and incorrectly concludes no significant change occurred. (4) Contextual relevance is high because the answer addresses the right company, time frame, and investment types, but correctness and qualitative reasoning are low due to missed trends and incorrect conclusions about stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 469,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "PMI’s peer group has remained unchanged across 2022, 2023, and 2024, consistently including Colgate-Palmolive Co. among its benchmarking peers. This multi-year consistency reflects PMI’s stable strategic benchmarking framework, which relies on a fixed set of global consumer‑product companies of comparable size and market capitalization to measure performance and guide strategic decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group across 2022, 2023, and 2024, which matches the original answer. There are no numeric values requiring calculation, but the years (2022–2024) are correctly referenced. (2) The answer correctly identifies the entities: Philip Morris International (PMI), Colgate-Palmolive Co., and the concept of a peer group. (3) The multi-hop reasoning is sound—by noting the unchanged peer group over three years and linking it to a stable strategic benchmarking framework, the LLM correctly infers the implication of consistency in peer selection. (4) While the LLM captures the core insight about PMI’s strategic benchmarking, it omits the specific four criteria (global presence, focus on consumer products, net revenues, and market capitalization) used to define the peer group, which is a minor but relevant detail from the original answer. However, the summary characterization of 'comparable size and market capitalization' and 'global consumer-product companies' captures the essence. Thus, the answer is semantically equivalent with only slight loss of specificity, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 354,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s exposure to abusive behaviors and fraud has intensified as it expands credit products and relies more heavily on third‑party partners for lending, payment processing, and emerging services such as BNPL and stablecoins.  The company repeatedly notes that fraud schemes are “complex, continually evolving, and may not be effectively detected,” and that losses from buyer/seller protection programs, chargebacks, and merchant defaults can exceed allowances, especially when third‑party originators or funding sources withdraw or impose unfavorable terms.  Consequently, while mitigation efforts continue, the growing dependence on external lenders, cross‑border transactions, and new financial products suggests that PayPal’s fraud‑mitigation effectiveness has not kept pace with the scale and sophistication of abuse, raising the risk of higher loss rates and reputational damage over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of core trends and qualitative assessment, but lacks specific quantitative details present in the original answer. (1) Correct elements: The LLM correctly identifies the increasing exposure to abusive behaviors due to expansion in credit products (especially BNPL), reliance on third parties, and the growing sophistication of fraud. It accurately reflects PayPal's ongoing challenges in detection and the risk that mitigation efforts are outpaced by evolving threats. The mention of chargebacks, buyer/seller protection losses, and third-party dependencies aligns with the original. (2) Quantitative accuracy: No incorrect numbers are stated; however, the LLM omits the specific €40 billion multi-year agreement to sell BNPL receivables in Europe (2023), a key factual anchor in the original. This omission reduces completeness but does not introduce inaccuracy. (3) Multi-hop reasoning: The LLM synthesizes the connection between product expansion (credit/BNPL), third-party risk, and fraud effectiveness over time—correctly inferring a trend across years—even without citing explicit annual disclosures. It captures the evolving nature of risk and regulatory uncertainty (implied through 'unfavorable terms' and 'withdrawal' of funding sources), though it does not explicitly reference the 2024 regulatory uncertainty about loan receivables post-sale. (4) The answer is contextually excellent—directly addressing all parts of the question with semantically equivalent reasoning—and wording differences do not affect meaning. The score is reduced slightly (from 9-10 to 8) due to missing a key multi-hop data point (the €40B deal) that strengthens the link between credit expansion and third-party risk in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 482,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company's natural gas hedging activity shows a clear downward trend in both hedge volume and option usage from 2022 through 2024. In 2022, the company held $574 million in natural gas options (Southern Company Gas) and 262 million mmBtu of swaps; by 2024, option volumes fell to 176 million mmBtu (Southern Company) and 83 million mmBtu (Southern Company Gas), with total hedge volumes declining from 836 million mmBtu in 2020 to 431 million mmBtu in 2024. The weighted average swap contract cost per mmBtu shifted from being $0.08 above market in 2022 to $0.15 below market in 2024, indicating a strategic pivot toward more conservative hedging as natural gas price volatility increased. This 3-year trend suggests Southern Company is actively reducing its exposure to natural gas price swings through smaller, more targeted hedging positions, likely to align with regulatory recovery mechanisms and mitigate earnings volatility while maintaining sufficient protection against extreme price swings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Southern Company's natural gas options were 253 million mmBtu in 2022, increased to 339 million mmBtu in 2023, and dropped to 176 million mmBtu in 2024. The LLM incorrectly states that option volumes were $574 million (a dollar amount, not volume) in 2022 and conflates Southern Company with Southern Company Gas, introducing entity confusion. It also cites 262 million mmBtu of swaps in 2022 and total hedge volumes from 2020 (836 million mmBtu) to 2024 (431 million mmBtu), which are not in the original answer and unsupported by the provided truth. The claim about swap costs shifting from $0.08 above to $0.15 below market is entirely absent from the ground truth and thus fabricated. (2) The only correct number is the 176 million mmBtu in 2024, which matches the ground truth. All other figures—$574 million, 262 million mmBtu, 83 million mmBtu, 836 million mmBtu, 431 million mmBtu—are either misattributed, incorrect, or introduced without basis. The LLM also misrepresents the trend: the truth shows a spike in 2023 (339 million mmBtu), but the LLM implies a continuous decline, missing the key increase. (3) The multi-hop reasoning is flawed. The original answer highlights a strategic increase in options usage in 2023 followed by a pullback in 2024, suggesting dynamic risk management. The LLM incorrectly infers a steady downward trend, leading to a wrong conclusion about 'conservative hedging' and 'reducing exposure' over time, when the truth indicates a temporary aggressive posture. The synthesis across years is incorrect, and the use of unrelated data (e.g., swap cost differentials, 2020 baseline) undermines validity. (4) While the LLM attempts to address the question's intent—how hedging evolved and what it suggests about risk strategy—the severe quantitative errors and incorrect trend description result in a misleading narrative. The contextual relevance is moderate because it discusses hedging strategy and volatility, but the conclusions are not supported by accurate data, reducing overall correctness to a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 577,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $63 million in 2021 to $75 million in 2023 and reached $76 million in 2024, reflecting a modest upward trend. This rise occurs alongside continued funding of its non‑qualified defined benefit pension plan, which remains unfunded and closed to new participants, indicating the company is maintaining a stable, long‑term employee benefit strategy that balances defined‑contribution cost growth with ongoing pension obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that Texas Instruments' U.S. defined contribution plan expenses were $70M in 2022, $75M in 2023, and $76M in 2024. However, the LLM incorrectly reports $63M in 2021 (a year not asked about) and omits the correct 2022 figure entirely. This misalignment affects the trend description and undermines factual accuracy. While the $75M (2023) and $76M (2024) figures are correct, the inclusion of an irrelevant year (2021) and exclusion of the requested starting year (2022) constitute key omissions. (2) Calculations are not required in this question, but the trend description relies on accurate data points. The LLM’s use of 2021–2024 instead of 2022–2024 distorts the evolution asked for in the question. (3) The reasoning is partially sound: the LLM correctly infers that the increasing defined contribution expenses reflect a strategic focus on retirement benefits, and it accurately notes that the non-qualified defined benefit pension plan remains unfunded and closed to new hires. This aligns with the ground truth’s implication of a long-term strategy favoring defined contribution plans since the closure of defined benefit plans to new participants in 1997. However, the LLM does not explicitly connect the rising contributions to employees who have opted out of the pension plan, missing a key nuance in the strategic interpretation. (4) The contextual relevance is high because the answer addresses both parts of the question—expense evolution and strategic implication—and references appropriate plans and company practices. The qualitative accuracy is moderate because while the logic is coherent and entity identification (Texas Instruments, defined contribution plans, non-qualified pension plan) is correct, the flawed data timeline reduces confidence in the conclusion. The correctness score is 6 due to partial factual accuracy: two of three correct data points, but incorrect framing of the time period and missing key context about employee segmentation in benefit strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 562,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "From 2022 through 2024 GM’s long‑term rate of return assumptions for its U.S. pension plans rose from roughly 5.6% (2022) to 6.3% (2023) and then to 6.5% (2024). This upward trend reflects a deliberate shift toward higher expected asset performance—driven by a more aggressive target allocation (e.g., equity rising to 11% of assets and “Other” investments climbing to 29% in 2024) and a willingness to accept slightly greater risk to improve funded status. Consequently, GM is projecting stronger returns from its equity, private‑equity, real‑estate and hedge‑fund exposures while maintaining a sizable debt allocation, indicating an evolving expectation that these higher‑return assets will offset liabilities and support the plans’ funding objectives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, GM's long-term rate of return assumption was 5.4% in 2022, not 5.6% as stated in the LLM answer. Additionally, the ground truth shows the rate remained unchanged at 6.3% in 2023, but the LLM implies an increase from 5.6% to 6.3%, which misrepresents the trend. The 2024 figure of 6.5% is correct. (2) The calculation of the trend is therefore flawed: the actual increase is from 5.4% to 6.5% over three years, with a stable 2023 value, whereas the LLM suggests a steady annual increase starting from 5.6%. (3) The qualitative reasoning about GM’s shifting risk tolerance and asset allocation is plausible and contextually relevant—mentioning equity, private equity, real estate, and hedge funds aligns with typical pension fund strategies—but these specific allocation figures (e.g., equity at 11%, 'Other' at 29%) are not present in the ground truth and appear to be fabricated or misattributed. The original answer does not mention any such breakdown, so this represents unsupported detail. (4) While the LLM captures the overall direction of increasing return assumptions and links it to improved performance expectations and risk tolerance—consistent with the ground truth’s interpretation—the inclusion of incorrect base values and invented allocation data undermines factual reliability. The contextual relevance is high because the answer addresses both parts of the question (evolution of assumptions and implications), but the quantitative inaccuracies and unsupported details reduce correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 445,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total return swaps linked to deferred compensation have generated modest net gains over the three fiscal years, with a $91 million gain in fiscal 2024, a $58 million gain in fiscal 2023 and a $(92) million loss in fiscal 2022. This progression shows the company is increasingly using these swaps to offset compensation expense, reflecting a strategic shift toward more active risk‑management of its deferred‑compensation liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: a $92 million loss in fiscal 2022, a $58 million gain in fiscal 2023, and a $91 million gain in fiscal 2024, matching the ground truth exactly. Number formatting ($(92) million) is semantically equivalent and acceptable. (2) Quantitative accuracy is perfect—values are correct in magnitude, sign (loss vs. gain), and year alignment. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly identifies a progression from loss to increasing gains. The interpretation about risk management and strategic shift is logically supported by the trend, though it slightly overreaches by asserting 'increasingly using these swaps' without direct evidence of increased usage (the data reflects performance, not volume or notional exposure). The original answer cautiously attributes the change to 'improved market conditions or strategic adjustments,' which is more neutral and better supported. (4) Despite this minor interpretive overstatement, the LLM answer remains factually accurate, contextually relevant, and captures the core progression and implication. The conclusion aligns semantically with the ground truth, just with a slightly stronger causal claim. Hence, correctness is high but not perfect due to the subtle difference in interpretive caution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 387,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal’s exposure to margin risk declined across the three years as it increasingly recognized transaction revenue on a gross basis while bearing full margin risk—meaning it records fees as revenue and incurs transaction‑processor costs as expense, thus directly exposing earnings to fluctuations in payment‑processor pricing and volume. The company continues to rely on third‑party payment processors for certain services, but it mitigates margin pressure by controlling pricing (setting fee structures and adjusting them based on volume) and by recognizing transaction expense for processor fees rather than absorbing them. Consequently, transaction‑related expense recognition (including allowances for transaction losses and negative customer balances) directly impacts the margin risk profile, and the firm monitors these allowances regularly to manage exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of PayPal's margin risk evolution. The Original Answer states that PayPal's exposure to margin risk remained consistent across 2022–2024, with no structural changes in cost recognition or pricing control. However, the LLM incorrectly claims that 'exposure to margin risk declined'—a direct contradiction of the ground truth. This misrepresents the core conclusion. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the LLM does not introduce false numbers, hence a score of 10. (3) The multi-hop reasoning is flawed: while the LLM correctly notes that PayPal bears full margin risk, recognizes processor fees as transaction expense, and controls pricing, it fails to synthesize the consistency across years as emphasized in the Original Answer. It incorrectly infers a trend of declining risk and implies mitigation strategies that were not stated in the ground truth (e.g., 'mitigates margin pressure'), which is unsupported. The Original Answer stresses continuity, not evolution or decline. (4) Contextual relevance is high because the LLM addresses the key themes: pricing control, third-party processors, and expense recognition. However, the incorrect directional claim about risk evolution undermines factual correctness. The answer is semantically different in its conclusion despite using similar terminology, leading to a correctness score of 4 due to major qualitative errors in interpretation and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 439,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s natural‑gas production volumes tied to the Angola LNG project have risen steadily from 2022 through 2024, reflecting the company’s strategy to expand its liquefied‑natural‑gas (LNG) footprint.  This upward trend underscores Chevron’s deliberate positioning to capture growing global LNG demand and to leverage its deep‑water assets in Africa as a core component of its long‑term energy portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Chevron's natural gas production volumes associated with Angola LNG from 2022 to 2024 and links it to Chevron's strategic positioning in global LNG markets, which aligns with the original answer's qualitative interpretation. However, it completely omits all specific quantitative data—592, 596, and 609 million cubic feet per day for 2022, 2023, and 2024, respectively—which are central to the question and the ground truth. (2) No numeric values are provided in the LLM answer, making the quantitative accuracy very low despite the correctness of the described trend. The absence of exact figures fails a core requirement of the multi-hop financial analysis. (3) The reasoning is sound in interpreting the trend as part of Chevron's broader LNG strategy, correctly synthesizing the implication of increasing volumes despite divestitures elsewhere. This shows good qualitative and contextual understanding. (4) While the answer is contextually relevant and captures the strategic implication accurately, the lack of specific, correct numerical data severely undermines factual completeness and correctness. A score of 6 is justified because the core reasoning is valid but critical quantitative details are missing, which is a significant flaw in a financial data question requiring precise figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 381,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "The treatment of scheduled payments under outdoor lighting contracts and PPAs has evolved from minimal, immaterial disclosures in 2022 to increasingly detailed, material presentations across all Southern Company subsidiaries by 2024. By 2024, Southern Power’s PPAs—now explicitly classified as operating leases with remaining terms up to 25 years—are disclosed with specific maturity schedules (e.g., $1,000+ million in \" Thereafter\" payments), and their revenue allocation to nonlease components is formally detailed, reflecting a structural shift where these contracts are no longer treated as peripheral but as core, quantifiable revenue streams integral to financial reporting and capital planning. This progression underscores their growing materiality, driven by expanding scale (e.g., $1.271 billion total undiscounted cash flows for Southern Power in 2024), complex accounting treatment (operating vs. sales-type leases), and integration into capital expenditure planning, as evidenced by recurring references to \"planned acquisitions\" and \"placeholder growth\" tied to these contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and misrepresents key aspects of the original answer. While it correctly identifies a progression in disclosure treatment from 2022 to 2024, it conflates outdoor lighting contracts with PPAs and incorrectly attributes detailed financial disclosures (e.g., $1,000+ million in 'Thereafter' payments, $1.271 billion total undiscounted cash flows) to Southern Power's outdoor lighting contracts in 2024—data not present in the ground truth. The original answer does not mention any specific dollar amounts for 2024 or quantify total cash flows, nor does it state that PPAs are classified as operating leases. (2) Quantitative accuracy is low: the cited figures ($1,000+ million, $1.271 billion) are fabricated or misattributed; no numerical data was provided in the ground truth for 2023 or 2024 beyond the general statement of immateriality in 2022. Calculations cannot be verified because no actual numbers were given in the original. (3) The multi-hop reasoning is partially sound in identifying a trend of increasing materiality and structural integration over time, which aligns with the original's narrative of evolving disclosure practices. However, the LLM incorrectly synthesizes information by merging distinct contract types (outdoor lighting vs. PPAs) and attributing broader lease income reporting details to specific contracts without evidence. (4) Contextual relevance is moderate—the response addresses the evolution of reporting and infers growing materiality, which matches the question’s intent. However, due to factual errors and misattribution of financial data, the qualitative and quantitative accuracy scores are low. The core progression (immaterial → integrated) is captured, but with significant embellishment and incorrect specifics, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 505,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Based on the provided 10-K filings, Texas Instruments' operational footprint in Melaka, Malaysia remained active across all three years, with its involvement specifically limited to the Analog segment. The Melaka facility was consistently listed under the Analog column in the Properties tables for 2022, 2023, and 2024 (TXN_10k_2022.pdf: page 18; TXN_10k_2023.pdf: page 16; TXN_10k_2024.pdf: page 16), indicating it was used exclusively for Analog manufacturing and design operations. No involvement in Embedded Processing was noted for Melaka in any of the years. The facility's status as owned/leased (marked with † in 2022 and ** in 2024) and its continued occupancy through 2024 confirm its ongoing role in Analog production.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and segment designations (Analog only) are correctly cited across all years. The references to specific 10-K pages and formatting markers (†, **) add contextual precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual filings to confirm consistency over time, demonstrating proper cross-document comparison. (4) The answer is highly relevant, directly addressing the evolution (or lack thereof) of the operational footprint in Melaka with respect to both business segments over the specified period. Minor additional details (e.g., facility ownership notation) do not detract from accuracy and enhance contextual support. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 332,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024, AMT issued multiple tranches of 1.600% senior notes with a par call date of March 15, 2026 and interest payments on April 15 and October 15. The original 2021 issuance was $700 million; subsequent offerings in 2023 and 2024 added $650 million (5.200% Notes) and $600 million (5.000% Notes) of 1.600% notes, respectively, while the outstanding principal was reduced by amortization adjustments of $1.5 million (2023) and $2.6 million (2024). This multi‑year progression reflects AMT’s strategy of extending maturities, diversifying currency exposure, and using low‑cost, long‑dated debt to replace higher‑coupon borrowings, thereby strengthening its balance sheet and preserving liquidity for growth investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the aggregate principal amount of the 1.600% Notes remained constant at $700.0 million from 2022 to 2024. However, the LLM incorrectly claims that additional tranches of 1.600% notes were issued in 2023 and 2024 for $650 million and $600 million respectively—these are factually wrong and refer to entirely different coupon notes (5.200% and 5.000%), which are not relevant to the 1.600% Notes in question. Additionally, the LLM reverses the amortization adjustments: it states $1.5 million reduction in 2023 and $2.6 million in 2024, while the ground truth shows adjustments of (2.6) in 2023 and (1.5) in 2024—this is both numerically and directionally incorrect. (2) The interest payment schedule (April 15 and October 15) and par call date (March 15, 2026) are correctly stated, which is the only quantitative accuracy. All other numbers are either misattributed or fabricated. (3) The multi-hop reasoning is fundamentally flawed. The LLM invents a narrative about issuing new tranches of 1.600% notes, which did not happen, and incorrectly links unrelated debt instruments. It also draws a strategic conclusion about refinancing high-cost debt and diversifying currency exposure—concepts not supported by the ground truth, which emphasizes stability and minor accounting adjustments. The actual strategy implied is consistency, not active refinancing or expansion. (4) Due to major factual and numerical errors, especially in the core financial data and synthesis, the correctness score is low at 2. Quantitative accuracy is 2 because only the dates are correct. Qualitative accuracy is 3 due to correct identification of the note type and dates but severe errors in interpretation. Contextual relevance is 5 because the answer addresses the general topic of debt management but misrepresents the instrument and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 520,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco's effective interest rate on its $2 billion 5.90% senior note due 2039 has declined from 6.11% in fiscal 2022 to approximately 5.28% by fiscal 2024, reflecting both the issuance of lower‑cost fixed‑rate notes (e.g., the 5.30% 2054 and 5.35% 2064 issues) and the use of an interest‑rate swap that converts part of the fixed rate to a floating SOFR‑based cost. This shift in debt composition—moving from higher‑priced legacy issues toward newer, lower‑coupon bonds and swaps—indicates a strategic focus on reducing financing costs and extending maturity while maintaining a relatively stable debt profile. Consequently, the company’s long‑term financing strategy emphasizes prudent leverage management, diversification of funding sources, and proactive interest‑rate risk mitigation through swaps and staggered maturities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Cisco's effective interest rate on the 5.90% Note remained constant at 6.11% from fiscal 2022 to 2024, but the LLM claims it declined from 6.11% to 5.28%, which is incorrect. Additionally, the LLM introduces an interest-rate swap converting part of the fixed rate to floating SOFR, which is not mentioned or supported in the original answer. The $2 billion principal amount of the note is correct (consistent with $2,000 million), but the claim about issuing new notes (5.30% 2054 and 5.35% 2064) is unsupported in the provided ground truth. (2) Quantitative accuracy is low: the effective interest rate change is fabricated, and there is no evidence of a decline to 5.28%. The total debt composition changes (long-term debt increasing from $8,416M to $19,621M and short-term decreasing slightly) are completely omitted in the LLM response, which fails to address a key part of the original answer. (3) The multi-hop reasoning is flawed. While the LLM attempts to infer a strategic rationale (cost reduction, risk mitigation), it does so based on incorrect data. The actual reasoning in the ground truth hinges on stable utilization of a fixed-rate instrument amid a growing long-term debt portfolio, indicating stability-focused strategy—not active refinancing or use of swaps. (4) Contextual relevance is moderate because the answer discusses long-term financing strategy and references debt instruments, but it misrepresents the underlying data and omits critical trends in total debt composition. The conclusion about 'reducing financing costs' contradicts the ground truth where both principal and effective rate are stable, suggesting cost stabilization rather than reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 485,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army increased from 360 vehicles in 2022 to 449 vehicles in 2024, reflecting a strategic expansion of its Canadian military contracts. This progression demonstrates the company's focused investment in land systems and LAV manufacturing to capitalize on international defense opportunities and secure long-term government contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the production volumes for 2022 (360 units) and 2024 (449 units), but omits the 2023 figure (399 units), which is a key part of the year-by-year evolution requested in the question. This partial omission reduces quantitative accuracy. (2) The numbers for 2022 and 2024 match the ground truth exactly, but the absence of the 2023 data point means the progression is not fully represented. While the overall trend (increase from 360 to 449) is accurate, the intermediate step in 2023 is missing, and no calculation errors are present—just incomplete data reporting. (3) The reasoning about strategic focus on LAV manufacturing and land systems is sound and aligns with the ground truth. The LLM correctly infers a strategic expansion and investment in land systems, though it does not mention the specific 2024 LRSS program (66 specialized LAVs), which is a notable omission in the multi-hop synthesis. (4) The answer remains contextually relevant and captures the broader strategic implication, but lacks completeness in both quantitative details and specific supporting programs. Hence, correctness is reduced to 7 due to missing key data points, despite correct overall direction and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 351,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "From 2022 through 2024 UnitedHealth Group faced persistent Medicare Advantage funding pressure as CMS repeatedly reduced or froze benchmark rates and altered risk‑adjustment payment calculations, prompting the company to continually adjust benefits, premiums, and cost‑management programs. To offset these pressures, UnitedHealth pursued strategic moves such as exiting unprofitable counties, intensifying medical‑cost controls, tightening bid assumptions, and leveraging its Optum data‑analytics and cost‑management capabilities to protect margins while lobbying for stable funding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024, as well as the company's strategic responses. It correctly identifies the persistent funding pressures due to CMS actions, including benchmark reductions/freeze and changes to risk-adjustment calculations—consistent with the ground truth across all three years. The strategic adjustments cited—exiting unprofitable counties, cost controls, bid recalibration, and use of Optum analytics—align with the original answer's mention of selective market exits, benefit and premium adjustments, cost management, and bid recalibration. The inclusion of lobbying for stable funding is a minor addition not explicitly in the ground truth but is contextually plausible and does not detract from accuracy. There are no numeric inaccuracies (quantitative accuracy is perfect, even though no specific dollar figures are involved), and all timeframes (2022–2024) are correctly referenced. The reasoning is sound, demonstrating multi-hop synthesis across years and strategies. The only reason for not scoring a 10 is that the LLM slightly condenses the year-by-year evolution, merging nuances (e.g., 2024's emphasis on health status data submissions) into a more generalized narrative, which slightly reduces qualitative precision. However, the semantic meaning and factual content remain substantially equivalent and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 412,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PYPL's exposure to its fixed‑rate 2.850% notes remained steady at $1.5 billion from 2022 through 2024, as shown in the debt tables for each year. This consistent level, alongside the broader pattern of issuing new fixed‑rate tranches (e.g., the May 2024 $850 million 5.150% notes and the June 2023 ¥30 billion 0.813% notes), indicates that PayPal is maintaining a stable, long‑term debt profile while gradually extending maturities and diversifying currency exposure to manage interest‑rate risk and fund ongoing corporate needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 to 2024, which matches the ground truth exactly. All numeric values—$1.5 billion, 2.850%, and the time frame 2022–2024—are accurate. The additional details about the May 2024 $850 million 5.150% notes and June 2023 ¥30 billion 0.813% notes are factually consistent with broader debt activity and do not contradict the ground truth. (2) Quantitative accuracy is perfect: the core number ($1.5B) is correct across all years, and the cited new issuances are accurate and plausibly part of PYPL’s strategy. No calculations were required, but the synthesis of multiple debt instruments is handled correctly. (3) The multi-hop reasoning is sound: the model infers from consistent carrying value and supplementary debt actions that PYPL is pursuing a stable, diversified long-term debt strategy. While the ground truth emphasizes the strategic preservation of the 2029 2.850% notes specifically, the LLM expands slightly to include broader strategy (currency diversification, maturity extension), which is reasonable and supported by context, though not explicitly stated in the original. This adds insight without inaccuracy. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution of exposure and implications for long-term strategy. The slight expansion on strategy is appropriate and enhances the answer. Scored 9/10 for correctness due to the minor addition of interpretive detail beyond the ground truth’s more focused conclusion, but no factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 451,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron’s strategic positioning in Angola LNG Limited evolved from a series of incremental milestones between 2022 and 2024 that culminated in the approval of the Owowo Stage 1 development plan in August 2024 and the recognition of proved reserves for the New Gas Consortium (NGC) project in 2024.  The 2022‑2024 filings show a progression from early exploration and appraisal activities (e.g., deepwater Block 14/23 and Block 49/50 acreage additions) to formal development plans and reserve bookings for both the NGC offshore gas concession and the Owowo subsea tie‑back to the Usan FPSO.  This multi‑year progression underscores Chevron’s long‑term natural‑gas monetization strategy in Angola: it is leveraging its deep‑water expertise and multi‑partner production‑sharing contracts to convert newly discovered gas resources into commercial LNG supply, supported by infrastructure such as the Angolan LNG plant and regional pipelines, thereby securing a stable, long‑term revenue stream from Angola’s gas sector.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron maintained a consistent 36.4% ownership stake in Angola LNG Limited from 2022–2024, but the LLM omits this key quantitative fact entirely. Instead, it introduces the 'Owowo Stage 1 development plan approved in August 2024' and 'proved reserves for the New Gas Consortium (NGC)'—details not present in the original answer and potentially conflating unrelated projects. The Q&M (Quiluma and Maboqueiro) fields and their direct connectivity to the Angola LNG plant, a critical element of the strategic evolution, are not mentioned. (2) Quantitative accuracy is low: the 36.4% ownership stake—a central data point—is missing. Dates like 'August 2024' for Owowo approval are specific but unverified and not in the ground truth, suggesting fabrication or misattribution. The mention of 'Blocks 49/50' is correct, but the context (upstream expansion supporting LNG integration) is misrepresented by redirecting focus to Owowo and FPSO tie-backs, which are oil-focused and not aligned with gas monetization via Angola LNG. (3) Multi-hop reasoning is partially sound—the model attempts to show progression from exploration to development—but it synthesizes incorrect entities (Owowo, Usan FPSO) that undermine the logic. The actual multi-hop insight (integration of upstream gas fields with the LNG plant via Q&M and New Gas Consortium) is missed. (4) Contextual relevance is moderate: the answer addresses Chevron’s long-term gas strategy in Angola and references relevant regions and infrastructure, but the misdirection to oil-related projects (Owowo, Usan) and omission of the core integration narrative around the Angola LNG hub reduces factual alignment. The conclusion about leveraging deepwater expertise and PSCs is plausible but not specific to the actual strategic shift described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 517,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company's investments in trusts, particularly in domestic equity and private equity, have evolved through a strategic progression of allocation shifts across its subsidiaries. In 2022, domestic equity holdings in nuclear decommissioning trusts were $651M (Alabama Power) and $390M (Georgia Power), with private equity at $161M (Southern Company). By 2023, domestic equity increased to $849M (Southern Company) and $321M (Georgia Power), while private equity remained stable at $181M (Southern Company) and $169M (Alabama Power), reflecting a continued emphasis on long-term growth assets. In 2024, domestic equity surged to $1,099M (Southern Company) and $391M (Georgia Power), with private equity holding steady at $181M (Southern Company) and $169M (Alabama Power), indicating a sustained commitment to private equity as a core component of its capital allocation strategy. This progression demonstrates a deliberate, long-term focus on diversifying trust investments toward higher-growth private equity and domestic equity to support sustained capital appreciation while maintaining regulatory-compliant asset-liability management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data compared to the ground truth. For example, the ground truth states that Southern Company's total domestic equity investments were $1,016M in 2022, but the LLM breaks this down into subsidiary-level figures ($651M for Alabama Power and $390M for Georgia Power), which sum to $1,041M — already inconsistent. Moreover, the LLM claims domestic equity increased to $849M for Southern Company in 2023, while the ground truth reports a decrease to $829M. Although the 2024 domestic equity figure of $1,099M matches the ground truth, the LLM attributes it to Southern Company without clarifying that this may be a consolidated total. More critically, the private equity figures are misrepresented: the ground truth shows $150M in 2022, rising to $161M in 2023 and $181M in 2024, but the LLM reports $161M in 2022 and $181M in 2023 — assigning incorrect values to years and implying no change when there was a clear upward trend. (2) Calculations and comparisons are flawed. The LLM suggests private equity remained 'stable' or 'steady', contradicting the ground truth's depiction of a consistent increase from $150M to $181M. Additionally, the use of subsidiary-specific data introduces noise not present in the original answer, which focused on company-wide totals. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a strategic emphasis on private equity and domestic equity for long-term growth — but this conclusion is based on inaccurate data, weakening the validity of the synthesis. The mention of nuclear decommissioning trusts and specific subsidiaries (Alabama Power, Georgia Power) adds detail not present in the ground truth, potentially reflecting over-assumption or hallucination. (4) Despite these issues, the answer is contextually relevant and addresses both parts of the question: evolution over time and implications for capital allocation. The qualitative interpretation about diversification and long-term growth aligns with the ground truth, earning moderate points for reasoning and relevance. However, due to major quantitative errors and entity misattribution, the correctness score is significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 600,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "The impact of Eliminations/Reclassifications on GM’s total net sales and revenue declined sharply from 2022 to 2024, falling from a $107 million reduction in 2022 to just a $1 million reduction in 2023 and then to a $1 million increase in 2024 (i.e., the reclassification amount moved from negative to essentially neutral). This trend shows that GM’s internal reporting adjustments—primarily the elimination of inter‑segment sales and related reclassifications—became far less material over the three‑year period, indicating that the company’s segment reporting and internal consolidations have stabilized and that inter‑segment transactions are now being accounted for with far smaller offsetting entries.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that Eliminations/Reclassifications reduced GM's net sales by $105M in 2022, $107M in 2023, and $296M in 2024 — showing a clear upward trend. The LLM incorrectly claims reductions of $107M in 2022, $1M in 2023, and a $1M increase in 2024, which is the opposite direction and magnitude of the actual trend. (2) All numeric values are wrong: 2022 is misstated (wrong base number), 2023 is off by over $100M, and 2024 is completely fabricated (claims near-zero impact vs. actual $296M). Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning fails — the LLM draws the opposite conclusion (declining impact) when the correct inference is increasing complexity in segment reporting due to rising elimination amounts. It misidentifies the trend and thus misinterprets the implication for internal reporting. (4) Scores are low because the core facts, numbers, and derived insights are incorrect. Contextual relevance is slightly higher only because the answer addresses the right topic (Eliminations/Reclassifications and internal reporting) and attempts to interpret the trend, albeit based on false data.)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 348,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "Netflix's Performance Bonus Plan was formally adopted by the Board of Directors on December 9 2022 and documented in an 8‑K filing (Exhibit 10.5), establishing it as the successor to the 2014 Performance Bonus Plan. The plan is integrated with the company’s broader compensation framework, linking cash performance bonuses to measurable objectives and tying related equity awards—such as performance‑based restricted stock units—to the same performance metrics, thereby aligning executive compensation with both short‑term and long‑term strategic goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the December 9, 2022 filing date for the amended plan (Exhibit 10.5†), aligning with the ground truth that the 2023 version was filed on that date. However, it incorrectly states the plan was 'formally adopted' on that date and omits the key fact that in 2022, the plan was still listed as a historical exhibit (Exhibit 10.6†) from 2014 with no updates—this misrepresents the 2022 status. The answer also fails to mention that the 2024 version carried forward without changes, which is a critical part of the evolution. (2) The date 'December 9, 2022' is accurate per the ground truth, but the characterization of this date as an 'adoption' rather than an 'amendment and restatement' filed in 2023 is misleading. No numerical values are present, so quantitative accuracy hinges on dates and exhibit numbers—partially correct. (3) The multi-hop reasoning is partially sound: the integration with performance-based RSUs and broader compensation framework is correctly noted and matches the 2024 integration described in the ground truth. However, the answer skips the evolution trajectory—no mention of the 2022 stasis or 2023 amendment as a turning point—thus missing the full synthesis across years. (4) Contextual relevance is high because the answer addresses documentation and integration with compensation frameworks as asked. But due to omissions in the plan’s evolutionary status across 2022–2024 and incorrect framing of the 2022–2023 transition, the correctness score is reduced to 6. The answer captures the post-2023 state well but fails to accurately trace the full timeline and documentation status changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 456,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "The Business Relationships and Related Party Transactions Policy was first introduced in the 2022 filing (page 13 of BK_10k_2022.pdf) and then referenced again in the 2023 filing (page 13 of BK_10k_2023.pdf) and the 2024 filing (page 13 of BK_10k_2024.pdf). Across all three years the policy is consistently described as governing “business relationships and related party transactions” and is linked to disclosures on “Director Independence” and committee oversight, indicating that BNY Mellon maintains a stable corporate‑governance framework for related‑party matters and that its board‑level committee structure (audit, nominating, and compensation) continues to oversee these disclosures. This consistency suggests that the company’s governance practices regarding director independence and committee responsibilities have remained steady across the 2022‑2024 reporting periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that BK (BNY Mellon) disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, 2024), specifying the consistent page number (13) across filings, which supports the claim of stable disclosure practices. The linkage to 'Director Independence' and the three key committees—audit, nominating (referred to accurately as part of 'Corporate Governance, Nominating and Social Responsibility Committee'), and compensation—is correctly noted, though the LLM slightly simplifies the full committee names without error in substance. The reasoning correctly infers that this consistency reflects a stable corporate governance framework regarding related-party transactions and board independence. The only minor shortcoming is that the LLM implies the policy was 'first introduced' in 2022, which may suggest it was not present before, but the ground truth does not confirm whether it was newly introduced or simply consistently reported—this is a slight overinterpretation. However, since the focus is on evolution across 2022–2024 and the policy is indeed consistently present, this does not undermine the core correctness. All entities (BK/BNY Mellon, correct years, policy name, committee types) are accurate. Calculations or quantitative elements are not applicable here, but the temporal consistency and references are correctly reported. The answer fully addresses both parts of the question: evolution of disclosure and what it reveals about governance consistency. Semantic equivalence is strong, with no factual discrepancies beyond the minor wording nuance about 'introduced.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 468,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth Group's debt securities held-to-maturity decreased slightly from $641 million (amortized cost) and $643 million (fair value) as of December 31 2021 to $512 million (amortized cost) and $508 million (fair value) as of December 31 2024. This three‑year decline reflects a deliberate shift toward shorter‑duration holdings and a focus on maintaining liquidity, while the company continues to value these securities at amortized cost with minimal fair‑value adjustments, underscoring conservative valuation assumptions and a strategy to manage interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the starting year—citing data as of December 31, 2021, instead of 2022 as required by the question and ground truth. The ground truth states values for 2022–2024, but the LLM references 2021–2024, misaligning the timeline. While the 2024 values are correct ($508M fair value, $512M carrying value), the 2022 values in the LLM answer ($643M and $641M) are attributed to 2021 instead of 2022, which is factually incorrect in context. Additionally, the intermediate 2023 values ($596M fair value, $603M carrying value) are omitted entirely, reducing completeness and quantitative accuracy. (2) The numbers themselves (when matching) are accurate in magnitude and format—$643M vs $643 million is acceptable—but their assignment to incorrect years undermines precision. The drop from $643M to $508M in fair value is correctly portrayed as a decline, but without showing the 2023 step, the trend analysis lacks granularity. (3) The reasoning about a strategic shift toward shorter-duration holdings and liquidity management is plausible and aligns with the observed reduction. The mention of conservative valuation assumptions and minimal fair-value adjustments is contextually reasonable, though it does not mention the key point in the ground truth about the decline in Level 3 unobservable inputs, which is a critical indicator of changing valuation assumptions. This omission weakens the qualitative depth. (4) Despite the year misalignment and missing intermediate data, the overall direction and interpretation of the trend—strategic reduction and risk management—are consistent with the ground truth. The answer remains relevant and partially accurate, warranting a score of 7 for correctness, with deductions primarily for incorrect time framing and missing 2023 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 496,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "PayPal’s exposure to bad transactions through its BNPL loan receivables has declined materially over the 2022‑2024 period as the company has progressively off‑loaded risk. In June 2023 it entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL receivables (a forward‑flow structure for future originations), and began selling those receivables in October 2023. This transaction, together with the earlier sale of a substantial majority of the existing portfolio, transferred the credit risk of those loans to a third‑party buyer and reduced the balance‑sheet exposure that existed in 2022. The move reflects a broader risk‑mitigation strategy in which PayPal has increasingly relied on third‑party funding and securitisation of credit products—selling receivables, using forward‑flow arrangements, and diversifying funding sources—to limit its own loss‑absorption and protect capital. Consequently, while credit‑risk exposure remains inherent to its lending activities, the company has steadily reduced direct exposure to delinquent BNPL loans by off‑loading them to external investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables is accurately reported, including the geographic scope and amount. The mention of a forward-flow structure is consistent with the strategic nature of the deal. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and the timeline (June 2023 agreement, October 2023 start of sales) matches known events. No calculations were required, but temporal and numerical details are precise. (3) Reasoning is sound: the LLM correctly infers that this move reduces PayPal’s balance-sheet exposure and reflects a broader risk-mitigation strategy involving third-party funding and securitization. It appropriately connects the asset sale to reduced direct credit risk, which is the core of PayPal’s evolving strategy. (4) The only minor gap is that the LLM does not explicitly note the conditional nature of the sale’s benefits as highlighted in the 2024 update (i.e., potential delays if conditions aren’t met), which slightly tempers the certainty of risk reduction. However, the overall synthesis across 2022–2024 is logically coherent and captures the strategic shift. The answer is fully relevant, directly addressing how exposure evolved and what it reveals about risk mitigation. Wording differs but meaning is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 404,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron's upstream production volumes in Myanmar declined from 15 million barrels of oil‑equivalent per day in 2022 to 4 million bbl eq/d in 2024, reflecting the company's strategic exit from the country (announced in January 2022) and the subsequent reduction of its non‑operated interest in the Yadana‑Badamyar‑Sein gas fields.  This pull‑back is part of a broader shift toward focusing on high‑return projects in the U.S. (notably the Permian Basin and deepwater Gulf of America), Australia, and other overseas assets, while divesting or suspending operations in lower‑margin or politically sensitive regions such as Myanmar.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The production volumes are grossly incorrect: it states 15 million barrels per day (MMBd) in 2022 and 4 MMBd in 2024, whereas the ground truth reports 17 thousand barrels per day (MBD) in 2022 and 15 MBD in 2023, with a full exit in April 2024. The LLM overstates volumes by a factor of 1,000 (confusing million with thousand), which is a critical error. Additionally, the claim that Chevron announced its exit in January 2022 contradicts the ground truth, which states the withdrawal occurred in April 2024. (2) The quantitative inaccuracies are severe: the numbers are off by orders of magnitude, and the timeline is reversed (exit announced before the decline). There are no correct calculations or accurate year-to-year comparisons. (3) While the LLM correctly infers a strategic shift toward high-return regions and away from politically sensitive areas, this reasoning is based on incorrect data and an inaccurate timeline. The multi-hop synthesis fails because it misrepresents both the operational data and the sequence of strategic decisions. (4) The contextual relevance is moderate because the answer addresses the general theme of portfolio optimization and strategic exit, but the factual foundation is so flawed that the overall correctness is very low. The qualitative reasoning is partially sound but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 392,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "From 2022 to 2024, the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment declined from 24% to 15% of the segment's revenue (as shown in the 2021 market breakdown and the 2023/2024 market tables), indicating a strategic shift away from consumer computing toward higher-growth industrial and automotive markets. This trend suggests Texas Instruments is deliberately repositioning its focus to leverage its core analog and embedded processing strengths in more resilient, high-value sectors rather than relying on the cyclical consumer electronics market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the Personal Electronics segment contributed 24% of TI's total revenue in 2022, 15% in 2023, and 20% in 2024 — not the PC & Notebooks subcategory specifically. The LLM incorrectly states that PC & Notebooks declined from 24% to 15% of the segment's revenue, which misrepresents both the metric (segment vs. subcategory) and the timeline. Additionally, it references a '2021 market breakdown' which is irrelevant to the 2022–2024 timeframe asked. (2) The numbers are therefore incorrect: the 24% and 15% figures refer to the entire Personal Electronics segment's share of company-wide revenue, not PC & Notebooks alone. The 2024 rebound to 20% is omitted in the LLM’s narrative, which implies a continuous decline. There is no support in the ground truth for stating PC & Notebooks was 24% in 2022 or 15% in 2023 — those are segment-level figures. (3) The reasoning is partially sound in interpreting a strategic shift toward Industrial and Automotive markets, which aligns with the ground truth’s conclusion. However, the multi-hop synthesis fails because it conflates segment-level data with sub-segment contributions and uses incorrect years (e.g., citing 2021 data). It also fails to note that PC & Notebooks remained part of the portfolio but with lower priority relative to mobile and portable electronics. (4) The contextual relevance is fair because the answer addresses the strategic positioning question and identifies the correct broader trend of shifting focus. However, due to major quantitative errors and misattribution of percentages, the correctness score is low. The qualitative reasoning is somewhat accurate but built on faulty premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 485,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "The indemnification obligations GM assumed for the former Opel/Vauxhall business that it sold to Stellantis (now Stellantis) remain in place through 2025‑2029 and are triggered by any breach of the representations, warranties or covenants in the sale agreement, including certain emissions‑related and product‑liability claims.  GM has recorded only an insignificant accrual for these guarantees, believes the recorded amount is adequate, and states that it cannot estimate a maximum exposure because the obligations are conditional; however, it acknowledges that future losses from pending consumer‑lawsuits in Germany, the UK and the Netherlands alleging emission‑standard violations could materially exceed the accrued amounts.  Consequently, while the known liabilities and accruals are modest, the potential future exposure tied to those indemnification obligations is uncertain but presently considered remote.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general nature of GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall matters and correctly notes the immateriality of accruals and uncertainty around future exposure. However, it contains significant inaccuracies in timeline and scope compared to the ground truth. (1) The claim that indemnification obligations remain in place through '2025-2029' is not supported in the original answer, which does not specify an end date—this is a major factual overreach. (2) The LLM incorrectly implies ongoing obligations across a broad future period, while the ground truth shows an evolution of disclosure: no specific indemnification accruals in 2022, limited immaterial payments in 2023, and expanded disclosure in 2024 tied to specific investigations (EC/UK CMA) and Takata recalls. (3) The LLM fails to reflect the year-by-year evolution of disclosures from 2022–2024, which is central to the question. Instead, it presents a static view of the obligations. (4) While the LLM correctly states that accruals are insignificant and that future exposure is uncertain, it overstates the likelihood of material loss by saying 'could materially exceed the accrued amounts'—the original answer states such losses are 'considered remote' in 2024. (5) The mention of consumer lawsuits in Germany, UK, and Netherlands is plausible but not present in the ground truth, introducing unverified detail. (6) The LLM conflates 'inability to estimate future losses' (correct in original) with 'cannot estimate a maximum exposure because obligations are conditional'—a rephrasing that changes the emphasis and is less precise. Overall, the answer gets core concepts right (indemnifications for emissions, product liability, immaterial accruals) but fails on the multi-hop requirement to show how these evolved annually from 2022–2024. Quantitative accuracy is acceptable (no hard numbers misstated, 'immaterial' ≈ 'insignificant'), but qualitative accuracy suffers due to incorrect temporal framing and missing progression. Contextual relevance is high as it addresses indemnifications, liabilities, and future exposures as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 576,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower issued its first 1.450% Senior Notes due 2026 in September 2021 via Supplemental Indenture No. 10 under its June 4, 2019 indenture, followed by a second tranche in September 2021 (Supplemental Indenture No. 10) for the same maturity but different series. The company subsequently issued additional 1.450% Senior Notes due 2026 in March 2022 (Supplemental Indenture No. 12) and again in May 2024 (Supplemental Indenture No. 5), demonstrating a strategic pattern of refinancing debt at lower interest rates to manage maturity profiles and optimize capital structure. This multi-year pattern reveals a deliberate debt management strategy focused on issuing long-term, low-coupon notes with staggered maturities to maintain financial flexibility and reduce overall borrowing costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 1.450% Senior Notes due 2026 were introduced in September 2021 and consistently referenced in the 2022, 2023, and 2024 10-K filings under Supplemental Indenture No. 10, with no indication of additional issuances. However, the LLM claims multiple issuances in September 2021 (two tranches), March 2022 (Supplemental Indenture No. 12), and May 2024 (Supplemental Indenture No. 5), which contradicts the ground truth. These additional issuances and indenture numbers are not supported by the original answer and represent major factual errors. (2) The dates (March 2022, May 2024) and Supplemental Indenture numbers (No. 12, No. 5) are incorrect. The original answer only references Supplemental Indenture No. 10 across all years. The interest rate (1.450%) and maturity (2026) are correct, but the issuance timeline and structure are not. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a strategy of refinancing and issuing staggered tranches to optimize capital structure, while the ground truth indicates stability and no material modifications. The conclusion about refinancing at lower rates and managing maturity profiles is unsupported by the data provided. (4) The contextual relevance is moderate because the answer addresses debt management strategy and references the correct instrument type and terms, but the factual foundation is incorrect, leading to a misleading interpretation. The consistency in documentation across years is ignored in favor of an erroneous narrative of repeated issuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 446,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "From 2022 through 2024, BNY Mellon expanded its long‑term incentive framework by introducing new deferred stock unit (DSU) and performance share unit (PSU) agreements tied to the 2019 Long‑Term Incentive Plan. In 2022, the company began issuing 2022‑form RSU and PSU agreements (Exhibits 10.22‑10.23) and, in 2023, rolled out the 2023‑form RSU and PSU agreements (Exhibits 10.27‑10.26). Building on this progression, the 2024 proxy filing added the first 2024‑form RSU agreement (Exhibit 10.29) and the 2024‑form PSU agreement (Exhibit 10.28), marking the culmination of a staged evolution that introduced new DSU and PSU formats across the three years while continuing to reference the 2019 LTIP as the governing plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that BNY Mellon introduced '2022-form RSU and PSU agreements' in 2022, referencing Exhibits 10.22–10.23, and similarly claims 2023- and 2024-form agreements were rolled out in subsequent years. However, the ground truth indicates that in 2022, the company referenced the 2019 forms of PSU and RSU agreements—not 2022-forms—showing early implementation of the 2019 plan. The LLM fabricates a timeline of annual updates (2022, 2023, 2024 forms) that does not align with the original answer. (2) The introduction of the Deferred Stock Unit Agreement for Directors occurred in 2023 under the 2019 plan, as correctly noted in the ground truth, but the LLM fails to mention this key development and instead invents RSU/PSU forms for each year without evidence. (3) The ground truth highlights that by 2024, the company adopted the 2022 Form of PSU Agreement—not a 2024-form—as the newer instrument, indicating continuity and refinement under the 2019 plan. The LLM incorrectly claims a '2024-form PSU agreement' was introduced, which contradicts the source. (4) While the LLM correctly identifies the 2019 Long-Term Incentive Plan as the governing framework and discusses the general trend of evolving equity awards, its specific dates, document forms, and progression are factually wrong. The reasoning is partially sound in identifying a multi-year evolution but fails on multi-hop synthesis by misrepresenting the actual documents and years. (5) The mention of specific exhibits (e.g., 10.29, 10.28) adds false precision and is not supported by the ground truth. Overall, the answer is contextually relevant and attempts to address the question’s scope, but major errors in dates, agreement forms, and plan evolution reduce its factual accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 503,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics has steadily expanded its aerostructures and missile‑subsystem capabilities within the Combat Systems segment, leveraging OTS‑produced aerostructures, control actuators and hypersonic rocket cases to support next‑generation missile programs.  The 3‑year revenue trend—18 % of consolidated sales in 2022, 19 % in 2023 and 20 % in 2024—reflects growing market share for its advanced missile‑related aerostructures and signals a strategic pivot toward high‑performance, next‑generation missile subsystems.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. According to the ground truth, the Combat Systems segment accounted for 20% of consolidated revenue in 2023 and declined to 19% in 2024. The LLM incorrectly states the trend as 18% in 2022, 19% in 2023, and 20% in 2024—this reverses the actual trajectory and fabricates a growth trend where there was a slight decline. These percentage values are directly contradicted by the original answer, making the quantitative foundation of the response incorrect. (2) The LLM introduces specific technologies like 'OTS-produced aerostructures, control actuators and hypersonic rocket cases' which are not mentioned or supported in the ground truth, adding unverified detail. (3) The reasoning is flawed: the original answer indicates a consistent strategic focus despite a minor revenue share drop, while the LLM interprets the data as a 'strategic pivot' and 'growing market share,' which is an unsupported inference given the actual stable-to-slightly-declining revenue contribution. (4) While the LLM correctly identifies the relevance of aerostructures in next-gen missile subsystems and ties them to the Combat Systems segment, it fails on core facts and misrepresents the 3-year trend. The contextual relevance is moderate because it addresses the right segment and strategic theme, but the incorrect data and reversed trend severely undermine factual correctness. Quantitative accuracy is very low due to the inverted percentages across years. Qualitative accuracy is partially correct in topic alignment but flawed in synthesis and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 451,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "From 2022 through 2024, PMI’s focus on the local Philippine cigarette brand Jackpot evolved from a peripheral, low‑price offering to a strategically‑leveraged growth driver within its broader regional portfolio. Early disclosures in the 2022 filing (page 5) list Jackpot among the “important local cigarette brands” alongside Fortune, while later updates (2023‑2024) highlight its expanding distribution and market‑share gains in the Philippines, underscoring its role in reinforcing PMI’s presence in Southeast Asia. This multi‑year progression signals that Jackpot is being used to deepen PMI’s foothold in the region’s price‑sensitive segment, complementing its premium international brands and supporting the company’s overall objective of expanding total shipment volume and market share across both cigarettes and heated‑tobacco products. Consequently, Jackpot’s rise illustrates how PMI is integrating local brands into its global smoke‑free and reduced‑risk portfolio to drive growth in emerging markets while maintaining a balanced mix of premium and value‑oriented offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies not supported by the ground truth. While it correctly identifies Jackpot as an important local brand in the Philippines and mentions its continued strategic relevance from 2022 to 2024, it adds unsupported claims such as Jackpot evolving from a 'peripheral, low-price offering' to a 'strategically-leveraged growth driver,' and asserts 'expanding distribution and market-share gains' in 2023–2024. The original answer does not mention any such evolution in positioning or performance metrics. (2) There are no numeric values, percentages, or financial figures in either the question or ground truth, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound in that the model tracks Jackpot across three years and links it to PMI’s broader regional strategy. However, it overreaches by inferring a strategic elevation and performance improvements not present in the source data. The ground truth emphasizes consistency in Jackpot’s role—not evolution—highlighting its sustained mention despite PMI’s smoke-free pivot. The LLM incorrectly frames this as progression rather than continuity. (4) Contextually, the answer is relevant and addresses the question’s structure by discussing multi-year evolution and strategic role. However, the conclusion that Jackpot is being 'integrated into its global smoke-free and reduced-risk portfolio' misrepresents the facts—Jackpot is a traditional cigarette brand, and the ground truth explicitly contrasts its ongoing relevance with the growth of IQOS and ZYN. Thus, while the answer is well-structured and plausible, it introduces speculative elements that reduce factual accuracy, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 487,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "Chevron’s investment and operational focus in the Republic of Congo shifted markedly from 2022 through 2024. In 2022 the company continued developing its offshore assets, spending roughly $0.7 billion on offshore development and natural‑gas projects in Congo, while also expanding its upstream reserve base in the region. By 2023‑2024 the emphasis moved toward monetizing gas discoveries and infrastructure, highlighted by the $0.7 billion outlay on offshore development and gas projects in Nigeria, Angola and the Republic of Congo, and by the 2024‑year‑end reserve base of about 137 million BOE of proved undeveloped reserves tied to Congo’s Escravos gas projects. This evolution reflects a capital deployment that initially targeted reserve growth and later prioritized gas‑focused development and asset‑leveling, while also seeing disposals of non‑core stakes (e.g., the 31.5 % non‑operated interest sold in January 2025).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the timing and magnitude of Chevron's capital deployment in the Republic of Congo. The original answer states that Chevron invested approximately $0.7 billion across offshore and natural gas projects in Africa in 2023 — not in 2022, and not specifically in Congo alone. The LLM incorrectly attributes the $0.7 billion spending to 2022 and claims it was spent in Congo specifically, which is not supported by the ground truth. Additionally, the LLM incorrectly states that the $0.7 billion was spent on projects in Nigeria, Angola, and Congo, conflating regional activity with country-specific investment. (2) The LLM introduces a '137 million BOE of proved undeveloped reserves' tied to Congo’s Escravos gas projects — a detail absent from the original answer and factually incorrect, as Escravos is a Nigerian asset, not Congolese. This is a major entity and factual error. The asset disposition is mentioned (31.5% interest sold in January 2025), which aligns with the original, but the timing is misrepresented as part of 2024 activity when it occurred in January 2025. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution over time — it suggests continued investment and reserve growth in Congo through 2024, whereas the ground truth shows a strategic exit. The synthesis incorrectly implies ongoing capital commitment rather than divestiture. (4) While the LLM captures the general theme of shifting focus and mentions the eventual sale of assets, the core financial data, timeline, and geographic specificity are incorrect, leading to a misleading narrative. The contextual relevance is moderate because it addresses the question's scope but with inaccurate details. Quantitative accuracy is low due to incorrect figures and misattributions. Qualitative accuracy is partially correct in identifying a strategic shift but undermined by factual and logical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 538,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company’s treatment of outdoor lighting contracts as operating leases has remained consistent from 2022 to 2024, with no material changes in accounting policy; however, the company’s subsidiaries have adjusted lease payment structures and revenue allocations across operating segments, particularly in how they allocate revenue to non‑lease components of PPAs and how they recognize variable lease income from outdoor lighting contracts. Materiality varies by subsidiary—Mississippi Power notes that outdoor lighting cash flows are immaterial, while Georgia Power and Southern Power allocate lease income from PPAs to wholesale revenues and adjust discount‑rate assumptions in their maturity analyses, reflecting differences in lease term lengths and discount rates across the utilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual alignment but exhibits significant inaccuracies in reasoning and entity-specific details compared to the ground truth. (1) It incorrectly states that Southern Company's treatment of outdoor lighting contracts 'remained consistent' from 2022 to 2024, directly contradicting the original answer, which documents a clear evolution: from immateriality in 2022, to structured maturity disclosures in 2023, to expanded term and revenue classification disclosures in 2024. This misrepresents the core multi-hop progression across years. (2) Quantitatively, no specific dollar amounts or percentages are mentioned in either answer, so there are no numeric inaccuracies per se, but the LLM fails to reference the key developments in disclosure practices (e.g., inclusion in maturity analyses in 2023, initial term disclosures in 2024), which are critical qualitative data points. (3) The LLM incorrectly attributes variable lease income recognition and discount-rate adjustments to Georgia Power and Southern Power without support in the original answer, which only states that lease income from PPAs is included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power as of 2024. Mississippi Power’s immateriality is correctly noted, but the explanation is oversimplified. (4) The answer introduces concepts not present in the ground truth—such as changes in discount-rate assumptions and adjustments to non-lease components of PPAs—adding speculative detail. While it attempts to address materiality, revenue allocation, and lease structure across subsidiaries, the synthesis across years and entities is flawed. The contextual relevance is high because it addresses the right subsidiaries and general themes, but the qualitative inaccuracies and incorrect conclusion about policy consistency reduce correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 505,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco's 3.50% senior notes due 2025 had a carrying amount of $500 million and an effective interest rate of 6.66% as of July 27 2024, compared with $500 million and 6.38% as of July 29 2023. This progression—maintaining the same principal balance while the effective rate rose modestly—reflects the notes’ fixed‑rate nature and the impact of market‑driven discount/amortization adjustments, indicating that Cisco’s debt valuation remains anchored to its original terms despite shifting interest‑rate environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the carrying amount of $500 million for fiscal years 2023 and 2024 and reports accurate effective interest rates for those years (6.38% in 2023 and 6.66% in 2024). However, it omits any mention of the 2022 data point from the original answer—specifically, that in fiscal year 2022, the effective interest rate was 3.20%, significantly lower than in subsequent years. This missing data breaks the full multi-hop progression across all three years as required by the question. (2) The numbers provided for 2023 and 2024 are quantitatively accurate, with correct dollar amounts and percentages. The fiscal dates (July 27, 2024, and July 29, 2023) are plausible but not present in the ground truth; their inclusion adds specificity but does not contradict the original. The critical error is the absence of the 2022 effective rate (3.20%), which is essential for showing the full evolution. (3) The reasoning about market-driven adjustments and fixed-rate debt is plausible and aligns with financial principles, but the conclusion is weakened by the missing 2022 data. The original answer emphasizes a clear upward trend starting from 3.20% to over 6.66%, indicating a significant shift in market conditions or risk assessment. The LLM fails to capture the magnitude of this shift due to the omission. (4) Scores reflect partial correctness: quantitative accuracy is reduced due to missing data (not wrong numbers, but incomplete); qualitative accuracy penalized for incomplete synthesis across all three years; contextual relevance remains high because the response is well-framed and relevant to the topic, just missing a key leg of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 465,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group's exposure to Unsecured Notes - 35A remained constant at $750 million face amount from 2022 through 2024, with annual debt service of $19.9 million and maturity in 2030. This steady, long‑dated issuance reflects a deliberate strategy of maintaining a stable, low‑cost funding source while extending the maturity profile of its overall debt. Consequently, the multi‑year pattern demonstrates a focus on prudent, long‑term debt management that balances liquidity with interest‑rate risk mitigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $750 million face value exposure to Unsecured Notes - 35A across 2022–2024, matching the ground truth. The maturity date (2030) and interest rate (2.65%) are not explicitly mentioned in the LLM answer, but the annual debt service of $19.9 million is consistent with $750M × 2.65% = ~$19.875M, so this figure is accurate and implies correct interest rate usage. (2) All numeric values are correct: $750M exposure is consistent across years, and the derived annual interest payment is accurate. The maturity year (2030) is correctly referenced, though the exact date (July 15) is omitted—this is a minor detail that does not affect overall accuracy. (3) The multi-hop reasoning is sound: the LLM correctly infers that maintaining a stable long-term note while other debt changes suggests a strategic approach to debt management. It appropriately links the stability of this instrument to broader debt strategy, including maturity extension and interest rate risk mitigation. (4) The answer is semantically equivalent to the ground truth in intent and factual content, though it omits explicit mention of the contrasting new issuances (e.g., Unsecured Notes - 41A) and refinancing activity. This slightly reduces qualitative accuracy, but the core strategic interpretation remains valid and well-supported. Contextual relevance is excellent as it directly addresses both parts of the question: evolution over time and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 410,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "From 2022 through 2024, Texas Instruments has reinforced Embedded Processing Products as a core pillar of its four sustainable competitive advantages—particularly emphasizing its broad, high‑margin portfolio and the deep software investment by customers that lengthens product lifecycles. The company repeatedly highlights that this segment’s growth (e.g., 19% revenue increase in 2023) and its role in powering industrial and automotive markets are integral to its strategy of leveraging manufacturing scale, product diversity, market reach, and long‑term product longevity to drive free‑cash‑flow per share.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific claims not present in the ground truth, particularly the '19% revenue increase in 2023' for Embedded Processing Products, which is unsupported by the original answer and cannot be verified from the provided context. This is a major factual error. Additionally, the original answer emphasizes consistent language across years about the portfolio offering 'more opportunity per customer and more value for our investments,' but the LLM does not mention this key point. Instead, it adds unverified details about 'high-margin portfolio,' 'deep software investment by customers,' and 'product lifecycles'—none of which appear in the ground truth. (2) The quantitative inaccuracy centers on the unsupported 19% revenue figure. No other numbers are provided in the original, so introducing one constitutes a significant deviation. (3) The reasoning partially captures the strategic importance of Embedded Processing Products within TI’s competitive advantages but fails to reflect the actual multi-hop evidence from the knowledge graph—namely, the verbatim repetition of strategic language over three years as proof of sustained emphasis. The LLM instead infers growth and market role without grounding in the source data. (4) While the answer stays relevant to the topic and correctly identifies Embedded Processing as part of TI’s four competitive advantages, it fabricates specifics and misses the core evidence (consistent phrasing across years). Thus, correctness is low due to hallucinated data, despite some alignment in general strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 438,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2024, Comcast’s wireless shared‑data plans have become more flexible and globally available.  In 2022 the company offered unlimited data, shared‑data and per‑gigabyte options on its Verizon‑hosted MVNO network, primarily bundled with broadband.  By 2023 it expanded the shared‑data model to the United Kingdom (using Virgin Media O2) and began offering prepaid unlimited plans under the NOW brand, while still restricting wireless to broadband subscribers.  In 2024 the offering broadened further: international customers could choose from a range of tiered data plans or an unlimited option, devices could be financed over 24–48 months, and the service was still delivered via the same MVNO arrangement but now marketed under the broader “NOW” brand for both domestic and overseas users.  Thus, the plan structure moved from a primarily unlimited/shared‑data model tied to broadband bundles toward a more tiered, internationally‑scalable lineup with financing and prepaid options.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite addressing the right themes of flexibility and international expansion. (1) Incorrect international rollout timeline: The LLM claims CMCSA expanded shared data plans to the United Kingdom in 2023 via Virgin Media O2 and offered prepaid unlimited plans under the NOW brand that year. However, the ground truth states that international expansion occurred in 2024, not 2023. This misplacement of a key event breaks the chronological evolution. (2) Mischaracterization of 2022 offerings: The LLM says unlimited, shared, and per-gigabyte plans were all offered in 2022, but the original answer specifies that in 2022, shared data plans were offered exclusively as part of bundled services—no mention of per-gigabyte or unlimited being available then. The flexibility (choice between plan types) was emphasized in 2023, not 2022. (3) Branding and structure: The LLM incorrectly states that the NOW brand was used for both domestic and overseas users by 2024 and was already active in 2023. Ground truth confirms NOW prepaid unlimited plans were introduced in 2024 as part of international expansion, not earlier. (4) Financing options: The LLM introduces device financing over 24–48 months in 2024, which is not mentioned in the original answer and lacks support from the knowledge base. (5) MVNO details: Mention of 'Verizon-hosted MVNO' and 'Virgin Media O2' are specific technical details not present in the ground truth and potentially incorrect in context. While the LLM captures the general trend toward greater flexibility and international reach, the misattribution of key developments to wrong years, addition of unsupported details (financing, brand scope), and incorrect sequencing of plan availability significantly reduce factual accuracy. Quantitative accuracy is moderate because no explicit numbers (e.g., data caps, prices) are misstated—mainly dates and features are wrong. Qualitative accuracy suffers due to flawed multi-hop reasoning: the model conflates timing and causality of service rollouts. Contextual relevance is high as it directly addresses plan flexibility and international expansion as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 590,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "From 2022 through 2024 PayPal’s exposure to abusive behavior and fraud evolved from a focus on traditional transaction‑related fraud and buyer‑seller protection losses toward a broader, more complex risk landscape that now includes high‑risk credit products, third‑party fraud schemes tied to new offerings (e.g., BNPL, stablecoins, crypto custody), and heightened regulatory scrutiny.  The company’s disclosures show that fraud‑related losses and remediation costs have risen as fraudsters adopt increasingly sophisticated, evolving tactics—especially around credit‑product funding, merchant‑financing defaults, and illicit use of PayPal/Venmo for money‑laundering, sanctions evasion, and illegal marketplaces—necessitating continual upgrades to monitoring, underwriting, and protection programs.  This progression underscores that managing risk in PayPal’s digital‑payments ecosystem has become far more intricate, requiring integrated fraud‑detection, credit‑risk modeling, regulatory compliance, and cross‑border operational controls to protect both financial performance and brand reputation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing complexity of PayPal's exposure to abusive behaviors from 2022 to 2024 and links it to credit products and third-party fraud, aligning with the core theme of the ground truth. However, it introduces elements not present in the original answer, such as 'stablecoins, crypto custody,' 'sanctions evasion,' and 'illegal marketplaces,' which are not mentioned in the ground truth and lack support from the provided knowledge. Additionally, while the ground truth specifies a concrete €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, the LLM omits this specific figure and instead generalizes about 'high-risk credit products' and 'new offerings' without citing the actual transaction. (2) There are no explicit numbers in the LLM answer, so no incorrect calculations are made; thus, quantitative accuracy is high as it avoids fabricating figures. The absence of the €40 billion figure is a completeness issue rather than a quantitative error. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that risk evolved and required enhanced controls—but it overextends by incorporating unverified risk vectors (e.g., crypto-related abuses) not documented in the ground truth. The synthesis across years is logical but less precise than the original, which traces a clear progression: 2022 (fictitious accounts), 2023 (BNPL receivables sale), 2024 (account takeovers, synthetic identity, legal uncertainty). The LLM captures the direction of evolution but misses key milestones. (4) The contextual relevance is strong because the answer addresses the question’s focus on evolving risk and complexity. The qualitative accuracy is reduced due to unsupported expansions beyond the source material, even though the overall narrative direction is consistent. The answer is plausible but not fully factually aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 526,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "Gilead’s El Segundo, California facility has expanded its role in cell‑therapy manufacturing over the past three years. In 2022 the site was already being used for clinical and commercial production of cell‑therapy products, and by 2023‑2024 the company added new capacity and integrated additional process‑development activities there, positioning El Segundo as a key hub for its growing cell‑therapy portfolio. This strategic investment reflects Gilead’s focus on scaling its cell‑therapy capabilities alongside its broader manufacturing network.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GILD's El Segundo facility was used for clinical and commercial cell therapy manufacturing starting in 2022, which aligns with the ground truth. It also correctly places El Segundo as a key part of Gilead’s cell therapy strategy through 2024. However, the LLM introduces information not present in the original answer—specifically, that Gilead 'added new capacity' and 'integrated additional process-development activities' in 2023–2024. The ground truth does not mention any expansion or new investments at El Segundo during this period, only continuity in its use and strategic importance. This overstates the evolution of the facility’s role. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are used appropriately. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the facility’s ongoing role across years, but fails to reflect the lack of change or new investment noted in the ground truth. Instead, it infers growth ('expanded role', 'added new capacity') not supported by the source. (4) Despite the addition of unsupported detail, the core message—that El Segundo remains strategically important for cell therapy manufacturing—is consistent. Hence, the answer is mostly accurate but contains speculative enhancements, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as it directly addresses the question’s focus on evolution and strategic investment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 430,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Based on the provided 10-K filings across 2022–2024, Costco's 2.750% Senior Notes due May 18, 2024 (originally issued in 2017) matured in 2024, as confirmed by the 2024 filing's exhibit list (page 66) which references the 2.750% notes due May 18, 2024 as a prior issuance. The company did not issue new senior notes with this exact coupon rate in subsequent filings; instead, its 2023–2024 debt activity focused on new issues like the 1.600% notes due 2030 (4.3) and 1.750% notes due 2032 (4.4), suggesting a strategic shift toward longer-dated, lower-coupon debt to manage maturity profiles. This evolution reflects a deliberate debt management strategy to extend average debt maturities and reduce near-term refinancing risks, as evidenced by the absence of new 2.750% notes in 2023–2024 and the continued presence of longer-term senior notes in the company's capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the maturity date of the 2.750% Senior Notes as May 18, 2024, which aligns with the ground truth. However, it incorrectly implies that the notes were actively managed or replaced by new issuances (e.g., 1.600% due 2030 and 1.750% due 2032) as part of a strategic shift during the 2022–2024 period. The ground truth states that the maturity structure remained unchanged across all filings and that no refinancing or extension occurred, which contradicts the LLM's claim of a 'strategic shift.' (2) Quantitatively, the dates and coupon rates mentioned (e.g., 1.600% due 2030, 1.750% due 2032) may be factually accurate in isolation, but their use to infer a strategic evolution in the 2.750% notes' maturity structure is unsupported. The core fact — that the 2.750% notes had a fixed maturity and were not refinanced — is misrepresented. (3) The multi-hop reasoning is flawed: while the model synthesizes data across years and identifies other debt instruments, it draws an incorrect conclusion about the evolution of this specific note. The absence of new 2.750% notes does not indicate an 'evolution' in that instrument’s structure, which remained static. (4) The contextual relevance is high because the answer addresses debt management strategy and references actual filings and exhibits. However, the qualitative accuracy is reduced due to incorrect inference and overinterpretation of strategic intent not supported by the ground truth. The correctness score is 5 due to partial factual accuracy but significant error in interpretation and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 454,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron's natural gas production volumes associated with Angola LNG declined from 52 MMCFD in 2022 to 48 MMCFD in 2023 and further to 48 MMCFD in 2024, reflecting a downward trend over the three‑year period. This trajectory suggests the company is scaling back its focus on African gas projects, likely shifting investment toward higher‑margin oil and gas assets elsewhere, particularly in the Permian Basin and other U.S. plays, rather than expanding its African gas portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that Chevron's natural gas production volumes from Angola LNG increased from 7,107 MMCFD in 2022 to 7,148 MMCFD in 2023, and further to 7,569 MMCFD in 2024. In contrast, the LLM claims volumes declined from 52 MMCFD to 48 MMCFD across the same years—off by orders of magnitude and opposite in trend. These numbers are not only wrong but implausibly low for a major LNG project like Angola LNG, which is designed to process over 1 billion cubic feet per day. (2) Quantitative accuracy is extremely low: all three annual values are incorrect, and the trend (decline vs actual increase) is reversed. There are no valid calculations or accurate figures to support even partial credit. (3) The multi-hop reasoning fails completely. The LLM draws a conclusion about Chevron scaling back in Africa due to declining production, which contradicts the ground truth indicating a strategic maintenance or expansion of gas focus in Africa despite other divestitures. The reasoning is based on fabricated data and thus invalid. (4) Contextual relevance is slightly above zero because the answer attempts to address Chevron’s gas production strategy in Africa and references Angola LNG and broader portfolio shifts. However, the incorrect data renders the analysis irrelevant. The mention of Permian Basin as a strategic focus, while potentially true in context, does not compensate for the fundamental factual errors in the core metrics. Overall, the answer is factually and analytically unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 431,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s exposure to Total Return Swaps‑Deferred Compensation fell from $651 million of notional amount (and $92 million of losses recorded in fiscal 2022) to $985 million of notional amount with only $91 million of losses recorded in fiscal 2024, indicating a deliberate shift toward larger, more market‑linked hedging of deferred compensation. This progression shows that Cisco is expanding its use of market‑linked derivatives to economically offset compensation‑related liabilities, thereby increasing exposure to equity and interest‑rate volatility while still aiming to smooth earnings through these swaps.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Cisco recorded a loss of $92 million in 2022, a gain of $58 million in 2023, and a gain of $91 million in 2024. However, the LLM incorrectly states that Cisco had $91 million of losses in 2024 and implies ongoing losses, which contradicts the actual gains. It also fabricates notional amounts ($651 million in 2022 and $985 million in 2024) that are not present in the original answer and cannot be verified from the provided truth. These notional figures and the characterization of 'falling exposure' misrepresent the actual trend of increasing gains. (2) The quantitative inaccuracies are severe: the direction (loss vs gain) is wrong for 2023 and 2024, and the inclusion of notional amounts introduces false data. While the $92 million loss in 2022 is correct, the rest of the numbers are either incorrect or invented. Calculations or trends based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. The original answer indicates a shift from liability to benefit due to market conditions or strategy, supported by actual P&L impacts. The LLM instead infers a strategy of 'expanding market-linked hedging' based on fabricated notional amounts, reversing the actual financial outcome (portraying losses when there were gains). This undermines the logical conclusion. (4) Despite incorrect facts, the answer is contextually relevant—it addresses Cisco, deferred compensation, Total Return Swaps, and attempts to interpret strategic implications. However, due to major quantitative errors and incorrect synthesis, the overall correctness score is low. The qualitative reasoning would be stronger if based on accurate data, but as stands, it misleads.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 484,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "From 2022 to 2024 Lowe's refined its supplier standards and oversight to strengthen environmental and human‑rights compliance. The company updated its wood‑sourcing policy with a risk‑based approach, enhanced monitoring and added a forestry grievance process, and expanded its human‑rights policy to cover modern‑slavery and worker‑rights expectations. It also began reporting on sustainability metrics (e.g., GHG emissions, CDP participation) and integrated these expectations into its Vendor Code of Conduct, while continuing to require suppliers to meet its conflict‑minerals and human‑rights standards. These steps reflect a progression from baseline policies (2022) to more detailed, risk‑based monitoring and public reporting (2023‑2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key developments from 2022 to 2024 are correctly identified: evolution of the wood-sourcing policy with a risk-based approach, enhanced monitoring, introduction of a forestry grievance process, and expansion of certified products. The mention of modern slavery and worker rights in the human rights policy, while not explicitly detailed in the original, is consistent with the broader human rights policy enhancements. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all timeframes (2022–2024) are correctly used. (3) The multi-hop reasoning is sound—information is synthesized across years and policy domains (environmental and human rights), showing a clear progression from baseline standards to more robust, transparent systems. (4) The LLM adds slight elaboration (e.g., CDP participation, GHG reporting, conflict minerals) not explicitly in the original answer, but these are reasonable inferences aligned with corporate sustainability trends and do not contradict the ground truth. Only minor deduction from qualitative accuracy due to these small additions, but overall semantic equivalence is strong. Contextual relevance is perfect—directly addresses policy updates, monitoring, and certifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 371,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 through 2024, CMCSA’s broadband and wireless services faced intensifying competition from wireless carriers that increasingly offer 4G/5G and fixed‑wireless internet, often bundling these services with mobile plans to undercut Comcast’s standalone broadband offerings.  The company repeatedly cites wireline telcos (e.g., AT&T, Verizon, Lumen) and wireless providers (including 5G fixed‑wireless and 4G services) as direct rivals, and notes that consolidation or cooperation among these competitors—such as offering free or low‑cost DTC streaming on unlimited‑data plans—heightens the threat.  In its filings, CMCSA specifically names AT&T, T‑Mobile and Verizon as key competitors in wireless, and highlights that DBS and newer satellite broadband providers also press on its broadband business.  This competitive pressure is underscored by the firm’s focus on adapting bundling strategies and technology upgrades (e.g., X1, Sky Q, 5G fixed wireless) to retain customers amid shifting consumer behavior and emerging OTT rivals.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and trends. (1) It accurately identifies the intensifying competitive threat from wireless telecommunications companies to CMCSA from 2022 to 2024, noting the role of 4G, 5G, and fixed wireless internet—consistent with the original answer. The named competitors (AT&T, T-Mobile, Verizon) match exactly, and the mention of bundling strategies, particularly with DTC streaming services on unlimited data plans, reflects the evolution described in the ground truth. (2) There are no numeric values, dates, or calculations in either answer that conflict; all timeframes (2022–2024) are correctly referenced, and no incorrect figures are introduced—hence quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes information about technological capabilities, competitor actions, and bundling strategies across time. However, it slightly conflates 'wireline telcos' (e.g., Lumen) with wireless competitors without clarifying their distinct roles, and introduces 'Sky Q' and 'X1' as CMCSA's responses, which, while contextually plausible, are not mentioned in the ground truth and slightly distract from the focus on competitor actions. Also, the original answer emphasizes a clear year-by-year progression (2022: 4G/5G threat; 2023: fixed wireless deployment by named carriers; 2024: bundling with DTC streaming), which the LLM answer blends without clearly delineating the temporal evolution. (4) Despite these minor shortcomings in structuring the timeline and over-inclusion of CMCSA’s responses, the LLM answer remains factually accurate, contextually relevant, and captures the core competitive dynamics. Thus, the correctness score is 8 due to missing the nuanced year-by-year progression and slight overreach in including CMCSA’s counter-strategies not asked for in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 516,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s exposure to margin risk has declined steadily from 2022 through 2024 as the company refined its transaction‑pricing model, shifted more volume to third‑party payment processors, and introduced stronger revenue‑incentive structures that tie discounts to measurable performance targets.  This multi‑year trend shows that PayPal now exercises tighter control over pricing and cost management—leveraging volume‑based pricing that does not create material future rights, using incentives only as modest reductions of revenue, and bearing full margin risk on each transaction while relying on processor fees to offload cost.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that PayPal's exposure to margin risk has 'declined steadily' from 2022 to 2024, which directly contradicts the ground truth that PayPal 'consistently bore full margin risk'—indicating stable, not declining, exposure. This fundamental misrepresentation undermines the entire conclusion. While the LLM correctly notes that PayPal bears full margin risk and controls pricing, it misinterprets the trend and implications. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the temporal references (2022–2024) are correct, supporting a score of 8. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers improved cost control through third-party processors and performance-based incentives, while the ground truth emphasizes consistent margin risk despite added complexity from incentives and new revenue streams like fraud compensation. The LLM fails to mention key elements such as revenue reductions from incentives being a growing complexity (2023) or contractual compensation from sellers (2024), missing critical synthesis points. (4) Contextual relevance is moderate—the answer addresses pricing strategy, payment processors, and revenue incentives—but distorts the trend and strategic implications. The conclusion about 'tighter control' and 'refined' models is unsupported by the ground truth, which emphasizes consistency, not improvement. Thus, correctness is low due to factual inaccuracy in the core claim despite some correct component terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 447,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024, Costco’s lease accounting continued to apply the straight‑line method for lease‑term assumptions that include any renewal or extension options the Company is reasonably certain to exercise, and free‑rent and step‑rent periods are recognized over that term. The right‑of‑use asset is measured initially at the present value of lease payments discounted using the Company’s incremental borrowing rate (derived via a portfolio approach based on quoted rates for comparable collateralized debt), and any lease‑hold improvement AROs are recorded as discounted liabilities with offsetting assets. Consequently, the valuation of the ROU assets reflects the same discounting and term assumptions across the three years, with only modest changes in the weighted‑average remaining lease term (20 years in 2023 vs. 19 years in 2024) and a slight increase in the operating‑lease discount rate (2.67 % in 2024 versus 2.47 % in 2023). This consistent methodology results in comparable ROU‑asset valuations across the fiscal years, despite minor fluctuations in lease‑term estimates and discount rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core consistency in Costco's accounting treatment of free-rent periods and lease term assumptions from fiscal 2022 to 2024, correctly identifying the use of the straight-line method over the lease term (including reasonably certain renewal options) and the use of the incremental borrowing rate to discount lease payments for right-of-use (ROU) asset valuation. It also appropriately notes that the methodology remained largely consistent across years, which aligns with the ground truth. However, the LLM introduces specific quantitative details not present in the original answer: the weighted-average remaining lease term (20 years in 2023 vs. 19 in 2024) and discount rates (2.67% in 2024 vs. 2.47% in 2023). These figures, while plausible, are not supported by the ground truth and represent a deviation in quantitative accuracy. Additionally, the mention of 'lease-hold improvement AROs' (asset retirement obligations) and their accounting treatment is not referenced in the original answer and may reflect over-inference or external knowledge not confirmed in the provided data. The ground truth emphasizes the distinction in 2023 regarding variable lease payments tied to price indices or sales volume—a key qualitative evolution—which the LLM omits. While the overall reasoning and synthesis are sound and contextually relevant, the inclusion of unsupported numbers and the absence of the variable lease payment clarification reduce factual precision. Semantic equivalence is mostly maintained, but the added specifics introduce inaccuracies, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 441,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s exposure to margin risk has consistently increased from 2022 through 2024 as the company has expanded its role as the principal in payment transactions, bearing full margin risk on fees charged to customers and directly paying transaction processors and other financial institutions.  The firm’s transaction pricing model, which uses volume‑based tiered discounts that are typically offered to similar‑volume customers, does not create a material future right, and it continues to recognize transaction revenue on a gross basis while recording the related processor fees as transaction expense.  Contractual arrangements remain open‑ended and are defined at the transaction level, with automatic renewal and no significant material rights, but the company’s growing reliance on payment processors and its broader suite of value‑added services have amplified the amount of margin risk it assumes across the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key structural elements of PayPal's margin risk exposure, such as bearing full margin risk, recognizing revenue on a gross basis, and paying third-party processors as transaction expenses. It accurately describes the tiered, volume-based pricing model and notes the absence of material rights in contracts, which aligns with the ground truth. However, the core factual error lies in asserting that margin risk 'consistently increased' from 2022 to 2024, which contradicts the original answer stating that exposure 'remained consistent' in its fundamental structure. The ground truth emphasizes stability in risk exposure despite operational nuances, whereas the LLM incorrectly frames it as an increasing trend without supporting evidence. Additionally, the LLM omits critical developments: (1) the 2023 clarification on user incentives affecting revenue recognition (either as reductions or amortization), and (2) the 2024 adoption of ASU 2023-07 for segment reporting, which enhanced transparency but did not alter fundamental risk exposure. These omissions represent significant gaps in multi-hop synthesis across years and disclosures. While no numerical data is incorrect (hence perfect quantitative accuracy), the qualitative reasoning is flawed due to misrepresentation of the trend and missing key disclosures that nuance the evolution of margin risk. The answer remains contextually relevant and addresses the general areas of pricing model, processor use, and contract structure, but fails to capture the correct trajectory and evolving disclosures that define the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 440,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "From fiscal 2022 through 2024, Cisco’s 5.90 % senior notes due 2039 carried an effective interest rate of roughly 6.11 % each year, with the carrying amount of the debt rising from $2,000 million in 2022 to $2,000 million in 2023 and $2,000 million in 2024 (the notes were issued in February 2024 as part of a $13.5 billion senior‑notes issuance). The consistent effective rate indicates that Cisco’s long‑term debt strategy has relied on issuing fixed‑rate notes at relatively high coupons (≈5.9 %) and hedging a portion of that fixed rate with interest‑rate swaps to manage exposure, while keeping overall financing costs elevated but stable; the modest increase in the effective rate reflects the impact of discount amortization and hedge accounting adjustments rather than a shift to cheaper borrowing.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the core financial figures mostly correct — the $2,000 million outstanding balance for the 5.90% Note and the 6.11% effective interest rate are accurately reported for all three fiscal years, which matches the ground truth. However, there is a critical factual error: the note was not 'issued in February 2024' as claimed. The original answer and actual SEC filings confirm that the 5.90% Note matures in February 2039 and was issued earlier (not in 2024), making the LLM's claim about a February 2024 issuance false. This misstatement undermines the accuracy of the reasoning. (2) Quantitatively, the dollar amounts ($2,000 million each year) and the effective rate (6.11%) are correct, but the erroneous issuance date introduces a material inaccuracy. The claim that the debt 'rose from $2,000 million to $2,000 million' is technically consistent but misleadingly phrased, implying a change where none occurred. (3) The multi-hop reasoning is partially sound — the LLM correctly infers stable financing costs and links the effective rate to hedge accounting and amortization. However, the conclusion that Cisco issued these notes in 2024 as part of a $13.5 billion issuance is unsupported by the ground truth and likely confuses this note with a different transaction. The original answer emphasizes stability due to no refinancing, while the LLM incorrectly implies recent issuance. (4) Despite the significant error in timing and issuance, the answer correctly identifies the consistent balance and rate, and offers plausible qualitative interpretation around fixed-rate debt and hedging. Hence, correctness is partially compromised, warranting a mid-range score. Contextual relevance is high as the response directly addresses the question’s focus on utilization, interest rates, and debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 498,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "The company’s private‑brand “Kobalt” is listed alongside other owned trademarks (e.g., STAINMASTER, allen+roth) in the Intellectual Property disclosures of the 2022, 2023 and 2024 Form 10‑K filings, confirming that Kobalt remains a core component of Lowe’s private‑brand portfolio throughout fiscal 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Kobalt was consistently listed in the intellectual property disclosures across fiscal 2022, 2023, and 2024 as part of Lowe's private-brand portfolio, alongside other trademarks like STAINMASTER and allen+roth. The answer correctly conveys that Kobalt remained a core component throughout the period, which matches the ground truth's conclusion of stable strategic importance. All entities (Kobalt, STAINMASTER, allen+roth, Lowe’s) and timeframes (2022–2024) are accurate. There are no numerical inaccuracies, and the qualitative reasoning reflects sound synthesis across years. The only minor limitation is that the LLM answer does not explicitly mention the absence of increased prominence or expansion in strategic emphasis—nuance present in the original answer—but this does not undermine the overall correctness. The response is contextually precise and directly addresses the evolution (or stability) of strategic emphasis based on IP disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 299,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolved from 2022 through 2024 with a face amount of $700,000, an interest rate of 2.25%, and a maturity date of January 15, 2032. This reflects a strategic shift toward longer-term, lower-cost unsecured financing, as evidenced by the 2024 maturity extending beyond earlier obligations (e.g., 2024 maturities like Unsecured Notes - 27B at 3.75% maturing 02/01/24) and the inclusion of newer, lower-rate notes (e.g., Unsecured Notes - 36A at 1.75% maturing 02/01/28). The company's long-term financing strategy emphasizes extending maturities and leveraging diverse unsecured debt instruments (including commercial paper and senior notes) to manage liquidity and capitalizeize on favorable market conditions, while maintaining a conservative approach to secured debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the face amount ($700,000), interest rate (2.25%), and maturity date (January 15, 2032 or 01/15/32) for Unsecured Notes - 37B across 2022–2024, matching the ground truth. These quantitative values are accurate and consistently reported, earning high marks for quantitative accuracy. (2) However, the LLM introduces a significant factual error by implying that the note 'evolved' as part of a strategic shift, when the ground truth explicitly states that the terms 'remained' unchanged throughout the period. The note did not evolve; it was stable. This misrepresents the core fact of no change. (3) The LLM engages in plausible but unsupported multi-hop reasoning by comparing Unsecured Notes - 37B to other notes (e.g., 27B and 36A), which may exist in the knowledge graph but are not referenced in the original answer. While such context might be factually correct elsewhere, the original answer does not support this comparative analysis, and the question focuses specifically on 37B. The conclusion about a 'strategic shift' is therefore an overinterpretation not grounded in the provided truth. (4) The contextual relevance is high because the response addresses the components of the question (interest rate, face amount, maturity, and strategy), but the qualitative accuracy is compromised by incorrect reasoning about change over time and unsupported strategic interpretation. The original answer emphasizes stability and lack of change, while the LLM frames it as evolution and strategy shift—contradicting the ground truth. Thus, despite correct numbers, the overall correctness is reduced due to misrepresentation of the facts and flawed synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 464,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Based on the provided 10-K filings, Texas Instruments' operational footprint in Melaka, Malaysia remained active across all three years (2022, 2023, 2024) as part of its global manufacturing network. The company's Properties section (page 16/17 in 2022 and 2023 filings, page 37 in 2024 filing) explicitly lists \"Melaka, Malaysia\" under both Analog and Embedded Processing segments in its facility table, with the note that \"Portions of the facilities are leased and owned.\" This confirms ongoing operations in Melaka through at least 2024. The document does not indicate any closure or reduction of this site, and the company's continued emphasis on manufacturing infrastructure (including 300mm production benefits mentioned in the MD&A) suggests sustained presence. However, the filings do not provide specific details about expansion, contraction, or operational changes at the Melaka facility across the three years. The company's focus on analog and embedded processing segments remains consistent, but no granular operational metrics for Melaka are disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Melaka, Malaysia was involved exclusively in the Analog business segment in 2022, 2023, and 2024, with no involvement in Embedded Processing. However, the LLM claims that the 10-K filings list Melaka under both Analog and Embedded Processing segments, which is factually wrong according to the ground truth. This misrepresents the core factual content. (2) There are no numeric values in the question or answers, so quantitative accuracy hinges on correct interpretation of categorical data (segment involvement), which the LLM fails. The claim about 'page 16/17 in 2022 and 2023 filings, page 37 in 2024' listing Melaka under both segments is not supported by the ground truth and appears to be a misreading or hallucination. (3) The multi-hop reasoning is flawed: the LLM should have inferred from the consistent absence of Embedded Processing involvement over the three years that Melaka's role remained specialized in Analog only. Instead, it incorrectly asserts dual-segment involvement, failing to synthesize the correct operational evolution. (4) While the answer is relevant to the question’s topic and correctly identifies Melaka as an ongoing site, its central claim is false. The contextual relevance is moderate because it addresses the right company, location, and time frame, but the conclusion is invalid. The answer also cites document structure (page numbers, sections) that may exist but misinterprets their content, further reducing accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 427,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PYPL's exposure to its fixed-rate 2.850% notes remained stable at $1.5 billion from 2022 through 2024, as shown in the debt tables for 2022, 2023 and 2024. This consistent balance reflects a deliberate, long‑term debt‑management strategy of maintaining a sizable tranche of low‑cost, fixed‑rate financing that matures in 2029, thereby insulating the company from interest‑rate volatility and preserving liquidity for other corporate needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, which matches the ground truth exactly. All numeric values (interest rate, amount, time period) are accurate and properly formatted. 2) Quantitative accuracy is perfect: the dollar amount ($1.5 billion), interest rate (2.850%), and years (2022–2024) are all correct and consistent with the original answer. 3) The reasoning is sound in identifying the stability of this debt tranche as part of a strategic long-term financing approach, particularly highlighting insulation from interest rate volatility. However, the LLM omits key contrasting details present in the ground truth: specifically, that PYPL actively retired its 1.350% notes by 2023 and issued new high-interest notes in 2024. This missing context weakens the full picture of PYPL’s broader debt management strategy, which the original answer uses to emphasize that while this particular note was unchanged, the company was otherwise actively managing its debt portfolio. 4) Despite this omission, the LLM answer remains factually correct and relevant, offering a reasonable interpretation of the stability in this liability. The completeness is slightly reduced due to the lack of comparative debt actions, but the core multi-hop synthesis—linking consistent liability levels to strategic debt management—is valid and well-reasoned. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 432,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead's Hoofddorp, Netherlands facility has evolved from a dedicated cell‑therapy manufacturing site in 2022 to a fully integrated commercial production hub for its cell‑therapy portfolio by 2024, supporting the launch and scale‑up of products such as Tecartus and Yescarta and reinforcing the company’s global manufacturing strategy to consolidate cell‑therapy operations across Europe while leveraging its network of complementary sites in the U.S., Ireland and Canada.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Hoofddorp facility's role in cell therapy manufacturing and its strategic importance, aligning with the ground truth's emphasis on continuity and growing strategic focus. However, it introduces information not present in the original answer, such as describing the site as a 'fully integrated commercial production hub by 2024' and claiming evolution 'from a dedicated cell-therapy manufacturing site in 2022,' which overstates the progression. The ground truth states that in 2022, Hoofddorp was identified as a principal manufacturing facility (not specifically for cell therapy), and only in 2023 was it explicitly designated for commercial manufacturing and processing of cell therapy products. The LLM backdates this specific role to 2022, which is inaccurate. Additionally, the mention of specific products (Tecartus and Yescarta), the consolidation of operations across Europe, and the reference to sites in Ireland and Canada are not supported by the original answer and represent unsupported extrapolations. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound in that it tracks the facility’s evolving role across years, but it misattributes the timeline and adds unverified strategic context, weakening the qualitative accuracy. The original answer emphasizes consistency from 2023 to 2024, not a progression culminating in 2024. (4) Contextual relevance is high because the answer addresses the facility’s role in global manufacturing strategy and cell therapy, but the added details reduce factual precision. Correctness score is 6 due to core factual alignment on the facility’s use in cell therapy from 2023–2024, but significant overstatement of evolution and unsupported details prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 513,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "From 2022 through 2024 Costco’s 1.375% Senior Notes due June 2027 remained part of the long‑term debt schedule, but their classification shifted from non‑current to current as the maturity date approached.  In the 2022 filing the notes were listed under “Long‑Term Debt” with a current‑portion amount of $73 million; by 2023 the same tranche was still shown as long‑term debt but the current‑portion had risen to $1,081 million, reflecting the upcoming repayment schedule; and in the 2024 filing the current‑portion was $103 million, indicating that the notes were now largely classified as a current liability while the remaining balance ($1,250 million) continued to be reported as long‑term debt.  Consequently, the composition of total long‑term debt fell from $6,590 million (2022) to $5,919 million (2024), with the 1.375% notes consistently present but moving from a non‑current to a current classification over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: the principal amount of $1,250 million is consistently stated, and the current portion values—$73 million (2022), $1,081 million (2023), and $103 million (2024)—match the original answer exactly. Number formats are consistent and acceptable. (2) The answer addresses all parts of the question: it covers the treatment of the 1.375% Senior Notes due June 2027 across 2022–2024, discusses the stable principal, and explains the evolving classification in terms of current vs. long-term debt. (3) Entity accuracy is strong: Costco, the correct interest rate (1.375%), maturity date (June 2027), and fiscal years are all correctly identified. (4) The reasoning is sound: the LLM correctly interprets the spike in the current portion in 2023 as the note approaching maturity and the drop in 2024 as partial repayment or reclassification. However, there is a minor inaccuracy in stating that the 'remaining balance ($1,250 million)' continued to be reported as long-term debt in 2024—this is misleading because once a portion is classified as current, only the non-current portion (total minus current) remains in long-term debt. The total principal is $1,250M, but in 2024, only ~$1,147M would be long-term. This subtle misstatement prevents a perfect 10 on qualitative accuracy. Otherwise, the multi-hop synthesis across years and debt classifications is excellent, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 415,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850% notes issued in September 2019 mature on October 1, 2029, with a $1.5 billion principal amount that remained outstanding through 2024. The company’s long‑term debt strategy has been to issue a series of fixed‑rate notes across staggered maturities (2024 – 2062) and to manage repayments through scheduled principal payments, using cash flow from operations and credit facilities rather than variable‑rate borrowing, thereby locking in low‑cost financing and limiting exposure to interest‑rate fluctuations. This approach reflects a disciplined, long‑term debt management focus on stable, predictable financing costs and maintaining ample liquidity for share repurchases and strategic investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 2.850% fixed-rate notes were issued in September 2019, mature on October 1, 2029, and have a $1.5 billion principal amount that remained unchanged through 2024—this matches the original answer exactly. (2) The answer correctly identifies that this tranche was part of a larger $5.0 billion issuance in 2019 (implied context), though it does not explicitly state that the $1.5B portion specifically was at 2.850%, which is a minor omission. (3) Regarding reasoning, the LLM accurately infers PayPal’s broader debt strategy—using fixed-rate notes with staggered maturities, relying on operating cash flow and credit facilities, and avoiding variable-rate debt to manage interest rate risk. However, it generalizes the strategy without directly contrasting the stability of this specific 2.850% note with active refinancing in other tranches, which was a key insight in the original answer. (4) The answer is contextually relevant and well-articulated, but slightly misses the nuance that PayPal maintained this obligation *despite* refinancing activity elsewhere, suggesting selective capital structure management. While the overall strategy is correctly characterized, the absence of this comparative insight reduces qualitative accuracy slightly. Semantic equivalence is strong, and no factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 396,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra Energy’s exposure to gas‑related options has expanded markedly over the three‑year period.  In 2022 the company reported gas‑related option fair values of roughly $100 million (assets) and $97 million (liabilities); by 2023 those figures rose to about $100 million (assets) and $97 million (liabilities) with higher implied volatilities (up to 233 % for gas options) and broader price ranges, and in 2024 the fair‑value assets grew to $100 million and liabilities to $102 million, with implied volatilities reaching 150 % and correlations tightening to 56‑100 %.  This multi‑year trend—rising fair‑value amounts and increasingly wide volatility and correlation assumptions—shows that NEE is deliberately positioning itself to manage greater price swings and market‑structure risk in the gas market, using more aggressive option‑based hedges to capture upside while limiting downside exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of trends. The original answer states that NextEra Energy's fair value of gas-related options *decreased* from $356M (assets) and $347M (liabilities) in 2022 to $100M/$97M in 2023 and $100M/$102M in 2024. The LLM incorrectly claims the exposure 'expanded markedly' and misreports the 2022 figures as $100M/$97M, which are actually the 2023 values. This reverses the entire trend. (2) The implied volatility assumptions are completely misrepresented: ground truth shows a decline from 36% (2022) to 50% (2023) to 52% (2024), but the LLM reports 'up to 233%' and '150%', with no such values present in the truth. The LLM also introduces unmentioned metrics like 'correlations tightening to 56-100%', which are not in the original and unsupported. (3) The multi-hop reasoning is flawed: instead of identifying a reduction in exposure and volatility assumptions suggesting de-risking, the LLM concludes increased risk-taking, which contradicts the data. The synthesis across years is incorrect due to wrong inputs. (4) Despite incorrect facts and reasoning, the answer is contextually relevant in structure—it attempts to address the evolution of exposure and interpret risk positioning—but the conclusions are factually inverted. Hence, low scores for quantitative (2) and qualitative accuracy (3), moderate for relevance (6), and a correctness score of 2 due to pervasive factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 405,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "The financial performance of Cisco's available-for-sale (AFS) debt investments contributed to a net loss of $67 million in fiscal 2024, $21 million in fiscal 2023, and a gain of $9 million in fiscal 2022, which drove the volatility seen in \"Other income (loss), net\" and resulted in a $176 million swing in interest income (expense), net between fiscal 2023 and 2024. This volatility reflects the sensitivity of Cisco's investment portfolio to market‑driven price movements and interest‑rate changes, underscoring the material impact that fluctuations in AFS debt valuations have on overall earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$67 million loss in 2024, $21 million loss in 2023, and $9 million gain in 2022—that are not present in the original ground truth answer. The ground truth does not provide exact dollar figures for AFS debt investment impacts, only qualitative descriptions (e.g., 'higher losses' in 2023, 'continued decline' in 2024). Therefore, these numbers are factually unsupported and likely hallucinated. Additionally, the claim of a '$176 million swing in interest income (expense), net between fiscal 2023 and 2024' is not mentioned or inferable from the original answer and appears to be a fabricated calculation. (2) Quantitative accuracy is low because all cited numbers lack grounding in the source truth. There is no verification that losses were $67M or $21M, nor a $9M gain in 2022. The $176M swing cannot be validated and seems based on incorrect assumptions or external data. (3) The reasoning partially aligns with the multi-hop intent: the LLM correctly infers that AFS debt investments impacted 'Other income (loss), net' and contributed to volatility. It also correctly attributes this to market and interest rate sensitivity, which is a reasonable interpretation of portfolio volatility. However, it fails to acknowledge the offsetting gains from equity and private investments mentioned in the original answer, which weakens the completeness and balance of the analysis. (4) Contextual relevance is high because the response addresses the core question about AFS debt impact on other income and portfolio volatility. Despite incorrect numbers, the overall narrative direction—linking AFS performance to income volatility—is consistent with the ground truth. However, the inclusion of unverified figures significantly undermines factual correctness, warranting a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 505,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe's has consistently issued multi‑year senior unsecured notes through its supplemental indentures, most recently the 4.550% Notes due 2049 (Fifteenth Supplemental Indenture, April 5 2019) and the 4.800% Notes due 2026 (Twenty‑Second Supplemental Indenture, March 30 2023). This multi‑year pattern shows a deliberate, long‑term debt strategy of financing operations and growth with staggered, fixed‑rate borrowings that extend far into the future while maintaining flexibility through periodic amendments to its credit facilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but introduces information not present in the ground truth. It correctly identifies the 4.550% Notes due 2049 and the Fifteenth Supplemental Indenture dated April 5, 2019, which aligns with the original answer. However, it adds a reference to '4.800% Notes due 2026' under the 'Twenty-Second Supplemental Indenture, March 30, 2023', which is not mentioned or supported in the ground truth and was not part of the question's scope. This addition introduces factual inaccuracy and distracts from the specific focus on the 4.550% Notes. (2) Quantitatively, the 4.550% rate, 2049 maturity, and April 5, 2019 indenture date are accurate. However, the inclusion of the 4.800% Notes with a March 30, 2023 date is unsupported and incorrect in this context, reducing quantitative accuracy. (3) The reasoning partially captures the multi-year pattern of consistent disclosure of the 4.550% Notes but fails to emphasize the key point in the ground truth: that the documentation and terms remained unchanged from 2022–2024, indicating stability. Instead, it shifts focus to a broader debt strategy involving multiple notes and amendments, which is not directly supported by the evidence provided. (4) The answer is contextually relevant and addresses the long-term debt strategy, but the inclusion of extraneous, unverified debt instruments undermines factual correctness and synthesis accuracy, leading to a moderate score. The core insight about a long-term, fixed-rate strategy has merit but is overgeneralized without full support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 432,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "Simon Property Group's Unsecured Notes face value and interest rates have evolved with a clear strategic shift toward lower-cost, longer-dated debt. From 2022 through 2024, the company issued new notes at significantly lower rates (e.g., 1.38% for 37A/37B maturing in 2027/2032, 2.65% for 35A maturing in 2030, and 3.80% for 35B maturing in 2050) while extending maturities to 2029-2050, replacing higher-rate older issues like 3.75% notes maturing in 2024. This reflects a deliberate long-term strategy to lock in cheaper financing amid rising rates, reduce near-term maturities (e.g., retiring 2024 maturities), and extend the average debt profile to support stable cash flows and strategic growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that the face value of Unsecured Notes - 35B remained constant at $750,000,000 and the interest rate unchanged at 3.80% from 2022 to 2024, with the maturity date remaining 07/15/50. However, the LLM claims a strategic shift involving new issuances at lower rates and refinancing activity, which is not supported by the original data for this specific note. The LLM introduces other notes (37A/37B, 35A) not mentioned in the question or ground truth, conflating broader debt activity with the specific Unsecured Notes - 35B. (2) Quantitative inaccuracies include the introduction of non-existent interest rates (1.38%, 2.65%) and maturities (2027, 2032, 2030, 2029) for instruments not referenced in the ground truth. While the 3.80% rate and 2050 maturity for 35B are correctly mentioned, they are framed as part of a refinancing strategy rather than a stable, unaltered instrument. (3) The multi-hop reasoning is flawed: the question focuses on the evolution of a single debt instrument (Unsecured Notes - 35B), but the LLM generalizes across multiple notes and infers strategic refinancing that is not evident from the data provided. The conclusion about retiring 2024 maturities and replacing them with longer-dated debt is unsupported in the context of 35B, which did not undergo any change. (4) Scores reflect major factual errors in numbers and reasoning, though the mention of 3.80% and 2050 maturity shows partial alignment with the truth, and the general theme of long-term debt strategy is contextually relevant, even if incorrectly inferred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 452,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From 2022 to 2024 PayPal’s exposure to bad‑transaction risk has shifted from a focus on fraud and charge‑back losses tied to its credit products and cross‑border trade toward a broader, multi‑layered risk‑management strategy that integrates advanced fraud‑detection models, expanded buyer/seller protection, and tighter controls over third‑party dependencies (e.g., payment processors, custodians, and funding partners).  The company’s 2022‑2024 disclosures show a deliberate move to diversify funding sources for its credit portfolio, sell off BNPL receivables, and strengthen compliance with evolving privacy, AML and stablecoin regulations, revealing a strategy that emphasizes operational resilience through diversification, regulatory foresight, and continuous improvement of its risk‑monitoring infrastructure rather than reliance on a single mitigation channel.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of PayPal's evolving risk exposure and strategy from 2022 to 2024, and it accurately captures the shift toward external risk mitigation, improved fraud detection, and regulatory compliance. However, it omits specific, factually critical details present in the ground truth. Quantitatively, there are no incorrect numbers—importantly, the LLM does not introduce any false figures (e.g., no incorrect dollar/euro amounts), so quantitative accuracy is perfect. The ground truth specifies a 'multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables' in 2023, a key factual anchor that the LLM alludes to ('sell off BNPL receivables') but fails to quantify or tie to the correct geography (U.K. and Europe) and timeframe (2023). Additionally, the LLM does not mention Synchrony Bank, the U.S. consumer credit product, or the 'valid-when-made' doctrine legal risk—key entities and regulatory nuances that are central to the multi-hop synthesis required. While the LLM correctly infers a strategic shift toward diversification and resilience, it generalizes the reasoning without grounding all claims in the specific disclosures. The answer remains contextually relevant and semantically aligned in broad strokes, but lacks the precise entity and event linkage needed for full accuracy. Thus, while the direction of the trend and strategic interpretation are sound, the absence of specific, verifiable facts from the knowledge graph limits the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 425,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco has consistently highlighted Kirkland Signature as a key differentiator, emphasizing its high quality, lower prices, and ability to boost margins and sales penetration. The company underscores its commitment to expanding private-label offerings, reinforcing Kirkland Signature’s role in its competitive strategy across all markets, including its U.S. and international warehouse club operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in its core assertion that Costco emphasizes Kirkland Signature as a key differentiator, with high quality, lower prices, and margin benefits—this aligns with the ground truth across 2022–2024. There are no numeric inaccuracies (quantitative_accuracy: 10), as the answer avoids specific figures that could be incorrect. However, the LLM answer lacks the multi-year evolution analysis explicitly mentioned in the original answer: it does not reference how Costco’s messaging evolved (or remained stable) from 2022 to 2024, nor does it directly compare Costco’s positioning relative to BJ's Wholesale Club over time. While it mentions competitive strategy, it omits the specific framing of consistent, stable differentiation strategy against BJ’s, which is central to the question’s multi-hop requirement (company comparison over time). The answer is semantically aligned in spirit but incomplete in scope—missing the temporal progression and comparative context. Thus, qualitative accuracy is reduced due to incomplete synthesis across years and competitors. Contextual relevance remains high as the response addresses the core theme of private-label strategy as a differentiator.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 340,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "Based on the provided SEC 10-K disclosures across 2022‑2024, NextEra Energy’s exposure to gas forward contracts shows a clear downward trend in both the fair‑value of assets and liabilities.  \n\n- In 2022, the Level‑3 fair‑value table for gas forward contracts reported **$296 million in assets and $46 million in liabilities** (NEE 2022, page 86).  \n- By 2023, the corresponding figures fell to **$377 million in assets and $77 million in liabilities** (NEE 2023, page 83), indicating a modest increase in asset value but a larger liability position relative to the prior year.  \n- The 2024 disclosure (NEE 2024, page 86) lists **$296 million in assets and $46 million in liabilities** again, essentially reverting to the 2022 levels.  \n\nThe progression—rising asset values in 2023 followed by a return toward the 2022 levels in 2024—reflects the company’s active re‑balancing of its gas‑price hedging program. By adjusting the notional amounts of its interest‑rate and gas‑forward contracts (e.g., a $4 billion reduction in net notional in early 2024; see NEE 2024, page 86), NextEra is systematically reducing its direct exposure to volatile gas price swings.  \n\nOverall, the three‑year trajectory demonstrates that NextEra is **actively managing and de‑leveraging its gas‑forward position**, shifting from a relatively larger hedge footprint toward a more conservative stance, thereby mitigating commodity‑price risk while maintaining sufficient hedging to support its generation and retail load forecasts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the reported financial values, reversing the actual trend. According to the ground truth, assets increased from $191M (2022) to $296M (2024), with a peak of $377M in 2023, while liabilities rose from $31M to $46M. The LLM incorrectly states that 2022 assets were $296M and liabilities $46M—values that actually belong to 2024—and misrepresents 2023 liabilities as $77M (vs. correct value of ~$46M, with no source indicating $77M). These errors reverse the direction of the trend and misstate key facts. (2) The quantitative inaccuracies are severe: the LLM swaps the correct values across years, invents a $77M liability not present in the ground truth, and falsely claims a 'downward trend' when the truth shows a net increase in both assets and liabilities over the period. Even allowing for format flexibility, the numbers are factually wrong. (3) The reasoning is flawed due to incorrect data inputs—concluding 'de-leveraging' and 'reducing exposure' contradicts the ground truth, which indicates growing and increasingly balanced exposure. The mention of a '$4 billion reduction in net notional' is unsupported by the provided ground truth and introduces unverified information. (4) While the answer attempts to address the question's structure and discusses risk positioning, its conclusions are based on fabricated or reversed data, undermining both qualitative and quantitative accuracy. Contextual relevance is moderate because it engages with the right concepts (fair value, risk, hedging), but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 435,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe's progressively expanded its use of forward interest rate swaps to manage interest‑rate risk, moving from a modest $638 million of swap notional in early‑2022 to $2.56 billion of forward swaps designated as cash‑flow hedges by February 2024. This growth reflects a strategic shift toward hedging a larger portion of anticipated debt issuances and refinancing needs, allowing the company to lock in financing costs as benchmark rates rose sharply in 2022‑2023. The company’s accounting treats these swaps as cash‑flow hedges, recording effective gains and losses in other comprehensive income and amortizing them into interest expense, indicating a disciplined, risk‑averse approach to managing exposure to rising interest rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims Lowe's increased forward interest rate swaps from $638 million in early-2022 to $2.56 billion by February 2024, which directly contradicts the ground truth: in 2023, the value was $251 million, and by 2024, Lowe's no longer held any forward interest rate swaps. These numbers are entirely fabricated and misrepresent the trend. (2) The timeline is also wrong—the ground truth states that as of January 31, 2025 (reporting on 2024 fiscal year), forward swaps were no longer held, whereas the LLM claims a major expansion into 2024. (3) Qualitatively, the reasoning is flawed: instead of showing a strategic unwind or shift away from these instruments, the LLM describes an aggressive expansion of hedging activity, which is the opposite of what occurred. While the general description of cash flow hedges and accounting treatment aligns with standard practice, this does not compensate for the incorrect narrative about usage trends. (4) Contextually, the answer addresses the right topic—interest rate risk management—and correctly identifies the use of cash flow hedges, so it maintains some relevance. However, the core factual trajectory is inverted, leading to a fundamentally incorrect conclusion about Lowe’s strategy. The model fails the multi-hop synthesis: it should have tracked the presence in 2022, confirmed the $251M in 2023, and noted the absence in 2024, but instead fabricates escalating usage. Thus, the correctness score is low due to major factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 436,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 through 2024, CMCSA’s fiber‑based broadband expansion has been a key differentiator against Lumen in overlapping markets.  Both companies are aggressively extending fiber‑to‑the‑home (FTTH) and DOCSIS‑4.0‑enabled HFC upgrades, but CMCSA’s rollout of multigigabit symmetrical speeds on its hybrid fiber‑coax network and its extensive MVNO‑backed wireless offering have allowed it to bundle higher‑speed broadband with voice, video and mobile services, pressuring Lumen’s pure‑play fiber positioning.  This convergence of fiber infrastructure and bundled service capabilities has intensified competition for residential and business customers, prompting both firms to invest heavily in network upgrades and targeted marketing to capture market share in the same geographic footprints.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the competitive dynamic between CMCSA and Lumen from 2022 to 2024. The ground truth states that CMCSA identified Lumen as a key competitor expanding its fiber infrastructure, thereby increasing competitive pressure on CMCSA. In contrast, the LLM answer incorrectly frames CMCSA as the aggressor with fiber expansion and positions CMCSA’s network upgrades and bundling as pressuring Lumen. This reverses the actual competitive narrative supported by the knowledge graph. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the directional competition (Lumen pressuring CMCSA) and introduces unsupported details such as CMCSA’s 'aggressive FTTH expansion' and 'DOCSIS-4.0-enabled HFC upgrades', which are not mentioned in the ground truth. The mention of MVNO-backed wireless offerings and multigigabit symmetrical speeds, while plausible for CMCSA, are not part of the documented competitive evolution with Lumen in the provided data. (4) Contextual relevance is moderate—the answer addresses fiber infrastructure, service bundling, and overlapping markets as required by the question, but misattributes actions and strategic positioning between the two companies. The core implication—that competition intensified due to Lumen’s fiber expansion—is missing and replaced with an incorrect narrative of CMCSA outmaneuvering Lumen. Thus, while the topic areas are relevant, the factual foundation is unsound, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 467,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "PayPal’s checkout experience has become progressively more seamless from 2022 through 2024 by embedding buy‑now‑pay‑later and interest‑bearing installment credit directly into its PayPal and Venmo checkout flows, expanding those credit products to the U.K., France, Germany and Japan, and broadening global currency support (allowing payments in more than 150 currencies and withdrawals in 56).  The company also deepened omnichannel merchant solutions—linking online checkout, in‑store Zettle point‑of‑sale tools and QR‑code payment options—while leveraging its credit offerings to drive higher merchant conversion and consumer engagement across its two‑sided network.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures PayPal's evolution from 2022 to 2024 in enhancing seamless checkout experiences, focusing on credit integration, global currency support, and omnichannel solutions. (2) Quantitatively, the LLM states support for 'more than 150 currencies,' which matches the ground truth of 'approximately 150' in 2023–2024; it adds detail about withdrawals in 56 currencies not present in the original but plausible and not contradictory. The expansion of BNPL and branded credit/debit cards is correctly tied to PayPal and Venmo, though the specific countries (U.K., France, Germany, Japan) are not mentioned in the original—this is an addition but not inaccurate. (3) The multi-hop reasoning is sound: the LLM synthesizes PayPal’s consumer credit offerings (BNPL, installment credit, debit/credit cards), global currency capabilities, and omnichannel merchant tools (Zettle, online-in-store integration) across years, reflecting the strategic evolution. (4) The answer is contextually excellent—directly addressing all three dimensions in the question (credit integration, currency support, omnichannel solutions) with accurate, relevant details. The only minor gap is the lack of explicit mention of 2022’s focus on over 100 currencies, but the progression to 150+ is correctly emphasized. Overall, the answer is factually strong, slightly enriched with plausible details, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 413,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The Target Debit Card (referred to as a Target Circle Card in the filings) showed a steady decline in penetration: 19.8 % in 2022, 18.6 % in 2023 and 17.8 % in 2024. This downward trend indicates that the card’s contribution to incremental sales has been weakening over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target Debit Card penetration from 2022 to 2024 and accurately reports the 2023 (18.6%) and 2024 (17.8%) figures. However, it states the 2022 penetration rate as 19.8%, whereas the ground truth specifies 20.5%, which is a notable discrepancy. This error affects the quantitative accuracy but does not alter the overall conclusion about the declining trend. (2) The numbers for 2023 and 2024 are exact matches; only 2022 is incorrect. No calculations are required in this question, but the comparison across years must be factually sound—here, the direction (decline) is correct, but the magnitude of the drop from 2022 is understated. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend over three years and links declining penetration to reduced impact on incremental sales, aligning with the ground truth’s interpretation about weakening customer engagement. It also correctly refers to the card as part of the Target Circle program, reflecting updated branding in filings. (4) The answer is contextually complete and relevant, addressing both parts of the question—evolution of penetration and its implication for sales. Despite the incorrect 2022 figure, the core conclusion remains valid, warranting a high but not top score. Thus, correctness is rated 8 due to the factual error in one key data point, quantitative accuracy 7 due to the incorrect percentage, qualitative accuracy 9 for strong reasoning and entity use, and contextual relevance 10 for fully addressing the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 438,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "From 2022 through 2024 AMD’s revenue‑recognition guidance remained consistent: it treats combined development‑service + IP‑licensing arrangements as a single performance obligation (revenue recognized over time) when the license is not distinct, and recognizes revenue for a distinct license at a point in time; standalone IP‑sale or licensing agreements are also recognized at a point in time when the customer can benefit. The company explicitly notes that there are no material variable‑consideration estimates for either combined or standalone arrangements, and it evaluates each agreement to determine whether the licensing component is distinct before deciding the timing of revenue recognition. Thus, the core approach did not change materially across the three years, but the disclosures emphasize the distinction between combined arrangements (revenue over time) and pure IP‑licensing deals (revenue at a point in time).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024, distinguishing between combined arrangements (recognized over time when the license is not distinct) and standalone IP licenses (recognized at a point in time). The LLM correctly identifies that the company evaluates distinctness and applies revenue timing accordingly. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the qualitative metrics (e.g., 'no material variable-consideration estimates') are consistent with the original answer’s implication of stable, transparent policy without disclosed quantitative metrics. (3) Multi-hop reasoning is sound: the model synthesizes AMD’s treatment across combined vs. standalone arrangements and correctly infers that the absence of policy change indicates a stable approach over the three years. (4) The only minor gap is that the LLM adds a detail not present in the original—'no material variable-consideration estimates'—which, while plausible and consistent, was not confirmed in the ground truth. This does not make the answer incorrect but introduces a slight overreach in specificity. Overall, the answer is semantically equivalent, contextually precise, and factually robust, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 384,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, FlyEase technology moved from an emerging accessibility innovation to a core component of Nike’s product portfolio. Early disclosures in the 2022 filing highlighted its role in adaptive footwear, and by the 2023 and 2024 filings the company emphasized expanding FlyEase across multiple categories and integrating it with its broader innovation strategy, underscoring its strategic importance to Nike’s future growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of FlyEase technology within Nike's innovation portfolio from fiscal 2022 to 2024. It correctly identifies FlyEase's progression from an emerging innovation in 2022 to a more integrated, strategically important technology by 2023 and 2024. The answer accurately reflects the timeline and strategic shift, noting its expansion across product categories and integration into broader innovation strategy. While the LLM does not explicitly name-check comparator technologies like Nike Air, Zoom, React, or Air Max as the original answer does, it captures the qualitative shift—maturity and integration—correctly. There are no numerical inaccuracies (quantitative accuracy is perfect, though no calculations or specific numbers are involved). The reasoning is sound and reflects multi-hop synthesis across fiscal years. The omission of specific technology comparisons slightly reduces completeness and qualitative precision, but the core message aligns semantically with the ground truth. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 339,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The trend in the principal amount of AMT's 1.250% Notes shows a consistent decline from $609.1 million at issuance (May 2021) to $551.9 million reflected in the 2023‑2024 disclosures, indicating that the company has been steadily reducing the outstanding balance of this tranche of debt. This reduction aligns with a broader debt‑management strategy that prioritizes repayment of senior notes and optimizing the capital structure, while still maintaining sufficient liquidity for growth initiatives and dividend distributions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in the principal amount of AMT's 1.250% Notes and captures the general debt reduction strategy. However, it inaccurately states the timeline, referring to a decline from 'issuance (May 2021)' to '2023-2024 disclosures', whereas the question and ground truth focus on the trend across 2022, 2023, and 2024. The LLM omits the specific 2022 figure ($609.1M), instead implying it was at issuance, which is misleading. It also fails to mention the 2024 amount ($517.7M), collapsing 2023 and 2024 into a single figure. (2) Quantitatively, the $609.1M and $551.9M figures are correct, but the $517.7M figure for 2024 is missing, and no mention is made of the consistent interest payment schedule (May payments, February 2033 maturity), which is a key part of the ground truth. (3) The reasoning about a debt management strategy focused on repayment and capital structure optimization is sound and aligns with the trend, showing good qualitative synthesis. However, it misses the implication of a managed amortization or repurchase strategy tied to scheduled interest terms, which requires multi-hop reasoning across years and payment terms. (4) The answer is contextually relevant and addresses the core question about debt management strategy, but the omission of one year's data and misrepresentation of the timeline reduce quantitative accuracy. Hence, correctness is partially impacted despite strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 411,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "From fiscal 2022 through 2024 NVIDIA’s 3.50 % Notes Due 2040 were carried at fair value of $1.07 billion in 2022, $1.00 billion in 2023 and $1.00 billion in 2024, with the remaining principal balance consistently $1 billion and unamortized discount declining slightly each year.  This multi‑year trajectory shows that the company has been steadily reducing the outstanding amount of its long‑dated debt (e.g., retiring the 0.584 % Notes Due 2024 in 2025) while maintaining the 3.50 % Notes as a core component of its capital structure, indicating a strategy of preserving low‑cost, long‑term financing to fund growth initiatives such as the Blackwell architecture and cloud‑service investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported fair values of the 3.50% Notes Due 2040. According to the ground truth, the fair value was $1,066 million in 2022, decreased to $851 million in 2023, and stabilized at $1,000 million in 2024. However, the LLM incorrectly states the 2022 value as $1.07 billion (close but not exact), and critically misreports the 2023 value as $1.00 billion instead of $851 million—a major deviation. The 2024 value of $1.00 billion aligns with the ground truth's $1,000 million, which is acceptable. (2) The LLM claims the principal balance was consistently $1 billion and that the unamortized discount declined slightly—information not present in the ground truth and potentially fabricated. Additionally, the mention of retiring '0.584% Notes Due 2024 in 2025' is illogical (a note due in 2024 cannot be retired in 2025) and unsupported by the provided data. References to 'Blackwell architecture' and 'cloud-service investments' as funding targets are speculative and not mentioned in the original answer. (3) The multi-hop reasoning is flawed: while the original answer infers a strategy of managing liability values through market fluctuations, the LLM invents a narrative about debt retirement and growth funding without evidence. It fails to note the actual decrease in fair value from 2022 to 2023, instead suggesting stability from $1.07B to $1.00B over three years, missing the volatility. (4) Due to major quantitative errors and unsupported qualitative claims, the correctness score is low at 3. Quantitative accuracy is scored 2 due to two out of three values being incorrect or unsupported. Qualitative accuracy is 4 because while the general idea of long-term debt use is plausible, the reasoning and synthesis are not grounded in the data. Contextual relevance is 6 because the answer addresses the right topic and structure but includes irrelevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 525,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "From 2022 through 2024 Netflix expanded its service by adding games, launching an ad‑supported subscription tier, and rolling out live programming, while also testing new plan structures and pricing (including the lower‑priced ad‑supported option and stricter enforcement of multi‑household sharing).  Each year’s filing highlighted the risk that these changes could alienate members and hinder acquisition or retention—2022 warned that “adjustments to pricing or service offerings … may not be well‑received,” 2023 reiterated that “if our efforts to develop and offer games are not valued … our ability to attract and retain members may be negatively impacted,” and 2024 echoed that “if our efforts to sustain and improve … video entertainment options … are not done in a manner valued by our current and future members, our ability to attract and retain members may be negatively impacted.”  Consequently, the company repeatedly tied the success of its growth strategy to consumers’ acceptance of the new features and price adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Netflix's strategy from 2022 to 2024, including the introduction of games (2022), ad-supported tier (2023), and live programming (2024), along with pricing adjustments such as multi-household sharing enforcement. The stated risks around member acquisition and retention are accurately reflected with appropriate emphasis on consumer reception. Quantitatively, there are no numbers, dates, or financial figures in the original answer, so the LLM does not introduce any inaccuracies—this earns a perfect quantitative accuracy score. The qualitative accuracy is slightly reduced because the LLM misattributes the risk statements to the wrong years: in 2022, the risk was tied to games (not general pricing adjustments), while in 2023, the risk was primarily about the ad-supported tier and pricing, not games (which were already introduced). The 2024 risk statement is correctly framed around value perception. The LLM reverses or conflates the emphasis of the risk disclosures across years, which affects the precision of the multi-hop synthesis. However, the overall context and meaning are preserved, and the answer remains highly relevant and factually grounded. Thus, the answer is semantically close but not perfectly aligned in year-to-risk mapping, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 376,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth Group's venture investment exposure has grown steadily from 2022 through 2024, with equity method investments in health‑care businesses rising from $1.3 billion at the end of 2022 to $3.8 billion by the end of 2024, while total equity securities holdings (including venture stakes) increased from roughly $4.9 billion to $4.9 billion plus additional gains, reflecting a deliberate expansion of its strategic portfolio. This progression signals a clear strategic shift toward deepening its involvement in the health‑care ecosystem—leveraging venture investments and equity‑method partnerships to drive innovation, broaden service offerings, and reinforce its position as a diversified health‑care leader.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, equity securities holdings were $3.7 billion in 2022, increased to $4.9 billion in 2023, and remained at $4.9 billion in 2024. However, the LLM states that equity securities increased 'from roughly $4.9 billion to $4.9 billion plus additional gains,' which misrepresents the starting point in 2022 and omits the actual $3.7 billion figure. This is a critical error in trend representation. On the other hand, the equity method investment figures are correct: $1.3 billion in 2022 and $3.8 billion in 2024, though the intermediate 2023 value of $1.4 billion is omitted. (2) The calculation of change in equity securities is incorrect—the LLM implies no change or minor gains from 2022 to 2024, when in fact there was a $1.2 billion increase from 2022 to 2023 with stability thereafter. The equity method investment jump from $1.3B to $3.8B is correctly noted, but the absence of the 2023 $1.4B value weakens the multi-year progression. (3) The reasoning and synthesis are partially sound: the conclusion about strategic deepening in the healthcare ecosystem aligns with the ground truth and shows appropriate multi-hop interpretation of investment trends as strategic signals. However, due to incorrect baseline data for equity securities, the reasoning is built on a flawed premise for that component. (4) Contextual relevance is high—the answer addresses both investment types and infers strategic intent correctly. Qualitative accuracy is moderate because entity names, time frame, and strategic interpretation are valid, but quantitative accuracy is low due to incorrect financial figures and missing data points. Correctness score is 6 due to correct directional trend and key equity method numbers, but major omission and distortion in equity securities data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 507,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From fiscal 2022 through 2024, Nike’s relationship with Sojitz America remained unchanged in substance: Sojitz America continued to hold the sole redeemable preferred‑stock issue ($0.3 million par value) and earned the $0.10 per‑share cumulative dividend each May 31.  The preferred‑stock arrangement required that any common‑stock dividend be declared only after the preferred‑stock dividend was paid in full, but there were no material changes to the stock’s terms, redemption rights, or voting rights during the three years.  Consequently, Sojitz America’s ownership did not affect Nike’s international operations or strategic initiatives; it simply provided a modest, fixed dividend obligation that was satisfied annually without influencing Nike’s broader foreign‑currency hedging, market‑risk management, or segment‑level financial performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative aspects: Sojitz America's $0.3 million par value preferred stock ownership and the $0.10 per share cumulative dividend paid each May 31 are factually accurate and consistent with the ground truth. These numbers are reported correctly across fiscal years 2022–2024, satisfying the quantitative accuracy criterion. (2) However, the qualitative and strategic interpretation is fundamentally incorrect. The ground truth states that in fiscal 2024, Nike explicitly highlighted Sojitz America's strategic role in providing import-export financing since 1972, especially amid rising global trade risks—marking an evolution from a purely financial to a more operationally strategic relationship. In contrast, the LLM claims the relationship 'did not affect Nike’s international operations or strategic initiatives' and that it 'simply provided a modest, fixed dividend obligation,' which directly contradicts the documented strategic evolution. (3) The multi-hop reasoning fails because the model does not synthesize the shift in narrative from financial to strategic engagement over time, particularly the 2024 disclosure emphasizing operational support. This omission or misrepresentation of a key qualitative shift severely undermines the answer's correctness. (4) While numbers are accurate (hence high quantitative score), the qualitative inaccuracy and failure to capture the strategic evolution result in a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the financial aspects of the relationship but misses the core strategic evolution that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 465,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 had a net carrying amount of $2.0 billion as of January 26 2025 and $2.0 billion as of January 28 2024 (see Note 12 – Commitments and Contingencies, “Commercial Paper” and “Notes Payable” tables). This stable carrying value indicates that the company has not retired or significantly re‑priced the 2050 notes during the fiscal years 2022‑2024, reflecting a consistent long‑term debt position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and trend. The ground truth states that the carrying value decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. The LLM claims a stable $2.0 billion in both 2024 and '2025' (a non-relevant fiscal year), missing the significant drop in 2023 entirely. This misrepresents the core quantitative trend. (2) The numbers are inaccurate: the LLM reports $2.0 billion for two years but omits the $1,604 million value in 2023 and mislabels the fiscal years. It references January 26, 2025, which is outside the 2022–2024 scope and not aligned with NVIDIA’s fiscal year-end (typically January of the following calendar year, but fiscal 2024 ends January 28, 2024). Thus, the LLM conflates dates and values. (3) The multi-hop reasoning fails: the question requires tracking a three-year trend and interpreting its implication. The LLM incorrectly infers stability due to two identical values, but the ground truth shows a U-shaped trend indicating active debt management. The conclusion about 'consistent long-term debt position' contradicts the actual fluctuation and strategic repositioning indicated in the original answer. (4) Contextual relevance is moderate because the answer discusses the correct financial instrument and metric (carrying value of 3.50% Notes Due 2050), but it fails to accurately report the evolution over the required period and draws an incorrect conclusion. The citation to Note 12 is plausible but does not excuse the factual inaccuracies. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 459,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife's reliance on global funding markets and short-term debt like commercial paper has evolved to emphasize diversification and cost efficiency. The company consistently leverages a broad mix of funding sources—including commercial paper, long-term debt, and collateral financing—to lower its cost of capital while maintaining flexibility. This strategy, highlighted across 2022–2024 filings, reflects a deliberate shift toward reducing dependence on any single market, as evidenced by its $465 million short-term debt and $15,086 million long-term debt at year-end 2024, alongside active use of its shelf registration for cost-effective capital access.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the qualitative evolution of MetLife's funding strategy correctly, noting consistent emphasis on diversification, use of commercial paper, and cost efficiency across 2022–2024. However, it introduces specific numerical figures—$465 million short-term debt and $15,086 million long-term debt at year-end 2024—that are not present in the original ground truth. Since the ground truth does not include any dollar amounts for debt levels, these numbers cannot be verified and appear to be hallucinated or incorrectly sourced, significantly undermining quantitative accuracy. (2) There are no calculations in the original answer to verify, but the inclusion of precise figures in the LLM response without basis in the ground truth constitutes a major factual error. Format variations would be acceptable if the numbers were correct, but here they are unsupported. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the continuity of MetLife’s funding strategy across years and identifies key instruments like commercial paper and shelf registrations. It also correctly infers that diversification reduces reliance on any single market. However, it fails to mention MetLife Funding’s role in extending loans to affiliates (a specific mechanism noted in 2022 and 2023) and omits the reaffirmation of confidence in lending counterparties in 2023. While the core strategy is accurately summarized, some entity-specific details are missing. (4) The contextual relevance is high because the answer addresses the central theme of evolving dependence on funding markets and the role of short-term debt. The qualitative accuracy is moderate due to correct reasoning but incomplete synthesis. The correctness score is reduced primarily due to unsupported numerical claims, which violate factual integrity despite otherwise reasonable interpretation of strategic trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 519,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantees to subsidiaries have remained modest and largely unchanged, with only immaterial amounts accrued for such guarantees in each year shown (e.g., none material as of 2024, 2023 or 2022).  The company’s notes payable to subsidiaries have grown substantially—from about $8 billion in 2022 to roughly $9.9 billion in 2023 and $2.0 billion short‑term notes plus $14.4 billion long‑term notes by the end of 2024—reflecting an increasing reliance on intercompany financing to fund its subsidiaries.  This expansion signals stronger liquidity commitments to its affiliated businesses, while the relatively small and stable service‑level guarantee exposure indicates limited contractual risk beyond the growing intercompany debt obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly in the 2024 notes payable figure. The ground truth states that notes payable to subsidiaries dropped sharply to $2.0 billion in 2024, while the LLM claims $2.0 billion in short-term notes plus $14.4 billion in long-term notes, totaling $16.4 billion, which is not supported by the original data. This is a major error that misrepresents the company's financial position. The 2022 ($8.1B) and 2023 ($9.9B) figures are approximately correct, though the LLM rounds $8.1B to $8B. (2) The calculation and trend interpretation are flawed: the original shows a sharp decline in intercompany notes in 2024, suggesting de-leveraging or restructuring, but the LLM incorrectly infers continued growth in intercompany financing, which contradicts the ground truth. (3) The qualitative assessment of service level guarantees is accurate—both the LLM and original agree they were consistently immaterial across all years, indicating stable contractual risk exposure. The LLM correctly identifies that service-level guarantees did not pose material risk, which aligns with the ground truth. (4) Contextually, the answer addresses both parts of the multi-hop question—evolution of service level guarantees and notes payable, and their implications for liquidity and risk—so relevance is high. However, due to the critical error in 2024 financial data and the resulting incorrect inference about increasing intercompany debt, the quantitative accuracy is low, pulling down the overall correctness score. The reasoning is partially sound but built on false numerical premises for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 458,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "American Express’s competitive positioning has remained strong through 2024, maintaining its status as the world’s fourth‑largest general‑purpose card network and leveraging premium branding, extensive rewards, and deep merchant relationships to compete against Visa, Mastercard, China UnionPay and emerging fintech platforms.  However, the company’s reliance on card‑network revenues makes it increasingly vulnerable to heightened regulatory scrutiny—particularly around interchange fees, consumer‑protection rules, and AML/CTF compliance—as well as to competitive pressure from global networks and alternative payment solutions.  In response, Amex has intensified investment in cybersecurity, expanded its digital‑payment and lending offerings, and deepened its regulatory engagement, while also restructuring its cost base and pursuing strategic exits (e.g., EU and Australia network licensing) to preserve profitability amid evolving legal and regulatory pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth in both factual content and reasoning. (1) All key facts are correct: American Express is correctly identified as the fourth-largest general-purpose card network (after Visa, Mastercard, and China UnionPay), and the competitive pressures from fintech platforms (e.g., PayPal, Venmo, Alipay) and regional systems (implied by 'alternative payment solutions') are accurately reflected. The strategic responses—investment in digital payments, cybersecurity, regulatory engagement, and cost restructuring—are consistent with the original. The exits from EU and Australia network licensing are explicitly mentioned, matching the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are used contextually and correctly. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics, regulatory developments, and strategic responses across time, correctly inferring the shift from market-driven competition to regulatory adaptation. The only minor gap is that the LLM does not explicitly mention Amex becoming a Category III firm in 2024 under U.S. bank regulation—a specific regulatory classification noted in the ground truth—which slightly weakens the completeness of the regulatory dependency narrative. However, the heightened regulatory scrutiny and compliance focus are clearly conveyed. (4) The answer is semantically equivalent to the original, with slightly more emphasis on Amex’s ongoing strength rather than the trajectory of increasing constraint, but the core evolution is accurately captured. Contextual relevance is excellent, addressing all dimensions of the question: competitive positioning, regulatory dependency, external pressures, and strategic responses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1664,
        "completion_tokens": 503,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 to 2024, ConocoPhillips refined its cash-settled PSU structure to align long-term incentives with shareholder value creation. For performance periods beginning in 2018 or later, recipients receive an accrued reinvested dividend equivalent charged to compensation expense, replacing the prior quarterly cash dividend equivalent for earlier periods. This evolution—documented in 2022 and 2023 filings—reflects a strategic shift toward tying compensation to sustained performance and equity-like outcomes, ensuring that cash-settled awards (now fully vested and settled in cash) directly link to the company’s long-term financial and operational goals. The change underscores a deliberate move to enhance alignment between executive compensation and the company’s multi-year value creation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates (2018 as the transition point), timeframes (2022–2024), and structural changes (accrued reinvested dividends for 2018+ periods) are correct. There are no numerical inaccuracies. (2) The answer correctly identifies the shift in dividend equivalent treatment: from no payments during the performance period (pre-2018) to accrued reinvested dividends paid at settlement (2018 onward), though it does not explicitly mention that pre-2018 dividend equivalents began only after the performance period ended, which is a minor omission. (3) The reasoning is sound: the LLM correctly infers that the change reflects stronger long-term incentive alignment and links cash-settled PSUs to sustained performance and equity-like outcomes. It appropriately notes the liability classification and cash settlement, though this detail is slightly less emphasized than in the original. (4) The answer is contextually excellent—directly addressing the evolution of the PSU strategy and its implications for incentive alignment. The only reason for not scoring a 10 is the slight underdevelopment of the pre-2018 structure, which slightly weakens completeness in the multi-hop comparison. Overall, the semantic meaning and factual content are substantially equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 379,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "The evolution of NextEra Energy’s Special Use Funds shows a steady increase from $8.698 billion at the end of 2021 to $9.800 billion by the end of 2024, reflecting growing cash resources that can be deployed to meet collateral and margin requirements tied to its extensive derivative portfolio.  This expanding fund base enhances the company’s liquidity positioning, providing a financial buffer to satisfy the collateral calls and posting obligations that arise when credit‑risk‑related triggers in its derivative contracts are activated.  Consequently, the rising fund balances underscore a strengthening capacity to manage derivative‑related collateral demands across the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. It states that Special Use Funds were $8.698 billion at the end of 2021, but the ground truth reports $8,698 million in 2023 (not 2021), and no data for 2021 is provided in the original answer. This misalignment undermines the quantitative timeline. The 2024 figure of $9.800 billion is correct and matches the ground truth. (2) The ground truth highlights a key reduction in potential collateral obligations from $5.2 billion in 2022 to $2.4 billion in 2023 in the event of a downgrade, along with a rise in actual cash collateral posted from $84M to $691M—critical details omitted in the LLM response. These omissions represent a failure to synthesize multi-hop information about risk exposure and liquidity management. (3) While the LLM correctly infers that growing Special Use Funds improve liquidity positioning and help meet derivative-related collateral obligations, it misses the strategic improvement in risk profile (i.e., reduced contingent exposure), which is central to the original answer’s reasoning. (4) The contextual relevance is high because the answer addresses liquidity and derivative collateral; however, the incorrect starting year, missing comparative data on collateral requirements, and lack of key disclosures from 2022 result in a partially correct but substantively incomplete response. Quantitative accuracy is low due to the wrong year attribution and missing figures, while qualitative accuracy is moderate due to sound logic but incomplete synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 435,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower's 1.600% Notes, issued on March 29 2021 with a $700 million aggregate principal amount and a maturity of April 15 2026, show a declining outstanding principal balance of $700 million in 2022, $698.5 million in 2023, and $698.5 million (reflecting a $1.5 million reduction) in 2024. This steady reduction in principal—driven by scheduled amortization and periodic adjustments—indicates a deliberate debt‑management strategy of gradually paying down this long‑dated, low‑coupon instrument while refinancing the proceeds into newer, higher‑yielding debt series. The pattern underscores AT's focus on optimizing its capital structure by retiring older, lower‑cost notes ahead of schedule and maintaining flexibility for future financing needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across 2022, 2023, and 2024. However, the LLM claims the principal declined to $698.5 million in 2023 and 2024, which is incorrect. Additionally, the LLM introduces a $1.5 million reduction not supported by the data. The adjustments to principal (amortization/accrued interest) did decrease from (3.7) million in 2022 to (2.6) million in 2024, but the LLM does not mention this key point and instead focuses on principal reduction, which did not occur. (2) The quantitative inaccuracies are severe: the principal amounts are wrong, the reduction amount is fabricated, and the amortization trajectory is misrepresented. While the initial issuance details (March 29, 2021, $700M, maturity April 15, 2026) are correct, the core financial data on principal is not. (3) The multi-hop reasoning is flawed because the model infers a debt retirement strategy based on non-existent principal amortization. The ground truth shows stable principal with declining adjustments, suggesting predictable liability management, not early repayment. The LLM incorrectly concludes that AT is retiring the notes ahead of schedule and refinancing into higher-yielding debt—this is unsupported by the data. (4) Scores are low due to major factual and quantitative errors. The contextual relevance is moderate because the answer addresses debt management strategy and the correct instrument, but the reasoning is based on incorrect data, undermining the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 446,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group has faced ongoing regulatory pressure on its Medicare Advantage risk‑adjustment payments, with CMS periodically adjusting the risk‑adjustment methodology and benchmark levels that directly affect reimbursement rates. In response, the company has adjusted its benefit designs, narrowed network offerings in high‑cost counties, and intensified cost‑management and pricing strategies to mitigate funding pressures, while also lobbying and engaging with regulators to influence policy outcomes. These adjustments have been reflected in its financial disclosures across the 2022‑2024 filings, highlighting both the exposure to risk‑adjustment volatility and the strategic actions taken to manage it.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core theme of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 and its strategic responses. It correctly identifies CMS methodology changes affecting reimbursement, and accurately summarizes key strategic adjustments: benefit design changes, network narrowing in high-cost areas, cost management, pricing strategies, and regulatory engagement. The answer is semantically aligned with the ground truth, which emphasizes evolving responses to CMS recalibrations across the three years, including benefit modifications, county exits (reflected as 'narrowed network offerings in high-cost counties'), and intensified cost controls. While the LLM does not explicitly break down the year-by-year evolution (e.g., noting that CMS made changes each year in 2022, 2023, and 2024), it correctly conveys the ongoing and persistent nature of the pressure and response, which is the central theme. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are cited), and all entities (UnitedHealth Group, CMS, Medicare Advantage, risk adjustment) are correct. The reasoning is sound, though slightly less granular than the ground truth in showing multi-hop synthesis across each year. The omission of the annual specificity slightly reduces qualitative accuracy, but the overall message remains factually and contextually accurate. Contextual relevance is excellent, directly addressing the question's focus on regulatory shifts and strategic responses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 430,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target has progressively expanded and refined its employee merchandise discount program over the three‑year period. In 2022 the company highlighted a broad suite of owned and exclusive brands—such as Auden, Cat & Jack, and up & up—alongside regular 5 % guest discounts and RedCard benefits, signaling an early focus on affordable, differentiated merchandise for staff. By 2023 the narrative emphasized “expanded supply‑chain capacity, same‑day fulfillment, and new owned brands like Figmint,” while still underscoring employee‑focused perks such as “starting wages of $15‑$24 per hour, tuition‑free education assistance, and free mental‑health services,” indicating a shift toward broader financial‑well‑being support. In 2024 the discussion of “investing in core strengths” and “new wellness products” dovetails with a renewed emphasis on employee benefits, including “free virtual health‑care visits, debt‑free education assistance, and enhanced merchandise discounts,” reflecting Target’s strategy of using expanded employee discounts and related benefits to bolster financial security and loyalty. Overall, the evolution shows a deliberate move from basic discount offerings toward a comprehensive, well‑being‑oriented compensation model that integrates higher wages, education aid, health resources, and richer merchandise perks to support employees’ financial health.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, with significant deviations from the ground truth in key areas. (1) Correct elements include the mention of starting wages increasing to $15–$24 per hour in 2023 and the inclusion of tuition-free education and mental health services as part of Target's evolving benefits. However, the LLM incorrectly claims that merchandise discounts were 'enhanced' or 'expanded' in 2024, which is not supported by the original answer—merchandise discounts remained consistent in scope and structure throughout the period. (2) Quantitative accuracy is partially correct: the $15–$24 wage range in 2023 matches the ground truth, but the LLM fabricates a '5% guest discount' and links it to employee benefits without evidence in the original; no percentage value for employee discounts is provided in the ground truth. Additionally, 'Figmint' and other brand names (Auden, Cat & Jack) are mentioned as if newly introduced in this context, but the original does not tie these to employee discounts or 2023/2024 changes. (3) The reasoning is flawed in its multi-hop synthesis: while the original emphasizes that merchandise discounts remained stable and were increasingly framed within a broader well-being strategy, the LLM incorrectly infers that the discounts themselves were enriched or expanded. This misrepresents the core evolution—Target’s strategy evolved in framing and context, not in the tangible scope of the discount benefit. (4) Contextual relevance is moderate: the LLM addresses employee financial well-being and attempts to trace a progression, but distracts with product and supply chain details unrelated to employee discount structure. The conclusion about a 'comprehensive, well-being-oriented model' aligns thematically, but the supporting evidence is misaligned. Overall, the answer captures the general direction of Target’s strategy but fails on precise factual evolution of the discount program, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1651,
        "completion_tokens": 539,
        "total_tokens": 2190
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "Based on the provided 10-K disclosures across 2022–2024, American Express maintained a strategic allocation to foreign government bonds and obligations, with fair value amounts of $630 million (2021), $581 million (2020), and $630 million (2023), reflecting a stable yet modest position. The weighted average yield on these securities increased from 6.45% (2023) to 5.86% (2024), indicating a shift toward higher-yielding instruments amid rising interest rates, while maturity distribution remained concentrated in shorter durations (e.g., \"Due after 1 year but within 5 years\" at 2.03% in 2024). This pattern suggests a deliberate, risk-averse approach to asset allocation—prioritizing capital preservation and yield optimization within the fixed-income portfolio without significant shifts in duration or credit exposure, aligning with a conservative risk appetite focused on liquidity and stability rather than aggressive growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that American Express held $630 million in 2021 and $581 million in 2020, which are not only irrelevant years but also contradict the original answer that only provides 2022–2024 data. The only correct dollar amount is $630 million in 2023, but the original answer specifies this was the amount in 2022, not 2023. The yields are partially correct: 6.45% for 2023 (within one year) and 5.86% for 2024 (within one year) are accurate, but the LLM fails to mention the 2022 yields (1.74% and 2.42%) and misrepresents the 2024 yield of 2.03% as applying to the 'after 1 but within 5 years' bucket without noting it was a sharp drop from 4.48% in 2023. (2) Calculations and comparisons are flawed: the LLM claims yields increased from 6.45% (2023) to 5.86% (2024), which is incorrect—this is a decrease, not an increase. It also omits the multi-year evolution for both maturity buckets, especially the significant drop in the longer-term yield from 4.48% to 2.03%. (3) Multi-hop reasoning is unsound: the LLM incorrectly infers a 'stable' and 'conservative' strategy, while the ground truth describes a dynamic shift—aggressive short-term positioning in 2023 followed by a retreat in 2024. This misreads the pattern and draws the opposite conclusion about risk appetite. The synthesis across years is flawed due to incorrect data and timeline confusion. (4) Contextual relevance is moderate—the answer addresses foreign government bonds, yields, and risk strategy, so it stays on topic, but the factual errors severely undermine correctness. Overall, major quantitative and qualitative errors lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 466,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "The collateral under master netting arrangements related to \"Other assets, including intangibles - net\" decreased from $800 million in 2022 to $491 million in 2024, reflecting a $309 million reduction over the two‑year period. This decline indicates that ExxonMobil has been unwinding or offsetting a portion of its derivative positions, suggesting a deliberate effort to manage and potentially reduce its derivative exposure as part of its broader risk‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the collateral was $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. However, the LLM states it was $800 million in 2022 and only reports a two-year decline to $491 million in 2024, completely omitting the 2023 value and misrepresenting the starting point. This results in an incorrect baseline and flawed trend portrayal. The $309 million reduction cited is accurate between $800M and $491M, but since the 2022 figure is wrong, the overall change is misrepresented. (2) The correct total decline from 2022 to 2024 is $1,003 million ($1,494M → $491M), not $309 million. The LLM’s calculation is mathematically correct for the numbers it uses, but those numbers do not match the source data. (3) The qualitative reasoning about derivative exposure management is sound and aligns with the original answer—reduction suggests strategic risk management or unwinding of positions. The entity (ExxonMobil/XOM) and metric ('Other assets, including intangibles - net') are correctly identified, and the interpretation of the trend is reasonable. However, the failure to include 2023 data and the incorrect 2022 figure breaks the multi-hop synthesis across all three years as required by the question. (4) While the answer is contextually relevant and offers a plausible interpretation, the severe quantitative error in the starting value and omission of a full year undermines factual correctness. Hence, correctness is scored at 5 (partially correct with major errors), quantitative accuracy at 4 (major number error despite correct arithmetic), qualitative accuracy at 6 (correct logic and entities but based on wrong data), and contextual relevance at 8 (on-topic and interprets implications appropriately).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 496,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "From 2022 through 2024, AMT issued multiple tranches of senior notes with varying coupon rates and maturities, including the 2.700% Notes in March 2021 (7‑year maturity) and subsequent reopenings or related issuances in 2023‑2024 that maintained similar long‑dated, low‑to‑mid‑single‑digit coupon structures. This pattern of issuing longer‑dated, relatively low‑coupon unsecured debt—often paired with targeted acquisitions and capital‑intensive growth projects—reveals a financing strategy focused on securing stable, low‑cost capital to fund aggressive expansion and site‑development while preserving flexibility to refinance or retire higher‑cost obligations as market conditions shift. Market conditions over the period, marked by declining interest rates and heightened demand for infrastructure assets, enabled AMT to lock in favorable rates and return excess capital to shareholders, underscoring a proactive approach to capital management amid a competitive and evolving financing landscape.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that the 2.700% Notes were issued on March 29, 2021, not in 2022 or later, and there is no evidence of 'multiple tranches' or 'reopenings' in 2023–2024. The principal amount remained constant at $700.0 million throughout, with no new issuances reported. The LLM incorrectly implies ongoing issuance activity during 2022–2024, which contradicts the ground truth. Additionally, the claim of a '7-year maturity' from a March 2021 issuance would imply a 2028 maturity, but the actual maturity is January 15, 2031 (nearly 10 years), so this is incorrect. The interest rate spread decrease from (5.0) to (4.4) by 2024 is entirely omitted. (2) Quantitatively, all key numbers are wrong: no new issuance occurred in 2022–2024, the maturity date is misrepresented, and the timeline of issuance is false. The LLM fabricates 'subsequent reopenings' and 'related issuances' with no support in the ground truth. (3) The multi-hop reasoning is flawed. The question asks specifically about the evolution of the 2.700% Notes over 2022–2024, not general financing strategy based on hypothetical new issuances. The ground truth shows stability in principal, maturity, and interest payment schedule, with only a minor reduction in interest rate spread—this nuance is missed. The LLM instead infers aggressive expansion and refinancing activity not supported by the data provided. (4) While the general theme of 'low-cost capital' and 'stable financing' has some alignment, the specific conclusions about market conditions enabling favorable rates and returning capital to shareholders are speculative and not grounded in the provided facts. The answer is contextually relevant in topic but fails on factual correctness and precise reasoning, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 503,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "From 2022 through 2024, the outstanding principal amount of NVIDIA’s 2.00% Notes Due 2031 remained unchanged at $1.25 billion (reflected as $1,250 million in the debt schedule), with only the amortization of the unamortized discount and issuance costs adjusting the net carrying amount from $1,200 million in 2022 to $1,250 million in 2024. This steady principal balance indicates that NVIDIA is maintaining a long‑term, low‑coupon debt position while managing its overall leverage through selective repayments of higher‑cost notes and reliance on other financing mechanisms such as its commercial paper program. The consistent issuance schedule underscores a strategy of preserving financial flexibility and funding growth initiatives without significantly increasing its long‑term debt burden.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value was $1.2 billion in 2022, increased slightly to $1.044 billion at the beginning of 2023, remained stable at $1.057 billion by end of 2023, and reached a carrying value of $1.25 billion in 2024. However, the LLM claims the principal was 'unchanged at $1.25 billion' throughout, and that the net carrying amount increased from $1,200 million ($1.2 billion) in 2022 to $1,250 million ($1.25 billion) in 2024 due to amortization of discount. This misrepresents the data: the 2022 value is correctly stated as $1.2 billion, but the 2023 values are omitted entirely, and the progression is incorrectly attributed to amortization rather than fair value or carrying value changes. The LLM also conflates 'fair value' (used in 2022 and 2023) with 'carrying value' (used in 2024) without clarification. (2) The numbers are partially correct: $1.2 billion in 2022 and $1.25 billion in 2024 align with the ground truth, but the 2023 figures ($1.044B and $1.057B) are completely missing. The LLM incorrectly implies the principal was always $1.25B, while the ground truth shows it was reported as lower in 2022 and 2023. (3) The reasoning is partially sound—NVIDIA does appear to maintain a stable long-term debt strategy—but the multi-hop synthesis is flawed because it ignores the 2023 data and misattributes the change in carrying amount to amortization without evidence from the source. The conclusion about managing leverage via repayments of higher-cost notes and commercial paper is plausible but not supported by the provided ground truth, introducing unsupported inference. (4) Despite the incorrect quantitative progression and missing 2023 data, the answer addresses the question's intent regarding debt strategy and correctly identifies the 2022 and 2024 values within acceptable format variation. The qualitative reasoning is coherent but based on inaccurate data synthesis, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 545,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "From 2022 through 2024, MetLife’s use of the deposit method of accounting for reinsurance agreements remained consistent, with deposit assets on reinsurance decreasing from $5.1 billion at the end of 2023 to $4.6 billion at the end of 2024, and corresponding deposit liabilities declining from $1.3 billion to $1.2 billion. This reduction reflects the impact of the November 2023 risk‑transfer transaction with Global Atlantic, which transferred a block of universal‑life and related products and resulted in a net reinsurance cost of $770 million recorded as a liability. The trend indicates that MetLife is consolidating and restructuring its reinsurance program—shifting risk to a third party and reducing reliance on traditional reinsurance—thereby streamlining its reinsurance strategy and potentially lowering long‑term exposure to reinsurance‑related volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MetLife's deposit assets on reinsurance increased from $1.8 billion in 2022 to $5.1 billion in 2024, showing a clear upward trend. However, the LLM claims assets decreased from $5.1 billion in 2023 to $4.6 billion in 2024, which contradicts the data. Additionally, the LLM omits the 2022 asset figure entirely and misrepresents the trend as decreasing rather than increasing. Deposit liabilities in the ground truth decreased slightly from $1.4B (2022) to $1.3B (2023) to $1.2B (2024), which the LLM partially gets right by noting the drop from $1.3B to $1.2B, but it fails to mention the 2022 liability of $1.4B and incorrectly frames the trend as a consistent decline without acknowledging the initial increase from 2022 to 2023. (2) The LLM introduces a 'net reinsurance cost of $770 million recorded as a liability' related to a November 2023 transaction with Global Atlantic, which is not present in the original answer and appears fabricated. The ground truth references a $10.3 billion reinsurance recoverables transaction in 2023, not a $770 million cost. The LLM also mischaracterizes the Global Atlantic transaction as reducing reinsurance reliance, while the original answer indicates it contributed to the increase in deposit assets under the deposit method. (3) The multi-hop reasoning is flawed: instead of recognizing that rising deposit assets indicate increased use of deposit-method reinsurance agreements (especially due to the Global Atlantic deal), the LLM incorrectly infers a reduction in reliance on reinsurance. This reverses the actual strategic implication. The synthesis across years and entities (MetLife, Global Atlantic) is incorrect. (4) The contextual relevance is moderate because the answer addresses reinsurance accounting and strategy, but the factual foundation is wrong. Quantitative accuracy is very low due to incorrect numbers and trends. Qualitative accuracy is poor due to incorrect reasoning and entity relationships. Correctness score is low because the core facts, trends, and strategic interpretation are all incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 581,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth Group's investment in Debt Securities - Held-to-Maturity declined slightly from a fair value of $596 million and carrying value of $641 million at the end of 2021 to $508 million fair value and $512 million carrying value by the end of 2024, reflecting a modest reduction in the held‑to‑maturity portfolio over the three‑year period. This progression indicates a relatively stable, low‑risk investment strategy focused on preserving capital rather than pursuing higher‑yield assets, while also suggesting that the company has been reallocating cash toward other growth initiatives or debt‑related financing activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. It incorrectly references 2021 data (fair value $596M, carrying value $641M), which is not part of the 2022–2024 window asked in the question and does not match ground truth for any year. The correct 2022 values were $679M (fair) and $696M (carrying), but the model omits these entirely. While the 2024 values ($508M fair, $512M carrying) are correct, the 2023 values are misrepresented—the model implies a drop from 2021 to 2024 without addressing 2023 explicitly, and the stated 2021 carrying value of $641M does not align with any known data point in the truth set. (2) Calculations: The model suggests a 'slight decline' from 2021 to 2024, but the actual trend starts in 2022 and shows a steeper decline: fair value dropped from $679M to $508M (25% decrease), not a 'modest reduction.' The carrying value decline from $696M to $512M is also underemphasized. (3) Multi-hop reasoning: The model fails to synthesize the correct 3-year progression (2022–2024) as required. It shifts the timeframe to 2021–2024, introducing a non-existent data point and missing the actual starting point. This breaks the multi-hop chain. (4) Despite incorrect numbers and timeline, the qualitative interpretation—that the decline suggests portfolio repositioning or capital reallocation—is partially aligned with the ground truth's conclusion. However, the LLM's characterization of a 'stable, low-risk strategy' contradicts the observed active reduction, which the original answer frames as strategic downsizing possibly due to market conditions. Thus, reasoning is partially sound but based on flawed data. Contextual relevance is fair as it addresses investment strategy and valuation adjustments, but with incorrect foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 492,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The Target Credit Card penetration rate (referred to as RedCard Penetration) declined from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024, indicating a downward trend. This decline suggests that the credit‑card strategy is becoming less effective at driving incremental sales, as a smaller share of purchases are being made with the Target‑branded cards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The downward trend is accurately described. 2) All numeric values and years are correct, with no calculation errors. Format variations (e.g., spacing in '20.5 %') do not affect accuracy. 3) The reasoning correctly identifies the declining penetration as a sign of reduced effectiveness in driving incremental sales. However, the LLM omits a key nuance from the original answer: despite the decline, Target's internal analysis still finds that the card contributes meaningfully to incremental sales, indicating ongoing strategic value. This omission weakens the qualitative completeness of the conclusion. 4) The answer is contextually relevant and addresses both parts of the question—trend evolution and strategic implication—but the strategic assessment is slightly less balanced due to missing the positive counterpoint present in the ground truth. Hence, high scores for quantitative accuracy and contextual relevance, a slightly lower qualitative accuracy due to incomplete reasoning synthesis, and an overall correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 331,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike's operational footprint in Laakdal, Belgium has remained a key owned European distribution hub throughout the 2022‑2024 fiscal years, with no indication of divestiture or major restructuring of that site in the disclosed documents. The company's focus on strengthening its European logistics network is underscored by its continued ownership of major distribution facilities in Laakdal, Belgium, as well as other strategic locations such as Taicang, China; Tomisato, Japan; and Icheon, Korea, highlighting a broader strategy of investing in owned distribution infrastructure to support growth and resilience across its European operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth regarding Nike's ownership and operational footprint in Laakdal, Belgium from fiscal years 2022 to 2024. It correctly states that Nike maintained ownership of the Laakdal facility throughout this period and characterizes it as a key owned European distribution hub, aligning with the original answer's description of it being one of the most significant international distribution centers. There are no numeric inaccuracies (quantitative accuracy is perfect), and the time frame (2022–2024) is correctly referenced. The reasoning about strategic focus on European logistics infrastructure is sound and supported by the consistency of ownership. However, the LLM adds information not present in the ground truth—specifically, mentioning other global facilities (Taicang, Tomisato, Icheon)—which, while potentially true, is extraneous and not part of the knowledge graph's verified data for this question. This slightly reduces qualitative accuracy due to unsupported multi-hop synthesis beyond the provided context. Nonetheless, the core answer addressing ownership stability and strategic implications is correct and semantically equivalent. Contextual relevance is high as the response directly addresses the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 363,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "From fiscal years 2022 through 2024, Lumentum Holdings’ competitive positioning in NVIDIA’s disclosed landscape shifted as NVIDIA expanded its own supply‑chain controls and IP safeguards.  The 10‑K filings show NVIDIA increasingly relying on internal design wins, multi‑year cloud agreements, and a broader ecosystem of CSPs and OEMs, while simultaneously tightening protection of its patents (issuing new patents through 2045) and leveraging its own foundry relationships (TSMC, Samsung) to secure wafer capacity.  This strategy reduces reliance on external suppliers—including Lumentum—and reinforces NVIDIA’s ability to dictate pricing and secure long‑term capacity, thereby pressuring Lumentum’s market share in the networking‑ASIC and interconnect segments.  Consequently, Lumentum’s relative importance in NVIDIA’s supply chain has diminished, as NVIDIA’s expanding IP portfolio and vertically integrated supply chain aim to insulate its core AI and data‑center platforms from competitive and supply‑chain disruptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but diverges significantly from the ground truth in key aspects of competitive positioning. (1) Correctly identifies NVIDIA's expanding IP protection (patents extending to 2045) and supply chain partnerships (TSMC, Samsung), which aligns with the original answer. However, the core claim—that Lumentum’s relative importance has diminished and its market share is being pressured—is not supported by the ground truth. The original answer emphasizes that Lumentum was consistently named as a competitor across 2022–2024, indicating sustained relevance, not diminishing influence. (2) Quantitatively, there are no explicit numerical errors; dates (e.g., patent expirations to 2045) and company names (Lumentum Holdings, TSMC, Samsung) are accurate. (3) The reasoning is flawed in its synthesis: while NVIDIA’s vertical integration is correctly noted, the conclusion that this reduces Lumentum’s importance misinterprets the competitive dynamic. Being a competitor does not imply supplier relationship; Lumentum competes in optical modules and interconnects, not necessarily as a direct supplier to NVIDIA. The LLM incorrectly frames Lumentum as part of NVIDIA’s supply chain rather than a rival in adjacent product domains. (4) Contextual relevance is moderate—addresses supply chain and IP strategies—but mischaracterizes the nature of the Lumentum-NVIDIA relationship. The original answer stresses persistent competitive positioning despite NVIDIA’s advancements; the LLM implies displacement, which is unsupported. Thus, while some facts are accurate, the overall conclusion is factually incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 458,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s reliance on rights holders has deepened as it shifts from acquiring licensed content to producing more originals and securing exclusive deals, while simultaneously navigating stricter global regulations that impose content quotas, levies and ownership limits. This evolution reflects a strategic pivot toward self‑generated libraries to differentiate its service amid intensifying competition, even as regulatory pressures and the fixed‑cost nature of long‑term licensing commitments constrain flexibility and increase financial risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its qualitative assessment and captures the strategic shift in Netflix's content acquisition approach, but it misrepresents the evolution of reliance on rights holders. The original answer states that reliance has remained a core risk, not that it has 'deepened'—in fact, Netflix has been reducing reliance through original content production. The LLM incorrectly frames the trend as increasing reliance, when the truth is that Netflix is actively trying to decrease dependency on licensed content due to rising competition and regulatory pressures. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, all years and contextual facts (e.g., regulatory changes, competition from studio-owned platforms) are correctly referenced. The answer correctly identifies the strategic pivot toward originals and the impact of regulations like content quotas, showing sound multi-hop reasoning across competitive and regulatory dimensions. While the core facts about strategy and regulation are present, the mischaracterization of the direction of reliance (increasing vs. decreasing) results in a moderate deduction in qualitative and overall correctness. Semantic equivalence is partially achieved, but the logical error in trend direction affects accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 370,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "Southern Company’s treatment of scheduled lease payments under outdoor lighting contracts has evolved in materiality, revenue classification, and presentation across the 2022–2024 filings. In 2022, these payments were disclosed within maturity analyses as part of operating lease obligations, with minimal emphasis on materiality and no separate revenue classification beyond \"lease income\" in aggregated disclosures. By 2023 and 2024, the company increasingly classified lease income from PPAs and outdoor lighting contracts as \"variable lease income\" or \"wholesale revenues,\" reflecting a shift toward distinguishing non-lease components (e.g., energy usage) from scheduled payments. Presentation in maturity tables was refined to isolate scheduled payments (e.g., $230M in 2024 for Alabama Power) while excluding variable amounts, which were noted as \"not reflected\" in analyses. This evolution underscores a move toward greater granularity in revenue recognition and transparency, particularly for PPAs accounted for as leases, while maintaining consistent materiality thresholds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding revenue classification and quantitative details, which are not supported by the ground truth. (1) The Original Answer states that in 2022, outdoor lighting lease cash flows at Mississippi Power were considered immaterial—this is accurate and directly from disclosures. However, the LLM incorrectly claims these were included in maturity analyses in 2022, contradicting the ground truth that they were not meaningfully reported until 2023. (2) The LLM introduces specific dollar amounts (e.g., $230M in 2024 for Alabama Power) that do not appear in the ground truth and are unsupported; the Original Answer contains no such figures. This is a critical failure in quantitative accuracy. (3) The LLM claims a shift in revenue classification to 'variable lease income' or 'wholesale revenues' by 2023–2024, but the Original Answer makes no mention of revenue classification changes—only presentation in maturity analyses. This misrepresents the nature of the evolution. (4) While the LLM correctly identifies a trend toward greater transparency and structured reporting in 2023–2024, aligning with the ground truth’s description of inclusion in maturity analyses, it fabricates details about revenue classification and specific financial figures. The multi-hop reasoning is partially sound in identifying a progression, but based on incorrect or invented data. (5) Contextually, the answer addresses materiality, presentation, and evolution over time, so it remains relevant, but factual correctness is compromised. Overall, the answer is partially correct in direction but incorrect in key facts, numbers, and financial classifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 464,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 increased from $606 million at the end of fiscal 2022 to $606 million at the end of fiscal 2023 and remained $606 million at the end of fiscal 2024, indicating no net change in the balance of this specific tranche over the three‑year period. This stability suggests that the company is not aggressively issuing or retiring this particular debt instrument, reflecting a measured approach to managing its long‑dated fixed‑rate notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the outstanding principal balance was $606 million in fiscal year 2022. According to the ground truth, it was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly claims the balance was $606 million at the end of 2022, which misrepresents the starting point and implies no change from 2022 to 2023, when in fact there was a significant reduction of $480 million. (2) The quantitative inaccuracies are critical: the model fails to report the correct 2022 balance, misstates the trend (no change vs. a major reduction), and thus invalidates any derived conclusions about debt strategy. While the 2023 and 2024 figures are correct, the error in 2022 undermines the entire analysis. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize the evolution across years. It missed the key event — a deliberate repayment in 2023 — and instead inferred a 'measured approach' due to stability, which contradicts the actual reduction that occurred. The original answer identifies a strategic debt reduction in 2023 followed by stabilization, which the LLM fails to capture. (4) Scores are low on correctness and quantitative accuracy due to the major factual error in the 2022 figure and the resulting incorrect interpretation. Qualitative accuracy is also low because the reasoning and conclusion are based on false premises. Contextual relevance is moderate because the answer addresses the right instrument and time frame and attempts to interpret strategy, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 446,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "From the 2022‑2024 10‑K disclosures, GM’s pension‑plan funding strategy shows a clear shift in its long‑term return assumptions.  \n\n- In the 2022 filing (page 84) the weighted‑average long‑term rate of return on U.S. plan assets was **5.6 %**, with a target allocation of roughly **8 % equity / 69 % debt / 23 % other**.  \n- By the 2023 filing (page 87) the same rate remained **5.6 %**, but the target mix moved to **11 % equity / 60 % debt / 29 % other**, reflecting a modest increase in equity exposure and a larger “other” (private‑equity, real‑estate, hedge‑fund) slice.  \n- The 2024 filing (page 88) reports that an investment‑policy study completed in **December 2024** raised the long‑term ROA from **6.3 % (2023) to 6.5 % (2024)**, and the target allocation shifted again to **11 % equity / 60 % debt / 29 % other** for U.S. plans (with non‑U.S. equity falling to **9 %**).  \n\nThis three‑year trend indicates that GM has been **gradually increasing the expected return assumption and modestly rebalancing the asset mix toward higher‑return, higher‑risk assets (equity and alternative investments) while maintaining a substantial debt base**. The adjustments are a direct response to evolving market conditions—namely low‑interest‑rate environments and the need to improve funded status—so that the pension portfolio can better meet its long‑term liability obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, GM's long-term rate of return was 5.4% in 2022, 6.3% in 2023, and 6.5% in 2024. However, the LLM states it was 5.6% in both 2022 and 2023, which is incorrect. The increase from 5.4% to 6.5% (1.1 percentage points) is misrepresented as a change from 5.6% to 6.5%, distorting the trend. Additionally, the LLM incorrectly claims the 2023 rate was 6.3% only in the 2024 filing, while asserting it was 5.6% in 2023—this contradiction undermines accuracy. (2) The allocation percentages (8%/69%/23%, etc.) are not present in the ground truth and appear fabricated; the original answer does not mention any asset mix breakdowns, so including them introduces false precision. (3) The reasoning about strategic asset mix shifts toward higher-risk assets is semantically aligned with the ground truth’s interpretation, showing correct qualitative logic about increasing return assumptions indicating more aggressive investment strategies. However, this is based on incorrect data, weakening the multi-hop synthesis. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of return assumptions and strategic implications—and attempts to cite specific pages and timing (e.g., December 2024 study). Despite incorrect numbers, the structure and intent align well with the question. Overall, major quantitative errors reduce correctness significantly, even though the directional interpretation is plausible.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 427,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "The treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings—specifically their inclusion in Supplemental Indentures No. 8 (March 2021), No. 10 (September 2021), and subsequent 2022-2024 indentures—indicates a deliberate, ongoing strategy to extend the maturity profile of its long-term debt and diversify funding sources. This reflects a focus on securing favorable long-term financing terms while maintaining flexibility for future capital structure optimization.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that only Supplemental Indenture No. 8 (dated March 29, 2021) was consistently referenced across the 2022–2024 filings for the 2.700% Senior Notes due 2031. However, the LLM incorrectly claims that Supplemental Indentures No. 8, No. 10 (September 2021), and 'subsequent 2022–2024 indentures' were involved, which contradicts the original answer and introduces non-existent documentation. This misrepresents the factual basis of the filings. (2) Quantitatively, the interest rate (2.700%) and maturity year (2031) are correct, as is the time range of the filings (2022–2024). However, the dates and numbers of the indentures are wrong: No. 10 is not mentioned in the ground truth, nor are any new indentures from 2022–2024. The March 2021 date is partially correct but lacks precision (should be March 29, 2021). (3) The multi-hop reasoning is partially sound in that it attempts to infer a long-term financing strategy from consistent treatment of debt instruments across years. However, it draws an incorrect conclusion about 'extending the maturity profile' and 'diversifying funding sources,' while the original answer emphasizes stability and lack of modification. The LLM implies active restructuring or extension activity, whereas the truth indicates continuity and no changes—suggesting confidence in existing terms, not active optimization. (4) Contextual relevance is moderate because the answer addresses long-term financing strategy and references indentures and debt management, which are relevant. However, due to factual errors in key entities (indenture numbers, dates) and flawed reasoning about strategic intent, the correctness score is low. The answer is not semantically equivalent to the ground truth and misleads on critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 501,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal’s exposure to abusive behaviors and fraud‑related risk grew as it expanded credit products and cross‑border transactions, prompting heightened focus on fraud detection, buyer/seller protection, and third‑party risk management. To mitigate these risks from 2022 through 2024, the company tightened credit‑risk models, diversified funding sources for its loan portfolios, sold off U.K. and European BNPL receivables under forward‑flow arrangements, and invested in enhanced fraud‑prevention tools and compliance programs while also navigating regulatory scrutiny across jurisdictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors and its risk mitigation strategies from 2022 to 2024. It correctly identifies the growing risk in credit products and cross-border transactions, and notes key strategic actions such as selling U.K. and European BNPL receivables under forward-flow arrangements—accurately reflecting the €40 billion multi-year agreement mentioned in the ground truth (the currency and amount are not specified in the LLM answer, but 'forward-flow arrangements' and the sale of BNPL receivables are correctly noted). The mention of tightened credit-risk models, enhanced fraud-prevention tools, compliance programs, and third-party risk management aligns with the original answer’s emphasis on detection, prevention, and third-party dependencies. However, the LLM answer lacks explicit year-by-year framing (e.g., identifying 2022 as the risk identification phase, 2023 as the offloading phase, and 2024 as the reinforcement phase), which slightly weakens the multi-hop synthesis. While it mentions regulatory scrutiny—contextually relevant—it does not explicitly highlight the persistent threat in digital payments or the reputational risks from third-party lenders as emphasized in 2024. Quantitatively, no incorrect numbers are stated; the absence of the €40 billion figure is an omission but not an error, and the use of 'forward-flow arrangements' implies the correct mechanism. The reasoning is sound and semantically equivalent in most aspects, with strong contextual relevance to the question. Minor gaps in completeness and temporal structuring prevent a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 453,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP's pension plan allocation to Collective Trust and Other Funds increased from $382 million in 2022 to $382 million in 2023 (no change reported) and then to $382 million in 2024, indicating a stable allocation, while the overall asset mix shows a consistent 0%‑2% target for real estate and a steady 70%‑80% debt exposure, suggesting the company maintains a conservative, income‑focused investment strategy for long‑term employee benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, UNP's allocation decreased from $756 million in 2022 to $382 million in 2023, representing a significant drop. However, the LLM states that the allocation was $382 million in 2022, 2023, and 2024—implying stability, which contradicts the documented 99% decrease from $756M to $382M over just one year. The LLM also fabricates a 'stable allocation' narrative and introduces irrelevant details about real estate targets (0%-2%) and debt exposure (70%-80%), which are not mentioned in the original answer and lack grounding in the provided truth. (2) The dollar amounts are wrong for 2022: $382M vs. the correct $756M. The 2023 figure ($382M) is accurate, but the implication of no change is false due to the incorrect 2022 baseline. The 2024 data is misrepresented—while no updated dollar value is given in the truth, the emphasis is on NAV-based valuation as a strategic shift despite reduced allocation, not on stability. (3) The multi-hop reasoning fails: the model does not recognize the downward trend (a key part of the question) and instead invents a narrative of stability and conservatism based on unsupported metrics. It misses the de-risking or rebalancing interpretation entirely, which is central to the original answer. (4) Scores are low due to major factual and numerical errors. The contextual relevance is moderate because the answer addresses pension allocation and investment strategy, but the incorrect data and reasoning severely undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 435,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer’s Breakthrough Performance Awards (BPAs) are accounted for as performance‑share awards that are amortized on a straight‑line basis over the probable vesting term into operating expenses, with the expense adjusted each reporting period for changes in the estimated number of shares that will be earned and the likelihood of achieving the performance goals.  The awards are valued at grant using the intrinsic‑value method based on the closing stock price, and expense is recognized ratably even if the performance targets are not ultimately met.  From 2022 through 2024 the methodology remained consistent—BPAs continue to be expensed over the expected vesting period, with adjustments for forfeitures and performance‑probability estimates—though the related expense fluctuated with the number of awards granted, vested, and forfeited each year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. It claims that Pfizer's BPA methodology 'remained consistent' from 2022 to 2024, which directly contradicts the ground truth showing a clear evolution: active grants in 2022, no grants or outstanding awards in 2023, and a new formalized methodology introduced in 2024. The LLM incorrectly implies continuity, missing the discontinuation in 2023 and the reintroduction/refinement in 2024. (2) Quantitatively, the LLM fails to report any of the specific numbers from the ground truth: no mention of the 1,165 thousand BPAs granted in 2022, no reference to the 859 thousand outstanding at year-end, and no values such as $38.73 or $59.05 per share. These omissions are critical as they are central to the question about grant activity and valuation. (3) The multi-hop reasoning is flawed. The question requires synthesizing changes across three years, including the absence of activity in 2023 and the methodological shift in 2024. The LLM fails to recognize the significance of zero grants and zero outstanding BPAs in 2023, instead asserting ongoing expense adjustments without acknowledging the program's dormancy. It also incorrectly states that the intrinsic value method was used at grant in an ongoing way, while the ground truth indicates this was part of a new 2024 framework. (4) Contextual relevance is moderate because the answer discusses BPA accounting concepts like amortization, intrinsic value, and performance adjustments, which are relevant topics. However, it applies them inaccurately to the timeline and Pfizer's actual disclosures, resulting in a factually incorrect narrative. The answer fabricates consistency where there was significant change, undermining its correctness despite using appropriate financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 497,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "The collateral under master netting arrangements related to investments, advances and long-term receivables decreased from $1,494 million in 2023 to $800 million in 2024, and was $641 million at the end of 2022. This downward trend indicates that ExxonMobil’s net exposure to derivative counterparties and associated margin requirements has been reduced over time, reflecting lower collateral needs as positions matured or were settled.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and the timeline. According to the ground truth, collateral was $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. However, the LLM incorrectly states that $1,494 million was in 2023, $800 million in 2024, and introduces a value of $641 million for 2022, which does not match the ground truth. This misalignment in both amounts and years severely undermines the quantitative accuracy. (2) The numbers are not only misplaced but one value ($641 million) is factually incorrect and not present in the original data. The trend described—downward—is consistent with the ground truth, but the specific figures and years are wrong, leading to incorrect calculations and comparisons. (3) The reasoning about reduced derivative exposure and margin requirements is semantically similar to the original answer and shows appropriate multi-hop interpretation of what declining collateral might imply. However, because the underlying data is incorrect, the conclusion, while plausible in direction, is based on flawed premises. (4) Contextual relevance is moderate: the answer addresses the right metric and company and attempts to interpret the trend correctly, but the core factual inaccuracies in numbers and years severely limit its correctness. The answer would have been stronger if it had correctly mapped the values to the correct years and included the final 2024 figure of $491 million instead of $800 million in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 419,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s Industrial Fiber Optics positioning evolved from a broad industrial portfolio in 2022 (highlighting optocouplers, industrial fiber optics, sensors and motion encoders across automation, energy and automotive) to a more focused emphasis on high‑performance optical components for networking and data‑center applications in 2023, and by 2024 the company was explicitly integrating industrial fiber optics into its broader semiconductor and infrastructure‑software strategy, leveraging these optics for AI‑driven data‑center connectivity and edge solutions. This trajectory reveals a strategic shift toward concentrating industrial fiber‑optic capabilities within high‑growth, high‑margin segments such as AI networking and data‑center infrastructure, while still maintaining a diversified industrial product base.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Broadcom's positioning of Industrial Fiber Optics. While the ground truth states that in 2022, 2023, and 2024, Industrial Fiber Optics remained consistently positioned within industrial markets—specifically in applications like factory automation, renewable energy, and automotive electronics—the LLM incorrectly claims a strategic shift toward 'high-performance optical components for networking and data-center applications' and 'AI-driven data-center connectivity' by 2024. This misrepresents the evolution: the original answer shows continuity in industrial focus with improved communication structure, not a pivot to data centers or AI infrastructure. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, all years (2022, 2023, 2024) are correctly referenced in terms of timeline, so no errors in dates or formatting. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the consistent industrial focus across years and instead invents a narrative of strategic redirection toward data centers and AI, which is not supported by the ground truth. It incorrectly links industrial fiber optics to AI and infrastructure software, which are not mentioned in the original answer. (4) Despite correct use of years and company (AVGO), the qualitative misrepresentation of strategic direction severely undermines accuracy. The answer is contextually relevant to Broadcom and industrial fiber optics but conveys a false trajectory. Hence, correctness and qualitative accuracy are low; contextual relevance is moderate due to topical alignment but incorrect emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 470,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s exposure to margin risk has declined materially from 2022 through 2024 as the company has shifted to a model where it bears full margin risk on payment transactions but mitigates that risk through tighter pricing controls and greater reliance on third‑party processors for a portion of the volume; the 2024 filing notes that “we bear full margin risk when completing a payment transaction” but also states that “the fee charged per transaction is adjusted up or down if the volume processed … is different from prior period defined volumes,” allowing it to manage pricing and protect margins, while the use of third‑party processors continues to be a key lever for handling transaction load and spreading risk across the ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that PayPal's exposure to margin risk has 'declined materially' from 2022 to 2024, which directly contradicts the ground truth that the risk profile remained stable with no material changes. This is a major factual error. While the LLM correctly quotes that PayPal 'bears full margin risk' in 2024, it misinterprets the implications by suggesting risk has decreased due to pricing adjustments and third-party processor use. The ground truth emphasizes consistency across all three years, with no indication of risk reduction. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—minor phrasing like 'adjusted up or down' based on volume is plausible and not factually incorrect, hence a score of 8. (3) The multi-hop reasoning is flawed: the model fails to synthesize the consistent narrative across 2022–2024 filings showing unchanged margin risk exposure. Instead, it fabricates a trend of declining risk and introduces unsupported claims about 'tighter pricing controls' and 'greater reliance' on third parties as risk mitigants, which are not present in the ground truth. (4) Contextual relevance is moderate because the answer discusses margin risk, pricing discretion, and third-party processors—key elements of the question—but misrepresents the evolution over time, leading to an incorrect conclusion. The core failure is in qualitative accuracy and overall correctness due to the false assertion of a changing risk profile.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 433,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "From 2022 to 2024, Pfizer’s relationship with Meridian evolved from a key part of its oncology portfolio to a fully terminated collaboration. Initially, Meridian was partnered with Pfizer on Xtandi (enzalutamide) for U.S. commercialization, with equal sharing of gross profits, losses, and commercialization costs, and Pfizer holding U.S. rights while Meridian had global rights outside the U.S. The partnership was later expanded to include other oncology products like Adcetris (brentuximab vedotin) with Astellas, but Meridian’s role was specifically tied to Xtandi. In December 2024, Pfizer and Meridian formally terminated their collaboration regarding relugolix (Orgovyx), marking the end of their formal relationship. This progression indicates Pfizer’s strategic shift away from relying on external partnerships for oncology products like Xtandi, moving toward greater internal control or alternative collaborations (e.g., with Astellas for Adcetris), while focusing on its core biopharmaceutical pipeline and commercialization strategies. The termination of the Orgovyx deal specifically underscores a deliberate exit from certain non-core oncology collaborations to streamline resources.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to reflect the actual relationship between Pfizer and Meridian Medical Technologies as documented in the ground truth. (1) The answer fabricates a partnership centered on oncology drugs like Xtandi and Adcetris, claiming Meridian had global rights outside the U.S. and that profits were shared equally—none of which is supported by the ground truth. In reality, Meridian Medical Technologies was a subsidiary focused on auto-injector devices (e.g., for EpiPen), not oncology, and was sold by Pfizer in late 2021 for $51 million, resulting in a $167 million net loss. By 2022, it was part of discontinued operations, and post-sale, Pfizer operated under a Manufacturing Supply Agreement (MSA) with a three-year term and extension option. By 2024, Meridian was only referenced in Pfizer’s glossary, indicating a formal but minimal relationship. (2) The LLM incorrectly states the termination of a collaboration on relugolix (Orgovyx) occurred in December 2024—this event and partnership are not supported by the provided truth data. There are no correct financial figures mentioned: the $51M sale price and $167M loss are entirely omitted and replaced with fictional arrangements. (3) The multi-hop reasoning fails: instead of tracing the divestiture and transition to a supply agreement, the model invents an oncology partnership lifecycle that contradicts the actual timeline and business focus. (4) The strategic interpretation—that Pfizer is moving away from external oncology collaborations—is irrelevant because the premise is false. Meridian was not an oncology partner but a medical device manufacturer divested years earlier. The answer lacks contextual, factual, and numerical alignment with the ground truth, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 489,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 through 2024 the regulatory landscape has tightened around product‑differentiation and communication for reduced‑risk products (RRPs/SFPs).  Across the EU, Australia, Canada, Turkey and several U.S. jurisdictions, governments have introduced or expanded plain‑packaging rules, banned or limited characterizing flavors (including menthol), imposed strict health‑warning and packaging standards, and extended traceability systems to all tobacco‑related products.  These measures increasingly restrict the ability of PMI to distinguish its heated‑tobacco and nicotine‑pouch offerings and to convey truthful, non‑misleading information to adult consumers.  Consequently, the competitive advantage that differentiated RRPs once provided is eroding, and PMI now faces a more constrained environment where regulatory bans or severe restrictions on sales and marketing can directly limit adult access to its lower‑risk products.  The company continues to oppose blanket bans and advocates for science‑based rules that allow product differentiation while protecting public health.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit and provides accurate qualitative context about increasing regulatory constraints on product differentiation and consumer communication for PMI's reduced-risk and smoke-free products from 2022 to 2024. It correctly identifies key regulatory trends (plain packaging, flavor bans, health warnings, traceability) across multiple jurisdictions that limit PMI's ability to differentiate RRPs/SFPs and communicate with adult consumers. There are no numeric inaccuracies (quantitative accuracy is 10), as the response contains no specific numbers that conflict with the ground truth, and it avoids making unsupported claims. However, the LLM answer does not fully replicate the year-by-year evolution of PMI's disclosed regulatory challenges as detailed in the original answer. Specifically, it omits the nuanced shift in language from 'RRPs' to 'SFPs' in 2024 and the progressive intensification of concern—from limiting differentiation (2022), to disproportionately impacting commercialization relative to competitors (2023), to continued burden under rebranded terminology (2024). This evolution reflects a multi-hop synthesis across annual reports that the LLM does not explicitly capture. While the general trend of increasing regulatory pressure is correctly conveyed, the absence of this specific progression reduces qualitative accuracy. The answer remains contextually relevant and well-informed, drawing on plausible regulatory developments, but falls short of fully mirroring the evidence-based, document-driven evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 443,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil's net exposure to collateral under master netting arrangements related to Notes and accounts receivable declined from $800 million in 2023 to $491 million in 2024, reflecting a $309 million reduction in the amount of collateral held. This downward trend indicates that the company is relying less on external collateral to mitigate derivative counter‑party risk, suggesting a strengthening of its internal risk‑management practices and possibly improved creditworthiness that reduces the need for such protective arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but omits the 2022 figure entirely, starting instead from 2023. The ground truth states that collateral decreased from $1,494 million in 2022 to $800 million in 2023 and then to $491 million in 2024. The LLM only reports the 2023–2024 change, missing the first leg of the trend, which is a significant omission for a question asking about the change from 2022 through 2024. (2) The numbers it does report are accurate: $800 million in 2023 and $491 million in 2024, with a correct difference of $309 million. However, the absence of the 2022 value ($1,494 million) undermines the completeness and quantitative accuracy, especially since the full three-year trend is central to the question. (3) The reasoning about derivative risk management is plausible and aligns semantically with the original answer—both suggest reduced reliance on collateral reflects improved risk management. However, the LLM infers 'improved creditworthiness' and 'strengthening internal practices' without direct support from the data provided in the ground truth, which only suggests a 'strategic reduction in derivative exposure or shift in risk management.' This adds speculative interpretation, though not entirely unreasonable. (4) The contextual relevance is high because the answer addresses the core trend and its implications, but the failure to include the full multi-hop data across 2022–2024 limits correctness. Quantitative accuracy is penalized due to the missing year and incomplete time series, though reported numbers are correct. Qualitative reasoning is sound but slightly overreaching in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 451,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "From 2022 to 2024 Duke Energy’s expected volatility assumption in the TSR‑based performance‑award model was reduced from roughly 26.9 % (used for 2021 awards) to about 18.7 % (used for 2024 awards). This downward trend signals that the company now perceives lower market‑price risk for its stock relative to its peer group, reflecting a more stable or less volatile equity outlook over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but omits a key detail from the ground truth — it fails to mention the increase in expected volatility from 26.9% in 2022 to 28.6% in 2023 before the drop to 18.7% in 2024. Instead, it presents a continuous downward trend from 26.9% to 18.7%, skipping the 2023 spike. This misrepresents the actual evolution of the assumption over time. (2) Quantitatively, the 26.9% and 18.7% figures are correctly cited, and the years 2022 and 2024 are accurately referenced, though the LLM incorrectly attributes 26.9% to '2021 awards' instead of 2022, introducing a timing misalignment. The 28.6% value for 2023 is entirely missing, which is a significant omission given the question asks about the evolution from 2022 to 2024. (3) The multi-hop reasoning is partially sound — the model correctly infers that decreasing volatility implies lower perceived market risk and connects this to stock outlook stability. However, by omitting the 2023 increase, it fails to acknowledge the non-linear trend and the temporary rise in perceived risk, which weakens the overall synthesis. (4) The contextual relevance is high as the answer addresses the core question about volatility trend and its implication on market risk perception. The qualitative reasoning is logical but based on incomplete data. Due to the missing intermediate data point and incorrect award year attribution, the correctness and quantitative accuracy scores are reduced, though not fully penalized as the start and end points are correct and the final interpretation aligns broadly with the trend's conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 442,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s short‑term debt tied to the 3.125% notes due January 2025 remained essentially unchanged in principal amount ($495 million) across fiscal years 2022, 2023 and 2024, but the current portion of that debt rose from $264 million in 2022 to $403 million in 2023 and $495 million in 2024, reflecting a shift toward classifying more of the notes as short‑term as they approached maturity. This evolution shows the company is actively managing its near‑term obligations by refinancing longer‑dated senior notes (e.g., issuing April 2022 and September 2021 notes with later maturities) and using cash‑flow‑generating activities such as asset sales and factoring to fund repayments, indicating a strategy of rolling over and extending maturities rather than retiring the 2025 notes outright.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that the obligation was $495 million in both 2022 and 2023 and only became a current liability in 2024. However, the LLM claims the current portion rose from $264M in 2022 to $403M in 2023 and $495M in 2024, which contradicts the ground truth—there is no mention of partial current portions in 2022 or 2023. These numbers ($264M, $403M) are entirely fabricated and not supported by the original answer. (2) The principal amount is correctly stated as $495 million across years, which matches the ground truth, but the breakdown into current portions is incorrect. The LLM incorrectly implies a gradual reclassification over three years, while the truth indicates a stable long-term classification until 2024, when it became current. (3) The reasoning about refinancing strategy—mentioning April 2022 and September 2021 note issuances, asset sales, and factoring—is not present in the original answer and introduces unverified multi-hop inferences. While plausible, these details are not supported by the ground truth and represent speculative expansion. (4) Contextually, the LLM addresses the question about debt evolution and refinancing strategy, so relevance is high. However, due to major quantitative errors and unsupported qualitative additions, the correctness score is low. The answer misrepresents the core financial data and adds unverified strategic interpretations, undermining factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 426,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "From 2022 through 2024 AMD’s strategy with AIB manufacturers shifted from broad inventory protection to tighter safeguards that preserve channel pricing and enable rapid response to market changes.  In 2022 the company emphasized inventory‑level safeguards for distributors and AIBs, but by 2023‑2024 it reinforced agreements that protect AIB inventory from price cuts and allow limited returns, while leveraging discrete graphics as a key differentiator for system integrators to create higher‑margin, differentiated products.  This evolution helped AMD maintain channel stability and use discrete GPUs to distinguish its offerings across the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of AMD's strategic positioning with AIB manufacturers from 2022 to 2024, particularly around inventory protection and the role of discrete graphics in differentiation. It accurately states that AMD maintained inventory protection policies, which aligns with the ground truth. However, the LLM introduces specific details not present in the original answer, such as 'limited returns' and a 'shift...to tighter safeguards,' which are not supported by the ground truth. The original answer emphasizes consistency in policy rather than a strategic shift or tightening. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the role of discrete graphics in differentiation and channel stability across years. However, it infers a policy evolution (from 'broad' to 'tighter') that isn't substantiated in the ground truth, which stresses continuity rather than change. This affects qualitative accuracy. (4) Contextual relevance is high—the answer addresses inventory protection, AIB relationships, and discrete graphics as differentiators across the three years, fully engaging with the question's scope. The main issue is the unsupported implication of policy tightening, which slightly distorts the factual narrative. Hence, correctness is 7 due to minor but meaningful over-interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 417,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "From 2022 through 2024 Disney’s DTC strategy shifted from an early‑stage, loss‑making investment to a more focused, growth‑oriented initiative.  In 2022 the company was still building out Disney+, ESPN+, Hulu and Star+ and absorbing heavy content‑production and marketing costs, acknowledging that the segment would “continue to generate losses.”  By 2023 and 2024 the narrative emphasized “strategic investments in our DTC offerings” that are expected to “drive growth” and “more than offset” declines in linear affiliate fees, while also noting that the business model “will generally not be profitable in the short term” and that “growth … is unlikely to be even quarter over quarter.”  Investment focus moved toward leveraging the Disney+ platform (including an ad‑supported tier and price increases), expanding international DTC services (e.g., Star+ and Disney+ Hotstar), and using DTC to retain and monetize audiences that were otherwise migrating away from traditional linear networks.  This evolution reflects a competitive positioning that treats DTC as a core growth engine to protect and eventually expand subscription and advertising revenue, while accepting that near‑term losses are necessary to achieve scale and offset the erosion of linear carriage fees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Disney's DTC strategy from 2022 to 2024 as described in the ground truth. (1) It correctly identifies the shift from cautious, loss-accepting investment in 2022 to a more confident, growth-oriented posture by 2023–2024. Key themes such as expected losses, strategic investment to offset linear declines, and competitive pressures are all present. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in tone, investment focus, and business rationale across years, correctly inferring that DTC became a core growth engine despite near-term losses. It adds contextual detail (e.g., ad-supported tier, international services like Star+ and Hotstar) that aligns with Disney’s actual strategy and enhances completeness without introducing inaccuracies. (4) The only minor gap is that the LLM does not explicitly mention the increasing competitive pressure on subscription fees and advertising rates in 2024 as stated in the original, though it does imply competition by noting DTC services compete for customers. This slight omission in specificity prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 402,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s Fixed‑Rate 2.850% notes, issued in September 2019 with a $1.5 billion principal and a 10‑year maturity (maturing Oct 1 2029), remained part of its senior unsecured debt through 2024. In May 2024 the company issued additional fixed‑rate notes (including $850 million of 5.150% notes maturing June 1 2034 and $400 million of 5.500% notes maturing June 1 2054), bringing total outstanding Notes to $10.6 billion as of December 31 2024. The 2.850% notes continue to be senior unsecured obligations with semiannual interest payments, subject to redemption provisions and covenants, and are reflected in the company’s debt maturity schedule with $1.5 billion principal still outstanding beyond 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.5 billion principal of the 2.850% notes and their 2029 maturity, which aligns with the ground truth. It also accurately notes that these notes remained outstanding through 2024. However, there is a discrepancy in the total debt figures: the LLM states $10.6 billion in total outstanding notes as of December 31, 2024, while the ground truth reports $10.574 billion in total term debt. Though close, this is not exact. More critically, the LLM omits the year-by-year evolution of total debt—$9.0 billion in 2022, $10.638 billion in 2023, and $10.574 billion in 2024—which is a key part of the original answer and the question’s focus on debt structure evolution. (2) The issuance of new 5.150% and 5.500% notes in May 2024 is correctly reported with accurate amounts ($850 million and $400 million) and maturities, supporting the narrative of a shifting financing strategy. The 2.850% notes’ unchanged status is correctly emphasized. (3) The multi-hop reasoning is sound in linking the unchanged 2.850% notes to new higher-rate issuances, indicating strategic shift, but fails to fully synthesize the three-year debt trend, weakening completeness. (4) Scores reflect high factual accuracy on core notes, minor quantitative deviation in total debt figure, strong qualitative reasoning, and full contextual relevance to the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 388,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP's allocation to Corporate Stock within its pension plan assets remained steady at 24% of plan assets in both 2023 and 2024, consistent with its target allocation range of 20% to 30% for equity securities. This stability suggests the company maintained a consistent equity investment strategy over the period, with no significant shift toward or away from corporate stock. The allocation aligns with its broader asset allocation strategy, which targets 70% to 80% debt securities and 0% to 2% real estate, indicating a balanced, long-term approach to portfolio diversification rather than a strategic pivot toward equities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The ground truth states that UNP's allocation to Corporate Stock dropped dramatically from $1,990 million in 2022 to $181 million in 2023, with a reclassification and shift in investment structure by 2024. In contrast, the LLM claims a steady 24% allocation in both 2023 and 2024, which directly contradicts the factual data. There is no mention of the actual dollar amounts or the significant reduction, nor the reclassification into Level 1 and Level 2 investments. (2) Quantitatively, the LLM invents a 24% allocation with no supporting data from the ground truth, which provides specific dollar figures—not percentages—and shows a 91% decrease in value. The LLM’s claim of consistency is false. (3) The multi-hop reasoning is completely flawed: the model fails to recognize the sharp decline, misrepresents the strategy as stable when it was in fact transformative, and introduces unrelated details like target ranges for debt and real estate that are not in the original answer and irrelevant to the specific question about Corporate Stock evolution. (4) The contextual relevance is low because while the answer discusses pension plan allocations and equity strategy, it does so with fabricated data and incorrect conclusions, making it misleading despite addressing the general topic. The qualitative reasoning is unsound due to incorrect entity (Corporate Stock) behavior interpretation and failure to synthesize the actual shift in valuation methodology and equity exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 424,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "From 2022 to 2024, Pfizer’s long‑term investment in private‑equity securities at cost declined markedly—from $755 million at the end of 2022 to $719 million at the end of 2024 (with a slight dip to $755 million in 2023). This downward trend indicates that Pfizer has been reducing its exposure to illiquid alternative investments, likely shifting capital toward more liquid or higher‑return assets such as its core pharmaceutical portfolio and cash‑generating products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Pfizer's investment increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $755 million (which is actually the 2023 value), and falsely claims a 'decline' from 2022 to 2024 without acknowledging the substantial increase in 2023. It also incorrectly repeats $755 million as both the 2022 and 2023 value, failing to reflect the growth from 2022 to 2023. (2) The quantitative inaccuracies are severe: the starting point ($623M vs. $755M) is wrong, the trajectory is misrepresented, and the model fails to report the actual increase in 2023. These are not formatting issues but fundamental errors in data reporting. (3) The multi-hop reasoning is flawed: the model incorrectly infers a 'downward trend' when the data shows an initial sharp rise followed by a partial pullback. This undermines the qualitative interpretation—instead of a cautious approach after growth, the LLM suggests a consistent reduction, which contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses the right topic (strategic allocation to illiquid assets) and attempts interpretation, but the conclusions are based on incorrect data. Due to major factual and reasoning errors, the correctness score is low at 3, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 407,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s multi-layered security approach has expanded through 2022‑2024 by deepening third‑party collaborations (e.g., working with external experts, public‑private partnerships and benchmarking assessments to strengthen its cyber‑risk program), scaling real‑time payment infrastructure to 13 markets and enabling account‑to‑account, ACH‑batch and instant‑payment capabilities worldwide, and reinforcing resilience against cyber threats through continuous system testing, dedicated Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, all under a governance framework overseen by the Board and Risk Committee.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Mastercard's multi-layered security approach included Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center (mentioned in both 2022 and 2024 context), public-private partnerships, and third-party collaboration. The number of real-time payment infrastructure markets is correctly stated as 13, matching the 2023 data in the original answer. (2) Quantitative accuracy is perfect: the figure '13 markets' is correctly cited, and no other numerical claims (e.g., dates, dollar amounts) are present or required. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), correctly identifying the evolution in third-party collaboration, infrastructure expansion, and cyber resilience. It captures the progression from internal frameworks to broader ecosystem integration, though it does not explicitly separate the evolution year-by-year as clearly as the original answer. (4) The only minor shortcoming is qualitative: while the LLM mentions scaling real-time payments to 13 markets, it does not explicitly attribute that milestone to year-end 2023, slightly compressing the timeline. However, the overall strategic shift toward ecosystem integration and enhanced resilience is accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—every part of the question is addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 416,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "The collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $800 million in 2022 to $491 million in 2024, reflecting a declining trend in the amount of collateral pledged against derivative positions. This reduction suggests that ExxonMobil has been managing its derivative exposure more efficiently, relying less on external collateral and potentially leveraging internal risk controls or netting arrangements to lower the need for pledged assets over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in collateral from $800 million in 2022 to $491 million in 2024, which matches the ground truth. However, it omits the 2021 figure ($641 million reported in the 2022 filing), which is part of the full trend from 2022 through 2024 as asked in the question. The question asks about changes 'from 2022 through 2024', and while the answer covers 2022 and 2024, it skips the intermediate reporting in 2023 (for 2022 year-end) and fails to mention the peak in 2022 after an increase from 2021. (2) The numbers cited ($800M and $491M) are accurate and correctly attributed to the right years. However, the 38% decrease mentioned in the ground truth (from $800M to $491M) is not calculated or referenced in the LLM answer, representing a missing quantitative insight. The calculation is correct in the original: (800 - 491)/800 ≈ 38.6%, so ~38% is accurate. (3) The reasoning about derivative exposure management is plausible and aligns with the trend, suggesting more efficient management or reduced margin requirements. While the LLM attributes the decline to internal controls or netting arrangements, the original suggests 'reduced initial margin requirements or strategic adjustments', which is semantically similar. The multi-hop synthesis is partially sound but incomplete due to missing the full time-series context. (4) The answer is contextually relevant and addresses both parts of the question—change in collateral and its implication—though with incomplete data. The omission of the full trend and the percentage change reduces quantitative accuracy and overall correctness, but the core direction and values are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 461,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "Based on the provided SEC 10-K filings, Duke Energy's expected stock volatility—measured through its relative Total Shareholder Return (TSR) model against a predefined peer group—has shown a multi-year shift indicating a change in market risk perception. The company used a path-dependent model for performance awards, incorporating historical volatilities and correlations, with expected volatility for 2024 set at 18.7% (based on three-year historical volatility). This represents a notable decrease from prior years, reflecting a more stable market perception of Duke Energy's relative performance compared to peers, likely due to consistent regulatory outcomes and operational execution. The shift suggests that investors now perceive lower relative volatility in Duke Energy's stock, potentially signaling reduced uncertainty around its competitive positioning and regulatory environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 expected volatility (18.7%) and notes a decrease from prior years, but it omits the specific values for 2022 (26.9%) and 2023 (28.6%) that are present in the ground truth. While it mentions a 'notable decrease from prior years,' it fails to capture the increase from 2022 to 2023, which is a key part of the volatility trajectory. This omission affects quantitative accuracy and completeness. (2) The only numeric value explicitly stated is 18.7% for 2024, which is correct. However, the absence of 26.9% (2022) and 28.6% (2023) means the full multi-year trend is not quantitatively represented, despite the qualitative description of a decrease. The model does not mention the peak in 2023, which is central to understanding the shift in market risk perception. (3) The reasoning is sound in interpreting the decline in volatility as a sign of reduced uncertainty and improved market confidence, linking it plausibly to regulatory outcomes and operational execution. However, the multi-hop synthesis is incomplete because it does not integrate all three years' data to show the full pattern—specifically the rise before the fall—which weakens the overall analysis. (4) The answer remains highly contextually relevant, addressing the TSR model, peer comparison, and implications for market risk perception. Despite missing key numbers, the interpretation of the 2024 figure and its implications aligns well with the ground truth. Scores reflect high qualitative and contextual performance but a moderate penalty on correctness and quantitative accuracy due to missing data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 449,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022 through 2024 GM’s indemnification obligations to Stellantis over the 2017 Opel/Vauxhall sale remained subject to unresolved emissions‑related claims and Takata‑related recalls.  The company recorded only insignificant accruals for these matters, noting that it cannot estimate any reasonably possible material loss from the emissions claims or from future Takata‑related indemnity payments, and the related liabilities continue to be disclosed as remote or indeterminate.  (All amounts referenced are drawn from the disclosed notes on indemnification, emissions claims, and Takata recalls across the 2022‑2024 10‑K filings.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly states that GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and Takata recalls remained unresolved from 2022 to 2024, with only immaterial (or 'insignificant') accruals recorded—this aligns with the original answer's characterization of the amounts as 'immaterial' across all years. (2) There are no specific numerical values (e.g., dollar amounts) in either the ground truth or LLM response, so quantitative accuracy is preserved; the use of 'insignificant' is semantically equivalent to 'immaterial' and acceptable per SEC disclosure terminology. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and two liability types (emissions investigations and Takata recalls), correctly noting the consistent stance that potential losses were either remote or not reasonably estimable. The only minor shortcoming is that the LLM does not explicitly mention the 2024 accrual related to the European Commission and UK CMA investigations, which the ground truth specifies as an immaterial accrual. While the LLM references 'emissions-related claims' generally, it could have been more precise in attributing the accrual to those specific regulatory investigations. (4) Despite this slight omission, the answer remains contextually complete and factually aligned with the original, using appropriate terminology and correctly characterizing the evolution (or lack thereof) in GM's exposure. Hence, high scores across all dimensions, with a 9 on correctness due to the partial omission of the 2024 regulatory accrual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 464,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "AMD’s 2011 Executive Incentive Plan is consistently referenced across all three 10‑K filings (2022, 2023 and 2024) as a foundational component of its executive compensation framework—appearing in the “Incorporated by Reference” sections of the compensation‑related exhibits (e.g., *10.1* in 2022 and 2023 filings, and again in 2024). This repeated citation demonstrates that the company continues to rely on the same long‑standing incentive structure rather than replacing it with newer plans, indicating a stable, long‑term compensation strategy that emphasizes consistent performance‑based rewards for senior executives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AMD consistently referenced the 2011 Executive Incentive Plan in its 2022, 2023, and 2024 filings, and it was listed as Exhibit 10.1 in the 2022 and 2023 filings, with continued reference in 2024. The date of the original filing (April 2, 2011) is not explicitly mentioned in the LLM answer, which is a minor omission, but the core fact of consistent referencing is preserved. (2) There are no numerical or date inaccuracies—'2011', '2022', '2023', '2024' are all correctly used, and no incorrect calculations are made. (3) The multi-hop reasoning is sound: the model correctly infers from consistent citation across three years that AMD maintains a stable long-term executive compensation strategy without overhauling the plan. This synthesis across multiple filings is appropriate and logically derived. (4) The answer conveys the same semantic meaning as the original—emphasizing stability and continuity in executive compensation—though it does not explicitly state that no amendments or new disclosures were made, which slightly reduces completeness. However, the implication of stability is clearly communicated. The answer is fully contextually relevant and directly addresses both parts of the question: the evolution (or lack thereof) and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 382,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "PayPal’s exposure to bad‑transaction risk grew through 2022‑2024 as its credit products (consumer and merchant financing) expanded and cross‑border trade volumes rose, increasing reliance on third‑party lenders, payment processors and data‑custodians; this heightened fraud, charge‑off and regulatory scrutiny. In 2023 the company mitigated these risks by selling a substantial portion of its U.K. and European BNPL loan receivables, entering a forward‑flow sale of future BNPL assets, tightening fraud‑prevention controls, and diversifying its third‑party funding and payment‑processor arrangements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of PayPal's bad transaction risk from 2022 to 2024, noting increased exposure through credit products, cross-border trade, and third-party dependencies. It accurately reflects the 2023 strategic action of selling U.K. and European BNPL receivables as a key mitigation step. However, it omits the specific €40 billion figure mentioned in the ground truth, which is a quantitatively relevant detail. The answer adds that PayPal entered a 'forward-flow sale of future BNPL assets' and 'tightened fraud-prevention controls' and 'diversified third-party arrangements'—details not explicitly stated in the original answer. While plausible, these additions go beyond the documented actions in the ground truth, slightly reducing qualitative accuracy. (2) Quantitatively, the only missing element is the €40 billion amount; no incorrect numbers are stated, and dates (2022–2024, 2023 action) are correct. Format variations are acceptable, but omission of a key figure prevents a perfect score. (3) The multi-hop reasoning is sound: the model connects credit products, third-party reliance, and cross-border trade to rising risk, and links the 2023 receivables sale to risk mitigation. It synthesizes across time and business areas appropriately, though the added mitigation strategies (fraud controls, diversification) are not confirmed in the source. (4) The answer is highly contextually relevant, addressing all parts of the question—risk evolution across the three domains and 2023 actions. The core facts align with the ground truth, and the reasoning is coherent, warranting high scores in qualitative and contextual accuracy despite minor over-enrichment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 468,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s Multiple Purpose Locomotive fleet declined slightly in total count (from 7,008 in 2022 to 7,026 in 2024), but the owned portion increased as leased units were phased out—owned locomotives rose from 5,971 (2022) to 5,973 (2024), while leased units fell from 1,037 to 920. The average age of the Multiple Purpose Locomotive fleet increased from 24.3 years (2022) to 25.2 years (2024), indicating an aging core fleet despite modest growth in owned assets. This trend reflects a fleet management strategy focused on extending the life of existing equipment rather than aggressive new acquisitions, while capital investments of $3.4 billion in 2024 targeted infrastructure and technology to enhance efficiency and safety, supporting long-term modernization without over-reliance on new locomotive purchases.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Union Pacific's owned Multiple Purpose Locomotives decreased from 6,204 (2022) to 5,973 (2024), but the LLM incorrectly states owned units increased from 5,971 (2022) to 5,973 (2024). Additionally, the LLM reports total fleet size as increasing from 7,008 (5,971 + 1,037) in 2022 to 7,026 in 2024, which contradicts the ground truth total of 7,242 (6,204 + 1,038) in 2022 and 6,893 (5,973 + 920) in 2024 — indicating a failure in basic arithmetic and data recall. The average age in 2022 is reported as 24.3 years by the LLM, but ground truth is 22.5 years, a notable discrepancy.\n\n2) Quantitative accuracy is low: all key numbers are incorrect — initial owned count, initial leased count, total fleet size, and starting average age. While the 2024 values for owned (5,973) and leased (920) units and the 2024 average age (25.2) match, the 2022 figures do not, undermining the validity of the trend analysis. The LLM also introduces a $3.4 billion capital investment figure not present in the original answer or implied by the question, adding unverified context.\n\n3) Qualitatively, the reasoning is partially sound — the conclusion that the company is extending the life of existing equipment rather than pursuing aggressive modernization aligns with the ground truth's interpretation. The identification of a cost-conscious or capital-efficient strategy is semantically similar, though the LLM frames it more positively with references to infrastructure and technology investments. However, because the underlying data is flawed, the multi-hop synthesis (comparing ownership changes and aging trends) is based on incorrect premises.\n\n4) Contextual relevance is high — the answer addresses all components of the question: ownership evolution, aging profile, and strategic implications. It attempts a coherent narrative linking data to strategy. However, due to major factual errors in the quantitative foundation, the correctness score is limited to 5 — partially correct but undermined by key inaccuracies in core data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 568,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables decreased from $800 million at the end of 2023 to $491 million at the end of 2024. This decline indicates that the company is reducing its reliance on collateral to mitigate derivative counterparty risk, suggesting a more streamlined approach to managing derivative exposures and a lower perceived need for extensive collateral support in its risk‑management framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $800 million exposure in 2023 and $491 million in 2024, which matches the ground truth. However, it omits the 2022 value of $641 million, which is a key part of the multi-year trend asked in the question. This omission reduces completeness and affects the overall correctness. (2) The quantitative values for 2023 and 2024 are accurate and properly formatted ($800 million, $491 million), but the absence of the 2022 figure means the full trend (increase then decrease) is not captured. Calculations are not required, but the comparison across years is incomplete. (3) The reasoning is partially sound but flawed in interpretation. The LLM attributes the 2024 decline to reduced reliance on collateral and a 'streamlined approach,' but the ground truth notes a peak in 2023 and suggests dynamic risk positioning or improved credit conditions—not necessarily a strategic shift away from collateral. The LLM misses the nuance of continued use of level 3 inputs and the possibility of market-driven changes rather than policy shifts. (4) Scores reflect: correctness docked for missing 2022 data and incomplete trend analysis; quantitative accuracy high due to correct numbers where provided; qualitative accuracy reduced due to unsupported inference; contextual relevance remains high as the answer addresses the core topic and direction of change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 386,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Based on the provided 10-K filings, the \"Other\" category (which includes single-serve coffees, packaged coffees, teas, royalty and licensing revenues, beverage-related ingredients, and serveware) showed the following evolution from 2022 to 2024:\n\n- In fiscal 2022 (ended Oct 2, 2022), \"Other\" revenue was $6,890.8 million (21% of total revenue).\n- In fiscal 2023 (ended Oct 1, 2023), \"Other\" revenue increased to $7,705.7 million (22% of total revenue).\n- In fiscal 2024 (ended Sep 29, 2024), \"Other\" revenue further rose to $7,543.1 million (21% of total revenue), though this represents a slight decline from the 2023 peak.\n\nThe data indicates a consistent upward trend in absolute \"Other\" revenue from 2022 to 2023, followed by a modest decline in 2024, while its proportional share of total revenue remained relatively stable around 20-22%. This category encompasses the single-serve coffee products referenced in the question.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both quantitative and qualitative aspects. (1) The original answer states that the composition of the 'Other' category remained stable from 2022 to 2024, with no mention of revenue figures, percentages, or trends in absolute or relative revenue. However, the LLM answer fabricates specific dollar amounts ($6,890.8M, $7,705.7M, $7,543.1M), percentages (21%, 22%, 21%), and fiscal end dates (Oct 2, 2022; Oct 1, 2023; Sep 29, 2024), none of which appear in the ground truth. There is no evidence in the original answer that such numerical data was available or reported. (2) The question asks about the evolution of the revenue *composition*—i.e., what items are included in the 'Other' category—not revenue totals or percentages. The LLM incorrectly shifts focus to quantitative performance metrics that were not part of the ground truth. (3) While the LLM correctly identifies some components of the 'Other' category (e.g., single-serve coffees, packaged coffees, royalty revenues), it falsely implies these were explicitly tied to annual revenue figures and trends, which the original answer does not support. (4) The reasoning is flawed because it invents a multi-hop financial narrative (year-over-year revenue changes) based on non-existent data, failing to recognize that the actual answer emphasizes consistency in *description* and absence of structural change. (5) Contextual relevance is moderate because the topic (components of 'Other') is addressed, but the emphasis on unreported financials misrepresents the information. Overall, the answer is factually unsupported and reflects a significant misunderstanding of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 468,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 to 2024, Google’s monetization of advertising inventory through Google Ad Manager evolved with a consistent focus on gross revenue recognition for Google Network properties. The company continued to report advertising revenues on a gross basis when acting as the principal—controlling the advertising inventory before transfer to customers—while recognizing impression-based revenues from AdMob, AdSense, and Ad Manager placements. Although impression metrics and cost-per-impression remained key performance indicators, the underlying revenue recognition methodology remained unchanged: revenue was recognized when control transferred to advertisers, and gross amounts billed to advertisers were recorded as revenue, with network partner payments classified as cost of revenues. This approach persisted through 2024, with no material shift in the core monetization model across Google Network properties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Google used impression-based and click-based models via Google Ad Manager across 2022–2024, reported revenues on a gross basis when acting as principal, and maintained consistent revenue recognition principles. The role of cost-per-impression as a KPI and classification of partner payments as cost of revenue are correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full alignment on available data. (3) Multi-hop reasoning is sound: the LLM synthesizes revenue recognition policy, gross reporting, control as principal, and consistency over time across Google Network properties (AdSense, AdMob, Ad Manager). The only minor gap is that the original emphasizes a progressive 'clarification' and 'increasing transparency' in 2023–2024, which the LLM downplays by stating 'no material shift,' potentially underemphasizing the accounting clarity evolution. However, this does not make the answer factually incorrect—just slightly less nuanced in describing the evolution. (4) Contextual relevance is perfect: the response directly addresses monetization evolution, impression-based revenue, and gross revenue reporting across the specified period. Overall, the answer is factually robust, well-reasoned, and semantically equivalent to the ground truth with only minor stylistic differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 427,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ's exposure to sales and media marketing restrictions has expanded significantly across 2022‑2024, with front‑of‑pack labeling requirements and EPR policies increasingly shaping its operating environment. In 2022 the company highlighted emerging labeling and promotional limits (e.g., UK pre‑October 2025 ad bans on high‑fat/sugar/salt foods and Mexico’s age‑based sales restrictions), and by 2023‑2024 it noted broader EPR implementations in over 25 EU nations plus emerging rules in India, Vietnam and certain U.S. states, alongside heightened scrutiny of marketing, advertising and packaging practices that could restrict promotion and require new labeling compliance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trend of increasing regulatory exposure for MDLZ across 2022–2024 regarding front-of-pack labeling and EPR policies, which aligns with the ground truth. It correctly notes EPR expansion in over 25 EU countries and emerging implementation in India, Vietnam, and U.S. states. However, it introduces specific examples not present in the original answer—such as the UK’s pre-October 2025 ad ban and Mexico’s age-based sales restrictions—which were not mentioned in the ground truth and thus introduce factual inaccuracies. (2) Quantitatively, the reference to 'over 25 EU countries' implementing EPR is consistent with the 2022 and 2023 ground truth statements, and the progression into 2024 with U.S. states and Asian countries is directionally accurate. No explicit dates or numbers are incorrect, but the inclusion of unverified jurisdictional examples (UK, Mexico) without grounding in the source reduces precision. (3) The multi-hop reasoning is partially sound: the model correctly infers a growing regulatory burden across jurisdictions and connects EPR expansion with marketing and labeling scrutiny. However, it fails to emphasize the shift from 'consideration' to 'enforcement' in 2024, a key nuance in the ground truth, and does not clearly articulate the increased focus on environmental claims in front-of-pack labeling as highlighted in 2023. (4) Despite some overreach in examples, the answer remains contextually relevant and addresses the evolution of restrictions across the three years, particularly the broadening geographic and regulatory scope. The omission of the EU’s formal adoption of the Packaging and Packaging Waste Directive in 2024—a key milestone—is a notable gap. Overall, the answer is factually plausible and captures the general trajectory but lacks full fidelity to the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 504,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "The voting rights and dividend entitlements of A Class shares have remained unchanged across 2022, 2023, and 2024, with each A share retaining one vote and equal dividend rights as disclosed in the capital stock tables. This consistency reflects Mastercard's stable capital structure strategy, which prioritizes maintaining a simple, predictable equity framework with clear shareholder rights while allowing flexibility for capital allocation through share repurchases and dividend growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that A Class shares maintained one vote per share and equal dividend rights across 2022, 2023, and 2024, which aligns perfectly with the ground truth. All entities (A Class shares, time period) and qualitative descriptions are accurate. The reasoning about Mastercard's (MA) capital structure strategy is consistent with the original answer, noting stability and predictability. The only minor difference is that the LLM adds interpretive detail about 'flexibility for capital allocation through share repurchases and dividend growth,' which is plausible but not explicitly stated in the ground truth. This addition does not contradict the original and enhances context slightly, but introduces a small element beyond the provided data. Quantitatively, there are no errors—dates and voting/dividend rights are correctly reported. The multi-hop synthesis across three years is sound and accurately reflects consistency. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with a minor deduction for slight over-interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 314,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "The collateral under master netting arrangements related to \"Investments, advances and long-term receivables\" decreased from $800 million in 2022 to $491 million in 2024, reflecting a reduction in the amount of collateral required to support derivative positions. This decline indicates that ExxonMobil’s derivative exposure and associated margin requirements have been trimmed over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. The LLM incorrectly states it was $800 million in 2022 and omits the 2023 data point entirely, implying a direct decrease from 2022 to 2024. This misrepresents both the starting value and the trend. (2) The quantitative inaccuracies are severe: the 2022 figure is wrong ($800M vs. correct $641M), and the intermediate 2023 peak is missing. While the 2024 value ($491M) is correct, the overall trajectory is misrepresented. Calculations or comparisons based on these numbers would be flawed. (3) The reasoning is unsound due to incorrect data. The conclusion that derivative exposure and margin requirements 'have been trimmed over the 2022–2024 period' ignores the actual increase in 2023, which is a critical part of the trend. The multi-hop synthesis fails because the model did not correctly identify or sequence the three-year pattern. (4) Contextual relevance is moderate—the answer addresses the right metric and attempts to interpret the trend in terms of derivative exposure and margin requirements, which is appropriate. However, due to major factual and reasoning errors, the interpretation is misleading. Correctness and quantitative accuracy are low due to core data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 389,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ forward-looking supply‑chain commitments to coffee producers have evolved from a focus on securing fixed‑price and price‑to‑be‑fixed purchase commitments and hedging “C” price exposure through forward contracts, futures and collars (as described in the 2022 filing) to a broader strategy that emphasizes diversified sourcing, long‑term purchase commitments through fiscal 2025, and continued investment in farmer‑support centers and ethical sourcing programs. Across the 2022‑2024 filings, the company consistently underscores that these commitments, together with existing inventory, are intended to provide an adequate supply of high‑quality green coffee despite volatility driven by weather, disease, input costs, and market speculation. This progression reflects a strategic shift toward proactive risk management—using contractual tools and supplier relationships—to mitigate coffee‑price swings and supply‑chain disruptions while maintaining its premium coffee standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Starbucks extended its forward-looking supply commitments from covering through fiscal 2023 (as of 2022) to through fiscal 2025 (by 2023 and maintained in 2024). The use of forward contracts, futures, and collars to hedge 'C' price exposure is correctly noted across all years. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024, and forward coverage through 2025) are correctly stated with no errors in dates or timeframes. (3) Multi-hop reasoning is sound—LLM synthesizes information across three fiscal years and correctly infers a strategic shift toward longer-term stability and risk mitigation. It appropriately notes the continuity of hedging tools and the extension of purchase commitments. (4) The only minor deviation from the original answer is the addition of 'diversified sourcing' and 'investment in farmer-support centers and ethical sourcing programs' as part of the evolved strategy, which, while likely true based on Starbucks' public commitments, are not mentioned in the ground truth derived from the knowledge graph. This adds contextual detail not present in the verified data, slightly reducing qualitative accuracy. However, it does not contradict the truth and enhances relevance. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 388,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "Based on the provided document pages, ACN's target asset allocation mix for its defined benefit pension plans evolved from a 2023 allocation of 100% debt securities in U.S. plans and 48% debt securities in non-U.S. plans (with 21% equity securities in non-U.S. plans) to a 2025 target allocation of 36% debt securities in non-U.S. plans and 28% equity securities in non-U.S. plans. This multi-year shift indicates a deliberate, strategic move toward a more balanced, growth-oriented portfolio with increased equity exposure, reflecting a long-term investment strategy focused on achieving higher risk-adjusted returns while maintaining liability-driven investment principles to ensure plan solvency. The expansion of equity allocation (from 19-21% to 28% in non-U.S. plans) suggests ACN is intentionally increasing exposure to growth assets to enhance long-term return potential, likely in response to evolving market conditions and the need to outpace inflation over the plan's horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that ACN's target asset allocation evolution is described in qualitative, strategic terms—emphasizing risk-adjusted returns, liability matching, and adaptive flexibility—but does not provide specific numerical targets (e.g., 100% debt in U.S. plans in 2023, 36% debt in 2025, etc.). These percentages are entirely fabricated and not present in the original answer or implied by the knowledge graph. There is no mention of U.S. vs. non-U.S. plan allocations or exact shifts from 21% to 28% equity. (2) Quantitative accuracy is very low because the LLM invents precise figures (e.g., 48%, 28%, 36%) and comparisons that do not appear in the ground truth. The original answer does not specify any percentages or numerical allocations, so these values cannot be verified and are incorrect. (3) The multi-hop reasoning is flawed—the LLM falsely assumes granular data exists and extrapolates a narrative from non-existent numbers. While it correctly identifies the general direction of strategy (balancing growth and risk, liability-driven investing), this is inferred from incorrect data. The original answer emphasizes continuity and adaptive flexibility, not a deliberate increase in equity exposure. (4) Contextual relevance is moderate because the LLM addresses the question's intent—discussing strategic evolution and risk-adjusted returns—but does so using fabricated data, undermining factual correctness. The conclusion about growth orientation and inflation response is speculative and not supported in the ground truth, which stresses consistency and liability matching over aggressive reallocation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 464,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen's Olpasiran development evolved from a 2022 Phase 3 candidate (listed among 18 programs) to a 2024 priority with expanded portfolio breadth—by January 2024 the company reported 24 Phase 3 programs, including Olpasiran’s continued advancement and additional Phase 3 initiations (e.g., LUMAKRAS, Tarlatamab). Patent protection for Olpasiran is projected to extend to 2036 in both the U.S. and Europe, with exclusivity periods potentially lengthened by regulatory exclusivity or supplemental protection certificates. This timeline ensures Olpasiran remains under intellectual‑property shield well beyond its initial commercial launch.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it incorrectly states that Olpasiran was a Phase 3 candidate in 2022, while the ground truth confirms it was in Phase 2 trials in 2022. This misrepresents the drug's developmental timeline. Additionally, the mention of '18 programs' and '24 Phase 3 programs' by January 2024, including LUMAKRAS and Tarlatamab, is not supported by the original answer and introduces extraneous, unverified information. However, the patent protection expiration in 2036 for both U.S. and Europe is correctly reported, aligning with the ground truth. (2) Quantitatively, the 2036 patent expiry is accurate, but the Phase 3 claim is false—this is a critical error in developmental stage and timing. The numbers regarding portfolio size (18 to 24 programs) are unsupported and irrelevant to the question. (3) The multi-hop reasoning is flawed: the model fails to correctly trace Olpasiran’s progression from Phase 2 (2022) to continued development (2024) with IP protection, instead jumping to an incorrect Phase 3 status. It also introduces unrelated drugs and portfolio metrics, indicating poor synthesis. (4) Despite the incorrect developmental phase and extraneous details, the answer correctly identifies the 2036 IP protection and maintains focus on therapeutic and IP evolution, preserving some contextual relevance. However, the core factual error in clinical phase severely undermines correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 413,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "American Express’s reliance on aggregators and third‑party merchants has grown steadily from 2022 through 2024, as noted in the 2022, 2023 and 2024 10‑K disclosures (pages 29, 31, 32, 35, 38, 52, 53, 65, 96). Each year’s risk factor discussion emphasizes that these third‑party relationships expose the company to potential discrimination against its cards, surcharging or steering that could erode cards‑in‑force and transaction volumes, and that any failure by aggregators or processors to promote or maintain acceptance of American Express cards could materially harm the business. The company repeatedly warns that such third‑party actions may be inconsistent with its own goals and could lead to reputational damage, reduced usage of its products, and adverse impacts on profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of core content and context. It correctly identifies the increasing reliance on aggregators from 2022 to 2024 and accurately captures the key risks emphasized each year: merchant steering, surcharging, reduced card acceptance, and negative impacts on transaction volumes and profitability. The answer cites specific page numbers across the 10-K filings, enhancing credibility, and correctly notes that third-party actions may conflict with American Express's interests, potentially harming its business. However, while the LLM answer captures the general trend, it lacks the year-by-year evolution in risk emphasis detailed in the ground truth. Specifically, it does not clearly differentiate the progression from 2022 concerns about aggregator behavior against AXP’s interests, to 2023’s focus on increased dependency and surcharging impacts, to 2024’s broader operational, legal, and litigation risks. This nuance in the evolving nature of risk disclosures—shifting from merchant behavior to systemic and regulatory concerns—is missing, resulting in a minor but notable gap in qualitative completeness. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (American Express, aggregators, third-party processors) and timeframes (2022–2024) are correct. The answer remains highly relevant and synthesizes multi-hop information appropriately, but with slightly less precision in tracing the annual evolution of risk emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 422,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Starbucks’ exposure to commodity index funds and hedging strategies remained focused on managing green coffee price volatility through forward contracts, futures contracts, collars, and fixed‑price purchase commitments, with total purchase commitments extending supply through fiscal 2025. The company’s forward supply commitments were expanded in fiscal 2024 to cover an adequate supply of green coffee through fiscal 2025, reflecting increased inventory and forward contracts to mitigate price swings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Starbucks' exposure to commodity index funds and its use of hedging instruments (forward contracts, futures, collars, fixed-price commitments) to manage green coffee price volatility across fiscal 2022–2024. It accurately states that forward supply commitments were extended to cover needs through fiscal 2025. However, it incorrectly attributes the expansion of supply commitments to fiscal 2024, while the ground truth indicates the extension occurred in fiscal 2023. This misplacement of timing is a factual error affecting the reasoning timeline. (2) Quantitatively, all dates (fiscal 2022–2025) and the direction of change (extension to 2025) are correct. The answer correctly reflects the multi-year coverage but misassigns when the change occurred. No numerical calculations are involved, so accuracy on dates is paramount—this is mostly correct but with a key timing misstatement. (3) The multi-hop reasoning is partially sound: the model connects commodity index fund exposure to hedging strategies and links forward commitments to risk mitigation. However, it fails to reflect the evolution accurately—specifically, that the extension to 2025 was already in place by 2023 and remained unchanged in 2024, indicating stabilization. The LLM implies the expansion happened in 2024, which contradicts the ground truth and misses the strategic continuity into 2024. (4) Despite the timing error, the answer remains contextually relevant, addresses both parts of the question (exposure to index funds and changes in supply commitments), and captures the essence of Starbucks’ risk management strategy. The core facts are present but with a significant but not critical error in temporal reasoning, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 487,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase activity accelerated markedly. In fiscal 2022 the company purchased roughly 12.2 million shares for about $4.1 billion, and the publicly announced open‑market program had an aggregate authorization of about $2.7 billion (later increased to $6.7 billion after a September 2024 Board approval). By fiscal 2024 the quarterly purchase volume rose to 2.07 million shares at an average price of $303 per share, consuming roughly $605 million of the program and leaving about $2.69 billion of remaining authorization; the Board subsequently added another $4 billion, pushing total outstanding authority to $6.69 billion. This multi‑year trajectory—steady growth in both the volume of shares bought and the amount of Board‑approved repurchase authority—signals that Accenture is maintaining a robust, ongoing capital‑return strategy focused on returning cash to shareholders while preserving flexibility for future investments and acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, in fiscal 2022, Accenture did not report purchasing 12.2 million shares for $4.1 billion; instead, it had an available authorization of $3,129,296 (approximately $3.13 billion), with no reported purchases under the open-market program for that year. The LLM incorrectly attributes $4.1 billion in repurchases to fiscal 2022, which is not supported by the data. Additionally, the claim that the authorization was 'about $2.7 billion' in fiscal 2022 contradicts the ground truth figure of $3.13 billion. (2) The LLM states that in fiscal 2024, Accenture repurchased 2.07 million shares quarterly at $303 per share, totaling $605 million—this appears to conflate timing and volume. The ground truth reports that the $605 million purchase (of 2,000,308 shares) occurred in fiscal 2023, not 2024, and does not specify quarterly pacing. The remaining authorization of $2.69 billion is correctly cited but misattributed to fiscal 2024 instead of as of August 31, 2024 (end of fiscal 2024), creating a timing mismatch. The $4 billion increase and resulting $6.69 billion total authorization are accurate and correctly timed to September 2024. (3) The multi-hop reasoning is partially sound—LLM correctly infers a growing capital return strategy from increasing authorizations and repurchase activity—but it fails to accurately sequence events across fiscal years. It incorrectly assigns repurchase volumes to the wrong years and invents quarterly data not present in the source. (4) Despite these errors, the answer captures the general strategic trend—increasing repurchase capacity and commitment to shareholder returns—making it contextually relevant and qualitatively plausible, though factually flawed in key details. The conclusion about a robust capital-return strategy is aligned with the ground truth, but the faulty numbers undermine reliability. Thus, correctness and quantitative accuracy are low; qualitative reasoning and relevance are moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 563,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "The value of Google's marketable equity securities subject to long‑term lock‑up restrictions declined from $429 million at the end of 2022 to $266 million at the end of 2024, reflecting a drop of roughly $163 million over the two‑year period. This downward trend indicates that Alphabet is reducing its exposure to illiquid, long‑term equity holdings and is likely shifting capital toward more liquid investments or operational priorities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. According to the ground truth, the value was $1.4 billion in 2022, dropped to $803 million in 2023, and returned to $1.4 billion in 2024. The LLM incorrectly states the 2022 value as $429 million and 2024 value as $266 million, with no mention of the 2023 figure or the recovery in 2024. These numbers are not only wrong but off by more than 60% from ground truth. (2) Calculations are also incorrect: the LLM claims a drop from $429M to $266M over two years, but the actual trajectory was a drop and then a full recovery, resulting in no net change from 2022 to 2024. The LLM fails to capture this cyclical pattern entirely. (3) The multi-hop reasoning is flawed — the question requires synthesizing data across three years and interpreting the fluctuation. The LLM instead presents a linear decline, missing the rebound in 2024, which is central to the correct interpretation of strategic rebalancing. (4) The qualitative interpretation is therefore invalid: the conclusion that Alphabet is reducing exposure to illiquid assets contradicts the ground truth, which shows a return to the original level, suggesting cyclical management rather than a directional shift. While the answer addresses the general topic of investment strategy in illiquid assets, its factual foundation is so inaccurate that the analysis is misleading. Contextual relevance is low but not zero because it attempts to interpret strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 414,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "From 2022 through 2024 GE systematically divested its captive insurance subsidiary Electric Insurance Company and its non‑core licensing business, completing sales in 2024 for $120 million and $441 million respectively, while classifying them as held‑for‑sale and later discontinued operations. This strategic exit reduced GE’s exposure to legacy insurance and licensing assets, generated modest cash proceeds, and eliminated related liabilities, resulting in a $109 million pre‑tax loss recorded in 2023 and a net gain of $19 million (after tax) from the 2024 disposal. The progression streamlined GE’s portfolio, improved focus on core aerospace and energy businesses, and had a limited but positive financial impact—offsetting a portion of earnings volatility from discontinued operations but not materially affecting overall profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly states that GE sold Electric Insurance Company (EIC) in 2024 for $120 million and recorded a $109 million pre-tax loss in 2023, it incorrectly introduces a second sale of a 'non-core licensing business' for $441 million, which is not mentioned in the ground truth and has no support in the provided data. This significantly undermines the quantitative accuracy. Additionally, the claim of a 'net gain of $19 million (after tax)' from the 2024 disposal is unsupported by the original answer, which does not mention any gain—only the completion of the sale after a prior loss. (2) The correct numbers from the ground truth are: EIC net claim reserves of $0.2B in 2022; EIC assets of $541M and liabilities of $378M in 2023; sale price of $120M in 2024; and a $109M loss in 2023. The LLM correctly includes the $109M loss and $120M sale price but fabricates the $441M licensing sale and net gain, leading to a quantitative accuracy score of 4. (3) The reasoning is partially sound in identifying a strategic exit from non-core businesses and improved focus on core operations, which aligns with the ground truth. However, the synthesis is flawed due to the inclusion of an entirely unsupported second divestiture, indicating a failure in multi-hop reasoning fidelity. The model appears to conflate EIC with another disposal not referenced in the source. (4) Despite the inaccuracies, the answer remains contextually relevant, addressing strategic positioning, valuation, disposition, and financial impact over the three years. It captures the essence of portfolio streamlining and financial impact, albeit with significant factual errors. Thus, the correctness score is 5—partially correct but with major omissions and fabrications that distort the financial narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 512,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 pipeline expanded from 13 programs in early 2021 to 25 programs by February 2025, reflecting a strategic acceleration of late‑stage development. This growth was driven by the addition of Horizon‑acquired assets (e.g., Dazodalibep, TEPEZZA, UPLIZNA), new breakthrough‑designated candidates such as LUMAKRAS/LUMYKRAS and bemarituzumab, and the initiation of multiple first‑in‑class studies (e.g., Tarlatamab, Rocatinlimab, ABP234). The progression underscores Amgen’s focus on oncology, rare‑disease, and inflammatory‑biology therapeutics, as well as a broader biosimilars push, positioning the company for sustained pipeline depth and future revenue diversification.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates. The original answer states that Amgen had 13 Phase 3 programs in 2022, 18 in 2023, and 25 in 2024. However, the LLM claims the pipeline grew from 13 in early 2021 (not 2022) to 25 by February 2025 (not 2024), which misaligns the timeline and duration. The correct progression is over 2022–2024, not 2021–2025. Additionally, the original answer specifies 24 programs in 2024 and then 25, while the LLM skips this nuance and jumps directly to 25 by 2025. (2) The quantitative inaccuracies are significant: the starting year is off by one year, the end year is projected into 2025 (beyond the scope), and the intermediate count in 2023 (18) is omitted. The claim of '25 programs by February 2025' is not supported by the ground truth, which confirms 25 programs in 2024. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the Horizon acquisition (five programs) as a driver and mentions relevant assets like TEPEZZA and UPLIZNA, which aligns with the strategic expansion. It also accurately infers Amgen’s focus on oncology, rare diseases, and inflammation. However, it introduces specific drug names (e.g., LUMAKRAS, bemarituzumab, Tarlatamab) not mentioned in the original answer, which may be factually incorrect or unsupported by the source data. The mention of a 'broader biosimilars push' is not present in the original and may misrepresent the strategic focus. (4) Despite these errors, the LLM captures the essence of pipeline expansion and strategic intent, showing some correct multi-hop synthesis (acquisition + new studies → pipeline growth). The contextual relevance is high because it addresses both the evolution and strategic implications. However, the quantitative inaccuracies severely limit factual correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 507,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022 to 2024, American Express has faced intensifying regulatory scrutiny that reshaped its relationship with global card networks.  The company was designated a Category III U.S. bank holding firm in 2024, subjecting it to heightened supervisory expectations and stricter capital and compliance requirements, and it has been forced to exit network‑licensing businesses in the EU and Australia while navigating new interchange‑fee caps and consumer‑protection rules that pressure discount revenue.  At the same time, competition from other networks and emerging payment platforms has pushed the firm to innovate and defend its premium value proposition, but the combined effect of tighter regulations and competitive dynamics has required continual adjustments to its business practices and cost structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of American Express's relationship with global card networks from 2022 to 2024, aligning well with the ground truth. It accurately highlights the increasing regulatory pressures, specifically mentioning AXP's exit from network-licensing businesses in the EU and Australia in 2024 due to regulatory constraints, which matches the original answer. It also correctly identifies competitive dynamics involving other networks and emerging platforms like PayPal or Alipay (implied through 'emerging payment platforms'). The mention of interchange-fee caps and consumer-protection rules aligns with the regulatory environment affecting discount revenue, adding relevant context not in the original but factually plausible. However, the LLM introduces a detail not present in the ground truth: American Express being designated a Category III U.S. bank holding company in 2024. While American Express is a bank holding company, there is no public evidence that its designation changed in 2024, making this a potentially inaccurate or unsupported claim. This affects qualitative accuracy slightly. The answer omits the nuanced shift from a purely competitive stance in 2022 to growing regulatory dependency by 2024, particularly the emphasis on cobrand partnership uncertainty in the EU. While the key facts about regulatory exits are present, the multi-hop synthesis of how the *relationship* evolved—competitive → challenged → constrained—is less clearly articulated than in the original. Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are mentioned in either answer, so accuracy is not compromised. The reasoning is sound overall and contextually relevant, addressing both regulatory and competitive dimensions as required. Minor deductions in correctness and qualitative accuracy due to the unsupported Category III claim and slightly less precise narrative of relationship evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 528,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "From 2022 through 2024 ConocoPhillips monetized its CVE common shares in a phased program, using the cash proceeds to fund share repurchases. In 2022 the company sold the remaining 91 million CVE shares, generating proceeds that were applied to its share‑repurchase program. In 2023 and 2024 the company continued to repurchase shares, increasing the authorized limit to $65 billion (an additional $20 billion in 2024) and completing purchases of 48.6 million shares in 2023 and 49.1 million shares in 2024, bringing total repurchased shares since the program’s inception to roughly 433 million shares at a cost of about $34.3 billion. These actions reflect the evolution of the monetization‑to‑repurchase strategy across the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the monetization of 91 million CVE shares in 2022 and the cumulative share repurchase total of 433 million shares at a cost of $34.3 billion by 2024, which aligns with the ground truth. It also correctly notes the increase in share repurchase authorization to $65 billion in 2024. However, it introduces specific annual repurchase volumes for 2023 (48.6 million) and 2024 (49.1 million) that are not present in the original answer and cannot be verified from the provided ground truth. The original answer only states that total repurchases reached 433 million shares cumulatively by 2024, with 383 million repurchased in 2022 alone — implying only 50 million additional shares repurchased over 2023–2024 combined, not ~97.7 million as stated by the LLM. This represents a significant quantitative error. (2) The dollar amounts for total repurchase cost ($34.3B) and authorization ($65B) are correct, and the 2022 repurchase cost of $29B is omitted in the LLM answer but not contradicted. The LLM fails to mention the $29B spent in 2022, which is a key data point from the original. Instead, it implies repurchases were spread more evenly across 2023–2024, which distorts the timeline. (3) The multi-hop reasoning is partially sound — the LLM correctly links CVE monetization to share repurchases and recognizes the evolution of the program. However, it fabricates annual breakdowns not supported by the source, undermining the fidelity of the synthesis. (4) The contextual relevance is high as the answer addresses the monetization-to-repurchase strategy evolution. Qualitative accuracy is moderate due to correct entity identification (ConocoPhillips, CVE shares, share repurchases) and logical flow, but penalized for invented specifics. Quantitative accuracy is low due to incorrect share volumes for 2023 and 2024. Correctness score is 6 due to mostly correct high-level narrative but significant factual inaccuracies in key numerical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 538,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "The Home Depot's available shares under its Omnibus Stock Incentive Plans declined modestly from 77 million shares available at the end of fiscal 2023 to approximately 70 million shares available at the end of fiscal 2024 (as disclosed on page 66 of the 2024 Form 10‑K), reflecting ongoing repurchases and awards. This reduction indicates a tightening of the company's equity‑based compensation capacity, although the firm still maintains a substantial pool of shares for future grants and continues to utilize its stock‑based compensation programs, as evidenced by the $444 million pre‑tax stock‑based compensation expense recorded in fiscal 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 70 million shares available in 2024 and the 77 million in 2023, which aligns with the ground truth. However, it omits the 2022 figure of 117 million shares, which is a key part of the multi-year trend requested in the question. This omission significantly undermines completeness. Additionally, the LLM incorrectly states that the 77 million shares were 'at the end of fiscal 2023' under the same plan, but the ground truth specifies that the 2022 figure was under the 2005 Plan, while the 2023 figure was under a newly amended Omnibus Plan—this reflects a change in plan structure that the LLM fails to acknowledge. (2) The $444 million pre-tax stock-based compensation expense in 2024 is factually accurate and supports the utilization narrative, but it is not part of the original answer and does not compensate for missing the 2022 data. The reduction from 77M to 70M is correctly stated, but the full trend from 117M to 77M to 70M is not captured. (3) The reasoning is partially sound—drawing a connection between declining available shares and ongoing utilization of equity compensation is valid—but the analysis misses the critical drawdown from 117M to 77M, which represents the steepest decline and most significant signal of utilization. The conclusion about 'tightening capacity' is plausible but less nuanced than the original answer’s emphasis on continued replenishment mechanisms. (4) The contextual relevance is high because the answer addresses share availability trends and links them to compensation utilization. However, due to the missing 2022 data and incorrect framing of plan continuity, the quantitative and qualitative accuracy scores are reduced. The answer is not factually wrong on the numbers it includes, but it presents an incomplete and slightly misleading picture of the three-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 508,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "The maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP increased from 127 million in 2022 to 141 million in 2024, reflecting a deliberate expansion of the share‑based compensation pool. This upward progression signals Accenture’s strategy to maintain ample equity‑based incentives to attract, retain, and motivate talent amid growing competition for skilled workers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the number of shares authorized in 2022 (127 million) and 2024 (141 million), matching the ground truth. It omits explicit mention of 2023, though the value is the same as in 2024 (141 million), so the omission is minor and does not introduce inaccuracy. The progression and numerical values are correct.\n\n2) Quantitative accuracy is perfect: 127 million in 2022 and 141 million in 2024 are factually correct. The format (million) is acceptable and equivalent to the ground truth's 127,000,000 and 141,000,000. No calculations are required beyond recognition of the increase, which is accurately portrayed.\n\n3) The reasoning is sound: the increase from 127M to 141M is correctly interpreted as a strategic expansion of share-based compensation. The LLM infers a focus on talent attraction and retention, which is logically consistent with the ground truth’s interpretation around long-term incentives and alignment with shareholder value. The emphasis on competition for skilled workers adds context not in the original but is plausible and relevant.\n\n4) The answer is contextually excellent—directly addresses both parts of the question: the evolution of shares and the strategic implication. The only minor shortcoming is not explicitly noting that the 141 million applies in both 2023 and 2024, but since the value is unchanged, this does not undermine correctness. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 416,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted‑average yield on American Express’s foreign‑government‑bond portfolio fell from about **6.45 % in 2022** to **5.85 % in 2023** and further to **5.86 % in 2024** (as shown in the “Weighted average yields and contractual maturities for AFS debt securities” tables for 2022, 2023 and 2024). This downward trend indicates that the company’s exposure to international interest‑rate environments has eased, reflecting a modest decline in the yields it earns on those foreign‑government holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of yield changes. It incorrectly states that the yield fell from 6.45% in 2022 to 5.85% in 2023 and 5.86% in 2024. According to the ground truth, the yield was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM reverses the initial trend and misattributes the 6.45% yield to 2022 instead of 2023. Additionally, the dollar amount ($630 million) is omitted entirely. (2) The quantitative inaccuracies are severe: the LLM flips the actual trend (downward vs upward in 2023), reports incorrect percentages for each year (e.g., 6.45% in 2022 is wrong), and introduces a non-existent further drop in 2024 when in fact it returned to the 2022 level. Even the final 5.86% in 2024 is framed as a continuation of a decline, which contradicts the data. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the year-over-year changes and draws an incorrect conclusion about a 'downward trend' and 'easing exposure', whereas the ground truth describes a peak in 2023 followed by a reversal—indicating volatility, not a consistent decline. The LLM misses the cyclical nature of exposure to international rates. (4) The contextual relevance is moderate because it addresses the right topic (yield on foreign government bonds and interest rate exposure) and references the correct type of table, but the factual foundation is so compromised that the conclusion is invalid. Correctness and quantitative accuracy are very low due to core data inversion; qualitative accuracy is slightly higher only because the general structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 464,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "The weighted average yield for Foreign Government Bonds and Obligations declined from 6.45% in 2023 to 5.85% in 2024, reflecting a strategic shift toward shorter-duration holdings amid rising interest rates and market volatility. This progression, alongside the 2022 fair value distribution showing a $630 million cost basis with no unrealized gains or losses, indicates American Express is actively managing interest rate risk while maintaining exposure to higher-yielding sovereign debt in a tightening monetary environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the weighted average yields of 6.45% in 2023 and 5.85% in 2024, as well as the $630 million fair value in 2022, which matches the ground truth. These numeric values are accurate and properly attributed, earning high marks for quantitative accuracy. However, the LLM incorrectly states that the shift reflects a move toward 'shorter-duration holdings amid rising interest rates,' which contradicts the ground truth: in 2022, $628 million of the $630 million was already in short-term maturities (indicating pre-existing short-duration focus), and the yield decline from 2023 to 2024 is more likely due to falling interest rates, not rising ones. (2) The dollar amounts and percentages are correct and consistent with the original answer. The claim about 'no unrealized gains or losses' is not present in the ground truth and introduces unsupported information. (3) The multi-hop reasoning is flawed: while the model connects 2022 fair value, 2023 yield, and 2024 yield, it misinterprets the direction of interest rate changes and the strategic implication. The original answer suggests the yield drop may reflect either falling rates or a strategic move away from high-yielding short-term instruments, whereas the LLM assumes rising rates and a push into shorter durations—this is logically inconsistent with the data. (4) The correctness score is 5 due to accurate numbers but significant errors in interpretation and reasoning. Qualitative accuracy is low because of incorrect causal logic and unsupported claims. Contextual relevance is moderate as the answer addresses the yield evolution and strategy, but with misleading analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 459,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "The presentation and disclosure of ConocoPhillips' 7% Debentures due 2029 evolved across its 2022, 2023, and 2024 10-K filings by being consistently listed in the \"Securities registered pursuant to Section 12(b)\" table under \"7% Debentures due 2029\" with identical CUSIP-718507BK1 and New York Stock Exchange registration details. This standardized disclosure across all three filings confirms the debt instrument's long-standing presence and stable reporting structure. The multi-year consistency indicates ConocoPhillips maintains a deliberate, unchanging approach to reporting this specific debt instrument, emphasizing its enduring significance in the company's capital structure without requiring adjustments or enhancements in disclosure practices over the reporting period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of disclosure. The ground truth states that in 2022, the 7% Debentures were listed alongside Common Stock, but in 2023 and 2024 they were separated into their own row with distinct identification, indicating a change in presentation. The LLM incorrectly asserts that the disclosure was 'consistent' and 'standardized' across all three years, which contradicts the documented evolution. (2) Quantitatively, the CUSIP number (718507BK1) and the security name '7% Debentures due 2029' are correctly identified, and the New York Stock Exchange registration is accurate—this supports a moderate quantitative accuracy score. However, the LLM fails to note the structural change in the table presentation from 2022 to 2023, which is a key qualitative and factual element. (3) The multi-hop reasoning is flawed: the question asks for an analysis of how the presentation evolved, requiring comparison across three filings. The LLM instead assumes consistency without acknowledging the shift in 2023 toward greater transparency through separation and distinct CUSIP labeling. This misrepresents the company's actual progression toward improved disclosure clarity. (4) While the answer is relevant to the topic and discusses the right instrument and filings, it draws the opposite conclusion from the evidence—claiming stability when the truth shows evolution. Hence, correctness and qualitative accuracy are low despite some correct details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 419,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "From fiscal year 2022 through 2024, the carrying value of NVIDIA’s 2.00% Notes Due 2031 rose from $1,044 million (as of January 29, 2023) to $1,057 million (as of January 28, 2024), and then to $1,250 million (as of January 26, 2025). This upward progression reflects the company’s strategy of maintaining a long‑dated, low‑coupon senior debt tranche while gradually increasing the absolute amount of debt outstanding to fund growth initiatives and avoid refinancing risk. By extending maturities and keeping the notes unsecured and senior, NVIDIA demonstrates a disciplined, capital‑efficient approach to managing its long‑term leverage and preserving financial flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a discrepancy in the 2022 value. The ground truth states NVIDIA's exposure was $1.2 billion in 2022, while the LLM reports $1,044 million (i.e., $1.044 billion) as of January 29, 2023 (which corresponds to FY2023). This suggests confusion in fiscal year alignment—NVIDIA’s fiscal year ends in January, so data reported as of January 2023 reflects FY2022, but the LLM incorrectly labels this as FY2022 when it should be labeled as the ending balance for FY2022 (reported in early 2023). The 2023 value ($1.057B) matches the ground truth. The 2024 value is correctly stated as $1.25B (or $1,250 million), matching the ground truth. (2) Calculations are not required in this question, but the progression of values must align temporally. The LLM misaligns the timeline by assigning the $1,044M figure to FY2022 when it should be clearly tied to the end of FY2022 (reported in Jan 2023), creating ambiguity. The upward trend is accurate, but the starting point is off. (3) The multi-hop reasoning is sound—the LLM correctly identifies the trend across three years and synthesizes it into a strategic interpretation about long-term debt management, refinancing risk, and financial flexibility. It adds contextual insight beyond the ground truth (e.g., 'low-coupon', 'unsecured and senior') that is plausible and relevant, though not explicitly confirmed in the ground truth. (4) The correctness score is 7 because core facts (trend and 2023/2024 values) are accurate, but the 2022 figure is inconsistent with the ground truth in both amount and labeling. Quantitative accuracy is 6 due to the incorrect initial value and potential fiscal year mislabeling. Qualitative accuracy is 8 because reasoning and strategy interpretation are strong and logically derived. Contextual relevance is 10—answer fully addresses both parts of the question and remains focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 521,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney's strategic positioning of Marvel has evolved across fiscal years 2022–2024 through its integration into Disney's broader content and distribution strategy, particularly within streaming services and as part of indefinite-lived intangible assets. Marvel's content is embedded in Disney+ and Disney+ Hotstar as a core component of the Disney brand, with plans to launch an ESPN-branded tile on Disney+ in early fiscal 2025 to expand sports content. Marvel's intangible assets, including trademarks and franchise rights, are classified as indefinite-lived intangible assets on Disney's balance sheet, reflecting their enduring value. The company has strategically leveraged Marvel's IP across linear networks, DTC platforms, and theme parks, while also investing in Marvel-related content production and licensing, as evidenced by its inclusion in Disney's content curation strategies and investments in new business lines like Venu Sports.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers or miscalculations, it scores highly on that dimension by default. The answer is contextually relevant, addressing Disney's strategic use of Marvel across streaming and intangible assets. However, it fails on key qualitative and factual points from the ground truth. Crucially, the original answer specifies that in fiscal 2023, Marvel was highlighted as a top-level branded tile on Disney+, which is a specific strategic move that the LLM omits. Instead, the LLM incorrectly shifts focus to a future ESPN-branded tile launching in fiscal 2025, which is irrelevant to Marvel’s positioning. Additionally, while the LLM correctly notes that Marvel is part of indefinite-lived intangible assets, it does not specify that this was explicitly stated in both 2022 and reaffirmed in 2024—key multi-hop evidence showing continuity in Marvel’s financial valuation. The LLM also introduces unrelated elements like 'Venu Sports' and ESPN+ integration plans, which distract from Marvel’s specific strategic evolution. The core idea—that Marvel is leveraged across platforms and valued as an indefinite-lived asset—is correct, but the lack of year-specific synthesis (2022: intangible asset listing; 2023: Disney+ tile; 2024: reaffirmed asset status) results in incomplete and partially misdirected reasoning. Thus, while some facts are accurate, the multi-hop synthesis across years and domains (branding + financial classification) is not adequately captured, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 447,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "American Express’s revenue structure has continued to rely on merchant‑discount (discount) revenue, which is recognized when card‑member transactions occur and includes fees earned from third‑party merchant acquirers under programs such as OptBlue; the company negotiates network‑rate fees with these acquirers on a case‑by‑case basis and records the fees as discount revenue at the point of sale.  From 2022 through 2024 the firm expanded merchant coverage by extending acceptance agreements with large‑merchant partners (often for three‑to‑seven‑year terms with auto‑renewal) and by investing in digital acquisition channels and B2B platforms, while also leveraging its network‑rate fee negotiations to offset downward pressure on discount rates caused by interchange‑fee caps and regulatory scrutiny.  This evolution reflects a strategic shift toward securing broader acceptance and higher‑value transactions, even as regulatory developments (e.g., EU interchange caps and CFPB late‑fee rules) have increased pressure on discount pricing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies American Express's reliance on discount revenue and the role of third-party merchant acquirers, including the OptBlue program and case-by-case negotiation of network rate fees, which aligns with the ground truth. It accurately states that fees are recorded as discount revenue at the point of sale. However, it omits key developments from 2023 and 2024 detailed in the original answer, particularly the introduction of 'processed revenue' from network partnership agreements (e.g., royalties and fees for facilitating transactions on partner-issued cards), which represents a significant evolution in revenue structure. Additionally, while the LLM mentions merchant coverage expansion, it does not specifically reference the strategic focus on global expansion through third-party acquirers, aggregators, and processors, nor the digital integration of its authorization platform as emphasized in 2024. (2) There are no numeric values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not compromised—score reflects full alignment on available factual data. (3) The reasoning is sound in describing the contractual dynamics and strategic responses to regulatory pressure, but fails to fully synthesize the multi-hop progression across 2022–2024, especially the shift toward processed revenue and deeper network partnerships. The answer captures the general trend but misses specific structural changes that mark the evolution. (4) The contextual relevance is high because the response addresses revenue structure, discount recognition, network fee negotiation, and merchant coverage—all core components of the question—though with incomplete detail on the temporal evolution and new revenue streams. Thus, while factually consistent where present, the answer lacks completeness in capturing the full scope of changes described in the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 534,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s regulatory risk disclosures evolved from 2022 through 2024 to emphasize tighter scrutiny of drug‑delivery device approvals, post‑marketing confirmatory study requirements, and heightened safety‑monitoring obligations.  In the 2022 filing (page 33), the company highlighted general COVID‑19‑related clinical‑trial and supply‑chain risks, but by 2023 (page 143) it specifically warned that accelerated or conditional approvals—such as for LUMAKRAS—would hinge on meeting regulators’ post‑approval study conditions and that any failure could trigger revocation or label changes.  The 2024 filing (page 161) further underscores that device‑related safety reviews, REMS assessments, and potential enforcement actions (e.g., fines or marketing‑authorization withdrawal) are now integral components of its risk narrative, reflecting a more detailed focus on the interplay between product approvals, device‑related regulatory compliance, and ongoing safety obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: the evolution of Amgen's risk disclosures from general (2022) to more specific post-marketing and safety compliance concerns (2023–2024), the mention of LUMAKRAS and its regulatory history (accelerated approval, Complete Response Letter, need for confirmatory studies), and the emphasis on device-related safety reviews, REMS, and enforcement risks like marketing withdrawal. (2) Quantitative accuracy is strong: the years (2022–2024) and page numbers (33, 143, 161) are correctly cited, and no numerical calculations are required. Format and references are consistent and plausible. (3) Multi-hop reasoning is sound—LLM synthesizes across three years of filings, correctly identifying the shift in risk narrative from broad dependencies to specific regulatory compliance challenges involving drug delivery devices and post-marketing obligations. It correctly links clinical trial dependencies (e.g., surrogate endpoints), post-marketing requirements (confirmatory studies), and safety reviews (REMS, pharmacovigilance) as requested. (4) Minor deduction in qualitative accuracy due to the introduction of 'REMS assessments' and 'fines' not explicitly mentioned in the ground truth, though these are reasonable inferences within regulatory context. Also, the ground truth emphasizes the 'transformation' in framing—from general to specific—which the LLM captures well but could have articulated more explicitly. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 441,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips' HSE audit program has evolved from 2022 to 2024 with expanded governance and tracking mechanisms. The 2024 filing shows the Board of Directors now receives annual cybersecurity reports and the Audit Committee receives biannual updates, including pre-read materials for non-agenda meetings, while 2022 documentation only referenced annual Board reporting without this structured escalation protocol. The company also strengthened its HSE audit tracking by requiring annual objectives/targets and mandatory tracking of improvement actions to completion, as noted in both 2023 and 2024 disclosures. Governance reporting now explicitly integrates HSE performance into Board oversight through the ERM program, with the AFC assisting in cybersecurity risk oversight – a structural enhancement from the 2022 framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) It incorrectly claims that cybersecurity reports and biannual Audit Committee updates were introduced in 2024, with pre-read materials and structured escalation protocols, which is not supported by the original answer and conflates cybersecurity governance with HSE audit evolution. The ground truth makes no mention of cybersecurity in the context of HSE audits or Board reporting changes. (2) The quantitative and temporal details (e.g., 'annual' vs 'biannual' reporting, 'pre-read materials for non-agenda meetings') are fabricated and not found in the original answer, which states that governance reporting to the Executive Leadership Team (ELT) and Board remained consistent from 2022 to 2024. (3) The multi-hop reasoning is flawed: the LLM fails to trace the actual evolution described—shifting from conformance audits (2022) to integration with safety systems like Life Saving Rules (2023) to 'Corporate HSE audits' indicating standardization (2024). Instead, it invents a cybersecurity-linked governance enhancement that misrepresents the scope, improvement tracking, and reporting structures. (4) While the LLM correctly notes that improvement actions are tracked to completion (mentioned in 2023 and 2024), it misattributes this as a 'strengthened' requirement with 'annual objectives/targets'—a detail absent from the ground truth. The original answer emphasizes continuity in tracking, not new requirements. (5) The integration of HSE into ERM and AFC involvement in cybersecurity risk is irrelevant to the question about HSE audit scope, tracking, and governance. Overall, the answer fabricates key details, misaligns timelines, and fails to capture the actual evolution, resulting in a low correctness score despite minor overlap in terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 506,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s pricing approach has shifted from traditional time‑and‑materials contracts toward outcome‑based and subscription‑style models that are tied to AI, cloud and other digital services, reflecting the need to monetize these technologies and the faster‑changing client demand they create. Across 2022‑2024 the company repeatedly highlighted the risk that rapid technological change could render existing pricing structures obsolete and that it must continually develop new commercial models to capture value. A second, consistent risk is the uncertainty surrounding AI‑related regulations and ethical concerns, which could increase compliance costs and expose Accenture to reputational or legal liability if its AI‑driven offerings are not properly managed.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Accenture's pricing models from traditional to outcome-based and subscription-style models tied to AI and cloud services, which aligns with the direction described in the ground truth. It correctly identifies the ongoing risk related to the pace of technological change and the need for timely development of new pricing models. However, it introduces a risk not present in the original answer—AI-related regulations and ethical concerns leading to compliance and reputational risks—which was not highlighted as a consistent risk across 2022–2024 in the ground truth. Instead, the original consistently emphasized the risk of revenue shortfalls and competitive disadvantages due to delayed introduction of value-reflective pricing models or slow client adoption. The LLM answer omits this core financial and competitive risk, which is central to the multi-year trend. While the qualitative shift in pricing strategy is reasonably described, the substitution of risks reduces factual accuracy. There are no numerical inaccuracies (hence full quantitative score), and the response remains contextually relevant to the question, but the reasoning and entity-level synthesis are partially flawed due to incorrect risk attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 355,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "From 2022 through 2024, GE’s holdings of the AerCap note increased from $944 million (2023) to $993 million (2024), reflecting a continued investment in the AerCap senior note. This progression suggests that GE is maintaining and modestly expanding its exposure to AerCap as part of its broader strategy to hold strategic equity‑linked securities that support its aviation finance and investment portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of GE's holdings in the AerCap note. The original answer states that GE's holdings decreased from $993 million (end of 2021, reported in 2022) to $944 million (end of 2023, reported in 2024), indicating a reduction. However, the LLM claims an increase from $944 million in 2023 to $993 million in 2024, which reverses the timeline and misrepresents the data. (2) The numbers themselves ($993M and $944M) are present in the correct answer but are assigned to incorrect years and interpreted as an increase instead of a decrease. There are no calculations in this question, but the comparison is fundamentally flawed. (3) The multi-hop reasoning fails: the LLM misaligns the reporting year with the actual year of the balance (e.g., 2022 filing reports 2021 year-end data), leading to incorrect inference. It also draws the opposite conclusion about GE’s investment strategy—claiming expansion when the truth is strategic reduction. (4) Due to major factual and directional errors, the correctness and quantitative accuracy scores are very low. Qualitative accuracy is also poor due to flawed reasoning and entity-time misalignment. Contextual relevance is moderate because the answer addresses the right companies and general topic, but with incorrect data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 378,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "From 2022 to 2024, Amgen advanced bemarituzumab from an early-stage candidate to a Phase 3 program (initiated in 2021) and continued enrolling patients through 2023, with its composition‑of‑matter patents in the U.S. and Europe projected to expire in 2029. The 2023 10‑K notes that the molecule remains in Phase 3 development and that its patent portfolio includes issued composition‑of‑matter claims extending to 2029 in both jurisdictions, with no additional exclusivity extensions disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bemarituzumab was in Phase 3 clinical trials through 2023 with U.S. and European composition-of-matter patents expiring in 2029, which aligns with the ground truth. However, it omits key developments from 2024—specifically, the expanded investigational scope to gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC, and the more detailed mechanism of action description. This missing 2024 update significantly affects completeness. (2) Quantitatively, the dates (2029 patent expiration) and trial phase (Phase 3) are accurate. The mention of Phase 3 initiation in 2021 is consistent with progression into 2022–2023 enrollment, though not part of the original question’s focus. No calculation errors. (3) The reasoning correctly links clinical development and IP status across years but fails to complete the multi-hop synthesis into 2024 developments, which is a required part of the evolution. The answer stops at 2023, missing the final step in the timeline. (4) Scores reflect high factual accuracy on numbers and entities (Amgen, Bemarituzumab, Phase 3, 2029 patents), but reduced qualitative and overall correctness due to omission of 2024 strategic expansion, which is central to the question’s ‘evolution’ aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 365,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "American Express has progressively shifted from a pure‑card‑issuer model toward a broader, technology‑driven platform that integrates digital payments, data analytics, and new financing products, while simultaneously expanding its deposit franchise and investing heavily in AI‑enabled systems and cybersecurity.  This evolution reflects a deliberate response to intensifying fintech disruption and competitive pressure from alternative payment mechanisms, positioning the company to leverage its premium brand and extensive merchant network to capture emerging revenue streams and maintain relevance in a rapidly changing payments landscape.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift of American Express in response to fintech disruption and mentions relevant themes like technological investment, digital payments, and competition. However, it fails to accurately reflect the year-by-year evolution (2022–2024) detailed in the ground truth. Specifically, it omits the key progression: from identifying alternative payment mechanisms as competitive threats in 2022 (e.g., digital wallets, BNPL), to recognizing broader ecosystem players like open banking and payment facilitators in 2023, and finally shifting to a dependency and integration posture in 2024. These specific multi-hop developments are central to the question and missing in the LLM response. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not violated—score is 10 by default. (3) The reasoning is partially sound but lacks the required synthesis across years and specific competitive dynamics. The LLM generalizes the strategic shift but does not demonstrate the granular, time-specific awareness that the ground truth reflects. It introduces elements not in the original answer (e.g., 'expanding its deposit franchise', 'AI-enabled systems', 'cybersecurity') which, while plausible, are not supported by the provided ground truth and distract from the core narrative of evolving strategic positioning toward alternative payment mechanisms. (4) The contextual relevance is high because the answer addresses fintech disruption and strategic adaptation, but correctness and qualitative accuracy are reduced due to omission of key factual progression and insertion of unsupported details. Thus, correctness and qualitative accuracy are moderate at best.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 477,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs declined from $117.11 in 2022 to $116.68 in 2023 and then to $98.2 in 2024, reflecting a downward trend in the compensation‑related valuation of these awards. This trend indicates that the company is adjusting its long‑term incentive compensation strategy, reducing the fair‑value cost of cash‑settled PSUs over time—likely to align expense with market conditions and possibly to moderate overall incentive‑compensation outlays.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the trend. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, while the LLM claims it declined from $117.11 in 2022 to $98.2 in 2024—reversing the actual trend and citing entirely different values. None of the LLM's numbers match the ground truth. (2) Quantitative accuracy is severely lacking: the correct values are $91.58 (2022), and $112.50 (2024), with no data provided for 2023 in the ground truth. The LLM fabricates intermediate data points and misrepresents the starting and ending values. Even if formatting variations were allowed, the numbers are not equivalent or plausibly derived. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers a cost-reduction strategy due to declining valuations, which contradicts the actual upward trend indicating increased incentive alignment. The conclusion about moderating compensation outlays is unsupported by the real data. (4) Contextual relevance is moderate because the answer addresses the right metric and company and attempts to interpret strategic implications, but the incorrect data leads to a fundamentally wrong analysis. The structure of the response is appropriate, but factual errors dominate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 369,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "From 2022 through 2024 PayPal’s exposure to abusive and fraudulent behavior grew markedly, especially as it expanded credit products such as PayPal Working Capital, merchant financing and consumer installment loans and introduced new financial services (e.g., BNPL, PYUSD stablecoin, cryptocurrency custody).  The company repeatedly notes that third‑party fraudsters are using stolen or synthetic identities to open fake PayPal accounts, make purchases with compromised payment instruments, and exploit its buyer‑ and seller‑protection programs, leading to higher loss rates and charge‑backs.  At the same time, PayPal’s credit‑risk models and underwriting have struggled with rising defaults, prompting the firm to sell large portions of its BNPL loan receivables and to rely on external lenders and securitization to fund these products.  The convergence of expanding credit exposure, increasingly sophisticated fraud schemes, and tighter regulatory scrutiny (e.g., antitrust, AML/CTF, and lending rules) suggests that PayPal’s risk‑management controls have been under sustained pressure and that its ability to contain fraud and credit losses remains a material vulnerability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024. It accurately identifies the growing concern around third-party fraud schemes involving fake accounts, stolen payment instruments, and abuse of protection programs. The mention of PayPal’s credit products, including BNPL and merchant financing, and the associated risk management challenges such as rising defaults and reliance on external funding (e.g., securitization and selling receivables), is consistent with the original answer. The reference to regulatory scrutiny (e.g., AML/CTF, lending rules) parallels the ground truth’s mention of regulatory uncertainties like the 'valid-when-made doctrine.' However, the LLM introduces specific product names like 'PayPal Working Capital' and 'PYUSD stablecoin' that are not mentioned in the original answer, which may be contextually relevant but not explicitly supported by the provided ground truth. Additionally, while the original answer specifies a €40 billion multi-year agreement to sell U.K. and European BNPL receivables as a concrete risk mitigation strategy, the LLM alludes to selling receivables and using securitization but lacks this specific quantitative detail. This omission affects completeness and precision slightly, though the overall trend and implications for risk management effectiveness are correctly interpreted. There are no calculation errors, and all years (2022–2024) are correctly referenced. The reasoning is sound, demonstrating multi-hop synthesis across fraud trends, credit product expansion, and risk mitigation strategies. The answer is highly contextually relevant and conveys a semantically equivalent conclusion: that PayPal’s risk management has been under pressure due to evolving threats. The slight deduction in qualitative accuracy reflects the lack of specificity on the €40 billion agreement and the introduction of unverified product names. Quantitative accuracy is high because no incorrect numbers are stated—only that a key number (€40B) from the ground truth is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 569,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "From 2022 through 2024, Cyramza’s intellectual property protection shifted from a compound patent that expired in 2026 (with data protection ending in 2024 in the U.S. and 2023 in Japan) to a new composition-of-matter patent extending exclusivity to 2031 in the U.S. and to 2028–2033 in Europe and Japan, while its data‑protection period was extended to 2028 in the U.S. and to 2033–2038 in major European markets and Japan. This progression reflects Eli Lilly’s long‑term oncology strategy of extending market exclusivity for key growth drivers—such as Cyramza, Verzenio, Retevmo, and emerging assets like Jaypirca—through layered patent term extensions and data‑protection safeguards, ensuring sustained revenue streams and protecting pipeline investments against generic competition.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, Cyramza's compound patents extend through 2026 in the U.S. and Japan, with data protection expiring as early as 2023 in Japan. However, the LLM claims a new composition-of-matter patent extends exclusivity to 2031 in the U.S. and 2028–2033 in Europe and Japan, and data protection to 2028 in the U.S. and 2033–2038 in major markets—none of which is supported by the original answer. These dates are entirely fabricated and represent a major deviation. Additionally, the original answer states no new indications were added in 2024, but the LLM implies continued IP development, suggesting an evolution not present in the source. While the LLM correctly identifies the broader strategic theme of protecting oncology assets, it incorrectly extends this to Cyramza specifically with false patent extensions and misrepresents the timeline and nature of IP protection. The mention of Verzenio, Retevmo, and Jaypirca is contextually relevant to Eli Lilly’s oncology strategy but is not supported by the original answer’s scope, introducing unverified assets. The reasoning is plausible but based on incorrect data, undermining the multi-hop synthesis. Thus, while the answer addresses the question's structure and attempts strategic interpretation, its factual foundation is largely incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 399,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "The 3.875% Notes due 2042 (PM42A) have remained part of PMI’s capital structure throughout 2022‑2024, while the company has actively managed other debt instruments—issuing new notes such as the 2.875% PM29 and 4.5% PM42, repaying older tranches, and adjusting borrowings under credit facilities—to reshape its overall leverage and funding mix. This active refinancing activity demonstrates a strategic evolution of PMI’s capital structure, even as the 3.875% 2042 notes have consistently stayed on the balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the specific debt instruments mentioned. The ground truth states that Philip Morris maintained the 3.875% Notes due 2042 and had 4.125% Notes due 2043 and 4.875% Notes due 2043 in 2022, which were replaced or retired by 2024, with no new long-dated notes issued beyond 2042. However, the LLM incorrectly references '2.875% PM29' and '4.5% PM42' notes, which are not present in the original answer and contradict the documented debt instruments. These are entirely fabricated or misidentified securities. (2) Quantitative accuracy is low because the percentages (2.875%, 4.5%) and maturities (PM29, PM42) do not match the ground truth. The correct instruments include 4.125% Notes due 2043 and 4.250% Notes due 2044 in 2023, none of which are mentioned in the LLM response. The LLM fails to note the retirement of the 2043 and 2044 tranches by 2024, a key point in the evolution of the capital structure. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that the 3.875% Notes due 2042 remained constant while other instruments were actively managed. It also captures the general idea of refinancing to reshape leverage. However, it fails to accurately synthesize the specific instruments across years, missing the introduction and subsequent removal of the 2043 and 2044 notes, which is central to the strategy. (4) Contextual relevance is high because the answer addresses the core theme of capital structure evolution and the stable role of the 2042 notes. Despite this, the incorrect debt instruments undermine factual correctness. The conclusion about strategic evolution is reasonable but based on inaccurate data, leading to a correctness score of 4—partially correct but with major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 490,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s exposure to abusive behaviors—particularly fraud, money‑laundering and misuse of its credit products—has been managed through a series of targeted actions beginning in 2022 and continuing through 2024.  In 2022 the company faced CFPB and FTC civil investigative demands related to Venmo’s unauthorized transfers and to commercial‑customer charge‑back practices, while in early 2023 it received a German competition‑authority request concerning surcharge restrictions.  By mid‑2023 PayPal entered into an enforceable undertaking with AUSTRAC that required an external auditor to review and report on its anti‑money‑laundering controls, and it launched a multi‑year sale of U.K. and European “buy‑now, pay‑later” loan receivables to mitigate credit‑risk exposure.  In 2024 the company further tightened its risk framework by strengthening third‑party custodian oversight for stablecoins (PYUSD), expanding fraud‑detection models, and continuing cooperation with U.S. and international regulators on AML, consumer‑protection and antitrust matters.  These steps collectively aim to reduce abusive behavior, limit regulatory penalties and protect the integrity of PayPal’s credit and payment platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it introduces some details not present in the original answer. Quantitatively, the key figure—PayPal's mid-2023 multi-year sale of U.K. and European BNPL loan receivables—is accurately reported, including the geographic scope and product type. However, the original answer specifies a €40 billion ceiling on the sale, which the LLM omits; this is a minor quantitative omission but not an error. The years (2022, 2023, 2024) are correctly used and sequenced. The LLM adds specific regulatory actions (CFPB, FTC, German competition authority, AUSTRAC) and mentions PYUSD stablecoin oversight, which are factually plausible and contextually relevant but not part of the ground truth. These additions do not contradict the original answer but expand beyond it, potentially reflecting broader risk management rather than focusing strictly on abusive behaviors in credit products. The core multi-hop reasoning is sound: the LLM correctly traces PayPal’s evolution from identifying risks (2022) to offloading credit risk via asset sales (2023) and enhancing fraud and third-party controls (2024). The emphasis on synthetic identities and stolen instruments from the original is missing, but the LLM covers analogous themes (fraud, money laundering, unauthorized transfers). The answer is semantically aligned with the original in structure and intent, showing a clear progression in risk mitigation strategy. Contextual relevance is high, as all points relate directly to abusive behaviors, credit products, and third-party risk. The score is reduced slightly (8/10) due to the omission of the €40 billion figure and the inclusion of unverified regulatory specifics, which, while plausible, are not in the ground truth and slightly shift focus from credit product abuse to broader compliance risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 504,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "From 2022 through 2024 AMD’s risk disclosures show a growing emphasis on the volatility of tax and tariff exemptions affecting its global supply chain.  In the 2022 filing (page 36) the company lists “loss or modification of exemptions for taxes and tariffs” among the general risks of its worldwide operations, and the 2023 discussion (page 41) expands this to note that changes in tax laws, trade‑protection measures and tariff exemptions could materially affect the business.  By the 2024 filing (pages 38‑40) the language is broader, describing “loss or modification of exemptions for taxes and tariffs” as one of several political, legal and economic risks that could have a material adverse effect, and it ties the risk to recent U.S. sanctions and export‑control changes that could alter exemption status.  This progression indicates that AMD perceives increasing regulatory uncertainty—especially around tax and tariff policies—as a material factor that could disrupt its international manufacturing and sales operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD's increasing emphasis on tax and tariff exemption risks from 2022 to 2024 is accurately portrayed. In 2022, the risk was listed among general political, legal, and economic risks; in 2023, it was expanded to include material impact from tax law and trade policy changes; by 2024, it was explicitly tied to U.S. sanctions and export controls—consistent with the ground truth's mention of geopolitical conflicts and regulatory changes. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and page references (36, 41, 38–40) are correctly cited and contextually appropriate, indicating precise sourcing. Format variations are not applicable here, but temporal and document references are accurate. (3) The multi-hop reasoning is sound: the model synthesizes risk language evolution across three annual filings, correctly infers increasing concern, and links it to broader regulatory and geopolitical developments. The conclusion about growing regulatory uncertainty is logically supported by the progression in disclosure tone and scope. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'volatility of tax and tariff exemptions' vs. 'exposure to risk of loss or modification'), the meaning is equivalent. The only minor gap is that the LLM emphasizes U.S. sanctions more than the ground truth, which frames the 2024 risk in broader geopolitical terms. This is a nuance, not an error, and does not detract from overall correctness. Scores reflect high accuracy, with a 9 in correctness due to this slight framing difference, and full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 487,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco's gains and losses from total return swaps tied to deferred compensation decreased from a $157 million gain in fiscal 2021 to a $91 million gain in fiscal 2022 and then to a $58 million gain in fiscal 2023, ultimately reaching a $91 million gain in fiscal 2024. This progression indicates that the company's exposure to deferred‑compensation‑linked derivatives has been relatively stable but modestly declining, reflecting a strategic shift toward using these swaps primarily to economically hedge compensation obligations rather than to generate significant earnings. Consequently, the company's reliance on such derivatives for profit generation is limited, with the primary purpose being risk mitigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Cisco had a loss of $92 million in 2022, a gain of $58 million in 2023, and a gain of $91 million in 2024. However, the LLM claims a $91 million gain in 2022 and a $58 million gain in 2023, which reverses the actual trend and misrepresents the financial performance. Additionally, the LLM introduces fiscal year 2021 with a $157 million gain, which is not part of the original question or answer and is unsupported by the provided truth. (2) The quantitative values are largely incorrect: the 2022 figure is wrong (reports $91M gain vs. actual $92M loss), 2023 is directionally correct in amount but misrepresented as a continuation of declining gains rather than a recovery from a loss, and 2024 is correct at $91M gain. The inclusion of 2021 data is extraneous and unverified. (3) The multi-hop reasoning is flawed: the model fails to capture the reversal from loss to gain across years, instead portraying a misleading narrative of declining gains. This undermines the correct interpretation of the trend, which should reflect a recovery or improvement in derivative performance, not stability or decline. (4) The contextual relevance is moderate because the answer addresses the right topic (total return swaps and deferred compensation) and attempts to interpret strategic implications, but the incorrect data leads to an invalid conclusion about 'stable but declining' exposure, whereas the truth suggests a volatile reversal indicating changing market or strategic conditions. Thus, while the framework of analysis is relevant, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 466,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From fiscal 2022 through 2024 Disney’s DTC strategy evolved from an early‑stage, high‑investment push—evidenced by the launch of Disney+ and continued heavy content spending—to a more disciplined, cost‑aware approach that emphasizes profitability and tighter integration with its broader streaming portfolio (including Hulu, ESPN+, Star+ and the upcoming ad‑supported tier). This progression reflects mounting financial risks and market pressures: escalating programming and production costs, intensified competition from other streaming services, and the need to balance subscriber growth with sustainable unit economics, all of which compel Disney to continually reassess investment levels, pricing and content allocation to protect margins while scaling its direct‑to‑consumer offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of Disney's DTC evolution and correctly identifies financial risks and market pressures such as rising costs and competition. However, it misrepresents the strategic trajectory: the ground truth indicates Disney increased investment in DTC from 2022 to 2024 despite risks, whereas the LLM claims a shift toward a 'more disciplined, cost-aware approach' and 'tighter integration' emphasizing profitability—this contradicts the actual progression of doubling down on investment. The mention of 'upcoming ad-supported tier' is not supported in the ground truth for 2024, and the integration details (Hulu, ESPN+, Star+) go beyond the provided information. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors in dates or numbers, earning full marks by default. (3) The multi-hop reasoning is partially sound: the model connects fiscal years 2022–2024 and identifies relevant themes (costs, competition, investment), but fails to accurately synthesize the strategic shift—Disney did not pivot to cost discipline but rather intensified investment amid pressure, which is a critical misinterpretation. (4) Contextual relevance is high as the response addresses the evolution, risks, and market pressures, but the incorrect characterization of Disney’s strategy as cost-disciplined and profitability-focused in 2024 undermines the qualitative accuracy, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 413,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s exposure to margin risk has declined across the three years, as reflected by its growing emphasis on fee‑based transaction revenue and tighter cost controls.  In each filing the company notes that it bears “full margin risk” when completing payment transactions and that transaction‑related expenses (e.g., fees paid to payment processors) are recorded as “transaction expense,” but the proportion of those expenses relative to total revenue has fallen – from $231 million of interest‑related cash outflows in 2021 to lower, proportionally‑smaller expense levels in 2023‑2024 – indicating reduced margin pressure.  Moreover, the firm’s ability to set and adjust fees independently of those processor costs, combined with the allowance for transaction losses and negative customer balances, shows that it now manages margin risk more conservatively, relying on disciplined pricing and lower reliance on discretionary fee rebates.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim and contains significant factual and reasoning errors. (1) The original answer states that PayPal's exposure to margin risk remained stable across 2022–2024, with consistent accounting treatment and no material changes. The LLM incorrectly asserts that margin risk exposure has 'declined' and that margin pressure has reduced, which contradicts the ground truth. (2) Quantitative inaccuracies include referencing '$231 million of interest-related cash outflows in 2021'—a figure not mentioned in the original answer and irrelevant to the question, which focuses on 2022–2024 and transaction expenses (not interest or cash outflows). No such trend in proportional expenses is supported by the ground truth. (3) The multi-hop reasoning fails: while the LLM correctly notes that PayPal bears 'full margin risk' and records processor fees as transaction expense, it incorrectly infers a declining risk trend and attributes it to tighter cost controls and pricing discipline—conclusions absent from the original. The original emphasizes consistency, not evolution or improvement. (4) The LLM introduces unsupported concepts like 'negative customer balances' and 'discretionary fee rebates' not present in the ground truth. Despite addressing the right entities (PayPal, payment processors, fee-setting discretion) and years, the answer misrepresents the central conclusion, leading to a low correctness score. Contextual relevance is moderate because it discusses the right themes but draws incorrect inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 426,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "The risk of new aircraft order cancellations has diminished markedly from 2022 through 2024 as commercial aviation demand recovered, with no material cancellations now anticipated and the company noting that supply‑chain constraints are expected to persist into 2024 but will not cause adverse impacts. This progression signals a stable, ongoing recovery in the commercial aviation sector, supporting continued aerospace sales growth and segment‑profit expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims the risk of cancellations has 'diminished markedly' and that 'no material cancellations are anticipated,' which directly contradicts the ground truth that Honeywell consistently highlighted cancellations as a key risk from 2022 to 2024. The original answer shows the risk evolved but remained prominent, indicating ongoing fragility, not stabilization. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable, but the LLM fabricates a trend (diminishing risk) not supported by the data. (3) The multi-hop reasoning fails: the ground truth requires synthesizing how the nature of the risk shifted from pandemic-related in 2022 to geopolitical and structural factors in 2023–2024, while the LLM incorrectly infers the risk has abated. It also introduces supply-chain constraints not mentioned in the original answer as a mitigated issue, which is unsupported. (4) Contextual relevance is moderate because the answer addresses Honeywell’s Aerospace business and the commercial aviation recovery, but the conclusion about stability and growth contradicts the original’s emphasis on continued uncertainty. The LLM misrepresents the progression and thus fails to accurately reflect the sector’s fragile recovery.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 370,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "The impact of product regulation on PMI’s competitive positioning has intensified markedly from 2022 through 2024, as regulators increasingly restrict product differentiation and adult consumer communication for Reduced‑Risk Products (RRPs) and Smoke‑Free Products (SFPs).  Across the filings, PMI notes that “restrictions on packaging design, mandatory plain‑packaging, bans on flavors, and heightened health‑warning requirements” are being adopted worldwide, limiting its ability to distinguish its heated‑tobacco and oral‑nicotine offerings from conventional cigarettes and from each other.  At the same time, the company emphasizes that “regulation and taxation should differentiate between cigarettes and products that present less risk,” warning that “blanket bans and unreasonable restrictions” could foreclose adult‑smoker access to its RRPs and erode brand equity.  This regulatory tightening, highlighted in the 2022‑2024 disclosures (e.g., page 89 on RRP regulation, page 12 on FDA marketing authorizations, page 20‑21 on cybersecurity and data‑privacy risks that affect communication), reveals a growing constraint on how PMI can legally promote product benefits and on the tax treatment of its SFPs, thereby compressing its competitive advantage and forcing reliance on regulatory compliance rather than product‑level differentiation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall trend—increasing regulatory pressure on PMI's competitive positioning from 2022 to 2024, particularly affecting RRPs and SFPs—and correctly identifies key regulatory constraints such as packaging restrictions, flavor bans, and health warnings. It accurately reflects PMI’s argument that regulation should differentiate between cigarettes and less-risk products. However, it diverges from the original answer in the evolution of PMI’s messaging across the years: the ground truth emphasizes a clear progression in narrative (2022: limited consumer access to truthful info; 2023: disproportionate impact vs. competitors and digital misinformation; 2024: shift to SFPs and regulatory asymmetries), which the LLM answer does not capture. Instead, it generalizes across 2022–2024 without delineating the year-by-year strategic shift or the specific evolution in focus from RRPs to SFPs. Additionally, while the LLM cites specific pages (e.g., page 89, 12, 20–21), these are not verifiable from the ground truth and introduce unconfirmed detail, though they do not contradict it. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is logically sound and contextually relevant, but the lack of precise multi-hop synthesis across years reduces qualitative accuracy. The answer captures the essence but misses the nuanced progression central to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1678,
        "completion_tokens": 415,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s exposure to margin risk has increased over 2022‑2024 as its transaction‑pricing model has shifted toward volume‑based, tiered fees that are adjusted to volume, while the company continues to bear full margin risk on each payment it processes.  This risk is amplified when the company uses payment processors or other financial institutions to complete transactions, because the fees paid to those third parties are recorded as transaction expense and are not offset by any contractual pricing rights.  At the same time, PayPal has expanded incentives to merchants and consumers—such as fee discounts, rebates and rewards—to drive volume, which reduces transaction revenue and therefore tightens margins.  Across the three years, the company’s exposure to margin risk has therefore evolved from a relatively stable fee structure in 2022 to a more volume‑sensitive, incentive‑driven model in 2023‑2024 that heightens margin volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of PayPal's margin risk evolution. While the ground truth states that PayPal consistently bore full margin risk across 2022–2024 with stable strategic exposure, the LLM incorrectly claims that margin risk has 'increased' and that the pricing model shifted to 'volume-based, tiered fees'—a detail not present in the original answer. The ground truth emphasizes consistent risk exposure with increasingly detailed disclosures, not a structural shift in pricing or rising risk. Additionally, the LLM asserts that incentives 'amplify' risk and 'tighten margins,' implying a negative financial impact, whereas the original answer frames incentives as revenue reductions managed through amortization or performance conditions—more neutral accounting treatments. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of fabricated numbers earns a perfect score by default. (3) The multi-hop reasoning is flawed: the LLM synthesizes an incorrect narrative of evolving risk and pricing models not supported by the source. It fails to recognize that the core message is consistency in margin risk with improved disclosure, not increasing risk due to new pricing or incentive structures. (4) Despite misrepresenting the qualitative evolution, the LLM does address all key themes—transaction pricing, payment processors, incentives—and remains contextually relevant to the question’s scope, hence a moderate contextual relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 434,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "From 2022 through 2024 AMD’s strategy shifted from broad inventory protection for its channel partners to a more targeted approach that emphasizes differentiated discrete‑graphics solutions for system integrators.  The company continued to rely on its co‑marketing and VAR channels to protect distributor inventories from price cuts, while simultaneously leveraging its discrete GPU and APU technologies to help SIs create differentiated products that stand out in the market.  This focus on discrete graphics as a key differentiator for system integrators persisted across the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in conveying AMD's strategy from 2022 to 2024 regarding AIB manufacturers and system integrators, with accurate qualitative elements and no numerical inaccuracies (thus quantitative accuracy is 10). The answer correctly identifies the continuity of inventory protection policies and the emphasis on discrete graphics as a differentiator for system integrators (SIs). However, it introduces a claim about a 'shift... to a more targeted approach' and mentions 'co-marketing and VAR channels'—details not present in the original ground truth. The ground truth specifies that inventory protection remained consistent across years, with only a subtle shift in emphasis in 2024 toward SIs leveraging regional or product strengths and faster adoption of new tech. The LLM overstates the evolution of the strategy and adds unverified channel mechanisms (VAR, co-marketing). While the core idea of discrete graphics as a differentiator is preserved and contextually relevant, the reasoning slightly misrepresents the nature and extent of strategic evolution, affecting qualitative accuracy. The answer addresses all main parts of the question but lacks the precise nuance about AIBs building board-level products and the 2024 shift in language toward strategic alignment with SIs. Thus, while semantically close, it misses some key details and introduces minor inaccuracies in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 389,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Disney’s investment‑credit exposure policy remained focused on limiting counterparty risk and preserving liquidity.  Across all three filings the company required that derivative counterparties maintain a minimum credit rating of **A‑ or better**, and it imposed **concentration limits** that capped exposure to any single institution at roughly **10 % of total cash and cash equivalents** (or a similar threshold when measured against total borrowings).  Collateral requirements were tied to rating downgrades: when a counterparty’s rating fell below **A‑**, the company required **collateral posting** (typically cash or high‑quality securities) to secure the derivative position, and it routinely required collateral for large exposures.  The **notional amounts** of its hedging programs—pay‑floating swaps, foreign‑exchange forwards, and cross‑currency swaps—declined modestly over the period (e.g., pay‑floating swaps fell from about **$14.5 bn** in 2022 to **$12.0 bn** in 2024), reflecting tighter risk limits but no fundamental change in the rating or collateral standards.  Overall, the evolution was one of **stricter adherence to the same basic framework**: high‑grade counterparties, collateral triggers on rating erosion, and concentration caps to keep exposure limited and manageable.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Disney's consistent policy of transacting only with counterparties rated A- or better and requiring collateral upon rating downgrades below A- or upon exceeding exposure limits, which aligns with the ground truth. However, it introduces specific quantitative thresholds—such as a '10% concentration cap' and notional swap values like $14.5B in 2022 falling to $12.0B in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These figures appear fabricated or inferred beyond available data. (2) The ground truth highlights a key evolution: a 24% concentration of cash and cash equivalents with a single institution in fiscal 2024, up from no such concentration in 2022. This critical point is entirely missing from the LLM response, despite being central to how Disney’s exposure management evolved. Instead, the LLM claims 'concentration caps' were maintained, contradicting the ground truth that shows a significant concentration emerged. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes counterparty ratings, collateral triggers, and risk mitigation strategies across years—but fails to detect and report the meaningful shift in actual exposure concentration, which represents a real evolution in practice despite unchanged policies. (4) While the qualitative understanding of Disney’s risk framework is accurate and contextually relevant, the inclusion of unverified numbers lowers quantitative accuracy. The absence of the 24% concentration fact—a core element of the true answer—results in a significant completeness gap, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 463,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes remained constant at $1.5 billion across 2022, 2023 and 2024, as shown in the debt tables for each year. This steady balance indicates a deliberate, long‑term debt‑management approach that relies on a fixed‑rate tranche with a distant maturity, allowing the company to lock in financing costs and avoid refinancing risk while maintaining a stable capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1.5 billion across 2022, 2023, and 2024, which matches the ground truth of $1,500 million (equivalent value, different format). All numeric values—amount ($1.5 billion = $1,500 million), interest rate (2.850%), and maturity year (2029)—are accurate. (2) Quantitative accuracy is perfect: the dollar amount, rate, and years are all correct, with acceptable formatting variation. (3) The reasoning is sound and captures the core implication of the stable liability: a strategic choice to maintain favorable fixed-rate debt for long-term stability, avoiding refinancing risk. However, the LLM omits mention of the issuance of new higher-interest debt in 2023 and 2024 (e.g., 5.150% and 5.500% notes), which the ground truth includes to strengthen the inference about strategic retention of low-cost debt. This is a minor gap in qualitative depth but does not invalidate the conclusion. (4) The answer is contextually fully relevant, directly addressing both the evolution of exposure and the strategic implication. The correctness score is 9 due to the omission of supporting evidence about new debt issuances, which slightly reduces completeness and qualitative richness, though the central facts and interpretation remain accurate and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 384,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell's exposure to raw material demand and supply risks in its Performance Materials and Technologies segment increased from 2022 to 2023, as evidenced by a 7% decline in segment sales and an 11% drop in segment profit in 2024 compared to 2023, driven by lower organic sales volumes and pricing pressures. This trend, coupled with ongoing supply chain constraints for key materials like copper, fluorspar, and nickel (highlighted in risk factors and raw material disclosures), suggests the company remains vulnerable to commodity market volatility, particularly as it faces persistent inflationary pressures and potential future supply disruptions despite mitigation strategies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim of a 7% decline in segment sales and 11% drop in segment profit in 2024 compared to 2023 is not supported by the ground truth, which does not mention any such financial performance metrics. These numbers are entirely fabricated. Additionally, the LLM introduces specific raw materials (copper, fluorspar, nickel) not referenced in the original answer, adding unsupported detail. (2) Quantitative accuracy is very low because the percentages (7%, 11%) are incorrect and not present in the ground truth. There are no sales or profit figures in the original answer, so these numbers cannot be verified and appear invented. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that raw material risks were a concern across years, it misrepresents the evolution: the original answer emphasizes a shift in framing and rebranding to Energy and Sustainability Solutions in 2024, which the LLM omits entirely. The LLM incorrectly suggests increasing exposure and declining performance, whereas the ground truth describes consistent risk disclosure with evolving context, not worsening conditions. (4) Contextual relevance is moderate because the answer addresses raw material risks and commodity volatility, which are central to the question, but it fails to capture the actual trend described—consistency of risk disclosure with changing emphasis and segment rebranding—instead inventing a narrative of deteriorating performance. The conclusion about ongoing vulnerability is partially aligned, but based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 444,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Over the 2022‑2024 period PMI’s peer‑group composition remained essentially unchanged – the same 20‑company consumer‑products and tobacco benchmark (including Imperial Brands PLC) was used in the 2022, 2023 and 2024 performance graphs. This consistency shows that PMI’s benchmarking strategy focuses on a stable set of global, consumer‑oriented peers of comparable size rather than frequently reshuffling the group. Consequently, the company can track its shareholder‑return performance against a consistent peer group, highlighting a strategic emphasis on relative positioning within a defined peer cohort rather than dynamic peer selection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It correctly states that Imperial Brands PLC was included in PM's peer group across all three years (2022–2024), matching the original answer's claim of consistent inclusion. (2) There are no numeric values requiring calculation (e.g., sums, percentages), but the temporal scope (2022–2024) is accurately referenced, and the assertion of unchanged peer group composition is consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM infers from the stable composition that PMI employs a consistent benchmarking strategy focused on global, consumer-oriented peers of comparable size—this aligns with and expands upon the original answer’s point about strategic alignment. The mention of using the peer group for tracking shareholder-return performance adds context supported by typical usage in 10-K filings, though this specific performance metric isn't in the ground truth; however, it does not contradict it and fits plausibly within the strategic interpretation. (4) Semantic equivalence is high: while the LLM uses 'PMI' instead of 'PM' (a common and acceptable shorthand), and adds slight elaboration on performance tracking, the core information—stable peer group including Imperial Brands, strategic consistency in benchmarking—is preserved and accurately synthesized. The only minor point preventing a perfect 10 is the slight expansion on performance metrics not explicitly in the ground truth, but this does not introduce inaccuracy. All entities (Imperial Brands PLC, time period) are correct. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 456,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PYPL's exposure to its fixed-rate 2.850% notes has steadily increased through 2022‑2024, rising from $1.5 billion in 2022 to $1.5 billion in 2023 and then to $1.5 billion (plus additional issuances) in 2024, reflecting a continued reliance on long‑dated, fixed‑rate debt to fund general corporate purposes and share buybacks. This progression indicates a deliberate, long‑term debt‑management strategy that locks in financing costs amid shifting interest‑rate environments while preserving flexibility for capital returns and strategic investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that PYPL's exposure to the 2.850% notes 'increased' and mentions 'additional issuances' in 2024, which contradicts the ground truth that the exposure remained stable at $1.5 billion across 2022, 2023, and 2024 with no repayments or refinancing. The dollar amounts ($1.5 billion) are numerically correct for each year, but the characterization of an 'increase' and new issuances is factually wrong. (2) Quantitative accuracy is partially correct in that the $1.5 billion figure is consistently reported, but the implication of growth or additional debt issuance is unsupported and incorrect. There are no calculations in the response, but the comparison over time is flawed. (3) The multi-hop reasoning fails because the model misinterprets the trend: it should have concluded no change in exposure and inferred strategic retention of low-cost debt, not increased issuance. The entity identification (PYPL, 2.850% notes) and years are correct, but the synthesis across years is inaccurate. (4) The contextual relevance is moderate because the answer discusses long-term debt strategy, which is relevant, but the flawed premise undermines the conclusion. Correctness is severely impacted by the false claim of increasing exposure, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 364,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "From 2022 to 2024, ConocoPhillips expanded the scope of its HSE audits to include more frequent, board‑level reporting and integrated audit findings directly into its enterprise risk management framework, while maintaining a focus on process‑safety fundamentals and continuous improvement. The company strengthened conformance tracking by implementing a centralized digital dashboard that logs corrective‑action plans, target dates, and status updates, ensuring timely closure of identified gaps. Governance of HSE practices was formalized through the Executive Leadership Team’s oversight of a dedicated HSE Council, with quarterly reviews presented to the Board of Directors, thereby embedding HSE performance into the broader corporate governance structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but introduces information not present in the ground truth, particularly regarding a 'centralized digital dashboard,' 'enterprise risk management framework,' and 'HSE Council' with 'quarterly reviews.' These specific mechanisms and structures are not mentioned in the original answer. While the general trend of increased integration with governance is accurate, the specific tools and bodies cited are unverified. The original answer notes that by 2023, audit outcomes were linked to annual objectives and reported to the ELT and Board, and in 2024, audits were conducted at the corporate level, indicating centralized oversight—this evolution is correctly captured in spirit but misrepresented in specific implementation details. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model correctly infers a trend toward greater governance integration from 2022 to 2024. However, it fabricates specific governance mechanisms (e.g., HSE Council, digital dashboard) not supported by the ground truth, indicating a failure to accurately synthesize only what is stated. The original answer does not mention frequency changes (e.g., 'more frequent, board-level reporting') beyond stating that reporting occurred to the Board, nor does it specify integration with enterprise risk management. (4) The correctness score is 6 due to accurate high-level trajectory but significant factual overreach in implementation details. Qualitative accuracy is 6 because core entities (ConocoPhillips, HSE audits, ELT, Board) and time frame are correct, but added structures are not. Quantitative accuracy is 10 by default (no numbers). Contextual relevance is 9—response stays on topic and addresses audit scope, conformance tracking, and governance, even if with embellishment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 530,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "AMD continued to reference the 2011 Executive Incentive Plan as a foundational governance document across its 2022, 2023, and 2024 filings, explicitly identifying it as Exhibit 10.1 in the 2022 and 2023 Annual Reports and in the 2024 proxy‑statement materials. While the company expanded its executive‑compensation disclosures to include newer plans and agreements (e.g., the 2023 “Item 9B” 10b5‑1 adoption details and the 2024 stock‑option and RSU agreements), it retained the 2011 Executive Incentive Plan as the baseline framework for measuring and reporting incentive‑based compensation, indicating its ongoing relevance amid broader compensation disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD consistently referenced the 2011 Executive Incentive Plan as a foundational document in 2022, 2023, and 2024, and it was cited as Exhibit 10.1 in the relevant filings. The LLM correctly notes its continued role as a baseline framework. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024) are correct, exhibit number (10.1) is accurately reported, and no incorrect figures are introduced. Format variations (e.g., 'proxy-statement materials' vs '10-K') are acceptable as proxy statements and 10-Ks both contain required disclosures. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers ongoing relevance despite newer plans. Minor deduction in qualitative accuracy because the ground truth specifies the 2011 plan was listed as Exhibit 10.1 in the 10-K for all three years, while the LLM mentions the 2024 proxy statement instead of the 10-K—this is a slight deviation in source specificity but does not undermine the factual core. (4) Contextual relevance is excellent: the answer directly addresses the evolution (or lack thereof) in AMD's reliance on the plan and its role amid broader disclosures. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original with only a minor variance in document type for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 394,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024 GM’s disclosures show a clear shift in how it treats its indemnification obligations tied to the legacy Opel/Vauxhall emissions and recall matters. In the 2022 filing the company notes that it “is unable to estimate any reasonably possible material loss” from the emissions‑related lawsuits and indemnity claims to Stellantis, but it does acknowledge that certain indemnification obligations remain subject to caps, thresholds and time limits. By the 2023 filing the language is essentially unchanged – GM still says it cannot estimate a possible loss and that the accrued amounts are “insignificant,” while reiterating that the indemnity obligations are “subject to time limitations, thresholds and/or caps.” The 2024 filing repeats the same position: GM continues to be unable to quantify any exposure beyond the amounts already accrued, emphasizing that any future indemnity payments would be “remote at this time.”  \n\nThis progression indicates that GM’s exposure to post‑sale liabilities arising from the Opel/Vauxhall sale remains limited to the accruals it has already recorded, and that any additional liability is considered uncertain and potentially immaterial. Consequently, while the indemnification framework is still in place, GM does not anticipate any significant financial impact from those legacy claims moving forward.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses key factual developments in GM's indemnification obligations from 2022 to 2024, particularly regarding the expansion of legal and regulatory exposure. While it correctly notes that GM did not record material accruals and maintained that further liability was remote, it fails to mention critical new information from the ground truth: (1) the explicit mention of lawsuits in Germany, the UK, and the Netherlands by 2023; (2) Stellantis initiating Takata-related recalls for which GM indemnified an immaterial amount; (3) the addition of Austria as a jurisdiction in 2024; and (4) the new regulatory investigations by the European Commission and UK CMA into end-of-life vehicle practices at Opel, which prompted an immaterial accrual. These omissions represent significant gaps in the multi-hop synthesis required to fully answer the question. The LLM incorrectly implies that the disclosures were 'essentially unchanged' across years, when in fact the scope of exposure expanded geographically and regulatorily. Quantitatively, the answer is accurate in stating that accruals were immaterial or insignificant and that GM could not estimate further losses—this aligns with the ground truth. However, the qualitative reasoning is flawed because it draws an overly confident conclusion about limited exposure without acknowledging the increasing complexity and persistence of liabilities. The answer is contextually relevant and addresses the core issue of indemnification and post-sale liability, but lacks the depth and evolution described in the original answer. Thus, while some facts are correct, the absence of key jurisdictional, regulatory, and recall-specific developments reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 474,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "Eli Lilly’s exposure to bamlanivimab has sharply declined from 2022 to 2024, as reflected by the royalty obligations to AbCellera and the product’s revenue contribution. In 2022, the company recognized $2.24 billion of net product revenue from COVID‑19 antibodies (including bamlanivimab) and recorded a $195 million milestone payment that was capitalized as intangible assets; by 2023 and 2024, revenue from these antibodies was essentially zero, with no remaining royalty accruals disclosed. Consequently, bamlanivimab’s contribution to total revenue has virtually disappeared, signaling that the drug’s long‑term strategic importance has faded and the company is now focused on other higher‑margin franchises.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall trend of declining exposure to bamlanivimab from 2022 to 2024, with revenue dropping to zero and royalty obligations ceasing, which aligns with the ground truth. However, there is a significant numerical discrepancy: the LLM reports $2.24 billion in net product revenue for COVID-19 antibodies in 2022, while the ground truth specifies $2,008.9 million ($2.0089 billion), a difference of over $230 million. This overstatement affects quantitative accuracy. Additionally, the LLM mentions a $195 million milestone payment capitalized as intangible assets, which is not present in the ground truth and introduces unverified information. (2) The ground truth specifies tiered royalty rates (mid-teens to mid-twenties) to AbCellera on global sales, but the LLM omits this detail and only states that royalty accruals ceased, missing a key aspect of financial exposure. (3) The reasoning is sound in linking declining revenue and lack of royalties to reduced strategic importance, and the conclusion about shifting focus to other franchises (e.g., cardiometabolic) is consistent with the trajectory described. The multi-hop synthesis—connecting revenue trends, royalty obligations, and strategic implications—is logically structured. (4) Despite the numerical inaccuracy and omission of royalty rate details, the answer remains contextually relevant and conveys the core message: bamlanivimab’s commercial and strategic role at Eli Lilly has ended. The answer is semantically close but penalized for factual precision in key figures and missing specifics on royalty structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 446,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "From 2022 through 2024, PMI’s strategic positioning around the Jackpot brand evolved from a focus on expanding its presence in key local markets to leveraging the brand as part of a broader portfolio of local cigarette brands that complement its international flagship products. This three‑year trajectory underscores PMI’s intent to deepen its reliance on locally relevant cigarette brands—such as Jackpot in the Philippines—while simultaneously advancing its smoke‑free and reduced‑risk product platforms, indicating a dual focus on both traditional cigarette market share growth in specific regions and the long‑term transition toward smoke‑free alternatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and strategic interpretation. It correctly identifies Jackpot as a local brand in the Philippines and acknowledges PMI's dual strategy of maintaining local cigarette brands while transitioning to smoke-free products. All dates (2022–2024) are accurate, and no numerical data is misstated (quantitative accuracy is perfect, as there are no figures to compute but time periods are correct). The reasoning is sound and reflects multi-hop synthesis across years, recognizing the continuity of Jackpot’s role and PMI’s broader strategic context. However, the LLM slightly overstates evolution by suggesting a shift 'from expanding presence to leveraging as part of a portfolio,' which is not explicitly supported in the ground truth. The original answer emphasizes consistency rather than strategic evolution—Jackpot was consistently listed as a key local brand each year without indication of a change in focus or expansion efforts. Thus, while the core facts and strategic duality are accurately captured, the characterization of 'evolution' introduces a nuance not present in the source, leading to a minor deduction in qualitative accuracy. Semantically, the answer remains highly equivalent and contextually relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 372,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "PayPal’s exposure to bad transactions through its credit and BNPL products has evolved through a series of strategic moves and ongoing risk management efforts. In 2023, the company began selling up to €40 billion of U.K. and European BNPL loan receivables to third parties, creating a forward‑flow arrangement for future eligible loans; however, the sale is subject to conditions that could delay or prevent the expected benefits. This divestiture is intended to reduce the company’s direct credit risk, but it also introduces reliance on third‑party funding and the risk that those parties may be unable to meet their obligations, potentially affecting the growth and profitability of PayPal’s credit products. At the same time, PayPal continues to face heightened fraud and abusive‑behavior risks, as third parties increasingly attempt to exploit its payment platform, which can increase loss rates, erode merchant and consumer confidence, and lead to higher remediation costs. Consequently, while the BNPL sale mitigates some credit‑risk exposure, the company’s overall vulnerability to fraud, third‑party disruptions, and regulatory scrutiny remains a material and evolving concern through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables is accurately reported, including the forward-flow arrangement and conditional nature of the sale. The focus on ongoing fraud risks, third-party processing vulnerabilities, and reputational/operational concerns is consistent with the original answer. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, with no miscalculations or misstatements. Format (€40 billion) matches expected precision. (3) Multi-hop reasoning is sound—LLM correctly synthesizes PayPal’s risk reduction via asset sale while maintaining exposure to fraud and third-party dependencies across 2022–2024. It captures the nuance that credit risk was reduced but not eliminated, and that new risks (e.g., third-party funding reliability) emerged. (4) The only minor shortcoming is a slightly less detailed treatment of 2022 risks compared to the original answer (e.g., no mention of synthetic identities or stolen financial instruments), but the core qualitative themes are preserved. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 362,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "Honeywell’s exposure to retail market fluctuations directly impacted its Safety and Productivity Solutions segment in 2022 (where operating results were adversely affected by reduced investment in process automation and safety monitoring amid retail market volatility), its Industrial Automation segment in 2024 (which saw a 11% sales decline driven by lower organic sales in Warehouse and Workflow Solutions due to reduced retail demand), and overall risk posture in 2023 (reflected in the segment’s 100 basis point margin compression to 19.5% as retail-driven demand softness persisted). This evolution demonstrates that Honeywell’s industrial portfolio remains highly sensitive to retail demand volatility, particularly in segments tied to commercial and industrial end-market spending, necessitating proactive mitigation strategies to manage cyclical exposure across its diversified operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as an '11% sales decline' in 2024 and '100 basis point margin compression to 19.5%' in 2023. These figures are entirely absent from the original answer and cannot be verified from the provided knowledge graph, making them factually unsupported. The ground truth does not include any numerical performance metrics—only qualitative risk disclosures. (2) Quantitative accuracy is severely compromised because the LLM fabricates precise financial data (percentages, margin figures) that do not appear in the original answer. There is no indication in the ground truth that operating results were 'adversely affected' in 2022 or that margins compressed in 2023; these are inferences or additions beyond the source. (3) Qualitatively, the LLM correctly identifies the multi-hop structure: it tracks the evolution of 'fluctuations in retail markets' across three years and maps it to the relevant segments (Safety and Productivity Solutions in 2022, Industrial Automation in 2024, and overall risk in 2023). The reasoning about persistent sensitivity to retail demand and the need for mitigation strategies aligns semantically with the conclusion in the original answer. However, the addition of unverified financial impacts undermines the reasoning integrity. (4) Contextual relevance is high because the LLM addresses all parts of the question and maintains focus on the evolution of retail market exposure across Honeywell’s segments. Despite incorrect numbers, the narrative structure and intent to synthesize across years and segments are appropriate. The core issue is hallucination of data, not misinterpretation of concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 472,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 through 2024, LLY’s collaboration with Incyte remained centered on Olumiant (baricitinib), with Incyte entitled to tiered double‑digit royalties (up to 20 %) on worldwide net sales and an additional low‑teens royalty on COVID‑19 sales that exceed a set threshold. Milestone payments tied to regulatory approvals and sales‑based targets were capitalized as intangible assets and amortized into cost of sales; as of December 31 2023, up to $100 million of additional sales‑based milestones remained payable. Olumiant contributed steadily to LLY’s revenue—$830.5 million in 2022, $922.6 million in 2023, and $957.4 million in 2024—while royalty payments to Incyte were recorded as cost of sales, reducing net revenue from the product. The partnership’s financial structure thus combined upfront milestones, performance‑based royalties, and shared development costs, positioning Olumiant as a growing but royalty‑paying component of LLY’s overall revenue base.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of LLY's collaboration with Incyte from 2022 to 2024, with accurate qualitative and quantitative details, though minor discrepancies affect full precision. (1) Quantitatively, the LLM correctly reports Olumiant’s revenue contributions: $830.5M (2022), $922.6M (2023), and $957.4M (2024), which align with known figures and show growth, supporting the narrative of increasing strategic importance. Royalty structure is accurately described as tiered, up to 20% on general sales and an additional low-teens royalty on high-volume COVID-19 sales. However, the milestone payment details are partially inaccurate: the original answer states LLY capitalized $260M in milestone payments by 2022 tied to regulatory approvals, with up to $200M in additional contingent payments (split evenly: $100M regulatory, $100M sales-based). The LLM correctly notes that up to $100M in sales-based milestones remained payable as of end-2023, but omits the regulatory portion and does not clarify that the $260M was already capitalized, instead generalizing about capitalization without specifying timing or amount. This is a minor omission but affects completeness of the financial structure evolution. (2) The answer is complete in addressing all question components: milestone payments, royalty structures, and Olumiant’s role in LLY’s revenue. It synthesizes across years and correctly frames the partnership maturation—shifting from milestone-driven to revenue- and royalty-driven—indicating sound multi-hop reasoning. (3) Entity accuracy is strong: LLY, Incyte, Olumiant (baricitinib), and correct fiscal years (2022–2024) are properly identified. Financial terms like 'cost of sales', 'intangible assets', and 'royalty payments' are used appropriately. (4) The reasoning is logical: the increasing revenue and consistent royalty structure support the conclusion that Olumiant is a growing but royalty-bearing part of LLY’s portfolio. The strategic emphasis on EUA and follow-on compounds is implied through revenue growth and sustained payments, though not explicitly stated as in the original answer. The omission of explicit mention of EUA and follow-on compounds in 2024 slightly weakens the strategic evolution narrative, but the financial consistency is well conveyed. Overall, the answer is factually strong, with high semantic equivalence, minor gaps in milestone detail, and excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 652,
        "total_tokens": 2237
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "From 2022 to 2024 Altria’s relationship with UST evolved through a series of strategic moves that reshaped its intangible‑asset valuation, ownership structure, and integration into the company’s smoke‑free transition. In 2022 Altria still held a minority stake in the UST‑related businesses, but by 2023 it had acquired the remaining 20 % of Helix (the parent of the on! oral‑nicotine pouch brand) and fully consolidated the UST‑derived MST and snus trademarks—assets that are recorded as indefinite‑lived intangibles on its balance sheet. The 2024 filing shows that these trademarks now represent the bulk of Altria’s $11.4 billion of indefinite‑lived intangible assets, and they are explicitly tied to the company’s “Moving Beyond Smoking” vision, positioning the former smokeless‑tobacco portfolio as a core platform for next‑generation oral nicotine products. Financially, the re‑valuation of these intangibles (from $8.8 billion in 2021 to $8.8 billion still, but now fully consolidated) reduced goodwill impairments and allowed Altria to allocate more capital toward smoke‑free innovations such as the on! brand and the Horizon heated‑tobacco joint venture, thereby deepening its integration of the former UST business into a broader, diversified, smoke‑free growth strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding ownership structure and financial figures. It incorrectly states that Altria held a 'minority stake' in UST-related businesses in 2022 and acquired the 'remaining 20%' of Helix in 2023. In reality, UST has been a wholly owned subsidiary since 2009, and Helix is a separate entity (a joint venture with Philip Morris International) not owned by UST. The claim of acquiring a 'remaining 20%' is false. Additionally, the LLM claims indefinite-lived intangibles rose to $11.4 billion in 2024, but the ground truth only confirms $8.8 billion in 2022 with no update for 2023 or 2024. The $8.8 billion figure is repeated but falsely attributed to 2021 instead of 2022. (2) Quantitative accuracy is low: the $11.4 billion figure is unsupported, the 20% acquisition is fabricated, and the timeline of $8.8 billion is misstated (2021 vs 2022). The ground truth does not provide 2024 valuation data, so asserting a new total is speculative. (3) Multi-hop reasoning is partially sound in linking UST's trademarks to Altria's smoke-free strategy, and correctly identifying indefinite-lived intangibles as a key metric. However, the synthesis is flawed due to incorrect entity relationships—Helix and NJOY are not part of UST, and UST’s ownership was never partial during this period. The strategic shift toward oral nicotine is contextually relevant but misattributed to UST integration rather than separate ventures. (4) Contextual relevance is high because the answer addresses all dimensions of the question—intangible assets, ownership, and strategy—and attempts to show evolution over time. However, the qualitative accuracy is undermined by core factual errors in entity structure and financials, leading to a low overall correctness score despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 502,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco's interest rate exposure on its 3.50% Senior Note decreased from a fair value hedge adjustment of $116 million in fiscal 2022 to a $30 million gain (reflected as a $‑30 million loss in the hedging column) in fiscal 2024, indicating that the company's borrowing costs have risen modestly as market rates have increased, while the overall capital‑market environment remains relatively stable with manageable volatility in interest‑rate hedging.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Cisco's effective interest rate on its 3.50% Senior Note rose from 3.20% in FY2022 to 6.38% in FY2023 and 6.66% in FY2024, indicating increasing borrowing costs. However, the LLM response discusses 'fair value hedge adjustment' of $116 million and a '$30 million gain', which are not mentioned in the ground truth and represent entirely different metrics (hedging gains/losses vs. effective interest rates). These dollar amounts do not appear in the original answer and are factually unsupported in this context. (2) There are no correct numerical matches: the ground truth uses percentages (3.20%, 6.38%, 6.66%), while the LLM uses dollar figures ($116M, $30M) that are unrelated to the effective interest rate trend. No calculations can be verified because the data types are incompatible. (3) The multi-hop reasoning fails: the question asks about the evolution of interest rate exposure in terms of borrowing costs, which requires tracking the effective interest rate over time. The LLM instead shifts focus to hedging adjustments, misidentifying the core metric. It does not address the effective interest rate at all, missing the key trend of rising costs from 3.20% to 6.66%. (4) The conclusion that 'borrowing costs have risen modestly' understates the actual doubling of rates and mischaracterizes the capital market conditions as 'relatively stable', whereas the ground truth implies tightening conditions due to significantly higher effective rates. Overall, the answer is factually incorrect, uses wrong metrics, and fails to report the actual trend in effective interest rates, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 476,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon's outstanding balance on its 2017 Notes declined from $17.0 billion at the end of 2021 to $15.0 billion by the end of 2022 and further to $13.0 billion by the end of 2023, reflecting scheduled principal repayments and the company’s active refinancing strategy. This steady reduction demonstrates Amazon’s disciplined debt‑management approach, using cash flow and new credit facilities to retire maturing senior notes ahead of schedule.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of Amazon's 2017 Notes. According to the ground truth, the balance was $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024. However, the LLM states it was $17.0 billion in 2021 (outside the requested 2022–2024 scope), $15.0 billion in 2022, and $13.0 billion in 2023—misaligning years and reporting an incorrect starting value. The 2024 data point is entirely missing, and the 2022 and 2023 figures are swapped in context. (2) The numbers are partially correct—$15.0 billion and $13.0 billion appear in the correct sequence but are assigned to the wrong years. The $16.0 billion figure for 2022 (ground truth) is completely omitted. There are no calculation errors per se, but the timeline is distorted. (3) The reasoning about Amazon’s debt management strategy is plausible and aligns qualitatively with the ground truth—mentioning disciplined debt management and use of cash flow—but incorrectly references 'retiring maturing senior notes ahead of schedule,' which contradicts the ground truth’s indication of 'gradual retirement' via scheduled repayments. The LLM also introduces 'refinancing' and 'new credit facilities,' which are not supported in the original answer. (4) While the general direction of debt reduction and strategic interpretation are relevant and semantically aligned, the misstatement of key figures and years undermines factual correctness. The answer fails the multi-hop requirement to accurately track the balance across the specified three-year period. Hence, correctness is scored at 5 due to partial accuracy; quantitative accuracy is low (4) due to year misalignment and missing data; qualitative reasoning is moderate (6) as logic is sound but based on flawed data; contextual relevance is high (8) because the response addresses the right topic and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 517,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "From fiscal 2022 through 2024, the outstanding principal balance of Broadcom’s 5.000% senior notes due April 2030 remained at $606 million in 2022 and 2023, with the effective interest rate holding steady at 5.18 % each year. This stability in both the balance and rate reflects a deliberate, low‑cost financing strategy that preserves cash while maintaining a long‑dated, fixed‑rate instrument, indicating that Broadcom is managing this debt tranche conservatively and without aggressive refinancing or restructuring.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $606 million and the effective interest rate of 5.18% for fiscal years 2022 and 2023, matching the ground truth. However, it omits explicit confirmation of the balance and rate in fiscal 2024, which the original answer confirms remained unchanged. While the implication of stability suggests continuity, the failure to explicitly state the 2024 data point constitutes a minor omission in completeness. (2) All numeric values—$606 million and 5.18%—are accurate and correctly attributed to the relevant years and instrument. No calculation errors are present. (3) The reasoning is sound in interpreting the stable balance and rate as indicative of a conservative debt management strategy, aligning with the ground truth's conclusion of a 'static approach.' However, the LLM adds interpretive language such as 'low-cost financing strategy' and 'preserves cash,' which, while plausible, go slightly beyond the factual synthesis provided in the ground truth. (4) Despite the minor omission in 2024 data and slight over-interpretation, the answer captures the core multi-hop progression and correctly identifies the lack of change in the debt instrument over time, making it largely accurate and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 362,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "The Performance Bonus Plan was formally adopted in 2014 (as noted in the 2014 Def 14A filing) and has been amended over time, including a 2022 amendment that updated the plan’s structure and related executive compensation agreements. Across 2022‑2024, the plan remained part of Netflix’s executive compensation framework, with its terms integrated into the company’s broader stock‑based and cash‑incentive arrangements, but it was not restated or fundamentally changed during those years.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Netflix's Performance Bonus Plan from 2022 to 2024. (1) It incorrectly states that the plan was not restated during 2022–2024, directly contradicting the ground truth: the 'Amended and Restated Performance Bonus Plan' was formally introduced via an 8-K filing on December 9, 2022, which is a key restatement event. The LLM acknowledges a 2022 amendment but downplays its significance and omits the formal restatement. (2) The claim that the plan was 'formally adopted in 2014' is irrelevant to the question, which focuses on 2022–2024 developments; this distracts from the required timeline and introduces extraneous information. (3) The LLM asserts no fundamental changes occurred during 2022–2024, but the ground truth shows increasing integration into executive compensation architecture in 2024, including alignment with updated stock option agreements and new instruments like the 'Performance-Based Restricted Stock Unit Award Agreement' and 'Executive Officer Severance Plan'—a level of integration not mentioned in the LLM response. (4) Multi-hop reasoning is weak: the model fails to connect the 2022 8-K filing to the formal restatement, does not trace the plan’s deepening integration in 2024, and misses the strategic evolution implied by the filings. (5) While the general context of the plan being part of executive compensation is correct, the absence of key events, mischaracterization of changes, and omission of integration details result in a substantially incorrect answer. Quantitative accuracy is partially preserved (dates like 2022 are mentioned), but the critical December 9, 2022, 8-K filing date is missing, and no incorrect numbers are present—just incorrect interpretation of events. Contextual relevance is moderate as it addresses executive compensation but misses the specific evolution asked for.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 520,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "From 2022 to 2024, AIG’s international terrorism exposure management evolved through enhanced modeling and reinsurance protections. The company continued to use third‑party vendor models to estimate losses from terrorism scenarios, including conventional bombs, anthrax and nuclear attacks, and applied adjustments for model gaps and the specific nature of its exposures. Reinsurance limits were secured on a worldwide aggregate excess‑of‑loss basis (e.g., $175 million in excess of a $350 million retention and $400 million in excess of a $550 million retention) and supplemented by private reinsurance and government‑sponsored programs such as TRIPRA. These measures, together with ongoing monitoring of concentrations (notably in New York City) and the purchase of targeted terrorism covers, were intended to mitigate the potential for large‑scale losses from terrorist events.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures general aspects of AIG's terrorism exposure management but misses key quantitative and strategic details from the ground truth. It correctly mentions the use of third-party models, reinsurance, and monitoring of concentrations, but fails to accurately report the specific modeled loss estimate of $1.3 billion in 2022 for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. Instead, it introduces reinsurance structures (e.g., $175M in excess of $350M retention) not present in the original answer, which undermines quantitative accuracy. (2) The original answer specifies AIG’s 2024 retention levels: $200M for Japan and $125M for the rest of the world, and notes $20.1B in collateral—none of which are mentioned in the LLM response. The LLM’s reinsurance figures appear fabricated or misattributed, as they do not align with the ground truth. (3) While the LLM demonstrates some multi-hop reasoning by connecting modeling, reinsurance, and risk monitoring across years, it fails to show the evolution from 2022 to 2024 as required. The original answer traces a clear progression: consistent modeling, increased targeted reinsurance in 2023, and expanded global property covers in 2024. The LLM collapses this timeline and does not distinguish year-by-year developments. (4) Despite missing key facts and introducing unverified numbers, the LLM answer remains contextually relevant, discussing appropriate themes like modeling, reinsurance, and risk mitigation. However, the lack of specific, accurate data and incorrect figures significantly reduces correctness and quantitative accuracy. The qualitative reasoning is partially sound but lacks precision and fidelity to the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 476,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth Group's venture investment strategy shifted from a focus on equity method investments in health‑care businesses (approximately $1.3 billion held through 2021‑2022) to a broader portfolio that includes larger holdings of equity securities and venture investments, reaching about $4.9 billion in equity securities and $3.8 billion in equity‑method health‑care investments by the end of 2024.  This expansion reflects a strategic evolution toward acquiring and investing in a wider range of health‑care technology and services companies, while still maintaining a significant portion of its prior equity‑method holdings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall evolution of UnitedHealth Group's venture investment strategy from 2022 to 2024, noting the increase in equity securities from $3.5B to $4.9B and the significant rise in equity method investments to $3.8B by 2024. However, it inaccurately states that the $1.3B in equity method investments was held through '2021-2022', while the ground truth specifies only 2022 (no 2021 data provided), introducing a minor temporal inaccuracy. (2) Quantitatively, the final figures for 2024 ($4.9B in equity securities and $3.8B in equity method investments) are correct. The 2022 equity securities value is omitted in the LLM answer (should be $3.5B), though the $1.3B equity method investment is correctly referenced. The 2023 data ($4.9B equity securities, $1.4B equity method) is not mentioned, representing a minor omission. (3) The multi-hop reasoning is generally sound—LLM correctly infers a strategic shift toward broader and deeper healthcare investments. It synthesizes the trend of increasing equity securities and the surge in equity method investments, aligning with the ground truth's conclusion of a pivot toward operational engagement. However, it misses the nuance that equity securities remained steady from 2023 to 2024 (not a continuous increase) and omits the slight dip in equity method investments in 2023 before the 2024 surge. (4) Despite minor omissions and a small temporal overextension to 2021, the LLM answer conveys the core strategic evolution accurately and remains contextually relevant, using appropriate financial terminology and logical interpretation. Hence, correctness is high but not perfect due to incomplete year-by-year coverage and one minor factual stretch.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 476,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria Group's capital structure evolution across 2022‑2024 shows a consistent, multi‑year strategy of maintaining a sizable, long‑dated debt tranche anchored by its 1.700% Notes due 2025. The 2022 filing lists the 2025 notes as part of its long‑term debt, and the 2023 and 2024 filings continue to disclose the same series of notes (1.700% 2025, 2.200% 2027, 3.125% 2031) alongside other long‑term borrowings, indicating that the company has not retired or significantly refinanced this tranche but rather has let it amortize while issuing new long‑term debt to fund acquisitions and litigation settlements. This steady retention of the 2025 notes reflects a deliberate, patient debt‑management approach that prioritizes stable, low‑coupon financing over aggressive refinancing, supporting the firm’s broader strategy of financing growth initiatives—such as the NJOY acquisition and litigation settlements—while preserving financial flexibility and a manageable debt‑to‑equity profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) Quantitatively, all dates (2022, 2023, 2024), note details (1.700% 2025 Notes, 2.200% 2027 Notes, 3.125% 2031 Notes), and the absence of the 1.000% 2023 Notes in 2023 are accurately reflected. There are no numerical or date inaccuracies. (2) The LLM correctly identifies that the 1.700% 2025 Notes remained in the capital structure across all three years, which matches the ground truth. It also correctly notes the continued presence of other long-term notes, supporting the idea of stable debt management. (3) The multi-hop reasoning is sound: the model synthesizes information across years and infers a strategic pattern—retaining low-cost debt rather than refinancing—consistent with Altria’s broader financial strategy. However, the LLM adds specific claims not present in the ground truth, such as using debt to fund the 'NJOY acquisition and litigation settlements' and 'amortize while issuing new long-term debt.' While plausible, these details are not supported by the original answer and represent an overextension of inference. (4) Despite these minor extrapolations, the core evolution and strategic interpretation are factually aligned. The answer is highly relevant, accurately captures the progression, and draws reasonable conclusions, warranting a high score but not perfect due to unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 396,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard's investment in Class A Treasury Stock increased from $51.354 billion at the end of 2022 to $60.429 billion by the end of 2023, and further to $71.431 billion by the end of 2024. This upward trend reflects a deliberate capital‑allocation strategy of returning cash to shareholders through aggressive share‑repurchase programs while maintaining ample liquidity for operational needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60,429 million) and 2024 ($71,431 million) values. However, the 2022 value is incorrect: the LLM states $51.354 billion, while the ground truth is $(36,658) million. This is a significant numerical discrepancy—approximately $14.7 billion off—suggesting an error in data retrieval or interpretation. The negative sign in the original answer (indicating a contra-equity account) is also missing in the LLM response, though this may reflect simplification for readability. (2) Calculations: The year-over-year increases are conceptually correct (rising trend), but due to the incorrect 2022 baseline, any derived change (e.g., 2022–2023 increase) would be inaccurate. The 2023 and 2024 figures match exactly when converted to billions ($60,429 million = $60.429 billion), so those are quantitatively accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers the strategic implication—increased share repurchases as part of capital allocation—aligning with the ground truth. The addition of 'maintaining ample liquidity' is a reasonable inference not contradicted by the original. (4) Scores justified as follows: Correctness 8 due to accurate trend and two out of three numbers; major error on 2022 value prevents a 9–10. Quantitative accuracy 7 due to one major factual error despite correct formatting and two correct values. Qualitative accuracy 9: reasoning and entity identification (Mastercard, Class A Treasury Stock, capital allocation) are correct. Contextual relevance 10: fully addresses both parts of the question and stays focused on the financial trend and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 493,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco's financial exposure through Total Return Swaps‑Deferred Compensation shifted from a $92 million loss in fiscal 2022 to gains of $58 million in fiscal 2023 and $91 million in fiscal 2024, reflecting the company's use of these swaps to economically hedge deferred compensation obligations and the resulting positive impact on operating expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92M loss in 2022, $58M gain in 2023, and $91M gain in 2024—with accurate fiscal years and directional changes, matching the ground truth exactly in quantitative terms. Number formatting ($92 million vs $92M) is semantically equivalent and acceptable. (2) All numeric values are correct and consistent with the original answer; no calculations were required beyond interpretation of gains/losses, which were accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution across three fiscal years and captures the reversal from loss to gain. It adds contextual insight about the purpose of the swaps (hedging deferred compensation) and impact on operating expenses, which is a reasonable inference and enhances the answer without contradicting the ground truth. (4) The only reason for not scoring a perfect 10 is that the LLM slightly extends beyond the original answer by introducing the rationale for use of swaps and impact on expenses, which, while plausible, were not part of the verified ground truth from the knowledge graph. However, this does not detract from factual correctness. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 361,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From 2022 through 2024 Netflix’s reliance on rights holders intensified as it faced mounting competition for exclusive content, heightened regulatory scrutiny over licensing terms and content quotas, and growing pressure on its content‑amortization model; the company’s disclosures highlight that securing favorable licensing agreements is critical to maintaining a compelling library, that disputes with studios or music‑rights organizations can lead to sudden content removals or increased costs, and that evolving cultural‑support laws and antitrust‑style reviews in various jurisdictions add uncertainty to future content availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Netflix's increasing dependency on rights holders from 2022 to 2024 is properly framed around content licensing risks, competition for exclusive rights, and regulatory pressures. The answer correctly reflects concerns about studios launching competing services (2022), IP disputes leading to content removal (2023), and regulatory constraints like content quotas and investment obligations (2024). (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM synthesizes evolving risks across three years and multiple external pressures (rights holders, regulators, competitors), accurately mirroring the progression in the ground truth. (4) Minor phrasing differences exist—e.g., 'content-amortization model' and 'antitrust-style reviews' are not in the original—but these additions are contextually plausible and do not introduce inaccuracies. The core message about growing strategic challenges due to external dependencies is preserved. Thus, correctness is 9 due to slight elaboration beyond the source, but overall fidelity is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 362,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group's financial disclosures across its 2022–2024 10-K filings show no explicit mention of \"service level guarantees\" or associated financial obligations in the provided pages. While the documents detail regulatory compliance, data security risks, and contingent liabilities (e.g., Note 4 in 2024 filing states \"None of the amounts accrued, paid or charged to income for service level guarantees were material\"), they do not quantify or describe any formal service-level commitments or their evolution over the three-year period. Consequently, the stability of such commitments across subsidiaries cannot be assessed from the supplied information, as no data on service-level guarantees—financial or otherwise—is disclosed in the context of evolving obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the ground truth. (1) While it correctly cites the immateriality of service level guarantee charges—quoting Note 4 from the 2024 filing stating they were not material—the LLM falsely claims there is 'no explicit mention' of service level guarantees or their evolution, when in fact the ground truth confirms consistent disclosure across all three years (2022–2024) that these amounts were immaterial. This core fact is misrepresented. (2) The LLM omits entirely the key quantitative data about UnitedHealth's notes payable to subsidiaries: the increase from $8.1B in 2022 to $9.9B in 2023 and sharp drop to $2.0B in 2024. These figures are critical to the multi-hop analysis of financial obligations and internal funding dynamics. Their absence constitutes a major failure in quantitative accuracy and completeness. (3) The reasoning is flawed: the LLM concludes that 'no data' exists on service-level guarantees, but the immateriality itself is the disclosed data point, and its consistency over three years is meaningful. The model fails to synthesize this with the fluctuating intercompany notes, which the ground truth uses to contrast stable external service obligations with volatile internal financing. (4) Contextual relevance is moderate because the response addresses the general topic and references a correct note (Note 4, 2024), but it incorrectly frames the absence of data rather than interpreting the significance of immaterial disclosures. Overall, the answer misunderstands the nature of financial materiality and misses the multi-hop link between service guarantees and internal financing trends, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 466,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s allocation to below‑investment‑grade securities in its long‑duration fixed‑income portfolio has been trimmed modestly over the three‑year period.  In 2022 the pension and post‑retirement plan assets held roughly 11 % of fixed‑income securities in below‑investment‑grade (about 9 % of total plan assets), and by 2024 that share fell to about 9 % of fixed‑income holdings (≈ 7 % of total pension assets and ≈ 4 % of total post‑retirement assets).  The shift reflects a deliberate move toward a higher‑quality, longer‑duration bond mix that better matches the liability profile and reduces equity volatility.  This trend signals that Altria is lowering its risk appetite for the long‑term obligations of its pension and post‑retirement plans, emphasizing capital preservation and liability‑driven investing over higher‑yield, lower‑quality credits.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, the pension plan had 16% of fixed income holdings (not 11%) in below investment grade, and the postretirement plan had 8%. The LLM incorrectly combines the two plans and misrepresents the 2022 allocation as 11% of fixed income holdings across both plans, which is factually wrong. Additionally, the LLM claims that by 2024 the allocation fell to 9% of fixed income holdings, but the original answer states that specific percentages for 2024 were not disclosed. This is a major error in both data reporting and transparency. The LLM also fabricates a 2024 figure of ≈7% of total pension assets and ≈4% of post-retirement assets, which are not supported by the source. (2) The calculation and comparison of percentages are incorrect. The ground truth shows a decrease in pension plan allocation from 16% to 11% of fixed income holdings (2022 to 2023), while postretirement increased slightly from 8% to 9%. The LLM fails to report 2023 data entirely and instead implies a linear decline to 2024 with no basis. (3) The multi-hop reasoning is flawed because the model does not correctly distinguish between the two plans or track their evolution separately over time. It merges pension and postretirement data, which undermines the required comparative analysis. Furthermore, it ignores the fact that postretirement allocation actually increased slightly in 2023, contradicting the claim of a uniform 'trimming' across plans. (4) While the qualitative interpretation about risk appetite and liability-driven investing is plausible and contextually relevant, it is based on incorrect data, leading to an unsupported conclusion of uniformly lowering risk appetite. The ground truth suggests a more nuanced, balanced strategy rather than a clear de-risking trend. Thus, the answer is partially correct in intent and relevance but fails on core factual accuracy and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 540,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s settlement‑exposure methodology has remained consistent from 2022 through 2024: it estimates gross settlement exposure by multiplying the average daily payment volume over the three months prior to period‑end by the estimated number of days of exposure, then subtracts risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) to arrive at net exposure. The company updates these estimates as needed, but the calculation approach—using average daily volume and a defined exposure period—has not changed. This steady methodology reflects a disciplined risk‑management framework that continues to quantify and mitigate settlement risk even as regulatory scrutiny, litigation and cross‑border investigations have intensified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Mastercard's methodology for estimating settlement exposure as consistent from 2022 through 2024, using the average daily payment volume over the three months prior to period-end multiplied by the estimated number of days of exposure—this matches the original answer exactly. It also correctly notes the subtraction of risk-mitigation arrangements (cash collateral, letters of credit, guarantees) to calculate net exposure, which is consistent with disclosed practices. (2) There are no numeric values requiring calculation (e.g., dollar amounts or percentages), but the temporal scope (2022–2024) and structural elements of the methodology are accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes information about methodology stability, risk mitigation practices, and external pressures (regulatory and litigation risks), even if it doesn’t name specific investigations (e.g., FTC, DOJ, European Commission) or litigation cases (U.S. Liability Shift Litigation, TCPA). These omissions slightly reduce completeness but do not affect the core factual accuracy. (4) The conclusion about the consistency reflecting a disciplined and robust risk management framework is semantically equivalent to the original answer’s interpretation. The only minor gap is the lack of explicit mention of unchanged risk-mitigation *requirements* based on individual risk assessments, though the concept is implied in referencing collateral and credit enhancements. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 460,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco's 5.90% senior note due February 15 2039 remained outstanding with a principal amount of $2 billion throughout fiscal 2022‑2024, and its effective interest rate stayed at 6.11% each year.  The company issued new senior notes in February 2024 and entered into an interest‑rate swap that converts the fixed rate of certain notes to a floating SOFR‑based rate, but the 5.90% note itself was not refinanced or re‑priced, indicating that Cisco is maintaining its long‑term debt structure while using swaps and new issuances to manage interest‑rate exposure and overall financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion principal amount on its 5.90% Note from fiscal years 2022 to 2024, with an effective interest rate of 6.11% throughout—this matches the ground truth exactly. The formatting variation ($2 billion vs $2,000 million) is acceptable and semantically equivalent. (2) All numeric values—interest rate (5.90% coupon, 6.11% effective), principal amount ($2 billion), and time period (2022–2024)—are accurate. No calculations were required, but the consistency across years is correctly reported. (3) The reasoning is sound and adds context not in the original answer: the mention of new senior notes issued in February 2024 and an interest-rate swap tied to SOFR demonstrates broader knowledge of Cisco’s debt management strategy. While the ground truth emphasizes the strategic retention of high-yield debt for predictability, the LLM complements this by explaining that Cisco is using swaps and new issuances to manage rate exposure—consistent with and enriching the original conclusion. The key point—that the 5.90% note itself was not refinanced—is correctly identified, confirming proper multi-hop synthesis across fiscal years and instruments. (4) The answer is fully contextually relevant, addressing both the evolution of utilization and effective interest rate, and drawing a valid inference about long-term debt strategy. The only reason for not scoring a 10 is that the LLM slightly shifts emphasis toward new instruments and swaps, which, while factually correct, slightly downplays the strategic implication in the original answer about maintaining predictable obligations despite refinancing opportunities. However, this does not constitute an error but rather a nuanced difference in framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 484,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO's 3.125% notes due January 2025 had an outstanding principal balance of $495 million at both October 30 2022 and October 31 2021, as shown in the fiscal‑year‑2022 and fiscal‑year‑2021 tables. This balance remained unchanged through fiscal 2024, indicating that the company has not reduced or increased the principal amount of this specific instrument and is maintaining its current debt level for the 3.125% notes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 and states it remained unchanged through fiscal 2024, which aligns with the ground truth. However, the LLM incorrectly references data from fiscal year 2021 (October 31, 2021) and mislabels the fiscal year 2022 date as October 30, 2022, while the ground truth confirms consistent reporting for fiscal years 2022, 2023, and 2024—without mentioning 2021. This introduces an irrelevant and potentially confusing data point not asked for in the question. (2) The numeric value ($495 million) is accurate and consistently reported; no calculation errors are present. The dates, however, are slightly off in labeling—fiscal year 2022 should correspond to the period ending in 2022, but the inclusion of October 31, 2021, refers to the prior fiscal year-end, which is extraneous. (3) The multi-hop reasoning is mostly sound—the model correctly infers that the principal remained stable across the relevant years and draws a reasonable conclusion about debt management strategy. However, referencing FY2021 introduces a minor logical misstep, as the question specifically asks for FY2022–FY2024. (4) Despite the minor error in date referencing, the core answer is factually correct, complete in trend description, and contextually appropriate. The conclusion about maintaining current debt levels matches the ground truth’s interpretation, warranting high scores in contextual relevance and qualitative accuracy, with a slight deduction in quantitative accuracy due to incorrect date labeling.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 444,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2024, CMCSA’s shared data plan offerings evolved from a primarily bundled, limited‑choice model to a more flexible, tiered structure. In 2022 the company offered only unlimited or shared‑data plans tied to its MVNO agreements, but by 2023 it introduced separate prepaid unlimited plans under the NOW brand and expanded shared‑data options for both domestic and international customers. By 2024 the portfolio included unlimited data, shared‑data, and per‑gigabyte plans, allowing customers to customize pricing and data allowances while still being offered as part of bundled broadband packages. This shift gave subscribers greater choice and flexibility in how they manage their wireless data usage.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of CMCSA's evolution in shared data plan offerings from 2022 to 2024, including increased flexibility and bundling with broadband, which aligns with the ground truth. However, there are significant factual inaccuracies in the timeline and offering details. (1) The claim that in 2022 CMCSA offered only unlimited or shared-data plans tied to MVNO agreements is incorrect; the original answer states that per-gigabyte pricing was already available in 2022, which the LLM omits. (2) The LLM incorrectly states that prepaid unlimited plans under the NOW brand were introduced in 2023, while the ground truth specifies this occurred in 2024. This misplacement of a key product launch affects the accuracy of the evolution narrative. (3) The LLM mentions expansion of shared-data options for international customers in 2023, which is not supported by the original answer—CMCSA's focus was on domestic wireless services. (4) While the LLM correctly notes that shared data plans remained part of broadband bundles and that customer flexibility increased, it fails to emphasize the strategic continuity of bundling from 2022 to 2023 and the 2024 expansion under NOW as a distinct development. The reasoning is partially sound but flawed in sequencing and entity attribution. Quantitative accuracy is high because there are no numerical errors (dates are mostly correct except for NOW brand timing), and contextual relevance is strong as the response addresses bundling strategy and customer flexibility. However, due to the misrepresentation of key developments and timeline inaccuracies, the overall correctness is only partially accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 455,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "From 2022 through 2024 UnitedHealth Group faced recurring Medicare Advantage funding pressures as CMS periodically reduced or froze benchmark payments and altered risk‑adjustment payment calculations, prompting retrospective RADV audits that could adjust payments and impose fines. In response, the company adjusted member benefits and premiums selectively, exited certain counties, intensified medical and operating‑cost management, and strengthened its cost‑containment and pricing strategies to mitigate the impact of these payment changes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core elements of UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024, as well as its strategic responses. It correctly identifies CMS's periodic reductions or freezes in benchmark payments and changes to risk-adjustment calculations, which aligns with the ground truth. The mention of retrospective RADV audits, while not explicitly detailed in the original answer, is contextually relevant and consistent with CMS enforcement mechanisms, so it does not constitute an error. The strategic responses—selective adjustments to benefits and premiums, exiting certain counties, and intensified cost management—are all supported by the original answer, which notes 'selective benefit adjustments' and 'intensified cost management' across the years. The expansion into 'strengthened cost-containment and pricing strategies' is a reasonable synthesis of the repeated emphasis on cost control. However, the LLM answer omits the explicit year-by-year evolution noted in the ground truth (e.g., the progression of discussion from 2022 to 2024 and the characterization of ongoing, reactive adaptation). While the multi-hop synthesis is sound and entities (UnitedHealth Group, CMS, Medicare Advantage, risk adjustment) are correctly identified, the answer condenses the timeline and does not fully reflect the evolving narrative across the three years, slightly reducing qualitative accuracy. There are no numerical inaccuracies—dates (2022–2024) are correct, and no specific dollar amounts or percentages are misstated. The answer is highly contextually relevant, directly addressing both parts of the question: exposure and strategic response. Thus, the correctness score is 8 due to minor omission of the temporal progression and nuance in the company's evolving commentary, but the core facts and reasoning remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 515,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s multi‑layered security approach has expanded from 2022 through 2024 by deepening third‑party collaboration (e.g., working with issuers, acquirers, governments and industry groups on cybersecurity standards, public‑private partnerships and third‑party assessments), integrating real‑time services into its network (including real‑time account‑based payments, tokenization, Click‑to‑Pay, and Mastercard Auth en ication with biometrics), and extending its real‑time payments infrastructure geographically (operating or implementing real‑time payments in 13 of the top 50 markets by GDP as of 2023 and launching new cross‑border remittance and alias‑based payout platforms in 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the expansion to 13 of the top 50 GDP markets by 2023 matches the original answer, and while the 2024 geographic expansion is described without a specific new number (e.g., 14 markets), it correctly references new cross-border platforms and alias-based payouts, consistent with continued expansion. The absence of the 2022 figure (12 markets) is a minor omission but not incorrect. (2) The LLM correctly identifies third-party collaboration with issuers, acquirers, governments, and industry groups, including public-private partnerships—matching the original's emphasis. It also accurately describes real-time service integration, listing tokenization, Click-to-Pay, and biometric authentication (Mastercard Auth), which are valid examples of value-added services integrated into transaction routing. (3) The reasoning is sound: the answer synthesizes evolution across three dimensions (collaboration, real-time services, geographic reach) over the 2022–2024 period, demonstrating multi-hop understanding. (4) The only minor gap is that the LLM does not explicitly mention the 2024 China joint venture, a key example of geographic and domestic processing expansion. However, it compensates by referencing new cross-border remittance and alias-based payout platforms in 2024, which reflect similar strategic movement. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight incompleteness on the China-specific development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 443,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon's financing strategy for its 1.500% Note due 2030 reflects a deliberate shift toward longer-duration, lower-coupon debt to manage refinancing risk and optimize capital structure. The company issued this specific tranche in 2020 (as referenced in the 2020 8-K filing under Exhibit 4.5) and subsequently refinanced portions of its maturing debt through new issuances in 2021 (e.g., 2021 8-K with 2031 notes) and 2022 (e.g., 2022 8-K with 2032 notes), indicating a strategy of proactively rolling over debt to extend maturities and lock in favorable rates amid rising interest rates. This approach prioritizes maintaining liquidity and flexibility while minimizing refinancing costs, as evidenced by the consistent use of low-coupon, long-term notes (e.g., 1.500% due 2030, 1.650% due 2028, 2.100% due 2031) to fund operations and strategic initiatives without overburdening the balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Amazon's financing strategy regarding the 1.500% Note due 2030 from 2022 to 2024. (1) Quantitatively, the LLM incorrectly claims the note was issued in 2020 'as referenced in the 2020 8-K filing under Exhibit 4.5'—while the ground truth confirms the note was indeed issued in 2020 and referenced in Exhibit 4.5, it was incorporated by reference in the 2022 filing, not newly issued then. More critically, the LLM fabricates refinancing activity: it states Amazon issued new notes in 2021 (2031 notes) and 2022 (2032 notes) via 8-K filings, which are not mentioned or supported in the ground truth. These specific refinancing events and associated percentages (1.650% due 2028, 2.100% due 2031) are entirely absent from the original answer and cannot be verified from the provided context. (2) The question asks about the evolution of strategy from 2022 through 2024, but the LLM focuses on earlier years (2020–2022) and omits the key developments in 2023 and 2024: the Term Loan Agreement of January 3, 2023 (Exhibit 10.8) and the 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), which are central to the ground truth’s analysis. (3) The reasoning is flawed: the LLM concludes Amazon is 'refinancing portions of maturing debt' with new long-term notes, while the ground truth shows Amazon is layering short-term credit facilities (revolving and term loans) alongside existing long-term debt—not replacing it. This reflects a different strategy: liquidity management rather than proactive long-term rollover. (4) The LLM answer is contextually relevant in discussing debt management and refinancing priorities, but its factual foundation is unsound. It fails the multi-hop requirement by not synthesizing exhibit-level changes across 2022–2024 filings and instead invents external events. While the general theme of 'locking in favorable rates' has some alignment, the absence of actual document-level evidence (Exhibit 4.6 in 2023/2024, new credit agreements) and introduction of false refinancing events severely undermines correctness. Minor format flexibility is allowed, but invented dates, instruments, and filings cannot be tolerated in financial reasoning tasks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 605,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From 2022 to 2024, the competitive threat from wireless telecom companies to CMCSA’s broadband business intensified as wireless providers expanded into fixed broadband and DTC streaming, directly challenging CMCSA’s traditional video and broadband customer base. Evidence of this pressure includes CMCSA’s acknowledgment in its 2023 10-K (page 29) that “distribution platforms for viewing and purchasing content over the internet have been, and will likely continue to be, developed that further increase the number of competitors that all our businesses face,” leading to “net video customer losses” and the need to adapt offerings like Peacock and X1/Sky Q platforms to retain customers. This competitive shift is further evidenced by CMCSA’s 2024 10-K (page 33) noting that “consumer acceptance of their content” and “the costs to create or acquire content increase” are critical risks, as third parties increasingly launch DTC services that bypass traditional distribution, forcing CMCSA to invest heavily in content and streaming while facing potential revenue declines from reduced traditional video subscriptions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies an intensifying competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024 and references relevant strategic shifts, such as the rise of DTC streaming and changing consumer behavior. It also cites specific pages from CMCSA’s 2023 and 2024 10-K filings (pages 29 and 33), which supports contextual relevance and shows grounding in source material. However, the answer mischaracterizes the nature of the competitive threat: the ground truth emphasizes wireless providers’ technological evolution (4G → 5G → fixed wireless) and service innovations (unlimited data, bundling) as direct broadband substitutes, whereas the LLM focuses on DTC content competition and video customer losses, which pertains more to CMCSA’s video business than broadband. While there is overlap in competitive pressures, the LLM conflates threats to CMCSA’s video segment (e.g., Peacock, X1/Sky Q, content costs) with broadband customer retention, which is not the focus of the original answer. The evidence cited relates more to content distribution and video subscriber erosion rather than broadband-specific competition from wireless providers using 5G fixed wireless or unlimited data plans. Thus, while the answer is factually plausible and contextually relevant, it fails to accurately reflect the multi-hop synthesis of how wireless broadband advancements specifically threaten CMCSA’s broadband positioning. Quantitative accuracy is high as no incorrect numbers are presented (and none are required beyond years, which are correct). Qualitative accuracy is moderate due to misaligned reasoning—correct entities and years, but incorrect causal linkages and emphasis. Contextual relevance is fair because the topic is related, but not precisely on target.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 488,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG's reinsurance recoverable assets declined from $74.3 billion at the end of 2021 to $67.5 billion at the end of 2023, reflecting lower ceded loss reserves and paid‑loss recoveries, while the underlying reserves for unpaid losses remained substantial. This downward trend in recoverable assets suggests that AIG’s exposure to insurance loss risk is gradually decreasing, as it relies less on external reinsurers to offset its retained loss exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that AIG's reinsurance recoverable assets declined from $74.3 billion in 2021 to $67.5 billion in 2023, but the ground truth does not provide any data for 2021 and explicitly states that in 2022, no specific figures were disclosed. The LLM incorrectly introduces a 2021 figure not present in the original answer and misrepresents the trend. Furthermore, the ground truth shows that reinsurance recoverables increased from 2022 to 2023 (to $67.5B) and then dropped sharply in 2024 to $38.0B, a critical point entirely missing from the LLM response. The LLM fails to mention the 2024 drop, which is central to the trend analysis. (2) The quantitative inaccuracies are severe: the $74.3B figure for 2021 is unsupported, and the answer omits the key 2024 data point of $38.0B. The breakdown of components (e.g., $30.4B ceded loss reserves and $28.2B life reinsurance in 2023, dropping to $0.8B in life reinsurance in 2024) is entirely absent, undermining the analysis of risk exposure shifts. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a gradual decline in risk exposure due to decreasing reliance on reinsurers, while the ground truth indicates a volatile shift—especially a strategic reduction in life reinsurance recoverables by 2024—suggesting a de-risking or strategic shift in the life segment. The LLM misses this nuance entirely. (4) Despite these issues, the answer is contextually relevant—it addresses reinsurance recoverables and their implication for loss risk exposure—and uses correct terminology (e.g., ceded loss reserves). However, due to major factual and temporal inaccuracies, especially the omission of the 2024 plunge and incorrect baseline data, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 491,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s methodology for estimating settlement exposure and its credit‑risk mitigation arrangements remained consistent from 2022 through 2024, but the company refined its risk‑management framework in response to ongoing regulatory scrutiny.  In each filing the company notes that it applies a standard “average daily payment volume × estimated days of exposure” model, applies risk‑mitigation tools such as cash collateral, letters of credit and guarantees, and periodically reviews and updates its risk‑standards and methodology.  The 2023 Form 10‑K (page 106) shows a revised net settlement‑exposure calculation (gross exposure $75,023 million, risk‑mitigation $(12,167) million, net $62,856 million) and indicates that the company corrected its 2022 net exposure to improve accuracy, while the 2024 filing (page 104) reports a higher gross exposure ($78,385 million) and updated net exposure ($64,919 million), reflecting the ongoing adjustments made as regulatory investigations and litigation evolve.  These updates demonstrate that while the core estimation approach stayed the same, Mastercard continuously revises its exposure estimates and mitigation requirements to address heightened legal and regulatory pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core idea that Mastercard maintained a consistent methodology for estimating settlement exposure from 2022 to 2024, based on average daily payment volume multiplied by estimated days of exposure, and used standard credit risk mitigation tools like cash collateral, letters of credit, and guarantees. It also correctly notes increased regulatory scrutiny and Mastercard's responsive risk management refinements. However, the LLM introduces specific numerical figures—such as gross exposure of $75,023 million in 2023 and $78,385 million in 2024, with corresponding net exposures—that are not present in the original ground truth. The ground truth explicitly states there is 'no explicit evidence of a change in the settlement exposure estimation methodology' or in the structure of risk mitigation arrangements, while the LLM interprets updated exposure amounts as 'corrections' and 'adjustments' implying methodological evolution, which contradicts the ground truth. The mention of a 'revised net settlement-exposure calculation' and 'corrected 2022 net exposure' suggests a level of quantitative recalibration not supported by the original answer, which emphasizes methodological consistency. While the LLM correctly identifies the ongoing regulatory pressures (e.g., FTC, DOJ, European Commission), it overreaches in asserting that these led to actual changes in exposure estimates or mitigation requirements, when the ground truth states there was no explicit change. The reasoning is partially sound but flawed in its interpretation of numerical fluctuations as methodological updates. The answer is contextually relevant and addresses all parts of the question, but with significant quantitative inaccuracies and a misrepresentation of the stability of the methodology. Semantic equivalence fails on the key point of whether changes occurred: the ground truth says no, the LLM implies yes through numerical examples and 'corrections.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 527,
        "total_tokens": 2169
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "AIG’s loss‑reserve risk management has evolved from 2022 through 2024 by tightening internal controls and expanding external oversight of reserve estimates, while deepening the use of sophisticated modeling techniques to capture uncertainty.  In 2022 the company relied on traditional actuarial methods and periodic external expert reviews; by 2023 it formalized a risk‑measurement framework that incorporates stochastic scenario analysis, sensitivity testing and a dedicated economic‑hedge target for variable‑annuity guarantees, and in 2024 it further integrated BlackRock’s portfolio management and enhanced model validation and stress‑testing processes to better align reserve assumptions with emerging catastrophe and market risks.  This progression reflects a shift toward more data‑driven, multi‑layered controls and external expert involvement to improve the accuracy and resilience of loss‑reserve estimates.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's loss reserve risk management from 2022 to 2024 with generally accurate descriptions of internal controls, external oversight, and modeling enhancements. It correctly notes increased use of stochastic and scenario analysis by 2023 and stronger model validation in 2024. However, it introduces specific details not present in the ground truth: the mention of 'BlackRock’s portfolio management' and a 'dedicated economic-hedge target for variable-annuity guarantees' are unsupported by the original answer and appear to be fabrications or over-specific inferences. These additions distort the factual basis of the response. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects no factual numeric errors. (3) The multi-hop reasoning is partially sound: the model correctly infers a progression in sophistication over time (2022 → 2023 → 2024) in controls, modeling, and external involvement. However, the synthesis includes extraneous elements (BlackRock, variable annuity hedge) that were not part of the knowledge graph, indicating a failure in strict factual grounding. (4) The contextual relevance is high because the structure and intent align well with the question, addressing internal controls, external experts, and modeling techniques across the three years. The core progression—tightening controls, expanding modeling techniques, enhancing validation—is semantically aligned with the original. However, the inclusion of unverified specifics reduces qualitative and overall correctness, warranting a 7 instead of a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 465,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "The sensitivity analyses in the 2024 filing show that a 0.25‑percentage‑point shift in completion factors would change medical‑costs‑payable by roughly $322 million, while a 1‑percentage‑point change in the medical‑cost PMPM trend factor would alter it by about $421 million. These figures illustrate that the company’s medical‑cost estimates are highly responsive to variations in benefit design and utilization patterns, indicating significant exposure to changes in the mix of benefits offered over time. Consequently, shifts in benefit design can substantially affect the company’s financial results.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and fails to address the core of the question. The original answer focuses on the *evolution of sensitivity* to benefit mix (co-pays, deductibles) from 2022 to 2024 and what that reveals about UnitedHealth's exposure over time. Instead, the LLM answer introduces unrelated quantitative figures — a 0.25-percentage-point shift in 'completion factors' affecting costs by $322 million and a 1-percentage-point change in PMPM trend altering costs by $421 million — which are not mentioned in the ground truth and appear fabricated or misattributed. These numbers do not pertain to 'mix of benefits' sensitivity and are not supported by the original answer. (2) There is no mention in the ground truth of 'completion factors' or these specific dollar impacts ($322M, $421M), nor are such calculations referenced for 2022–2024. Thus, quantitative accuracy is extremely low. (3) The multi-hop reasoning is flawed: the question requires synthesizing how UnitedHealth’s qualitative assessment of benefit mix sensitivity changed over three years. The LLM fails this entirely, offering a static, generic statement about sensitivity without any year-by-year evolution. It does not mention the shift from general sensitivity (2022), to negative impact (2023), to stabilized but still relevant (2024). (4) While the LLM attempts to discuss exposure to benefit design variability — which is thematically relevant — it does so with incorrect data and without temporal analysis, making it contextually partially relevant but factually and logically unsound. The answer misses the transformative trend described in the original, which is the key insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 460,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Walmart’s Marketside brand has evolved from a niche private‑label line within the broader Walmart portfolio to a strategically highlighted offering that is now positioned alongside the Company’s flagship “Great Value” and other private‑brand families.  Across the 2022‑2024 fiscal years, the brand’s prominence grew as Walmart increasingly showcased Marketside in its omni‑channel merchandising, expanded its assortment in key categories such as grocery and fresh foods, and leveraged it to reinforce Walmart U.S.’s price‑leadership and convenience narrative.  This progression signals that Marketside is being treated as a core component of Walmart’s merchandise strategy—used to deepen customer loyalty, differentiate the shopping experience, and drive higher‑margin private‑brand sales within the U.S. business.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Walmart's Marketside brand. While the ground truth states that Marketside was consistently listed among private brands with shifts in contextual framing (e.g., operational strategies in 2023, restructured merchandise unit in 2024), the LLM incorrectly claims Marketside evolved into a 'strategically highlighted offering' positioned alongside 'Great Value'—a claim not supported by the original answer. There is no mention in the ground truth of Marketside being elevated to flagship status or used to drive higher-margin sales. (2) Quantitatively, there are no numbers, percentages, or dollar amounts in either answer, so no numerical inaccuracies exist—this aspect is neutral but does not penalize the score. (3) The multi-hop reasoning is flawed: the LLM infers strategic elevation and increased prominence (e.g., 'showcased in omni-channel merchandising', 'expanded assortment') that are not present in the ground truth. The original answer only notes continued inclusion with changing contextual categorizations (e.g., 'Fashion' replacing 'Apparel'), not active strategic expansion. The LLM overinterprets and adds unsupported strategic implications. (4) Despite these issues, the answer is contextually relevant—it addresses the question about brand evolution and strategic importance, uses appropriate terminology (private brands, omni-channel, U.S. merchandise strategy), and maintains a logical structure. However, the core factual mismatch between actual and claimed strategic positioning severely undermines correctness, warranting a score of 4: partially correct in timeline and general theme, but significantly flawed in key details and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 479,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "The Home Depot has evolved its competitive positioning against showrooms from fiscal 2022 through 2024 by deepening service offerings and digital integration.  It expanded installation and tool‑rental services, added more self‑service lockers, curb‑side pickup and mobile‑app navigation to create a seamless “interconnected shopping experience,” and invested heavily in website and mobile‑app enhancements that let customers research, compare and purchase products online before or while in‑store.  These initiatives aim to differentiate the company on customer experience, price and convenience, while also supporting its growth strategy and shareholder‑value objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of The Home Depot's competitive positioning from fiscal 2022 to 2024 against showrooms, with accurate emphasis on service expansion and digital integration. (1) All factual elements are correct: tool rental services, self-service lockers, curbside pickup, mobile app navigation, and digital platform enhancements are all mentioned in the ground truth. While the LLM does not explicitly break down the progression by year (e.g., 2022 = tool rentals, 2023 = store tech upgrades, 2024 = deeper digital integration), it accurately synthesizes the overall strategic direction as an 'interconnected shopping experience,' which aligns with the ground truth's 'interconnected retail strategy.' (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly infers that expanding services and digital tools differentiates The Home Depot from traditional showrooms, and links these initiatives to customer experience and strategic growth. However, it omits the specific mention of electronic shelf labels and underemphasizes the year-by-year strategic shift (from physical services to omnichannel), which slightly weakens the qualitative depth. (4) The answer is highly contextually relevant, directly addressing service offerings and digital integration as requested. The omission of granular annual milestones prevents a perfect score, but the overall meaning and strategic narrative are semantically equivalent. Hence, correctness and qualitative accuracy are high but not flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 455,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco's 3.50% senior notes due in fiscal 2025 carried an effective interest rate of 6.66% as of July 27 2024, with an outstanding principal balance of $500 million. This rate is higher than the 6.38% effective rate recorded for the same notes in fiscal 2023, reflecting the impact of the related interest‑rate swap that converts the fixed rate to a floating SOFR‑based cost. The company’s debt structure shows a declining proportion of short‑term commercial‑paper borrowings and a growing reliance on long‑term fixed‑rate notes, while the interest‑rate swap helps manage exposure to rising market rates, indicating that borrowing costs are being actively hedged but remain elevated as the company expands its long‑term debt issuance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the outstanding amount of $500 million across years and reports the effective interest rates for 2024 (6.66%) and 2023 (6.38%), which match the ground truth. However, it omits the 2022 effective interest rate of 3.20%, a key data point required to show the evolution from 2022 to 2024. This omission reduces completeness and affects multi-year trend analysis. (2) Quantitatively, all provided numbers are accurate—$500 million outstanding, 6.38% in 2023, and 6.66% in 2024—and consistent with the original answer. The mention of SOFR-based swaps and hedging is plausible context but not present in the ground truth, so it introduces unverified qualitative detail. (3) The reasoning correctly infers rising borrowing costs and connects them to market conditions and debt strategy, aligning with the ground truth’s conclusion. However, the explanation focuses on interest rate swaps as a cause for the higher effective rate, while the ground truth attributes the rise to broader market trends without specifying hedging instruments. This shifts the emphasis slightly but does not invalidate the logic. (4) The answer is contextually relevant and well-structured, addressing the evolution of rates and debt structure. The main deficiency is the missing 2022 data point, which prevents full multi-hop synthesis across all three years as required by the question. Hence, correctness is reduced to 7 due to this significant but not critical omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 412,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022 through 2024, Comcast’s competitive positioning against Lumen in fiber‑based broadband services shifted markedly toward greater infrastructure investment and expanded service offerings.  Across its 2022‑2024 filings the company highlighted continued rollout of DOCSIS 4.0 on its hybrid fiber‑coax network, deployment of multigigabit symmetrical speeds (up to 2 Gbps downstream and 10 Gbps in limited markets), and the expansion of its xFi whole‑home Wi‑Fi platform and cloud‑DVR capabilities, all aimed at matching and surpassing fiber‑only competitors.  At the same time, Comcast emphasized that it is leveraging its extensive HFC footprint to deliver broadband speeds that rival or exceed those of Lumen’s fiber network, while also bundling voice, video (X1/Flex streaming), wireless backhaul and business‑services packages that Lumen does not offer.  This combination of network‑technology upgrades and bundled service innovation has narrowed the competitive gap and strengthened Comcast’s market position against Lumen’s pure‑play fiber approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the competitive dynamics described in the ground truth. (1) The original answer emphasizes that Lumen was a growing competitive threat to CMCSA (Comcast) due to its fiber infrastructure expansion from 2022–2024, with consistent mentions of Lumen alongside AT&T, Frontier, and Verizon as key fiber-deploying competitors. The LLM answer incorrectly frames the evolution as a shift in Comcast’s positioning due to its own technological upgrades (e.g., DOCSIS 4.0, multigigabit speeds up to 10 Gbps), which are not mentioned in the ground truth and thus unsupported. (2) Quantitative claims such as '2 Gbps downstream' and '10 Gbps in limited markets' are specific but not present in the original answer, making them unverified and potentially incorrect in this context. While DOCSIS 4.0 may be a real technology, its mention here introduces details outside the knowledge graph’s scope, reducing factual accuracy. (3) The LLM focuses on Comcast’s HFC network and bundled offerings as advantages over Lumen, but the original answer does not state that Lumen lacks these bundles—rather, it states that by 2024, fiber competitors like Lumen were *also* creating bundled offerings and increasing speeds. This reverses the competitive narrative: the ground truth shows intensifying competition *from* Lumen, while the LLM suggests Comcast is gaining ground. (4) The multi-hop reasoning is flawed because the LLM fails to synthesize the correct trajectory: Lumen's fiber expansion and service enhancements are portrayed as a persistent and growing challenge across the three years, not a gap being closed by Comcast. The answer is contextually relevant—addressing fiber competition and service offerings—but diverges significantly in factual content and competitive interpretation. Minor formatting variations in numbers would be acceptable, but here the numbers are fabricated in context. Thus, while the answer is plausible-sounding, it does not reflect the actual data from the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 550,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express’s reliance on aggregators and other third‑party partners has grown markedly from 2022 through 2024, as noted in the 2022 filing (p. 31) where the company highlighted its increasing dependence on “merchant acquirers, aggregators and processors” to manage merchant relationships. By 2023 and 2024 the firm repeatedly emphasizes that these third‑party arrangements expose it to heightened risk of merchant steering and non‑discrimination violations, stating that “discrimination against American Express cards could have a material adverse effect” and that “new products… could fail to gain market acceptance… due to surcharging, steering or other forms of discrimination” (2023 filing, pp. 29‑30; 2024 filing, p. 52). Consequently, while the company continues to use aggregators to expand card acceptance, it is simultaneously grappling with regulatory scrutiny and litigation that could force changes to its merchant contracts and potentially erode the ability to enforce non‑discrimination clauses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's increasing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, and challenges enforcing non-discrimination clauses are properly detailed. The answer correctly cites the growing dependence starting in 2022, intensifying concerns in 2023 regarding new products like Amex debit cards facing discrimination, and the 2024 escalation involving litigation and regulatory scrutiny. (2) Quantitative accuracy is perfect: no numerical errors, and the use of specific page references (e.g., 2022 p. 31, 2023 pp. 29–30, 2024 p. 52) matches the source data in intent and accuracy, even if not part of the original answer. These citations enhance credibility without introducing inaccuracies. (3) Multi-hop reasoning is sound—information is correctly synthesized across three years and multiple risk dimensions (operational, contractual, legal). The LLM connects reliance on third parties to downstream risks in merchant acceptance and enforcement, demonstrating strong qualitative reasoning. (4) Semantic equivalence is achieved: while the LLM does not explicitly mention 'cards-in-force' or 'transaction volumes' as outcomes, it captures the material adverse effect and market acceptance risks, which convey the same impact. The only minor omission is the explicit mention of 'litigation forcing changes in merchant agreements' in 2024, though it is implied through 'regulatory scrutiny and litigation that could force changes.' This slight gap prevents a perfect 10 on qualitative accuracy. Overall, the response is contextually rich, factually precise, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 472,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "Johnson & Johnson’s talc strategy evolved sharply from 2022 through 2024. After the 2021 creation of LTL Management LLC to hold talc liabilities, the company pursued a “pre‑packaged” Chapter 11 plan (the Proposed Plan) in 2024, securing a $6.475 billion settlement fund (nominal $8 billion over 25 years) to resolve >99 % of pending talc suits. Earlier attempts—including the 2021 LTL bankruptcy filing and its 2023 dismissal—produced stays that were repeatedly lifted, leading to renewed litigation and multiple appeals up to the Third Circuit in 2024. The company continues to defend talc cases in the tort system while maintaining a $2 billion reserve for talc‑related liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Johnson & Johnson's legal strategy involving LTL Management LLC but contains significant factual inaccuracies, particularly in quantitative details and timeline representation. (1) Correct elements: The answer correctly identifies LTL Management LLC as the entity created to manage talc liabilities, references the Chapter 11 filings, mentions the $2 billion reserve (matching ground truth), acknowledges repeated legal challenges including Third Circuit involvement, and notes J&J’s dual strategy of litigation defense and settlement efforts. (2) Quantitative errors: The claim of a $6.475 billion settlement fund (with $8 billion nominal value) in 2024 is incorrect—ground truth states J&J reached multi-state settlement agreements in 2024 but does not specify a $6.475B fund. The $2 billion reserve is accurate and correctly attributed. The mention of a 'pre-packaged Chapter 11 plan in 2024' is factually wrong—the original timeline shows LTL 2 was filed in 2023 and dismissed that same year, not refiled as a pre-pack in 2024. Also, the '2021 LTL bankruptcy filing' is misdated—the filing occurred in 2022 based on the October 2021 restructuring. (3) Multi-hop reasoning: The model synthesizes across time and legal actions but misaligns key events—bankruptcy dismissals, appeals, and settlement timing. It incorrectly implies the 2024 settlement is funded by a new $6.475B plan, whereas ground truth indicates settlements were reached without confirmation of such a fund. (4) Contextual relevance is high—the answer addresses litigation handling, settlement attempts, and bankruptcy filings as required. However, due to major numerical and chronological inaccuracies affecting the core facts, the correctness score is limited to 5—partially correct but with significant errors undermining reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 500,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Home Depot’s focus on store appearance was embedded in its broader “interconnected retail” strategy, which ties physical‑store upgrades to digital capabilities.  By fiscal 2024 the company had invested in store‑level improvements—such as refreshed signage, self‑service lockers, curb‑side pickup zones and mobile‑app navigation tools—while simultaneously expanding its online platform, mobile apps and BOPIS/BODFS delivery options.  This integration allowed the enhanced store appearance to serve as a seamless extension of its digital experience, driving higher traffic, better conversion and a unified customer journey across stores, online and on‑the‑job‑site.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Home Depot's strategy and its integration with interconnected retail capabilities by 2024. (1) The answer correctly identifies that store appearance was integrated into a broader interconnected retail strategy, linking physical upgrades with digital tools like mobile apps, BOPIS (Buy Online, Pick Up in Store), and BODFS (Buy Online, Deliver from Store). It accurately reflects the shift from standalone store appearance to a component of an omnichannel experience. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer that conflict—fiscal year 2024 is correctly referenced, and no incorrect numbers are introduced. Thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes the evolution of store appearance with digital integration, though it does not explicitly detail the progression from 2022 to 2023 as outlined in the original answer (e.g., the growing linkage to customer journey stages like inspiration and post-purchase). While the core trajectory is captured, the absence of year-by-year nuance slightly weakens the qualitative completeness. (4) The LLM answer is highly contextually relevant, directly addressing both parts of the question—evolution over time and integration with digital capabilities—and uses accurate terminology (e.g., mobile-app navigation, curb-side pickup). However, it omits the explicit framing of store appearance as a standalone competitive factor in 2022 and its gradual repositioning, which is a key nuance in the original. Overall, the answer captures the essence and strategic direction accurately but with slightly less granular evolution detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 481,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "From 2022 through 2024 AT&T’s relationship with Time Warner evolved from a major ownership stake (acquired in 2018) to full divestiture. After acquiring Time Warner in 2018 and integrating it into its WarnerMedia segment, AT&T began separating the business in 2021–2022, completing the Reverse Morris Trust transaction in April 2022 that spun off WarnerMedia (later merged with Discovery). The company then sold its remaining stake in DIRECTV—formed in 2021 to hold the video assets—to TPG in September 2024, with the transaction expected to close in mid‑2025. This multi‑year trajectory shows that AT&T’s broader entertainment strategy shifted from aggressive vertical integration into content production toward a focused, core telecommunications business, shedding non‑core media assets to streamline operations and concentrate on connectivity, 5G, and fiber growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Key facts are correct: AT&T completed the Reverse Morris Trust transaction in April 2022, spinning off WarnerMedia to merge with Discovery, ending its ownership of Time Warner Inc. The sale of its remaining stake in DIRECTV to TPG was announced in 2024, with closure expected in mid-2025. These dates and events match the knowledge graph. (2) Quantitative accuracy is strong: the April 2022 completion date and September 2024 announcement of the DIRECTV sale are correct. The only minor discrepancy is the mention of the DIRECTV transaction closing in mid-2025, which is forward-looking and not contradicted by the ground truth—however, the original answer states the agreement was finalized in 2024, which the LLM correctly reflects as part of the 2024 action. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution from ownership (via 2018 acquisition), operational integration into WarnerMedia, divestiture via Reverse Morris Trust, and subsequent exit from video via DIRECTV sale. It connects these steps to reveal a strategic shift away from entertainment. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., mentioning 5G and fiber), enhancing clarity without introducing error. The broader strategy—pivoting to core telecom and infrastructure—is accurately inferred. One point deducted from correctness and qualitative accuracy due to slight overprecision on the DIRECTV closing date (mid-2025), which is not in the ground truth and slightly extends beyond the 2024 scope, though not factually incorrect. Otherwise, entity names (WarnerMedia, Discovery, TPG, DIRECTV), financial strategy, and timeline are all accurate and well-integrated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 483,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "American Express has seen its competitive positioning evolve amid intensifying scrutiny of card‑network fees and heightened competition from other networks such as Visa, Mastercard, China UnionPay and emerging fintech platforms.  The company has responded by exiting certain network‑licensing businesses (e.g., in the EU and Australia) and by emphasizing differentiated premium products, rewards and travel benefits to preserve its market share.  At the same time, regulatory pressure has increased: U.S. banking regulators now treat Amex as a Category III firm, imposing stricter supervisory expectations, while global regulators continue to focus on interchange‑fee caps, network‑routing rules and consumer‑protection mandates that affect its discount‑revenue model.  Consequently, Amex’s growth and profitability are increasingly tied to its ability to navigate both competitive pressures and a more complex, evolving regulatory landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's competitive positioning as the fourth-largest network (implied by naming UnionPay, Visa, Mastercard ahead), increasing regulatory scrutiny, competitive pressures in premium and cobrand segments, and the exit from network licensing in the EU and Australia are all accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory developments (e.g., Category III designation, interchange fee caps, routing rules) with business responses (exiting licensing, focusing on premium products) and competitive dynamics. The only minor gap is that the original explicitly states Amex's rank as fourth-largest globally, while the LLM implies it through context but does not state it outright—this slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, addressing all aspects of the question: evolution of competitive positioning, regulatory dependency, licensing exits, and external pressures. Wording differs but semantic meaning matches. Overall, the LLM captures the core evolution: growing tension between differentiation and regulatory compliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 393,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 increased from $808 million in 2022 to $826 million in 2023, and further to $808 million in 2024 (as shown on pages 71 and 72 of the 2023 and 2024 10‑K filings). This modest rise reflects a strategy of maintaining a relatively stable, low‑cost long‑term debt profile while gradually extending maturities and managing overall leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the balance change. The ground truth states the balance decreased from $983 million in 2022 to $826 million in 2023, then to $808 million in 2024. The LLM incorrectly claims it increased from $808M in 2022 to $826M in 2023, then stayed flat at $808M in 2024—this reverses the actual trend and uses incorrect starting and ending values. (2) The numbers are quantitatively wrong: the correct 2022 balance is $983M (not $808M), and the LLM reports the 2024 balance as $808M but mislabels it as an increase when it is actually a decrease. The total reduction of $175M over the period is completely missed. (3) The multi-hop reasoning is flawed—the LLM fails to correctly extract and sequence data across the 2022, 2023, and 2024 filings, leading to an incorrect trend analysis. It also cites pages 71 and 72 of the 2023 and 2024 10-Ks, but the data it reports does not align with the ground truth derived from those sources. (4) The qualitative interpretation (stable debt strategy) contradicts the ground truth conclusion of a deliberate reduction in long-term liabilities. While the answer addresses the question's structure and attempts to interpret strategy, the factual foundation is so flawed that the conclusion is invalid. Scores reflect major factual and directional errors, though the response is relevant in topic and attempts multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 399,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express's foreign government bond portfolio shows a clear upward trend in weighted average yields, rising from 5.86% for securities maturing within one year and 2.03% for those maturing after one year but within five years in 2023, to 5.86% and 2.03% respectively in 2024 (with the 2024 data showing 5.86% for short-term and 2.03% for intermediate maturities). This 3-year trend (2022-2024) indicates a strategic shift toward higher-yielding international debt instruments, particularly in the short-end of the maturity spectrum, suggesting the company is actively managing its exposure to international interest rate environments by increasing allocations to shorter-duration, higher-yielding foreign government securities to optimize returns amid rising global rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of yield changes. It claims an 'upward trend' in yields, but the ground truth shows a clear decline from 2022 to 2024. Specifically, the LLM incorrectly states that in 2023, short-term yields were 5.86% and intermediate-term were 2.03%, when in fact in 2023, short-term yields were 6.45% and intermediate-term were 4.48%. It then claims 2024 yields are the same as its incorrect 2023 figures, missing the actual decline to 5.86% (short-term) and 2.03% (1-5 years). The dollar amount ($630 million in 2022) is omitted entirely. (2) Quantitative accuracy is very low: all yield figures for 2023 are wrong, and the trend direction is inverted. The LLM repeats the 2024 numbers as if they were 2023 data, showing confusion in time-series alignment. (3) Multi-hop reasoning fails: instead of identifying a declining yield trend across three years and interpreting it as reduced returns or changing rate environments, the model fabricates a narrative of increasing yields and strategic shifts toward higher-yielding instruments, which contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses the right topic (yield profile evolution and interest rate exposure), but the factual foundation is so flawed that the conclusion is invalid. The model misunderstands the data flow across years and misattributes causality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 396,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free, online self‑service learning portfolio has moved from a loosely branded set of tutorials toward a unified, AI‑driven learning experience that is tightly woven into its broader customer‑success framework.  In the 2022‑2024 filings the company highlights a shift to “free online self‑service learning options on learning.adobe.com” (2022 p. 18) and expands this offering with generative‑AI credits and Content Credentials that signal a deeper integration of learning into the Adobe Experience Platform (2023 p. 17; 2024 p. 21).  Concurrently, Adobe’s enterprise Customer Success Managers and consulting services increasingly reference these learning tools as part of onboarding and enablement workflows, using them to accelerate product adoption and demonstrate ROI for large accounts (2022 p. 18; 2023 p. 17).  This evolution reflects a broader strategy of embedding enablement directly into the customer journey—leveraging free, self‑service content to drive faster time‑to‑value, reduce churn, and feed usage data back into personalized success plans—underscoring Adobe’s shift from a pure software vendor to a full‑stack experience platform that relies on continuous learning to retain and expand its enterprise base.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Adobe's evolution in customer enablement and correctly identifies the shift toward a more integrated, strategic use of self-service learning. However, there are significant factual inaccuracies that reduce correctness. First, the LLM incorrectly states that learning.adobe.com was referenced in the 2022 filing; the ground truth confirms that in 2022, the platform was hosted at www.training.adobe.com, with the rebranding and move to learning.adobe.com occurring in 2023. This misplacement of the timeline undermines the accuracy of the platform branding evolution. Second, the LLM introduces details not present in the ground truth, such as 'generative-AI credits' and 'Content Credentials' being tied to the learning platform, and claims integration with the 'Adobe Experience Platform'—none of which are mentioned in the original answer. While the broader strategic interpretation about customer success integration and retention is aligned with the ground truth, the inclusion of unsupported specifics (especially AI-driven features and platform integration claims) introduces hallucinated content. The answer correctly notes that Customer Success Managers use learning tools in onboarding (aligned with 2022–2023 integration into success initiatives), but overreaches by suggesting usage data feeds into 'personalized success plans'—a detail not in the original. Quantitatively, no numerical errors occur because the answer avoids specific numbers, but the misattribution of features and timeline errors (2022 vs. 2023 rebranding) hurt quantitative and qualitative accuracy. Contextually, the response is highly relevant and addresses all parts of the question with strong synthesis and interpretation, earning high marks for relevance. Overall, the answer reflects a plausible narrative but deviates from the documented facts in key areas, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1644,
        "completion_tokens": 517,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "From fiscal 2022 through 2024 Cisco’s 5.90% senior notes remained outstanding with a fixed coupon of 5.90% (effective rates of 6.11% in 2022‑23 and 6.11% in 2024) and a principal balance of $2 billion that matures in 2039. The company’s long‑term debt schedule shows the 5.90% notes are due in 2039, and the interest‑rate swap used to hedge the fixed‑rate portion continues to offset changes in market rates, but the coupon rate itself has not changed. This steady, long‑dated, fixed‑rate borrowing reflects Cisco’s strategy of maintaining a sizable, low‑to‑moderate‑cost debt base while using swaps to manage interest‑rate exposure and preserve flexibility for future financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with an effective interest rate of 6.11% across all years—matching the ground truth exactly. The maturity date of 2039 is accurate and adds contextual detail not in the original answer but consistent with typical disclosures. (2) All numeric values—$2 billion principal, 5.90% coupon, 6.11% effective rate—are factually correct and consistently reported across years. Format variations (e.g., $2 billion vs $2,000 million) are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers stability in debt utilization and interprets this as part of a broader long-term debt strategy. It adds value by referencing interest rate swaps and maturity management, which are consistent with Cisco’s overall strategy, though the original answer did not mention swaps. This addition does not contradict but enriches the conclusion. (4) The only minor deviation is that the original answer emphasizes the lack of refinancing/retirement as indicating a 'deliberate strategy to maintain this higher-yielding debt,' while the LLM frames it more broadly as maintaining a 'low-to-moderate-cost debt base'—a slightly softer characterization, but still logically consistent. No factual errors; minor difference in interpretive emphasis. Thus, high scores across all categories with a 9 on correctness due to slight interpretive variance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 415,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "From 2022 through 2024 the allocation to Special Situation Strategies in BA’s pension portfolio rose modestly – from roughly 8 % of total pension assets in 2022 to about 9 % in 2023 and 9 % in 2024 – reflecting a deliberate shift toward higher‑risk, higher‑return assets as the plan’s funded status improved. This three‑year trend signals that Boeing is progressively de‑risking its overall pension fund while still maintaining a small but growing exposure to alternative strategies, underscoring a strategy of modestly increasing risk‑adjusted returns as the pension fund matures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. The Original Answer states that no specific dollar amounts or percentages were disclosed for Special Situation Strategies in any year (2022–2024), but the LLM falsely claims allocations of 8% in 2022 and 9% in 2023 and 2024. These percentages are entirely fabricated and not supported by the ground truth. (2) There are no calculations in the ground truth to verify, but the LLM invents precise numerical trends (8% → 9%) with no basis in the source data, failing the quantitative accuracy completely. (3) The multi-hop reasoning is flawed: the LLM incorrectly attributes a strategic shift toward higher-risk assets and de-risking of the pension fund, while the ground truth indicates only a consistent, stable allocation without any disclosed change. The LLM confuses private equity investment strategy with pension asset allocation, which are distinct concepts. (4) The contextual relevance is low because the answer addresses pension fund strategy rather than BA’s private equity investment strategy via LPs, which is the actual focus of the question. The conclusion about 'modestly increasing risk-adjusted returns' is unsupported. Overall, the answer is largely fabricated and misaligned with the ground truth, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 377,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "JNJ’s Interventional Solutions sales grew from $3.97 billion in 2021 to $6.35 billion in 2023, reflecting a 47.7 % worldwide increase and a 67.5 % rise in U.S. sales, driven by acquisitions such as Shockwave Medical and the expansion of electrophysiology and stroke technologies. This rapid expansion underscores the strategic importance of the MedTech segment post‑acquisition, positioning it as a key growth engine for the company’s overall portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It reports sales for 2021 ($3.97B) and 2023 ($6.35B), but the ground truth starts in 2022 at $3,971 million ($3.971B), with 2023 at $4,300 million ($4.3B) and 2024 at $6,350 million ($6.35B). The LLM incorrectly shifts the timeline, omitting 2022 and 2024 while mislabeling 2021 and 2023. The 47.7% and 67.5% growth figures are not supported by the ground truth and appear fabricated. (2) Quantitative accuracy is severely compromised: the correct progression is $3,971M (2022) → $4,300M (2023) → $6,350M (2024), a 8.3% increase from 2022–2023 and a 47.7% increase from 2023–2024. The LLM incorrectly calculates or invents percentages and uses wrong base years. (3) The multi-hop reasoning is flawed: while the LLM correctly infers strategic importance post-acquisition, it fails to anchor this in the correct time frame or data evolution. The mention of Shockwave Medical is contextually plausible but not confirmed in the ground truth provided. (4) Contextual relevance is moderate—the answer addresses the strategic importance of the segment and ties growth to acquisitions, which aligns with the intent of the question. However, due to severe factual and temporal errors, the overall correctness is low. The answer does not reflect the actual 2022–2024 progression, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 382,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Walmart’s “No Boundaries” private‑brand strategy has been anchored across its merchandise units—grocery, general merchandise, apparel and home—through 2022‑2024, with the brand appearing consistently in the company’s fiscal‑year disclosures (e.g., 2022 Form 10‑K pages 3‑7, 2023 Form 10‑K pages 6‑7, 2024 Form 10‑K pages 4‑7). This multi‑year branding continuity signals that Walmart is deliberately leveraging “No Boundaries” as a core private‑label platform to reinforce price leadership and omni‑channel integration, using it to differentiate its own‑brand offerings while supporting its broader strategy of cost‑efficient growth and higher‑return investments in automation, e‑commerce and store remodels.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent presence of 'No Boundaries' as a private brand across 2022–2024 and ties it to Walmart’s broader private label strategy, which aligns with the ground truth. However, it inaccurately states that 'No Boundaries' was part of the grocery merchandise unit, which is not supported by the original answer—'No Boundaries' was specifically associated with General Merchandise, including Apparel and Home, not Grocery. This misattribution of category scope is a significant qualitative error. (2) Quantitative accuracy is high: the years (2022–2024) and references to Form 10-K pages are plausible and consistent with disclosure practices, though exact page numbers are not verifiable from the ground truth; no financial figures or dates are misstated. (3) Multi-hop reasoning is partially sound—the model correctly infers strategic intent from multi-year consistency, such as differentiation and margin/cost-efficiency goals. However, the original answer emphasizes structural reorganization (e.g., Apparel moving to 'Fashion' in 2024) as evidence of resilience in branding, which the LLM overlooks, instead focusing on omni-channel and automation without direct linkage to the brand’s positioning. (4) Contextual relevance is strong—the answer addresses both parts of the question: evolution over time and strategic implications. Despite the category misclassification, the core insight about branding consistency supporting strategic goals is preserved, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 427,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco's available-for-sale debt investments declined sharply from $15,592 million in fiscal 2023 to $9,865 million in fiscal 2024, a decrease of $5,727 million. This reduction contributed to a $166 million net loss on those investments in fiscal 2024, up from a $21 million loss in fiscal 2023, and was a key factor behind the $306 million other‑income (loss) reported for fiscal 2024. Consequently, the investment portfolio's performance negatively impacted other income (loss) in both 2023 and 2024, with the fiscal 2024 loss being substantially larger.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$15,592 million in fiscal 2023 and $9,865 million in fiscal 2024, with a $5,727 million decrease—that are not present in the original answer (ground truth). The ground truth does not provide any dollar amounts for the size of Cisco's available-for-sale debt investments or their changes over time. Similarly, the LLM cites a $166 million net loss in 2024 and $21 million loss in 2023, and links these to a $306 million other-income (loss) figure, none of which appear in the original answer. These specific figures and calculations cannot be verified against the ground truth and appear to be hallucinated or derived from external data not referenced in the provided context. (2) While the original answer confirms that Cisco experienced higher losses in available-for-sale debt investments in both 2023 and 2024, negatively impacting other income (loss), net, it does not quantify these losses or the portfolio size. Therefore, the LLM's quantitative claims fail verification and significantly reduce accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the negative impact of these investments on other income (loss), net in both years and infers a worsening trend, which aligns with the original answer’s description of continued negative impact. However, the reasoning is undermined by reliance on unsupported numbers. (4) Despite the factual inaccuracies in numbers, the LLM captures the qualitative trend correctly—deteriorating performance of debt investments negatively affecting other income in both years, with increasing severity. This supports a moderate qualitative accuracy and good contextual relevance, as it addresses the core question about performance evolution and impact on income. However, the invention of precise financial figures results in a low quantitative accuracy and a significant drop in overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 524,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express's reliance on third-party merchant acquirers has grown strategically from 2022 through 2024, particularly to expand merchant coverage and drive transaction growth across all merchant segments. The company explicitly states that its ability to \"expand merchant coverage globally and our success, as well as the success of third-party merchant acquirers, aggregators and processors, in signing merchants to accept American Express\" depends on value propositions for merchants and acquirers, merchant awareness, and scaling acceptance programs—especially in new industries and international markets. This is reinforced by its OptBlue program (referenced in Note 103), where third-party acquirers process transactions on its behalf, with network rate fees recorded as discount revenue. The company also notes that merchant acceptance agreements with large merchants often have fixed terms (3–7 years) with auto-renewal features, while small/mid-sized merchants typically have no fixed duration, making third-party partnerships critical for scaling coverage without direct contractual constraints. (Based on synthesis of AXP_10k_2022 p.111, AXP_10k_2023 p.101, AXP_10k_2024 p.127, and merchant coverage discussion in AXP_10k_2024 p.128).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the evolution of American Express's reliance on third-party merchant acquirers from 2022 to 2024 is accurately described, including the strategic importance of programs like OptBlue, the financial treatment of network rate fees as discount revenue, and the growing dependency on third-party acquirers, aggregators, and processors for global merchant coverage. The distinction between fixed-term agreements with large merchants and the more flexible arrangements with small/mid-sized merchants is correctly noted and supports the argument for increased reliance on third parties. (2) Quantitative accuracy is perfect: no specific numerical values (e.g., dollar amounts, percentages) are misstated, and all referenced programs and financial treatments (e.g., discount revenue recognition) match the ground truth. Format and terminology are consistent and accurate. (3) Multi-hop reasoning is strong: the answer synthesizes information across all three years (2022–2024), correctly tracing the evolution from initial use of third-party acquirers to deeper strategic integration. It references specific sections of the 10-Ks (e.g., p.111, p.101, p.127, p.128) and correctly identifies the progression in language and strategic emphasis. (4) The only minor shortcoming is that the LLM does not explicitly state the shift in 2023 regarding the financial structure of the acquirer relationships as a 'reinforcement of financial integration'—a nuance present in the original answer—but this is implied through the mention of network rate fees being recorded as discount revenue. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1679,
        "completion_tokens": 491,
        "total_tokens": 2170
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s multi‑year initiative to enhance financial shared‑service capabilities—focused on integrating and standardizing HR, IT, procurement, supply‑chain and finance processes—has been progressing through 2022‑2024 as a proactive, enterprise‑wide effort not tied to any internal‑control deficiency.  The company has continued to align and streamline the design and operation of its financial control environment as part of this initiative, while maintaining effective disclosure controls and procedures.  (All referenced material appears in the 2022‑2024 10‑K filings, particularly the discussion of the shared‑service integration in Item 9A of each filing.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Johnson & Johnson's initiative from 2022–2024 to enhance financial shared services through enterprise-wide standardization across HR, IT, procurement, supply chain, and finance is correctly described as proactive and not driven by internal control deficiencies. The mention of alignment and streamlining of financial control environment is consistent across years. (2) Quantitative accuracy is perfect—no numerical errors; time frame (2022–2024) is correctly referenced, and no incorrect figures are introduced. (3) Multi-hop reasoning is sound: the LLM synthesizes the consistent narrative across three years of 10-K filings, particularly drawing from Item 9A, and correctly infers that this is an ongoing, strategic effort rather than a reactive one. (4) The only minor shortcoming is completeness: while the LLM mentions the continuation of the initiative, it does not explicitly highlight the evolution across the years (e.g., 2022 focus on system standardization, 2023 on control environment alignment, 2024 on operational efficiency), which slightly reduces qualitative depth. However, the semantic meaning remains substantially equivalent. Contextual relevance is excellent, directly addressing the question with appropriate sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 378,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "American Express has shifted from a primarily premium‑card issuer toward a broader, technology‑driven platform that actively competes with alternative payment mechanisms such as open‑banking APIs, digital wallets and real‑time settlement systems.  Over the 2022‑2024 period the company has intensified investment in these innovations—highlighted by its focus on AI/machine‑learning, open‑banking integration, and real‑time payment capabilities—to offset competitive pressure from fintech rivals and to preserve its value‑proposition for high‑spending card members.  This strategic adaptation reflects a deliberate move to embed new digital‑payment functionalities into its network while maintaining its traditional rewards and service strengths.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of American Express's strategic positioning from 2022 to 2024. It accurately captures the increasing competitive pressure from alternative payment mechanisms such as digital wallets, open banking, and real-time settlement systems. The answer correctly notes American Express's strategic shift toward embracing these technologies, including investments in open banking and real-time payments, which matches the ground truth's description of a move from viewing these innovations as threats to integrating them into its core roadmap. The mention of AI/machine learning is not present in the original answer but does not contradict it and may reflect additional context; however, this detail is not supported by the provided ground truth, making it a minor addition that doesn't detract significantly. The core evolution—increased competitive pressure and strategic adaptation—is correctly synthesized across the 2022–2024 timeframe. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop understanding (acknowledging threat in 2022, expanded scope in 2023, strategic dependence by 2024), though the LLM condenses this progression without explicitly referencing the year-by-year shift in stance. Despite this, the overall qualitative accuracy is high. Contextual relevance is excellent—the response directly addresses competitive pressure and strategic adaptation to technological innovations as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 441,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "Adobe’s strategic focus on creative collaboration tools has evolved through a series of acquisitions and product integrations, beginning with its 2022 purchase of Frame.io and culminating in the 2023 launch of Adobe Express and expanded Firefly AI capabilities. The company has embedded Frame.io’s cloud‑native collaboration platform into its core Creative Cloud suite—linking it with Premiere Pro, After Effects, Photoshop, Illustrator and Express—to deliver real‑time, frame‑accurate review and approval workflows, while also leveraging Frame.io’s Camera‑to‑Cloud and integration with Adobe Stock and Firefly Services for end‑to‑end content creation. This progression signals Adobe’s intent to build a unified, AI‑enhanced ecosystem that blends generative AI (Firefly), collaborative editing (Frame.io) and accessible content creation (Express) into a single, subscription‑driven platform, reinforcing its strategy of offering end‑to‑end creative solutions that increase user stickiness, drive recurring revenue and differentiate Adobe in the competitive creative‑software market.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, Adobe did not acquire Frame.io in 2022—Frame.io was acquired in 2021, and by 2022 it was already listed as a trademark, which the original answer correctly notes. The LLM incorrectly states the acquisition occurred in 2022, misaligning the timeline. Additionally, the LLM mentions the '2023 launch of Adobe Express and expanded Firefly AI capabilities' as part of the Frame.io evolution, which is not supported by the ground truth and distracts from the core focus on Frame.io's integration. While Frame.io's integration with Premiere Pro and After Effects is correctly noted for 2023, the LLM incorrectly claims integration with Illustrator and Express as part of the 2023–2024 evolution, which is not in the original answer. The 2024 expansion into casting, location scouting, and marketing campaign management—and integration with Photoshop, Lightroom, and Workfront—is partially correct (Photoshop is mentioned, others are not), but the LLM overgeneralizes and misattributes timing and scope. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), so accuracy hinges on dates and event sequencing. The incorrect dating of the Frame.io acquisition and the introduction of other products (Express, Firefly) as part of the Frame.io evolution undermine quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM conflates Adobe’s broader creative collaboration strategy with the specific evolution of Frame.io, failing to isolate and trace Frame.io’s positioning year-by-year as required. It introduces unrelated elements (Firefly, Express) as if they were part of Frame.io’s integration path, weakening the logical synthesis. (4) Despite these issues, the answer is contextually relevant—it addresses Adobe’s strategy in creative collaboration tools and correctly identifies Frame.io as a cloud-native platform with frame-accurate commenting and integration into Creative Cloud. The overarching theme of Adobe building an end-to-end, AI-enhanced ecosystem is plausible but goes beyond the evidence provided in the ground truth. The answer captures the strategic direction but misrepresents the factual progression of Frame.io specifically, warranting a mid-range correctness score due to partial factual alignment but significant errors in timeline and entity relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 639,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s outstanding balance on its 2017 Notes declined from $15 billion at the end of 2022 to $13 billion by the end of 2023 and then to $11.25 billion by the end of 2024. This reduction reflects the company’s strategy of actively managing its debt maturities and optimizing the capital structure—repaying portions of the notes as they mature and replacing higher‑cost borrowings with newer, lower‑cost financing, thereby lowering overall interest expense and preserving liquidity for other investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical values provided. According to the ground truth, the outstanding balance was $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024. However, the LLM incorrectly states it as $15B in 2022 (should be $16B), $13B in 2023 (should be $15B), and $11.25B in 2024 (should be $13B). These errors affect all three data points, making the quantitative progression entirely incorrect. (2) The calculation of the trend is also flawed—while the ground truth shows a consistent $1B decline from 2022 to 2023 and then $2B from 2023 to 2024, the LLM implies a $2B drop from 2022 to 2023 and a $1.75B drop to 2024, which does not match the actual filing data. (3) The reasoning about Amazon’s debt management strategy contains plausible elements (e.g., refinancing, optimizing capital structure), but this goes beyond the information in the original answer, which only inferred a 'deliberate strategy to gradually pay down' the liability based on the observed reduction. The LLM introduces unverified claims about replacing higher-cost debt and reducing interest expense, which are not supported in the ground truth. (4) Despite incorrect numbers and over-extended interpretation, the answer is contextually relevant—it addresses the evolution of the debt balance and attempts to interpret the strategic implication, fulfilling the question's structure. However, due to severe quantitative inaccuracies and unsupported qualitative inferences, the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 430,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing's emphasis on \"Upgrades and Conversions\" within its Global Services segment has evolved from a standalone mention in 2022 (highlighted in the segment overview as part of its service portfolio) to a more prominent focus in 2023 and 2024, where it is explicitly tied to sustaining aerospace platforms through engineering, maintenance, modifications, and digital services. This 3-year trajectory underscores a strategic shift toward extending the lifecycle and performance of existing aircraft and defense systems—particularly critical amid production challenges in commercial aviation (e.g., 737 MAX and 787 delays)—to maintain revenue stability and customer retention in a competitive market. The company is leveraging upgrades and conversions as a core growth lever to offset commercial aircraft delivery volatility, signaling a deliberate pivot toward higher-margin, long-term service engagements over new platform development.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric data, so there are no incorrect numbers, dates, or calculations—this aligns with the original answer which also lacks specific financial figures. Thus, quantitative accuracy is fully preserved. (2) However, the qualitative content diverges significantly from the ground truth. The original answer states that 'Upgrades and Conversions' were consistently listed as a core service from 2022 to 2024 without change in prominence, indicating stability rather than evolution. In contrast, the LLM claims a 'strategic shift' and increasing prominence in 2023–2024, including assertions that the service became 'explicitly tied' to sustaining platforms and linked to digital services—details not supported by the ground truth. These represent significant factual overreach and misrepresentation of the trajectory. (3) The multi-hop reasoning is flawed: while the LLM synthesizes contextually plausible strategic rationale (e.g., offsetting 737 MAX delays), this is speculative and not grounded in the actual filing content reflected in the original answer. The knowledge graph shows consistent inclusion, not growing emphasis. (4) Despite incorrect reasoning and unsupported claims about evolution and strategic pivot, the LLM does address the correct segment (Global Services), correct service line ('Upgrades and Conversions'), and correct time frame (2022–2024), and correctly infers lifecycle extension as a strategic theme. Hence, partial credit is given for contextual relevance and directional insight, but major deductions apply for factual inaccuracy in the characterization of change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 450,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson announced in January 2021 that, beginning January 1 2026, all eligible U.S. non‑union employees—regardless of hire date—will earn pension benefits under the Retirement Value formula, while benefits accrued under the prior Final Average Pay formula for service before January 1 2026 will remain unchanged. This change was reflected in the 2023 and 2024 pension disclosures as an amendment that reduces the projected benefit obligation and was communicated as part of the company’s broader pension‑plan modernization.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key date (January 1, 2026) for the implementation of the Retirement Value formula and accurately states that all U.S. non-union employees, regardless of hire date, will be covered under the new formula from that date. It also correctly notes that pre-2026 accrued benefits under the Final Average Pay formula remain protected. These core facts align with the ground truth. However, the LLM omits important evolution details from 2022 to 2024: specifically, that in 2022, J&J mentioned the formula without context; in 2023, it clarified that post-2014 hires were already under the Retirement Value formula; and in 2024, the language was repeated unchanged. This missing progression weakens the completeness of the answer. (2) Quantitatively, all dates (January 1, 2026, and reference to 2023/2024 disclosures) are accurate. No financial figures are involved, so no calculation errors exist. The mention of the pension amendment reducing the projected benefit obligation is consistent with typical accounting impacts and does not contradict the ground truth. (3) The reasoning is logically sound and reflects correct synthesis of the policy change and its implications, but it fails to demonstrate the multi-hop tracking of how communication evolved year-over-year from 2022–2024 as required by the question. The answer treats the disclosures as static in 2023 and 2024 without acknowledging the incremental clarification in 2023 about post-2014 hires. (4) The answer is contextually relevant and captures the central element of the pension strategy shift. However, due to the omission of the year-by-year communication evolution and lack of detail on eligibility clarification over time, it falls short of full qualitative and completeness accuracy, warranting a 7 in correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 497,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO's 5.000% notes due April 2030 were issued in April 2020 (as referenced in Exhibit 4.18 of the 2020 10-K filing) and have remained outstanding through fiscal years 2022–2024, with no indication of repayment or refinancing in the provided debt disclosures. The company's debt management strategy for this instrument reflects a long-term approach, as the notes mature in 2030 and are grouped with other senior notes having maturities extending beyond 2030 (e.g., 2032, 2034), suggesting a strategy of maintaining a stable, long-duration debt profile without active refinancing of this specific tranche during the observed period. The consistent reporting of the full $1,856 million principal amount (as shown on page 81 of the 2024 10-K) indicates no material reduction in outstanding balance, implying the company is managing this debt as part of its broader long-term financing structure rather than seeking to retire it prematurely.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the principal balance amounts and the trend over time. The ground truth states that the outstanding balance decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. However, the LLM claims the balance remained constant at $1,856 million through 2024, which contradicts the ground truth. This error fundamentally undermines the entire response. (2) The quantitative inaccuracies are severe: the LLM reports $1,856 million as the principal, which does not match any value in the ground truth ($1,086M → $606M). There is no indication of the reduction, and the cited figure appears to be either from a different note series or misattributed. Additionally, the claim that the notes were issued in April 2020 is not part of the ground truth and cannot be verified here, but more importantly, it distracts from the actual trend in principal balance. (3) The multi-hop reasoning is flawed because the LLM fails to track the change in principal over time across fiscal years 2022–2024. Instead of identifying a deliberate reduction, it asserts stability and long-term holding, which is the opposite of the actual debt management strategy indicated by the repayment. The synthesis across years is incorrect, and the conclusion about strategy is therefore invalid. (4) Contextual relevance is moderate because the answer addresses the right instrument (5.000% notes due 2030) and discusses debt management strategy, but the incorrect data leads to a misleading interpretation. While the structure and intent of the response are appropriate, the factual foundation is entirely wrong, warranting a very low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 474,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T’s strategic relationship with Time Warner Inc. evolved through a series of milestones that culminated in its full integration into the WarnerMedia segment and eventual divestiture. The company acquired Time Warner in 2018, embedding its entertainment assets within AT&T’s broader portfolio, and later combined WarnerMedia with Discovery in a transaction finalized in 2022, which re‑classified the business as discontinued operations. Following the separation, AT&T continued to operate the remaining WarnerMedia assets until it completed the sale of its stake in DIRECTV to TPG in 2024, marking the end of its direct involvement with the former Time Warner assets. This timeline reflects a progression from acquisition and integration, through operational restructuring and strategic refocusing, to the final divestiture of the WarnerMedia segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the timeline that affects quantitative and qualitative accuracy. (1) Correct elements: The acquisition of Time Warner in 2018, the combination of WarnerMedia with Discovery, the characterization of the transaction as a strategic divestiture, and the 2024 sale of AT&T's stake in DIRECTV are all factually accurate. The answer correctly frames AT&T's strategic pivot away from media back to core telecom services. (2) Quantitative issue: The LLM states the WarnerMedia-Discovery transaction was 'finalized in 2022' but incorrectly implies it occurred late enough to be considered a 2022 event from AT&T's reporting perspective; however, the ground truth specifies the Reverse Morris Trust transaction was completed in April 2022, which is correct—but the LLM omits the precise month and mischaracterizes the timing slightly by not acknowledging that the separation was already reflected in 2022 financials, not a 2023 or 2024 development. More critically, the original answer notes the separation occurred in April 2022, so describing it as simply '2022' is acceptable, but the LLM's phrasing could imply it happened later in the year. (3) Multi-hop reasoning is sound: The model correctly synthesizes the evolution from acquisition (2018), through restructuring (2022 separation), to final exit via DIRECTV sale (2024), showing understanding of the strategic arc. (4) The mention of TPG as the buyer of DIRECTV is accurate and adds detail not in the original answer, which strengthens completeness. However, the original answer emphasizes that DIRECTV was the 'last major asset tied to the entertainment strategy,' a contextual nuance slightly underemphasized in the LLM response. Overall, core facts and sequence are correct, with only minor imprecision in temporal framing, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 517,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2024, AIG’s international terrorism exposure management remained anchored in a risk‑limit framework that relies on third‑party vendor models to generate modeled loss scenarios for various attack modes.  The company continuously updates these models, adjusts them for identified gaps, and monitors concentrations (e.g., New York City) to set retention and attachment points.  Reinsurance protections are structured to cover losses above these retention thresholds, with aggregate and per‑occurrence limits placed on worldwide catastrophe and terrorism covers.  Geographic attachment points are defined by the modeled loss scenarios and are applied consistently across the international portfolio to ensure that reinsurance recoveries are triggered only after the predetermined attachment points are exceeded.  This approach is described in the “Terrorism Risk” sections of the 2022, 2023 and 2024 Form 10‑K filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing AIG's general approach to terrorism exposure management, including the use of modeled loss scenarios, reinsurance protections, and geographic attachment points. However, it fails to include specific quantitative details from the ground truth, such as the $1.3 billion modeled loss for a five-ton bomb attack in New York City in 2022, and the exact attachment points of $200 million for Japan and $125 million for the rest of the world in 2024. These omissions significantly reduce factual completeness and accuracy. (2) Quantitative accuracy is low because the answer does not mention any specific dollar amounts, years with corresponding figures, or loss scenarios despite their availability in the ground truth. The absence of the $1.3B loss estimate, $200M/$125M attachment points, and TRIPRA reference constitutes major factual gaps. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that AIG uses models, reinsurance, and geographic triggers across years—but it does not demonstrate synthesis of year-specific developments (2022 vs 2023 vs 2024) or evolution over time. The ground truth shows a clear progression from reactive modeling to structured segmentation, which the LLM answer does not capture. (4) Contextual relevance is high because the response stays on topic and references the correct sections of the 10-K filings, but the lack of specific data points and evolutionary insight limits its correctness. The answer reads more like a generic description than a precise, evidence-based evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 441,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson's pipe-working tools, part of the Safety & Productivity segment within Tools & Home Products, have been integrated into a broader strategic shift toward industrial automation and software-driven solutions. This evolution reflects a deliberate divestiture of non-core residential/commercial offerings (e.g., InSinkErator, Climate Technologies) and a focused repositioning of the Safety & Productivity business toward professional tools embedded in industrial workflows, aligning with the company's transformation into a pure-play industrial automation leader. The segment's modest revenue ($1.4B in 2022, $1.39B in 2024) and persistent earnings ($250M in 2022, $308M in 2024) underscore its role as a stable, high-margin niche within the larger portfolio, supporting Emerson's strategic pivot toward software and intelligent devices rather than expanding pipe-working tool lines.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct contextual elements but significantly diverges from the ground truth in describing Emerson's product portfolio evolution for pipe-working tools. While the ground truth emphasizes a multi-year technological evolution—specifically the integration of battery-powered tools, diagnostic systems, and digital capabilities—the LLM instead frames the evolution around corporate restructuring and divestitures (e.g., InSinkErator, Climate Technologies), which are not mentioned in the original answer and are unrelated to pipe wrenches. The LLM introduces financial figures ($1.4B in 2022, $1.39B in 2024, $250M and $308M earnings) that are not present in the ground truth, making them unverifiable and potentially inaccurate in this context. (2) Quantitatively, the numbers provided by the LLM are internally consistent and plausibly formatted, but since they do not appear in the original answer and are not supported by the knowledge graph, they cannot be confirmed as correct. Their inclusion creates a false sense of precision. There are no explicit calculation errors, but the use of unsupported financial data reduces quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about the evolution of a specific product line (pipe-working tools) from 2022 to 2024, requiring synthesis of product-level changes over time. The LLM instead shifts focus to corporate strategy and segment-level financials, failing to describe the actual product advancements (e.g., battery hydraulic tools, sewer cameras, digital integration) that define the portfolio evolution. This indicates a failure in synthesizing the correct product trajectory. (4) Despite the misalignment with the ground truth, the LLM answer remains contextually relevant by addressing Emerson’s strategic positioning and segment focus. It correctly identifies the Safety & Productivity segment and implies a move toward professional tools, which aligns broadly with the company's direction. However, it omits all specific product developments and incorrectly attributes the strategic shift to divestitures rather than product innovation, resulting in a partially correct but factually incomplete and misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 600,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s accounting for free‑rent periods has remained consistent through 2022‑2024: the company recognizes lease incentives on a straight‑line basis over the original lease term (including any renewal periods it is reasonably certain to exercise), which spreads the rent expense evenly and reduces the initial right‑of‑use asset valuation compared with a “pay‑as‑you‑go” approach. This methodology is disclosed in the lease‑accounting notes (pages 45‑46, 47) and is applied uniformly across operating and finance leases, so the ROU asset and corresponding lease liability are recorded at the present value of future lease payments, with the free‑rent period reducing the recorded asset and expense. Consequently, the valuation of the right‑of‑use asset is lower than it would be if the incentives were accounted for after they are earned, but the overall impact on the consolidated balance sheet is limited to the straight‑line amortization of the incentive over the lease term.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Costco's consistent application of the straight-line recognition method for free-rent periods from 2022 to 2024, and accurately explains that lease incentives reduce the initial right-of-use (ROU) asset valuation by being incorporated into the present value calculation of lease payments. The explanation of the impact on ROU assets and lease liabilities is factually sound and aligns with ASC 842 principles. There are no numeric inaccuracies—no specific dollar amounts, dates, or percentages are misstated (quantitative accuracy is perfect). However, the LLM answer omits a key qualitative point from the original answer: the evolution in disclosure depth over time. Specifically, while the accounting policy remained unchanged, Costco provided more detailed disclosures in 2022 about the use of discounted future minimum lease payments and its incremental borrowing rate, which were not repeated in 2023 and 2024. This reduction in disclosure specificity is a central part of how the 'accounting treatment and disclosure' evolved, but the LLM answer fails to mention this shift, focusing only on the stable methodology. Thus, while the core accounting mechanics are correctly described, the multi-hop synthesis across years regarding disclosure trends is incomplete. This limits the qualitative accuracy despite sound reasoning on the accounting treatment itself. Contextual relevance is high as the response directly addresses lease accounting, ROU assets, and time period evolution, but misses the nuance of changing disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 431,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft's 2.000% Notes issuance evolved through three supplemental indentures filed in 2015–2016: the Tenth Supplemental Indenture (Nov 3 2015) added 2.000% Notes due 2022, the Eleventh Supplemental Indenture (Aug 8 2016) added 2.000% Notes due 2023, and these were later amended by the Eighth Supplemental Indenture (Dec 6 2013) which originally included 3.625% Notes due 2023. All are governed by the same master indenture dated May 18 2009, with each supplemental indenture filed as an 8‑K and referenced in the 2022, 2023, and 2024 Form 10‑K filings (Exhibits 4.13 and 4.14).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Microsoft's 2.000% Notes were consistently referenced under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity in 2023, and remained unchanged across 2022–2024 filings. However, the LLM incorrectly claims that the Tenth Supplemental Indenture (Nov 3, 2015) added 2.000% Notes due 2022, which is not supported by the ground truth. Additionally, the LLM references the Eighth Supplemental Indenture (Dec 6, 2013) as amending the 2.000% Notes, but this indenture originally governed 3.625% Notes, not 2.000% Notes, and predates the others illogically. (2) The dates and sequence are factually wrong: Dec 6, 2013 cannot 'amend' an indenture from 2016. The maturity timeline is misrepresented—there is no mention of 2.000% Notes due 2022 in the ground truth; only 2023-dated notes are referenced. (3) The multi-hop reasoning is flawed: the LLM fails to track the consistent documentation and maturity evolution across years, instead fabricating a timeline with incorrect supplemental indentures and maturities. It misidentifies which indentures govern the 2.000% Notes and incorrectly implies structural changes when the ground truth emphasizes stability. (4) While the mention of Exhibits 4.13 and 4.14 and Form 10-K filings shows some contextual awareness, the core facts—maturity dates, indenture sequence, and note specifications—are incorrect, leading to a low correctness score. The answer is partially relevant but fundamentally inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 430,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon's revenue recognition for third-party seller services remained consistent in timing and composition through 2022‑2024, with commissions and fulfillment fees recognized when the associated services are rendered—typically upon delivery of the product to a carrier or customer. The 2022 10‑K (page 20) notes that revenue from third‑party seller services is recorded when the service occurs, and the 2023 10‑K (page 43) details that these commissions and related fulfillment and shipping fees are recognized at that time. Subsequent filings (2024 10‑K, page 75) continue to describe the same recognition policy, confirming no material evolution in how Amazon accounts for these revenues across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Amazon's revenue recognition for third-party seller services—commissions and fulfillment fees—is recognized when services are rendered, typically upon delivery to a carrier or customer, and this policy remained consistent from 2022 to 2024. The answer cites specific 10-K pages (2022, p.20; 2023, p.43; 2024, p.75), which supports its claims, though the exact page numbers are not in the ground truth; however, such details are permissible as long as they are plausible and do not contradict. The LLM correctly notes no material evolution in revenue recognition policy, which matches the original answer’s conclusion of consistent treatment with increasing disclosure clarity. The only minor shortcoming is that the original answer highlights an evolution in disclosure clarity (especially in 2023 with more precise language), while the LLM emphasizes consistency to the point of downplaying the enhanced transparency in reporting. This nuance is not omitted entirely but is less emphasized, slightly affecting qualitative accuracy. All entities (Amazon, third-party seller services, commissions, fulfillment fees), years (2022–2024), and reasoning (multi-hop synthesis across three years of disclosures) are correct. There are no numerical inaccuracies, as the answer relies on qualitative disclosures rather than financial figures, and the reasoning is sound. The response is highly relevant and directly addresses the question’s focus on timing and composition of revenue recognition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 435,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations through 2022‑2024 demonstrates a deliberate long‑term liability management strategy that preserves the parent company's credit support for legacy telecom entities, ensuring they can meet debt and other financial commitments while AT&T maintains overall balance‑sheet flexibility and minimizes direct exposure to those obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuation of AT&T's guarantee for Southwestern Bell Telephone Co. from 2022 to 2024, aligning with the ground truth on the core fact of sustained liability. However, it introduces speculative elements not present in the original answer, such as 'maintains overall balance-sheet flexibility' and 'minimizes direct exposure,' which are not supported by the evidence cited in the ground truth (i.e., the repeated inclusion of Exhibit 4-b). The ground truth emphasizes the *unchanging nature* of the commitment and lack of restructuring, while the LLM interprets this as a strategy to preserve credit support and reduce exposure—this is a plausible inference but goes beyond the documented evidence. (2) Quantitatively, all years (2022, 2023, 2024) are correctly referenced, and no financial figures are misstated, so quantitative accuracy is perfect. (3) The multi-hop reasoning is partially sound—correctly identifying the repetition of the guarantee across years—but fails to emphasize the key insight from the ground truth: the *absence of change* in language or structure, which indicates no strategic shift. Instead, the LLM assumes strategic intent around flexibility and minimized exposure, which is not directly inferable from the exhibit filings alone. (4) Contextual relevance is high because the answer addresses the long-term liability management strategy as asked, but qualitative accuracy is reduced due to unsupported interpretation. Correctness score reflects mostly accurate facts but significant overinterpretation of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 441,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 increased from $826 million in 2022 to $808 million in 2023 and then to $808 million again in 2024 (as shown on the 2022 and 2024 debt tables). This modest, stable holding reflects a long‑term, low‑cost financing strategy that supports the company’s capital structure while preserving flexibility for other investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and their temporal order. According to the ground truth, the investment was $983 million in 2022, $826 million in 2023, and $808 million in 2024. However, the LLM incorrectly states that the amount increased from $826 million in 2022 to $808 million in 2023, which is both numerically and directionally wrong—$808 million is less than $826 million, and the 2022 figure should be $983 million, not $826 million. This misrepresentation distorts the trend entirely. (2) The numbers are not only incorrect but also misassigned to years, leading to a false narrative of stability or slight increase when the actual data shows a clear downward trend from $983M to $808M over two years. The LLM also incorrectly implies that $808M appears in both 2023 and 2024, while the ground truth shows $826M in 2023. (3) The reasoning about long-term strategy is partially plausible—stable long-dated debt can reflect a deliberate capital structure—but because it is based on incorrect data, the conclusion is unsupported. The ground truth notes a 'gradual decline' and a fixed effective rate of 2.29%, which the LLM omits entirely, missing a key element of the strategy. (4) The contextual relevance is moderate because the answer addresses the right instrument and general strategic implications, but the severe quantitative inaccuracies undermine both qualitative and overall correctness. The multi-hop synthesis fails due to incorrect data retrieval and timeline confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 425,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco's long-term debt structure shows a strategic reduction in overall leverage and a focused approach to managing near-term obligations. The company retired its $1,000 principal 2.750% Senior Notes due May 2024 in May 2024 using cash and short-term investments, while maintaining its core long-term debt profile including $1,250 of 1.375% Senior Notes due June 2027 and $1,750 of 1.600% Senior Notes due April 2030. This evolution reflects a capital management strategy prioritizing the retirement of higher-cost near-term debt (like the 2.750% notes) while preserving lower-rate, longer-dated obligations to maintain financial flexibility and reduce interest expense. The company's debt-to-equity ratio and current portion of debt both declined significantly from 2023 to 2024, indicating a deliberate effort to strengthen the balance sheet through targeted debt reduction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the 1.375% Senior Notes and total long-term debt figures. The ground truth states that the 1.375% Senior Notes due June 2027 remained constant at $1,250 million across 2022–2024, which the LLM correctly identifies. However, the LLM introduces new information not in the original answer—specifically, the retirement of $1,000 million 2.750% Senior Notes due May 2024 and the existence of $1,750 million 1.600% Senior Notes due April 2030—which are not mentioned in the ground truth and cannot be verified from the provided data. These additions suggest fabrication or hallucination of specific debt tranches. (2) The quantitative accuracy is compromised: while $1,250 million for the 1.375% notes is correct, the total long-term debt figures in the ground truth ($6,590M → $6,484M → $5,919M) are not reflected in the LLM answer, nor is the gradual reduction across all years emphasized. Instead, the LLM focuses on a 2024 event (retirement of 2.750% notes) without referencing 2022–2023 trends in total debt. The debt-to-equity ratio and current portion of debt declines are also not in the ground truth and appear to be unsupported additions. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a capital management strategy of retiring higher-cost near-term debt while preserving low-rate long-term debt. This aligns semantically with the ground truth’s conclusion about selective capital management. However, because the reasoning is based on unverified debt instruments rather than the actual data (i.e., overall debt reduction without changes to the 1.375% notes), the logic, while plausible, is not fully grounded in the provided facts. (4) Contextual relevance is high—the answer directly addresses the evolution of long-term debt and capital strategy. The qualitative reasoning is strong and coherent, but the inclusion of unsupported specifics reduces factual reliability. Correctness score is 6 due to partial factual accuracy and plausible but unverified details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 560,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s multi-layered security framework—encompassing cybersecurity programs, third‑party assessments, and robust governance oversight—has been expanded in parallel with its real‑time payments infrastructure, which grew from real‑time clearing and settlement capabilities in 13 markets by 2021 to broader account‑to‑account and disbursement platforms by 2024. This coordinated scaling reflects a strategic focus on mitigating payment‑processing risk as the company globalizes, ensuring that new payment flows (e.g., VCNs, real‑time account‑based payments, cross‑border remittances) are protected by the same layered security and compliance controls that safeguard its core switching network.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. According to the ground truth, Mastercard was operating or implementing real-time payments in 12 of the top 50 GDP markets as of December 31, 2021—not 13 markets by 2021 as stated in the LLM answer. The 13-market figure actually corresponds to 2023, not 2021. This misplacement of data across years undermines the accuracy of the timeline. Additionally, the LLM claims expansion 'to broader account-to-account and disbursement platforms by 2024' and references VCNs and cross-border remittances, which are not mentioned in the original answer and go beyond the provided evidence. (2) The original answer notes a qualitative shift in 2024 with 'several countries around the world' but does not specify new platforms or use cases like VCNs, making these additions speculative. There are no dollar amounts or complex calculations, but the misattribution of the 13-market figure to 2021 instead of 2023 is a clear quantitative and temporal error. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that security and infrastructure expansion are strategically aligned to manage risk during global scaling. This interpretation aligns with the original answer’s conclusion about parallel development suggesting intentional risk management. However, the LLM overreaches by implying that security controls directly enabled expansion, while the original answer explicitly states that filings do not confirm such causation. (4) Despite these issues, the LLM captures the core strategic theme: that Mastercard scales security alongside infrastructure to maintain trust. This makes the answer contextually relevant and directionally insightful, though factually flawed in key details. Hence, correctness is reduced to 5 due to significant factual inaccuracies, despite reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 517,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 shows a consistent pattern of refinancing across fiscal years 2022, 2023, and 2024, as evidenced by multiple supplemental indentures filed in 2022, 2023, and 2024 that reference the 2021 notes. This pattern indicates a strategic approach to long-term debt management, where Microsoft proactively restructures its debt obligations to optimize maturity profiles and potentially capitalize on favorable market conditions, rather than allowing debt to mature in a single large lump sum.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly affect factual correctness. (1) It incorrectly claims Microsoft filed 'multiple supplemental indentures' in 2022, 2023, and 2024 related to the 4.000% Notes due 2021, but the ground truth only confirms the Third Supplemental Indenture was listed in 2022 (Exhibit 4.6), with no new supplemental indentures in 2023 or 2024—only continued disclosure. (2) The LLM implies active refinancing or restructuring occurred each year, but the original answer states there were no structural changes in 2023 and the 2024 filing merely continued disclosure despite maturity, suggesting possible rollover or delayed settlement, not proactive refinancing. (3) The term 'refinancing' and 'restructures its debt obligations' is speculative and unsupported by the evidence provided; the ground truth emphasizes transparency and disclosure discipline, not strategic restructuring. (4) While the LLM correctly identifies the note and its due date, and the general idea of ongoing disclosure, it misinterprets the nature and frequency of actions taken, leading to an incorrect conclusion about Microsoft’s strategy. (5) The reasoning fails on multi-hop synthesis: it conflates continued disclosure with active debt management, whereas the ground truth distinguishes between post-maturity reporting and actual refinancing. Quantitative accuracy is moderate—dates and percentages are correct, but no actual financial figures (e.g., amounts outstanding) are mentioned in either answer, so no calculation errors occur. Contextually, the answer addresses the question’s scope and attempts strategic interpretation, but the conclusion is based on flawed premises. Thus, the answer is partially correct in context and entities but flawed in reasoning and factual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 487,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated reference to the 1.500% Note due 2030 across multiple 10‑K filings signals that the company views this senior unsecured debt as a core, long‑term financing building block of its capital structure. By consistently including the same note in its debt disclosures, Amazon reinforces a strategy of maintaining a stable, low‑cost funding source that can support its growth initiatives—particularly AWS expansion and large‑scale infrastructure projects—while preserving flexibility to issue newer tranches (e.g., the 2021‑2022 notes) and manage overall leverage alongside other debt instruments. This consistency contrasts with its other debt issues, which have varied maturities and coupon rates, underscoring a deliberate focus on a reliable, long‑dated borrowing pillar within its broader financing mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.500% Note due 2030 and its consistent disclosure across years, accurately reflecting Amazon's use of long-dated, fixed-rate debt. All numeric values (coupon rate, maturity year) are correct and match the ground truth. There are no calculation errors. (2) Quantitative accuracy is perfect: the 1.500% coupon and 2030 maturity are consistently and correctly referenced. No dollar amounts or other figures are misstated. (3) The multi-hop reasoning is largely sound—LLM correctly infers that the repeated mention of this note signals a strategic, long-term capital structure approach. It appropriately contrasts this instrument with other debt of varying maturities and rates. However, it omits specific references to the 2022, 2023, and 2024 filing contexts and does not mention key comparative instruments like the 4.700% Note due 2024 or 2032, which are central to the ground truth’s analysis of layered maturities and refinancing risk. This weakens the depth of the synthesis across years. (4) Despite missing some granular, year-by-year contextual details and specific comparative instruments, the LLM captures the core strategic implication—using the 1.500% Note as a stable, low-cost pillar in a diversified debt portfolio. The answer is well-reasoned and contextually relevant, but slightly less complete in multi-hop detail than the original. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 408,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "AT&T’s 41.3% stake in SKY Mexico was held under equity‑method accounting through 2023, with the investment balance declining from $3.5 billion (2022) to $1.25 billion (2023) as cash distributions and impairments reduced the carrying amount. In June 2024 the company sold its entire SKY Mexico interest, completing the exit from the Mexican pay‑TV joint venture. This divestiture reflects AT&T’s broader strategy of shedding non‑core international pay‑TV assets—following its WarnerMedia spin‑off and sale of DIRECTV equity—so it can concentrate on its core U.S. telecom and wireless operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AT&T's 41.3% ownership stake in SKY Mexico and its equity method accounting treatment through 2023, as well as the full exit in June 2024. It accurately frames the divestiture as part of AT&T’s broader strategy to exit non-core international pay-TV assets and focus on U.S. telecom operations, aligning with the ground truth. However, the LLM introduces two specific dollar amounts—$3.5 billion (2022) and $1.25 billion (2023)—for the investment balance that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but represent unverified quantitative additions, reducing confidence in quantitative accuracy. (2) The percentage (41.3%) and the June 2024 exit date are correct and match the ground truth. The decline in carrying amount due to cash distributions and impairments is plausible and consistent with equity method accounting, but the specific numbers are not corroborated in the original answer, making this a partial error in quantitative precision. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes ownership, accounting treatment, exit timing, and strategic rationale across years and connects the SKY Mexico exit to broader divestitures like WarnerMedia and DIRECTV. This demonstrates strong qualitative understanding and contextual synthesis. (4) The answer is highly contextually relevant, addressing all components of the question—ownership evolution, accounting treatment, exit, and strategic implications—with accurate entity and timeline alignment. The correctness score is 8 due to the introduction of unsupported financial figures, which, while potentially accurate, deviate from the verified ground truth and introduce uncertainty in quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 495,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path approach for its U.S. pension plan shifted from a 15 % equity / 75 % fixed‑income / 10 % other allocation in 2022 to a 9 % equity / 80 % fixed‑income / 11 % other target for 2025, reflecting a deliberate de‑risking as the plan’s funded ratio improved. This progression—moving from higher growth exposure toward greater liability‑hedging assets—shows the company is systematically reducing risk in response to a stronger funded status.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's de-risking strategy and the shift toward liability-hedging assets as the funded status improved, which aligns with the ground truth. However, it introduces specific numerical allocations (15% equity, 75% fixed income, etc.) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be factually incorrect or oversimplified, as the original answer does not specify exact percentages but rather describes the directional shift. (2) There is no verification of the 15%/75%/10% or 9%/80%/11% allocations in the ground truth; thus, the quantitative accuracy is compromised. The original answer discusses the glide path mechanism and its basis on funded status at year-end for future targets (e.g., 2022 target based on 2021 data), but no exact portfolio weights are given. The LLM appears to have either hallucinated or inferred precise figures not supported by the source. (3) The multi-hop reasoning is sound in concept: the model correctly synthesizes the idea that improved funded status leads to de-risking and reallocation toward liability-hedging assets. It captures the forward-looking nature of the glide path (e.g., 2025 target based on 2024 data), which reflects understanding of the strategy’s mechanics. (4) Despite the lack of numerical support, the qualitative interpretation and strategic insight are strong and semantically aligned with the original. The answer is highly relevant and addresses both parts of the question—evolution of the glide path and what it reveals about de-risking—though with unsupported specifics. Hence, correctness is reduced due to unverified numbers, but not severely penalized as the core logic and directionality are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 484,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s credit‑risk mitigation framework has been refined over the three‑year period to address heightened regulatory scrutiny and litigation exposure.  In the 2022 filing the company disclosed a net settlement exposure of $55.7 billion (2022) and noted that it periodically reviews its risk‑management methodology, revising estimated exposure as needed; by 2023 the net exposure had risen to $62.9 billion, and in the 2024 filing it reached $64.9 billion, reflecting both growth in gross exposure and the application of more robust risk‑mitigation arrangements (cash collateral, letters of credit and guarantees).  The company also expanded its collateral requirements for customers failing risk‑standard reviews and increased monitoring of its credit‑risk portfolio, demonstrating an adaptive, proactive stance that integrates regulatory guidance (e.g., FTC/Durbin, DOJ antitrust CID, European Commission investigations) and litigation outcomes into its evolving risk‑management policies.  This progression illustrates Mastercard’s ability to adjust its risk‑mitigation strategies in response to emerging legal and regulatory pressures while maintaining a low historical loss rate.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not mention specific net settlement exposure figures of $55.7B (2022), $62.9B (2023), or $64.9B (2024); these numbers are fabricated or incorrectly sourced. There is no mention in the original answer of gross exposure growth or numerical trends in settlement exposure, making the LLM's detailed dollar amounts unsupported. This severely undermines factual correctness. (2) While the LLM correctly identifies the types of risk mitigation tools (cash collateral, letters of credit, guarantees) and references real regulatory actions—the FTC consent agreement, DOJ antitrust investigation, and European Commission probe—it incorrectly implies that these led to measurable increases in collateral requirements and exposure figures not present in the ground truth. The original answer emphasizes consistency in the core framework, not expansion or robustness of arrangements. (3) The multi-hop reasoning is partially sound: the LLM connects regulatory and litigation developments across years and links them to risk management adaptability, which aligns with the question’s intent. It correctly notes Mastercard’s ongoing monitoring and revision of risk standards in response to external pressures, and the low loss rate is appropriately highlighted. However, it overstates evolution by suggesting proactive expansion of collateral requirements and methodology changes driven by litigation outcomes, whereas the ground truth stresses consistency in strategy despite escalating risks. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of strategies and adaptability) and integrates relevant regulatory and legal contexts across 2022–2024. The qualitative reasoning is logical and well-structured, but the inclusion of false quantitative data reduces overall correctness. The conclusion about adaptability is plausible but overstated given the original emphasis on stability. Thus, the correctness score is 6 due to major numerical inaccuracies offset by otherwise reasonable synthesis and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 573,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The Home Depot's available shares under its Omnibus Stock Incentive Plan declined from approximately 77 million shares at the start of fiscal 2024 to about 70 million shares by February 2, 2025, reflecting ongoing use of the share pool for grants and other awards. This downward trend indicates that the company is actively allocating a substantial portion of its equity reserve to future stock‑based compensation, suggesting a continued emphasis on using equity incentives to attract and retain talent despite a shrinking pool of authorizable shares.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in available shares from 77 million to 70 million and the timeframe (through February 2, 2025), which aligns with the ground truth for 2023 and 2024. However, it omits the 2022 figure of 117 million shares, which is a key part of the multi-year trend requested in the question. This omission reduces completeness and quantitative accuracy. (2) The numbers cited (77 million and 70 million) are accurate as per the ground truth for the respective years, though the starting point is mischaracterized as 'start of fiscal 2024' rather than the 2022 figure under the prior plan. The date 'February 2, 2025' correctly corresponds to the 2024 filing, but the LLM mislabels it as an endpoint without referencing the earlier 2022 baseline. (3) The reasoning about the company's stock-based compensation strategy—emphasizing continued use of equity incentives despite a shrinking pool—is logically sound and semantically equivalent to the ground truth's interpretation. The synthesis of trend implications is accurate, though based on incomplete data. (4) The contextual relevance is high because the answer addresses the evolution and strategic implication, but the failure to include the 2022 data point limits the full multi-hop analysis across 2022–2024, warranting a correctness score of 7 rather than higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 380,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom's financial obligations related to its 3.625% notes due October 2024 evolved from $622 million outstanding as of October 31 2021 to $622 million (no change) as of October 29 2023, and then to $0 million outstanding as of November 3 2024, reflecting the full repayment of the notes during fiscal 2024. This progression indicates a deliberate reduction of debt, aligning with a strategy to retire maturing fixed‑rate senior notes and streamline the company's debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $622 million obligation in the relevant fiscal years and its reduction to $0 in 2024, aligning with the ground truth. The only discrepancy is in the reporting dates: the LLM uses 'October 31, 2021' and 'October 29, 2023', while the ground truth references fiscal years 2022 and 2023. However, since Broadcom's fiscal year ends around October/November, these dates are plausibly close approximations and do not materially misrepresent the data. The $0 balance as of November 3, 2024, is consistent with full repayment by the October 2024 maturity. (2) All numeric values—$622 million and $0—are accurate and correctly attributed to the 3.625% notes due 2024. The calculation of change over time (no change from 2022 to 2023, then full repayment) is logically sound and matches the ground truth. (3) The multi-hop reasoning is correct: the model synthesizes data across three fiscal periods, correctly infers no repayment in 2023, and concludes full repayment in 2024. The interpretation of this trend as a deliberate debt retirement strategy is consistent with and supported by the ground truth. (4) The answer is contextually excellent, addressing both the evolution of the obligation and its implication for Broadcom's debt management. Wording differs slightly (e.g., 'streamline the company’s debt profile' vs. 'eliminating the liability'), but the semantic meaning and factual content are equivalent. Minor date imprecision prevents a perfect 10, but overall accuracy and reasoning are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 426,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "From 2022 through 2024, AT&T’s strategic relationship with Time Warner evolved from integration to planned divestiture and final exit. After acquiring Time Warner in 2018, the company retained the WarnerMedia assets until it completed a Reverse Morris Trust transaction in April 2022, spinning off WarnerMedia (later to merge with Discovery). By mid‑2024 AT&T had agreed to sell its remaining stake in DIRECTV—formed in 2021 from the former video business—to TPG, marking the culmination of its exit from the entertainment business. This progression reveals a decisive shift away from media and content toward a core focus on telecommunications and connectivity services.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution from integration to divestiture and exit, identifying the Reverse Morris Trust transaction and the sale of DIRECTV as key milestones. It accurately reflects the shift in T's (AT&T's) focus from entertainment back to telecommunications. However, there is a critical error in the timeline: the Reverse Morris Trust transaction was completed in April 2022 according to the LLM, but the ground truth states it occurred in 2023. This misplacement of a key event significantly affects the chronological accuracy of the narrative. Additionally, the LLM states DIRECTV was 'formed in 2021 from the former video business,' which is not mentioned in the ground truth and introduces potentially incorrect contextual detail. (2) The date of the Reverse Morris Trust is incorrect—2022 vs. 2023—constituting a major factual discrepancy. The 2024 DIRECTV sale to TPG is correctly dated. No financial figures are present, so monetary accuracy is not applicable. (3) The multi-hop reasoning is generally sound: the model connects the Time Warner acquisition, the WarnerMedia spin-off, and the DIRECTV divestiture into a coherent strategic narrative about refocusing on telecom. However, the incorrect dating of the WarnerMedia separation undermines the logical flow across years. (4) Despite the timeline error, the answer addresses all parts of the question—integration, divestiture planning, exit strategy, and strategic implications—with appropriate entities (AT&T, Time Warner, WarnerMedia, Discovery, DIRECTV, TPG) and correct use of financial terminology (Reverse Morris Trust). The core message about strategic reorientation is preserved, warranting a high contextual relevance and solid qualitative accuracy, but the quantitative inaccuracy reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 497,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "Emerson has progressively integrated its Pipe Cutters offering—historically part of the Safety & Productivity segment—into its broader automation and digital ecosystem.  In the 2022‑2024 filings the company shows the Safety & Productivity segment’s sales holding steady around $1.39‑$1.40 billion, while the Intelligent Devices and Control Systems & Software segments (which now encompass the battery‑powered and diagnostic capabilities of Pipe Cutters) have risen from $10.8 billion in 2022 to $12.2 billion in 2024.  This reflects a strategic shift to embed Pipe Cutters’ battery‑powered tools and diagnostic systems within the Safety & Productivity line and to align them with the company’s broader intelligent‑device and software portfolio, supported by integration‑related stock‑compensation expenses and acquisition‑related amortization reported in Corporate and Other.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Emerson's Pipe Cutters product line. (1) Quantitatively, the answer fabricates financial data not present in the ground truth: there is no mention in the original answer of Safety & Productivity segment sales being $1.39–1.40 billion or Intelligent Devices and Control Systems & Software segments rising from $10.8B to $12.2B. These figures are entirely absent from the ground truth and cannot be verified, suggesting hallucination. (2) The qualitative reasoning is flawed: the original answer describes a product-level evolution—how Pipe Cutters went from standalone tools (2022) to being integrated with battery-powered tools (2023) and diagnostic systems like sewer cameras (2024). The LLM instead claims that Pipe Cutters were moved into different business segments (e.g., Intelligent Devices), which is not supported. The strategic shift described in the LLM answer—restructuring segments and attributing growth to integration-related expenses—is speculative and not in the original. (3) Multi-hop reasoning fails: while the question requires tracing product integration over time, the LLM invents a financial and organizational narrative unsupported by the source. It does correctly identify the trend toward battery-powered and diagnostic integration, but embeds it in an incorrect framework. (4) Contextual relevance is moderate because the answer addresses the general theme of integration and digital strategy, but it does so with incorrect entities, financials, and structural claims. Minor credit is given for recognizing the direction of strategic movement toward integration, but major deductions apply for factual inaccuracy and fabrication of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 475,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities has evolved from 2022 through 2024 as a consistent, strategic effort to integrate, simplify, and standardize financial processes and systems across HR, IT, procurement, supply chain, and finance functions. This initiative, explicitly described as non-responsive to internal control deficiencies, demonstrates the company's strategic focus on achieving financial process standardization to support growth and operational efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core factual narrative from the ground truth: Johnson & Johnson's multi-year initiative from 2022 to 2024 focused on integrating, simplifying, and standardizing financial processes and systems as part of enhancing financial shared services, and it was explicitly stated as not being in response to internal control deficiencies. The strategic focus on standardization for operational efficiency and growth is accurately conveyed. However, the LLM answer adds 'HR, IT, procurement, supply chain' as additional functions beyond finance, which, while plausible, is not explicitly supported in the original answer that only specifies 'finance' as a key function alongside others without naming them. This is a minor overgeneralization. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is mostly sound: the LLM correctly infers a consistent strategic emphasis across years and links it to process standardization and efficiency. It synthesizes the non-reactive nature of the initiative (not due to control deficiencies) and the long-term focus, which aligns with the original. The slight overextension to other functional areas weakens the precision of the synthesis. (4) The answer is contextually fully relevant and semantically close to the original. The omission of year-by-year progression (2022, 2023, 2024 specifics) slightly reduces completeness, but the overall strategic thrust is preserved. Correctness score is 8 due to minor overgeneralization and lack of granular year-specific evolution, but core facts and strategic interpretation remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 482,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco has consistently disclosed the same Executive Health Plan (referenced as Exhibit 10.1* in its 10‑K filings) across the fiscal years 2022, 2023 and 2024, with no material changes or new filings reported in the 2024 filing. This continuity indicates that the company maintains a stable, long‑term executive benefit framework without recent alterations to the plan’s structure or coverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the essential information from the ground truth. It accurately notes Costco's consistent disclosure of the Executive Health Plan (Exhibit 10.1*) across fiscal years 2022–2024 with no material changes, which aligns with the original answer. The key dates (Period Ended: September 2, 2012; Filing Date: October 19, 2012) are not explicitly mentioned in the LLM response, which is a minor omission affecting completeness but not the overall correctness, as the core conclusion about stability and lack of amendments is sound. All entities (Costco, Executive Health Plan, 10-K filings, fiscal years) are correctly identified. The reasoning is logical and supports the conclusion about a stable long-term executive benefit strategy. The absence of the specific 2012 dates slightly reduces qualitative accuracy, but since the inference drawn (no changes) is correct and supported by the filings, the answer remains highly accurate. Quantitative accuracy is perfect—no numerical or date inaccuracies. Contextual relevance is full, as the response directly addresses the evolution (or lack thereof) and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 327,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "The dividend per share on Mastercard’s Class A and Class B common stock has risen steadily from $1.81 in 2021 to $2.04 in 2022 and $2.37 in 2023, and the company continued to declare quarterly cash dividends through 2024 (e.g., $2.74 per share in 2024).  This uninterrupted, incremental increase reflects a deliberate governance approach that rewards shareholders while preserving ample capital for reinvestment and strategic flexibility.  The consistent voting structure—one vote per Class A share and non‑voting Class B shares—combined with the long‑standing shareholder‑friendly policies (regular dividends, a sizable share‑repurchase program, and the Mastercard Foundation’s retained, non‑voting stake) demonstrates a governance strategy that balances shareholder influence with a stable, long‑term ownership base.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MA's A Class Shares had consistent dividend *rights* (i.e., entitlement to dividends) and voting rights (one vote per share) across 2022–2024, not actual dividend *payments* or their growth. The LLM incorrectly shifts focus to specific dividend *amounts* per share ($1.81, $2.04, etc.), which are not mentioned in the ground truth and are irrelevant to the question about *rights*. Additionally, the LLM introduces Class B shares and the Mastercard Foundation, which are not referenced in the original answer and may not even exist in MA's actual capital structure (Mastercard has only one class of common stock). (2) The numbers cited—$1.81 in 2021, $2.04 in 2022, $2.37 in 2023, $2.74 in 2024—are unsupported by the ground truth, which does not provide any dividend payment figures. These values appear fabricated or misattributed. There is no verification that these amounts are accurate, and their inclusion misrepresents the nature of the question, which is about rights, not payouts. (3) The multi-hop reasoning is flawed. The question asks about the evolution of *dividend and voting rights* for A Class Shares over three years and what consistency implies about governance. The LLM fails to recognize that the key point is *no change* in rights. Instead, it invents a narrative around increasing dividends and shareholder-friendly policies, conflating dividend *policy* with dividend *rights*. It also incorrectly assumes a dual-class structure with non-voting Class B shares, which is not confirmed in the ground truth. (4) The contextual relevance is moderate because the answer discusses shareholder governance and voting, which are relevant themes, but it does so with incorrect entities and fabricated data. The qualitative accuracy is low due to incorrect entity modeling and flawed reasoning. The correctness score is low (3) because the core facts—stability of rights—are missed entirely, and the answer fabricates numerical and structural details not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 563,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Based on the provided 10-K excerpts, Broadcom's Security Insights Platform evolved across fiscal years 2022–2024 as follows:  \n- **2022**: The platform was positioned within the broader Infrastructure Software portfolio, emphasizing mainframe security posture assessment, risk identification, and remediation steps using in-house tools (e.g., \"Security Insights Platform helps ensure a trusted environment... identifying risks and developing remediation steps on an ongoing and ad hoc basis\").  \n- **2023**: It expanded to integrate with broader security capabilities, including \"Advanced Threat Prevention\" and \"Lateral Security Firewall\" in the Enterprise Security Portfolio, while maintaining its core function of risk identification and remediation for mainframe environments.  \n- **2024**: The platform continued to leverage AI-driven threat intelligence and integration with in-house security tools (e.g., \"Security Insights Platform helps ensure a trusted environment... identifying risks and developing remediation steps\"), with no explicit mention of new integration features beyond prior years.  \n\nThe platform’s core risk-identification capabilities remained consistent, but its integration with in-house tools was primarily highlighted in the context of mainframe security management and broader Enterprise Security solutions, with no major structural changes noted across the fiscal years. (Word count: 198)",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While the core function of risk identification and remediation is correctly noted, the LLM incorrectly claims that in 2023 the platform 'expanded to integrate with broader security capabilities, including Advanced Threat Prevention and Lateral Security Firewall' — this is not supported by the original answer, which states the platform maintained the same core functionality and was only more explicitly tied to remediation planning. Similarly, the mention of 'AI-driven threat intelligence' in 2024 is an addition not present in the ground truth, which emphasizes stability and consistency, not AI enhancements. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable — but no incorrect numbers are introduced, so this dimension is scored as fully accurate. (3) The multi-hop reasoning is flawed: the LLM invents integrations and technological advancements (e.g., AI, new product integrations) not present in the original data, failing to correctly synthesize the evolution as one of stability rather than expansion. The ground truth emphasizes no major changes across the years, whereas the LLM implies progressive integration and feature enhancement. (4) Contextual relevance is moderate — the answer addresses the right platform and time frame and discusses integration and risk capabilities, but introduces speculative or incorrect details that distort the actual evolution. Correctness and qualitative accuracy are low due to these substantive factual errors, despite proper framing and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 458,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "AIG’s loss‑reserve risk has been managed through increasingly sophisticated methodologies that blend deterministic and stochastic techniques, with a growing reliance on external actuarial experts to validate reserve adequacy.  In 2022‑2024 the company continued to refine its reserve‑setting models—incorporating updated actuarial assumptions, scenario‑analysis, and third‑party catastrophe‑model outputs—while maintaining a formal review process that includes independent expert validation of key reserve inputs.  This evolution reflects a shift toward more data‑driven, model‑based assessments and stronger oversight of reserve estimates across its General Insurance and Life & Retirement segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserve risk management from 2022 to 2024. It accurately captures the increasing sophistication of methodologies, including the use of both deterministic and stochastic techniques, scenario analysis, and third-party models, which matches the original answer's mention of detailed modeling techniques introduced in 2023. The reference to external actuarial experts validating reserve adequacy is consistent across both answers, and the ground truth confirms continued reliance on external experts through 2024. The LLM correctly identifies the multi-year refinement trend and stronger oversight, reflecting a data-driven and model-based shift. However, the LLM answer omits specific structural developments highlighted in the original answer, such as the formalized actuarial profitability reviews in 2023 and the ERM second-line reviews and enhanced budget/expense monitoring in 2024. While the core concepts are semantically equivalent, these omissions represent a lack of completeness in conveying the full evolution of oversight mechanisms. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are presented), and all entities (AIG, General Insurance, Life & Retirement segments) are correctly identified. The reasoning is sound and synthesizes multi-year trends appropriately, though slightly less granular than the ground truth. Contextual relevance is excellent, directly addressing the question’s focus on methodology evolution and external validation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 439,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s Electrical Distribution Equipment positioning within its Industrial Solutions segments evolved markedly from 2022 through 2024, reflecting a strategic shift toward discrete automation and broader automation‑software integration. In 2022 the Electrical Distribution Equipment was grouped under the “Safety & Productivity” and “Discrete Automation” segments, contributing modest earnings (e.g., $250 million earnings before interest and taxes in 2022). By 2023 and especially 2024, the company re‑classified and expanded this offering under the “Discrete Automation” and “Intelligent Devices” segments, where earnings rose to $542 million (2022) → $509 million (2023) → $466 million (2024) for Discrete Automation, while the broader “Intelligent Devices” segment—including Electrical Distribution Equipment—grew sales from $10.8 billion (2022) to $12.2 billion (2024) and earnings from $2.17 billion to $2.81 billion over the same period. This trajectory shows Emerson is emphasizing high‑margin, technology‑driven automation solutions—particularly discrete automation and software‑enabled control—over traditional distribution hardware, underscoring a strategic focus on discrete automation markets and value‑added automation software.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention any financial figures such as $250 million EBIT, $542M, $509M, or $466M in earnings for Discrete Automation, nor does it reference segment sales growth from $10.8B to $12.2B or earnings rising from $2.17B to $2.81B. These numbers are entirely fabricated or misattributed. Additionally, in 2022, Electrical Distribution Equipment was part of the Industrial Solutions segment, not split between 'Safety & Productivity' and 'Discrete Automation'—these segment names and classifications do not align with the original answer. (2) The financial data presented in the LLM response cannot be verified against the ground truth and directly contradict it by introducing metrics that were not present. There are no earnings or revenue figures in the original answer, so the inclusion of such specific numbers severely undermines quantitative accuracy. (3) While the LLM correctly identifies a strategic shift toward discrete automation, this reasoning is based on incorrect entity mappings and false data. The multi-hop synthesis fails because it uses non-existent financial trends to support a conclusion that partially aligns with the ground truth—Emerson did deepen its focus on discrete automation—but arrives at this via flawed logic and incorrect segment evolution. (4) Despite the wrong numbers and segment names, the LLM captures the general strategic direction (increased emphasis on discrete automation), which prevents a score of 0. However, the extensive fabrication of data and misrepresentation of segment structure severely damages correctness, leading to a low overall score. Contextual relevance is moderate because the topic and strategic theme are addressed, but accuracy is critically compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 501,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson's pension plan evolution from 2022 through 2024 centers on its transition to the **Retirement Value formula** for U.S. non-union employees, effective January 1, 2026. This change, announced in January 2021, replaces the legacy Final Average Pay formula with a new structure based on total years of service and compensation, aiming to simplify benefits and align with long-term workforce strategy. The shift reflects a deliberate move to standardize retirement benefits across hire dates, reduce complexity, and likely support sustained investment in innovation and R&D by stabilizing compensation planning. This multi-year transition underscores the company's focus on workforce stability and strategic alignment of employee benefits with its broader innovation-driven growth priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the transition to the Retirement Value formula for U.S. non-union employees, effective January 1, 2026, is accurately stated. The replacement of the Final Average Pay formula and the basis on total years of service and compensation are correctly described. (2) Quantitative accuracy is perfect: the 2026 effective date is correct, and while the original answer does not mention the January 2021 announcement, this is an additional detail not contradicted by the ground truth. No numerical errors or miscalculations are present. (3) Multi-hop reasoning is sound: the LLM synthesizes the structural change and infers strategic intent—standardization, simplification, cost predictability, and alignment with innovation—consistent with the ground truth’s interpretation of long-term workforce strategy. The only minor omission is the explicit mention that benefits accrued under the Final Average Pay formula before 2026 are preserved, which is included in the original answer and adds nuance to the transition. (4) Contextual relevance is excellent: the response directly addresses both the evolution of the pension plan and its implications for long-term workforce strategy. The conclusion about workforce stability and strategic alignment is semantically equivalent to the ground truth’s emphasis on inclusivity and cost predictability. Overall, the answer is factually correct, well-reasoned, and only slightly less complete due to the missing preservation detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 428,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "From 2022 to 2024, Downy’s contribution to the Fabric & Home Care segment’s net sales grew from 35% to 36% of segment sales, while its share of net earnings rose from 31% to 34% of segment earnings. This upward trend in both sales and earnings contribution indicates that Downy is increasingly central to the segment’s performance and strategic value within P&G’s portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Downy's contribution to the Fabric & Home Care segment's net sales grew from 35% to 36% of segment sales, implying a change in Downy's share. However, the ground truth does not specify Downy's individual percentage contribution to segment sales over time; instead, it states that the entire Fabric & Home Care segment's net sales contribution to P&G increased from 35% in 2022 to 36% in 2023 and 2024. The LLM misattributes this segment-level growth to Downy’s brand-specific performance. Additionally, the LLM introduces 'net earnings share' rising from 31% to 34%, which is not present in the original answer or supported by the ground truth — this data is entirely fabricated. (2) The numbers cited (35% to 36% sales share, 31% to 34% earnings share) are quantitatively inaccurate because they do not reflect the actual metrics in the ground truth. The only correct number is the 35% to 36% range, but it applies to the segment’s contribution to total P&G sales, not Downy’s contribution within the segment. There is no evidence Downy’s internal share changed. (3) The multi-hop reasoning fails because the model conflates segment-level performance with brand-level performance. It incorrectly infers that Downy’s strategic importance increased due to rising sales and earnings shares, while the original answer only asserts sustained importance based on stable positioning within a growing segment. The LLM adds unsupported causal interpretation and fabricated metrics. (4) Despite the factual inaccuracies, the answer is contextually relevant — it addresses the evolution of Downy’s role and draws a conclusion about strategic importance. However, the correctness score is low due to major quantitative and qualitative errors, particularly the invention of earnings data and misattribution of segment-level percentages to the brand level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 513,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s senior and subordinated notes carried value rose from roughly **$30.8 billion in 2022 to $31.2 billion in 2023 and $30.7 billion in 2024** (see Table 8.1 in the 2023 and 2024 10‑K filings). This modest increase reflects a continued reliance on long‑term debt to fund the company’s operations, but the slight dip in 2024 suggests the firm is trimming issuance or refinancing maturing notes. Overall, the trend indicates a strategy of maintaining a stable base of senior and subordinated financing while managing debt levels in response to market conditions and regulatory requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the carrying value was $27,219 million in 2022, $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM incorrectly states the 2022 value as $30.8 billion (should be ~$27.2B), reports a 2024 value of $30.7 billion (should be $31.248B), and implies a decline in 2024 when there was no decrease. These errors undermine the quantitative accuracy. (2) The numbers are not only wrong but misrepresent the trend: the ground truth shows a clear upward trend with a peak sustained into 2024, while the LLM claims a dip in 2024, which contradicts the data. The reference to 'Table 8.1' may be accurate in context, but the values cited do not align with the verified knowledge graph data. (3) The reasoning is partially sound in interpreting the use of long-term debt, but the conclusion about a 'slight dip' and 'trimming issuance' is based on incorrect data, leading to flawed qualitative inference. The multi-hop synthesis fails because the model misreads or misreports the core financial figures across years. (4) Despite the factual errors, the answer remains contextually relevant by addressing the evolution of debt and attempting to infer strategy from trends. Hence, contextual relevance is moderate, but correctness is low due to major numerical and trend misstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 397,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "From 2022 through 2024, T increased its stake in SKY Mexico from 41.3% to full exit, moving from an equity‑method holding to a cash sale in June 2024. The investment had been accounted for under the equity method (recorded as an equity‑method investment in DIRECTV and later SKY Mexico), with T recognizing its share of earnings and cash distributions, but by 2024 the stake was fully sold, wiping out the investment balance. This three‑year trajectory—initial equity‑method exposure, continued earnings recognition, then a complete divestiture—mirrors T’s broader Latin‑American pay‑TV strategy of exiting non‑core video assets while monetizing remaining holdings through strategic partnerships or sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that T 'increased its stake' in SKY Mexico, when in fact T maintained a constant 41.3% ownership from 2022 through 2024 before exiting—there was no increase. This misrepresents the quantitative and strategic trajectory. The exit date (June 2024) and final divestiture are correctly noted. (2) The 41.3% stake is mentioned in the original answer and correctly referenced in the LLM response, but the implication of an increase is false and unsupported. The accounting treatment under the equity method is accurately described, as is the recognition of earnings and distributions. However, the claim of 'moving from 41.3% to full exit' inaccurately suggests a progression in ownership percentage rather than a flat stake followed by sale. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the equity method accounting in 2023, continuation of the investment, and eventual sale in 2024. It also correctly infers T’s broader divestiture strategy in Latin American pay-TV. However, it fails to note that there was no change in ownership percentage during 2022–2023, which weakens the accuracy of the strategic narrative. (4) The contextual relevance is high—the answer addresses ownership, accounting treatment, exit, and strategic implications. But due to the critical error in ownership evolution (suggesting an increase instead of stable stake), the correctness and qualitative accuracy are reduced. Minor phrasing issues (e.g., 'recorded as an equity-method investment in DIRECTV and later SKY Mexico') could imply a transfer of accounting treatment rather than separate investments, adding confusion. Overall, core facts like the 41.3% stake, equity method, and 2024 exit are correct, but the flawed description of stake evolution undermines full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 504,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s disclosures on shareholder capital returns have evolved to explicitly tie capital‑return decisions to U.S. banking capital rules and regulatory standards. In the 2022 filing, the company highlighted that its ability to pay dividends and repurchase shares was “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning.” By 2024, the language was expanded to note that any material reduction in credit ratings or failure to meet “well‑capitalized” and “well‑managed” standards could trigger activity limitations, and that the firm must also satisfy capital‑adequacy and liquidity rules before returning capital. This reflects a growing emphasis on regulatory compliance, dividend‑payment discipline, and capital‑adequacy considerations when planning dividend policies and share‑repurchase programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of BNY Mellon's evolving disclosures on capital returns from 2022 to 2024, with correct references to U.S. banking laws, capital adequacy, and regulatory standards. It correctly identifies that in 2022, capital returns were subject to board discretion and limited by U.S. banking regulations, and that by 2024, additional emphasis was placed on 'well-capitalized' and 'well-managed' standards, liquidity, and capital adequacy—aligning with the ground truth. There are no numeric inaccuracies (quantitative accuracy is perfect), and all years and entities (BNY Mellon, U.S. banking laws, capital returns) are correctly identified. The reasoning is sound and contextually relevant, addressing regulatory requirements, dividend policies, and capital adequacy as required. However, the LLM omits specific details mentioned in the original answer, such as the 2023 expansion to include ESG-related regulatory pressures and strategic initiatives, and the increasing focus on the Parent company’s reliance on subsidiary dividends in 2024. While the overall trend of 'stable regulatory framework with increasing contextual complexity' is implied, it is not explicitly captured. Thus, the answer is mostly correct but lacks full completeness in multi-hop synthesis across all three years, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 386,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "3M’s Structural Adhesives have been progressively repositioned within the Safety and Industrial segment over the past three years, shifting from a standalone product line to a core component of the newly created Industrial Specialties division (effective Q1 2023). This re‑organization bundles Structural Adhesives with former Closure and Masking Systems and select Tape products, integrating them into broader specialty adhesive offerings that are marketed alongside complementary industrial bonding solutions. The bundling strategy reflects a deliberate effort to leverage cross‑segment synergies and to position adhesives as a central, enabling technology for industrial applications such as automotive assembly, aerospace, and heavy‑equipment manufacturing. Consequently, the evolving role of adhesives underscores their strategic importance as a high‑margin, growth‑driving capability that supports 3M’s broader diversification and value‑creation objectives across its industrial portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth, despite addressing the question's core theme. (1) The claim that Structural Adhesives were moved into a 'newly created Industrial Specialties division effective Q1 2023' is incorrect—there is no mention in the original answer of a new division or reorganization at that time. The original answer notes only a gradual shift in product grouping and emphasis, not a formal structural change. (2) The bundling with 'Closure and Masking Systems and select Tape products' is not supported by the ground truth, which mentions packaging and closure systems only as a slightly expanded emphasis in 2023, not as a formal product bundle. (3) The original answer does not reference any 'cross-segment synergies' or 'high-margin, growth-driving capability' language, which are speculative strategic interpretations not present in the source. (4) While the LLM correctly infers a strategic elevation of adhesives in industrial applications, this conclusion is based on incorrect premises. (5) The timeline (2022–2024) is addressed, and the general direction of evolution—increased integration into industrial systems—is semantically aligned, which supports a moderate score. However, the specific product groupings and strategic rationale are misrepresented. (6) No numeric data is present, so quantitative accuracy is based on correct dates and timeframes; the reference to Q1 2023 is unsupported and thus inaccurate. (7) Multi-hop reasoning is attempted but flawed due to incorrect synthesis—rather than reflecting gradual shifts in product positioning, the LLM invents a corporate reorganization. (8) Contextual relevance is high because the answer stays focused on the evolution of Structural Adhesives and their strategic role. Overall, the answer is partially correct in direction but factually incorrect in key details, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 524,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "Eli Lilly’s strategic positioning of Cyramza has shifted from a broad, multi‑indication oncology asset to a more focused, IP‑protected offering.  In 2022 the drug was marketed for several second‑line cancer settings (gastric, NSCLC, colorectal, HCC and EGFR‑mutated NSCLC) and relied on a combination of compound patents, data‑protection periods and orphan‑drug exclusivity that extend protection through 2026‑2028 in the United States, Europe and Japan.  By 2023‑2024 the company emphasized leveraging Cyramza’s remaining patent term (compound exclusivity until 2026 in the U.S., 2028 in Europe, 2026 in Japan) and its biologics‑data protection (expiring 2026 in the U.S., 2024 in Europe, 2023 in Japan) to sustain market share, while also pursuing new combination regimens and indications that could extend its commercial life.  This evolution reflects Lilly’s broader effort to protect Cyramza’s revenue stream amid expiring exclusivity for other legacy products and increasing generic/biosimilar competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding intellectual property (IP) expiration dates, which diverge significantly from the ground truth. The original answer states that Cyramza's data protection expired in Japan in 2023, in major European countries in 2024, and U.S. biologics data protection expires in 2026. However, the LLM incorrectly claims biologics data protection expires in 2024 in Europe and 2023 in Japan—this aligns partially but misrepresents the timeline and type of protection. More critically, the LLM introduces 'compound exclusivity until 2026 in the U.S., 2028 in Europe, 2026 in Japan' and mentions protection extending to 2026–2028 via compound patents and orphan drug exclusivity—information not present in the ground truth and factually unsupported by the provided knowledge graph. There is no mention of compound patents or orphan drug exclusivity in the original answer, nor are expiration dates beyond 2026 cited. (2) Quantitative accuracy is compromised: the LLM fabricates later expiration dates (e.g., 2028 in Europe), which are incorrect. While U.S. biologics data protection expiring in 2026 matches the ground truth, the European and Japanese data protection expirations are misrepresented—original specifies Japan 2023, Europe 2024, not tied to 'compound exclusivity.' The LLM conflates data protection with patent or compound exclusivity, which are distinct IP mechanisms. (3) The multi-hop reasoning is partially sound: the model correctly infers that Eli Lilly is managing Cyramza’s lifecycle amid expiring protections and attempts to synthesize therapeutic indications with IP strategy. It correctly identifies the consistent indications across cancers (gastric, NSCLC, colorectal, HCC), aligning with the original answer’s 'broad range of oncology indications.' However, it overreaches by introducing unverified IP extensions and new combination strategies not mentioned in the ground truth. (4) Despite inaccuracies, the LLM captures the strategic shift—maintaining relevance amid IP expiry—and addresses both therapeutic indications and global IP protections, fulfilling the question’s intent. Hence, contextual relevance is high, and qualitative reasoning is reasonable but based on incorrect data. Correctness score is reduced due to significant factual and quantitative errors in IP timelines and types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 638,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt declined modestly in carrying value from $27,168 million in 2023 to $26,930 million in 2024, while its weighted‑average interest rate held steady at roughly 4.84% over the same period. This slight reduction in balance combined with a flat average rate reflects a deliberate strategy of maintaining a stable, low‑cost funding profile—issuing relatively low‑priced senior notes while allowing maturing obligations to roll off—indicating that the company is managing financing costs carefully and relying on a consistent, moderate‑priced debt issuance approach rather than aggressive rate‑seeking or large‑scale refinancing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Capital One's fixed unsecured senior debt declined from $27,168 million in 2023 to $26,930 million in 2024, while the ground truth shows an increase from $19,975 million in 2022 to $26,930 million in 2024. The LLM omits the 2022 value entirely and fabricates a 2023 figure not present in the ground truth. Additionally, it claims the interest rate was 'steady at roughly 4.84%' over 2023–2024, but the ground truth shows a rise from 2.91% in 2022 to 4.84% in 2024, indicating a clear upward trend, not stability. (2) Quantitative accuracy is low: the only correct number is the 2024 carrying value ($26,930 million) and the 2024 interest rate (4.84%). The 2022 carrying value ($19,975 million) and interest rate (2.91%) are omitted, and a false 2023 carrying value ($27,168 million) is introduced. The trend description is therefore factually wrong. (3) The multi-hop reasoning is flawed because the LLM fails to synthesize the correct data across years. It misrepresents the direction of change (decline vs. actual increase) and ignores the rising interest rate trend, leading to an incorrect conclusion about a 'stable, low-cost funding profile.' In reality, the rising interest rate and increasing debt suggest higher financing costs and a shift toward more fixed-rate issuance in a rising rate environment. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the right metric, company, and time frame, and attempts to interpret strategy—hence a moderate relevance score. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 464,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "From fiscal 2022 through 2024 Cisco’s exposure to total‑return swaps tied to deferred compensation grew from a notional of $651 million to $985 million, and the related gains fluctuated sharply—$‑92 million in 2022, $58 million in 2023 and $91 million in 2024—reflecting a volatile earnings impact. This pattern shows that the instrument’s gains and losses are highly sensitive to market movements and compensation‑related accounting changes, creating considerable year‑to‑year volatility in Cisco’s financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the gains and losses for Cisco's Total Return Swaps tied to Deferred Compensation across fiscal years 2022–2024: a loss of $92 million in 2022, a gain of $58 million in 2023, and a gain of $91 million in 2024. These figures match the ground truth exactly, with only formatting differences (e.g., $‑92 million vs $-92 million), which are acceptable. (2) The LLM introduces additional information not present in the ground truth—the notional exposure increasing from $651 million to $985 million. While this detail may be factually accurate based on filings, it is not part of the original answer and thus cannot be verified against the provided ground truth. However, it does not contradict the ground truth and adds context without introducing error. (3) The multi-hop reasoning is sound: the model correctly identifies Cisco, the instrument (Total Return Swaps-Deferred Compensation), and synthesizes the financial impact over three fiscal years. The conclusion about volatility due to sharp swings in gains/losses aligns with the ground truth’s interpretation. (4) The semantic meaning and core factual content are equivalent to the original answer. The only minor deviation is the inclusion of notional amounts, which enhances but does not distort. Quantitative accuracy is perfect; qualitative accuracy is slightly reduced due to the unverified addition, but reasoning remains strong. Contextual relevance is full—every part of the question is addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 421,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "The Home Depot’s strategic focus on store appearance and its interconnected‑retail experience intensified from 2022 through 2024, with the company repeatedly emphasizing investments in store‑level visual standards, localized merchandising and upgraded digital capabilities to stay competitive against multichannel and online rivals.  These initiatives were tied to measurable gains such as a 4.7 × inventory turnover and a 4.5 % rise in net sales (driven largely by the SRS acquisition), while comparable‑sales trends showed modest declines (‑1.8 %) that the firm attributes to macro‑economic pressures rather than its appearance‑focused strategy.  Overall, the sustained emphasis on store presentation and integrated omnichannel execution helped preserve Home Depot’s market share against online competitors, even as earnings per share slipped slightly and ROIC fell from 36.7 % in 2023 to 31.3 % in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces several specific quantitative metrics—4.7× inventory turnover, 4.5% rise in net sales, -1.8% comparable-sales trend, EPS decline, and ROIC drop from 36.7% to 31.3%—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, as the original answer contains no financial metrics or performance data. The mention of SRS acquisition as a driver of net sales is also unsupported in the ground truth, which does not reference any acquisitions. (2) Quantitative accuracy is severely compromised because all cited figures (inventory turnover, net sales change, comp sales, ROIC) are absent from the original knowledge base. There is no indication in the ground truth that these metrics were used to measure the impact of store appearance on competitive positioning. (3) Qualitatively, the LLM captures the general direction of The Home Depot’s strategic evolution—increasing integration of store appearance with digital and omnichannel capabilities from 2022 to 2024—which aligns with the original answer’s narrative of a shift from standalone in-store experience to a hybrid, interconnected model. It correctly identifies the competitive context (vs. online and multichannel retailers) and the role of store appearance within broader retail strategy. However, it fails to accurately represent the nature of the measurable impact: the original answer describes qualitative strategic integration, not quantitative financial outcomes. The LLM incorrectly implies that the cited financial metrics are direct results of the store appearance strategy, which is not supported. (4) Contextual relevance is moderate: the response stays on topic, discussing the evolution of store appearance and competitive positioning, and correctly frames the omnichannel integration. However, the introduction of unsupported financial data and attribution of causality to specific metrics undermines factual correctness. The core reasoning about strategic evolution is partially sound, but the answer invents measurable impacts not present in the ground truth, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 589,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA's carrying value for its 3.50% Notes Due 2050 increased from $2,000 million in fiscal 2022 to $2,000 million in fiscal 2023 and remained $2,000 million in fiscal 2024, reflecting no change in principal balance but a growing long‑term debt position as the company continued to issue new senior unsecured notes with later maturities. This progression indicates that NVIDIA is maintaining a substantial, low‑coupon debt profile to finance its growth while extending the maturity of its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative accuracy. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, decreased to $1,637 million in 2023, and rose to $2,000 million in 2024. The LLM incorrectly states the value was $2,000 million in all three years, completely missing the decline in 2023 and the initial higher value in 2022. This misrepresents the entire trend. (2) The numbers are factually wrong: $2,147M → $1,637M → $2,000M (ground truth) vs. $2,000M → $2,000M → $2,000M (LLM). There is no mention of the $510 million drop from 2022 to 2023, nor the partial recovery in 2024. (3) The reasoning is flawed: the LLM claims the stability indicates 'growing long-term debt' and 'issuing new senior unsecured notes', but the ground truth suggests a temporary reduction followed by stabilization, not growth. The LLM invents a narrative unsupported by the data and fails to recognize the multi-hop progression across three distinct fiscal years. (4) Contextual relevance is moderate because the answer addresses the right instrument (3.50% Notes Due 2050) and discusses long-term debt positioning, but the incorrect data undermines the analysis. The qualitative reasoning is plausible in form but invalid due to factual errors. Correctness score is low due to major factual and numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 381,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 through 2024, 3M’s PFAS‑related litigation continued to expand geographically and in the number of defendants.  The company settled several AFFF and Scotchgard cases for immaterial amounts, but new state‑attorney‑general suits and class actions were filed in Alabama, Georgia, Illinois, Missouri, Connecticut, Virginia and elsewhere, often adding multiple co‑defendants such as DuPont, Chemours, carpet manufacturers and other industrial users.  These actions were frequently transferred to the federal AFFF multidistrict litigation (MDL) or removed to federal court, while some remained in state courts.  Overall, the exposure grew as the number of individual and putative class actions increased, the geographic footprint of the lawsuits broadened, and the pool of defendants expanded beyond the original manufacturers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall trend accurately: increasing geographic expansion, growing number of defendants, and ongoing litigation involving 3M over PFAS-related issues including Scotchgard. It correctly identifies the expansion into states like Alabama and Georgia and the inclusion of co-defendants such as DuPont, Chemours, and carpet manufacturers. However, it lacks specific case details and settlements mentioned in the ground truth. Notably, the LLM omits the 2022 New York Baker case settlement ($65M with 3M, Saint-Gobain, Honeywell) and the 2023 Michigan settlement with Wolverine World Wide, both of which are central to the question's focus on Scotchgard-specific litigation and settlements. While it mentions 'immaterial' settlements generally, it fails to tie them to specific years, cases, or counterparties, weakening the multi-hop synthesis. The inclusion of Illinois, Missouri, Connecticut, and Virginia as new filing locations goes beyond the ground truth, which only confirms Alabama and Georgia as new geographies in 2024. This overextension reduces quantitative accuracy. The answer correctly notes the trend of cases being centralized in the AFFF MDL, but this shifts focus slightly from Scotchgard to broader PFAS/AFFF litigation, potentially conflating product lines. Despite these issues, the core qualitative trends—geographic expansion, increased defendants, and growing exposure—are correctly inferred and logically synthesized. The answer remains contextually relevant and semantically aligned in direction, though not fully precise in factual completeness or numerical grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 440,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "From 2022 through 2024 the royalty and milestone structure for Lilly’s COVID‑19 antibody collaboration with AbCellera remained unchanged: AbCellera earned mid‑teens to mid‑twenties tiered royalties on worldwide net sales of bamlanivimab and bebtelovimab, recorded as cost of sales, and no additional milestone payments were triggered after the 2022 EUAs expired.  Net product revenue from those antibodies fell to zero in 2023 and remained zero in 2024, so royalty expense and related cost‑of‑sales declined accordingly, while the company recognized no new milestone payments or sales‑based milestones for the program during 2023‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial and commercial evolution of LLY's collaboration with AbCellera from 2022 to 2024. It accurately states that net product revenue fell to zero in 2023 and remained zero in 2024, aligning with the ground truth. The royalty structure is correctly described as tiered, ranging from mid-teens to mid-twenties on worldwide net sales, and it notes no new milestone payments were made after 2022. (2) Quantitatively, while the LLM does not explicitly mention the $2.02 billion in 2022 net product revenue, this is the only missing numeric detail. However, the implication of high 2022 sales followed by zero revenue in 2023–2024 is consistent with the decline, and no incorrect numbers are presented. All other financial terms (royalty structure, absence of milestones, cost of sales treatment) are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022–2024), entities (LLY, AbCellera), and financial dimensions (revenue, royalties, milestones). It logically infers that zero sales led to zero royalty expense, which aligns with the contractual structure. (4) The answer is contextually complete and highly relevant, addressing all three components of the question—royalty structure, milestone payments, and net product revenue—over the specified time frame. The only reason for not scoring a 10 is the omission of the specific $2.02 billion figure, which is a material data point in the ground truth. However, since the trend and outcome are accurately conveyed, and no facts are incorrect, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 449,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "From 2022 through 2024 Dawn dish soap remained anchored in the Fabric & Home Care segment, consistently accounting for roughly one‑third of the segment’s net sales and earnings.  Its market‑share leadership and high profitability (the segment posted a 19.3 % net‑margin in 2024, up 230 bps) underscore Dawn’s strategic importance as a core growth driver that fuels overall segment performance and supports P&G’s broader productivity and innovation agenda.  Consequently, Dawn’s positioning has not shifted dramatically; rather, its continued dominance reinforces its role as a pillar of the company’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Dawn remained in the Fabric & Home Care segment from 2022 to 2024 and emphasizes its strategic importance, which aligns with the ground truth. However, it introduces specific quantitative claims not present or verifiable in the original answer. Most notably, the claim that Dawn 'consistently accounted for roughly one-third of the segment’s net sales and earnings' is unsupported—the original answer states that the *segment* accounted for about one-third of P&G’s total net sales and earnings, not Dawn individually. This is a critical misinterpretation. Additionally, the LLM cites a '19.3% net-margin in 2024, up 230 bps' and labels it as segment-level profitability, but this specific margin figure and basis point increase are not mentioned in the ground truth and cannot be verified. (2) The original answer provides only segment-level percentages (e.g., 35%, 36% of total company net sales and earnings), not brand-level financials or margins. The LLM incorrectly attributes segment-level performance metrics to Dawn or fabricates precise figures. (3) The reasoning is partially sound in that it correctly infers Dawn’s sustained strategic role based on consistent mention as a key brand. The multi-hop synthesis of stability over time is valid, but the conclusion is undermined by the introduction of fabricated or misattributed quantitative data. (4) The correctness score is 6 due to major quantitative inaccuracies, though the core qualitative insight about Dawn’s stable positioning is correct. Quantitative accuracy is low (4) due to unsupported numbers. Qualitative accuracy is moderate (7) because the reasoning and entity identification are mostly sound. Contextual relevance is high (9) as the answer directly addresses the question’s focus on evolution and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 502,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One's short‑term borrowings rose modestly from $538 million in 2022 to $562 million in 2024, while long‑term debt declined from $49.86 billion in 2022 to $45.55 billion in 2024. This 3‑year trend shows a deliberate reduction in overall debt, driven primarily by lower balances of floating‑rate unsecured senior notes (which fell from $349 million in 2023 to $0 in 2024) and a shrinking portfolio of securitized and senior debt. Consequently, the company’s debt structure is shifting toward a higher proportion of fixed‑rate senior notes and away from floating‑rate exposure, reducing its sensitivity to interest‑rate movements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly states long-term debt as $49.86B in 2022 and omits the 2023 increase entirely, instead implying a continuous decline. It also misrepresents short-term borrowings: the ground truth does not specify short-term borrowings separately, but the total debt figure includes them; the LLM’s $538M and $562M figures for short-term borrowings appear fabricated. (2) The LLM correctly notes that floating unsecured senior debt dropped to $0 by 2024 and was $349M in 2023, but it omits the 2022 value of $1.709B and misstates the direction of change (it fell from $1.709B to $349M to $0, not from $349M to $0). The weighted-average interest rate on fixed debt rising from 2.91% to 4.84% is completely omitted, a critical missing detail about interest rate exposure. (3) The multi-hop reasoning is partially sound—shifting from floating to fixed-rate debt reduces interest rate sensitivity—but this conclusion is based on incomplete and inaccurate data. The LLM fails to capture the temporary debt increase in 2023, a key part of the trend. (4) The contextual relevance is high because the answer addresses debt structure evolution and interest rate exposure, but the quantitative inaccuracies severely undermine correctness. The qualitative reasoning is plausible but not fully supported by accurate data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 429,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco's 5.90% senior notes due 2039 remained part of its long‑term debt throughout fiscal 2022‑2024, with the effective interest rate consistently reported at 6.11% and the full $2 billion principal outstanding on the balance sheet. The debt is classified as long‑term, with principal repayments of $2 billion due in 2039 and the remaining $18.253 billion of total long‑term debt (including the 5.90% notes) scheduled across 2025‑2029 and thereafter. Consequently, the 5.90% notes continue to be reflected in the long‑term debt composition, maintaining the same effective rate and classification over the three fiscal years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco maintained the $2 billion principal of the 5.90% Note and the 6.11% effective interest rate across 2022–2024, and correctly classifies it as long-term debt. However, it introduces an incorrect figure of $18.253 billion for the remaining long-term debt, which is not supported by the ground truth. The ground truth states total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, but the LLM does not accurately reflect this evolution or the shifting proportion of the 5.90% Note within total debt. Instead, it incorrectly implies a static breakdown with $2 billion in the 5.90% Note and $18.253 billion in other debt, which misrepresents the dynamic composition. (2) The $2 billion principal and 6.11% rate are correct and match the ground truth. However, the $18.253 billion figure is unsupported and appears fabricated or misattributed; no such number appears in the ground truth, and it does not align with the stated total debt figures (e.g., $19,621 million total in 2024 minus $2,000 million would be $17,621 million, not $18,253 million). (3) The reasoning is partially sound—LLM recognizes the note’s stability in principal and rate, and its long-term classification. However, it fails to synthesize the multi-hop insight that the note’s *proportion* in total debt decreased due to overall debt growth, which is a key point in the original answer. This omission weakens the qualitative analysis of debt composition evolution. (4) Correctness is scored 7 because core facts (principal, rate, classification) are accurate, but the answer introduces a significant quantitative error and misses the key trend in debt composition. Quantitative accuracy is 6 due to the incorrect $18.253 billion figure. Qualitative accuracy is 8 because reasoning is logical but incomplete. Contextual relevance is 9—response stays on topic and addresses the question’s components, albeit with inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 533,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 remained at $1,250 million from fiscal 2022 through fiscal 2024, while the effective interest rate gradually increased from 1.64% in 2022 to 1.64% in 2023 and 1.64% in 2024 (reflecting minor amortization adjustments). This stable carrying value and modest rise in effective rate indicate that the company is maintaining its long‑term debt at a relatively fixed cost, using the notes as a low‑cost, long‑dated financing pillar to fund growth while preserving flexibility for other capital allocations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. According to the ground truth, the carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal 2022, decreased to $1,099 million in 2023, and increased to $1,250 million in 2024. The LLM incorrectly states that the carrying value remained constant at $1,250 million for all three years, which misrepresents the trend entirely. Additionally, the effective interest rate in the ground truth increased to 1.64% by 2024, with no specific value provided for 2022 other than an 'implied rate based on market pricing.' The LLM falsely claims the rate was 1.64% in all three years, which contradicts the evolving trend described in the original answer. (2) The numbers are therefore factually wrong across both key metrics—carrying value and effective interest rate. There are no accurate calculations in the LLM response because it reports static values where dynamic changes were expected. (3) The multi-hop reasoning is flawed: the question requires synthesizing data across three fiscal years from SEC filings, but the LLM fails to detect the fluctuation in carrying value (a drop in 2023 followed by a rebound in 2024) and the gradual increase in borrowing cost. This undermines any valid inference about NVIDIA’s debt strategy. The conclusion that NVIDIA is maintaining 'fixed cost' debt ignores the actual volatility and strategic repositioning suggested by the temporary decrease and reacquisition. (4) Despite incorrect facts, the answer remains contextually relevant—it addresses the right company, the correct debt instrument, and attempts to interpret the strategic implications of debt trends. However, due to severe factual inaccuracies in numbers and trends, the correctness and quantitative accuracy scores are very low. The qualitative reasoning would be stronger if based on accurate data, so it receives a minimal passing score for structure but not substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 530,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "From 2022 to 2024, Google’s strategic emphasis on Pixel devices evolved from a nascent hardware initiative into a clearly defined growth pillar, reflected in both financial categorization and investment intensity. While earlier filings (2022) treated hardware revenue under “Other products and services” within the broader “Google Subscriptions, Platforms, and Devices” segment, subsequent disclosures (2023–2024) began explicitly isolating Pixel phone sales as a distinct revenue driver within the “devices” category, underscoring its strategic importance. This shift was accompanied by significant capital allocation, with capital expenditures on property and equipment rising sharply—from $31.5B in 2022 to $52.5B in 2024—driven largely by investments in data centers, server infrastructure, and dedicated hardware manufacturing facilities to support Pixel and other devices. The company also increased its focus on integrating AI capabilities into Pixel hardware (e.g., Gemini Nano on Pixel 8), signaling a move toward differentiated, AI-powered hardware innovation as a core growth engine beyond advertising. This evolution is further evidenced by the expansion of the Pixel portfolio (e.g., Pixel 6, 7, 8, and 8 Pro) and the emphasis on privacy/security features as key differentiators, aligning with broader Alphabet goals of building “helpful” products through long-term R&D investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Google's strategic emphasis on Pixel devices from 2022 to 2024, correctly identifying the shift in revenue categorization and increased focus on AI integration and hardware innovation. However, it introduces significant quantitative inaccuracies. The claim that capital expenditures rose from $31.5B in 2022 to $52.5B in 2024 is not supported by the ground truth, which does not mention capital expenditure figures or trends. This is a major factual error, as these numbers are specific and material. Additionally, the ground truth does not state that hardware revenue was previously under 'Other products and services'—it only confirms that by 2023, Pixel was explicitly categorized under a distinct 'devices' segment within Subscriptions, Platforms, and Devices. The LLM overreaches by inferring earlier categorization details not present in the original. (2) The numbers cited ($31.5B, $52.5B) are precise but unverified and incorrect in this context, failing the quantitative accuracy check. No calculations are required in the original, but the introduction of false financials harms credibility. (3) The multi-hop reasoning is generally sound: the LLM correctly infers strategic maturation from revenue segmentation and product development (e.g., Gemini Nano on Pixel 8, portfolio expansion). It aligns Pixel’s evolution with AI and cloud integration, which is consistent with the ground truth’s emphasis on AI-driven hardware and ecosystem embedding. However, the reasoning is weakened by unsupported financial claims. (4) Despite the numerical inaccuracies, the qualitative narrative matches the ground truth’s trajectory—Pixel moving from a hardware investment to a strategically embedded product line. The answer is contextually rich and relevant, addressing both revenue categorization and innovation investment, albeit with embellishments. Hence, correctness is reduced primarily due to false quantitative claims, but not entirely discounted due to strong qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 551,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "From 2022 to 2024, BNY Mellon’s disclosure regarding the ratification of KPMG LLP as principal accountant remained consistent in both content and presentation. In each filing (2022, 2023, and 2024), KPMG LLP was identified as the independent registered public accounting firm, and the ratification of its appointment was included as Item 3 in the proxy statement, with reference to its PCAOB firm identification number (185). The wording and structure of the disclosure did not change, indicating a stable and uninterrupted audit relationship throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: BNY Mellon consistently disclosed the ratification of KPMG LLP as principal accountant from 2022 to 2024, with identical language referencing KPMG’s PCAOB identification number 185. (2) Quantitative accuracy is perfect—no calculations are required, but the inclusion of the correct PCAOB number (185) and the correct years (2022–2024) matches the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of proxy filings, identifies the consistent placement of the disclosure (Item 3), and draws the appropriate conclusion about audit relationship stability. (4) The answer addresses all parts of the question—evolution (or lack thereof) in disclosure and what it reveals about audit stability—and does so with precise, contextually appropriate language. Minor wording differences (e.g., 'independent registered public accounting firm' vs. 'principal accountant') do not affect meaning and are standard terminology. No omissions or inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 321,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Based on the disclosed multi‑year trends in the pension‑plan investment allocations, Lilly’s exposure to private alternative investments has risen steadily: the Level 3 private‑alternative‑investment balance grew from $25.5 million (2022) to $25.2 million (2023) and $41.8 million (2020), with the 2023 fair‑value hierarchy showing $25.1 million in equity‑like funds and $25.2 million in other private‑alternatives. This upward trajectory, together with the company’s continued allocation to hedge funds and equity‑like funds within the broader private‑alternative bucket, signals a deliberate, long‑term strategy to increase holdings in illiquid assets—likely to enhance returns and diversify the portfolio while accepting the associated valuation complexity and risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, LLY's allocation to private alternative investments was $10,542.5 million in 2022, $10,335.2 million in 2023, and $10,051.0 million in 2024—showing a slight decline over time, not growth. The LLM incorrectly reports values such as $25.5 million (2022), $25.2 million (2023), and even references $41.8 million in 2020 (which is both incorrect and outside the requested time frame). These numbers are off by orders of magnitude and completely misrepresent the scale and direction of the trend. (2) The quantitative inaccuracies are severe: the actual amounts are in the tens of billions, not millions, and the trajectory is downward, not upward. Additionally, the LLM references 2020 data, which is irrelevant to the 2022–2024 question. (3) The multi-hop reasoning is flawed—the model fails to correctly extract and compare year-over-year allocations from the source data, leading to an incorrect conclusion about a 'steady rise.' While it correctly identifies that private alternatives include categories like equity-like funds and hedge funds, this does not compensate for the core factual errors. (4) The contextual relevance is moderate because the answer addresses the right topic (LLY’s investment strategy in illiquid assets) and attempts to interpret strategic intent, but the conclusion about increasing holdings is invalid due to incorrect data. The qualitative reasoning would score higher if based on accurate inputs, but as it stands, the logic is built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 435,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "Procter & Gamble’s positioning of Tampax within the Baby, Feminine & Family Care segment remained consistent across 2022‑2024, with the brand continuing to be highlighted as a core growth driver in Feminine Care.  The 2024 MD&A notes that Feminine Care net sales grew modestly on higher pricing and a favorable mix of premium products, while unit volume declined slightly; this reflects an ongoing emphasis on premium‑priced Tampax offerings rather than a shift in category classification.  Consequently, Tampax continued to be treated as a key sub‑category within Feminine Care, with strategic focus on premium innovation and market‑share gains rather than re‑classifying it into a different segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key factual changes in category classification and segment evolution over the years. It incorrectly states that Tampax remained under 'Feminine Care' throughout 2022–2024, while the ground truth shows a reclassification in 2023 where 'Menstrual Care' replaced 'Feminine Care' as a sub-category, and in 2024, 'Baby Care' was removed from the segment. The LLM fails to mention this strategic repositioning and structural change. (2) Quantitatively, the LLM does not include any specific percentages (e.g., 25% of net sales in 2022, 24% in 2023 and 2024), which are critical to the original answer. While it references 'modest growth' and 'higher pricing', these are qualitative descriptors not tied to the actual sales contribution figures provided in the ground truth. No calculation errors occur because no calculations are attempted, but key numeric context is omitted. (3) The multi-hop reasoning is flawed: the question asks for evolution across three years in terms of category classification and product line emphasis, requiring synthesis of structural changes in P&G’s reporting segments. The LLM instead focuses narrowly on Tampax as a 'core growth driver' and premium innovation, which is contextually relevant but does not address the organizational and categorical shifts. It conflates product strategy with segment classification. (4) The contextual relevance is moderate because the answer discusses Tampax within the correct broader segment and touches on strategic emphasis, but it fails to capture the core evolution in taxonomy and portfolio strategy. The qualitative accuracy is low due to misrepresentation of the category name continuity and omission of the removal of 'Baby Care' in 2024. Overall, the answer provides some correct context about Tampax’s strategic importance but misses the central factual evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 520,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One’s fair value measurements for net derivative assets (liabilities) are derived using discounted cash flow models that incorporate significant unobservable inputs, primarily default rates and swap rates. In 2024, the weighted‑average default rate used was 4% with a range of 53%–163%, while the weighted‑average swap rate was 4% (range 3%–5%). These inputs are consistent with the 2023 and 2022 disclosures, which also reported a 4% weighted‑average default rate and similar swap‑rate ranges, indicating that the valuation methodology and key unobservable inputs remained largely unchanged from 2022 through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One did not disclose the valuation technique in 2022, but the LLM claims the use of discounted cash flow models and specific default/swap rates for that year, which is incorrect. The fair value in 2022 was $19 million, not addressed in the LLM response, and the net unrealized loss of $20 million is omitted. In 2023, the fair value was $58 million with default rates of 53–163% and swap rates of 3–5%, which the LLM partially gets right but incorrectly presents as having a 'weighted-average' of 4% for both years, which is not in the original answer. The 2024 fair value is correctly stated as $58 million and swap rate range (3–5%) is accurate, but again, the 4% weighted-average default rate is fabricated. (2) Quantitative accuracy is low: the LLM invents 'weighted-average' figures (4% default rate) not present in the ground truth, and incorrectly applies them across all years. The 53–163% default rate range is implausible (likely a misreading of basis points or a data error), but since the original answer includes it, partial credit is given for repetition, though the interpretation is flawed. (3) Multi-hop reasoning fails: the question asks for evolution from 2022 to 2024, but the LLM asserts consistency across all years, contradicting the ground truth that shows a shift in transparency and methodology starting in 2023. The progression from undisclosed method in 2022 to explicit DCF use in 2023–2024 is entirely missed. (4) Contextual relevance is moderate—the answer discusses the right topic (valuation methods, unobservable inputs) and timeframe, but misrepresents the evolution and key facts. Due to major factual and reasoning errors, especially in numbers and temporal progression, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 501,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco's available-for-sale (AFS) debt investments generated a $67 million unrealized loss in fiscal 2024 and a $21 million loss in fiscal 2023, while the related \"other income (loss), net\" swung from a $392 million gain in 2022 to a $306 million loss in 2024. This trend shows that the AFS portfolio increasingly contributed negative earnings, reflecting heightened market‑price volatility and credit‑risk exposure that amplified losses over time. Consequently, the growing unrealized losses underscore a rising financial risk associated with Cisco's debt‑investment holdings, even as overall cash and investment balances declined.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and misrepresents the original answer. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, but the LLM claims a $392 million gain in 'other income (loss), net' for that year — this figure is unsupported by the original data. For 2023, the original answer notes higher losses in AFS debt investments drove a decline in 'other income (loss), net', but does not specify a $21 million loss from AFS investments alone; the LLM incorrectly quantifies this. In 2024, the LLM cites a $67 million unrealized loss from AFS debt investments, which is not mentioned in the original answer — the ground truth only confirms that AFS losses again significantly contributed to lower 'other income (loss), net', partially offset by equity gains. The 'other income (loss), net' swing from $392M gain in 2022 to $306M loss in 2024 is entirely fabricated, as the original does not provide these figures. (2) Calculations cannot be verified because the numbers themselves are incorrect; the LLM introduces precise dollar amounts where the original answer only provides qualitative assessments. (3) The multi-hop reasoning is partially sound — the LLM correctly infers increasing risk from worsening performance over time — but it fails to accurately synthesize the actual disclosures: absence of data in 2022, qualitative negative impact in 2023 and 2024. Instead, it invents metrics, undermining the reasoning. (4) Contextual relevance is high because the answer addresses the right question about impact on 'other income (loss), net' and risk implications over time, and uses correct entities (Cisco, AFS debt investments, fiscal years 2022–2024). However, the quantitative inaccuracies severely reduce correctness and qualitative accuracy, resulting in a partial but misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 517,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks' green coffee supply outlook has evolved from a fiscal 2022 commitment that \"total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee through fiscal 2023\" (SBUX_2022.pdf, p.33) to a fiscal 2023 projection stating \"total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee through fiscal 2025\" (SBUX_2023.pdf, p.12), and finally to the fiscal 2024 disclosure that \"total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee through fiscal 2025\" (SBUX_2024.pdf, p.12). This multi-year progression demonstrates a deliberate shift from short-term assurance to a longer-term, forward-looking supply strategy that explicitly extends through fiscal 2025, indicating Starbucks is proactively managing coffee supply risks through extended fixed-price contracts, hedging instruments, and diversified sourcing relationships to mitigate volatility in commodity markets and supply chain disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply adequacy: from projecting adequacy through fiscal 2023 in the 2022 report, to extending it through fiscal 2025 in both the 2023 and 2024 reports. All dates and timeframes match the ground truth. (2) Quantitative accuracy is perfect—fiscal years (2022, 2023, 2024, 2025) are correctly cited, and the progression in projection length (from +1 year to +2 years, then maintained) is accurately represented. The inclusion of document citations (SBUX_2022.pdf, etc.) adds precision, though not required. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports to identify a trend in supply chain strategy. The conclusion about extended purchase commitments and risk mitigation aligns with the ground truth. The only minor deviation is that the LLM emphasizes 'fixed-price contracts' and 'hedging instruments'—details not explicitly mentioned in the ground truth—though these are reasonable inferences consistent with risk mitigation. The core insight about strengthening sourcing strategy and supply chain resilience is fully supported. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution over time and strategic implications—and maintains focus on sourcing strategy and risk mitigation. The slight expansion on mechanisms (hedging, fixed-price contracts) does not detract from factual correctness but adds plausible detail. Thus, the answer earns a 9/10 for correctness—excellent but not perfectly aligned in wording with the ground truth's more conservative phrasing on strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 456,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA's financial exposure to the 2.00% Notes Due 2031 has remained unchanged in principal amount ($1.2 billion) across fiscal years 2022‑2024, but the company has reduced its short‑term exposure by repaying the 0.584% Notes Due 2024 in 2025 and by reclassifying the 2031 notes as long‑term (the long‑term portion rose from $8.46 billion in 2024 to $8.46 billion in 2025 after the short‑term portion was removed). This trend shows that NVIDIA is actively managing its debt maturities—maintaining a stable long‑term funding base while shedding near‑term obligations—to strengthen liquidity and focus on longer‑dated financing for future growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in 2022, decreased to $1,044 million in 2023, and increased to $1,250 million in 2024. The LLM claims the principal amount remained unchanged at $1.2 billion across all years, which contradicts the ground truth—especially the drop in 2023 and rise in 2024. Additionally, the LLM introduces unrelated information about '0.584% Notes Due 2024' and repayment in 2025, which are not mentioned in the original answer and are irrelevant to the question. (2) The numbers are factually wrong: $1,200M → $1,044M → $1,250M (ground truth) vs. a constant $1,200M (LLM). The LLM also fabricates a reclassification event increasing long-term debt to $8.46B in 2025, which is not supported by the original answer and introduces data outside the 2022–2024 scope. (3) The multi-hop reasoning is flawed: instead of tracking the evolution of exposure to the specific 2031 notes over the requested period, the LLM shifts focus to debt reclassification and repayment of unrelated notes, failing to synthesize the correct trend. (4) The contextual relevance is moderate because it discusses long-term debt strategy, which is part of the question, but the factual inaccuracies and introduction of irrelevant instruments severely undermine correctness. The conclusion about 'stable long-term funding' contradicts the ground truth's interpretation of 'dynamic approach' due to fluctuations. Thus, the answer fails on core factual accuracy and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 453,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "From 2022 to 2024, 3M’s Safety and Industrial segment shifted from being primarily a collection of diverse industrial products to a more clearly defined, safety‑focused business unit.  The 2023 and 2024 10‑K filings show that Safety and Industrial now explicitly groups “Respiratory, hearing, eye and fall protection solutions” with industrial abrasives, adhesives, tapes and electrical products, emphasizing fall‑protection and other personal‑protective equipment as core offerings.  This re‑categorization is reflected in the segment’s revenue (declining modestly from $11.6 bn in 2022 to $10.96 bn in 2024) and its operating income growth (rising to $2.49 bn in 2024 from $1.14 bn in 2022), while the company continues to allocate resources toward safety‑related innovations and to separate safety products from other industrial lines.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of MMM's (3M's) Fall Protection Solutions within the Safety and Industrial segment. (1) The original answer indicates that Fall Protection Solutions remained part of a broader safety suite in 2022–2023 and saw a subtle repositioning in 2024 toward integration with industrial safety systems, without becoming a standalone emphasized category. In contrast, the LLM claims a strategic shift making safety products 'core offerings' and implies a re-categorization that elevated fall protection, which is not supported by the ground truth. (2) The LLM introduces specific financial figures—segment revenue declining from $11.6B in 2022 to $10.96B in 2024 and operating income rising from $1.14B to $2.49B—that are either incorrect or unsupported. The ground truth contains no such financial data, and these numbers cannot be verified; more critically, the tripling of operating income while revenue slightly declines contradicts typical financial logic and suggests fabrication. (3) The multi-hop reasoning is flawed: the LLM infers a strategic repositioning based on non-existent financial trends and mischaracterizes product categorization changes. There is no evidence in the original answer that fall protection was elevated or re-grouped in 2023; the shift described occurs only subtly in 2024. (4) While the answer addresses the general topic of product categorization within the Safety and Industrial segment, it distorts the nature and timing of changes and introduces irrelevant and inaccurate financial metrics. The contextual relevance is moderate because it discusses the right segment and product line, but the substance is largely incorrect. Minor note: 'MMM' is correctly interpreted as 3M, and the years are correctly framed. Overall, major factual and quantitative errors lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 512,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s revenue from bamlanivimab (the COVID‑19 antibody portfolio) was reported as part of “COVID‑19 antibodies” in the revenue tables. In 2022 the company recorded $2.01 billion of COVID‑19‑antibody revenue; by 2023 that figure had fallen to $14.7 million, and in 2024 the revenue line for COVID‑19 antibodies shows $0 million (the column for 2024 lists “‑” for COVID‑19 antibodies). This decline indicates that Lilly’s reliance on its COVID‑19 antibody portfolio has sharply decreased over time, with essentially no material sales remaining by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its overall narrative but contains a significant quantitative inaccuracy. The ground truth states that Eli Lilly's revenue from bamlanivimab dropped from $2.01 billion in 2022 to $0 in 2023 and remained $0 in 2024. However, the LLM claims that revenue was $14.7 million in 2023, which contradicts the ground truth. This discrepancy affects the factual accuracy of the answer, even though the general trend of decline is correctly identified. (2) The 2022 figure ($2.01 billion) is correct, and the 2024 figure ($0 million) aligns with the ground truth (with the '–' symbol interpreted correctly as zero). However, the $14.7 million figure for 2023 is incorrect and not supported by the original answer. There is no indication in the ground truth that any revenue was recorded in 2023. (3) The multi-hop reasoning is sound in that the model correctly identifies bamlanivimab as part of the broader 'COVID-19 antibodies' portfolio and tracks its revenue over time. The conclusion about decreasing reliance on the portfolio is logically supported by the observed trend, even if the intermediate value is off. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: the revenue evolution and what it indicates about reliance. The qualitative reasoning is strong, but the quantitative error prevents a higher score. The correctness score is 7 because the core trend and conclusion are accurate, but the specific 2023 number is wrong, which is a material deviation in a financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 432,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Starbucks’ exposure to commodity index funds and coffee‑price volatility was managed through a mix of fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures and collars that hedge “C” price exposure, and by maintaining total purchase commitments plus inventory sufficient to meet demand through fiscal 2025.  This approach reflects a proactive risk‑management strategy that locks in supply and mitigates price swings, ensuring continuity of green‑coffee supply while the company expands its licensed‑store footprint and secures long‑term coffee‑supply commitments extending to fiscal 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies Starbucks' exposure to commodity index funds and coffee price volatility from fiscal 2022 to 2024, and notes the use of financial instruments like forward contracts, futures, and collars to hedge 'C' price exposure—consistent with the original answer. (2) All dates (fiscal 2022–2025) are correct and align with the ground truth; no numeric values (e.g., dollar amounts) are present, but temporal references are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes Starbucks’ evolving risk management strategy over time, noting increased supply visibility through fiscal 2025 by 2024, which reflects the progression described in the original answer. (4) The only minor omission is the lack of explicit mention that Starbucks *acknowledged* the influence of commodity index funds in *each* of the three fiscal years—an important nuance about ongoing exposure awareness. However, the overall strategy and tools used are accurately described, and the conclusion about strengthening risk management is logically supported. The answer is semantically equivalent in intent and meaning, with slightly less emphasis on the year-by-year acknowledgment of index fund influence. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 387,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "Google's reliance on Google Ad Manager for impression-based monetization evolved through a strategic shift in depreciation schedules that directly impacted long-term profitability. In January 2023, Google adjusted the estimated useful lives of servers and network equipment—extending server life from 4 to 6 years and network equipment from 5 to 6 years—resulting in a $3.9 billion reduction in depreciation expense and a $3.0 billion increase in net income for 2023. This adjustment, driven by improved utilization and efficiency of technical infrastructure, reduced ongoing depreciation costs and enhanced profitability, supporting sustained investment in infrastructure while improving margins on ad revenue. The change reflects a maturing monetization strategy where efficient infrastructure management underpins long-term profitability in Google's core advertising business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: in 2023, Google extended server depreciation from 4 to 6 years and network equipment from 5 to 6 years, resulting in a $3.9 billion reduction in depreciation expense and a $3.0 billion increase in net income. These numbers match the ground truth exactly, and the January 2023 timing is consistent with the reporting period. (2) Quantitative accuracy is perfect—dollar amounts, years, and the direction of impact (reduced expense, increased net income) are all correct. The model accurately reflects the financial impact without miscalculation. (3) The reasoning is sound and captures the multi-hop connection between infrastructure depreciation changes and their effect on profitability in impression-based monetization via Google Ad Manager. It correctly infers that lower depreciation costs improve margins and support long-term profitability, which aligns with the ground truth’s emphasis on cost structure optimization. However, the LLM omits explicit mention of the continuation of gross revenue reporting in 2024 and the ongoing strategic importance of Ad Manager in that year, which is a minor gap in completeness. (4) Despite this omission, the answer conveys the core evolution and implications accurately, with excellent contextual relevance and strong qualitative reasoning. The missing 2024 update prevents a perfect 10, but all other aspects are factually correct and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 405,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "From 2022 to 2024, the company transitioned from using 2022 Form of Performance Share Unit Agreements (filed in 2022 10-Q) to 2023 and 2024 versions (filed in 2023 and 2024 10-Qs), reflecting an evolution in the structure and terms of these awards under the 2019 Long-Term Incentive Plan. This progression indicates a strategic refinement in executive compensation to align with evolving performance metrics and market conditions, emphasizing long-term incentive alignment while maintaining flexibility in equity-based compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding dates and document references. According to the ground truth, in 2022 BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45), not a 2022 form as claimed by the LLM. In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), which the LLM completely omits. By 2024, BK incorporated the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), not a 2023 or 2024 version as the LLM states. Thus, the LLM incorrectly identifies the forms used in each year and misrepresents the evolution. (2) The quantitative inaccuracies are severe: the LLM fabricates the use of '2023 and 2024 versions' of the agreement, which are not mentioned in the ground truth. It also misattributes filings to 10-Qs when the original answer does not specify the filing type. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the pattern of referencing prior-year agreements and re-filing the foundational plan, instead suggesting a linear annual update that does not match the evidence. It misses the key insight that the 2019 plan was re-filed in 2023, indicating structural continuity. (4) While the general theme of 'strategic refinement' and 'alignment with performance metrics' is consistent with the ground truth's interpretation, the factual foundation is incorrect, undermining the conclusion. The answer is contextually relevant and attempts to interpret the strategy, but the incorrect entities and timeline severely limit accuracy. Hence, correctness is scored low due to core factual errors, despite some thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 451,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "3M’s Safety and Industrial segment has progressively narrowed its product focus, moving from a broader portfolio that included general industrial adhesives and tapes to a more specific emphasis on electrical products and materials for construction and maintenance, power distribution, and electrical OEMs. This evolution—highlighted in the 2022, 2023 and 2024 segment tables and the 2024 restructuring that created the Industrial Specialties division—signals a strategic shift toward serving electrical OEM markets more directly, underscoring 3M’s intent to deepen its presence in that high‑value, technology‑driven segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but introduces inaccuracies and misrepresents the evolution described in the ground truth. While it correctly identifies the Safety and Industrial segment and references electrical OEMs across 2022–2024, it incorrectly claims a 'progressive narrowing' of the portfolio from general industrial adhesives to electrical products, which is not supported by the original answer. The ground truth focuses solely on the evolution of *descriptive language* in disclosures, not an actual strategic shift or portfolio narrowing. Additionally, the mention of a '2024 restructuring that created the Industrial Specialties division' is extraneous and not part of the original answer, introducing unsupported information. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound in that it tracks changes over time within the segment, but it fails to accurately reflect the nature of the change: the original answer emphasizes increasing *descriptive specificity* in reporting (e.g., 'electrical OEMs' → 'electrical original equipment manufacturers (OEMs)'), whereas the LLM interprets this as evidence of a broader strategic realignment and portfolio shift, which is an overinterpretation. The conclusion about 'deepening presence' is speculative and not directly supported by the linguistic evolution alone. (4) Correctness is scored at 5 due to partial factual alignment (correct years, correct segment, correct general direction of increased focus) but significant deviation in the core claim—language evolution vs. actual product portfolio change. Qualitative accuracy is low due to flawed reasoning and introduction of unsupported details. Contextual relevance is moderate because the answer addresses the right segment and timeframe and attempts to interpret strategic intent, even if incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 536,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One's fixed unsecured senior debt carrying value increased from $24,134 million in 2022 to $27,168 million in 2023, and further to $26,930 million in 2024, while the weighted‑average interest rate rose from 4.45% in 2022 to 4.84% in 2023 and 4.84% in 2024 (the 2024 table shows 4.84% for fixed senior debt). This multi‑year progression reflects a strategy of gradually increasing debt issuance to fund growth while taking advantage of relatively stable or slightly higher rates, indicating a focus on maintaining liquidity and financing expansion without dramatically shifting the cost structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, not $24,134 million as stated by the LLM. The 2023 and 2024 carrying values ($27,168M and $26,930M) are correct. The interest rates are also incorrect: the ground truth shows 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024, but the LLM claims 4.45% in 2022 and 4.84% in both 2023 and 2024, misrepresenting the trend. (2) These errors affect both the starting point and the rate of change. The correct progression shows a sharp rise in interest rates from 2.91% to 4.45% to 4.84%, indicating a response to a rising rate environment, whereas the LLM implies rates were already high in 2022 and plateaued, which contradicts the data. (3) The multi-hop reasoning is partially sound—the LLM attempts to interpret the strategy behind the debt evolution—but the flawed data leads to an incorrect conclusion. The ground truth suggests a strategic move to lock in long-term financing amid rising rates, while the LLM incorrectly frames it as taking advantage of 'stable or slightly higher rates' and 'gradually increasing issuance,' which does not align with the actual sharp rate increase from a much lower base. (4) The contextual relevance is fair because the answer addresses all parts of the question (carrying value, interest rate, and strategy) and uses appropriate financial terminology, but the quantitative inaccuracies severely undermine correctness. The qualitative reasoning would score higher if based on accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 454,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA's 3.50% Notes Due 2040 were issued in 2020 and remained outstanding through fiscal years 2022–2024, with their carrying value increasing from $1,000 million (amortized cost) as of January 28, 2023 to $1,000 million (amortized cost) as of January 26, 2025, reflecting no principal repayment but accrued interest and unamortized discount adjustments. The multi-year presence of these notes—alongside other long-term debt maturing in 2026–2060—demonstrates a deliberate strategy of issuing long-duration, fixed-rate senior unsecured debt to finance operations and acquisitions while maintaining flexibility through features like make-whole redemption and covenant compliance. This progression underscores NVIDIA's focus on capital structure optimization, leveraging low-cost debt to support growth initiatives (e.g., Blackwell architecture investments) without diluting equity, while managing interest rate risk through staggered maturities and strategic refinancing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, NVIDIA reported the fair value of its 3.50% Notes Due 2040 as $1,066 million in fiscal 2022, decreasing to $851 million in fiscal 2023, and then reporting a carrying amount of $1,000 million in fiscal 2024. The LLM incorrectly states that the carrying value was $1,000 million in both 2023 and 2025 (which is outside the requested 2022–2024 scope), and fails to mention the fair value disclosures in 2022 and 2023 entirely. The issuance date of 2020 is not in the ground truth and cannot be verified from the provided data. (2) The numbers are largely incorrect or misattributed: no mention of $1,066M (2022) or $851M (2023) fair values; instead, it asserts a constant $1,000M amortized cost, which contradicts the progression in the original answer. The fiscal years are also misaligned (e.g., January 28, 2023 and January 26, 2025 are specific dates not referenced in the ground truth and do not map cleanly to fiscal years 2022–2024). (3) The multi-hop reasoning is flawed: the model invents a narrative about capital structure optimization, make-whole redemption, and Blackwell architecture investments that are not supported by the provided ground truth. While the general idea of long-term debt strategy is relevant, the specific evolution of valuation treatment (from fair value to carrying amount) is ignored, which is central to the question. (4) The contextual relevance is moderate because the answer discusses long-term debt strategy, which aligns with the question’s intent, but it fails to accurately describe the actual accounting treatment changes over the three years. The qualitative reasoning is speculative and not grounded in the data provided, leading to a low correctness score despite some relevant thematic elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 510,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion at the end of 2022 to $13.0 billion by the end of 2024, reflecting a $3.0 billion reduction over this period. This reduction trajectory indicates a deliberate strategy to systematically lower the company's debt obligations, likely to improve its balance sheet strength, reduce interest expense, and enhance financial flexibility as part of its broader debt management approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall reduction in Amazon's 2017 Notes from $16.0 billion to $13.0 billion between 2022 and 2024, which matches the ground truth. However, it omits the intermediate 2023 value of $15.0 billion, which is a key part of the multi-year trajectory described in the original answer. This omission reduces completeness and quantitative precision. (2) The total reduction of $3.0 billion is accurate ($16.0B - $13.0B), but the answer skips the stepwise decline (a $1.0B drop in 2023, then $2.0B more by 2024), which weakens the detailed quantitative accuracy. (3) The reasoning about Amazon’s debt management strategy—systematic debt retirement to improve balance sheet strength, reduce interest expense, and enhance financial flexibility—is logically sound and consistent with the implications of the reduction pattern. This reflects strong qualitative accuracy and appropriate synthesis. (4) The answer is highly contextually relevant, directly addressing both parts of the question—evolution of the balance and strategic interpretation—even though it condenses the timeline. The omission of the 2023 data point prevents a perfect score, but the core facts and strategic inference remain correct and meaningful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 354,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple's repeated inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings demonstrates its ongoing reliance on short-term debt instruments to manage liquidity and interest rate exposure. In a rising rate environment, this structure increases sensitivity to interest expense, as the variable-rate notes directly track market rates—potentially elevating borrowing costs if rates climb significantly, though the company may mitigate this through hedging or strategic refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key factual nuances from the ground truth, affecting its qualitative accuracy. (1) Quantitatively, there are no explicit numbers (e.g., dollar amounts, interest rates) in either answer, so no numeric inaccuracies exist—this aspect is acceptable. The dates (2019 maturity, 2022–2024 filings) are correctly referenced, satisfying quantitative accuracy. (2) However, the LLM incorrectly implies that Apple maintained active short-term debt instruments (Floating Rate Notes due 2019) beyond their maturity date, suggesting 'ongoing reliance' on them. The ground truth clarifies that these notes were included via incorporation by reference to an Officer's Certificate from 2014, not because they remained outstanding. This is a critical factual misinterpretation: the disclosures reflect legal or reporting continuity, not active debt. (3) The multi-hop reasoning is partially sound—linking floating rate notes to interest expense sensitivity in a rising rate environment is valid. However, the conclusion that Apple had ongoing exposure due to 'reliance' misrepresents the nature of the disclosure. The persistence in filings likely reflects boilerplate or legal carryover, not strategic debt management. (4) The answer is contextually relevant and addresses both parts of the question—exposure to short-term debt and interest expense sensitivity—but fails to accurately explain *why* the notes appear post-maturity. Thus, while the conceptual logic about variable-rate debt is correct, the factual basis for ongoing exposure is flawed, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 442,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "From 2022 to 2024, Google’s hardware strategy shifted from modest early‑stage investment to a more mature, revenue‑generating focus. In 2022 the company reported limited hardware revenue and emphasized long‑term R&D, but by 2023 and especially 2024 hardware (including the Pixel line) contributed a growing share of Google Services revenue and was highlighted as a key growth engine in the “Google Subscriptions, Platforms, and Devices” section. This progression—rising R&D spend, expanding revenue contribution, and greater product integration—signals Alphabet’s intent to deepen its hardware portfolio and position it as a core, sustainable pillar of its long‑term market strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Google's strategic evolution with the Pixel family from 2022 to 2024, but contains some mischaracterizations in entity classification and revenue categorization that affect reasoning accuracy. (1) All dates (2022–2024) are correctly used, and there are no explicit numerical claims (e.g., revenue figures, percentages) that could be quantitatively inaccurate—thus quantitative accuracy is perfect by default. (2) The answer correctly identifies the shift from long-term investment/R&D focus in 2022 to growing revenue contribution by 2023–2024, aligning with the ground truth. However, it inaccurately states that hardware contributed to 'Google Services revenue,' which contradicts the original answer: in 2023 and 2024, Pixel was part of a distinct 'devices' revenue category, not subsumed under Google Services. Additionally, the mention of 'Google Subscriptions, Platforms, and Devices' as a reported segment is not reflected in the ground truth and appears to be a misinterpretation or conflation with internal reporting structures not cited in the original. (3) The multi-hop reasoning is partially sound—investment in 2022, measurable performance in 2023, maturity in 2024—but the synthesis misattributes the financial reporting structure, weakening the qualitative accuracy. (4) Despite these issues, the core message—that Pixel evolved from an R&D focus to a strategic, revenue-generating hardware line—matches the ground truth, and the long-term positioning conclusion is valid. Hence, correctness is high but not fully accurate due to entity and categorization errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 447,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab’s use and pledging of client securities has expanded markedly from 2022 through 2024, driven by growth in margin lending, securities‑lending, and collateral requirements for clearing and repurchase transactions. The company routinely pledges client‑held securities to meet Federal Reserve and Options Clearing Corporation margin rules, to collateralize interest‑rate swaps cleared through CCPs, and to satisfy collateral calls in its securities‑lending and repurchase programs; the fair value of pledged client securities rose from $31.4 billion in 2021 to $31.4 billion (plus additional pledges for short‑term borrowings) in 2024, reflecting both higher client margin balances and the firm’s broader collateral‑management strategy. This trend indicates that Schwab is increasingly relying on client collateral to fund its brokerage and liquidity operations, positioning collateral management as a core component of its risk‑mitigation and funding approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that no specific dollar value was provided for pledged securities in 2022, and there is no mention of a $31.4 billion figure in 2021 or 2024 in the original answer. This number is entirely fabricated or misattributed, severely undermining factual correctness. Additionally, the LLM claims a rise from $31.4B in 2021 to $31.4B in 2024 (plus other pledges), implying stagnation, which contradicts the qualitative trend described. (2) The original answer does not provide any numerical values for pledged securities across 2022–2024, so citing specific dollar amounts—even if plausible—is factually unsupported and incorrect. There is no mention of 2021 data in the question or ground truth, making the LLM’s reference to it irrelevant and erroneous. (3) While the LLM captures the general direction of Schwab’s evolving collateral use—margin lending, securities lending, clearinghouse requirements, and regulatory compliance—it incorrectly frames the evolution as quantitatively driven by increasing pledged amounts, when the ground truth emphasizes disclosure depth and expanded use cases (e.g., listed options cleared by OCC in 2024), not volume trends. The multi-hop synthesis is partially sound in identifying activities but fails to accurately reflect the progression of disclosures and strategic emphasis. (4) Despite the factual errors, the LLM answer remains contextually relevant, addressing all key aspects of the question—margin lending, securities lending, collateral management strategy—and drawing a reasonable conclusion about increased reliance on client collateral. However, the inclusion of false quantitative data and references to unsupported years (2021) significantly reduces correctness. The qualitative reasoning is partially aligned but built on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 519,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s collaboration with primary insurers on long‑term care premium‑rate increases has evolved from a largely ad‑hoc, 2022‑era reliance on ceding companies to file rate‑increase requests, to a more coordinated, multi‑year premium‑deficiency testing process that began in 2021 and was refined through 2023‑2024.  Each year the company updated its actuarial assumptions—particularly morbidity, mortality and projected premium‑rate‑increase success rates—during third‑quarter premium‑deficiency reviews, locking in those assumptions for the remaining life of the policies unless a new deficiency emerges.  This systematic, data‑driven approach reflects GE’s run‑off reinsurance risk‑management strategy: by continuously recalibrating reserve assumptions and working closely with primary insurers to anticipate and implement premium adjustments, GE limits unexpected reserve volatility and aligns its exposure to the long‑tail, low‑frequency claims that characterize its run‑off portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general theme of GE's evolving collaboration with primary insurers and its reinsurance risk management strategy, but contains significant factual and chronological inaccuracies that undermine its correctness. (1) The claim that a 'multi-year premium-deficiency testing process began in 2021' is not supported by the ground truth, which begins the evolution in 2022 and does not reference 2021. This misrepresents the timeline. (2) The LLM emphasizes 'actuarial assumptions—particularly morbidity, mortality and projected premium-rate-increase success rates—updated during third-quarter premium-deficiency reviews' and 'locking in assumptions,' which are details absent from the original answer and not corroborated by the knowledge graph. These specifics introduce unsupported technical processes. (3) While the original answer notes increasing structure—from indirect involvement in 2022, to formalized collaboration in 2023, to using experience and precedents in 2024—the LLM reframes this as a continuous actuarial recalibration process, missing the core progression of collaboration with primary insurers. (4) The original highlights GE's growing 'active participation in filing proposed increases' and 'reinforced collaborative framework,' which the LLM does not accurately reflect, instead focusing on internal actuarial processes. (5) The strategic conclusion about proactive risk management is partially aligned, but the LLM attributes it to a data-driven assumption-updating process rather than the ground truth's emphasis on tighter integration with ceding companies. Quantitative accuracy is moderate: no explicit numbers are wrong, but the dates (2021 start) are incorrect. Qualitative accuracy suffers due to misrepresentation of the nature and evolution of collaboration. Contextual relevance is high, as the answer addresses the run-off strategy and premium increases, but with flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 520,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS's investment exposure to residential mortgage-backed securities (RMBS) declined modestly from $71 million at the end of 2023 to $71 million at the end of 2024 (the same absolute amount, but the proportion of its overall debt‑security portfolio fell from roughly 2.8 % in 2023 to about 2 % in 2024 as total debt securities dropped from $2.5 billion to $2.5 billion while RMBS holdings remained stable). This reduction reflects a deliberate shift toward higher‑quality, shorter‑duration assets and a lower weighting of structured‑credit instruments in the company's portfolio. Consequently, the 3‑year trend shows a consistent de‑emphasis on RMBS and other mortgage‑related securities, indicating that CVS is actively reducing its exposure to residential mortgage‑backed securities to mitigate interest‑rate and credit risk within its structured‑credit holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, CVS's RMBS exposure was $721 million in 2022, decreased to $614 million in 2023, and then increased to $71 million in 2024. The LLM incorrectly states that RMBS exposure was $71 million in both 2023 and 2024, completely missing the correct 2022 and 2023 figures. This misrepresents the entire trend. (2) The quantitative inaccuracies are severe: the LLM omits the correct $721M (2022) and $614M (2023) values, falsely claims $71M in 2023 (it was actually in 2024), and incorrectly implies stability in RMBS holdings when in fact there was a significant drop from 2022 to 2023 followed by a partial rebound in 2024. Additionally, the claim that total debt securities were $2.5 billion in both years is unsupported and irrelevant to the question. (3) The multi-hop reasoning is flawed: the LLM concludes a 'consistent de-emphasis' and 'deliberate shift' based on incorrect data, contradicting the ground truth which shows a cautious reduction in 2023 followed by a strategic rebalancing in 2024. The LLM fails to capture the dynamic risk management narrative, instead portraying a steady decline that did not occur. (4) Despite incorrect facts, the answer is contextually relevant—it addresses the right topic (RMBS exposure and risk positioning) and uses appropriate financial reasoning terms (structured credit, interest-rate risk). However, due to fundamental errors in data and trend interpretation, the correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 426,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "Capital One's short‑term borrowings rose modestly from $668 million in 2020 to $820 million in 2021 and then to $562 million in 2024, while long‑term debt increased from $39.9 billion in 2020 to $42.3 billion in 2021, $49.9 billion in 2023 and $45.0 billion in 2024. This three‑year progression shows a deliberate shift toward higher‑priced, longer‑dated senior and subordinated notes and securitized debt, indicating a strategy of extending maturity and relying more on capital‑market funding rather than short‑term wholesale markets. Consequently, the company’s capital structure has become more leveraged with a larger share of long‑term, fixed‑rate obligations, reflecting a focus on stable, diversified funding sources and improved debt‑management discipline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It references data from 2020 and 2021, which are outside the requested 2022–2024 timeframe, and provides incorrect values for both short-term borrowings and long-term debt. For example, it states short-term borrowings were $562 million in 2024, but the ground truth reports total short-term borrowings and long-term debt combined as $45.551 billion in 2024. The LLM conflates individual components (e.g., short-term borrowings) with total debt, leading to a massive underreporting of scale. (2) Quantitative accuracy is severely lacking: the ground truth shows total debt (short-term + long-term) at $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM instead cites long-term debt as $49.9B in 2023 and $45.0B in 2024, which is close but still inaccurate, and omits short-term borrowings' contribution to total debt. More critically, it introduces data from 2020–2021, which were not part of the question. (3) The reasoning is flawed: while the LLM attempts to infer a strategy around extending maturities and shifting to fixed-rate debt, it misses key insights from the ground truth—specifically, the elimination of floating unsecured senior debt by 2024 and the rising weighted-average interest rates (2.76% → 4.84%). These are central to understanding COF’s response to rising rates. The LLM’s conclusion about 'higher-priced, longer-dated' notes lacks support from actual interest rate data. (4) Contextual relevance is moderate because the answer discusses capital structure and debt management strategy, which are relevant themes, but the incorrect time frame, entities, and numbers undermine the validity. The synthesis fails the multi-hop requirement: it does not correctly aggregate or compare total debt across the correct years or link it to interest rate trends and debt composition changes as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 514,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA's long-term liability for the 3.50% Notes Due 2050 remained constant at $2.0 billion from fiscal 2022 through fiscal 2024, showing no increase or decrease over the three‑year period. This stability suggests a deliberate, steady capital‑structure approach—maintaining a sizable, long‑dated fixed‑rate debt tranche while the company focuses on growing cash flow from operations rather than expanding debt.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that NVIDIA's liability for the 3.50% Notes Due 2050 remained constant at $2.0 billion from fiscal 2022 to 2024. The ground truth shows a clear decrease from $2,147 million in 2022 to $1,637 million in 2023, then to $1,604 million in 2024. The LLM incorrectly reports stability, which contradicts the actual trend of reduction. (2) Quantitatively, all numbers are wrong: $2.0 billion (i.e., $2,000 million) does not match any of the actual values ($2,147M, $1,637M, $1,604M), and there is no indication of the downward trend. The claim of 'no increase or decrease' is false. (3) The multi-hop reasoning is flawed—the question requires tracking a liability across three fiscal years and interpreting the trend. The LLM failed to detect the decrease, leading to an incorrect conclusion about capital structure strategy. Instead of recognizing a debt reduction strategy, it inferred a strategy of stability, which is unsupported. (4) Contextual relevance is partially met as the answer addresses the right company, debt instrument, and time frame, and attempts to interpret strategic implications. However, due to complete factual inaccuracy in numbers and trend, the qualitative and quantitative accuracy scores are very low. The correctness score is 1 due to major factual and analytical errors despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 387,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple's recurring issuance of 0.45% Notes due 2016 across 2022, 2023 and 2024 reflects its disciplined long-term debt management strategy, consistently refinancing a fixed-rate tranche to maintain a stable, low-cost capital structure while extending maturity profiles. This pattern demonstrates a deliberate, predictable approach to debt financing that supports liquidity flexibility and reinforces investor confidence in its capital allocation framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Apple 'recurring[ly] issued' the 0.45% Notes due 2016 in 2022, 2023, and 2024. The original answer clarifies that these notes were issued in 2013 and matured in 2016; they were not reissued or refinanced in the 2022–2024 period. The LLM incorrectly interprets continued disclosure as ongoing issuance, which is a fundamental error. (2) Quantitatively, while the interest rate (0.45%) and maturity year (2016) are correctly referenced, the assertion of 'issuance' in 2022–2024 is false—no new issuance occurred. There are no calculations in either answer, but the temporal facts (years) are misapplied by the LLM. (3) The multi-hop reasoning fails: the LLM should have inferred from the persistent disclosure in 10-Ks that Apple retains historical debt details for transparency, not that it is actively refinancing. Instead, it constructs a narrative of strategic refinancing unsupported by the data. (4) The contextual relevance is partially maintained because the answer discusses debt strategy, but the core premise is wrong. The original answer emphasizes transparency and legal continuity; the LLM invents a refinancing strategy. Thus, scores are low: correctness penalized heavily for factual inaccuracy, quantitative accuracy fails due to misuse of dates, qualitative reasoning is flawed, and relevance is minimal despite topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 392,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) measured at fair value declined from $2.675 billion in 2022 to $2.335 billion in 2023 and further to $1.670 billion in 2024, reflecting a reduction in both notional exposure and fair‑value gains/losses; the accompanying risk inputs—including credit‑valuation adjustments, discount rates, and prepayment assumptions—were adjusted each year, with observable market inputs (e.g., SOFR‑linked rates) increasingly dominating and unobservable inputs becoming less material. This multi‑year trend indicates that the company’s derivative portfolio is becoming less sensitive to extreme unobservable assumptions and that its valuation is increasingly anchored in broader, more transparent market rates, suggesting a modest decline in inherent modeling risk and exposure over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, $58 million in 2023, and remained at $58 million in 2024. The LLM incorrectly reports values of $2.675 billion, $2.335 billion, and $1.670 billion for 2022–2024, which are off by more than an order of magnitude. These numbers do not match the ground truth in any format variation and represent a complete factual mismatch. (2) The significant unobservable inputs in the ground truth shift from 'default' at 4% in 2023 to 'swap rates' at 4% in 2024. The LLM instead references general trends like 'SOFR-linked rates' and 'credit-valuation adjustments' without identifying the specific significant unobservable inputs or their changes. It also fails to mention the $20 million net unrealized loss held in 2022 or the $43 million realized loss reduction referenced in the original. (3) The multi-hop reasoning is flawed: the LLM draws a conclusion about declining modeling risk due to increased use of observable inputs, but this interpretation is not supported by the actual data in the ground truth, which shows a shift in the type of unobservable input (from default to swap rates), not a reduction in their use. The actual progression indicates a change in key risk drivers, not a broad decline in unobservable input reliance. (4) The contextual relevance is moderate because the LLM addresses derivative valuation and risk inputs in a general sense and attempts to interpret trends over time. However, due to severe factual inaccuracies in numbers, entities, and key risk inputs, both quantitative and qualitative accuracy are extremely low. The answer fabricates data and misrepresents the evolution of Capital One’s derivative positions, leading to an incorrect overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 512,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "From fiscal 2022 through 2024, the carrying amount of the 1.55% Notes Due 2028 rose from **$1.099 billion (as of Jan 29 2023)** to **$1.115 billion (as of Jan 28 2024)**, reflecting a modest increase in the outstanding principal balance. This progression shows that NVIDIA’s long‑term debt strategy has remained focused on maintaining a relatively stable, low‑coupon senior note issuance—relying on incremental borrowings at very low rates rather than large‑scale new issuances—while repaying higher‑rate notes (e.g., the 0.584% Notes Due 2024 were fully retired in fiscal 2025). The steady, low‑cost debt profile supports the company’s capital‑intensive growth initiatives without significantly diluting its balance‑sheet leverage.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2B in 2022, $1.1B in 2023, and $1.25B in 2024. However, the LLM reports $1.099B (as of Jan 29, 2023) and $1.115B (as of Jan 28, 2024), omitting the 2022 figure entirely and misrepresenting the trend. The LLM implies a steady increase, while the truth shows a dip in 2023 followed by a rebound in 2024. These discrepancies in both magnitude and direction of change are material. (2) The dates cited (Jan 29, 2023 and Jan 28, 2024) correspond to fiscal year-ends for 2023 and 2024, but the LLM fails to report the 2022 value required by the question, breaking completeness. The numbers themselves ($1.099B and $1.115B) do not match the ground truth of $1.2B and $1.25B, even allowing for formatting variations—these are not minor rounding differences. (3) The qualitative reasoning about NVIDIA’s long-term debt strategy—maintaining stable, low-coupon debt and retiring higher-rate notes—is plausible and contextually sound, and the mention of retiring the 0.584% Notes Due 2024 adds relevant context. However, this insight is not fully supported by the incorrect numerical trend presented. The multi-hop synthesis is partially correct but undermined by inaccurate data. (4) The contextual relevance is high, as the answer addresses the evolution of debt exposure and interprets it in terms of strategy. However, the correctness score is limited to 5 due to major quantitative errors that distort the factual progression. While the direction of change (slight increase from 2023 to 2024) is weakly aligned, the omission of the 2022 value and incorrect magnitudes reduce confidence in the overall accuracy. The answer does not fully reflect the 'slight increase in 2024 after a minor reduction in 2023' pattern, instead suggesting a continuous modest rise from a lower base.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 515,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "From 2022 through 2024 GE’s exposure to trailing legal liabilities remained substantial but showed a clear downward trajectory, driven by the company’s systematic reduction of its legacy financial‑services footprint and the settlement of key Alstom‑related matters.  In 2022 the company disclosed that it was still subject to “legacy legal proceedings and legal compliance risks that relate to claimed anti‑competitive conduct or corruption by Alstom in the pre‑acquisition period,” and it continued to carry reserves for shareholder suits tied to historical financial‑reporting issues.  By 2023 the company reported that it had completed the final capital contribution required under the 2018 Kansas Insurance Department permitted accounting practice and was actively managing its run‑off insurance and Bank BPH exposures, noting that “future adverse changes to these assumptions could result in an increase to future policy benefit reserves and… the amount of capital we are required to contribute.”  The 2024 filing confirms that the company’s statutory testing of insurance reserves now reflects updated assumptions but still carries the risk of additional capital calls, while the “material trailing legal liabilities from businesses that we dispose of or that are inactive” continue to be monitored.  This progression indicates that while the contingent liabilities linked to the Alstom acquisition and earlier financial‑reporting litigation have not disappeared, they are becoming less material to GE’s overall financial position, reflecting a persistent but diminishing exposure that the company manages through ongoing capital planning, reserve assessments, and strategic wind‑down of its former financial‑services operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth, particularly in its core claim about the trajectory of GE's legal liabilities. The original answer states that GE's exposure to trailing legal liabilities from the Alstom acquisition and shareholder lawsuits remained persistent and did not diminish from 2022 to 2024, with ongoing risks and potential for adverse financial impact. In contrast, the LLM answer incorrectly asserts a 'clear downward trajectory' and 'diminishing exposure,' which is not supported by the ground truth. This misrepresents the key conclusion of the progression. Additionally, the LLM introduces specific details not present in the original answer, such as the '2018 Kansas Insurance Department permitted accounting practice,' 'Bank BPH exposures,' and 'statutory testing of insurance reserves,' which are irrelevant to the question about Alstom and shareholder litigation. These appear to conflate GE with another company or unrelated business segments. While the LLM correctly identifies that legacy Alstom matters (anti-competitive conduct/corruption) and shareholder lawsuits related to financial reporting were ongoing, it mischaracterizes the evolution and financial impact. The reasoning is flawed in its synthesis: it fails to correctly link the multi-hop elements (Alstom acquisition legacy → ongoing liabilities → persistent financial/reputational risk) and instead introduces a narrative of resolution and wind-down that is unsupported. Quantitative accuracy is partially acceptable because there are no explicit numerical errors (no numbers are cited), but the temporal references (2022–2024) are correctly used. Contextually, the answer addresses the right topic and time frame, but the inclusion of extraneous insurance-related details reduces relevance. Overall, the answer is partially correct on entities and timeline but fundamentally wrong on the evolution and financial impact of the liabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1798,
        "completion_tokens": 531,
        "total_tokens": 2329
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "From 2022 to 2024, CVS’s exposure to hedge fund and private‑equity limited‑partnership investments fell sharply: the Level 3 pension‑plan assets tied to those partnerships dropped from $461 million (2022) to $252 million (2023) and to $252 million (2024), while the related “other investments” balance fell from $432 million (2022) to $252 million (2023) and remained at $252 million (2024). This reduction reflects a deliberate shift away from illiquid alternative‑investment holdings toward more liquid, market‑valued assets such as cash, debt and equity securities, indicating that CVS is simplifying its pension‑fund strategy and likely seeking to lower risk and improve transparency in its retirement‑plan portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that CVS's exposure to hedge fund limited partnership investments increased from $214M (2022) to $225M (2023) to $252M (2024), whereas the LLM claims a sharp decline from $461M to $252M and then flat at $252M. These numbers do not match any part of the ground truth and appear to conflate different metrics (e.g., Level 3 assets or 'other investments'). (2) The quantitative inaccuracies are severe: the starting value ($461M vs $214M), the trend (decrease vs increase), and the intermediate values are all wrong. Even allowing for format variations, the numbers are not equivalent. The claim that 'other investments' fell from $432M to $252M is unsupported by the ground truth, which does not mention such a category. (3) The multi-hop reasoning is flawed—the LLM infers a strategic de-risking and shift to liquidity, which contradicts the actual strategy of gradually expanding alternative investments. The conclusion is therefore the opposite of the correct interpretation. (4) The contextual relevance is low but not zero, as the answer addresses pension fund strategy and alternative investments, albeit with incorrect data and reasoning. Due to complete factual inaccuracy in numbers and direction of change, and a resulting inverted conclusion, the correctness score is 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 386,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "From 2022 to 2024, Colgate‑Palmolive’s focus on the Africa/Eurasia region shifted toward cost‑efficiency and growth initiatives within the Oral, Personal and Home Care segment. Operating profit in Africa/Eurasia was $203 million in 2022, with capital expenditures of $33 million and depreciation/amortization of $9 million. In 2023, restructuring charges allocated to the region were modest (about 5 % of the $32 million pre‑tax productivity initiative costs), and by 2024 the company continued to invest in the region, reporting $378 million of depreciation/amortization for Oral, Personal and Home Care overall and maintaining capital spending aimed at supporting growth in Africa/Eurasia.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. While it correctly states the 2022 operating profit of $203 million and the 2022 depreciation/amortization of $9 million, it incorrectly claims $378 million in depreciation/amortization for 2024 for Oral, Personal and Home Care overall, which is not supported by the ground truth and conflates segment-level data with regional data. More critically, it misrepresents the 2023 restructuring charges: the ground truth states that 10% of restructuring charges were allocated to Africa/Eurasia as part of the 2022 Global Productivity Initiative, amounting to $20–$24 million, but the LLM claims only 5% of $32 million (~$1.6 million), which is both the wrong percentage and wrong total initiative cost. Additionally, the LLM incorrectly implies continued growth investment in 2024, while the ground truth shows a decline in depreciation/amortization to $8 million in 2024, indicating reduced capital investment. (2) Key number verification: $203M operating profit (correct), $9M D&A in 2022 (correct), but $378M D&A in 2024 is entirely incorrect (should be $8M for the region); restructuring charge allocation is miscalculated and misattributed. (3) Multi-hop reasoning fails: the model does not correctly synthesize the trajectory from profitability to restructuring to capital spending trends. Instead of identifying a pattern of cost optimization and declining investment, it incorrectly infers ongoing growth investment. (4) Scores reflect major quantitative errors and flawed reasoning, though the answer is contextually relevant in addressing the region and general themes of financial focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 454,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "From 2022 through 2024, AIG’s modeled terrorism loss estimates remained anchored in third‑party scenario models that are regularly updated to reflect changing exposures and market conditions.  The company retained core attachment points of $200 million for Japan and $125 million for the rest of the world, and it continued to purchase per‑risk and aggregate excess‑of‑loss reinsurance that caps losses at $400 million (U.S. windstorm/earthquake) and $175 million (global aggregate) for catastrophe events.  Reinsurance recoverable assets grew to $38 billion in 2024, comprising $3.8 billion of paid‑loss recoveries, $29.1 billion of ceded loss reserves (including IBNR), $4.3 billion of ceded unearned‑premium reserves and $0.8 billion of life‑reinsurance recoverables, all supported by $20.1 billion of collateral.  The attachment points and reinsurance structures have been unchanged, but the underlying modeled loss estimates have been refined each year to incorporate updated vendor model inputs and experience, resulting in adjusted reserve and reinsurance recoverable figures that are reflected in the company’s loss‑reserve development and reinsurance‑recoverable disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key elements such as AIG's use of third-party models, core attachment points ($200M in Japan, $125M elsewhere), and the $38.0 billion reinsurance recoverable assets in 2024 with $29.1 billion in ceded loss reserves, which aligns with the ground truth. However, it introduces new figures not present in the original answer—specifically $3.8 billion in paid-loss recoveries, $4.3 billion in ceded unearned premium reserves, $0.8 billion in life-reinsurance recoverables, and $20.1 billion in collateral—which are not supported by the ground truth and appear to be fabricated or misattributed. Additionally, the LLM mentions reinsurance structures capping losses at $400M (U.S. windstorm/earthquake) and $175M (global aggregate), which are not referenced in the original answer and are irrelevant to the terrorism exposure focus. (2) While the $38B total and $29.1B ceded loss reserves are accurate, the breakdown of the remaining $8.9B is incorrect and unsupported. The ground truth does not mention paid-loss recoveries or collateral amounts, so these reduce quantitative accuracy. (3) The multi-hop reasoning is generally sound—AIG’s evolving modeling approach, consistent attachment points, and increased reinsurance reliance are correctly synthesized across years. However, the inclusion of unrelated catastrophe caps and unsupported asset breakdowns indicates flawed synthesis or overextrapolation. (4) The answer is contextually relevant and captures the evolution of AIG’s terrorism risk management, but the addition of unverified financial details lowers quantitative accuracy. The core facts are mostly correct, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 466,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The trend in NVIDIA’s liability for the 2.00% Notes Due 2031—$1.2 billion at the end of fiscal 2022, a modest decline to $1.044 billion in fiscal 2023, and a rebound to $1.25 billion in fiscal 2024—reflects a deliberate, opportunistic approach to long‑term debt management: the company selectively retired or reduced higher‑cost or near‑term maturities (e.g., the 0.584% 2024 notes) while maintaining a sizable exposure to its 2031 tranche to preserve low‑cost financing and flexibility, indicating that NVIDIA is balancing debt reduction with the strategic retention of inexpensive, long‑dated capital to support ongoing investments and shareholder returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024. These match exactly with the original answer, and formatting variations (e.g., using ' ' or 'billion') are acceptable. (2) Quantitative accuracy is perfect—no calculation errors or misstatements of amounts or years. (3) The reasoning is mostly sound and adds contextual insight about NVIDIA’s broader debt strategy, such as referencing the retirement of other notes (e.g., 0.584% 2024 notes), which is plausible but not mentioned in the ground truth. While this additional detail is reasonable and consistent with strategic debt management, it introduces unverified specifics not present in the source, slightly weakening the qualitative accuracy. The core inference—that NVIDIA maintains stable long-term liabilities to support investments—is aligned with the ground truth. (4) The answer is highly relevant, directly addressing the trend and its implications for long-term debt strategy. The slight deduction in qualitative accuracy is due to the introduction of external-sounding details (e.g., specific mention of other notes) that, while logical, go beyond the provided data. Overall, the answer is factually correct on all key points and conveys a semantically equivalent conclusion with slightly expanded interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 387,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05% Notes due 2017 were first issued in 2014 (as disclosed in the 4.4 Officer’s Certificate of May 6, 2014) and have remained part of the company’s long‑term debt structure through 2022, 2023 and 2024, as evidenced by their continued appearance in the “Notes to Consolidated Financial Statements” and the “Exhibit 4.1 – Description of Securities” tables in the 2022, 2023 and 2024 Form 10‑K filings. This persistence shows that the instrument has been continuously visible and retained within Apple’s capital structure, underscoring the long‑term visibility and continuity of Apple’s debt financing strategy for that specific tranche.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces a significant factual inaccuracy that undermines its overall correctness. (1) Quantitatively, the LLM states the 1.05% Notes due 2017 were issued in 2014, citing an Officer’s Certificate from May 6, 2014. However, the ground truth does not confirm this issuance date, and more critically, notes that the instrument matured in 2017—yet the LLM claims it remained part of Apple’s long-term debt structure through 2022, 2023, and 2024. This is factually incorrect: a note due in 2017 cannot legally remain outstanding past its maturity without being refinanced or reissued, which the LLM does not clarify. The original answer correctly speculates about rollover or refinancing but does not assert continued existence as an active instrument. (2) The LLM incorrectly implies the notes are still an active part of the debt structure, whereas the ground truth emphasizes their inclusion is likely for historical or documentation continuity under the same indenture, not as live debt. (3) The reasoning is partially sound in noting consistent disclosure across filings, supporting transparency and stable disclosure practices. However, it fails to recognize the contradiction in a 2017-due note persisting into 2024 as an active liability, showing flawed multi-hop logic. (4) Contextually, the answer addresses the question about visibility and continuity well and correctly references Form 10-K disclosures and exhibit tables, earning high marks for relevance. Overall, while the direction of reasoning aligns with the ground truth, the assertion of ongoing active status of a matured note reduces factual accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 457,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "Schwab's ability to migrate IDA balances to its balance sheet evolved from 2022 through 2024 under increasingly restrictive terms in the IDA agreements. Initially, the 2019 IDA agreement allowed migration of up to $10 billion of balances annually (subject to designations and capital requirements), but the 2023 replacement agreement eliminated the fixed-rate designation requirement and imposed stricter minimums: maintaining at least $60 billion in IDA balances (with a $90 billion cap) after September 2025, and requiring minimum balances above fixed-rate obligations through 2025. Schwab migrated $10.1 billion of IDA balances by December 2021 under the prior agreement, but under the 2023 terms, it did not migrate any balances to its balance sheet in 2023 or 2024, instead using $5 billion of fixed-rate obligations to buy down obligations with $249 million in fees. The required IDA balance minimum increased from $50 billion (pre-2023) to $60 billion post-2025, with a maximum of $90 billion, and the ability to migrate fixed-rate obligations was limited to specific designations under the new agreement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. While it correctly notes that Schwab migrated $10.1 billion of IDA balances by year-end under the 2019 agreement, it incorrectly states this occurred by December 2021 instead of 2022, which misaligns the timeline. The claim that Schwab migrated $10.1 billion by December 2021 contradicts the ground truth stating the migration occurred by year-end 2022. Additionally, the LLM introduces specific figures not present in the ground truth—such as a $5 billion use of fixed-rate obligations and $249 million in fees—which are unsupported and appear fabricated. It also cites future balance thresholds ($60 billion minimum, $90 billion cap) effective after September 2025, but the original answer does not mention these specific numbers or dates, making them extraneous and potentially incorrect. (2) Quantitative accuracy is compromised due to the incorrect timing of the $10.1 billion migration and the introduction of unverified figures like $5 billion and $249 million. The ground truth does not reference any such transactions or fees, nor does it specify exact thresholds beyond stating new minimum and maximum balance requirements were introduced in 2023. The evolution described hinges on accurate sequencing and constraints, but the added numbers undermine reliability. (3) The multi-hop reasoning is partially sound—LLM correctly infers a strategic shift from active migration (2022) to non-migration under new constraints (2023–2024). It identifies the replacement of the 2019 agreement with a 2023 version and the cessation of balance sheet migration, which aligns with the ground truth. However, the reasoning is weakened by unsupported details and misattributed timelines. (4) Contextual relevance is high because the response addresses the core evolution of migration ability and changes in agreement terms. Despite inaccuracies, it attempts to synthesize across years and agreements. However, the inclusion of unverified specifics reduces overall correctness. The answer conveys a similar narrative arc but with significant factual deviations, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 586,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "From 2022 through 2024 the estimated losses for Bank BPH’s borrower‑litigation portfolio rose from $2.46 billion (as of 12/31/2024) to $2.669 billion (as of 12/31/2023), reflecting a continued increase in the number of lawsuits, findings of liability and more severe remedies.  To maintain regulatory capital, the company made a non‑cash capital contribution of $1.797 billion in 2023 (no additional cash contribution was required in 2024), and the carrying value of the Bank BPH mortgage portfolio was fully offset by a valuation allowance, leaving essentially no net carrying value at year‑end 2024.  These dynamics are detailed in the 2022‑2024 10‑K notes on discontinued operations and the litigation‑loss reserves.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the direction and values of estimated losses over time. It incorrectly states that estimated losses rose from $2.46 billion in 2024 to $2.669 billion in 2023, reversing the correct temporal order. Ground truth shows losses increased from $1,359 million in 2022 to $2,669 million in 2023, then declined to $2,461 million in 2024. The LLM misrepresents $2.46 billion as the 2022 figure when it should be the 2024 value, and omits the 2022 baseline entirely. The $1.797 billion non-cash contribution in 2023 is correctly reported, but the LLM fails to mention the $530 million cash contribution in 2022, a key part of capital contributions. (2) Quantitative accuracy is compromised: while $2.669 billion (2023) and $2.46 billion (2024) are numerically close to ground truth ($2,669M and $2,461M), the assignment to years is reversed, and the 2022 value ($1,359M) is omitted. The $1.797 billion non-cash contribution is correct, but absence of the $530M 2022 cash contribution reduces completeness. The carrying value dropping to zero by end-2024 is correctly implied via 'fully offset by valuation allowance'. (3) Multi-hop reasoning is partially sound—LLM connects litigation losses, capital contributions, and carrying value across years, and correctly references discontinued operations and reserves. However, the reversed timeline undermines the strategic narrative: ground truth shows escalating exposure in 2023 followed by stabilization in 2024, whereas LLM implies continued worsening. (4) Contextual relevance is high—the answer addresses all key themes (losses, contributions, carrying value) and cites appropriate disclosures. However, due to major quantitative and directional errors in loss evolution and incomplete capital contribution data, the correctness score is limited to 5, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 520,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined modestly from 2022 to 2024, with fair value decreasing from $574 million (unrealized loss $12 million) at the end of 2022 to $568 million (unrealized loss $12 million) in 2023 and further to $568 million (unrealized loss $12 million) in 2024, reflecting minimal change in both fair value and unrealized losses despite broader market volatility. This stable yet small position suggests the company maintains a conservative risk‑management approach, limiting exposure to illiquid, rate‑sensitive assets while focusing on more predictable, lower‑volatility investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, CVS's CMBS exposure showed significant changes from 2022 to 2024: fair value was $574M in 2022 with $12M unrealized losses, increased to $675M in 2023 with a sharp rise in unrealized losses to $100M, and then dropped drastically to $3M in 2024. The LLM claims fair value remained nearly unchanged at ~$568M across all three years with constant $12M unrealized losses, which contradicts the ground truth. (2) Quantitative accuracy is extremely low: all three years' values are wrong. The 2023 fair value is reported as $568M instead of $675M, missing a 17.6% increase, and 2024 is stated as $568M instead of $3M — an error of over 18,000%. The LLM also completely omits the $100M unrealized loss in 2023, a critical data point indicating rising risk. (3) The qualitative reasoning fails because it draws conclusions from fabricated data. The claim of 'minimal change' and 'stable position' contradicts the actual volatile trend and the decisive de-risking move in 2024. The LLM’s inference about conservative risk management is not supported by the real data, which instead suggests a reactive strategy following deteriorating asset quality in 2023. (4) Contextual relevance is low but not zero because the answer addresses the right topic (CMBS exposure and risk management), uses correct terminology, and attempts multi-year analysis. However, due to pervasive factual errors, the synthesis and conclusions are invalid. The model failed to perform the required multi-hop reasoning across years and misrepresented the entire trajectory of CVS’s CMBS holdings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 458,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private brand portfolio featuring Marketside has expanded steadily across its fiscal years 2022‑2024, with the brand’s assortment growing and its presence reinforced through strategic investments in supply‑chain automation and omni‑channel capabilities. This three‑year progression signals a deliberate focus on strengthening Walmart’s private‑label strategy in the grocery segment, aiming to capture greater margin and customer loyalty by offering differentiated, value‑oriented products under the Marketside label.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric values, so quantitative accuracy is not applicable—no incorrect numbers are present, hence a score of 10. However, the answer fabricates strategic initiatives not supported by the ground truth, such as 'growing assortment,' 'strategic investments in supply-chain automation,' and 'omni-channel capabilities,' which are not mentioned in the original answer or implied by the knowledge graph. These additions misrepresent the factual progression of Marketside. (2) While the time frame (2022–2024) and entity (Walmart, Marketside) are correct, the LLM incorrectly infers growth and expansion of Marketside specifically, whereas the ground truth only confirms its consistent inclusion in the private brand portfolio. The introduction of 'bettergoods' in 2024 as a new brand is omitted entirely, which is a key element in understanding Walmart’s dual strategy. (3) The multi-hop reasoning is flawed: the original answer synthesizes data across three years to show continuity of Marketside alongside innovation (new brands), indicating a balanced private label strategy. The LLM instead focuses solely on Marketside’s expansion, missing the broader strategic context of portfolio diversification and modernization. It fails to mention the coexistence of legacy and new brands, which is central to the correct interpretation. (4) The contextual relevance is moderate—the answer addresses Walmart’s private label strategy in the grocery segment and references the correct time frame and brand, but it emphasizes unverified operational investments and omits critical evidence of strategic balance, leading to a misleading conclusion about the nature of Walmart’s strategy. Thus, while the general direction is relevant, the factual and reasoning gaps reduce correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 495,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 through 2024 Lowe's strengthened its oversight of supplier sustainability by expanding its formal policies and investments. In 2022 it updated its wood‑sourcing rules and added new risk‑level assessments, then in 2023 deepened its Vendor Code of Conduct and human‑rights policy, introduced a more robust monitoring system and a forestry grievance process, and began reporting progress to CDP and the Dow Jones Sustainability Index. Building on that, in 2024 Lowe's set a net‑zero emissions target for scope 1‑3 by 2050 with interim 2030 goals (42 % cut in scope 1‑2 and 25 % cut in scope 3), allocated over $550 million to energy‑efficiency and renewable‑energy projects, expanded its SmartWay transportation partnership, and increased its sustainable‑product offering and independent certifications across the supply chain. These policy enhancements and capital investments collectively reinforced Lowe's supply‑chain sustainability framework over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key details from the ground truth, particularly regarding the timing and nature of policy updates and investments. (1) Incorrectly states that Lowe's updated its wood-sourcing rules in 2022 with new risk-level assessments; the ground truth indicates these updates occurred in 2023, not 2022. (2) Claims in 2023 Lowe's 'deepened' its Vendor Code of Conduct and human rights policy—this is not supported by the original answer, which states these were already in place in 2022 and monitored, with no mention of 2023 enhancements to those specific policies. (3) Introduces new information not in the ground truth: reporting to CDP and Dow Jones Sustainability Index, net-zero emissions target by 2050 with 2030 goals, and allocation of over $550 million to energy-efficiency and renewable-energy projects. The ground truth states that $550 million was invested by 2022 in operational sustainability initiatives broadly, not specifically in energy/renewables, and that over $400 million was invested through 2023—not $550 million allocated later. (4) The LLM answer incorrectly shifts the timeline of investments, implying growing capital allocation when the ground truth shows a decline from $550M by 2022 to $400M through 2023. (5) While the mention of a forestry grievance process in 2023 aligns with the truth, the LLM attributes it to 2023 as part of broader monitoring improvements, whereas the ground truth shows it was introduced in 2023 and formalized by 2024. (6) The answer adds 'SmartWay partnership' and 'sustainable-product offering' expansions not mentioned in the original. Overall, the LLM fabricates or misattributes specific policy actions and financial figures, failing the multi-hop synthesis of accurate, year-by-year developments. However, it correctly identifies the general trend of strengthening monitoring and enforcement, and the focus on wood sourcing and supplier standards, maintaining contextual relevance. Quantitative accuracy is low due to incorrect dollar amounts, misassigned years, and fabricated percentages (e.g., 42%, 25%). Qualitative accuracy is moderate—some correct themes but flawed entity-event mapping. Contextual relevance is high as it addresses supplier practices, policies, and investments in sustainability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 618,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 2.40% Notes due 2023 were first disclosed in the 2013 Indenture (4.3) and have remained part of its long‑term debt schedule through the 2022, 2023 and 2024 Form 10‑K filings, with the most recent reference appearing in the 2024 filing’s Exhibit 4.3 and the 2023 filing’s Exhibit 4.3. This three‑year continuity shows that the company consistently includes the 2.40% 2023 notes as a stable component of its debt portfolio, reflecting a strategy of maintaining a predictable, low‑coupon tranche while it issues new longer‑dated securities to refinance maturing obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in detail and reasoning. (1) Quantitatively, all key facts are accurate: the 2.40% Notes due 2023 were indeed disclosed in Apple's 2022, 2023, and 2024 filings, and referenced in Exhibit 4.3 across years, consistent with the original answer. The mention of the 2013 Indenture aligns with the Officer's Certificate dated May 3, 2013, in the ground truth. (2) The numbers, percentages, and years are correct; no calculation errors exist. (3) The multi-hop reasoning is sound—LLM correctly synthesizes disclosure patterns across three years and links them to debt management strategy. However, the LLM slightly mischaracterizes the strategic implication by suggesting the note is part of a 'stable component of its debt portfolio' and used as a 'predictable, low-coupon tranche' while issuing new debt—this level of strategic inference (refinancing intent) is not directly supported in the ground truth, which emphasizes transparency and continuity in disclosure, not active refinancing strategy. (4) Despite this interpretive overreach, the core factual chain—consistent disclosure across 2022–2024, inclusion in Exhibits 4.3, and sustained transparency—is accurate and relevant. The answer addresses both parts of the question: evolution of disclosure and strategic implication. Thus, it earns high marks for contextual relevance and quantitative accuracy, with a slight deduction in qualitative accuracy due to unsupported strategic interpretation, leading to a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 432,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "From 2022 to 2024, GE’s holdings of the AerCap note declined from $900 million (2022) to $944 million (2023) and further to $982 million (2024), reflecting a modest increase in absolute amount but a continued presence within its broader Level 3 debt‑security portfolio. This progression—maintaining a sizable, though not expanding, exposure to the AerCap note while overall Level 3 investment‑security holdings grew—indicates that GE’s strategy has been to preserve a stable allocation to high‑yield debt instruments, using the AerCap note as a consistent component of its diversified fair‑value‑measured assets rather than aggressively scaling up or down its position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numerical values. It states that GE's holdings were $900 million in 2022, but the ground truth is $976 million. The 2023 value ($944 million) is correct, and the 2024 value ($982 million) is also correct. However, the initial figure is wrong, which distorts the entire trend. The LLM incorrectly describes the progression as a 'decline from $900M to $944M to $982M', which is logically inconsistent (both numbers are higher than $900M), suggesting confusion in reasoning. (2) Quantitative accuracy is low because the first data point is off by $76 million, a substantial error. While the other two figures are accurate, the misstatement of the starting value undermines the validity of any trend analysis. Additionally, the description of the movement as a 'decline' followed by increases contradicts the numbers presented and the actual trend in the ground truth (which shows a decrease from 2022 to 2023, then an increase in 2024). (3) The multi-hop reasoning is partially sound in that the model attempts to interpret the pattern and link it to GE's broader investment strategy in Level 3 assets and high-yield instruments. However, because the foundational data is incorrect, the conclusion—though contextually plausible—is based on flawed premises. The model correctly identifies the AerCap note as part of GE's Level 3 debt securities and infers a strategy of stability, which aligns with the ground truth's mention of 'slight overall stability.' (4) Contextual relevance is high because the answer addresses both parts of the question: the evolution of holdings and the strategic implication. The language about 'preserving a stable allocation' and 'consistent component' is semantically close to the ground truth's 'dynamic approach' with 'overall stability.' However, due to the critical error in the 2022 figure and the resulting flawed trend description, the correctness score is significantly reduced. Minor formatting issues (use of thin spaces) do not affect meaning but do not compensate for factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 563,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "The U.S. pension plan’s glide‑path approach shifted markedly from 2022 to 2024: the target allocation for growth (equity) assets fell from 15 % in 2022 to 9 % in 2023 and remained at 9 % for the 2025 target, while the liability‑hedging portion (fixed‑maturity securities) rose from 75 % to 80 % over the same period. This progression—moving from a higher equity exposure toward a more conservative, liability‑driven mix—reflects a deliberate de‑risking strategy that intensifies as the plan’s funded ratio improves, reducing reliance on growth assets and increasing holdings of stable, interest‑rate‑sensitive securities to protect the plan’s solvency.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct qualitative direction of AIG's glide path evolution—shifting from growth to liability-hedging assets as part of a de-risking strategy in response to improved funded status—which aligns with the ground truth. However, the quantitative details are factually incorrect. The LLM states that growth asset allocation fell from 15% in 2022 to 9% in 2023 and remained at 9% for 2025, and that liability-hedging assets rose from 75% to 80%. These specific percentages (15%, 9%, 75%, 80%) are not supported by the ground truth, which does not provide exact allocation figures but instead describes the general mechanism and directional shift of the glide path based on funded status at year-end determining targets for future years (e.g., 2021 status sets 2022 target, 2022 status sets 2024 target, etc.). The LLM invents precise numbers that are not present in the original answer, which is a critical error in a financial context. Additionally, the claim that the 2023 target was 9% for growth assets and that this was maintained for 2025 misrepresents the timing and structure of the glide path adjustments described in the ground truth. The original answer emphasizes the decision rule (funded status at year-end sets future targets) and the principle of de-risking, not specific percentage allocations. Thus, while the reasoning and intent (de-risking via increasing liability-hedging assets) are sound and contextually relevant, the fabricated numbers severely undermine factual accuracy. Multi-hop synthesis is partially correct—the model connects funded status to allocation changes—but fails to accurately represent how and when targets are set across years. The absence of exact figures in the ground truth means the LLM should not have introduced specific percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 487,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments' strategic emphasis on embedded processing products remained consistently prioritized across 2022, 2023, and 2024, as evidenced by its recurring focus on this segment as a core growth driver in annual reports (2024: p.14, 18; 2023: p.18, 20; 2022: p.18, 21). The company explicitly identifies embedded processing—alongside analog—as one of its four sustainable competitive advantages, highlighting its role in driving long-term free cash flow per share growth through diversified customer relationships, software investment by end-users, and stable market demand across industrial and automotive sectors. This multi-year consistency reveals that embedded processing is not a cyclical product line but a foundational pillar of TI's business model, deliberately engineered to generate predictable, high-margin cash flow that directly fuels shareholder returns and sustained capital allocation discipline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing as a core strategic focus from 2022 to 2024, alongside analog products, as part of its sustainable competitive advantages. The role of this product line in driving long-term free cash flow per share growth is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic statements, correctly infers continuity, and draws a valid conclusion about the foundational role of embedded processing in TI's cash flow model. The only minor deviation is that the LLM adds slightly more interpretive detail (e.g., 'predictable, high-margin cash flow', 'capital allocation discipline') not explicitly stated in the original, but these are reasonable inferences and do not contradict the ground truth. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: evolution over time and implications for long-term cash flow. The inclusion of page references (e.g., 2024: p.14, 18) suggests fidelity to source documents, even if not in the original answer. Overall, this is a semantically equivalent, slightly enriched version of the ground truth, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 420,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024 Lowe’s private‑brand strategy shifted from a broad, value‑oriented portfolio toward a more curated mix that emphasizes high‑margin, technology‑enabled products such as Kobalt tools and the STAINMASTER flooring line, while integrating these brands into its omnichannel and digital‑first initiatives. The company increasingly leveraged Kobalt and other private‑label lines to drive Pro‑customer penetration and online sales, pairing brand‑specific marketing with data‑driven personalization and seamless in‑store pickup or delivery options. This evolution reflects a strategic focus on aligning private‑brand growth with Lowe’s broader digital transformation and sustainability goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces unsupported claims not present in the ground truth, affecting factual accuracy and reasoning. (1) Correct elements: The focus on 'Kobalt' and 'STAINMASTER' aligns with the original answer, and the mention of digital transformation in the context of private brands is consistent with fiscal 2024 developments. The emphasis on omnichannel and digital initiatives is contextually relevant. (2) Quantitative accuracy: There are no numeric values in either answer, so no discrepancies exist; dates (fiscal 2022–2024) are correctly referenced. (3) Multi-hop reasoning issues: The ground truth notes a narrowing of disclosed IP from including 'RONA' and 'Reno Depot' in 2022 to only 'Kobalt', 'STAINMASTER', and 'allen+roth' in 2023–2024, suggesting a strategic refocusing. The LLM omits this key evolution and instead asserts a shift toward 'high-margin, technology-enabled products' and links to 'sustainability goals'—claims not supported by the original data. The integration of private brands with digital transformation is plausible but overstated without direct evidence of 'data-driven personalization' or 'brand-specific marketing' tied to IP strategy. (4) The answer is contextually relevant and well-structured, but the qualitative inaccuracies—particularly the unsupported strategic narrative about margin focus and sustainability—reduce its correctness. The core observation about digital integration in 2024 earns partial credit, but the absence of the brand list evolution weakens completeness and reasoning. Hence, correctness is scored at 6 for partial alignment with facts, strong relevance, and accurate time framing, but with significant unverified assertions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 467,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 2022 10‑K already framed client relationships and trust as a core differentiator in software, consulting and infrastructure, noting that “technology innovation; performance; price; quality; brand; our breadth of capabilities, products and services; talent; client relationships and trust” drive competition. By 2024 the language had evolved to stress that these attributes—especially “client relationships and trust”—are now integral to IBM’s hybrid‑cloud and AI strategy, positioning the firm as a leader that can “leverage the power of hybrid cloud and artificial intelligence (AI)” to create sustained value for clients. The multi‑year progression shows a deliberate, long‑term focus on building and monetizing trust as a strategic moat, reinforcing IBM’s positioning in the high‑value hybrid‑cloud and AI markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of dates (2022 and 2024) and correctly identifies IBM as the company in focus, with no numerical inaccuracies (no financial figures were involved, but time periods are correct). It accurately reflects that IBM emphasized 'client relationships and trust' as a competitive differentiator and shows evolution in how this was framed—from a general competitive factor in 2022 to a strategic asset tied to hybrid cloud and AI by 2024. However, the LLM answer omits key multi-hop details present in the ground truth: specifically, the expansion of IBM’s trust narrative through strategic partnerships with AWS, Microsoft, SAP in 2023, and the addition of cybersecurity partners like Palo Alto Networks in 2024. These ecosystem developments are critical to the full evolution of IBM’s trust-based strategy and are missing from the LLM response, weakening the qualitative accuracy and completeness. While the LLM captures the directional shift and strategic intent, it fails to synthesize the full 3-year progression across multiple filings and partnerships, particularly the 2023 pivot and ecosystem emphasis. The reasoning is sound but incomplete. Contextual relevance is high, as the answer stays focused on IBM’s strategic positioning in hybrid cloud and AI with appropriate linkage to trust. Wording differences are acceptable under semantic equivalence, but the omission of partner ecosystem evolution constitutes a significant gap in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 411,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "From 2022 through 2024, Gilead’s El Segundo, California facility transitioned from primarily supporting early‑stage clinical manufacturing to becoming a core commercial manufacturing site for its cell‑therapy products.  The facility was used for both clinical‑trial production of investigational cell‑therapy products and, beginning in 2023, for the commercial manufacture and processing of approved therapies such as Tecartus and Yescarta, expanding its role beyond the limited clinical‑only use noted in 2022.  This evolution reflects Gilead’s strategy to leverage its El Segundo capabilities to scale cell‑therapy output for both pipeline candidates and marketed products.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about the evolution of Gilead's El Segundo facility. According to the ground truth, the facility's role remained consistent from 2022 to 2024, with no significant changes in responsibilities—it was used for both clinical and commercial manufacturing throughout all three years. The LLM incorrectly states that the facility transitioned from 'primarily supporting early-stage clinical manufacturing' in 2022 to commercial production beginning in 2023, implying a shift that did not occur. This misrepresents the timeline and nature of the facility’s utilization. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not heavily applicable, but the dates and progression described are factually wrong. The qualitative error is severe: the model fabricates a narrative of evolution and expansion that contradicts the documented continuity. While the answer is contextually relevant—focusing on the correct facility, company, and topic—it fails on factual accuracy and multi-hop reasoning, as it does not correctly synthesize the consistent role of the site across years. The mention of Tecartus and Yescarta, while plausible products, is not supported in the original answer and adds unsupported specificity. Overall, the answer sounds plausible but conveys false information about strategic changes that did not occur.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 391,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Lowe's has consistently issued new 4.550% senior notes through its indenture amendments, with key additions in 2023 (4.800% 2026 notes and 5.150% 2033 notes) and 2024 (3.650% 2029 and 4.550% 2049 notes), while maintaining a rolling maturity profile that extends debt obligations through 2063. This multi-year pattern demonstrates a deliberate long-term debt strategy focused on extending maturities and diversifying funding sources, as evidenced by the sequential issuance of new tranches (e.g., 2023's 2026/2033 notes and 2024's 2029/2049 notes) that replace or supplement older maturing obligations, ensuring sustained access to capital markets for ongoing liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Lowe's consistently referenced the same 4.550% Notes due April 5, 2049 across 2022–2024 under the Fifteenth Supplemental Indenture dated April 5, 2019, with no indication of new issuances of 4.550% notes in 2023 or 2024. However, the LLM claims Lowe's issued new tranches such as '4.800% 2026 notes', '5.150% 2033 notes', '3.650% 2029 notes', and a '4.550% 2049 notes' in 2024 — none of which are supported by the original answer. These specific coupon rates, maturity years, and issuance years are entirely fabricated or misattributed. (2) Quantitatively, all dates (2026, 2029, 2033, 2049, 2063) and interest rates (3.650%, 4.800%, 5.150%) cited in the LLM answer are incorrect and not present in the ground truth. The only correct quantitative element is the mention of the 4.550% 2049 notes, but even this is misrepresented as a new 2024 issuance rather than a long-standing instrument consistently carried forward. There are no calculations in the question, so scoring focuses on factual numeric accuracy. (3) The multi-hop reasoning is flawed. The original answer emphasizes stability and consistency in referencing a single long-term instrument over time as evidence of a strategy to avoid refinancing risk. In contrast, the LLM infers a dynamic strategy of rolling issuance and maturity extension based on non-existent new debt tranches, leading to an incorrect interpretation of Lowe's debt strategy. The model fails to recognize that no structural change occurred — the same note was simply carried forward in disclosures. (4) Contextual relevance is moderate because the LLM attempts to address the evolution of debt structure and long-term strategy, but its conclusions are based on false premises. While the general idea of 'extending maturities' and 'diversifying funding' might align with plausible corporate behavior, it does not reflect the actual pattern described in the ground truth, which is one of stability, not active issuance. Thus, the reasoning and factual basis are unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 573,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 through 2024 the legal exposure tied to 3M’s Scotchgard‑related PFAS litigation shifted from a few isolated state‑court suits to a large, multidistrict‑litigation (MDL) docket that now encompasses dozens of AFFF and drinking‑water cases across the United States, with settlements in some jurisdictions (e.g., the $65 million New York PWS settlement) and ongoing bellwether trials in Michigan and elsewhere.  The trend shows that PFAS‑related litigation has generated a growing stream of settlement and accrual activity—though most individual exposures remain immaterial—while also prompting heightened regulatory scrutiny and compliance costs at 3M’s manufacturing sites, underscoring the material financial risk that PFAS‑related lawsuits pose to the company’s earnings and cash flow.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core trend of escalating PFAS-related legal exposure for 3M from 2022 to 2024 and correctly identifies the $65 million New York settlement, which aligns with the ground truth. However, it inaccurately frames the litigation evolution by emphasizing a 'multidistrict litigation (MDL) docket' encompassing 'dozens of AFFF and drinking-water cases' as the central structure, while the original answer specifies that in 2023, 3M faced approximately 68 AFFF suits *outside* the MDL, implying the MDL was not the primary venue. This misrepresents the legal structure. Additionally, the LLM mentions a '$65 million New York PWS settlement' as if it were newly finalized in the 2024 timeframe, but the ground truth states the $65 million settlement (involving New York and Michigan) was already contributed in 2022 and finalized in New York in 2024—this nuance is lost, risking misinterpretation of timing. The LLM omits key details such as the Canadian class action, Illinois case, and litigation in Alabama and Georgia with trial dates set for 2026. It also fails to mention Saint-Gobain and Honeywell as co-contributors to the $65 million settlement. While the conclusion about growing financial risk is valid and contextually sound, the answer synthesizes the multi-hop progression less precisely than required, particularly in geographic and procedural details. Quantitative accuracy is high—$65 million is correctly cited, and no incorrect numbers are introduced. Wording differences are acceptable under semantic equivalence, but the omission of specific jurisdictions, entities, and timing nuances reduces completeness and qualitative accuracy. The answer remains contextually relevant and correctly infers the increasing financial impact, warranting a solid but not top-tier score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 488,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "From 2022 through 2024, Gilead’s Foster City facility evolved from a hub focused primarily on early‑stage R&D and API development into a more integrated manufacturing and innovation center.  While the site continues to host discovery‑stage research—including work on capsid inhibitors (lenacapavir), FXR agonists (cilofexor) and next‑generation oncology candidates—its manufacturing responsibilities have expanded to include commercial‑scale production of key products such as Biktarvy, Veklury, Tecartus and Yescarta, as well as the processing of cell‑therapy products (CAR‑T) and biologics.  This broader role aligns with Gilead’s global strategy of consolidating manufacturing capabilities across its worldwide network, ensuring supply‑chain resilience, and supporting the company’s growing oncology, virology and liver‑disease portfolios.  Consequently, the Foster City campus now serves both as a research‑innovation engine and as a critical node for large‑scale drug substance and product manufacturing that feeds into Gilead’s worldwide operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Gilead's Foster City facility. Contrary to the ground truth, the LLM claims that Foster City expanded into commercial-scale manufacturing of key products like Biktarvy, Veklury, Tecartus, and Yescarta, and that it processes CAR-T and biologics at scale. However, the original answer states that from 2023–2024, the facility's role was narrowed to early-stage development and clinical manufacturing (not commercial-scale), with commercial manufacturing shifted to other sites like La Verne and Oceanside. This is a major contradiction. Additionally, while the LLM correctly identifies ongoing R&D activities (e.g., capsid inhibitors, FXR agonists), these specific drug names are not mentioned in the ground truth and cannot be verified from the provided data, introducing unconfirmed details. (2) There are no explicit numbers (dollar amounts, percentages, headcount, etc.) in either answer, so quantitative accuracy is not heavily applicable; however, the use of correct years (2022–2024) and alignment with general timeline structure earns partial credit. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers strategic consolidation of *commercial* manufacturing in Foster City, when the truth indicates a narrowing of focus and a shift *away* from commercial manufacturing there. The synthesis across time and function is therefore invalid. (4) Contextual relevance is moderate—the response addresses R&D, manufacturing, and strategic alignment as asked, but with incorrect substance. The framing of Foster City as both an innovation engine and large-scale manufacturing node contradicts the ground truth, which emphasizes a strategic refocusing *away* from broad responsibilities toward early development and clinical production. Thus, despite addressing the right themes, the factual core is incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 527,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "AIG’s loss‑reserve oversight has become more structured and data‑driven from 2022 through 2024, with heightened reliance on external actuarial reviews and third‑party catastrophe models to stress‑test reserves.  The company expanded its hedging framework for variable‑annuity guarantees, introducing an explicit economic‑hedge target and daily monitoring of derivative positions to align market‑risk exposures with reserve assumptions.  Simultaneously, AIG deepened its reinsurance‑credit oversight and diversified its investment‑management contracts (e.g., the BlackRock agreements) to better align asset‑liability management with reserve‑backed cash‑flow needs.  These changes collectively improve visibility, reduce model risk, and integrate both internal and external validation into the reserve‑setting process.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) It references specific initiatives like a 'hedging framework for variable-annuity guarantees', 'economic-hedge target', 'daily monitoring of derivative positions', 'BlackRock agreements', and 'reinsurance-credit oversight' that are not mentioned or supported in the original answer and represent fabricated details. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable, but the LLM invents processes (e.g., daily monitoring, explicit targets) that imply precision not grounded in the source. (3) The multi-hop reasoning fails: while the original describes a progression from internal/external reviews (2022) to stochastic models and scenario analysis (2023) to ERM integration with second-line review (2024), the LLM misrepresents this evolution by focusing on hedging, asset-liability management, and third-party catastrophe models not cited in the ground truth. (4) The only correct element is the general direction of increased structure and use of external reviews, which aligns loosely with 2022–2024 trends. However, the core mechanisms and evolution described—especially the integration into ERM, experience studies, and enhanced governance—are omitted and replaced with irrelevant financial engineering concepts. Thus, the answer lacks factual fidelity, introduces hallucinated programs, and fails to capture the actual evolution of AIG’s loss reserve risk management as documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 427,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "From 2022 to 2024, Texas Instruments expanded its Melaka, Malaysia footprint from a modest presence (listed as “Melaka, Malaysia” under both Analog and Embedded Processing in 2022) to a clearly designated “Melaka, Malaysia †” facility that is highlighted in the 2024 Properties table as a dedicated site for Analog manufacturing only. This progression—from a shared‑use location in 2022 to a stand‑alone Analog‑focused site by 2024—reflects TI’s strategic shift toward deepening its analog semiconductor manufacturing capacity in Southeast Asia while maintaining a smaller Embedded‑Processing footprint in the region. Consequently, the three‑year evolution signals that TI is concentrating its Analog production in Melaka, using the site as a regional hub to support its analog product growth, whereas Embedded Processing remains more dispersed across other locations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly claims that in 2022, Melaka was listed under both Analog and Embedded Processing, and that it evolved into a dedicated Analog-only site by 2024. The ground truth states that Melaka was consistently used exclusively for Analog manufacturing from 2022 to 2024, with no indication of Embedded Processing operations at any point during this period. (2) There is no mention of a 'modest presence' or 'shared-use location' in 2022 in the original data, nor any designation like 'Melaka, Malaysia †' indicating a change in status—these details are fabricated. (3) The reasoning about a 'strategic shift' or 'deepening analog capacity' due to a footprint expansion is unsupported; the ground truth emphasizes stability and specialization, not evolution or strategic change in Melaka. (4) While the answer correctly identifies Melaka's role in Analog manufacturing, it misrepresents the timeline and nature of operations, failing the multi-hop synthesis by inventing a progression that did not occur. The contextual relevance is moderate because it addresses the right company, location, and product lines, but the core narrative is factually incorrect. Quantitative and qualitative accuracy are low due to invented details and flawed logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 372,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024 Lowe’s progressively increased its use of forward interest‑rate swaps to hedge the interest‑rate risk of anticipated debt issuances.  In 2022 the company held a modest amount of forward swaps, which grew to a larger notional position by early 2023 and remained in place through 2024, reflecting a deliberate expansion of its hedging program.  This progression indicates that Lowe’s is systematically locking in financing costs and managing exposure to rising benchmark rates as it plans future borrowing, underscoring a proactive, risk‑mitigation strategy around its forecasted debt financings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The ground truth states that Lowe's used forward interest rate swaps in 2022, had a $251 million fair value position in 2023, and completely discontinued these instruments by 2024. In contrast, the LLM claims Lowe's 'progressively increased' and 'expanded' its use of forward swaps through 2024, which is the opposite of the actual trend. (2) There are no correct quantitative values in the LLM response—it omits the $251 million fair value figure from 2023 and fabricates a growing notional position with no supporting data. The ground truth includes specific financial disclosures that the LLM ignores. (3) The multi-hop reasoning is fundamentally flawed. The question requires synthesizing information across three fiscal years to identify a strategic shift from hedging forecasted debt (via forward swaps) to managing existing debt (via fixed-to-floating swaps). The LLM fails this synthesis, instead asserting a non-existent continuity and expansion of forward swap usage. (4) The contextual relevance is low but not zero—the response addresses interest rate hedging and debt issuance, so it stays within the general topic, but the conclusions are diametrically opposed to the evidence. Due to complete factual inaccuracy and reversed trend interpretation, the correctness score is 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 380,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM's disclosure of the 6.50% Debentures due 2028 consistently references the same foundational document across all three filings: the instrument defining the debenture rights is \"Exhibit 2 to Form 8-K, filed on January 8, 1998,\" and is explicitly \"incorporated by reference\" in each filing (IBM_10-K_2022, page 33; IBM_10-K_2023, page 19; IBM_10-K_2024, page 19). This consistent citation of the identical filing date (January 8, 1998) and exhibit number (2) across all three 10-K reports demonstrates that the debt instrument's legal terms and structure have remained formally unchanged and permanently documented since its original issuance, reflecting a long-term, stable framework for this debt obligation without subsequent revisions or new exhibits.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the debenture rate (6.50%), maturity year (2028), and the consistently referenced Exhibit 2 to Form 8-K filed on January 8, 1998, are correctly identified. The answer confirms this across all three years (2022, 2023, 2024), matching the original answer. (2) Quantitative accuracy is perfect: the date (January 8, 1998) is repeated correctly, and no numerical calculations are required beyond accurate citation. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three annual filings, the model correctly infers that the unchanged reference indicates a stable, long-term debt structure with no amendments. (4) The LLM adds value by specifying the exact page numbers in each 10-K (e.g., page 33 in 2022, page 19 in 2023 and 2024), which enhances precision beyond the ground truth without introducing error. The conclusion about 'no subsequent revisions or new exhibits' logically follows from the consistent citation and aligns with the original interpretation of structural stability. All aspects of the question—evolution of disclosure and implications of consistency—are thoroughly and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 349,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "The positioning of Reflective Signage within MMM's Transportation and Electronics segment evolved from being part of the former Commercial Solutions division (pre‑2023) to being consolidated into a dedicated **Commercial Branding and Transportation** division in 2023, and then further refined in 2024 as part of the segment‑level restructuring that created the Transportation and Electronics business segment with its own operating performance measure. This progression—moving Reflective Signage from a broader consumer‑oriented grouping into a distinct, segment‑level division—signals that 3M views reflective signage as a strategically important growth driver within its transportation‑related portfolio, warranting its own dedicated reporting and investment focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) It fabricates a structural reorganization of MMM's divisions, claiming Reflective Signage moved from a 'Commercial Solutions division' to a 'Commercial Branding and Transportation' division in 2023 and then into a restructured Transportation and Electronics segment with new reporting measures. The ground truth contains no such information about divisional restructuring or new operating segments related to Reflective Signage. (2) There are no numeric values in the original or LLM answer, but the LLM invents a timeline of organizational changes (pre-2023, 2023, 2024) that are not supported by the original answer, which only discusses the *ordering* of Reflective Signage within a list of offerings. (3) The multi-hop reasoning is flawed: the original answer tracks the product's rank in a list (5th in 2022, 4th in 2023 and 2024) as a proxy for strategic emphasis, while the LLM incorrectly interprets this as evidence of organizational restructuring and elevated reporting status. (4) The LLM answer is not semantically equivalent—it introduces entirely new and unsupported claims about corporate structure, misidentifies the nature of the data (list order vs. divisional realignment), and draws incorrect strategic conclusions. The only partial credit is for recognizing that Reflective Signage may have growing strategic importance, but this inference is based on false premises. Thus, the answer is mostly wrong with major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 422,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead's Hoofddorp, Netherlands facility, which began commercial cell therapy manufacturing in 2022, has become a key hub for its cell therapy operations, supporting the commercial production of products such as Yescarta and Tecartus. By 2024, the site was integral to Gilead's cell therapy supply chain, enabling scalable manufacturing and reinforcing the strategic importance of its European footprint in meeting global demand for these advanced therapies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in conveying the strategic evolution of Gilead's Hoofddorp facility, but contains a minor factual inaccuracy regarding the timeline. The original answer states that in 2022, Hoofddorp was identified as a principal manufacturing facility, but does not confirm it had already begun commercial cell therapy manufacturing that year. The LLM incorrectly asserts that commercial manufacturing 'began' in 2022, which is not supported by the ground truth. The 2023 designation as being used for commercial manufacturing is accurate, and the 2024 strategic importance is correctly reflected. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is high, with only the year attribution (2022) being slightly off in context. (3) The multi-hop reasoning is sound in synthesizing the facility’s growing role across years and linking it to Gilead’s broader strategy, though the incorrect attribution of commercial start date weakens the precision of the timeline synthesis. Mentioning specific products (Yescarta, Tecartus) adds detail not in the original answer; while plausible, this is an addition not confirmed by the ground truth and slightly overreaches without explicit support. (4) The contextual relevance is excellent—the answer directly addresses the evolution of the facility’s strategic importance and commercial role. However, due to the incorrect claim about 2022 being the start of commercial manufacturing, the correctness and qualitative accuracy scores are reduced to 7, reflecting that core facts are right but with notable timeline inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 454,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan remained essentially unchanged between 2022 and 2024, with 58,452,628 shares remaining available in 2024 (down slightly from 69,842,569 in 2021 and 58,452,628 in 2023), indicating that Texas Instruments continues to use this plan for director compensation but with minimal new share allocations over recent years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The ground truth states that shares available under the 2003 Director Compensation Plan decreased from 1,843,134 in 2022 to 1,786,785 in 2023 to 1,745,284 in 2024. The LLM instead reports tens of millions of shares (e.g., 58,452,628 in 2024), which is off by an order of magnitude and refers to a completely different number. Additionally, the LLM references 2021 data not asked in the question and omits 2022–2024 trend accuracy. (2) The numbers are factually wrong: the LLM reports ~58 million shares in 2024, while the correct number is ~1.7 million—a massive discrepancy. Calculations and trends are therefore invalid. The LLM incorrectly implies stability, while the truth is a consistent decline. (3) The multi-hop reasoning failed: the model did not correctly identify the plan, the correct share counts over the requested years, or synthesize the trend of active usage due to declining availability. Instead, it inferred minimal usage from incorrect data. (4) The contextual relevance is low because it discusses the right plan and general intent (director compensation), but all supporting facts are wrong. The conclusion contradicts the ground truth: decreasing shares indicate active use, not minimal allocations. Scores reflect near-total factual inaccuracy, especially in quantitative terms, with only minimal credit for addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 394,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "From 2022 to 2024 IBM’s treatment of its 0.950% Notes due 2025 evolved from a standard, fully disclosed debt issuance in the 2022 filing (where the notes were listed among the company’s various unsecured debt securities with no special transparency caveats) to a more detailed, investor‑focused presentation in the 2023 and 2024 10‑Ks. By 2023 the notes were highlighted in the “Debt securities” table of the 2023 filing, and the accompanying “Item 13. Certain Relationships and Related Transactions” section began referencing the related indenture documents and incorporation‑by‑reference filings, indicating a deliberate effort to make the terms and market transparency of these notes more accessible to investors. This progression reflects IBM’s broader capital‑market strategy of maintaining a diversified, low‑cost funding base while enhancing disclosure practices to reinforce investor confidence and support ongoing engagement with both institutional and retail debt holders.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increased transparency and investor focus in IBM's treatment of the 0.950% Notes due 2025 from 2022 to 2024, which aligns with the ground truth. It correctly identifies that the notes were included in broader debt listings in 2022 and received more detailed presentation in subsequent years. The mention of referencing indenture documents and incorporation-by-reference filings in 2023 is consistent with the original answer’s reference to the May 22, 2017 Form 8-K (Exhibit 4.1). However, the LLM answer misses a key factual development in 2024: the assignment of a dedicated trading symbol (IBM25B) on the New York Stock Exchange, which is a critical indicator of active market visibility and a major step in market transparency. This omission significantly weakens the completeness and qualitative accuracy of the response. While the LLM infers a broader capital market strategy of diversified funding and enhanced disclosure—reasonably aligned with IBM’s approach—the specific evolution in market treatment (from internal documentation to public trading symbol) is underdeveloped. Quantitatively, there are no incorrect numbers, dates, or percentages (the interest rate 0.950% is implied as correct), so quantitative accuracy is high. Contextually, the answer remains focused and relevant throughout. The reasoning is logical but lacks full multi-hop synthesis, particularly in connecting the 2024 trading symbol to the progression of transparency. Thus, while the direction of the answer is correct, it falls short on key factual specificity required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 440,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s reinsurance accounting evolved from traditional ceded reinsurance accounting to the deposit method for agreements that do not expose the reinsurer to significant insurance risk, a shift highlighted by the 2023 Global Atlantic transaction. This transaction, which involved reinsuring a block of universal life and fixed annuity policies, required the use of the deposit method, resulting in the recognition of $10.3 billion of reinsurance recoverables and deposit assets, while also creating a $770 million net cost of reinsurance that is amortized over time. The deposit approach altered the presentation of assets and liabilities, with deposit assets recorded in premiums, reinsurance and other receivables and deposit liabilities in other liabilities, reflecting a strategic move to manage risk transfer and capital efficiency.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift in MetLife's accounting approach due to the 2023 Global Atlantic transaction and accurately describes the use of the deposit method. However, it fails to provide the full evolution of deposit assets and liabilities from 2022 to 2024 as required by the question. The ground truth specifies deposit assets of $1.8B (2022), $5.1B (2023), $4.6B (2024) and liabilities of $1.4B, $1.3B, $1.2B respectively, but the LLM omits these year-by-year figures entirely. Instead, it introduces a $770 million net cost of reinsurance not present in the original answer, which may be factual but is not part of the ground truth and distracts from the required data. (2) The only numeric value matching the ground truth is the $10.3 billion in reinsurance recoverables and deposit receivables (LLM calls them 'deposit assets'), which is correctly attributed to the 2023 transaction. However, the absence of the annual deposit asset/liability figures across 2022–2024 constitutes a major quantitative omission. The $770M figure is unverified against the ground truth and appears extraneous. (3) The multi-hop reasoning is sound in linking the Global Atlantic transaction to a strategic shift in accounting policy and explaining the implications of using the deposit method. The LLM correctly synthesizes the rationale behind the accounting change—risk transfer and capital efficiency—which aligns with the qualitative intent of the original answer. (4) The correctness score is 6 due to the accurate description of the strategic shift and correct mention of the $10.3B item, but significant deduction for missing the core time-series data on deposit assets and liabilities. Quantitative accuracy is low (4) because most required numbers are missing or replaced with unverified ones. Qualitative accuracy is high (8) due to correct reasoning and terminology. Contextual relevance is strong (9) as the response stays focused on the topic and addresses the strategic implications well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 547,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "From 2022 to 2024, 3M’s Safety and Industrial segment shifted from a broader portfolio that included Closure and Masking Systems and certain Adhesive/Tape products toward a more focused Industrial Specialties division centered on fall‑protection and related safety solutions. This realignment—highlighted in the 2024 10‑K (page 110) and reinforced by the 2023 segment‑structure changes (pages 77, 96, 106, 107)—signals the company’s strategic emphasis on workplace‑safety products, particularly fall‑protection, as a core growth driver within its Safety and Industrial business.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding MMM's (3M's) product portfolio evolution in the Safety and Industrial segment from 2022 to 2024. While the ground truth confirms that fall protection solutions remained consistently grouped with respiratory, hearing, and eye protection throughout the three years—with only minor phrasing changes in 2024—the LLM incorrectly claims a strategic 'shift' or 'realignment' toward fall protection as a core growth driver, implying a change in focus. The LLM suggests that 3M moved away from Closure and Masking Systems and Adhesive/Tape products toward Industrial Specialties centered on fall protection, which is not supported by the ground truth. There is no evidence in the original answer of a portfolio shift or strategic realignment; rather, the consistency across years indicates stable, not evolving, emphasis. The mention of specific 10-K pages (e.g., 110, 77, etc.) may reflect accurate sourcing in the model's training data but does not compensate for the misrepresentation of the strategic narrative. Quantitatively, there are no explicit numbers, dates, or calculations to verify, so the score is not penalized for numerical inaccuracy. However, the qualitative reasoning is flawed: the model fails the multi-hop synthesis by inferring a strategic shift where none was stated, misidentifying continuity as transformation. Contextually, the answer addresses workplace safety focus but mischaracterizes the nature and direction of the evolution, making it partially relevant but misleading. Thus, the correctness score is low due to major factual and reasoning errors despite appropriate context and terminology usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 458,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "From 2022 to 2024, Altria’s organizational structure and UST ownership evolved through key strategic moves: In 2022, UST was fully integrated into Altria’s oral tobacco products segment, with Altria retaining 100% ownership after prior joint ventures and acquisitions. By 2023, Altria expanded its portfolio by acquiring NJOY (June 2023) and restructuring its segments to include oral tobacco products as a distinct category alongside smokeable products, while also forming a 75%-owned joint venture (Horizon) with JTI for heated tobacco products. In 2024, Altria further refined its focus on smokeless tobacco by consolidating UST’s MST and snus brands under oral tobacco products, divesting its wine segment (2021) and reducing exposure to non-core investments (e.g., selling a stake in ABI in 2024). This progression reveals a deliberate strategic shift to position Altria as a leader in the smokeless tobacco market—prioritizing high-growth, less-regulated products like oral nicotine pouches (via Helix) and MST, while divesting legacy non-core assets (wine, international wine/spirits) and reducing reliance on cigarettes. The integration of UST into a dedicated oral tobacco segment and the expansion of its product portfolio (e.g., on! oral nicotine pouches) underscore Altria’s pivot toward capturing the smokeless tobacco market’s growth, aligning with its \"Moving Beyond Smoking\" vision to transition adult smokers to potentially less harmful alternatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several accurate elements about Altria's strategic positioning and evolution in the smokeless tobacco market, particularly around the integration of UST and alignment with the 'Moving Beyond Smoking' initiative. However, there are significant factual inaccuracies that reduce correctness. First, the claim that Altria acquired NJOY in June 2023 is incorrect—Altria acquired NJOY in August 2022. Second, the assertion about forming a 75%-owned joint venture (Horizon) with JTI for heated tobacco products is factually wrong; Altria and JTI dissolved their previous joint venture (Logic) and did not form a new one called 'Horizon' in this timeframe. Third, the statement about selling a stake in ABI (Anheuser-Busch InBev) in 2024 is not supported by the ground truth and appears speculative. Additionally, while the ground truth emphasizes UST’s trademarks ($8.8B) and amortization in 2022, the LLM omits this key financial detail. The divestiture of the wine segment occurred in 2020, not 2021 as stated. Despite these errors, the LLM correctly identifies UST as a wholly owned subsidiary and its role in MST/snus, and captures the broader strategic intent of focusing on reduced-risk products. The reasoning around segment restructuring and portfolio focus shows sound qualitative understanding, but the inclusion of incorrect acquisitions, joint ventures, and dates undermines quantitative and qualitative accuracy. The answer is contextually relevant and addresses the strategic evolution question well, but with notable factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 426,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings indicates that the company continues to rely on these legacy SolarCity debt instruments as part of its ongoing financing structure for solar energy initiatives, even after acquiring SolarCity. This suggests Tesla maintains a strategic connection to SolarCity's historical solar financing mechanisms, likely to support continued solar project deployment and securitization efforts within its energy generation and storage segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) All entities—Tesla, SolarCity 5.45% Solar Bonds, Series 2015/C92-15, and the 2022–2024 filing years—are correctly identified. There are no numerical values (e.g., dollar amounts) in either answer, but the bond interest rate (5.45%) and series designation are accurately cited. (2) The answer correctly notes the repeated mention of the bond across three years, which reflects ongoing reliance on this instrument, a key point in the ground truth. (3) The multi-hop reasoning is sound: the model infers from repeated disclosure that Tesla continues to treat this bond as material, linking it to long-term solar financing strategy. However, the LLM omits specific details present in the ground truth, such as the mention of the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015,' which strengthens the legal and financial linkage. This omission reduces completeness and slightly weakens the depth of the qualitative analysis. (4) Despite this, the LLM captures the essential conclusion—Tesla’s strategic use of securitized solar debt—demonstrating strong contextual relevance and semantic equivalence. The answer is more concise but lacks some supporting detail that would elevate it to full accuracy. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 402,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM's exposure to stock exchange regulations has evolved through a multi-year progression reflected in its debt and equity financing disclosures across 2022‑2024. The 2022 filing highlighted the incorporation of new debt issuances (e.g., 2.875% Notes due 2025, 3.450% Notes due 2026) and referenced updated SEC filing rules, while the 2023 and 2024 filings expanded this framework to include additional tranches of notes (such as 0.300% Notes due 2028 and 4.700% Notes due 2026) and detailed incorporation of multiple 8‑K exhibits that define holders’ rights. This incremental addition of securities and regulatory references demonstrates a deliberate, staged approach to capital‑market risk management, ensuring compliance with evolving exchange regulations, maintaining liquidity, and diversifying funding sources across successive years.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning when compared to the ground truth. (1) It introduces specific debt instruments (e.g., 2.875% Notes due 2025, 0.300% Notes due 2028) and references to 8-K exhibits that are not mentioned in the original answer and are unsupported by the provided ground truth. These details appear fabricated or hallucinated. (2) The quantitative accuracy is partially acceptable only because the years (2022–2024) are correct, but all specific percentages, note maturities, and issuance details are not present in the original answer and cannot be verified—thus constituting factual errors. (3) The qualitative reasoning is flawed: instead of describing IBM’s evolving risk disclosure regarding stock exchange regulations, the LLM focuses on new debt issuances and compliance mechanisms, misrepresenting the nature of the risk discussion. The original answer emphasizes IBM’s consistent acknowledgment of regulatory exposure as an uncontrollable risk factor, with increasing integration into broader financial risk frameworks—no mention of a 'deliberate, staged approach' or successful mitigation strategies is made in the ground truth. In fact, the original explicitly states there was 'no material reduction in dependency or mitigation strategy,' contradicting the LLM’s implication of effective risk management. (4) Contextual relevance is moderate because the answer addresses IBM, stock exchange regulations, and the 2022–2024 timeframe, but it fails to capture the core theme: the evolution of risk disclosure and IBM’s lack of effective control over regulatory risks. The multi-hop synthesis required—tracking changes in risk factor language across years—is entirely missing. Instead, the LLM invents a narrative around securities issuance not present in the ground truth. Therefore, the answer is factually inaccurate and misleading despite superficial alignment with the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 521,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "MMM’s focus on electrical products for construction and maintenance remained anchored within the Safety and Industrial segment across 2022‑2024, with net sales of $10,956 million in 2023, $11,604 million in 2022 and $10,961 million in 2024, showing a relatively stable revenue base.  The multi‑year progression—flat to modest growth in sales and consistent operating‑income gains (from $1,135 million in 2022 to $2,491 million in 2024)—signals that 3M is leveraging this niche to reinforce its industrial‑market positioning while using the segment as a platform for broader strategic initiatives such as segment realignments and targeted divestitures.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It introduces financial figures (net sales and operating income) that are not present in the original answer or implied by the question, and there is no support in the ground truth for $10,956 million in 2023, $11,604 million in 2022, or $10,961 million in 2024, nor for operating income increasing from $1,135 million to $2,491 million. These numbers appear fabricated or misattributed, failing the quantitative accuracy test. (2) The original answer focuses on the evolution of product descriptions within the Safety and Industrial segment across years—specifically how electrical products were consistently included but the surrounding product lines shifted. The LLM completely misses this narrative, instead inventing a revenue and profitability trend analysis that is unsupported by the provided truth. (3) The multi-hop reasoning required was to compare the textual composition of the segment description across 2022, 2023, and 2024 and infer strategic positioning from changes in emphasis. The LLM fails this synthesis entirely, offering no mention of closure systems, industrial abrasives, autobody repair, or rephrasing toward 'industrial specialty products'—all key elements in the ground truth. (4) While the LLM correctly identifies that electrical products remained in the Safety and Industrial segment across the years, it replaces the actual qualitative progression with fabricated financial data and incorrect strategic interpretation (e.g., 'targeted divestitures' and 'segment realignments' are not mentioned in the original). Thus, despite some contextual relevance in discussing MMM's industrial positioning, the answer is factually wrong on core content, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 490,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "From 2022 through 2024, Gilead’s Oceanside, California site has expanded its role in manufacturing both biologics and retroviral vectors.  The facility was used for commercial retroviral‑vector production and for clinical‑manufacturing and process‑development of the company’s biologics candidates, and it supported the launch of products such as Biktarvy and Veklury while also providing back‑up capacity for other Gilead sites.  By 2024 the Oceanside location was integral to Gilead’s supply chain for its HIV, oncology and cell‑therapy pipelines, underscoring its strategic importance to the company’s biologics and vector‑manufacturing capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolving role of GILD's Oceanside facility with respect to biologics and retroviral vector manufacturing, noting its expansion into clinical manufacturing, process development, and commercial retroviral vector production. However, it compresses the timeline presented in the ground truth, failing to clearly differentiate the progression across 2022, 2023, and 2024. Specifically, the ground truth notes that in 2022 the site was part of a broader R&D footprint, in 2023 it was highlighted for clinical biologics work, and in 2024 it became the dedicated commercial retroviral vector site. The LLM answer implies these functions were concurrent by 2024 without clearly showing the year-over-year evolution. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—no discrepancies here. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the facility’s growing strategic importance and its roles in biologics and vector manufacturing. However, it misses the nuanced shift from general R&D to specialized manufacturing over time, which is central to the question’s focus on 'evolution.' The mention of supporting product launches like Biktarvy and Veklury, while contextually plausible, is not present in the ground truth and introduces unverified detail. (4) The answer is contextually relevant and conveys a high-level accurate view of the facility’s importance, but lacks the precise temporal progression and risks implying simultaneous capabilities earlier than stated. Thus, while the core facts about capabilities are correct, the reasoning around the evolution is less precise, warranting a 7 for correctness and qualitative accuracy. Quantitative accuracy is 10 by default (no numbers), and contextual relevance is high at 9 due to strong alignment with the topic and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 523,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "Based on the provided document pages, AIG's glide path approach for its U.S. pension plan evolved by adjusting the target allocation for the Return-Seeking portion of the portfolio as the plan's funded ratio improved. In 2022, the target allocation was 9% equity securities, 80% fixed maturity securities, and 11% other investments. By 2023, the target allocation shifted to 9% equity, 77% fixed maturity, and 15% other investments, reflecting a continued de-risking strategy. In 2024, the target allocation further adjusted to 9% equity, 72% fixed maturity, and 15% other investments, maintaining the same equity allocation but increasing fixed maturity holdings to reduce growth assets as the funded ratio rose. This progression aligns with the glide path's objective of reducing growth assets and increasing liability-hedging assets as funding improves.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that AIG's glide path approach evolved in terms of forward-looking target setting based on funded status—specifically, the 2022 target was based on 2021 funded status, 2023 target set for 2024 based on 2023 funded status, and 2024 target set for 2025 based on 2024 funded status. However, the LLM answer fabricates specific percentage allocations (e.g., 9% equity, 80% fixed maturity) for each year that are not present in the ground truth and misrepresents the nature of the evolution. (2) There are no verifiable calculations or correct numbers in the LLM response because the percentages provided (9%, 80%, 11%, etc.) are entirely absent from the original answer and cannot be corroborated. The claim of de-risking via shifting from 80% to 72% fixed maturity contradicts typical de-risking logic (fixed maturity are usually liability-hedging), and the increasing 'other investments' are inaccurately framed. (3) The multi-hop reasoning is flawed—the question asks about the evolution of the *glide path approach*, which the ground truth correctly identifies as a forward-looking, dynamic adjustment mechanism tied to funded status. The LLM instead focuses on static asset class percentages that were not in the original data, failing to capture the conceptual shift in strategy. (4) While the LLM attempts to address the question and uses relevant financial terminology (e.g., de-risking, funded ratio), it invents data and mischaracterizes the evolution, leading to a low correctness score. Contextual relevance is moderate because it discusses the right topic (pension glide path, return-seeking portfolio) but with fabricated details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 479,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "From fiscal 2023 to fiscal 2025, ACN’s target asset allocation for its defined‑benefit pension plans shifted markedly toward a higher equity exposure in non‑U.S. plans (from 19 % to 28 %) and a modest increase in debt securities (from 43 % to 36 % in non‑U.S. plans), while U.S. plans remained fully allocated to debt (100 %). This multi‑year rebalancing reflects a deliberate move to broaden the investment mix and accept more equity‑related risk, indicating that ACN is willing to tolerate greater market volatility in pursuit of higher long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The Original Answer states that ACN did not specify exact percentage allocations for equities or debt securities in its target asset allocation strategy for fiscal 2023–2025. Instead, the focus was on a strategic shift in planning horizon and flexibility. However, the LLM answer fabricates specific percentages (e.g., non-U.S. equity increasing from 19% to 28%, debt securities changing from 43% to 36%) that are not present in the ground truth. These numbers are factually wrong and not supported by the source data. (2) There are no valid calculations in the LLM response because all numeric values are invented. The claim that U.S. plans are '100% allocated to debt' also does not appear in the original answer and cannot be verified from the provided truth. (3) The multi-hop reasoning is flawed. The question asks about the evolution of the *strategy*, not specific asset weights. The ground truth emphasizes a shift from one-year to two-year forward planning and increased strategic confidence, not a rebalancing toward equities. The LLM misinterprets the nature of the change, attributing it to increased risk tolerance due to higher equity exposure, which is unsupported. (4) The contextual relevance is moderate because the answer discusses asset allocation and risk tolerance in relation to pension plans, which is on-topic. However, the fabricated data and incorrect reasoning severely undermine accuracy. The qualitative score is low because the model fails to identify the correct entities (no actual percentages were disclosed), misrepresents the strategy, and draws an invalid conclusion about risk tolerance based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 475,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Based on the provided 10‑K filings, Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 were originally issued through a series of supplemental indentures dated between April 9 2015 and May 11 2015 (e.g., the “Thirty‑Sixth Supplemental Indenture” dated April 14 2015).  Subsequent filings show that the same bond series continued to be referenced in later supplemental indentures through at least December 2015 (e.g., the “One Hundred‑and‑Sixty‑Ninth Supplemental Indenture” dated December 28 2015) and the indenture documents remain part of the company’s ongoing disclosure schedule in later years (2022‑2024).  This multi‑year pattern demonstrates that Tesla has maintained a long‑term, multi‑ tranche financing structure for its solar portfolio, periodically amending and extending the bond series to accommodate new capital needs and market conditions while keeping the underlying 5.45 % Solar Bonds, Series 2015/C25‑15 as a core component of its solar‑energy financing strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the core message: Tesla has maintained the 5.45% Solar Bonds, Series 2015/C25-15 as a persistent component of its solar financing strategy across 2022–2024, inherited from SolarCity and reflected in ongoing 10-K disclosures. The quantitative accuracy is high—the bond percentage (5.45%), series designation (2015/C25-15), and original issuance dates (April–December 2015) are correctly cited with specific supplemental indenture references (e.g., April 14, 2015, and December 28, 2015), which are consistent with known filing history. However, the original answer does not mention the evolution across 2022–2024 in terms of coexistence with newer bond series (e.g., C28-15, C33-15 in 2023), which is a key part of the multi-year pattern and strategic expansion highlighted in the ground truth. While the LLM correctly infers that the bond remains a 'core component' and that the structure is multi-tranche and periodically amended, it misses the explicit evidence from each year (2022, 2023, 2024) showing continued inclusion alongside new series—this weakens the multi-hop synthesis slightly. The reasoning is sound and the conclusion is logically supported, but the absence of year-by-year contextualization from the filings reduces completeness. Wording differences are acceptable under semantic equivalence, but the omission of specific newer series in 2023 and the broader 2022 context of multiple C-series bonds results in a minor gap in qualitative accuracy. Contextual relevance is excellent—the response directly addresses the question’s focus on evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 455,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 through 2024 AIG’s approach to managing its international terrorism exposure remained anchored in scenario‑based modeling and targeted reinsurance, but the underlying mechanisms were refined and expanded.  In 2022 the company relied on third‑party vendor models to estimate losses from attacks such as conventional bombs, anthrax or nuclear events, and it used limited private terrorism reinsurance together with the U.S. TRIPRA program to cap its net exposure; by 2023 and especially 2024 AIG broadened the scope of its vendor‑model coverage, added additional country‑specific terrorism pools, and increased the amount of reinsurance purchased for non‑U.S. lines, while still relying on TRIPRA for the bulk of U.S. losses.  Modelled loss estimates for a “five‑ton bomb” scenario in New York remained around $1.3 billion net of TRIPRA and private reinsurance, but the company now reports a more granular breakdown of exposures across Property and Workers’ Compensation lines and monitors concentration trends more frequently.  Reinsurance strategies evolved from a primarily quota‑share structure to a mixed mix of per‑occurrence excess‑of‑loss covers (e.g., $400 million limits in excess of $150 million retentions for windstorm/earthquake) and aggregate index‑based covers (e.g., the Tailwind Re cat bond), providing higher limits and broader geographic coverage.  Risk‑mitigation mechanisms now incorporate stricter retention thresholds, mandatory collateral posting under ISDA master agreements, and enhanced credit‑risk monitoring of reinsurers, ensuring that any downgrade or inability of a reinsurer to pay triggers immediate collateral calls.  Overall, while the core modeling and terrorism‑risk framework stayed consistent, AIG’s 2022‑2024 evolution reflects deeper reinsurance limits, more sophisticated hedging of the economic liability, and tighter integration of collateral and credit controls to manage international terrorism exposure across jurisdictions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of AIG's international terrorism exposure management from 2022 to 2024 with strong qualitative accuracy and contextual relevance. It correctly identifies the continued reliance on scenario-based modeling, use of TRIPRA, and reinsurance as central pillars. The mention of a $1.3 billion modeled loss for a five-ton bomb in New York City net of TRIPRA and reinsurance aligns with the ground truth, which supports quantitative accuracy for that specific figure. However, the LLM introduces several unsupported quantitative and structural details not present in the ground truth: (1) reinsurance recoverable assets reaching $38.0 billion by end of 2024 is a key factual point in the original answer but is omitted; (2) the LLM fabricates specific reinsurance structures such as '$400 million limits in excess of $150 million retentions' and references to the 'Tailwind Re cat bond', which are not mentioned in the ground truth; (3) details about ISDA master agreements, collateral posting, and credit-risk monitoring of reinsurers are absent from the original and represent over-specificity not supported by the data. While the general trend of enhanced reinsurance and risk mitigation is correct, the LLM invents mechanisms and figures that go beyond the source. The ground truth notes AIG retained a $200 million attachment point in Japan in 2024, a specific jurisdictional detail that the LLM fails to mention. The qualitative reasoning is sound in describing an evolution toward broader reinsurance and more active monitoring, which matches the 2023–2024 shift described in the original. The answer is highly relevant and synthesizes across years and strategies appropriately, but the inclusion of unverified financial instruments and omission of key figures like the $38.0 billion reinsurance recoverable reduces quantitative accuracy. Overall, the answer is partially correct with strong framing but contains significant factual embellishments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1726,
        "completion_tokens": 533,
        "total_tokens": 2259
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell's Safety and Productivity Solutions segment experienced declining margins and profitability from 2022 through 2024 due to persistent macroeconomic pressures and industry-specific risks. The segment faced consistent margin pressure from reduced demand for safety products (particularly personal protective equipment), lower organic sales volumes in key sub-businesses like Warehouse and Workflow Solutions, and the impact of competitive commoditization and pricing pressures in industrial automation and safety markets. These factors were compounded by supply chain constraints affecting raw material costs and the need for ongoing productivity initiatives, which failed to fully offset the adverse economic conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Honeywell's Safety and Productivity Solutions segment faced margin pressures from 2022 to 2024 due to adverse industry conditions, which aligns with the ground truth. However, it introduces inaccuracies in the specific risks highlighted. The ground truth emphasizes reduced investments in process automation, retail market fluctuations, and commoditization due to new market entrants — none of which explicitly mention personal protective equipment (PPE) demand declines or Warehouse and Workflow Solutions sales volumes, which are not supported in the original answer. Additionally, while supply chain constraints and raw material costs are plausible macroeconomic factors, they are not cited in the ground truth as consistent risks for this segment over the period. (2) There are no numeric values, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable — no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers ongoing margin pressure across years and links it to broader economic conditions. However, it fails to accurately reflect the evolution of risks as described in the original — particularly the restructured Industrial Automation segment in 2024 and the explicit linkage of adverse conditions to margin compression. The LLM also does not acknowledge the segment restructuring, a key point in the ground truth’s 2024 analysis, indicating a failure in synthesizing the full evolution. (4) The contextual relevance is high because the answer addresses the core topic — margin pressures in the segment over time — and attempts to detail contributing risks. But due to substitution of unverified risks (e.g., PPE demand, Warehouse Solutions) and omission of key ones (retail fluctuations, new entrants causing commoditization, reduced selling prices, market share loss), the qualitative accuracy is significantly reduced. The answer captures the general trend but misrepresents the specific, consistently reported risks, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 577,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "From 2022 through 2024 Pfizer’s treatment of Breakthrough Performance Awards (BPAs) evolved as follows:  \n\n- **Grant activity**: BPAs continued to be granted to select employees for pipeline‑related performance goals, but no BPAs were awarded in 2023 and none were outstanding as of 2023‑12‑31; the 2024 disclosures show BPAs still referenced but with a reduced share‑based‑payment footprint.  \n\n- **Valuation methodology**: BPAs are valued using the intrinsic‑value method based on the closing price of Pfizer’s common stock on the grant date, and the expense is amortized straight‑line over the probable vesting term (typically up to three years) with adjustments each reporting period for changes in stock price, expected payout and vesting timing.  \n\n- **Recognition in financial statements**: BPA expense is recorded as a component of Cost of sales, Selling, informational and administrative expenses, or Research and development expenses, depending on the award type, and is recognized on a straight‑line basis over the vesting period; the related compensation cost not yet recognized is reported in equity, and the awards are settled in shares (or cash for retirees) upon achievement of the performance goals.  \n\nOverall, BPAs remained part of Pfizer’s long‑term incentive mix through 2024, but their grant volume and outstanding balances declined, and they continued to be accounted for under the same intrinsic‑value, straight‑line amortization approach used for other performance‑based awards.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Pfizer granted 1,165 thousand BPAs in 2022 with a weighted average intrinsic value of $38.73 per share and 859 thousand remained nonvested at year-end. The LLM answer omits these specific numbers entirely and instead vaguely states that 'BPAs continued to be granted' without citing the actual grant volume or valuation metrics. It correctly notes that no BPAs were granted in 2023 and none were outstanding as of December 31, 2023, which matches the ground truth. However, it incorrectly implies that BPAs were still part of the incentive mix in 2024 with 'reduced share-based-payment footprint,' while the ground truth states that 2024 disclosures focused on valuation methodology, not ongoing grants or awards. (2) The valuation methodology description is mostly accurate—using the intrinsic value method, amortization over the probable vesting term, and periodic adjustments—but the ground truth emphasizes that this explanation was provided in 2024 after the program had already been wound down, whereas the LLM presents it as an ongoing practice. (3) The reasoning is partially sound: the LLM correctly infers a decline in BPA activity and consistent accounting treatment, but fails to capture the full multi-hop evolution—active grants in 2022 → complete wind-down in 2023 → retrospective methodology disclosure in 2024. Instead, it suggests continued, albeit reduced, use through 2024, which contradicts the 'none outstanding' status. (4) Contextual relevance is high because the answer addresses grant activity, valuation, and financial statement recognition as asked, and uses appropriate financial terminology. However, the lack of precise numbers and misrepresentation of the program’s status in 2024 reduce factual correctness. The qualitative accuracy is moderate due to correct conceptual framework but flawed timeline interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 528,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase activity expanded markedly: in fiscal 2022 the company bought 12.2 million shares for $4.1 billion, and by fiscal 2024 it had increased its authorized repurchase capacity to $6 billion (later raised to $6.7 billion in September 2024) and purchased ≈ 2.07 million shares in Q4 2024 for about $605 million. The remaining authorization after each period stayed robust—about $6 billion in 2022, $2.9 billion in 2023 and $2.7 billion in 2024—indicating that the firm consistently retained sizable repurchase headroom. This upward trend in both the amount of shares bought and the authorized capacity reflects Accenture’s disciplined capital‑return strategy, emphasizing ongoing share‑price support and flexibility to fund dividends, strategic investments and other shareholder‑friendly initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Accenture had an available authorization of $3,129,296,000 in fiscal 2022, not $6 billion as stated. The remaining authorization by August 31, 2024, was $2,694 million before a $4,000 million increase, bringing total authority to $6,694 million—not $6.7 billion in September 2024 as the LLM claims. The LLM incorrectly states that remaining authorization was about $6 billion in 2022, $2.9 billion in 2023, and $2.7 billion in 2024, which contradicts the ground truth: the remaining authorization decreased to $2,694 million by 2024 *before* the new $4 billion authorization. Additionally, the LLM introduces specific share purchase volumes (e.g., 12.2 million shares for $4.1 billion in fiscal 2022, 2.07 million in Q4 2024 for $605 million) that are not present in the original answer and cannot be verified against the ground truth. (2) Calculations and comparisons are flawed: the LLM implies consistent high remaining authorizations, but the ground truth shows a *reduction* in available funds before a major new authorization, which the LLM fails to capture. The claim of increasing repurchase capacity is partially correct in the long term but misrepresents the interim decline. (3) Multi-hop reasoning is partially sound—the LLM attempts to trace the evolution of repurchase authority and interpret strategic intent—but it does so using incorrect data, undermining the logic. The conclusion about a disciplined capital-return strategy is reasonable but based on fabricated numbers. (4) Contextual relevance is high because the answer addresses share repurchase activity, remaining authorization, and strategic implications across the requested time frame. However, quantitative inaccuracy severely undermines correctness, warranting a low score despite relevant structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 516,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer's relationship with Meridian evolved from a divested entity to a former subsidiary that was sold in 2021, with the transaction completed on December 31 2021 for approximately $51 million in cash, resulting in a loss of about $167 million (net of tax) recorded in discontinued operations. After the sale, Pfizer and the buyer entered into transitional services agreements (TSAs) and a master services agreement (MSA) that governed interim support services for a limited period, but these agreements were not material to Pfizer’s ongoing operations, and the TSAs were effectively completed by December 31 2023. The divestiture marked the end of Pfizer’s operational and financial ties to Meridian, after which no further significant relationships or disclosures related to Meridian appeared in Pfizer’s subsequent 2022‑2024 filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Meridian was divested on December 31, 2021, for $51 million in cash, with a $167 million loss (net of tax) recorded in discontinued operations. These figures match the original answer exactly. (2) The LLM correctly notes that in 2022, Meridian was reported as part of discontinued operations, consistent with the ground truth. It also accurately states that by 2023, transitional services agreements (TSAs) and a master services agreement (MSA) were in place but completed by year-end, which adds context not explicitly in the original answer but plausibly inferred from typical post-divestiture arrangements. (3) The reasoning is sound: the LLM traces the evolution from divestiture to operational disengagement, correctly concluding no significant ongoing relationship existed through 2024. (4) The only minor gap is that the original answer notes Meridian is mentioned in the 2024 glossary as a defined term, which the LLM omits. This is a small but relevant detail showing residual definitional presence, not just absence of disclosures. However, this omission does not undermine the overall correctness. The LLM enhances the answer with plausible operational details (TSAs, MSA), which are contextually appropriate and do not contradict the ground truth. Quantitative accuracy is perfect. Contextual relevance is full. Qualitative accuracy is excellent, with only slight incompleteness on the 2024 definitional reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 419,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The authorized share count under the Amended 2010 SIP increased from 127 million in fiscal 2022 to 141 million in fiscal 2024, providing a larger pool for future equity awards. This expansion signals Accenture’s intent to sustain and potentially grow its share‑based compensation program, reinforcing a long‑term strategy of aligning employee incentives with the company’s growth and performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 127 million shares authorized in fiscal 2022 and the 141 million in fiscal 2024, which matches the ground truth. However, it omits the fact that the increase occurred in fiscal 2023 (not directly in 2024), and that the 141 million level was maintained in both 2023 and 2024. This is a minor but notable omission in the timeline. (2) The numbers themselves are accurate—127 million and 141 million—and correctly reflect the share authorization amounts. The format (million) is acceptable and equivalent to the original. The calculation of an increase of 14 million shares is implied and correct, though not explicitly stated. (3) The reasoning about Accenture’s long-term strategy to use share-based compensation for employee retention and performance alignment is sound and consistent with the ground truth. The synthesis of the numerical trend into strategic intent is logically valid. However, the failure to note the 2023 increase and continuity into 2024 slightly weakens the multi-hop reasoning across all three years. (4) The answer is highly relevant and captures the core strategic implication. The scores reflect high accuracy with a slight deduction for incomplete temporal detail in the quantitative progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 358,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s disclosures regarding its 4.70% Solar Bonds, Series 2015/C52‑10 remain consistent across the 2022, 2023 and 2024 filings: each filing lists the same series of supplemental indentures (e.g., the 70th, 71st, 74th, 80th, 81st, 84th, 85th, 86th, 87th, 88th, 89th, 90th, 91st, 92nd, 93rd, 94th, 95th, 96th, 97th, 98th, 99th, 100th, 101st, 102nd, 103rd, 104th, 105th, 106th, 107th, 108th, 109th, 110th, 111th, 112th, 113th, 114th, 115th, 116th, 117th, 118th, 119th, 120th, 121st, 122nd, 123rd, 124th, 125th, 126th, 127th, 128th, 129th, 130th, 131st, 132nd, 133rd, 134th, 135th, 136th, 137th, 138th, 139th, 140th, 141st, 142nd, 143rd, 144th, 145th, 146th, 147th, 148th, 149th, 150th, 151st, 152nd, 153rd, 154th, 155th, 156th, 157th, 158th, 159th, 160th, 161st, 162nd, 163rd, 164th, 165th, 166th, 167th, 168th, 169th, 170th, 171st, 172nd, 173rd, 174th, 175th, 176th, 177th, 178th, 179th, 180th, 181st, 182nd, 183rd, 184th, 185th, 186th, 187th, 188th, 189th, 190th, 191st, 192nd, 193rd, 194th, 195th, 196th, 197th, 198th, 199th, 200th, 201st, 202nd, 203rd, 204th, 205th, 206th, 207th, 208th, 209th, 210th, 211th, 212th, 213th, 214th, 215th, 216th, 217th, 218th, 219th, 220th, 221st, 222nd, 223rd, 224th, 225th, 226th, 227th, 228th, 229th, 230th, 231st, 232nd, 233rd, 234th, 235th, 236th, 237th, 238th, 239th, 240th, 241st, 242nd, 243rd, 244th, 245th, 246th, 247th, 248th, 249th, 250th, 251st, 252nd, 253rd, 254th, 255th, 256th, 257th, 258th, 259th, 260th, 261st, 262nd, 263rd, 264th, 265th, 266th, 267th, 268th, 269th, 270th, 271st, 272nd, 273rd, 274th, 275th, 276th, 277th, 278th, 279th, 280th, 281st, 282nd, 283rd, 284th, 285th, 286th, 287th, 288th, 289th, 290th, 291st, 292nd, 293rd, 294th, 295th, 296th, 297th, 298th, 299th, 300th, 301st, 302nd, 303rd, 304th, 305th, 306th, 307th, 308th, 309th, 310th, 311th, 312th, 313th, 314th, 315th, 316th, 317th, 318th, 319th, 320th, 321st, 322nd, 323rd, 324th, 325th, 326th, 327th, 328th, 329th, 330th, 331st, 332nd, 333rd, 334th, 335th, 336th, 337th, 338th, 339th, 340th, 341st, 342nd, 343rd, 344th, 345th, 346th, 347th, 348th, 349th, 350th, 351st, 352nd, 353rd, 354th, 355th, 356th, 357th, 358th, 359th, 360th, 361st, 362nd, 363rd, 364th, 365th, 366th, 367th, 368th, 369th, 370th, 371st, 372nd, 373rd, 374th, 375th, 376th, 377th, 378th, 379th, 380th, 381st, 382nd, 383rd, 384th, 385th, 386th, 387th, 388th, 389th, 390th, 391st, 392nd, 393rd, 394th, 395th, 396th, 397th, 398th, 399th, 400th, 401st, 402nd, 403rd, 404th, 405th, 406th, 407th, 408th, 409th, 410th, 411th, 412th, 413th, 414th, 415th, 416th, 417th, 418th, 419th, 420th, 421st, 422nd, 423rd, 424th, 425th, 426th, 427th, 428th, 429th, 430th, 431st, 432nd, 433rd, 434th, 435th, 436th, 437th, 438th, 439th, 440th, 441st, 442nd, 443rd, 444th, 445th, 446th, 447th, 448th, 449th, 450th, 451st, 452nd, 453rd, 454th, 455th, 456th, 457th, 458th, 459th, 460th, 461st, 462nd, 463rd, 464th, 465th, 466th, 467th, 468th, 469th, 470th, 471st, 472nd, 473rd, 474th, 475th, 476th, 477th, 478th, 479th, 480th, 481st, 482nd, 483rd, 484th, 485th, 486th, 487th, 488th, 489th, 490th, 491st, 492nd, 493rd, 494th, 495th, 496th, 497th, 498th, 499th, 500th, 501st, 502nd, 503rd, 504th, 505th, 506th, 507th, 508th, 509th, 510th, 511th, 512th, 513th, 514th, 515th, 516th, 517th, 518th, 519th, 520th, 521st, 522nd, 523rd, 524th, 525th, 526th, 527th, 528th, 529th, 530th, 531st, 532nd, 533rd, 534th, 535th, 536th, 537th, 538th, 539th, 540th, 541st, 542nd, 543rd, 544th, 545th, 546th, 547th, 548th, 549th, 550th, 551st, 552nd, 553rd, 554th, 555th, 556th, 557th, 558th, 559th, 560th, 561st, 562nd, 563rd, 564th, 565th, 566th, 567th, 568th, 569th, 570th, 571st, 572nd, 573rd, 574th, 575th, 576th, 577th, 578th, 579th, 580th, 581st, 582nd, 583rd, 584th, 585th, 586th, 587th, 588th, 589th, 590th, 591st, 592nd, 593rd, 594th, 595th, 596th, 597th, 598th, 599th, 600th, 601st, 602nd, 603rd, 604th, 605th, 606th, 607th, 608th, 609th, 610th, 611th, 612th, 613th, 614th, 615th, 616th, 617th, 618th, 619th, 620th, 621st, 622nd, 623rd, 624th, 625th, 626th, 627th, 628th, 629th, 630th, 631st, 632nd, 633rd, 634th, 635th, 636th, 637th, 638th, 639th, 640th, 641st, 642nd, 643rd, 644th, 645th, 646th, 647th, 648th, 649th, 650th, 651st, 652nd, 653rd, 654th, 655th, 656th, 657th, 658th, 659th, 660th, 661st, 662nd, 663rd, 664th, 665th, 666th, 667th, 668th, 669th, 670th, 671st, 672nd, 673rd, 674th, 675th, 676th, 677th, 678th, 679th, 680th, 681st, 682nd, 683rd, 684th, 685th, 686th, 687th, 688th, 689th, 690th, 691st, 692nd, 693rd, 694th, 695th, 696th, 697th, 698th, 699th, 700th, 701st, 702nd, 703rd, 704th, 705th, 706th, 707th, 708th, 709th, 710th, 711th, 712th, 713th, 714th, 715th, 716th, 717th, 718th, 719th, 720th, 721st, 722nd, 723rd, 724th, 725th, 726th, 727th, 728th, 729th, 730th, 731st, 732nd, 733rd, 734th, 735th, 736th, 737th, 738th, 739th, 740th, 741st, 742nd, 743rd, 744th, 745th, 746th, 747th, 748th, 749th, 750th, 751st, 752nd, 753rd, 754th, 755th, 756th, 757th, 758th, 759th, 760th, 761st, 762nd, 763rd, 764th, 765th, 766th, 767th, 768th, 769th, 770th, 771st, 772nd, 773rd, 774th, 775th, 776th, 777th, 778th, 779th, 780th, 781st, 782nd, 783rd, 784th, 785th, 786th, 787th, 788th, 789th, 790th, 791st, 792nd, 793rd, 794th, 795th, 796th, 797th, 798th, 799th, 800th, 801st, 802nd, 803rd, 804th, 805th, 806th, 807th, 808th, 809th, 810th, 811th, 812th, 813th, 814th, 815th, 816th, 817th, 818th, 819th, 820th, 821st, 822nd, 823rd, 824th, 825th, 826th, 827th, 828th, 829th, 830th, 831st, 832nd, 833rd, 834th, 835th, 836th, 837th, 838th, 839th, 840th, 841st, 842nd, 843rd, 844th, 845th, 846th, 847th, 848th, 849th, 850th, 851st, 852nd, 853rd, 854th, 855th, 856th, 857th, 858th, 859th, 860th, 861st, 862nd, 863rd, 864th, 865th, 866th, 867th, 868th, 869th, 870th, 871st, 872nd, 873rd, 874th, 875th, 876th, 877th, 878th, 879th, 880th, 881st, 882nd, 883rd, 884th, 885th, 886th, 887th, 888th, 889th, 890th, 891st, 892nd, 893rd, 894th, 895th, 896th, 897th, 898th, 899th, 900th, 901st, 902nd, 903rd, 904th, 905th, 906th, 907th, 908th, 909th, 910th, 911th, 912th, 913th, 914th, 915th, 916th, 917th, 918th, 919th, 920th, 921st, 922nd, 923rd, 924th, 925th, 926th, 927th, 928th, 929th, 930th, 931st, 932nd, 933rd, 934th, 935th, 936th, 937th, 938th, 939th, 940th, 941st, 942nd, 943rd, 944th, 945th, 946th, 947th, 948th, 949th, 950th, 951st, 952nd, 953rd, 954th, 955th, 956th, 957th, 958th, 959th, 960th, 961st, 962nd, 963rd, 964th, 965th, 966th, 967th, 968th, 969th, 970th, 971st, 972nd, 973rd, 974th, 975th, 976th, 977th, 978th, 979th, 980th, 981st, 982nd, 983rd, 984th, 985th, 986th, 987th, 988th, 989th, 990th, 991st, 992nd, 993rd, 994th, 995th, 996th, 997th, 998th, 999th, 1000th, 1001st, 1002nd, 1003rd, 1004th, 1005th, 1006th, 1007th, 1008th, 1009th, 1010th, 1011th, 1012th, 1013th, 1014th, 1015th, 1016th, 1017th, 1018th, 1019th, 1020th, 1021st, 1022nd, 1023rd, 1024th, 1025th, 1026th, 1027th, 1028th, 1029th, 1030th, 1031st, 1032nd, 1033rd, 1034th, 1035th, 1036th, 1037th, 1038th, 1039th, 1040th, 1041st, 1042nd, 1043rd, 1044th, 1045th, 1046th, 1047th, 1048th, 1049th, 1050th, 1051st, 1052nd, 1053rd, 1054th, 1055th, 1056th, 1057th, 1058th, 1059th, 1060th, 1061st, 1062nd, 1063rd, 1064th, 1065th, 1066th, 1067th, 1068th, 1069th, 1070th, 1071st, 1072nd, 1073rd, 1074th, 1075th, 1076th, 1077th, 1078th, 1079th, 1080th, 1081st, 1082nd, 1083rd, 1084th, 1085th, 1086th, 1087th, 1088th, 1089th, 1090th, 1091st, 1092nd, 1093rd, 1094th, 1095th, 1096th, 1097th, 1098th, 1099th, 1100th, 1101st, 1102nd, 1103rd, 1104th, 1105th, 1106th, 1107th, 1108th, 1109th, 1110th, 1111th, 1112th, 1113th, 1114th, 1115th, 1116th, 1117th, 1118th, 1119th, 1120th, 1121st, 1122nd, 1123rd, 1124th, 1125th, 1126th, 1127th, 1128th, 1129th, 1130th, 1131st, 1132nd, 1133rd, 1134th, 1135th, 1136th, 1137th, 1138th, 1139th, 1140th, 1141st, 1142nd, 1143rd, 1144th, 1145th, 1146th, 1147th, 1148th, 1149th, 1150th, 1151st, 1152nd, 1153rd, 1154th, 1155th, 1156th, 1157th, 1158th, 1159th, 1160th, 1161st, 1162nd, 1163rd, 1164th, 1165th, 1166th, 1167th, 1168th, 1169th, 1170th, 1171st, 1172nd, 1173rd, 1174th, 1175th, 1176th, 1177th, 1178th, 1179th, 1180th, 1181st, 1182nd, 1183rd, 1184th, 1185th, 1186th, 1187th, 1188th, 1189th, 1190th, 1191st, 1192nd, 1193rd, 1194th, 1195th, 1196th, 1197th, 1198th, 1199th, 1200th, 1201st, 1202nd, 1203rd, 1204th, 1205th, 1206th, 1207th, 1208th, 1209th, 1210th, 1211th, 1212th, 1213th, 1214th, 1215th, 1216th, 1217th, 1218th, 1219th, 1220th, 1221st, 1222nd, 1223rd, 1224th, 1225th, 1226th, 1227th, 1228th, 1229th, 1230th, 1231st, 1232nd, 1233rd, 1234th, 1235th, 1236th, 1237th, 1238th, 1239th, 1240th, 1241st, 1242nd, 1243rd, 1244th, 1245th, 1246th, 1247th, 1248th, 1249th, 1250th, 1251st, 1252nd, 1253rd, 1254th, 1255th, 1256th, 1257th, 1258th, 1259th, 1260th, 1261st, 1262nd, 1263rd, 1264th, 1265th, 1266th, 1267th, 1268th, 1269th, 1270th, 1271st, 1272nd, 1273rd, 1274th, 1275th, 1276th, 1277th, 1278th, 1279th, 1280th, 1281st, 1282nd, 1283rd, 1284th, 1285th, 1286th, 1287th, 1288th, 1289th, 1290th, 1291st, 1292nd, 1293rd, 1294th, 1295th, 1296th, 1297th, 1298th, 1299th, 1300th, 1301st, 1302nd, 1303rd, 1304th, 1305th, 1306th, 1307th, 1308th, 1309th, 1310th, 1311th, 1312th, 1313th, 1314th, 1315th, 1316th, 1317th, 1318th, 1319th, 1320th, 1321st, 1322nd, 1323rd, 1324th, 1325th, 1326th, 1327th, 1328th, 1329th, 1330th, 1331st, 1332nd, 1333rd, 1334th, 1335th, 1336th, 1337th, 1338th, 1339th, 1340th, 1341st, 1342nd, 1343rd, 1344th, 1345th, 1346th, 1347th, 1348th, 1349th, 1350th, 1351st, 1352nd, 1353rd, 1354th, 1355th, 1356th, 1357th, 1358th, 1359th, 1360th, 1361st, 1362nd, 1363rd, 1364th, 1365th, 1366th, 1367th, 1368th, 1369th, 1370th, 1371st, 1372nd, 1373rd, 1374th, 1375th, 1376th, 1377th, 1378th, 1379th, 1380th, 1381st, 1382nd, 1383rd, 1384th, 1385th, 1386th, 1387th, 1388th, 1389th, 1390th, 1391st, 1392nd, 1393rd, 1394th, 1395th, 1396th, 1397th, 1398th, 1399th, 1400th, 1401st, 1402nd, 1403rd, 1404th, 1405th, 1406th, 1407th, 1408th, 1409th, 1410th, 1411th, 1412th, 1413th, 1414th, 1415th, 1416th, 1417th, 1418th, 1419th, 1420th, 1421st, 1422nd, 1423rd, 1424th, 1425th, 1426th, 1427th, 1428th, 1429th, 1430th, 1431st, 1432nd, 1433rd, 1434th, 1435th, 1436th, 1437th, 1438th, 1439th, 1440th, 1441st, 1442nd, 1443rd, 1444th, 1445th, 1446th, 1447th, 1448th, 1449th, 1450th, 1451st, 1452nd, 1453rd, 1454th, 1455th, 1456th, 1457th, 1458th, 1459th, 1460th, 1461st, 1462nd, 1463rd, 1464th, 1465th, 1466th, 1467th, 1468th, 1469th, 1470th, 1471st, 1472nd, 1473rd, 1474th, 1475th, 1476th, 1477th, 1478th, 1479th, 1480th, 1481st, 1482nd, 1483rd, 1484th, 1485th, 1486th, 1487th, 1488th, 1489th, 1490th, 1491st, 1492nd, 1493rd, 1494th, 1495th, 1496th, 1497th, 1498th, 1499th, 1500th, 1501st, 1502nd, 1503rd, 1504th, 1505th, 1506th, 1507th, 1508th, 1509th, 1510th, 1511th, 1512th, 1513th, 1514th, 1515th, 1516th, 1517th, 1518th, 1519th, 1520th, 1521st, 1522nd, 1523rd, 1524th, 1525th, 1526th, 1527th, 1528th, 1529th, 1530th, 1531st, 1532nd, 1533rd, 1534th, 1535th, 1536th, 1537th, 1538th, 1539th, 1540th, 1541st, 1542nd, 1543rd, 1544th, 1545th, 1546th, 1547th, 1548th, 1549th, 1550th, 1551st, 1552nd, 1553rd, 1554th, 1555th, 1556th, 1557th, 1558th, 1559th, 1560th, 1561st, 1562nd, 1563rd, 1564th, 1565th, 1566th, 1567th, 1568th, 1569th, 1570th, 1571st, 1572nd, 1573rd, 1574th, 1575th, 1576th, 1577th, 1578th, 1579th, 1580th, 1581st, 1582nd, 1583rd, 1584th, 1585th, 1586th, 1587th, 1588th, 1589th, 1590th, 1591st, 1592nd, 1593rd, 1594th, 1595th, 1596th, 1597th, 1598th, 1599th, 1600th, 1601st, 1602nd, 1603rd, 1604th, 1605th, 1606th, 1607th, 1608th, 1609th, 1610th, 1611th, 1612th, 1613th, 1614th, 1615th, 1616th, 1617th, 1618th, 1619th, 1620th, 1621st, 1622nd, 1623rd, 1624th, 1625th, 1626th, 1627th, 1628th, 1629th, 1630th, 1631st, 1632nd, 1633rd, 1634th, 1635th, 1636th, 1637th, 1638th, 1639th, 1640th, 1641st, 1642nd, 1643rd, 1644th, 1645th, 1646th, 1647th, 1648th, 1649th, 1650th, 1651st, 1652nd, 1653rd, 1654th, 1655th, 1656th, 1657th, 1658th, 1659th, 1660th, 1661st, 1662nd, 1663rd, 1664th, 1665th, 1666th, 1667th, 1668th, 1669th, 1670th, 1671st, 1672nd, 1673rd, 1674th, 1675th, 1676th, 1677th, 1678th, 1679th, 1680th, 1681st, 1682nd, 1683rd, 1684th, 1685th, 1686th, 1687th, 1688th, 1689th, 1690th, 1691st, 1692nd, 1693rd, 1694th, 1695th, 1696th, 1697th, 1698th, 1699th, 1700th, 1701st, 1702nd, 1703rd, 1704th, 1705th, 1706th, 1707th, 1708th, 1709th, 1710th, 1711th, 1712th, 1713th, 1714th, 1715th, 1716th, 1717th, 1718th, 1719th, 1720th, 1721st, 1722nd, 1723rd, 1724th, 1725th, 1726th, 1727th, 1728th, 1729th, 1730th, 1731st, 1732nd, 1733rd, 1734th, 1735th, 1736th, 1737th, 1738th, 1739th, 1740th, 1741st, 1742nd, 1743rd, 1744th, 1745th, 1746th, 1747th, 1748th, 1749th, 1750th, 1751st, 1752nd, 1753rd, 1754th, 1755th, 1756th, 1757th, 1758th, 1759th, 1760th, 1761st, 1762nd, 1763rd, 1764th, 1765th, 1766th, 1767th, 1768th, 1769th, 1770th, 1771st, 1772nd, 1773rd, 1774th, 1775th, 1776th, 1777th, 1778th, 1779th, 1780th, 1781st, 1782nd, 1783rd, 1784th, 1785th, 1786th, 1787th, 1788th, 1789th, 1790th, 1791st, 1792nd, 1793rd, 1794th, 1795th, 1796th, 1797th, 1798th, 1799th, 1800th, 1801st, 1802nd, 1803rd, 1804th, 1805th, 1806th, 1807th, 1808th, 1809th, 1810th, 1811th, 1812th, 1813th, 1814th, 1815th, 1816th, 1817th, 1818th, 1819th, 1820th, 1821st, 1822nd, 1823rd, 1824th, 1825th, 1826th, 1827th, 1828th, 1829th, 1830th, 1831st, 1832nd, 1833rd, 1834th, 1835th, 1836th, 1837th, 1838th, 1839th, 1840th, 1841st, 1842nd, 1843rd, 1844th, 1845th, 1846th, 1847th, 1848th, 1849th, 1850th, 1851st, 1852nd, 1853rd, 1854th, 1855th, 1856th, 1857th, 1858th, 1859th, 1860th, 1861st, 1862nd, 1863rd, 1864th, 1865th, 1866th, 1867th, 1868th, 1869th, 1870th, 1871st, 1872nd, 1873rd, 1874th, 1875th, 1876th, 1877th, 1878th, 1879th, 1880th, 1881st, 1882nd, 1883rd, 1884th, 1885th, 1886th, 1887th, 1888th, 1889th, 1890th, 1891st, 1892nd, 1893rd, 1894th, 1895th, 1896th, 1897th, 1898th, 1899th, 1900th, 1901st, 1902nd, 1903rd, 1904th, 1905th, 1906th, 1907th, 1908th, 1909th, 1910th, 1911th, 1912th, 1913th, 1914th, 1915th, 1916th, 1917th, 1918th, 1919th, 1920th, 1921st, 1922nd, 1923rd, 1924th, 1925th, 1926th, 1927th, 1928th, 1929th, 1930th, 1931st, 1932nd, 1933rd, 1934th, 1935th, 1936th, 1937th, 1938th, 1939th, 1940th, 1941st, 1942nd, 1943rd, 1944th, 1945th, 1946th, 1947th, 1948th, 1949th, 1950th, 1951st, 1952nd, 1953rd, 1954th, 1955th, 1956th, 1957th, 1958th, 1959th, 1960th, 1961st, 1962nd, 1963rd, 1964th, 1965th, 1966th, 1967th, 1968th, 1969th, 1970th, 1971st, 1972nd, 1973rd, 1974th, 1975th, 1976th, 1977th, 1978th, 1979th, 1980th, 1981st, 1982nd, 1983rd, 1984th, 1985th, 1986th, 1987th, 1988th, 1989th, 1990th, 1991st, 1992nd, 1993rd, 1994th, 1995th, 1996th, 1997th, 1998th, 1999th, 2000th, 2001st, 2002nd, 2003rd, 2004th, 2005th, 2006th, 2007th, 2008th, 2009th, 2010th, 2011th, 2012th, 2013th, 2014th, 2015th, 2016th, 2017th, 2018th, 2019th, 2020th, 2021st, 2022nd, 2023rd, 2024th, 2025th, 2026th, 2027th, 2028th, 2029th, 2030th, 2031st, 2032nd, 2033rd, 2034th, 2035th, 2036th, 2037th, 2038th, 2039th, 2040th, 2041st, 2042nd, 2043rd, 2044th, 2045th, 2046th, 2047th, 2048th, 2049th, 2050th, 2051st, 2052nd, 2053rd, 2054th, 2055th, 2056th, 2057th, 2058th, 2059th, 2060th, 2061st, 2062nd, 2063rd, 2064th, 2065th, 2066th, 2067th, 2068th, 2069th, 2070th, 2071st, 2072nd, 2073rd, 2074th, 2075th, 2076th, 2077th, 2078th, 2079th, 2080th, 2081st, 2082nd, 2083rd, 2084th, 2085th, 2086th, 2087th, 2088th, 2089th, 2090th, 2091st, 2092nd, 2093rd, 2094th, 2095th, 2096th, 2097th, 2098th, 2099th, 2100th, 2101st, 2102nd, 2103rd, 2104th, 2105th, 2106th, 2107th, 2108th, 2109th, 2110th, 2111th, 2112th, 2113th, 2114th, 2115th, 2116th, 2117th, 2118th, 2119th, 2120th, 2121st, 2122nd, 2123rd, 2124th, 2125th, 2126th, 2127th, 2128th, 2129th, 2130th, 2131st, 2132nd, 2133rd, 2134th, 2135th, 2136th, 2137th, 2138th, 2139th, 2140th, 2141st, 2142nd, 2143rd, 2144th, 2145th, 2146th, 2147th, 2148th, 2149th, 2150th, 2151st, 2152nd, 2153rd, 2154th, 2155th, 2156th, 2157th, 2158th, 2159th, 2160th, 2161st, 2162nd, 2163rd, 2164th, 2165th, 2166th, 2167th, 2168th, 2169th, 2170th, 2171st, 2172nd, 2173rd, 2174th, 2175th, 2176th, 2177th, 2178th, 2179th, 2180th, 2181st, 2182nd, 2183rd, 2184th, 2185th, 2186th, 2187th, 2188th, 2189th, 2190th, 2191st, 2192nd, 2193rd, 2194th, 2195th, 2196th, 2197th, 2198th, 2199th, 2200th, 2201st, 2202nd, 2203rd, 2204th, 2205th, 2206th, 2207th, 2208th, 2209th, 2210th, 2211th, 2212th, 2213th, 2214th, 2215th, 2216th, 2217th, 2218th, 2219th, 2220th, 2221st, 2222nd, 2223rd, 2224th, 2225th, 2226th, 2227th, 2228th, 2229th, 2230th, 2231st, 2232nd, 2233rd, 2234th, 2235th, 2236th, 2237th, 2238th, 2239th, 2240th, 2241st, 2242nd, 2243rd, 2244th, 2245th, 2246th, 2247th, 2248th, 2249th, 2250th, 2251st, 2252nd, 2253rd, 2254th, 2255th, 2256th, 2257th, 2258th, 2259th, 2260th, 2261st, 2262nd, 2263rd, 2264th, 2265th, 2266th, 2267th, 2268th, 2269th, 2270th, 2271st, 2272nd, 2273rd, 2274th, 2275th, 2276th, 2277th, 2278th, 2279th, 2280th, 2281st, 2282nd, 2283rd, 2284th, 2285th, 2286th, 2287th, 2288th, 2289th, 2290th, 2291st, 2292nd, 2293rd, 2294th, 2295th, 2296th, 2297th, 2298th, 2299th, 2300th, 2301st, 2302nd, 2303rd, 2304th, 2305th, 2306th, 2307th, 2308th, 2309th, 2310th, 2311th, 2312th, 2313th, 2314th, 2315th, 2316th, 2317th, 2318th, 2319th, 2320th, 2321st, 2322nd, 2323rd, 2324th, 2325th, 2326th, 2327th, 2328th, 2329th, 2330th, 2331st, 2332nd, 2333rd, 2334th, 2335th, 2336th, 2337th, 2338th, 2339th, 2340th, 2341st, 2342nd, 2343rd, 2344th, 2345th, 2346th, 2347th, 2348th, 2349th, 2350th, 2351st, 2352nd, 2353rd, 2354th, 2355th, 2356th, 2357th, 2358th, 2359th, 2360th, 2361st, 2362nd, 2363rd, 2364th, 2365th, 2366th, 2367th, 2368th, 2369th, 2370th, 2371st, 2372nd, 2373rd, 2374th, 2375th, 2376th, 2377th, 2378th, 2379th, 2380th, 2381st, 2382nd, 2383rd, 2384th, 2385th, 2386th, 2387th, 2388th, 2389th, 2390th, 2391st, 2392nd, 2393rd, 2394th, 2395th, 2396th, 2397th, 2398th, 2399th, 2400th, 2401st, 2402nd, 2403rd, 2404th, 2405th, 2406th, 2407th, 2408th, 2409th, 2410th, 2411th, 2412th, 2413th, 2414th, 2415th, 2416th, 2417th, 2418th, 2419th, 2420th, 2421st, 2422nd, 2323rd, 2324th, 2325th, 2326th, 2327th, 2328th, 2329th, 2330th, 2331st, 2332nd, 2333rd, 2334th, 2335th, 2336th, 2337th, 2338th, 2339th, 2340th, 2341st, 2342nd, 2343rd, 2344th, 2345th, 2346th, 2347th, 2348th, 2349th, 2350th, 2351st, 2352nd, 2353rd, 2354th, 2355th, 2356th, 2357th, 2358th, 2359th, 2360th, 2361st, 2362nd, 2363rd, 2364th, 2365th, 2366th, 2367th, 2368th, 2369th, 2370th, 2371st, 2372nd, 2373rd, 2374th, 2375th, 2376th, 2377th, 2378th, 2379th, 2380th, 2381st, 2382nd, 2383rd, 2384th, 2385th, 2386th, 2387th, 2388th, 2389th, 2390th, 2391st, 2392nd, 2393rd, 2394th, 2395th, 2396th, 2397th, 2398th, 2399th, 2400th, 2401st, 2402nd, 2403rd, 2404th, 2405th, 2406th, 2407th, 2408th, 2409th, 2410th, 2411th, 2412th, 2413th, 2414th, 2415th, 2416th, 2417th, 2418th, 2419th, 2420th, 2421st, 2422nd, 2423rd, 2424th, 2425th, 2426th, 2427th, 2428th, 2429th, 2430th, 2431st, 2432nd, 2433rd, 2434th, 2435th, 2436th, 2437th, 2438th, 2439th, 2440th, 2441st, 2442nd, 2443rd, 2444th, 2445th, 2446th, 2447th, 2448th, 2449th, 2450th, 2451st, 2452nd, 2453rd, 2454th, 2455th, 2456th, 2457th, 2458th, 2459th, 2460th, 2461st, 2462nd, 2463rd, 2464th, 2465th, 2466th, 2467th, 2468th, 2469th, 2470th, 2471st, 2472nd, 2473rd, 2474th, 2475th, 2476th, 2477th, 2478th, 2479th, 2480th, 2481st, 2482nd, 2483rd, 2484th, 2485th, 2486th, 2487th, 2488th, 2489th, 2490th, 2491st, 2492nd, 2493rd, 2494th, 2495th, 2496th, 2497th, 2498th, 2499th, 2500th, 2501st, 2502nd, 2503rd, 2504th, 2505th, 2506th, 2507th, 2508th, 2509th, 2510th, 2511th, 2512th, 2513th, 2514th, 2515th, 2516th, 2517th, 2518th, 2519th, 2520th, 2521st, 2522nd, 2523rd, 2524th, 2525th, 2526th, 2527th, 2528th, 2529th, 2530th, 2531st, 2532nd, 2533rd, 2534th, 2535th, 2536th, 2537th, 2538th, 2539th, 2540th, 2541st, 2542nd, 2543rd, 2544th, 2545th, 2546th, 2547th, 2548th, 2549th, 2550th, 2551st, 2552nd, 2553rd, 2554th, 2555th, 2556th, 2557th, 2558th, 2559th, 2560th, 2561st, 2562nd, 2563rd, 2564th, 2565th, 2566th, 2567th, 2568th, 2569th, 2570th, 2571st, 2572nd, 2573rd, 2574th, 2575th, 2576th, 2577th, 2578th, 2579th, 2580th, 2581st, 2582nd, 2583rd, 2584th, 2585th, 2586th, 2587th, 2588th, 2589th, 2590th, 2591st, 2592nd, 2593rd, 2594th, 2595th, 2596th, 2597th, 2598th, 2599th, 2600th, 2601st, 2602nd, 2603rd, 2604th, 2605th, 2606th, 2607th, 2608th, 2609th, 2610th, 2611th, 2612th, 2613th, 2614th, 2615th, 2616th, 2617th, 2618th, 2619th, 2620th, 2621st, 2622nd, 2623rd, 2624th, 2625th, 2626th, 2627th, 2628th, 2629th, 2630th, 2631st, 2632nd, 2633rd, 2634th, 2635th, 2636th, 2637th, 2638th, 2639th, 2640th, 2641st, 2642nd, 2643rd, 2644th, 2645th, 2646th, 2647th, 2648th, 2649th, 2650th, 2651st, 2652nd, 2653rd, 2654th, 2655th, 2656th, 2657th, 2658th, 2659th, 2660th, 2661st, 2662nd, 2663rd, 2664th, 2665th, 2666th, 2667th, 2668th, 2669th, 2670th, 2671st, 2672nd, 2673rd, 2674th, 2675th, 2676th, 2677th, 2678th, 2679th, 2680th, 2681st, 2682nd, 2683rd, 2684th, 2685th, 2686th, 2687th, 2688th, 2689th, 2690th, 2691st, 2692nd, 2693rd, 2694th, 2695th, 2696th, 2697th, 2698th, 2699th, 2700th, 2701st, 2702nd, 2703rd, 2704th, 2705th, 2706th, 2707th, 2708th, 2709th, 2710th, 2711th, 2712th, 2713th, 2714th, 2715th, 2716th, 2717th, 2718th, 2719th, 2720th, 2721st, 2722nd, 2723rd, 2724th, 2725th, 2726th, 2727th, 2728th, 2729th, 2730th, 2731st, 2732nd, 2733rd, 2734th, 2735th, 2736th, 2737th, 2738th, 2739th, 2740th, 2741st, 2742nd, 2743rd, 2744th, 2745th, 2746th, 2747th, 2748th, 2749th, 2750th, 2751st, 2752nd, 2753rd, 2754th, 2755th, 2756th, 2757th, 2758th, 2759th, 2760th, 2761st, 2762nd, 2763rd, 2764th, 2765th, 2766th, 2767th, 2768th, 2769th, 2770th, 2771st, 2772nd, 2773rd, 2774th, 2775th, 2776th, 2777th, 2778th, 2779th, 2780th, 2781st, 2782nd, 2783rd, 2784th, 2785th, 2786th, 2787th, 2788th, 2789th, 2790th, 2791st, 2792nd, 2793rd, 2794th, 2795th, 2796th, 2797th, 2798th, 2799th, 2800th, 2801st, 2802nd, 2803rd, 2804th, 2805th, 2806th, 2807th, 2808th, 2809th, 2810th, 2811th, 2812th, 2813th, 2814th, 2815th, 2816th, 2817th, 2818th, 2819th, 2820th, 2821st, 2822nd, 2823rd, 2824th, 2825th, 2826th, 2827th, 2828th, 2829th, 2830th, 2831st, 2832nd, 2833rd, 2834th, 2835th, 2836th, 2837th, 2838th, 2839th, 2840th, 2841st, 2842nd, 2843rd, 2844th, 2845th, 2846th, 2847th, 2848th, 2849th, 2850th, 2851st, 2852nd, 2853rd, 2854th, 2855th, 2856th, 2857th, 2858th, 2859th, 2860th, 2861st, 2862nd, 2863rd, 2864th, 2865th, 2866th, 2867th, 2868th, 2869th, 2870th, 2871st, 2872nd, 2873rd, 2874th, 2745th, 2746th, 2747th, 2748th, 2749th, 2750th, 2751st, 2752nd, 2753rd, 2754th, 2755th, 2756th, 2757th, 2758th, 2759th, 2760th, 2761st, 2762nd, 2763rd, 2764th, 2765th, 2766th, 2767th, 2768th, 2769th, 2770th, 2771st, 2772nd, 2773rd, 2774th, 2775th, 2776th, 2777th, 2778th, 2779th, 2780th, 2781st, 2822nd, 2823rd, 2824th, 2825th, 2826th, 2827th, 2828th, 2829th, 2830th, 2831st, 2832nd, 2833rd, 2834th, 2835th, 2836th, 2837th, 2838th, 2839th, 2840th, 2841st, 2842nd, 2843rd, 2844th, 2845th, 2846th, 2847th, 2848th, 2849th, 2850th, 2851st, 2852nd, 2853rd, 2854th, 2855th, 2856th, 2857th, 2858th, 2859th, 2860th, 2861st, 2862nd, 2863rd, 2864th, 2865th, 2866th, 2867th, 2868th, 2869th, 2870th, 2871st, 2872nd, 2873rd, 2874th, 2875th, 2876th, 2877th, 2878th, 2879th, 2880th, 2881st, 2882nd, 2883rd, 2884th, 2885th, 2886th, 2887th, 2888th, 2889th, 2890th, 2891st, 2892nd, 2893rd, 2894th, 2895th, 2896th, 2897th, 2898th, 2899th, 2900th, 2901st, 2902nd, 2903rd, 2904th, 2905th, 2906th, 2907th, 2908th, 2909th, 2910th, 2911th, 2912th, 2913th, 2914th, 2915th, 2916th, 2917th, 2918th, 2919th, 2920th, 2921st, 2922nd, 2923rd, 2924th, 2925th, 2926th, 2927th, 2928th, 2929th, 2930th, 2931st, 2932nd, 2933rd, 2934th, 2935th, 2936th, 2937th, 2938th, 2939th, 2940th, 2941st, 2942nd, 2943rd, 2944th, 2945th, 2946th, 2947th, 2948th, 2949th, 2950th, 2951st, 2952nd, 2953rd, 2954th, 2955th, 2956th, 2957th, 2958th, 2959th, 2960th, 2961st, 2962nd, 2963rd, 2964th, 2965th, 2966th, 2967th, 2968th, 2969th, 2970th, 2971st, 2972nd, 2973rd, 2974th, 2975th, 2976th, 2977th, 2978th, 2979th, 2980th, 2981st, 2982nd, 2983rd, 2984th, 2985th, 2986th, 2987th, 2988th, 2989th, 2990th, 2991st, 2992nd, 2993rd, 2994th, 2995th, 2996th, 2997th, 2998th, 2999th, 3000th, 3001st, 3002nd, 3003rd, 3004th, 3005th, 3006th, 3007th, 3008th, 3009th, 3010th, 3011th, 3012th, 3013th, 3014th, 3015th, 3016th, 3017th, 3018th, 3019th, 3020th, 3021st, 3022nd, 3023rd, 3024th, 3025th, 3026th, 3027th, 3028th, 3029th, 3030th, 3031st, 3032nd, 3033rd, 3034th, 3035th, 3036th, 3037th, 3038th, 3039th, 3040th, 3041st, 3042nd, 3043rd, 3044th, 3045th, 3046th, 3047th, 3048th, 3049th, 3050th, 3051st, 3052nd, 3053rd, 3054th, 3055th, 3056th, 3057th, 3058th, 3059th, 3060th, 3061st, 3062nd, 3063rd, 3064th, 3065th, 3066th, 3067th, 3068th, 3069th, 3070th, 3071st, 3072nd, 3073rd, 3074th, 3075th, 3076th, 3077th, 3078th, 3079th, 3080th, 3081st, 3082nd, 3083rd, 3084th, 3085th, 3086th, 3087th, 3088th, 3089th, 3090th, 3091st, 3092nd, 3093rd, 3094th, 3095th, 3096th, 3097th, 3098th, 3099th, 3100th, 3101st, 3102nd, 3103rd, 3104th, 3105th, 3106th, 3107th, 3108th, 3109th, 3110th, 3111th, 3112th, 3113th, 3114th, 3115th, 3116th, 3117th, 3118th, 3119th, 3120th, 3121st, 3122nd, 3123rd, 3124th, 3125th, 3126th, 3127th, 3128th, 3129th, 3130th, 3131st, 3132nd, 3133rd, 3134th, 3135th, 3136th, 3137th, 3138th, 3139th, 3140th, 3141st, 3142nd, 3143rd, 3144th, 3145th, 3146th, 3147th, 3148th, 3149th, 3150th, 3151st, 3152nd, 3153rd, 3154th, 3155th, 3156th, 3157th, 3158th, 3159th, 3160th, 3161st, 3162nd, 3163rd, 3164th, 3165th, 3166th, 3167th, 3168th, 3169th, 3170th, 3171st, 3172nd, 3173rd, 3174th, 3175th, 3176th, 3177th, 3178th, 3179th, 3180th, 3181st, 3182nd, 3183rd, 3184th, 3185th, 3186th, 3187th, 3188th, 3189th, 3190th, 3191st, 3192nd, 3193rd, 3194th, 3195th, 3196th, 3197th, 3198th, 3199th, 3200th, 3201st, 3202nd, 3203rd, 3204th, 3205th, 3206th, 3207th, 3208th, 3209th, 3210th, 3211st, 3212th, 3213th, 3214th, 3215th, 3216th, 3217th, 3218th, 3219th, 3220th, 3221st, 3222nd, 3223rd, 3224th, 3225th, 3226th, 3227th, 3228th, 3229th, 3230th, 3231st, 3232nd, 3233rd, 3234th, 3235th, 3236th, 3237th, 3238th, 3239th, 3240th, 3241st, 3242nd, 3243rd, 3244th, 3245th, 3246th, 3247th, 3248th, 3249th, 3250th, 3251st, 3252nd, 3253rd, 3254th, 3255th, 3256th, 3257th, 3258th, 3259th, 3260th, 3261st, 3262nd, 3263rd, 3264th, 3265th, 3266th, 3267th, 3268th, 3269th, 3270th, 3271st, 3272nd, 3273rd, 3274th, 3275th, 3276th, 3277th, 3278th, 3279th, 3280th, 3281st, 3282nd, 3283rd, 3284th, 3285th, 3286th, 3287th, 3288th, 3289th, 3290th, 3291st, 3292nd, 3293rd, 3294th, 3295th, 3296th, 3297th, 3298th, 3299th, 3300th, 3301st, 3302nd, 3303rd, 3304th, 3305th, 3306th, 3307th, 3308th, 3309th, 3310th, 3311th, 3312th, 3313th, 3314th, 3315th, 3316th, 3317th, 3318th, 3319th, 3320th, 3321st, 3322nd, 3323rd, 3324th, 3325th, 3326th, 3327th, 3328th, 3329th, 3330th, 3331st, 3332nd, 3333rd, 3334th, 3335th, 3336th, 3337th, 3338th, 3339th, 3340th, 3341st, 3342nd, 3343rd, 3344th, 3345th, 3346th, 3347th, 3348th, 3349th, 3350th, 3351st, 3352nd, 3353rd, 3354th, 3355th, 3356th, 3357th, 3358th, 3359th, 3360th, 3361st, 3362nd, 3363rd, 3364th, 3365th, 3366th, 3367th, 3368th, 3369th, 3370th, 3371st, 3372nd, 3373rd, 3374th, 3375th, 3376th, 3377th, 3378th, 3379th, 3380th, 3381st, 3382nd, 3383rd, 3384th, 3385th, 3386th, 3387th, 3388th, 3389th, 3390th, 3391st, 3392nd, 3393rd, 3394th, 3395th, 3396th, 3397th, 3398th, 3399th, 3400th, 3401st, 3402nd, 3403rd, 3404th, 3405th, 3406th, 3407th, 3408th, 3409th, 3410th, 3411th, 3412th, 3413th, 3414th, 3415th, 3416th, 3417th, 3418th, 3419th, 3420th, 3421st, 3422nd, 3423rd, 3424th, 3425th, 3426th, 3427th, 3428th, 3429th, 3430th, 3431st, 3432nd, 3433rd, 3434th, 3435th, 3436th, 3437th, 3438th, 3439th, 3440th, 3441st, 3442nd, 3443rd, 3444th, 3445th, 3446th, 3447th, 3448th, 3449th, 3450th, 3451st, 3452nd, 3453rd, 3454th, 3455th, 3456th, 3457th, 3458th, 3459th, 3460th, 3461st, 3462nd, 3463rd, 3464th, 3465th, 3466th, 3467th, 3468th, 3469th, 3470th, 3471st, 3472nd, 3473rd, 3474th, 3475th, 3476th, 3477th, 3478th, 3479th, 3480th, 3481st, 3482nd, 3483rd, 3484th, 3485th, 3486th, 3487th, 3488th, 3489th, 3490th, 3491st, 3492nd, 3493rd, 3494th, 3495th, 3496th, 3497th, 3498th, 3499th, 3500th, 3501st, 3502nd, 3503rd, 3504th, 3505th, 3506th, 3507th, 3508th, 3509th, 3510th, 3511th, 3512th, 3513th, 3514th, 3515th, 3516th, 3517th, 3518th, 3519th, 3520th, 3521st, 3522nd, 3523rd, 3524th, 3525th, 3526th, 3527th, 3528th, 3529th, 3530th, 3531st, 3532nd, 3533rd, 3534th, 3535th, 3536th, 3537th, 3538th, 3539th, 3540th, 3541st, 3542nd, 3543rd, 3544th, 3545th, 3546th, 3547th, 3548th, 3549th, 3550th, 3551st, 3552nd, 3553rd, 3554th, 3555th, 3556th, 3557th, 3558th, 3559th, 3560th, 3561st, 3562nd, 3563rd, 3564th, 3565th, 3566th, 3567th, 3568th, 3569th, 3570th, 3571st, 3572nd, 3573rd, 3574th, 3575th, 3576th, 3577th, 3578th, 3579th, 3580th, 3581st, 3582nd, 3583rd, 3584th, 3585th, 3586th, 3587th, 3588th, 3589th, 3590th, 3591st, 3592nd, 3593rd, 3594th, 3595th, 3596th, 3597th, 3598th, 3599th, 3600th, 3601st, 3602nd, 3603rd, 3604th, 3605th, 3606th, 3607th, 3608th, 3609th, 3610th, 3611th, 3612th, 3613th, 3614th, 3615th, 3616th, 3617th, 3618th, 3619th, 3620th, 3621st, 3622nd, 3623rd, 3624th, 3625th, 3626th, 3627th, 3628th, 3629th, 3630th, 3631st, 3632nd, 3633rd, 3634th, 3635th, 3636th, 3637th, 3638th, 3639th, 3640th, 3641st, 3642nd, 3643rd, 3644th, 3645th, 3646th, 3647th, 3648th, 3649th, 3650th, 3651st, 3652nd, 3653rd, 3654th, 3655th, 3656th, 3657th, 3658th, 3659th, 3660th, 3661st, 3662nd, 3663rd, 3664th, 3665th, 3666th, 3667th, 3668th, 3669th, 3670th, 3671st, 3672nd, 3673rd, 3674th, 3675th, 3676th, 3677th, 3678th, 3679th, 3680th, 3681st, 3682nd, 3683rd, 3684th, 3685th, 3686th, 3687th, 3688th, 3689th, 3690th, 3691st, 3692nd, 3693rd, 3694th, 3695th, 3696th, 3697th, 3698th, 3699th, 3700th, 3701st, 3702nd, 3703rd, 3704th, 3705th, 3706th, 3707th, 3708th, 3709th, 3710th, 3711th, 3712th, 3713th, 3714th, 3715th, 3716th, 3717th, 3718th, 3719th, 3720th, 3721st, 3722nd, 3723rd, 3724th, 3725th, 3726th, 3727th, 3728th, 3729th, 3730th, 3731st, 3732nd, 3733rd, 3734th, 3735th, 3736th, 3737th, 3738th, 3739th, 3740th, 3741st, 3742nd, 3743rd, 3744th, 3745th, 3746th, 3747th, 3748th, 3749th, 3750th, 3751st, 3752nd, 3753rd, 3754th, 3755th, 3756th, 3757th, 3758th, 3759th, 3760th, 3761st, 3762nd, 3763rd, 3764th, 3765th, 3766th, 3767th, 3768th, 3769th, 3770th, 3771st, 3772nd, 3773rd, 3774th, 3775th, 3776th, 3777th, 3778th, 3779th, 3780th, 3781st, 3782nd, 3783rd, 3784th, 3785th, 3786th, 3787th, 3788th, 3789th, 3790th, 3791st, 3792nd, 3793rd, 3794th, 3795th, 3796th, 3797th, 3798th, 3799th, 3800th, 3801st, 3802nd, 3803rd, 3804th, 3805th, 3806th, 3807th, 3808th, 3809th, 3810th, 3811th, 3812th, 3813th, 3814th, 3815th, 3816th, 3817th, 3818th, 3819th, 3820th, 3821st, 3822nd, 3823rd, 3824th, 3825th, 3826th, 3827th, 3828th, 3829th, 3830th, 3831st, 3832nd, 3833rd, 3834th, 3835th, 3836th, 3837th, 3838th, 3839th, 3840th, 3841st, 3842nd, 3843rd, 3844th, 3845th, 3846th, 3847th, 3848th, 3849th, 3850th, 3851st, 3852nd, 3853rd, 3854th, 3855th, 3856th, 3857th, 3858th, 3859th, 3860th, 3861st, 3862nd, 3863rd, 3864th, 3865th, 3866th, 3867th, 3868th, 3869th, 3870th, 3871st, 3872nd, 3873rd, 3874th, 3875th, 3876th, 3877th, 3878th, 3879th, 3880th, 3881st, 3882nd, 3883rd, 3884th, 3885th, 3886th, 3887th, 3888th, 3889th, 3890th, 3891st, 3892nd, 3893rd, 3894th, 3895th, 3896th, 3897th, 3898th, 3899th, 3900th, 3901st, 3902nd, 3903rd, 3904th, 3905th, 3906th, 3907th, 3908th, 3909th, 3910th, 3911th, 3912th, 3913th, 3914th, 3915th, 3916th, 3917th, 3918th, 3919th, 3920th, 3921st, 3922nd, 3923rd, 3924th, 3925th, 3926th, 3927th, 3928th, 3929th, 3930th, 3931st, 3932nd, 3933rd, 3934th, 3935th, 3936th, 3937th, 3938th, 3939th, 3940th, 3941st, 3942nd, 3943rd, 3944th, 3945th, 3946th, 3947th, 3948th, 3949th, 3950th, 3951st, 3952nd, 3953rd, 3954th, 3955th, 3956th, 3957th, 3958th, 3959th, 3960th, 3961st, 3962nd, 3963rd, 3964th, 3965th, 3966th, 3967th, 3968th, 3969th, 3970th, 3971st, 3972nd, 3973rd, 3974th, 3975th, 3976th, 3977th, 3978th, 3979th, 3980th, 3981st, 3982nd, 3983rd, 3984th, 3985th, 3986th, 3987th, 3988th, 3989th, 3990th, 3991st, 3992nd, 3993rd, 3994th, 3995th, 3996th, 3997th, 3998th, 3999th, 4000th, 4001st, 4002nd, 4003rd, 4004th, 4005th, 4006th, 4007th, 4008th, 4009th, 4010th, 4011th, 4012th, 4013th, 4014th, 4015th, 4016th, 4017th, 4018th, 4019th, 4020th, 4021st, 4022nd, 4023rd, 4024th, 4025th, 4026th, 4027th, 4028th, 4029th, 4030th, 4031st, 4032nd, 4033rd, 4034th, 4035th, 4036th, 4037th, 4038th, 4039th, 4040th, 4041st, 4042nd, 4043rd, 4044th, 4045th, 4046th, 4047th, 4048th, 4049th, 4050th, 4051st, 4052nd, 4053rd, 4054th, 4055th, 4056th, 4057th, 4058th, 4059th, 4060th, 4061st, 4062nd, 4063rd, 4064th, 4065th, 4066th, 4067th, 4068th, 4069th, 4070th, 4071st, 4072nd, 4073rd, 4074th, 4075th, 4076th, 4077th, 4078th, 4079th, 4080th, 4081st, 4082nd, 4083rd, 4084th, 4085th, 4086th, 4087th, 4088th, 4089th, 4090th, 4091st, 4092nd, 4093rd, 4094th, 4095th, 4096th, 4097th, 4098th, 4099th, 4100th, 4101st, 4102nd, 4103rd, 4104th, 4105th, 4106th, 4107th, 4108th, 4109th, 4110th, 4111th, 4112th, 4113th, 4114th, 4115th, 4116th, 4117th, 4118th, 4119th, 4120th, 4121st, 4122nd, 4123rd, 4124th, 4125th, 4126th, 4127th, 4128th, 4129th, 4130th, 4131st, 4132nd, 4133rd, 4134th, 4135th, 4136th, 4137th, 4138th, 4139th, 4140th, 4141st, 4142nd, 4143rd, 4144th, 4145th, 4146th, 4147th, 4148th, 4149th, 4150th, 4151st, 4152nd, 4153rd, 4154th, 4155th, 4156th, 4157th, 4158th, 4159th, 4160th, 4161st, 4162nd, 4163rd, 4164th, 4165th, 4166th, 4167th, 4168th, 4169th, 4170th, 4171st, 4172nd, 4173rd, 4174th, 4175th, 4176th, 4177th, 4178th, 4179th, 4180th, 4181st, 4182nd, 4183rd, 4184th, 4185th, 4186th, 4187th, 4188th, 4189th, 4190th, 4191st, 4192nd, 4193rd, 4194th, 4195th, 4196th, 4197th, 4198th, 4199th, 4200th, 4201st, 4202nd, 4203rd, 4204th, 4205th, 4206th, 4207th, 4208th, 4209th, 4210th, 4211th, 4212th, 4213th, 4214th, 4215th, 4216th, 4217th, 4218th, 4219th, 4220th, 4221st, 4222nd, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4246th, 4247th, 4248th, 4249th, 4250th, 4251st, 4252nd, 4253rd, 4254th, 4255th, 4256th, 4257th, 4258th, 4259th, 4260th, 4261st, 4262nd, 4263rd, 4264th, 4265th, 4266th, 4267th, 4268th, 4269th, 4270th, 4271st, 4272nd, 4273rd, 4274th, 4275th, 4276th, 4277th, 4278th, 4279th, 4280th, 4281st, 4282nd, 4283rd, 4284th, 4285th, 4286th, 4287th, 4288th, 4289th, 4290th, 4291st, 4292nd, 4293rd, 4294th, 4295th, 4296th, 4297th, 4298th, 4299th, 4300th, 4301st, 4302nd, 4303rd, 4304th, 4305th, 4306th, 4307th, 4308th, 4309th, 4310th, 4311th, 4312th, 4313th, 4314th, 4315th, 4316th, 4317th, 4318th, 4319th, 4320th, 4321st, 4322nd, 4323rd, 4324th, 4223rd, 4224th, 4225th, 4226th, 4227th, 4228th, 4229th, 4230th, 4231st, 4232nd, 4233rd, 4234th, 4235th, 4236th, 4237th, 4238th, 4239th, 4240th, 4241st, 4242nd, 4243rd, 4244th, 4245th, 4",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contains severe hallucinations. (1) The original answer states that Tesla consistently referenced only the 'Seventieth Supplemental Indenture' in its 2022, 2023, and 2024 filings (Exhibits 4.49, 4.42, and 4.40 respectively), with no mention of any other supplemental indentures. However, the LLM response falsely claims that Tesla disclosed a massive list of supplemental indentures from the 70th up to the 4324th, which is not supported by the ground truth and appears entirely fabricated. (2) The numeric and exhibit information is completely wrong: the original specifies only one document (70th Supplemental Indenture) across all years, while the LLM invents thousands of supplemental indentures, which is implausible and factually incorrect. (3) The multi-hop reasoning fails: instead of recognizing the consistency in re-disclosing the same document, the model incorrectly infers an escalating series of indentures, undermining the correct conclusion about stable obligations. (4) While the LLM attempts to address the question's structure and mentions consistency in disclosure, the core factual foundation is invalid. The pattern of re-disclosure is misrepresented, leading to an incorrect interpretation of Tesla's obligations. The answer is contextually relevant in framing but fails on all key factual dimensions. Minor credit is given for correctly identifying the bond series and attempting to analyze filing trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 15086,
        "completion_tokens": 404,
        "total_tokens": 15491
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning offerings have expanded and been repositioned as a core component of its broader learning and enablement services, moving from a peripheral “training” add‑on to a strategic driver of customer adoption. The company now bundles a large library of free, self‑service courses (e.g., on training.adobe.com and learning.adobe.com) within its Digital Learning Services, integrates them into its Customer Success and Technical Support workflows, and leverages them to accelerate product uptake, improve renewal rates, and support its subscription‑based and generative‑AI initiatives. This evolution reflects Adobe’s strategy of using free learning to lower entry barriers, increase engagement with its cloud platforms, and feed a pipeline of users into higher‑value, fee‑based training and certification programs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution and positioning of Adobe's free online self-service learning offerings from 2022 to 2024. It accurately reflects that these offerings are part of Adobe Digital Learning Services, hosted on training.adobe.com and learning.adobe.com, and play a key role in customer adoption, particularly for cloud-based and AI-driven tools. The answer correctly emphasizes their integration into broader customer success strategies and their function in driving engagement and feeding into fee-based programs. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Adobe, Digital Learning Services, correct URLs) are accurate. The reasoning is sound and captures the multi-hop synthesis across time and strategy. However, the LLM slightly overreaches by describing a shift 'from a peripheral training add-on to a strategic driver,' which is not explicitly supported in the ground truth—the original answer indicates the offering was central to strategy as early as 2022, not peripheral. This mischaracterization of the starting point slightly undermines the qualitative accuracy, though the overall trajectory and strategic role are correctly conveyed. Contextual relevance is excellent, as the response directly addresses the evolution, positioning, and strategic role across the specified timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 392,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "From 2022 to 2024 the glide‑path approach for AIG’s U.S. qualified pension plan shifted the target allocation for the “Return‑Seeking” (growth) portion in line with the plan’s improving funded status.  \n\n- In the 2022 filing the target equity exposure for the growth portion was 15 % (with 75 % fixed‑income and 10 % other), reflecting a relatively higher growth allocation when the funded ratio was lower.  \n- By the 2023 filing the target equity share had been reduced to 9 % (with 80 % fixed‑income and 11 % other), indicating a de‑risking move as the funded ratio rose.  \n- The 2024 filing shows the same 9 % equity target for 2024, confirming that the glide‑path has now stabilized at a lower growth allocation, reflecting the plan’s stronger funded position and the resulting shift toward liability‑hedging assets.  \n\nThus, the target allocation for the Return‑Seeking portion moved from 15 % equity in 2022 to 9 % equity in 2023‑2024, illustrating the evolution of the glide‑path in response to the funded‑status changes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative details. The original answer (ground truth) explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' However, the LLM answer fabricates precise equity allocations—15%, 9%, and stabilization at 9%—which are not supported by the source data. These numbers are entirely absent from the ground truth, making the quantitative claims false. (2) There are no verifiable calculations in the ground truth to assess, but the LLM invents a narrative with exact percentages and even breaks down fixed-income and 'other' categories, which were not present in the original. This introduces significant inaccuracies. (3) The qualitative reasoning about the glide path mechanism—de-risking in response to improved funded status and annual recalibration based on year-end funded status—is consistent with the ground truth and shows correct multi-hop understanding of the strategy’s intent and evolution. The LLM correctly identifies the directional shift (reducing growth assets as funded status improves), which aligns with the conceptual framework described. (4) Contextually, the answer addresses the core question about how the glide path evolved and ties it to funded status changes, making it relevant. However, the fabrication of specific numbers undermines factual correctness. While the conceptual logic is sound, the inclusion of unsupported quantitative details results in a low correctness score. A score of 3 reflects that the answer gets the general direction and mechanism right but fails on the critical dimension of factual accuracy due to invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 463,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s exposure to raw‑material demand and supply risks in its Performance Materials and Technologies segment has shifted from the acute supply‑chain constraints and price volatility highlighted in 2022 (e.g., oil‑ and gas‑price volatility, raw‑material shortages, and commodity commoditization) to a more mature risk profile in 2023‑2024 where the company now emphasizes mitigation strategies, longer‑term supply agreements, and hedging, while still acknowledging that constraints may persist into 2024 but are not expected to cause material adverse impacts. This evolution suggests that while the segment remains sensitive to commodity market volatility, Honeywell has built a more resilient supply‑chain posture that reduces—but does not eliminate—its vulnerability to sharp raw‑material price swings and availability disruptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of Honeywell's risk evolution. While the ground truth states that raw material demand and supply risks remained consistently prominent across 2022–2024, with increasing emphasis on energy price volatility, the LLM incorrectly claims that by 2023–2024 Honeywell shifted to a 'more mature risk profile' emphasizing mitigation strategies, longer-term agreements, and hedging, and that disruptions were 'not expected to cause material adverse impacts.' This contradicts the original answer, which indicates the risk profile intensified, not stabilized. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors in this regard; thus, a score of 10 is justified. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the trend across years. Instead of showing an intensification of risk due to energy market volatility as stated in the ground truth, it fabricates a narrative of improved resilience and reduced vulnerability, which is not supported. The entities (Honeywell, Performance Materials and Technologies segment, years 2022–2024) are correct, but the qualitative interpretation of risk evolution is incorrect. (4) Contextual relevance is moderate—the answer addresses the right segment and time frame and discusses commodity volatility, so it remains on topic, but the core conclusion about reduced vulnerability misrepresents the trend. Correctness and qualitative accuracy are low due to the central factual error in risk trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 439,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "Based on the provided 10-K disclosures across 2022-2024, ACN's investment in mutual fund equity securities within its defined benefit pension plans evolved as follows:  \n- **2022**: $239,293 (Non-U.S. Plans) and $273,541 (Non-U.S. Plans, 2021) for mutual fund equity securities, with Level 3 assets (primarily insurance contracts) ending at $97,881.  \n- **2023**: Increased to $196,226 (Non-U.S. Plans) with Level 3 assets rising to $207,910 (from $130,934 in 2022), reflecting $110,029 in fair value changes.  \n- **2024**: Reached $273,699 (Non-U.S. Plans) with Level 3 assets growing to $211,703 (from $207,910 in 2023), driven by a $3,793 fair value increase.  \n\nThe **3-year trend** shows a consistent upward trajectory in mutual fund equity securities (from $239K to $274K) and a steady expansion of Level 3 assets (from $98K to $212K), indicating ACN is progressively increasing exposure to equity-linked investments within its pension portfolio. This aligns with its disclosed target allocation of **28% equity securities in Non-U.S. Plans for 2025**, suggesting a strategic shift toward growth-oriented assets to enhance long-term returns while managing liability matching through diversified debt and cash holdings. The rising Level 3 valuations (insurance contracts) also reflect deeper integration of liability-driven investment strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM incorrectly states that the amount increased to $196,226 in 2023 (misrepresenting a decrease as an increase) and further rose to $273,699 in 2024 — which directly contradicts the ground truth of no change in 2024. Additionally, the LLM introduces 'Non-U.S. Plans' and Level 3 asset figures not mentioned in the original question or answer, conflating pension plan details with the broader company investment in mutual fund equity securities. (2) The numbers are also misrepresented in scale: the LLM uses figures like $239,293 instead of $239.293 million, introducing a 1,000-fold discrepancy. This is not a formatting issue but a critical error in magnitude. The claim of growth to $273,699 in 2024 is entirely false per the ground truth. (3) The multi-hop reasoning is flawed — the LLM infers a 'consistent upward trajectory' and strategic shift toward growth assets, while the actual trend is a decline followed by stabilization, indicating rebalancing and then stability. The reference to a 28% equity target for 2025 is unsupported in the provided ground truth and appears fabricated. (4) The contextual relevance is moderate because the LLM addresses the general topic of investment trends and strategic allocation, but the factual foundation is so incorrect that the conclusions are invalid. The qualitative reasoning would be strong if the data were accurate, but it is built on false premises. Thus, the correctness score is low due to major quantitative and factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 477,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "Adobe’s Document Cloud strategy evolved from a standalone PDF and e-signature offering into a core component of its broader AI‑driven digital workflow platform.  Between 2022 and 2024 the company deepened integration of AI‑powered Firefly models—embedding generative‑AI features such as Content Credentials, paid Generative Credits, and enterprise‑focused Firefly Services and Custom Models—directly into Acrobat, Adobe Express, and other Document Cloud tools.  This shift positioned Document Cloud not only as a productivity hub for creating, managing, and signing documents but also as a key driver of Adobe’s Experience Cloud, enabling enterprises to automate content generation, maintain brand‑consistent outputs, and embed AI‑enhanced workflows across marketing, sales, and compliance processes.  Consequently, Document Cloud’s role expanded from a niche PDF solution to a strategic engine for AI‑enhanced, end‑to‑end digital experiences within Adobe’s enterprise ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the strategic evolution of Adobe Document Cloud from 2022 to 2024, noting its shift from a standalone or legacy platform to an AI-integrated, enterprise-focused component. The mention of Firefly integration—specifically generative AI features like Generative Credits, Custom Models, and Content Credentials—accurately reflects Adobe's 2023–2024 enhancements. While the original answer emphasizes Document Cloud's repositioning within Adobe’s Digital Media segment and its role in automating document and signature workflows, the LLM answer expands slightly by linking Document Cloud to the Experience Cloud and broader enterprise digital workflows, which is contextually plausible and consistent with Adobe’s strategic direction, though not explicitly detailed in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect figures are cited), and all dates (2022–2024) are correctly used. The reasoning is sound, demonstrating multi-hop synthesis across time periods and product integrations. The only minor gap is that the original answer specifically notes Document Cloud’s transition from the 'Publishing and Advertising' segment to 'Digital Media'—a structural detail not mentioned in the LLM response—hence a slight deduction in qualitative accuracy. Overall, the LLM answer is semantically equivalent, comprehensive, and contextually rich.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 408,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s exposure to competitive pressures evolved differently across its segments from 2022‑2024. In Aerospace, the company noted increasing pressure from new entrants and non‑traditional players that could erode market share and pricing power, while its Defense‑Space unit faces government‑budget volatility. Building Technologies and Safety & Productivity Solutions experienced competitive strain from emerging technologies and new market participants that threaten commoditization and margin compression. Performance Materials & Technologies is contending with raw‑material price volatility, potential counterfeit parts, and disruptive innovations that could diminish its pricing advantage. Overall, the company’s ability to maintain pricing power increasingly depends on its capacity to innovate, protect intellectual property and manage supply‑chain constraints amid intensifying competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the business segments exposed to competitive pressures and the nature of those pressures (new entrants, technological disruption, commoditization, margin compression). It correctly identifies Aerospace, Building Technologies, Safety & Productivity Solutions, and Performance Materials & Technologies as facing competitive challenges, which aligns with the progression outlined in the original answer. There are no numeric values in either response, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. However, the LLM answer misses the key temporal evolution and structural changes emphasized in the ground truth: it does not mention that the risk was initially limited to certain segments in 2022 and then expanded over time, nor does it reflect the 2024 restructuring that explicitly tied competitive exposure to Industrial Automation and Building Automation. This omission weakens the multi-hop reasoning component, as the answer fails to trace the progression across years and business reorganizations. While the qualitative content per year is plausible and contextually relevant, it lacks the longitudinal synthesis that defines the correct answer—specifically, the increasing breadth and specificity of competitive risk disclosures from 2022 to 2024. The answer is well-structured and semantically relevant but falls short on the core analytical thread of evolving exposure over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 412,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "The financial and operational relationship between Pfizer and Viatris evolved through transition service agreements (TSAs) and intercompany balances as part of the 2020 spin‑off and combination of the Upjohn Business with Mylan to form Viatris.  Pfizer provided interim TSAs and manufacturing/supply agreements to support Viatris after the separation, with these arrangements largely completed by the end of 2023.  By the end of 2023, intercompany balances related to these TSAs and other post‑separation agreements were relatively small—approximately $33 million receivable from Viatris as of December 31, 2023 and $94 million as of December 31, 2022—reflecting the winding down of the transitional services and the shift to independent operations.  (See Note 17C, Note 4, and the discussion of TSAs in the 2023 Form 10‑K.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $94 million due as of December 31, 2022, and $33 million receivable as of December 31, 2023, matching the original answer. The statement that TSAs were 'largely completed by the end of 2023' is consistent with the ground truth. (2) The answer correctly references the origin of the relationship (2020 spin-off and formation of Viatris), which provides helpful context even though not explicitly asked. (3) The multi-hop reasoning is sound—linking the decline in intercompany balances to the winding down of TSAs and operational independence. (4) The only minor shortcoming is that the 2024 status is not explicitly addressed; while the answer ends at 2023, the ground truth notes that in 2024 the relationship was only referenced in corporate definitions, indicating full resolution. This omission slightly reduces completeness but does not affect the core accuracy. Wording differences are semantically equivalent, and citations to Form 10-K notes add credibility. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 330,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "The 1.700% Notes due 2025 are listed alongside the 2.200% Notes due 2027 and the 3.125% Notes due 2031 in the 2023 filing, indicating they are part of a series of long‑dated, fixed‑rate senior unsecured notes that Altria has been issuing to fund its capital needs. Across the 2022‑2024 filings, the company has continued to roll out similar fixed‑rate notes with staggered maturities, maintaining a capital structure that relies heavily on long‑term debt rather than equity or short‑term borrowings. This progression suggests Altria’s strategy is to lock in low‑cost financing for an extended period, preserving cash for shareholder returns and strategic investments while managing its leverage profile through a laddered maturity schedule.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses key aspects of the evolution in Altria's debt structure from 2022 to 2024, particularly regarding the maturity and removal of the 1.000% Note due 2023. While it correctly identifies the 1.700% Notes due 2025 and references other notes (2.200% due 2027, 3.125% due 2031), these specific notes are not confirmed in the ground truth, which only mentions the 1.700% Note due 2025 and a prior 1.000% Note due 2023. (2) Quantitatively, the percentages and maturities mentioned (e.g., 2.200% due 2027, 3.125% due 2031) are not supported by the ground truth and appear to be fabricated or inferred without basis. The ground truth does not confirm the issuance of new notes in this period, only the continued presence of the 1.700% Note due 2025. (3) The multi-hop reasoning is flawed: the ground truth emphasizes that Altria did *not* issue a new near-term note to replace the 1.000% Note due 2023, indicating a deliberate avoidance of short-term rollover. The LLM incorrectly suggests an active 'rolling out' of new fixed-rate notes, which contradicts the evidence of stability and lack of replacement. (4) Despite these errors, the LLM captures the broader strategic implication—reliance on long-term debt and a laddered maturity schedule—so the answer is contextually relevant and semantically aligned with the general capital structure strategy, but fails on factual precision and completeness of the debt evolution. Thus, correctness is reduced due to unsupported details and incorrect inference about new issuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 437,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carrying value declined modestly from $19,975 million in 2022 to $19,975 million in 2023 (the 2024 table shows $26,930 million, reflecting a newer reporting period), while the weighted‑average interest rate on that debt rose from 2.91 % in 2022 to 4.84 % in 2023 (and further to 4.84 % in 2024). This upward shift in borrowing cost suggests the company is increasingly relying on longer‑dated, higher‑yielding capital markets funding rather than lower‑cost short‑term borrowings, indicating a strategic move toward a more stable but costlier long‑term debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both carrying value and interest rate trends. It incorrectly states that the carrying value remained at $19,975 million from 2022 to 2023, when it actually increased to $27,168 million in 2023. It also misrepresents the 2023 interest rate as 4.84%, when it was 4.45% in 2023 (only rising to 4.84% in 2024). The 2024 carrying value is correctly cited as $26,930 million, but the prior years are wrong. (2) Quantitative accuracy is low: the carrying value change from 2022 to 2023 is completely misrepresented (no decline or stability—there was a significant increase), and the interest rate progression is inaccurate (claims 4.84% in 2023, but ground truth is 4.45%). The final 2024 rate is correct. (3) The multi-hop reasoning is partially sound—the interpretation of a shift toward higher-cost, long-term debt is consistent with the trend—but it is based on incorrect data, undermining the validity. The model fails to correctly synthesize the year-over-year evolution due to data inaccuracies. (4) Contextual relevance is high because the answer addresses all parts of the question (trend in carrying value, interest rate, and strategic implication) and uses appropriate financial reasoning. However, the correctness score is low due to major quantitative errors that distort the factual narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 381,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "From 2022 through 2024, Tesla’s 5.45% Solar Bonds, Series 2015/C92‑15 evolved from a single $250 million issuance in 2015 (documented in the 2015 supplemental indentures filed in 2015) to a series of incremental supplemental indentures that added new tranches and extended maturities through 2016‑2017, as reflected in the 2022‑2024 10‑K filings (pages 102, 103, 105). This progression shows that the company has been systematically refinancing and expanding its solar‑bond program rather than abandoning it, indicating a continued, structured strategy to fund solar projects through debt rather than relying primarily on equity or cash flow.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Tesla's 5.45% Solar Bonds, Series 2015/C92-15. (1) QUANTITATIVE INACCURACY: The claim that the bond evolved through 'incremental supplemental indentures that added new tranches and extended maturities through 2016–2017' is false. The ground truth indicates no new tranches or maturity extensions occurred during 2016–2017; the bond was simply carried forward in disclosures. The $250 million issuance amount is plausible but not confirmed in the ground truth, which focuses on documentation presence, not principal value. (2) COMPLETENESS: The answer fails to address the core trend—declining prominence amid the rise of newer bond series like C102-15 and C106-10—entirely omitting any mention of these newer instruments that signal strategic evolution. (3) ENTITY & TEMPORAL INACCURACY: The LLM incorrectly implies active refinancing and expansion of C92-15 between 2016–2017 based on 2022–2024 filings, but the filings only reference past supplemental indentures without indicating ongoing activity. There is no evidence in the ground truth of refinancing or tranche additions during that period. (4) REASONING FAILURE: The conclusion that Tesla is 'systematically refinancing and expanding' the C92-15 bond series contradicts the ground truth, which shows the bond remained listed but with reduced emphasis as newer bonds emerged. The correct inference is continuity in reporting, not active expansion. (5) SEMANTIC NON-EQUIVALENCE: The LLM invents a narrative of dynamic bond program growth, while the original answer describes static disclosure with strategic shift toward newer instruments. Despite addressing solar financing strategy, the LLM’s reasoning is built on incorrect premises, leading to a misleading interpretation. Contextual relevance is moderate because it discusses the right topic and timeframe but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 520,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 through 2024 AIG’s oversight of loss‑reserve risk remained anchored in a rigorous, multi‑layered framework that combined internal controls, external expert reviews, and quantitative modeling.  Across the three years the company continued to rely on actuarial methods and stochastic scenario analyses to estimate reserves, while enhancing its reinsurance‑collectibility monitoring and expanding the use of third‑party catastrophe and credit‑risk models to stress‑test assumptions.  Governance was reinforced by regular risk‑committee reporting, second‑line challenge functions, and ongoing validation of key reserve‑related estimates—including loss‑reserve discounts, reinsurance recoverables, and embedded‑derivative valuations—ensuring that oversight mechanisms, modeling approaches, and external reviews were consistently applied and refined year over year.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall direction and key themes of AIG's evolving loss reserve risk management from 2022 to 2024, and there are no numeric inaccuracies (quantitative accuracy is perfect, as no specific numbers are involved and no false claims are made). The answer correctly identifies the continuity in internal controls, external reviews, and modeling techniques such as stochastic and scenario analyses. It also appropriately highlights governance elements like risk-committee reporting and second-line challenge functions. However, it does not clearly differentiate the year-over-year evolution emphasized in the original answer: (1) the 2022 focus on internal controls and external reviews, (2) the 2023 expansion to include sensitivity analyses and experience studies, and (3) the 2024 integration into a more structured ERM system with enhanced audits and reporting. While the LLM conveys that practices were 'refined year over year,' it lacks the specific progression and maturation narrative, particularly the increasing formalization of second-line reviews and Internal Audit Group involvement in 2024. This omission reduces qualitative accuracy, as the multi-hop synthesis across the three years is not fully articulated. Contextual relevance is high, as the response stays focused on oversight, modeling, and external reviews. Overall, the answer captures the essence but misses key structural developments that define the evolution, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 423,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s allocation to U.S. Treasury and foreign government securities has steadily declined across the three fiscal years, falling from roughly $1,147 million in 2022 to $1,147 million in 2023 and then to $1,147 million in 2024 (as shown in the Level 1/Level 2 fair‑value breakdown of pension plan assets on page 92). This downward trend reflects a deliberate shift toward a more liability‑driven investment strategy: the company is increasing its fixed‑income exposure to better match the duration of its pension liabilities while reducing reliance on government securities for growth. Consequently, the evolving composition signals that Altria is prioritizing asset‑liability alignment and risk‑controlled funding of its pension obligations over maintaining a larger government‑security portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. It states that Altria's allocation to U.S. Treasury and foreign government securities remained constant at $1,147 million across 2022–2024, which directly contradicts the ground truth showing a percentage decline from 19% to 16% to 8%. The dollar amount being identical across all three years is implausible and indicates a failure to extract or interpret the data correctly. Additionally, the ground truth is based on percentages of total pension assets, not absolute dollar values, and the LLM incorrectly shifts focus to nominal amounts without justification. (2) The calculation and numeric representation are entirely wrong. There is no indication in the ground truth that the dollar value was $1,147 million in any year, let alone all three. The percentages in the original answer (19% → 16% → 8%) show a clear downward trend, but the LLM fails to report these or any accurate proxies. Even if dollar values were used, they should reflect changing proportions of a potentially changing total asset base, not a flat number. (3) The reasoning is partially sound in interpreting a strategic shift, but it draws the opposite conclusion from the evidence. The LLM claims Altria is reducing government securities while increasing fixed-income exposure broadly, yet the ground truth notes a reduction in below-investment-grade securities and a more conservative posture—consistent with de-risking, not increasing fixed-income duration for liability matching. The LLM also introduces the concept of a 'liability-driven investment strategy' not mentioned or implied in the original, and misattributes the rationale. It fails to mention the declining expected rate of return (6.6% → 6.1%), a key indicator of a more cautious outlook. (4) The contextual relevance is moderate because the answer addresses pension asset allocation and attempts to interpret strategic intent, but the factual inaccuracies and flawed reasoning severely undermine its validity. The answer synthesizes information poorly and introduces misleading details (e.g., repeated $1,147M) that suggest hallucination or misreading of source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 588,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose slightly to $562 million in 2024, while long‑term debt increased from $47,832 million in 2022 to $49,318 million in 2023 and $49,856 million in 2024.  The 3‑year trend shows a modest reduction in floating‑rate unsecured senior debt (from $1,597 million to $349 million) and a shift toward more fixed‑rate senior notes and securitized obligations, indicating that the firm has been trimming its exposure to floating‑rate debt and relying more on fixed‑rate and securitized financing, which changes its interest‑rate sensitivity and overall debt‑structure profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports long-term debt alone as $47,832M ($47.832B) in 2022, which already exceeds the total debt in the ground truth, and continues to rise to $49.856B in 2024—this misrepresents both the magnitude and trend. Additionally, the LLM states short-term borrowings were $883M in 2022, but the ground truth does not provide a standalone short-term borrowing figure; instead, it implies that short-term components like floating unsecured senior debt were $1.709B in 2022, not $883M. The LLM’s floating unsecured senior debt drop from $1,597M to $349M is partially aligned with the truth ($1.709B to $349M), but omits that it dropped to $0 in 2024, a critical detail. The securitized debt trend is completely missing in the LLM answer—no mention of its rise to $18.043B in 2023 and decline to $14.264B in 2024. (2) Calculations and comparisons are flawed: the LLM suggests total debt increased steadily, while the truth shows an increase then a decrease. The weighted-average interest rates for securitized and fixed-rate debt—key to understanding interest rate exposure—are entirely omitted. (3) Multi-hop reasoning is partially sound in identifying a shift toward fixed-rate debt and reduced floating-rate exposure, which aligns with the strategic interpretation in the ground truth. However, the conclusion lacks depth due to missing data on interest rates and incorrect base figures. The synthesis across years and debt types is incomplete. (4) Despite incorrect numbers, the answer addresses the general direction of debt structure change (toward fixed-rate), so it retains some qualitative and contextual relevance. However, the severe quantitative errors undermine the correctness score, warranting a 3. Quantitative accuracy is very low (2) due to incorrect magnitudes and missing metrics. Qualitative accuracy is moderate (4) because the directional trend is somewhat correct. Contextual relevance is acceptable (7) as the response stays on topic and attempts multi-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 601,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings indicates that this specific financing instrument remains a persistent and integral component of its capital structure, particularly for funding solar projects. The consistent inclusion of this bond series in the exhibits and disclosures across all three filings underscores its ongoing role in Tesla's strategy to leverage debt financing for solar energy initiatives, reflecting its continued reliance on this mechanism despite evolving market conditions and the company's broader financial landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Tesla, 5.45% Solar Bonds, Series 2015/C25-15, and the years 2022–2024 are accurately referenced. (2) Quantitative accuracy is perfect: the bond interest rate (5.45%), series designation (2015/C25-15), and issuance context (April 14, 2015, via the Thirty-Sixth Supplemental Indenture) are factually correct as per the original answer, though the LLM does not explicitly mention the indenture date or document name. This omission is minor and does not affect the core factual correctness. (3) The multi-hop reasoning is sound: the LLM correctly infers from repeated disclosure across three years that the bond remains an active and strategic part of Tesla’s capital structure for solar financing. The conclusion about ongoing reliance and strategic importance is logically supported by the consistent inclusion in filings. (4) Semantic equivalence is strong—while the LLM omits the specific mention of the 'Thirty-Sixth Supplemental Indenture' and its date, it captures the essential meaning: the bond's persistent role in financing solar projects. The answer is contextually relevant, fully addressing both parts of the question—Tesla’s reliance on the instrument and its ongoing role in capital structure. The only reason for not scoring a 10 is the slight lack of specificity around the legal document details, which are part of the ground truth but not critical to the overall interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 410,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s Class A Treasury Stock holdings increased from 475 shares (cost $60,429 million) in 2022 to 497 shares (cost $71,431 million) in 2023, and further to 503 shares (cost $73,200 million) by the end of 2024. This steady rise reflects an active share‑repurchase program, indicating that the company is allocating capital toward buying back its own stock rather than returning cash as dividends or pursuing large acquisitions. The trend suggests a strategy of deploying excess cash to enhance shareholder value and support the stock price while maintaining flexibility for other investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and years. According to the ground truth, Mastercard's investment in Class A Treasury Stock was $(51,354) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. However, the LLM states the cost was $60,429 million in 2022 (wrong year), $71,431 million in 2023 (misplaced), and $73,200 million in 2024 (inaccurate and not in ground truth). Additionally, the LLM introduces share counts (475, 497, 503 shares) which are not present in the original answer and appear fabricated. (2) Quantitative accuracy is severely compromised: the values are shifted across years, and the 2024 figure is incorrect ($73,200M vs $71,431M). The ground truth shows a consistent increase from 2022 to 2024, but the LLM misaligns the data. (3) The reasoning about capital allocation strategy—emphasizing buybacks over dividends or acquisitions—is qualitatively reasonable and aligns with the trend interpretation in the original answer. However, the multi-hop synthesis fails because the model misattributes values to incorrect years and invents share quantities not supported by the source. (4) Despite incorrect numbers and misaligned years, the LLM captures the general direction of the trend (increasing treasury stock) and infers a plausible strategic motive, which maintains moderate contextual relevance. However, the severe quantitative errors undermine factual correctness, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 413,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell's Safety and Productivity Solutions segment faced mounting macroeconomic pressures from 2022 through 2024, as evidenced by declining segment profit and margins driven by reduced customer investments in automation and plant capacity utilization. This trend—highlighted by a 11% year-over-year segment profit decline in 2024 and a 100-basis-point margin compression—signals broader industrial sector headwinds, including weakened capital spending, supply chain constraints, and economic uncertainty that are suppressing demand for productivity-enhancing technologies across manufacturing and industrial operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of increasing macroeconomic pressure on Honeywell's Safety and Productivity Solutions segment from 2022 to 2024, particularly due to reduced investments in automation and plant capacity utilization, which aligns with the original answer. It also correctly infers that this reflects broader industrial sector headwinds. However, the LLM introduces specific quantitative claims—'11% year-over-year segment profit decline in 2024' and '100-basis-point margin compression'—that are not present in the original (ground truth) answer and cannot be verified from the provided context. Since the evaluation is based on factual alignment with the ground truth (not external data), these unsupported numbers reduce accuracy. (2) The quantitative accuracy is low because the percentages and financial metrics are fabricated or at least unverifiable; the ground truth does not include any numerical data, so introducing specific figures constitutes a factual overreach. (3) The qualitative reasoning is sound: the LLM correctly synthesizes the idea that reduced automation spending and capacity utilization reflect macroeconomic pressures, and it maintains focus on the correct company, segment, and time period. The logic connecting industrial weakness to reduced demand for productivity technologies is reasonable and contextually appropriate. (4) Contextual relevance is high because the answer addresses the core question about evolving risks and macroeconomic implications. However, the correctness score is reduced due to the inclusion of unverified quantitative claims, which misrepresent the precision of the information. While the directionality of the trend (worsening conditions) is consistent, the unsupported numbers undermine factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 491,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 through 2024, Cyramza’s lifecycle positioning shifted as its patent and data‑protection coverage expired: U.S. compound‑patent protection ended in 2026, with European and Japanese compound patents lasting until 2028 and 2026 respectively, while its U.S. data‑protection period concluded in 2026; consequently, after 2024 the product moved from an actively protected, growth‑driving indication toward a phase of declining exclusivity, relying only on remaining foreign compound patents and any potential later‑filed method‑of‑use or formulation extensions to maintain limited market presence.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding dates and jurisdictional details of intellectual property expiration. According to the ground truth, data protection expired in Japan in 2023 and is set to expire in major European countries in 2024, while U.S. compound patents extend to 2026 and European compound patents to 2028. However, the LLM incorrectly states that U.S. data protection concluded in 2026 (no such event mentioned in ground truth), and misrepresents Japanese compound patent expiry as 2026 (ground truth says data protection expired in Japan in 2023, with no mention of compound patent expiry date for Japan). It also incorrectly implies U.S. compound patent protection ended in 2026 (ground truth says it extends to 2026, implying still active in 2024, not ended). (2) The quantitative inaccuracies are critical: the model flips expiration timelines and misattributes them across regions. For example, stating 'U.S. data-protection period concluded in 2026' is factually wrong — the ground truth does not mention U.S. data protection at all, and certainly not its conclusion. Similarly, claiming European compound patents last until 2028 is correct, but pairing it with a false Japanese 2026 expiry introduces confusion. (3) The reasoning is partially sound in that it recognizes a shift toward declining exclusivity, which aligns with the narrowing protection window described in the original answer. However, it fails the multi-hop synthesis by incorrectly mapping protection types (data vs. compound patent) to jurisdictions and timelines. It also omits the key point that therapeutic indications remained unchanged from 2022 to 2024, which is a major component of lifecycle positioning. (4) The contextual relevance is moderate because it addresses lifecycle positioning and IP trends, but the qualitative accuracy is low due to incorrect dates and misattribution of IP types. The correctness score is low because the core facts — especially dates and jurisdiction-specific IP status — are wrong, undermining the answer's reliability despite some correct conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 575,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities measured at fair value showed a modest increase from $1,670 million in assets and $2,335 million in liabilities at the end of 2023 to $1,670 million in assets and $2,335 million in liabilities at the end of 2024, reflecting essentially stable fair‑value balances. The fair‑value measurements rely on Level 3 inputs—including unobservable discount rates, default and prepayment assumptions, and credit spreads—used in discounted‑cash‑flow models for derivative contracts, with changes in these inputs driving the periodic adjustments recorded in earnings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, it reports derivative assets and liabilities in the billions (e.g., $1,670 million and $2,335 million), while the ground truth states net derivative assets/liabilities of $19 million in 2022, $58 million in 2023, and $58 million in 2024. The LLM confuses gross assets and liabilities with net values and cites figures that are off by orders of magnitude. (2) The time frame is also incorrect: the LLM only discusses 2023 and 2024, omitting 2022 entirely, despite the question asking for evolution from 2022 to 2024. (3) The answer incorrectly implies stability from 2023 to 2024 without acknowledging the significant increase from $19M to $58M between 2022 and 2023, which is a key point in the original answer. (4) While the LLM correctly identifies that unobservable inputs (Level 3) such as default rates, prepayment assumptions, and discount rates are used in discounted cash flow models, it fails to report the specific unobservable inputs mentioned in the ground truth—such as swap rates (3–5%, weighted at 4%) and default rates (53–163%)—and does not note their consistent use across years. (5) The reasoning is flawed: it claims stability in fair value between 2023 and 2024, which aligns with the ground truth, but uses incorrect base figures and omits the critical 2022-to-2023 increase. (6) The answer does not compute or mention the net derivative position at all, instead quoting gross assets and liabilities that appear unrelated to the ground truth. Overall, the LLM fails on factual accuracy, completeness, and correct synthesis of multi-hop financial data, resulting in a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 470,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s charitable match program expanded its reach, with thousands of employees worldwide utilizing the program in fiscal 2024 to benefit more than 1,300 charitable organizations (up from 1,500 organizations in fiscal 2022, as noted in the 2022 filing). This growth aligns with the company’s broader human‑capital objectives—such as increasing diversity, equity and inclusion targets and tying executive bonuses to human‑capital advancements—by reinforcing Qualcomm’s focus on community engagement and employee involvement as key performance drivers for executive compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change in the number of supported organizations. The ground truth states that the number decreased from over 1,500 in 2022 to over 1,300 in 2024, but the LLM incorrectly claims it increased from 1,500 to 1,300, which is both numerically and logically wrong (1,300 is fewer than 1,500). This misrepresents the trend. Additionally, the LLM implies the 1,500 figure was from the 2022 filing, which may be technically correct, but frames it as if the number grew to 1,300, which is inaccurate. (2) Quantitative accuracy is low because the core numbers—while present—are misused in comparative analysis. The LLM says 'more than 1,300... up from 1,500', which is mathematically false. This is a major error in numerical reasoning. Employee participation is correctly described as 'thousands' in both years, which matches the ground truth. (3) The qualitative reasoning is partially sound: the link between human capital goals and executive compensation is correctly identified, including the use of non-financial modifiers (0.9–1.1) and alignment with DEI objectives. However, the conclusion that the program 'expanded its reach' contradicts the slight decline in organizations supported, undermining the validity of the synthesis. The model fails to acknowledge the nuance that despite fewer organizations, sustained participation still reflects alignment with human capital goals. (4) Contextual relevance is high because the answer addresses all components of the question—program evolution, employee participation, number of organizations, and executive compensation linkage—and uses appropriate terminology. However, due to the significant quantitative and directional error in the trend analysis, the overall correctness score is low. Minor note: 'fiscal 2024' is used correctly, and the global scope of participation is accurately reflected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 520,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's positioning of Acrobat evolved from 2022 to 2024 as a core component of Document Cloud, with increasing integration into Creative Cloud and AI capabilities. In 2022, Acrobat was highlighted as part of Document Cloud's document services platform for digital workflows, emphasizing PDF technology and integration with Adobe Sign. By 2023, the focus shifted to AI-driven enhancements, with Acrobat AI Assistant introduced as part of Adobe's broader AI strategy to modernize document productivity, while continuing to emphasize its role in Document Cloud's end-to-end workflows. In 2024, Acrobat AI Assistant was further integrated into the Document Cloud ecosystem, enabling AI-powered features like automated document tagging and content-aware editing, reinforcing its strategic role within Adobe's AI-enhanced document services and broader Document Cloud positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Acrobat's role as a core component of Document Cloud in 2022, its integration with Adobe Sign and Creative Cloud, and the evolution toward AI-driven features are all accurately represented. The introduction of the 'Acrobat AI Assistant' in 2023 and its deeper integration by 2024 are correctly noted. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), correctly identifying the shift from PDF standardization to AI-enhanced productivity. The only minor shortcoming is that the LLM does not explicitly mention the 2024 trademark registration of 'Acrobat AI Assistant', which is a specific detail from the ground truth. Additionally, the 2022 emphasis on market leadership in legal, financial, and publishing sectors is slightly underemphasized. (4) Despite these minor omissions, the LLM captures the core evolution and strategic trajectory accurately, with excellent contextual relevance and semantic equivalence. The answer is concise, logically structured, and fully addresses the question’s components: role in Document Cloud, integration with other services, and product enhancements over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 382,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "From 2022 through 2024 the financial impact of Lilly’s COVID‑19 antibody collaboration with AbCellera shifted dramatically.  Net product revenue from the antibodies fell to $0 in 2023 and 2024 after reaching $2.24 billion in 2021 and $2.02 billion in 2022, while royalty payments to AbCellera—recorded as cost of sales—were likewise eliminated once sales ceased.  Consequently, the royalty expense that had previously been a component of cost of sales disappeared, and no new milestone or royalty obligations tied to bamlanivimab or bebtelovimab were recognized after 2022.  (All figures are drawn from the disclosed revenue tables and the discussion of the AbCellera agreement.)",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial evolution of LLY's collaboration with AbCellera, noting the drop in net product revenue to $0 in 2023 and 2024 after $2.02 billion in 2022, and the cessation of royalty payments. However, it incorrectly references $2.24 billion in 2021, which is not part of the original question or ground truth—this figure, while potentially accurate from external knowledge, introduces data outside the 2022–2024 scope and distracts from the required time frame. The ground truth does not mention 2021, so including it reduces quantitative accuracy. (2) The $2.02 billion figure for 2022 is correct and matches the original answer. The statement that there were no sales or royalties in 2023 and 2024 aligns with the ground truth. However, the inclusion of the 2021 number, though possibly factual, is extraneous and not part of the required multi-hop analysis from 2022–2024, leading to a partial deduction in quantitative accuracy. (3) The reasoning is sound: the LLM correctly infers that no sales lead to no royalties, and it connects the financial metrics to the contractual terms (royalties as cost of sales). It synthesizes the cause-effect relationship between revenue decline and royalty obligations, demonstrating strong qualitative reasoning. (4) Contextual relevance is perfect—the answer directly addresses the evolution of net product revenue and royalty payments over the specified period, even if it includes an unnecessary prior-year figure. The core multi-hop synthesis (from sales to royalty impact across years) is accurate and well-articulated. Thus, correctness is high but not perfect due to the extraneous 2021 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 462,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s reliance on the modified coinsurance agreement as a percentage of its closed block remained consistently at 59% throughout 2022, 2023 and 2024, as disclosed in the 2022, 2023 and 2024 10‑K filings (e.g., “The Company has reinsured, with an unaffiliated third‑party reinsurer, 59% of the closed block through a modified coinsurance agreement”). This unchanged 59% share demonstrates that the company maintains a stable, long‑term risk‑transfer strategy for the closed block, preserving a consistent level of capital relief and limiting exposure to retained mortality risk over multiple years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core trend of MetLife's reliance on the modified coinsurance agreement, stating a consistent 59% reinsurance level across 2022, 2023, and 2024. However, it rounds the 2022 figure to 59% when the ground truth specifies 59.25%, which is a minor but notable loss of precision. This does not materially alter the conclusion but affects quantitative accuracy. (2) The percentages are mostly accurate—59% for 2023 and 2024 match exactly, while 2022 is approximated. The LLM uses 'consistently at 59%' which implies no change, slightly oversimplifying the small drop from 59.25% to 59%. No calculations are required beyond reporting, so no computational errors exist. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers strategic continuity in risk transfer, aligning with the ground truth’s interpretation about long-term liability management. The mention of 'capital relief' and 'limiting exposure to retained mortality risk' adds contextually appropriate qualitative insight not in the original but consistent with it. (4) The answer is semantically equivalent in intent and meaning, with only minor rounding affecting precision. Scores reflect high accuracy, with a 9 instead of 10 due to the slight inaccuracy in the 2022 percentage representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 377,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s security strategy has evolved from a primarily network‑centric, multi‑layered protection model in 2022 to a more collaborative, real‑time, and ecosystem‑wide approach by 2024.  In 2022 the focus was on layered defenses of its core payment network and third‑party risk management; by 2024 the company is actively integrating its virtual‑card, tokenization and real‑time account‑based payment capabilities with external platforms, launching Alias‑Based Remittances, and partnering with central banks, fintechs and other ecosystem players to embed security directly into cross‑border disbursement flows.  This shift signals a strategic move toward proactive, partnership‑driven cybersecurity that embeds security into new payment rails and real‑time infrastructure, reinforcing Mastercard’s broader goal of building a secure, inclusive and interoperable global payments ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Mastercard's security strategy from 2022 to 2024 with correct emphasis on third-party collaboration and real-time infrastructure. However, it lacks specific quantitative details present in the ground truth: the exact number of real-time payment markets (12 in 2022, 13 in 2023) is omitted, and the 2024 description uses vague phrasing ('several countries globally') without confirming continuity or expansion. These omissions affect quantitative accuracy. (2) No incorrect numbers are stated, but the absence of verifiable metrics from the knowledge graph—especially the precise market counts per year—means the answer cannot be fully validated as quantitatively accurate. The LLM introduces new elements like 'Alias-Based Remittances' and 'virtual-card, tokenization' integration not mentioned in the ground truth, which, while plausible, are unsupported by the provided data and risk introducing hallucinated specifics. (3) The multi-hop reasoning is generally sound: the model correctly infers a strategic shift toward deeper third-party integration and real-time infrastructure as a cybersecurity posture. It synthesizes the trajectory of collaboration and infrastructure growth logically, even if some supporting facts are generalized or augmented. (4) Contextual relevance is high—the response directly addresses the question’s focus on evolution, third-party collaboration, and real-time infrastructure, and draws a valid strategic conclusion about proactive, partnership-driven security. The qualitative accuracy is strong in reasoning and entity identification (Mastercard, third-party providers, real-time payments), though slightly weakened by unsupported specifics. Overall, the answer is factually aligned in direction and theme but lacks key granular evidence, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 505,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From 2022 through 2024, LLY’s allocation to private alternative investments—specifically equity‑like funds—grew steadily, rising from $25.4 million (recorded as Level 3) in 2022 to $25.1 million (Level 3) in 2023 and $25.1 million again in 2024, with the total fair‑value of those funds increasing from $2,844.7 million in 2022 to $4,093.7 million in 2023 and $4,093.7 million in 2024. This upward trend indicates that LLY is progressively increasing its exposure to illiquid, equity‑style private assets, reflecting a strategic shift toward longer‑term, higher‑potential investments in less liquid asset classes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numerical values. It incorrectly states that LLY's allocation to equity-like funds was $25.4 million in 2022 and $25.1 million in 2023 and 2024, which is grossly wrong—the actual allocations were $2,844.7 million in 2022, $4,014.1 million in 2023, and $4,093.7 million in 2024. The LLM confuses Level 3 valuation inputs (a categorization of fair value hierarchy) with actual investment amounts, leading to a misrepresentation by orders of magnitude. While the final total fair value numbers for 2023 and 2024 are partially correct ($4,093.7 million), the 2023 figure is misrepresented as a jump from $2,844.7M to $4,093.7M, omitting the reported dip in 2023 to $4,014.1M. (2) Calculations and trends are therefore flawed: the correct trend is an increase from 2022 to 2024 with a minor dip in 2023, but the LLM implies steady growth and misaligns the timeline. The $25 million figures appear to be a misreading of a footnote or Level 3 disclosure unrelated to total allocation. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that increasing allocations suggest a strategic shift toward illiquid, long-term assets, which aligns with the ground truth. However, due to incorrect data, the reasoning is based on faulty premises. (4) Contextual relevance is fair, as the answer addresses the question’s structure and attempts to interpret strategic implications, but the severe quantitative errors undermine the validity of the conclusion. The answer mixes correct high-level interpretation with catastrophic data inaccuracies, warranting a low correctness score despite some structural fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 462,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "From 2022 to 2024, Cascade’s contribution to the Fabric & Home Care segment grew significantly: its share of net sales rose from 17% in 2023 to 19.3% in 2024 (a 230‑basis‑point increase), and its net earnings share climbed from 17.5% to 19.8% (also a 230‑basis‑point rise). This reflects Cascade’s expanding role within the segment, driven by higher pricing and favorable mix, even as overall segment net sales grew modestly (4% in 2024). Consequently, Cascade’s relative contribution to both sales and earnings has risen markedly over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) Quantitatively, the LLM fabricates specific figures not present in the original answer: it claims Cascade's share of net sales rose from 17% in 2023 to 19.3% in 2024 and cites net earnings share increases, none of which appear in the ground truth. The original answer does not provide Cascade's individual contribution to net sales or earnings at any point—only the overall Fabric & Home Care segment’s contribution (35% in 2022, 36% in 2023 and 2024). (2) The LLM incorrectly implies that Cascade’s standalone sales share within the segment is reported and growing significantly, while the ground truth only confirms Cascade remained a 'key brand' with stable positioning—no granular sales or earnings percentages for Cascade itself are provided. (3) The reasoning is flawed: the LLM invents a '230-basis-point increase' and attributes growth to 'higher pricing and favorable mix,' which are unsupported claims absent from the source. (4) Contextually, the answer addresses the question’s theme (Cascade’s positioning), so it is relevant, but it fails on factual accuracy and multi-hop synthesis—no evidence supports the detailed metrics or conclusions drawn. The original answer indicates stability, not growth, in Cascade’s role. Thus, the correctness and quantitative accuracy scores are very low; qualitative accuracy is slightly higher only because the model attempts reasoning within the right segment context, but it is ultimately speculative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 419,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 through 2024 Lowe’s deepened its supplier sustainability framework and wood‑sourcing policy with a risk‑based approach, expanded monitoring and grievance processes, and heightened oversight by the Board’s sustainability committee.  The company set a net‑zero GHG target for 2050, raised interim 2030 goals (42 % cut in scope 1/2 emissions, 25 % cut in scope 3), and tied these ambitions to its capital‑allocation strategy—investing over $550 million in energy‑efficiency, renewable‑energy and SmartWay‑certified transportation projects while reporting progress in its Corporate Responsibility Report and to CDP.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key areas. (1) Quantitative inaccuracies: The $550 million investment in environmental facility upgrades is correctly mentioned, but the LLM introduces a $50 million Gable Grants program as $50 million over five years—this detail is missing entirely in the LLM response. Instead, the LLM fabricates or misattributes additional investments tied to SmartWay and renewable energy without grounding in the original answer. More critically, the LLM invents specific GHG reduction targets (42% scope 1/2, 25% scope 3 by 2030) and a 2050 net-zero goal, which are not present in the original answer and thus factually unsupported. (2) Completeness: The question asks about evolution in supplier sustainability monitoring and wood sourcing practices across 2022–2024 with specific enhancements to policy and investment. The LLM omits the 2022 Vendor Code of Conduct, the country-level risk classification updates in 2023, and the forestry grievance process. It also fails to mention the 2024 integration of a more robust risk-based approach into wood sourcing policy. While it mentions a risk-based approach generally, it lacks the specific policy evolution described in the ground truth. (3) Entity accuracy: References to 'Board’s sustainability committee' and 'CDP reporting' are not in the original and may be plausible but are unverified and distract from the actual policy developments. The core entities—Lowe's, years 2022–2024, wood sourcing, supplier monitoring—are correctly identified. (4) Reasoning: The LLM synthesizes information but does so incorrectly by introducing unrelated environmental goals (GHG targets) not tied to supplier or wood sourcing practices. It conflates broader corporate sustainability with the specific supplier and sourcing policies asked in the question. (5) Semantic equivalence: While the tone and structure suggest a comprehensive answer, the factual core diverges—especially in invented metrics and omitted policy milestones. The mention of $550 million aligns with the original, but other investments and strategic shifts are misrepresented. Overall, partial credit is given for correct mention of the $550M investment and general direction of sustainability enhancement, but major deductions for hallucinated data and missing multi-hop details on policy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 635,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s exposure to competitive pressures and product commoditization has intensified across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024. In Safety and Productivity Solutions, segment profit fell 11% in 2024 versus 2023, with margin compression tied to commoditization risks noted in risk factors and lower demand for safety products. Building Technologies saw modest sales growth but margin gains driven by pricing power amid competitive pressures, while Industrial Automation’s segment profit declined 11% in 2024, reflecting commoditization concerns highlighted in risk disclosures. Across all segments, risk factors consistently cite \"new market entrants and new technologies that may lead to product commoditization\" as a key threat, signaling escalating market pressures that increasingly challenge Honeywell’s ability to maintain pricing power and margin resilience. This progression underscores a strategic shift toward managing commoditization risks through innovation and portfolio optimization, particularly as competitive dynamics accelerate.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—such as an 11% decline in segment profit for Safety and Productivity Solutions and Industrial Automation in 2024—that are not present in the original ground truth and cannot be verified from the provided context. These numbers are factually unsupported by the original answer, which focuses solely on qualitative risk disclosures, not actual financial performance. Additionally, the claim that Building Technologies achieved 'margin gains driven by pricing power' contradicts the original narrative of increasing commoditization pressure and is not supported by the ground truth. (2) Quantitative accuracy is severely compromised: the LLM fabricates percentage declines (11%), profit trends, and margin dynamics with no basis in the original answer, which contains no financial metrics or performance data. Even allowing for format variation, invented numbers cannot be considered accurate. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the three business segments and associates them with competitive pressures and commoditization risks over time. It correctly notes that 'new market entrants and new technologies' are cited as risks across segments. However, it misrepresents the nature of the source information—risk factor disclosures—by conflating them with actual financial outcomes, thus failing to accurately reflect the progression of risk disclosures over 2022–2024 as described in the ground truth. The original answer emphasizes the *expansion* of risk language across segments over time (S&PS in 2022, HBT in 2023, IA in 2024), which the LLM omits entirely, losing the temporal progression and structural logic of the original. (4) While the LLM captures the general theme of increasing competitive pressure and commoditization risk, it substitutes qualitative disclosure trends with fabricated quantitative performance data, undermining factual correctness. The contextual relevance is moderate because it addresses the right segments and risks, but the qualitative accuracy is reduced due to incorrect reasoning structure and missing the core insight about the *progressive expansion* of risk disclosures across years and divisions. Correctness is scored low due to major factual and representational errors despite some thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 629,
        "total_tokens": 2214
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "From fiscal 2022 through 2024 Qualcomm’s automotive business shifted from a modest, niche offering to a core growth engine within its QCT segment.  In the 2022 filing (p. 7) the company highlighted that “Automotive (2) Includes revenues from products sold for use in automobiles, including connectivity, digital cockpit and ADAS/AD,” and later disclosed that automotive revenue grew to $2.9 billion in fiscal 2024 (p. 73), up from $1.5 billion in fiscal 2022 (p. 73).  This expansion reflects Qualcomm’s strategic focus on the “digital cockpit” and connected‑car platforms, leveraging its 5G, AI and low‑power compute technologies to capture a share of the projected 70 % of new vehicles that will have embedded cellular connectivity by 2028 (p. 8).  Consequently, the automotive revenue stream, previously a small component of total QCT sales, now represents a material and fast‑growing segment of Qualcomm’s overall revenue base.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures key elements of Qualcomm's strategic evolution in the digital cockpit market from 2022 to 2024, particularly the growth in automotive revenue and reference to market projections (e.g., 70% of new vehicles with embedded connectivity by 2028), which aligns with the ground truth. Quantitatively, the revenue figures are accurate: $1.5 billion in fiscal 2022 and $2.9 billion in fiscal 2024 (per p.73 of the filing), and the mention of digital cockpit, connectivity, and ADAS/AD as components of automotive revenue in 2022 is correctly cited (p.7). However, the LLM answer misses the nuanced progression in segment reporting and revenue recognition that is central to the question. Specifically, it fails to note that in 2023, Qualcomm began explicitly recognizing digital cockpit products as part of its automotive revenue stream—a key transition from vision to monetization—and in 2024, formally integrated digital cockpit into structured segment reporting under QCT. While the LLM implies integration by referencing QCT and growth, it does not articulate the multi-hop evolution from strategic positioning (2022) to monetization (2023) to formal operational integration (2024). This omission weakens the qualitative accuracy, as the reasoning does not fully trace the disclosed strategic evolution across the three years. The answer is contextually relevant and well-supported with citations, but lacks the precise disclosure-based timeline of strategic maturation. Wording variations are acceptable, but missing the 2023 inflection point in revenue recognition is a significant gap in synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 441,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "From 2022 through 2024 Adobe expanded Frame.io’s integration and functional scope within its Creative Cloud ecosystem.  The 2022 filing notes Frame.io’s cloud‑native collaboration platform supporting video, still images, design files and PDFs, with direct integration into Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and Camera‑to‑Cloud upload capabilities.  By 2023 the platform was highlighted as part of Adobe GenStudio for large‑scale content production, and the 2024 filing emphasizes that Frame.io now works natively with the full suite of Creative Cloud apps (including Express and Firefly‑powered tools) and adds broader support for still images, design files and PDFs, while continuing to provide frame‑accurate commenting and approvals.  Enterprise‑level capabilities have grown to include customizable workflow controls, advanced permissioning and analytics, positioning Frame.io as a core hub for end‑to‑end creative production across Adobe’s products.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Frame.io's integration and expansion within Adobe's ecosystem and correctly identifies key capabilities such as support for video, still images, design files, and PDFs, as well as integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. It also correctly notes Frame.io's inclusion in Adobe GenStudio for large-scale content production by 2023, aligning with the 2024 ground truth. However, there are significant factual inaccuracies in the timeline and feature rollout: the LLM incorrectly states that integrations with Photoshop, Lightroom, and Workfront were already present in 2022, while the ground truth indicates these deeper integrations occurred by 2024. Additionally, the LLM backdates the GenStudio inclusion to 2023, whereas the original answer specifies this as a 2024 development. The LLM also introduces 'Express' and 'Firefly-powered tools' and 'Camera-to-Cloud' capabilities not mentioned in the ground truth, which lacks any mention of Express or Firefly integrations. While the enterprise capabilities (customizable workflows, permissions, analytics) are plausibly inferred, the original answer emphasizes new use cases like casting, location scouting, and marketing campaign management—specific functional expansions missing from the LLM response. These omissions and chronological inaccuracies undermine the multi-hop reasoning, particularly the synthesis of year-by-year progression. Quantitative accuracy is high because there are no numerical errors (dates are used correctly in context, even if misassigned), and contextual relevance is strong as the answer addresses media types, integrations, and enterprise features as asked. However, the reversal of the integration timeline and addition of unsupported details reduce qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 503,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares continued to carry one vote per share and dividend rights, while Class B shares remained non‑voting but retained dividend rights; the company consistently declared quarterly cash dividends of $0.49 per share in 2022 and later increased the per‑share dividend to $2.74 annually by 2024, reflecting a stable dividend policy.  The ownership structure shows a gradually declining Mastercard Foundation stake (from ~10.4 % in 2023 to 9.3 % in 2024) and a rising share of voting power held by public Class A shareholders (from 89.5 % to 90.6 %), indicating that governance remains anchored in a broadly dispersed public equity base with a diminishing but still significant foundation influence, suggesting a stable, shareholder‑friendly governance framework over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies not supported by the ground truth. While it correctly states that MA's Class A shares have 'one vote per share' and 'dividend rights'—consistent with the original answer—it introduces specific dividend amounts ($0.49 per share in 2022, $2.74 annually by 2024) and ownership percentages (Mastercard Foundation stake at 10.4% in 2023, 9.3% in 2024; public voting power rising from 89.5% to 90.6%) that are not present in the ground truth and cannot be verified from the provided information. These numbers appear fabricated or hallucinated, as the original answer makes no mention of dividend amounts or ownership stakes. (2) The quantitative accuracy is low because the introduced figures—dividend payments and ownership percentages—are unsupported. Even if the trend of increasing dividends or shifting ownership were plausible, the absence of such data in the ground truth means their inclusion undermines factual correctness. (3) The reasoning partially addresses the question by noting stability in voting and dividend rights, which aligns with the original answer’s conclusion about governance stability. However, the multi-hop synthesis is flawed: the model infers trends in ownership and dividend policy that are not documented in the ground truth, leading to an overextended and unjustified narrative about governance evolution. (4) Contextual relevance is moderate because the answer focuses on shareholder governance and attempts to interpret trends, but it adds extraneous details not grounded in the source data. The core point about stable rights is correct, but the added specifics reduce overall accuracy. The correctness score is 4 due to partial factual alignment but significant hallucination of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 485,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment has experienced declining sales and margins tied to retail‑market volatility: in 2024, sales fell $705 million due to weaker demand for personal‑protective equipment and warehouse‑workflow projects, causing segment profit to drop $247 million and margin to slip 100 basis points to 19.5% (page 25‑26).  Earlier, in 2023 the segment’s sales rose only 1% with profit up 5% as organic growth in Building Solutions offset currency headwinds (page 28).  This pattern shows the segment is increasingly vulnerable to swings in consumer‑driven demand, making its performance sensitive to broader retail‑market fluctuations across fiscal years 2022‑2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that in 2024, sales fell by $705 million and profit dropped $247 million with a margin decline to 19.5% is not supported by the ground truth, which does not provide specific financial figures for the impact of retail market fluctuations. These numbers appear fabricated or misattributed, as the original answer focuses on qualitative risk disclosures rather than actual financial performance declines. Similarly, the statement about 2023 sales rising 1% and profit up 5% due to Building Solutions growth is not mentioned in the ground truth and introduces data points absent from the source. (2) Quantitative accuracy is low because all cited dollar amounts, percentages, and margin changes are unsupported by the original answer. There are no calculations or figures in the ground truth to verify these claims, making them factually incorrect in context. (3) Qualitatively, the LLM correctly identifies that the Safety and Productivity Solutions segment (later renamed Industrial Automation) was exposed to retail market fluctuations across 2022–2024 and that this reflects sensitivity to consumer demand. It also correctly infers ongoing vulnerability, aligning with the ground truth’s conclusion about persistent exposure despite restructuring. However, it mischaracterizes the nature of the information—presenting actual financial impacts rather than risk disclosures—and fails to mention the evolution of segment naming (S&P Solutions to Industrial Automation), weakening the multi-hop synthesis. (4) Contextual relevance is high because the answer addresses the core theme of retail market impact and consumer demand sensitivity over time. However, the incorrect presentation of precise financial figures as if they were reported outcomes—rather than qualitative risk statements—undermines factual correctness, warranting a moderate score overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 532,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the royalty structure for Olumiant remained anchored to a tiered, double‑digit royalty on worldwide net sales (up to 20 %) with an additional low‑teens royalty on COVID‑19 sales that began after the 2020 amendment.  Milestone payments tied to regulatory approvals and sales thresholds continued to be capitalized as intangible assets and amortized into cost of sales, while Incyte’s eligibility for up to $100 million of further success‑based regulatory and sales milestones persisted.  The only notable evolution was the 2020 addition of a COVID‑19‑specific royalty provision and the associated sales‑based milestones; no structural changes to the royalty rate or milestone framework occurred between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains key inaccuracies in the evolution of the financial obligations between LLY and Incyte from 2022 to 2024. (1) Quantitatively, the numbers are mostly accurate: the $100 million in regulatory milestones and $100 million in sales-based milestones, up to 20% royalty rates, and low-teens royalty on COVID-19 sales are correctly stated. However, the LLM incorrectly attributes the COVID-19 royalty provision to a 2020 amendment, while the ground truth does not specify the timing of that amendment—this misrepresents the timeline. (2) The LLM claims 'no structural changes occurred between 2022 and 2024,' which directly contradicts the ground truth: in 2023, milestone payments were capitalized as intangible assets and amortized into cost of sales—a significant accounting and financial obligation shift. The LLM acknowledges capitalization but fails to recognize it as an evolution, instead treating it as a static feature. (3) The ground truth emphasizes a shift from milestone-driven obligations to a stable royalty-based model by 2024, with most contingent payments likely triggered or expired. The LLM misses this dynamic evolution and incorrectly implies that Incyte remained eligible for milestone payments throughout 2024, which is not supported by the ground truth. (4) While the LLM correctly identifies the entities (LLY, Incyte, Olumiant) and the core royalty structure, it fails in multi-hop reasoning by not synthesizing the change in nature of obligations over time—this is a critical omission for a question about evolution. (5) The answer is contextually relevant and well-structured, but the lack of recognition of the transition from milestones to royalties reduces factual correctness. Thus, the answer is factually incomplete and contains a misleading assertion about the stability of the structure, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 509,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "From 2022 to 2024, Procter & Gamble’s Baby, Feminine & Family Care segment saw modest net‑sales growth (essentially flat in 2024 after a slight decline in 2023) driven by higher pricing and a more favorable product mix, while unit volume fell modestly. Within the segment, the Feminine Care sub‑category—home to the Always brand—maintained its position as a global market‑share leader (over 25 % share) and posted a 13 % increase in net earnings, helped by pricing gains and premium‑product mix. Overall, Always remained one of the segment’s most prominent brands, but its relative prominence was tempered by the segment’s flat sales and slight share erosion, with the brand’s growth now relying more on price and mix improvements than volume expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) The question asks about the evolution of Always' strategic positioning from 2022 to 2024, specifically regarding product categorization and prominence relative to other brands. The original answer correctly details how Always moved from being categorized under 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to a more targeted 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023–2024, signaling a sharpened focus on menstrual care. The LLM answer ignores this categorization shift entirely. (2) Quantitatively, the LLM introduces unsupported figures: '13% increase in net earnings', 'over 25% market share', and 'flat sales in 2024 after decline in 2023'—none of which appear in the ground truth and cannot be verified from the provided context. These numbers are factually ungrounded, leading to a very low quantitative accuracy score. (3) The reasoning is flawed: instead of tracing the brand’s categorization and structural positioning within P&G’s reporting segments over time (a multi-hop task across years), the model fabricates financial performance metrics and discusses pricing and volume trends not mentioned in the original. It also incorrectly implies that Always’ prominence declined due to 'slight share erosion', which contradicts the ground truth stating Always remained a major brand alongside Always Discreet and Tampax. (4) While the answer is contextually relevant in discussing Always within the Baby, Feminine & Family Care segment, it misses the actual evolution in product classification and strategic focus, which is the central point. The answer substitutes real structural changes with imagined financial performance, resulting in a low correctness score despite some topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 491,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN's target asset allocation strategy for defined benefit pension plans has evolved across fiscal years as follows:  \n- **Fiscal 2023 (target stated in 2022 filing)**: U.S. Plans: 100% Debt securities; Non-U.S. Plans: 48% Debt, 21% Insurance contracts, 10% Other (reflecting a conservative, duration-matching focus).  \n- **Fiscal 2024 (target as of August 31, 2023)**: U.S. Plans: 94% Debt, 23% Equity; Non-U.S. Plans: 42% Debt, 21% Insurance, 23% Equity (introducing modest equity exposure while maintaining liability-driven investment principles).  \n- **Fiscal 2025 (target stated in 2023 and 2024 filings)**: U.S. Plans: 100% Debt; Non-U.S. Plans: 36% Debt, 28% Equity, 21% Insurance, 8% Other (significantly increasing equity allocation to 28% for non-U.S. plans and maintaining 100% debt for U.S. plans).  \n\nThis progression reveals a deliberate, multi-year strategy to **gradually increase equity exposure—particularly in non-U.S. plans—to enhance risk-adjusted returns while maintaining liability duration matching through fixed-income allocations**. The shift from a near-exclusively debt-heavy stance (2023) to a more balanced, growth-oriented allocation (2025) reflects ACN’s recognition of evolving market conditions and the need to balance long-term return objectives with the imperative to manage liability-driven risks. The consistent emphasis on duration matching (e.g., debt securities aligned with liability profiles) underscores a disciplined approach to preserving funded status while seeking incremental returns above inflation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that ACN maintained a consistent target asset allocation framework across fiscal years 2023–2025, emphasizing duration matching and diversification with no indication of specific percentage allocations by plan type (U.S. vs. Non-U.S.) or shifts in equity/debt weights. However, the LLM fabricates detailed numerical breakdowns (e.g., 'U.S. Plans: 100% Debt', '28% Equity for non-U.S. plans') that are not present in the original answer or supported by the knowledge graph. These specific percentages and the claimed evolution—especially the increase in equity exposure—are not mentioned in the ground truth, which instead emphasizes strategic continuity and flexibility without specifying such reallocations. The multi-hop reasoning is flawed because it invents data rather than synthesizing actual disclosures. While the LLM correctly identifies the qualitative theme of balancing risk-adjusted returns with liability duration matching, this insight is applied to a factually incorrect foundation. The contextual relevance is moderate because the response addresses the right topic and attempts to interpret strategic intent, but the invented figures severely undermine correctness. There is no evidence in the ground truth for a 'gradual increase in equity exposure' or distinct U.S./Non-U.S. allocation paths. Thus, despite plausible-sounding analysis, the answer is largely incorrect due to hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1719,
        "completion_tokens": 420,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe's exposure to forward interest rate swaps declined sharply from 2022 to 2024, falling from $2,560 million of notional amount in 2022 to $638 million in 2023 and then to $251 million in 2024, reflecting a strategic shift away from cash‑flow hedges toward a greater reliance on fixed‑to‑floating fair‑value swaps on existing debt. This change is accompanied by a reclassification of the swaps from cash‑flow hedge accounting to fair‑value hedge accounting, which eliminates net earnings impact because the hedges are now treated as perfectly effective under the shortcut method. The transition reveals that Lowe's is managing interest‑rate risk primarily through direct hedge accounting on its debt instruments rather than through speculative or forward‑looking derivative positions, underscoring a more disciplined and balance‑sheet‑focused approach to mitigating benchmark‑rate volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Lowe's did not report a current fair value for forward interest rate swaps, but the LLM claims a notional amount of $2,560 million, which is unsupported. In 2023, the fair value was $251 million (correctly cited by the LLM), but this is a fair value, not a notional amount, and the LLM misrepresents it as part of a declining notional trend. By 2024, Lowe's no longer held forward interest rate swaps at all, but the LLM incorrectly states a $251 million exposure in 2024, reversing the actual timeline and facts. (2) The numbers are fundamentally wrong: the $2,560M and $638M figures for 2022 and 2023 notional amounts are not in the ground truth and appear fabricated. The $251M figure is correct for 2023 fair value but misapplied to 2024 and treated as notional. No quantitative trend of declining notional exposure is supported. (3) The reasoning is flawed: the LLM asserts a continuous decline in exposure, but the ground truth shows a complete discontinuation of forward swaps by 2024, not a gradual decline. The shift from cash flow to fair value hedges is correctly identified in direction but misrepresented in timing and mechanism. The claim about 'shortcut method' and 'eliminates net earnings impact' is speculative and not in the original data. (4) While the general theme of a strategic shift in hedging is present, the incorrect numbers, misstated years, and invented notional amounts severely undermine factual correctness. The answer is contextually relevant to interest rate risk management but fails on core accuracy, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 460,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO's financial exposure to the 5.000% notes due April 2030 decreased from $606 million in fiscal 2022 to $606 million in fiscal 2023 and remained $606 million in fiscal 2024, indicating that the company maintained a stable position in this specific tranche of its long‑dated debt. The overall senior‑note portfolio grew substantially, with total principal outstanding rising from $40.8 billion in 2022 to $69.8 billion in 2024, reflecting a strategic shift toward issuing higher‑yielding fixed‑rate notes (e.g., the 5.000% 2030 notes) and leveraging new financing to fund acquisitions and growth initiatives. This progression suggests AVGO is actively managing its debt maturity profile and capital structure by extending average debt tenor and diversifying funding sources.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, not $606 million as stated by the LLM. The LLM incorrectly claims the amount was $606 million in 2022 and remained flat through 2024, while the truth is it decreased from $1,086M to $606M by 2023 and stayed at $606M in 2024. This misrepresents the entire trend. (2) The quantitative inaccuracies are severe: the starting value is wrong, the progression is misrepresented as stable instead of declining, and no mention is made of the actual $480 million reduction over the period. The LLM also introduces unrelated information about total senior notes increasing from $40.8B to $69.8B, which, while potentially contextually relevant, distracts from the specific question about the 5.000% 2030 notes and is not supported in the ground truth. (3) The multi-hop reasoning is flawed: the question asks about the evolution of exposure to a specific debt instrument and what that indicates about debt management. The correct inference is a deliberate reduction strategy. The LLM instead infers a strategy of maintaining stable exposure and issuing higher-yielding debt, which contradicts the evidence of a clear reduction from over $1B to $606M. The reasoning is based on incorrect data and thus invalid. (4) Contextual relevance is moderate because the LLM addresses debt management strategy and references the correct company and note, but the core facts are wrong, leading to an incorrect conclusion. The inclusion of broader debt portfolio trends is extraneous and not asked for. Scores reflect major factual and quantitative errors undermining correctness and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 478,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s 7.620% debentures, issued in 2022 with a $276 million principal and a 2030 maturity, were described in the 2022 filing as redeemable at any time at UPS’s option, with a redemption price tied to the greater of the principal plus accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield plus five basis points. By the 2023 filing the same debentures were still outstanding with the identical redemption mechanics, but the interest rate had been reduced from 8.375% to 7.620% effective April 1 2020 and remained unchanged thereafter. The 2024 filing shows no change to the debenture terms—still maturing on April 1 2030, callable at UPS’s option, with the same “greater of” redemption formula and semi‑annual interest payments—indicating that the treatment and disclosure of these debentures have remained consistent through 2022‑2024 regarding interest rate, redemption rights, and maturity structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the issuance date. The original answer states that the debentures had a maturity date of April 1, 2030, and that the interest rate was reduced in April 2020 from 8.375% to 7.620%, implying the instrument predates 2022. However, the LLM incorrectly states the debentures were 'issued in 2022', which contradicts the ground truth and misrepresents the timeline. All other quantitative details—$276 million principal, 7.620% interest rate, April 1, 2030 maturity, redemption terms—are accurate. (2) Quantitative accuracy is high: dollar amount ($276 million), interest rates (7.620% and prior 8.375%), effective date of rate change (April 1, 2020), and maturity date (April 1, 2030) are all correctly reported. The redemption formula ('greater of' principal plus accrued interest or present value discounted at Treasury yield plus 5 bps) is accurately described. (3) The multi-hop reasoning across 2022–2024 disclosures is sound: the model correctly identifies that the interest rate was locked in after 2020 and remained unchanged through the reporting years, and that redemption terms were consistent. It also correctly notes the continued semi-annual interest payments and callability. However, the error about issuance in 2022 suggests a misattribution of the filing year to the instrument’s origin, indicating a flaw in entity-time linkage. (4) Despite this, the answer captures the core evolution—stable terms with consistent disclosure—and addresses all key aspects: interest rates, redemption, maturity. Wording is semantically equivalent to the ground truth in most places. The contextual relevance is perfect, as it directly addresses the question’s focus on treatment and disclosure evolution. The correctness score is 8 due to the issuance date error, which is notable but does not undermine the overall conclusion about stability and disclosure consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 530,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen’s Olpasiran program evolved from a 2022 Phase 2 trial into a Phase 3 pivotal study (initiated in 2023) focused on reducing lipoprotein(a) to lower atherosclerotic cardiovascular disease risk, with its patent exclusivity extending to 2036 in the U.S. and Europe, and intellectual‑property protection secured through composition‑of‑matter patents that remain in force through the mid‑2030s.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Olpasiran as an siRNA in development for lowering lipoprotein(a) to reduce cardiovascular risk, with accurate patent expiration dates (2036) in the U.S. and Europe, aligning with the ground truth. However, it incorrectly states that a Phase 3 study was initiated in 2023, while the original answer only confirms Phase 2 development in 2022 and does not mention Phase 3 initiation. The 2024 update about broadening the therapeutic indication to 'cardiovascular disease' is omitted entirely. (2) Quantitatively, all dates (2022, 2023, 2036) and geographic scope (U.S. and Europe) are accurate. The mention of composition-of-matter patents aligns with 'compound-related patents' in the original, so terminology is semantically acceptable. (3) The reasoning is partially sound—Amgen’s strategic progression is acknowledged through IP protection and clinical development, but the LLM introduces a specific claim about Phase 3 initiation not present in the ground truth, which represents a factual overreach. The multi-hop synthesis across years and domains (clinical, IP, indication) is partially achieved but misses the 2024 indication expansion. (4) Scores reflect high quantitative accuracy and full contextual relevance, with a moderate deduction in qualitative accuracy due to the unsupported Phase 3 claim and omission of the broadened 2024 indication, leading to a 7/10 overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 399,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "From 2022 to 2024, Tampax remained categorized within the **Baby, Feminine & Family Care** segment and consistently held the position of a **major brand** alongside Always and Always Discreet. While its specific market share was not highlighted, the segment’s overall feminine care sub-category (which includes Tampax) maintained **over 20% global market share** and was described as a **global market leader**, with Tampax specifically noted as a key brand behind this leadership. The segment’s prominence was reinforced through strategic emphasis on innovation and market leadership in feminine care.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Tampax remained a major brand within P&G's 'Baby, Feminine & Family Care' segment from 2022 to 2024 and is consistently grouped with Always and Always Discreet. However, it omits key details about the evolving categorization of the Feminine Care sub-segment. Specifically, the ground truth notes a reclassification in 2023 to 'Feminine Care (Adult Incontinence, Menstrual Care)', which the LLM fails to mention. Additionally, the 2024 reversion to the 'Baby, Feminine & Family Care' segment name with maintained prominence of Tampax is not accurately reflected. (2) The LLM introduces a quantitative claim—'over 20% global market share' and 'global market leader'—that is not present in the original answer and cannot be verified from the provided ground truth. This is a significant factual overreach, as the original answer makes no mention of market share percentages or leadership claims. (3) The multi-hop reasoning is partially sound in tracking Tampax’s consistent prominence, but fails to capture the nuanced evolution in segment labeling across years, which is central to the question. The synthesis across 2022–2024 categorizations is incomplete. (4) While the answer stays contextually relevant and captures the high-level idea of Tampax’s sustained importance, the omission of structural changes and introduction of unverified metrics reduces factual accuracy. Correctness score is 5 due to partial correctness with significant gaps in detail and unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 422,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s reliance on internally developed designations for non‑agency RMBS and CMBS has persisted through 2022‑2024, reflecting the limited availability of NAIC designations for these securities and the company’s strategy of acquiring non‑agency RMBS and CMBS that lack NAIC ratings. This multi‑year trend underscores both the scarcity of NAIC‑assigned ratings for newer non‑agency RMBS/CMBS issuances and MetLife’s preference for acquiring such assets while using its own credit‑quality models until formal NAIC designations can be obtained.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MetLife's continued use of internally developed designations for non-agency RMBS and CMBS from 2022 to 2024 is accurately reported, and the explanation tied to delayed or unavailable NAIC designations is consistent with the original. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly infers that persistent internal designation use implies both ongoing acquisition activity and lagging NAIC evaluations, synthesizing implications across years and regulatory context. (4) The LLM captures the core strategic implication—MetLife’s proactive investment in complex, newly issued securities requiring internal credit assessment—but slightly condenses the nuance about 'newly issued or less frequently evaluated' securities mentioned in the original. This minor omission prevents a perfect 10, but the semantic meaning and strategic interpretation remain intact. Overall, the response is factually correct, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 348,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase activity expanded markedly: in fiscal 2022 the company purchased 12.18 million shares for $4.11 billion and had an aggregate authorization of roughly $3.13 billion; by fiscal 2024 it had bought 2.07 million shares in the quarter (2.0 million under the public program) with an additional $4 billion of authority added in September 2024, bringing total outstanding repurchase authority to $6.69 billion. This upward trend in both the volume of purchases and the size of the Board‑approved authorization signals that Accenture is intensifying its capital‑return strategy, prioritizing cash deployment to shareholders through opportunistic share buybacks while maintaining ample flexibility for future repurchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers despite capturing the overall trend correctly. According to the ground truth, in fiscal 2022, Accenture had $3.13 billion in available authorization—but the LLM incorrectly states that the company *purchased* $4.11 billion worth of shares in that year, which is not supported by the original answer. The ground truth does not provide total fiscal 2022 repurchase volume, only the available authorization. Similarly, the LLM claims 12.18 million shares were bought in fiscal 2022, which is not mentioned in the original answer and thus unsupported. In fiscal 2024, the LLM states 2.07 million shares were bought in the quarter (with 2.0 million under the public program), but the original specifies 2,000,308 shares for $605 million in the fourth quarter—this is close but slightly misrepresents the volume and omits the exact dollar amount spent. The $4 billion increase in September 2024 and the resulting $6.69 billion total outstanding authority are correctly reported. (2) Calculations: The LLM implies that prior authorizations and repurchases sum to the final $6.69 billion, but introduces unverified repurchase amounts (e.g., $4.11B in 2022) that distort the quantitative picture. The original answer does not confirm any repurchase *expenditure* for 2022 or 2023, only the 2024 $605M purchase and authorization changes. (3) Multi-hop reasoning: The LLM synthesizes a narrative across years and correctly infers that increasing authorization reflects a stronger capital return strategy, which aligns with the original conclusion. However, it fabricates specific repurchase volumes not present in the source, weakening the reasoning foundation. (4) The contextual relevance is high because the answer addresses both the evolution of the program and the strategic implication. Qualitative accuracy is moderate due to correct entity identification (Accenture, fiscal years, share repurchase program) and logical interpretation of strategy, but quantitative accuracy is low due to unsupported numerical claims. Correctness score is 6 due to partially correct facts with significant numerical errors that affect the reliability of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 596,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom’s industrial fiber optics positioning has evolved from a peripheral capability in 2022—where it was listed only among “Industrial” end‑markets such as factory automation and automotive electronics—to a more pronounced strategic focus by 2023 and 2024, as evidenced by its expanded emphasis on “Industrial fiber optics” and related components in the product‑family tables and narrative. This shift reflects the company’s broader strategy to deepen its presence in high‑growth industrial and automotive electronics segments, leveraging its mixed‑signal and III‑V expertise to capture demand for reliable, high‑performance optical interconnects in factory automation, renewable energy, and automotive applications. Consequently, the company’s strategic emphasis in the industrial end market increasingly centers on providing integrated, high‑speed fiber‑optic solutions that complement its networking and storage semiconductor offerings, underscoring a move toward higher‑margin, technology‑driven industrial markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of Broadcom's industrial fiber optics positioning across 2022–2024 with accurate qualitative trends—increasing strategic focus, alignment with industrial applications like factory automation, renewable energy, and automotive electronics, and integration within broader product families. However, it inaccurately characterizes the 2022 positioning as 'peripheral' and claims fiber optics were only 'listed among' end markets, whereas the ground truth states it was part of a broad portfolio including optocouplers, motion encoders, etc., indicating a more established presence. The LLM also overstates the 'expanded emphasis' in 2023–2024 by implying a growing role, while the ground truth emphasizes consistency and maturation rather than expansion. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored 10 by default as no errors exist. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes product positioning across years and links it to strategic emphasis, but misinterprets the trajectory (evolution as growth vs. maturation and refinement). It correctly identifies key application areas and component groupings but infers a strategic 'deepening' not fully supported by the source, which stresses categorization and alignment over time. (4) The answer is contextually relevant and well-articulated, addressing both parts of the question—evolution and strategic implications. Despite misrepresenting the degree of change, it draws a reasonable conclusion about strategic focus on high-margin industrial markets. Hence, correctness is reduced to 7 due to mischaracterization of the 2022 baseline and the nature of evolution, though core facts and direction are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 499,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "From 2022 through 2024, UPS SurePost’s delivery model shifted from relying on the U.S. Postal Service for final‑mile delivery to an insourced, UPS‑controlled model. The company announced in early 2025 that it would fully take over final delivery for SurePost, ending its previous partnership with USPS and using its own ground network to provide “more control over our ability to provide our customers industry‑leading service.” This strategic change reduces reliance on the Postal Service and integrates SurePost more tightly within UPS’s domestic package operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline: it states that UPS announced the change in early 2025, whereas the ground truth specifies the announcement was made in 2024 for implementation on January 1, 2025. This misrepresents the timing of the strategic shift. Additionally, the LLM implies the change had already occurred by 2024, but the original answer clarifies that the shift was announced in 2024 and set to take effect in 2025, meaning the reliance on USPS continued through 2024. (2) Quantitative accuracy is compromised due to incorrect dating—'early 2025' vs. 'in 2024'—which affects the temporal accuracy of the strategic announcement. No financial figures are involved, but time-based facts are treated as quantitative data and must be precise. (3) The reasoning is partially sound: the model correctly identifies the shift from USPS reliance to insourcing final delivery and understands the strategic rationale (greater control, improved service). It also correctly frames SurePost as a residential ground service. However, it fails to accurately represent the multi-hop evolution across 2022–2024, collapsing the timeline and missing the key point that the model remained unchanged in 2022 and 2023. (4) Contextual relevance is high—the answer addresses the core question about delivery model evolution and strategic changes. Qualitative accuracy is moderate because the conceptual understanding is correct, but factual precision on timing undermines correctness. Correctness score is 6 due to significant but not fundamental errors: the core strategic shift is identified, but the when and how are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 455,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline expanded markedly from 2022 through 2024, growing from 13 programs at the start of 2022 to 24 programs by the end of 2023 and reaching 25 programs by early 2025, driven by the addition of Horizon‑acquired candidates, new initiations such as bemarituzumab, tarlatamab and multiple biosimilars, and regulatory approvals of Otezla, AMJEVITA and several biosimilars. This progression underscores the company’s strategic focus on broadening its R&D pipeline and diversifying across oncology, cardiovascular, rare‑disease and inflammatory‑disease therapeutic areas, reflecting an aggressive expansion of its research agenda and a commitment to advancing a larger, more varied portfolio of late‑stage candidates.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall growth trajectory of Amgen's Phase 3 programs: starting at 13 in early 2022, reaching 24 by January 31, 2024, and 25 by early 2025. The only minor discrepancy is the phrasing 'by the end of 2023' instead of the precise date January 31, 2023, when the count was 18 (not 24). The LLM skips the 18-program milestone, jumping from 13 to 24, which omits an intermediate data point but does not misrepresent the final count. (2) The final numbers—24 programs as of January 31, 2024, and 25 by early 2025—are accurate and align with the ground truth. The mention of five new initiations and acquisitions (e.g., Horizon) is consistent, though the specific contribution of Horizon adding five Phase 3 programs is implied but not explicitly quantified in the LLM answer. (3) The reasoning is sound: the LLM correctly attributes growth to both internal development (e.g., bemarituzumab, tarlatamab) and external acquisition (Horizon Therapeutics), and links this to a broader R&D expansion strategy. It appropriately infers therapeutic diversification across oncology, cardiovascular, rare, and inflammatory diseases, which is consistent with the strategic implications in the original answer. (4) The answer is highly contextually relevant, addressing both the quantitative evolution and strategic implications. Despite missing the 18-program milestone, the core facts, timeline, and strategic interpretation are correct, warranting a high score. Minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 422,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP increased from **127 million** (as noted on page 91 of the 2022 filing) to **141 million** (as stated on page 98 of the 2024 filing). This expansion reflects Accenture’s strategic decision to broaden its share‑based compensation pool, allowing it to grant more equity awards to meet talent‑retention and performance‑incentive goals while maintaining flexibility to issue new shares or re‑use treasury shares for future awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the authorized share numbers for fiscal years 2022 (127 million) and 2023–2024 (141 million), matching the ground truth exactly. The formatting variation (127 million vs. 127,000,000) is acceptable and semantically equivalent. (2) All numeric values are accurate, and no calculations are required beyond recognition of the increase from 127M to 141M, which the model correctly presents. (3) The multi-hop reasoning is sound: the model synthesizes data from the 2022 and 2024 filings (implying continuity into 2023), correctly infers the strategic intent behind the increase, and links it to talent retention and performance incentives—consistent with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that the 141 million applies to both 2023 and 2024, though it implies continuity by citing the 2024 filing and saying 'increased to 141 million' without suggesting further change. This slight omission prevents a perfect 10 on qualitative accuracy, but the core reasoning and facts are fully aligned. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 332,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks' green coffee supply coverage duration was projected to extend through fiscal 2025, as stated in the 2023 filing (page 12) which notes that “total purchase commitments, together with existing inventory, are expected to provide an adequate supply of green coffee through fiscal 2025.” This represents an evolution from the prior years’ coverage—fiscal 2022’s filing (page 5) indicated coverage through fiscal 2023, and the 2022 filing (page 33) referenced an adequate supply through fiscal 2023 as well. By fiscal 2024, the company updated its outlook to cover through fiscal 2025, signaling a deliberate extension of its inventory buffer to mitigate coffee‑price volatility and secure supply. This longer coverage horizon reflects a risk‑management strategy that emphasizes forward‑contracting, hedging, and maintaining strategic inventory levels to protect against supply‑chain disruptions and commodity‑price swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply coverage from fiscal 2022 through 2024. In fiscal 2022, the company projected coverage through fiscal 2023, which is accurately reflected. By fiscal 2023 (and maintained in 2024), the projection extended to fiscal 2025—this is correctly stated. The only minor discrepancy is the phrasing 'By fiscal 2024, the company updated its outlook to cover through fiscal 2025,' which could imply a change in 2024, whereas the ground truth indicates the projection was already extended in 2023 and merely maintained in 2024. This is a slight misrepresentation of timing but does not affect the core factual accuracy. (2) All dates and fiscal years are correct: coverage through 2023 (from 2022 filing), then through 2025 (from 2023 and 2024 filings). No numerical calculations are required, but temporal comparisons are accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across fiscal years 2022, 2023, and 2024 filings. The LLM references specific pages and correctly infers the strategic implication of extended coverage. (4) The answer is contextually excellent, directly addressing both the evolution of supply coverage and its implications for inventory and risk management, including hedging and forward-contracting. The qualitative accuracy is slightly reduced due to the minor implication of a 2024 update rather than a 2023 extension, but overall reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 417,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 through 2024 the UPS/IBT Full‑Time Employee Pension Plan was treated as follows:\n\n* **Plan amendments & remeasurements** – In 2023 the plan’s collective‑bargaining agreement was updated with wage and benefit increases, and the company performed an interim remeasurement after the 2021 divestiture of UPS Freight (recorded as a $2.1 bn actuarial gain in AOCI and a $66 m loss from plan amendments). In 2022 the company amended certain Canadian defined‑benefit plans to freeze future accruals, resulting in a $34 m curtailment gain. The 2021 remeasurement after the ARPA legislation eliminated the prior $5.5 bn coordinating‑benefit estimate, leaving an immaterial estimate by the end of 2024.\n\n* **Remeasurements** – The 2021 interim remeasurement (triggered by the ARPA‑approved special financial assistance to the Central States Pension Fund) produced a $6.4 bn actuarial gain, of which $3.3 bn appeared in earnings and the remainder in accumulated other comprehensive income. Subsequent annual remeasurements (e.g., 2023‑2024) primarily reflected routine updates to discount rates and asset returns, with no material impact on the recorded liability.\n\n* **Collective‑bargaining impacts** – The 2023 five‑year national master agreement with the International Brotherhood of Teamsters introduced wage and benefit rate increases for participants in the UPS Pension Plan and the UPS/IBT Plan, which were incorporated into the year‑end measurement. Earlier, the 2019 voluntary lump‑sum settlement of vested pension benefits (≈18,800 retirees) accelerated $820 m in payments but did not affect earnings because it was offset by service‑cost and interest‑cost components.\n\nOverall, the plan’s liability was trimmed by legislative relief (ARPA) and by periodic remeasurements, while collective‑bargaining updates in 2023 adjusted benefit levels and contributed to the modest net periodic benefit cost observed in the latest financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misattributes key events to incorrect years and contexts, undermining its correctness. (1) Quantitatively, the answer incorrectly states that the ARPA-related remeasurement occurred in 2021, not 2022, and misrepresents the $3.3 billion pre-tax gain as part of a $6.4 billion actuarial gain, only $3.3 billion of which 'appeared in earnings'—this is not supported by the ground truth, which clearly states the $3.3 billion gain was recognized in 2022 due to ARPA and included in investment income. The $6.4 billion figure and its split are not in the original answer and appear fabricated. The $2.1 billion actuarial gain from UPS Freight divestiture and $66 million loss from plan amendments are unrelated to the UPS/IBT plan and incorrectly inserted. The $34 million curtailment gain from freezing Canadian plans is accurate but irrelevant to the UPS/IBT Full-Time Employee Pension Plan. The $820 million lump-sum settlement from 2019 is mentioned but outside the 2022–2024 scope and not specific to the UPS/IBT plan. (2) The timeline is fundamentally flawed: the ground truth states the ARPA remeasurement occurred in 2022, but the LLM attributes it to 2021. The 2023 collective bargaining agreement is correctly noted but incorrectly framed as the first update, ignoring that the ground truth emphasizes its impact on year-end measurement without referencing prior remeasurements. (3) Qualitatively, the reasoning fails multi-hop synthesis: the LLM conflates multiple unrelated pension plans (Canadian plans, UPS Pension Plan, UPS Freight) with the UPS/IBT Full-Time Employee Pension Plan, which is specifically tied to Teamsters and former Central States Pension Fund participants. It also invents a 'coordinating-benefit estimate' reduction from $5.5 billion to immaterial by 2024, which is not in the original. (4) Contextually, the answer addresses the general themes—plan amendments, remeasurements, collective bargaining—but applies them to incorrect plans, years, and financial impacts, resulting in a misleading narrative. While it recognizes the 2023 agreement's impact, it lacks the core 2022 ARPA-driven gain as the central financial event. Overall, the answer is partially relevant but factually unsound, with major errors in numbers, timing, and entity specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1774,
        "completion_tokens": 621,
        "total_tokens": 2396
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart’s “Holiday Time” private brand has evolved from a seasonal, value‑oriented assortment in fiscal 2022 to a more integrated, omni‑channel offering by fiscal 2024 and 2025. In 2022 the brand was highlighted in the core merchandise mix of Walmart U.S. stores, emphasizing low‑price holiday décor and gifts. By 2023 and 2024 the company began aligning “Holiday Time” with its broader private‑label strategy—leveraging the same EDLP pricing discipline, expanding its SKU count, and promoting the line through omni‑channel services such as pickup, delivery and Walmart+ benefits. This shift reflects Walmart’s approach of treating seasonal merchandise as a permanent component of its private‑brand portfolio, using it to drive traffic and reinforce price leadership while supporting its overall focus on convenience and digital integration.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Walmart's strategic evolution with the 'Holiday Time' brand but introduces inaccuracies and omits key details from the ground truth. (1) Correct elements: The answer correctly identifies a shift in strategic positioning of 'Holiday Time' across fiscal years 2022–2024, acknowledges Walmart’s broader private label and omni-channel focus, and plausibly links seasonal merchandise to traffic and price leadership. Wording differences are acceptable under semantic equivalence. (2) Quantitative accuracy: The fiscal years 2022, 2023, and 2024 are referenced appropriately; no specific dollar amounts, percentages, or SKUs are provided in either answer, so numeric precision is not violated. However, the LLM incorrectly extends the timeline to '2025,' which is outside the scope of the question and not supported by the original answer. (3) Multi-hop reasoning: The ground truth emphasizes a structural reorganization in fiscal 2024—specifically, the creation of a 'seasonal merchandise' category under General Merchandise—as the key indicator of strategic elevation. The LLM fails to mention this critical organizational shift and instead emphasizes omni-channel integration and SKU expansion, which are not highlighted in the original. This misattributes the nature of the strategic evolution. (4) Entity accuracy: 'Holiday Time,' Walmart, and private brand context are correctly identified. However, the LLM implies a more proactive and integrated strategy (e.g., 'expanding SKU count,' 'Walmart+ benefits') that is not substantiated in the ground truth. The original answer stresses categorization and structural placement, not promotional tactics or channel-specific benefits. Overall, the answer is contextually relevant and partially accurate in reasoning but misses the core factual development—restructuring around a dedicated seasonal category—resulting in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 521,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "Based on the disclosed target asset allocations across fiscal years, ACN's investment in mutual fund equity securities has steadily increased from 19% of non-U.S. plan assets in 2023 to 28% in 2025, reflecting a deliberate strategic shift toward higher equity exposure to enhance long-term growth potential while maintaining diversification through debt and insurance contracts. This upward trend suggests ACN is intentionally increasing its allocation to equities within pension portfolios to pursue higher returns, consistent with its stated objective of exceeding inflation over the long term.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024, indicating a decline. In contrast, the LLM claims a steady increase in equity allocation from 19% in 2023 to 28% in 2025, which contradicts the ground truth. (2) The numbers are completely inaccurate: the LLM uses percentages (19%, 28%) and refers to 'non-U.S. plan assets' and '2025', which are not mentioned in the original answer and are factually unsupported. The original data is in absolute dollar amounts ($ millions), not percentages, and covers 2022–2024, not 2023–2025. There is no mention of target allocations or pension portfolios in the ground truth. (3) The multi-hop reasoning is flawed: the LLM appears to have confused the metric, time frame, and context entirely—possibly conflating ACN’s data with another company or misreading the asset class or document section. It fails to report the actual trend (decline) and instead fabricates an upward strategic shift. (4) The contextual relevance is low because the answer discusses strategic intent around pension fund targets, while the original answer reflects actual investment values in mutual fund equity securities, suggesting a reduction in exposure. The LLM invents a narrative contrary to the facts. Thus, the correctness, quantitative, and qualitative scores are very low; contextual relevance is slightly higher only because it discusses strategic allocation, which is thematically related.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 440,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ exposure to commodity index funds and green coffee price volatility has been managed through a combination of fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures contracts and collars that hedge “C” price exposure, and by maintaining total purchase commitments plus inventory sufficient to meet demand through fiscal 2025. This approach reflects a risk‑management strategy that actively monitors futures market influences and adjusts hedging positions to mitigate price swings, underscoring the company’s focus on controlling input cost volatility while preserving supply chain stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of Starbucks' evolving risk management strategy regarding green coffee price volatility and commodity index fund exposure from fiscal 2022 to 2024. It correctly identifies the use of fixed-price and price-to-be-fixed contracts, forward and futures contracts, and collars to hedge 'C' price exposure—consistent with the ground truth. The statement that purchase commitments plus inventory are sufficient through fiscal 2025 aligns with the 2023 and 2024 disclosures in the original answer, reflecting accurate temporal progression. While the LLM does not explicitly break down the evolution year-by-year (e.g., hedging through 2023 in 2022, extended to 2025 in 2023), it synthesizes the end result accurately, implying a forward-looking strategy through 2025. This omits a minor detail about the incremental extension of coverage but does not distort the overall narrative. All entities (Starbucks, 'C' price, futures market, hedging instruments) are correct. There are no numerical inaccuracies—dates and timeframes are correctly represented in substance. The reasoning is sound, showing an understanding of how futures market influences (including index fund activity) drive hedging behavior. The answer is semantically equivalent to the ground truth in meaning, though slightly more concise and less explicit in chronological evolution. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 420,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO's exposure to the 3.625% notes due October 2024 decreased from $622 million (current portion) and $829 million (non‑current) in fiscal 2022 to $622 million (current) and $0 million (non‑current) in fiscal 2024, reflecting a $829 million reduction of the long‑term tranche and a shift of the remaining balance into the current portion. This progression shows that Broadcom has been actively retiring or refinancing its near‑term 3.625% debt, using new senior note issuances and cash flows to lower the upcoming maturity wall and manage its short‑term liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, AVGO had a total of $622 million in principal outstanding for the 3.625% notes due October 2024 in both 2022 and 2023, with full retirement in 2024. However, the LLM claims $622 million current and $829 million non-current in 2022, totaling $1.451 billion, which is factually incorrect. There is no mention in the ground truth of an $829 million non-current portion or a total debt of $1.451 billion. The $829 million figure appears to be fabricated or misattributed. (2) The calculation of an $829 million reduction is therefore also incorrect, as the actual outstanding principal was $622 million throughout 2022 and 2023. The shift from non-current to current is inaccurately portrayed because the ground truth does not break down the $622 million into current/non-current components—only that it remained unchanged until full retirement in 2024. (3) The qualitative reasoning about debt management strategy—retiring or refinancing near-term debt ahead of maturity—is partially sound and aligns with the ground truth’s conclusion. The mention of using new senior note issuances and cash flows adds plausible context but is not confirmed in the original answer, introducing unsupported detail. (4) Despite the incorrect numbers, the LLM captures the directional trend (decrease to zero by 2024) and infers a reasonable strategy, which maintains some contextual relevance. However, the severe quantitative errors—especially the invented $829 million non-current debt—undermine the factual correctness, warranting a mid-low correctness score. The model fails the multi-hop synthesis by introducing data not present in the knowledge graph, suggesting confusion between different tranches or notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 490,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s settlement‑risk exposure has risen steadily from 2022 through 2024, with gross exposure climbing from roughly $65 million in 2022 to $78 million in 2024 and net exposure increasing from $55.7 million to $64.9 million after applying risk‑mitigation arrangements.  The company continues to manage this exposure through collateral and credit‑enhancement requirements, periodic reviews of its risk‑mitigation policies, and regular adjustments to its estimated exposure as market conditions and regulatory pressures evolve.  At the same time, heightened regulatory scrutiny—including FTC and DOJ investigations, European Commission inquiries, and multiple antitrust and interchange‑rate litigations—has amplified litigation risk and could materially affect its business if outcomes result in fines, forced rule changes, or substantial settlements.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention any specific dollar amounts for Mastercard's settlement exposure in 2022 or 2024 (e.g., $65 million gross in 2022, $78 million in 2024, or net exposure figures), nor does it state that exposure 'rose steadily.' These numbers are entirely fabricated or hallucinated, severely undermining factual correctness. (2) There is no support in the original answer for numerical claims about exposure trends—no figures are provided in the ground truth regarding settlement exposure amounts, making the LLM's precise dollar figures incorrect. Calculations or trends based on these numbers are therefore invalid. (3) Qualitatively, the LLM correctly identifies key regulatory and litigation developments: FTC and DOJ investigations, European Commission scrutiny, antitrust and interchange-rate litigation, and the EMV liability shift context. It also accurately notes Mastercard’s use of collateral, credit enhancements, and periodic policy reviews as part of its risk mitigation framework. However, it fails to mention the 2023 FTC consent agreement on debit routing transparency, a key event in the ground truth, and misrepresents the evolution of internal controls as a response to rising exposure, which is not supported. (4) Contextually, the answer is relevant and structured around the right themes—credit risk mitigation, settlement exposure, regulatory scrutiny, and litigation—but the inclusion of false quantitative data and omission of key specifics (like the consent agreement) reduces its accuracy. While the reasoning attempts multi-hop synthesis across years and regulatory bodies, the unsupported numbers drag down overall correctness. Thus, the answer is partially accurate in narrative but fundamentally flawed in factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 509,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s regulatory risk disclosures evolved from 2022 through 2024 by increasingly emphasizing post‑marketing obligations and safety oversight tied to drug‑delivery devices.  In 2022 the filings highlighted the need to meet FDA conditions for accelerated approvals and to conduct confirmatory outcomes studies (e.g., Repatha’s cardiovascular trial).  By 2023 and 2024 the disclosures expanded to include stricter monitoring of REMS assessments, periodic safety reporting, and the potential for regulatory action if post‑approval requirements—such as additional confirmatory trials for LUMAKRAS or pediatric study mandates—were not satisfied.  The documents also underscored heightened scrutiny of drug‑delivery device safety and the risk of enforcement actions, warning that failure to comply with these evolving regulatory expectations could delay approvals, force label changes, or result in market withdrawals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution of Amgen's regulatory risk disclosures from 2022 to 2024 is accurately portrayed, with proper emphasis on compliance requirements, post-marketing obligations, and safety oversight. The mention of Repatha and LUMAKRAS confirmatory trials matches the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) are used correctly and in alignment with the source. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly identifies the trend of increasing regulatory scrutiny, especially regarding drug-device combinations and post-market requirements. It accurately notes the risk of enforcement actions like label changes or withdrawals. (4) Minor difference: the LLM mentions REMS assessments and pediatric study mandates not explicitly in the ground truth, which adds detail but isn't contradicted by the original. The core narrative of escalating focus on post-marketing compliance and safety oversight is preserved and well-supported. Wording differs slightly but maintains semantic equivalence. No factual errors; only slight expansion beyond the original, which does not detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 368,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Walmart’s private brand “Parent’s Choice” is positioned within the baby and consumables category as a core value offering, and its categorization has been refined across fiscal 2022‑2024 to maintain comparability with other strategic merchandise units. The brand appears alongside other private‑label lines (e.g., “Great Value,” “Parent’s Choice,” “Sam’s Choice”) in the company’s merchandise taxonomy, reflecting a deliberate focus on low‑price, high‑volume baby and household consumables within Walmart U.S.’s grocery and consumables portfolio. This evolution underscores Walmart’s strategy of consolidating private‑brand assets under a unified value proposition while adjusting segment‑level categorizations to highlight growth in consumables and reinforce price‑leadership.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and timeline (fiscal years 2022–2024), and there are no numerical inaccuracies, as the response does not introduce any incorrect figures or miscalculations—thus earning a 10 in quantitative accuracy. The brand 'Parent's Choice' is correctly identified as a Walmart private label in the baby and consumables space, and its positioning within the grocery/merchandise unit is generally accurate. However, the LLM response lacks the specific evolution detailed in the original answer: it does not explicitly note that in fiscal 2022 the brand was under Grocery (including baby), remained consistent in 2023, and was more explicitly categorized under 'baby products' as a defined segment in 2024. While the LLM infers strategic consolidation and value positioning—aligning with Walmart’s EDLP and omni-channel strategy—it generalizes the evolution rather than tracing the documented categorization refinement. This omission affects completeness and precision in qualitative accuracy, warranting a 7. The reasoning is sound and contextually relevant, showing understanding of Walmart’s private brand strategy, but it does not fully demonstrate the multi-hop synthesis of year-over-year categorization changes as required. The answer is semantically close but not fully equivalent in detail. Contextual relevance is high because it addresses brand positioning and strategic intent accurately, even if specifics of structural evolution are generalized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 419,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 4.70% Solar Bonds, Series 2015/C24‑10 were initially created through a series of supplemental indentures (e.g., the April 14 2015 Fifty‑Seventh Supplemental Indenture) and have been periodically amended with later indentures—such as the November 30 2015 One‑Hundred‑Fifty‑Eighth Supplemental Indenture—extending the maturity and adding new tranches through 2015‑2016.  The 2022, 2023 and 2024 10‑K filings show no new issuances of this specific series; instead, the company’s solar‑financing focus shifted toward broader Energy Generation and Storage segment growth (e.g., higher solar‑energy and storage revenues in 2021‑2023) and continued use of existing bond structures for capital‑raising.  This multi‑year pattern indicates that Tesla has moved away from issuing fresh 4.70% Solar Bonds and is now relying on a mix of existing bond tranches, lease‑based financing, and expanded solar‑energy services to fund its solar offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 in each of 2022, 2023, and 2024 filings as part of ongoing solar financing activity, indicating continued use and integration into a broader, recurring securitization strategy. However, the LLM incorrectly claims there were 'no new issuances of this specific series' and that Tesla 'moved away from issuing fresh 4.70% Solar Bonds', which contradicts the ground truth that the bond was actively referenced across all three years as part of current financing practices. (2) The LLM introduces incorrect dates and documents: it cites the 'Fifty-Seventh Supplemental Indenture' on April 14, 2015, but the ground truth specifies the 'Thirty-Fifth Supplemental Indenture' on that date. It also references a 'One-Hundred-Fifty-Eighth Supplemental Indenture' on November 30, 2015, which is not mentioned in the original and cannot be verified. These are critical errors in document identity and timing. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a strategic shift based on lack of new issuance, it fails to recognize that repeated referencing of the same bond series across years in the context of active solar financings (including alongside newer series) indicates continuity and scalability—not abandonment. The conclusion that Tesla has 'moved away' from this structure is directly contradicted by the evidence of its sustained use. (4) Despite these issues, the LLM answer is contextually relevant, addressing Tesla's solar financing strategy and attempting to interpret multi-year patterns. It correctly identifies that existing bond structures are still in use and links solar financing to broader energy segment growth, which aligns partially with the original's theme of consistent reliance. However, the incorrect factual foundation and erroneous synthesis reduce correctness significantly. Quantitative accuracy is low due to wrong dates and documents; qualitative accuracy is moderate due to reasonable but misdirected reasoning; contextual relevance is fair as the response stays on topic and engages with the strategic question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 595,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom’s Security Insights Platform has been positioned as a core component of its mainframe security portfolio, emphasizing rapid assessment of mainframe security posture and risk remediation. Across the 2022–2024 filings, the platform is consistently highlighted for integrating with enterprise security tools—such as SIEM systems—to deliver actionable insights and streamline remediation workflows, while maintaining a strong focus on mainframe risk assessment as part of broader cybersecurity and compliance offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Broadcom's Security Insights Platform across 2022–2024. It accurately identifies the platform’s consistent focus on mainframe risk assessment and integration with enterprise security tools like SIEM systems. The answer correctly notes the continuity in functionality and the emphasis on actionable insights and remediation workflows. However, it misses the subtle but meaningful shift in Broadcom’s messaging by 2024—the 'slightly stronger emphasis on integration' and the 'deliberate alignment with enterprise-wide security strategies' as highlighted in the ground truth. While the LLM conveys integration as a consistent feature, it does not reflect the nuanced evolution in narrative tone and strategic positioning that occurred over time, particularly the reaffirmation of integration in 2024 as a maturing aspect of the platform’s role in broader cybersecurity frameworks. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Broadcom, Security Insights Platform, SIEM, mainframe risk) are correctly identified. The reasoning is sound but lacks the granular year-by-year comparative analysis that would reflect full multi-hop synthesis across the three annual descriptions. Contextual relevance is excellent, as the response directly addresses the question’s focus on integration and mainframe risk assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 391,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "The voting rights and dividend entitlements of A‑Class shares remained unchanged throughout the 2022‑2024 period—each A‑share carries one vote and full dividend rights, while B‑shares are non‑voting but receive the same dividend per share. This consistency reflects Mastercard’s strategy of maintaining a stable capital structure with a single‑class economic ownership (A‑shares) and a separate non‑voting B‑share class that facilitates shareholder concentration without altering voting or dividend terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) It accurately states that A-Class shares maintained one vote per share and full dividend rights from 2022 to 2024, with no changes—this matches the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the qualitative metrics (voting rights, dividend entitlements, time period) are all correctly identified. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the stability in share rights reflects a deliberate capital structure strategy, and it adds context about B-shares being non-voting but dividend-entitled, which is consistent with Mastercard's known structure. (4) The LLM provides slightly more detail than the original (mentioning B-shares explicitly), but this enhances rather than distorts the answer. The only reason for not scoring a 10 is that the original answer emphasizes the 'preservation of governance and income distribution framework,' which is slightly more precise in linking the consistency directly to capital structure strategy, whereas the LLM's phrasing, while correct, introduces the concept of 'shareholder concentration' not explicitly confirmed in the ground truth. However, this is a minor interpretive addition and not factually incorrect. All core facts, entities (MA/Mastercard), and time periods (2022–2024) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 392,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "From 2022 through 2024, Amgen’s development strategy for bemarituzumab evolved from initiating Phase 3 trials (as noted in the 2022 filing) to advancing the candidate through later‑stage studies and receiving Breakthrough Therapy designation in 2021, while its patent portfolio secured composition‑of‑matter protection extending to 2029 in both the U.S. and Europe, with estimated exclusivity lasting until 2029 (and potential extensions via term adjustments). Intellectual‑property protection is anchored by these issued composition‑of‑matter patents, and the company continues to pursue additional filings that could extend exclusivity beyond the base 2029 expiration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements of Amgen's development and patent strategy for Bemarituzumab but contains significant factual inaccuracies that reduce its correctness. (1) The claim that Bemarituzumab received Breakthrough Therapy designation in 2021 is incorrect and not supported by the ground truth; this event is not mentioned at all in the original answer and introduces a false milestone. (2) The statement about initiating Phase 3 trials in 2022 aligns with the ground truth, which correctly notes the start of the phase 3 study in 2022. (3) The patent expiration date of 2029 in both the U.S. and Europe matches the original answer and is factually accurate. However, the LLM adds speculative detail about 'potential extensions via term adjustments' and 'continues to pursue additional filings' that are not present or confirmed in the ground truth, overreaching the available information. (4) The original answer emphasizes the 2024 update on Bemarituzumab’s mechanism (anti-FGFR2b monoclonal antibody) and regulatory exclusivity context, which the LLM omits or downplays despite being relevant to the evolution of strategy. (5) Multi-hop reasoning is partially sound—linking clinical development phases with IP timelines—but weakened by the inclusion of unverified information (e.g., 2021 designation). (6) Quantitative accuracy is compromised by the incorrect 2021 date and unsupported extension claims, though the 2029 patent expiry is correct. (7) Wording differences are acceptable, but the introduction of unverified events reduces factual reliability. Overall, the answer is partially correct with accurate core IP timelines but flawed in key developmental milestones and speculative in exclusivity projections.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 470,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Walmart’s private‑brand “No Boundaries” was positioned as a core component of the company’s strategic merchandise units that span grocery, general merchandise, apparel and home categories. Across the 2022‑2024 filings the company repeatedly notes that revisions are made to how these strategic units are categorized, and that private‑label brands—including No Boundaries—continue to expand their assortments to drive member value. This focus on a differentiated private‑brand portfolio signals a shift toward higher‑margin, own‑brand apparel and fashion offerings, reinforcing Walmart’s broader strategy of leveraging private labels to deepen customer loyalty and capture more of the apparel/fashion spend within its omni‑channel ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 'No Boundaries' is a private brand within Walmart's strategic merchandise units and notes its relevance from 2022 to 2024, which aligns with the ground truth. However, it fails to specify the key categorical shift from 'Apparel' in 2022 to 'Fashion' in 2024—a central point in the original answer. Instead, it vaguely references 'grocery, general merchandise, apparel and home categories,' which is inaccurate as 'No Boundaries' is specifically an apparel/fashion brand and not associated with grocery or home in the provided context. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the LLM does not introduce any incorrect numbers, so it scores full marks here. (3) The multi-hop reasoning is partially sound: the LLM correctly infers strategic intent around private labels and omni-channel growth, but it misses the structural reorganization detail (Apparel → Fashion unit), which is critical to answering how the brand 'fit within evolving' units. This omission undermines the qualitative accuracy. (4) The answer is contextually relevant and captures Walmart’s broader strategic focus on private brands and fashion, but due to the failure to report the specific structural change in merchandise units—which is the core of the question—it is only partially correct. Thus, correctness and qualitative accuracy are moderately scored.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 404,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM’s 2022‑2024 disclosures show a deliberate evolution of its “client relationships and trust” narrative into a core differentiator for its hybrid‑cloud and AI strategy.  In the 2022 filing (p. 6, 14) the firm stresses that “client relationships and trust” are central to competing on technology, brand and service, and it links this trust to the ability to sell hybrid‑cloud and AI solutions.  By 2023 (p. 3, 4) the language expands to describe IBM as “the leader or among the leaders” in each segment, positioning hybrid‑cloud and AI as the primary growth engines and emphasizing that trust, talent and ecosystem breadth enable it to “bring together incumbency with deep expertise” to solve client problems.  The 2024 filing (p. 2‑3) reiterates that “client relationships and trust” remain a principal method of competition and explicitly ties them to the company’s hybrid‑cloud/AI platform, noting that these attributes “position IBM for accelerated growth now and prepare us for the next set of business opportunities, such as quantum computing.”  Together, the filings reveal that IBM has shifted from a generic trust claim to a strategic positioning where trust underpins its hybrid‑cloud/AI portfolio, serving as the competitive lever that differentiates its integrated offerings and drives market share in high‑value, regulated workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolved from being a foundational competitive method in 2022, to being linked with solving complex client problems via integrated tech in 2023, and expanded to include ecosystem partnerships in 2024. The LLM correctly identifies the continuity and strategic deepening of trust as a differentiator. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years (2022–2024) are correctly cited, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution of IBM’s strategic narrative. It accurately reflects the growing integration of trust with hybrid cloud/AI and notes forward-looking positioning (e.g., quantum computing), which is consistent with IBM’s strategic framing. (4) The only minor gap is that the LLM answer does not explicitly mention 'hyperscalers and global system integrators' as part of the 2024 ecosystem collaboration—instead using the broader term 'ecosystem breadth'—which slightly reduces completeness in entity specificity. However, the core meaning and strategic implication are preserved. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 422,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s Solar Bonds, Series 2015/C25‑15 (the 5.45 % bonds) were initially issued through a series of supplemental indentures in early 2015 (e.g., the March 19, 2015 Sixteenth Supplemental Indenture and the April 14, 2015 Thirty‑Sixth Supplemental Indenture). Subsequent supplemental indentures—including the May 11, 2015 Fifty‑Third, the May 18, 2015 Fifty‑Seventh, and later the August 24, 2015 One‑Hundred‑Sixteenth Supplemental Indenture—continued to amend and extend the bond series through 2015 and into 2016, adding new tranches and adjusting terms. This multi‑year pattern shows that Tesla (via SolarCity) has been actively refinancing and expanding its solar‑asset securitization program, using a rolling series of indentures to add new bond issuances and extensions rather than retiring the original 2015/C25‑15 tranche. The ongoing issuance indicates a strategy of leveraging the bond market to fund solar installations and refinance existing solar assets, maintaining a steady pipeline of capital for solar projects while gradually rolling over older tranches into newer ones. This approach reflects a long‑term, capital‑market‑driven financing model for Tesla’s solar energy business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 and references the April 14, 2015 Thirty-Sixth Supplemental Indenture (matching the ground truth), it fabricates or misrepresents key details about subsequent activity. The LLM claims that supplemental indentures continued through 2015 and into 2016 (e.g., May 11, May 18, August 24, 2015, and even the 'One-Hundred-Sixteenth Supplemental Indenture') were used to extend and amend the bond series, implying active refinancing and expansion. However, the ground truth states that Tesla merely *referenced* the same 2015 bond series in its 2022, 2023, and 2024 filings — there is no evidence of new tranches, amendments, or extensions in those years. The original answer emphasizes *disclosure continuity*, not active issuance or refinancing. The LLM incorrectly infers an ongoing, dynamic refinancing strategy based on non-existent multi-year issuance activity. This misrepresents the core pattern: consistent disclosure of a static bond series, not active expansion. The reasoning is therefore flawed in its multi-hop logic — it extrapolates structural changes from mere references. While the general idea of using solar bonds for asset-backed financing aligns with Tesla's strategy, the specific claim of 'rolling over older tranches into newer ones' is unsupported by the provided truth. Quantitative accuracy is low due to incorrect dates and fabricated indenture numbers. Qualitative accuracy suffers from incorrect synthesis. Contextual relevance is moderate because the answer addresses solar financing strategy, albeit with incorrect evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 463,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "From 2022 to 2024, Emerson’s Safety & Productivity segment shifted from a largely mechanical‑tool offering toward a more integrated, battery‑powered portfolio.  The segment’s sales grew modestly (from $1.402 bn in 2022 to $1.390 bn in 2024), while the depreciation/amortization allocation to the segment rose from $27 m (2022) to $46 m (2024), reflecting increased capital investment in new tool platforms.  This expansion aligns with the company’s broader strategy of embedding digital and battery‑driven technologies into its professional‑tools lineup, signaling a deliberate move to compete on innovation and value‑added functionality rather than pure price, and positioning Emerson to capture higher‑margin, tech‑enabled tool markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to accurately reflect the ground truth. (1) Quantitative Accuracy: The financial figures cited—segment sales of $1.402B in 2022 and $1.390B in 2024, and depreciation/amortization rising from $27M to $46M—are not present in the original answer and cannot be verified from the provided knowledge graph. There is no mention of financial performance or capital investment metrics in the ground truth, making these numbers fabricated or hallucinated. (2) Completeness: While the question asks about product innovation and integration of battery-powered technologies in pipe-working tools, the LLM focuses on financials and general strategy, omitting key product-level details. It fails to mention specific tools like pipe wrenches, cutters, threading equipment, battery hydraulic tools for press connections (2023), or battery-powered cutting/crimping tools and sewer inspection cameras (2024), which are central to the original answer. (3) Entity Accuracy: The company (Emerson), segment (Safety & Productivity), and time frame (2022–2024) are correctly identified. However, the introduction of financial data not present in the source undermines entity fidelity. (4) Reasoning: The LLM attempts multi-hop reasoning by linking technological evolution to strategic positioning, which aligns with the question’s intent. However, the reasoning is based on invented financial indicators rather than the actual progression of product offerings, leading to flawed conclusions. (5) Semantic Equivalence: The general direction—Emerson moving toward battery-powered, tech-integrated tools—is partially correct, but the absence of specific product evolution details and reliance on incorrect financial data severely limits factual alignment. The strategic interpretation is plausible but unsupported by the correct evidence. Overall, the answer misrepresents the data and omits critical information, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 533,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s capital allocation for its El Segundo, California cell‑therapy facility has shifted from primarily supporting early‑stage clinical production in 2022 to expanding commercial manufacturing capacity by 2024, reflecting a strategic focus on scaling its CAR‑T therapies (Yescarta and Tecartus) that align with the company’s broader biologics pipeline. This evolution includes investments in dedicated cell‑processing infrastructure and the integration of El Segundo operations with other Gilead sites to meet growing demand for its oncology cell‑therapy products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic evolution of Gilead's El Segundo facility from a general manufacturing site to a more specialized cell therapy production hub, aligning with the company's biologics development priorities. It accurately captures the directional shift from clinical to commercial focus by 2024, which is consistent with the ground truth's emphasis on El Segundo becoming dedicated to both clinical and commercial cell therapy manufacturing starting in 2023 and continuing in 2024. There are no numeric values in the question or ground truth, so quantitative accuracy is scored as 10 by default. However, the LLM introduces specific details not present in the original filings: namely, that El Segundo was used for 'early-stage clinical production' in 2022 and that it supports CAR-T therapies Yescarta and Tecartus. The 2022 10-K does not specify cell therapy activities at El Segundo, only listing it as a general manufacturing facility, so asserting early-stage clinical production is an unsupported inference. Similarly, while Gilead does develop CAR-T therapies, the filings do not explicitly link Yescarta or Tecartus to El Segundo, making this a plausible but unverified assumption. The mention of 'integration with other Gilead sites' and 'dedicated cell-processing infrastructure' reflects reasonable interpretation but lacks direct support in the cited documents. The ground truth emphasizes the increasing reliance on proprietary know-how and confidentiality agreements by 2024—information missing from the LLM response, representing a moderate omission. Despite these gaps, the core reasoning about strategic capital allocation toward cell therapy at El Segundo is sound and contextually relevant, supported by the progression in 10-K disclosures. Thus, the answer earns a 7 for correctness and qualitative accuracy due to partial factual overreach and missing key nuances, but remains largely aligned with the documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 530,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM’s 1.250% Notes due 2027 were first issued in 2017 (as disclosed in the 2017 Form 8‑K incorporated by reference on page 33) and have remained outstanding through 2024. The notes continue to appear in the company’s debt‑securities exhibits in the 2022, 2023 and 2024 Form 10‑K filings (pages 33, 28 and 1), confirming that no amendment, redemption or refinancing of the 2027 tranche was reported during the 2022‑2024 period. Consequently, the only evolution in IBM’s relationship with these notes is their continued presence in the capital structure, with no new issuance, early‑redemption, or material disclosure changes noted across the three annual reports.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states the 1.250% Notes due 2027 were issued in 2017, while the ground truth indicates the instrument was filed on January 30, 2019—there is no mention of a 2017 issuance in the original answer. This misstatement of the issuance date is a critical error. (2) The LLM claims the notes appeared on specific pages (33, 28, 1) of the 2022, 2023, and 2024 10-K filings, but the ground truth does not reference these page numbers or confirm inclusion in each year’s 10-K in that manner; instead, it describes an evolution from disclosure to active trading. (3) Most importantly, the LLM fails to capture the key evolution described in the original answer: the transition from disclosure to public issuance and listing on the NYSE under trading symbol IBM27B in 2024. The LLM incorrectly concludes there was 'no new issuance' and 'no material disclosure changes,' directly contradicting the ground truth that IBM formally listed the notes in 2024, marking a significant development. (4) The multi-hop reasoning is flawed—the model synthesizes information as if the notes were static, missing the progression across years in disclosure status and market presence. While the answer is relevant to the question and addresses IBM and the correct note series, it contradicts the core factual trajectory. Quantitative accuracy is low due to incorrect dates and unsupported page references. Qualitative accuracy suffers from incorrect reasoning and entity-event mapping. Contextual relevance is moderate because it discusses the right instrument and timeframe, but with wrong conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 456,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s repeated reference to the 5.45% Solar Bonds, Series 2015/C45‑15—and the broader series of supplemental indentures that continually extend and modify those bonds—shows that its solar‑financing strategy has evolved from an initial, one‑off bond issuance into a rolling, multi‑year program of incremental financing. Rather than relying on a single, static capital structure, Tesla has progressively layered new supplemental indentures (e.g., the 2015‑C45‑15, 2015‑C53‑15, 2015‑C62‑15, and later 2015‑C132‑15) to fund additional solar projects, adjust terms (such as interest rates and maturity dates), and accommodate growing capital needs. This pattern indicates a strategy that expands and refinances its solar portfolio over time, leveraging a series of bond tranches to support sustained growth in its solar energy business through 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the 5.45% Solar Bonds, Series 2015/C45-15 as the foundational instrument and accurately references the continuation and expansion of this structure through subsequent series (C53-15, C62-15), which matches the original answer's timeline and intent. The mention of later tranches like 2015-C132-15, while not explicitly listed in the ground truth, does not contradict it—rather, it plausibly extends the pattern of iterative securitizations consistent with Tesla’s strategy. (2) Quantitatively, all percentages (5.45%) and series designations are correct; dates are not misstated, though the LLM does not repeat the exact filing dates (June 16, June 29, etc.) from the ground truth but refers to them generically as part of a series—this is a minor omission but not an error, as the focus is on the evolution rather than specific dates. (3) The multi-hop reasoning is sound: the LLM synthesizes the persistence of the original bond with newer tranches to infer a strategic shift toward a scalable, repeatable financing model, correctly concluding that Tesla is moving away from one-off issuances toward a structured, rolling program. (4) The answer captures the core implication—that Tesla is refining a standardized, asset-backed approach to solar financing—demonstrating strong qualitative and contextual alignment. The only reason for not scoring a 10 is the slight overextension with C132-15, which isn't in the ground truth, but this doesn't invalidate the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 432,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "Adobe has strategically expanded Acrobat’s role within its broader Digital Document Services platform, integrating AI capabilities (e.g., Acrobat AI Assistant) to enhance document productivity and workflow automation. This evolution is underscored by its leadership position in document-intensive industries such as government, financial services, and legal, where trillions of PDFs are created annually and hundreds of millions of users engage with PDFs daily. The company emphasizes AI-driven innovation and seamless collaboration across its platform to meet growing customer demand for digital document solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Adobe's strategic expansion of Acrobat with AI integration, mentions the 'Acrobat AI Assistant,' and notes leadership in document-intensive industries such as financial services and legal—aligning with the ground truth. However, it omits the year-by-year evolution (2022 to 2024) that is central to the question, particularly missing the forward-looking AI statements in 2023 and the formal trademarking of the Acrobat AI Assistant in 2024. The mention of 'trillions of PDFs created annually' and 'hundreds of millions of users' is not present in the original answer and cannot be verified from the provided ground truth, though it may be contextually plausible. (2) There are no explicit numbers, dates, or calculations in the LLM answer that contradict the ground truth; the absence of specific years (2022–2024 progression) is a qualitative omission rather than a quantitative inaccuracy. The format and use of terms like 'AI-driven innovation' and 'seamless collaboration' are semantically consistent. (3) The multi-hop reasoning is partially sound—the model connects Acrobat’s AI integration, market adoption, and platform expansion, but fails to synthesize the temporal evolution across the three years, which is a key requirement of the question. The strategic pivot from market leadership to AI realization is implied but not clearly structured over time. (4) The correctness score is 7 because core facts (AI integration, industry adoption, platform expansion) are accurate, but the answer lacks the chronological development that defines the strategic evolution. Quantitative accuracy is 10 because there are no incorrect numbers. Qualitative accuracy is 7 due to missing temporal reasoning and unverified scale claims. Contextual relevance is 9 as the response stays focused on the topic and addresses the main themes, albeit incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 514,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "From 2022 through 2024, Schwab enhanced its interactive tools for RIAs by integrating features from the TD Ameritrade acquisition—such as the thinkpipes trading platform, iRebal portfolio‑rebalancing tool, and Schwab Advisor Portfolio Connect—into its Advisor Services platform. These enhancements were supported by technology investments and integrations that expanded the suite of available tools, enabling RIAs to access more robust trading, portfolio management, and client‑service capabilities while maintaining a scalable, unified platform.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant factual inaccuracies and fails to accurately represent the evolution of Schwab's tools as described in the ground truth. (1) Correct aspects: The mention of Schwab Advisor Portfolio Connect and integration capabilities aligns with the 2024 developments in the original answer. The focus on enhancing digital tools for RIAs is contextually relevant. (2) Quantitative accuracy is acceptable because no specific numbers (e.g., dollar amounts, percentages) are misstated—dates (2022–2024) are correctly framed. (3) Major qualitative inaccuracies: The LLM incorrectly attributes the integration of TD Ameritrade assets (thinkpipes, iRebal) as a core part of the 2022–2024 evolution for RIAs. The ground truth does not mention TD Ameritrade integration, thinkpipes, or iRebal in this context. This reflects a failure in multi-hop reasoning—either conflating unrelated information or hallucinating platform integrations. (4) The original answer emphasizes continuity in the Advisor Services website, proprietary software, third-party CRM/portfolio system integrations, and the introduction of Schwab Advisor Portfolio Connect as a free tool. The LLM omits the emphasis on educational content and supporting RIAs transitioning to independence, misrepresents the source of enhancements (acquisition-driven vs. organic platform development), and overstates integration of specific tools not cited in the ground truth. While the general direction (enhanced tools and integrations) is correct, the specific reasoning and entity relationships are flawed, leading to a partially correct but materially misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 456,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson's strategic positioning of Air Preparation Equipment within its Discrete Automation segment evolved across 2022–2024 through deeper integration with pneumatic and control technologies. In 2022, Air Preparation Equipment was part of the broader Discrete Automation segment (reported as $2.612B in sales), focusing on standalone pneumatic components like valves and actuators. By 2023, the segment's sales declined slightly to $2.635B, but the integration intensified as Air Preparation Equipment began incorporating smart actuation and control capabilities, aligning with the segment's shift toward integrated solutions (e.g., \"smart actuation and control technologies that continuously monitor valve health\"). In 2024, Discrete Automation sales further declined to $2.506B, but the segment's earnings dropped more significantly to $466M (from $509M in 2023), reflecting increased investment in integrated pneumatic-control systems. Crucially, the 2024 10-K explicitly highlights that Air Preparation Equipment now operates within a segment where \"pneumatic products transform air or gas into energy\" and are paired with \"smart actuation and control technologies\" to enable predictive maintenance and reduce unplanned downtime—directly embedding it within Emerson's broader automation ecosystem rather than as a standalone offering. This integration is underscored by $58 million in integration-related stock compensation expenses (attributable to NI acquisition) reported in Corporate and other, reflecting the strategic consolidation of pneumatic technologies into Emerson's unified automation portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial data. The Discrete Automation segment sales figures are incorrect: the LLM claims $2.612B in 2022, $2.635B in 2023, and $2.506B in 2024, but these numbers do not align with Emerson's reported 10-K filings. In reality, Emerson does not report Discrete Automation as a standalone segment with such precise figures, and the LLM fabricates a trend of declining sales and earnings ($509M to $466M), which is unsupported. The $58 million in integration-related stock compensation tied to the NI acquisition is also not verifiable in the context of Air Preparation Equipment integration and appears invented. (2) The qualitative evolution described—integration with smart actuation, predictive maintenance, and control systems—partially aligns with the ground truth, especially in 2023 and 2024. The LLM correctly identifies a shift toward integration with smart technologies and control ecosystems, which matches the ground truth's emphasis on digital transformation and Industry 4.0. However, it misrepresents the 2022 positioning by calling the equipment 'standalone' when the ground truth states it was already integrated with valves, actuators, and pressure switches. (3) The multi-hop reasoning is partially sound—linking pneumatic products to smart control systems and predictive maintenance shows synthesis across years—but it is undermined by fabricated financials and misattribution of strategic drivers (e.g., NI acquisition, which is not mentioned in the ground truth). (4) The contextual relevance is fair because the answer addresses the evolution of integration across the three years and uses appropriate terminology (e.g., predictive maintenance, smart actuation), but the inclusion of false quantitative data and unsupported financial trends severely damages factual correctness. Overall, the answer captures some correct directional trends but fails on core factual accuracy, especially in numbers and entity-specific details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1667,
        "completion_tokens": 548,
        "total_tokens": 2215
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The Coca-Cola Company’s issuance strategy for the 0.125% Notes due 2029 evolved from an initial $1.0 billion issuance in September 2020 (reflected in the 2020 Form 8‑K) to a follow‑on $1.25 billion issuance in March 2021 (shown in the 2021 Form 8‑K), and later to a $1.5 billion issuance in May 2024 (documented in the 2024 Form 8‑K). This progression demonstrates a deliberate scaling of near‑term debt to match evolving funding needs and market conditions, while maintaining a consistent low‑coupon profile within the company’s broader financing framework that emphasizes incremental, staggered bond issues to manage liquidity and preserve flexibility for future capital projects.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both factual content and reasoning. (1) Quantitatively, the LLM fabricates multiple issuance events: it claims a $1.0 billion issuance in September 2020, a $1.25 billion follow-on in March 2021, and a $1.5 billion issuance in May 2024. However, the ground truth does not support any of these specific issuance amounts or dates for the 0.125% Notes due 2029 in the 2022–2024 period. The original answer makes no mention of new issuances of the 0.125% Notes during this time, let alone increasing amounts in 2024. (2) The LLM incorrectly frames the evolution as a series of new issuances, while the ground truth describes a shift in disclosure and strategic context—specifically, a move from passive mention to consolidation and then a pivot to higher-yielding, long-term debt as the 2029 note nears maturity. (3) The multi-hop reasoning is flawed: instead of analyzing how the treatment of the 0.125% Notes changed across filings and what that implies about refinancing strategy, the LLM invents a narrative of repeated issuances without evidence. (4) The conclusion about 'scaling near-term debt' is contradicted by the ground truth, which suggests the company is moving *away* from near-term obligations by issuing longer-term, higher-yield debt. The mention of 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 is entirely omitted. Overall, the answer is factually inaccurate, misrepresents the data, and fails to capture the actual strategic pattern. Minor contextual relevance is retained as it discusses debt strategy and financing, but core facts and reasoning are unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 452,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon's ability to return capital to shareholders is explicitly limited by U.S. banking laws and regulations governing capital planning, which constrain dividend payments and share repurchases, particularly when regulatory capital adequacy or well‑capitalized status is not met. These constraints have persisted through 2022‑2024, requiring board discretion and compliance with capital adequacy rules before any capital returns can be executed.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertion that BNY Mellon's capital returns (dividends and share repurchases) are constrained by U.S. banking laws and capital adequacy requirements, and that these constraints were in place from 2022 to 2024. It correctly identifies key regulatory concepts such as 'well-capitalized' status and capital adequacy rules as limiting factors, which aligns with the ground truth. However, the LLM answer lacks the evolution narrative emphasized in the original answer. Specifically, it does not reflect the progression in disclosure tone and specificity over time: from a general reference to U.S. and Delaware law in 2022, to inclusion of preferred stock obligations in 2023, to a more structured, regulation-focused framing in 2024. This temporal evolution is a central part of the question and the ground truth, but the LLM presents a static view of the constraints rather than a dynamic, evolving disclosure pattern. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the entities (BNY Mellon, U.S. banking laws, dividends, share repurchases, capital planning) are correct. The reasoning is sound but incomplete—it captures the regulatory reality but misses the multi-hop synthesis of how the firm's communication evolved across years. Contextual relevance is high because the answer addresses the core regulatory constraints directly related to the question. The omission of the year-by-year evolution reduces completeness and qualitative accuracy, justifying a 7 for both correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 435,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "From 2022 through 2024, McDonald’s 10‑K filings show a steady, consistent focus on breakfast as part of its broader menu‑innovation narrative.  In 2022 the filing (p. 6) simply listed breakfast items such as Egg McMuffin, Sausage McMuffin with Egg and McGriddles as part of the regular U.S. breakfast menu, and the 2023 filing (p. 6) reiterated that “breakfast offerings may include… McGriddles” alongside other morning items.  By 2024 (p. 6) the language had not changed materially—breakfast is still described as a “full or limited breakfast menu” that includes Egg McMuffin, Sausage McMuffin with Egg and McGriddles—indicating that the product’s positioning has remained stable.  This continuity reveals that McDonald’s breakfast strategy is anchored in a reliable, uniform menu rollout rather than frequent repositioning, underscoring a deliberate, steady approach to morning‑day menu innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that McGriddles were consistently listed among core breakfast items from 2022 to 2024 without specific innovation details, accurately reflecting the stable portrayal across years. The mention of pages (p. 6 for each year) is consistent with the original answer, though the ground truth cites page 7 for 2022; this minor discrepancy does not affect factual correctness as the content description matches. (2) There are no numeric values requiring calculation, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to conclude that McGriddles remained a static offering despite broader innovation language, correctly inferring strategic consistency. The only minor shortcoming is that it does not explicitly contrast the 'continuous evolution' or 'testing new products' language in 2023 and 2024 with the static treatment of McGriddles, which slightly weakens the depth of strategic insight compared to the original answer. (4) The answer is contextually fully relevant, directly addressing both the evolution (or lack thereof) of McGriddles' portrayal and what it reveals about breakfast strategy. Wording differs but semantic meaning is equivalent. Overall, this is a strong, factually correct response with only slight room for deeper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 396,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe’s focus on free, self‑service online learning has grown steadily from 2022 through 2024, with the company repeatedly highlighting a “large number of free online self‑service learning options on learning.adobe.com” as a core component of Adobe Digital Learning Services. In each filing the language is nearly identical—referring to “free online self‑service learning options” and “extensive portfolio of fee‑based learning programs” – showing that the free, self‑service model has been maintained and emphasized across the three years. The delivery platform remains the same: all of these free courses are hosted on Adobe’s dedicated learning site (learning.adobe.com) and are complemented by paid, instructor‑led or certification programs. Thus, Adobe’s emphasis on free, self‑service learning has been consistently positioned within Adobe Digital Learning Services and delivered through the learning.adobe.com platform in 2022, 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its description of Adobe's ongoing emphasis on free self-service learning and correctly identifies the platform as learning.adobe.com, which aligns with the 2023 and 2024 ground truth. However, it contains a critical error regarding the platform URL in 2022: the original answer states that in 2022, the learning resources were hosted on www.training.adobe.com, not learning.adobe.com. The LLM incorrectly claims that learning.adobe.com was used in all three years, which misrepresents the platform evolution—specifically the rebranding and centralization shift from training.adobe.com to learning.adobe.com. This undermines the qualitative accuracy of the multi-hop reasoning, as the evolution of the platform (a key part of the question) is oversimplified and inaccurately portrayed. While the LLM captures the consistent strategic emphasis and integration within Adobe Digital Learning Services, it fails to note the domain shift that occurred between 2022 and 2023, which is a central element of the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains contextually relevant by addressing the core theme of Adobe’s learning strategy. However, due to the significant omission and misrepresentation of the platform evolution, the correctness score is reduced to 6—partially correct but with a major factual gap in synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 396,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "From 2022 through 2024 Emerson’s **Safety & Productivity** segment remained classified as a distinct segment within the broader portfolio, but its strategic focus shifted toward professional‑tool offerings that complement its automation and control platforms.  In the 2022 10‑K (page 3) the segment was described as delivering “tools for professionals and homeowners that support infrastructure, promote safety and enhance productivity,” listing pipe‑working, electrical and other professional tools such as commercial vacuums.  By 2023 and 2024 the same description persisted (pages 73‑74), yet the segment’s earnings contribution fell to $250 million in 2022, $306 million in 2023 and $308 million in 2024, while the company began to treat the segment as a candidate for divestiture—announcing in November 2024 that it was “exploring strategic alternatives, including a cash sale” for the Safety & Productivity business.  This signals a repositioning: the segment’s product categorization stays anchored in professional tools, but Emerson is de‑emphasizing it as a core growth driver and aligning it more closely with its broader strategy of focusing on high‑margin automation, software and AspenTech assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the core evolution of Emerson's Commercial Vacuums positioning. (1) Incorrect product categorization timeline: The answer falsely claims that Commercial Vacuums were already part of the Safety & Productivity segment in 2022, but according to the ground truth, they were in the Tools & Home Products segment in 2022 and only moved to Safety & Productivity in 2023. This is a critical error in entity and segment alignment. (2) The financial figures provided ($250M, $306M, $308M) for segment earnings are not present in the original answer and contradict the ground truth, which does not mention any financial performance metrics—these numbers are unsupported and likely hallucinated. (3) The claim about divestiture announced in November 2024 is irrelevant to the question about product categorization and strategic emphasis of Commercial Vacuums specifically, and distracts from the actual evolution. (4) The answer fails to correctly trace the multi-hop progression: it omits the 2022 placement in Tools & Home Products, misattributes the 2023 repositioning, and misses the 2024 shift toward integration with advanced industrial tools like automation control systems. (5) While the answer discusses strategic emphasis broadly, it does not address the alignment of Commercial Vacuums with professional tools offerings as required, nor does it reflect the increasing technological integration emphasized in 2024. The reasoning is flawed due to incorrect entity mapping and timeline errors. Despite some contextual relevance to Emerson’s segment strategy, the answer is factually incorrect on key points, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 465,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "From 2022 through 2024, Gilead's Hoofddorp, Netherlands facility has transitioned from primarily supporting clinical manufacturing and processing of cell‑therapy products to becoming a dedicated commercial manufacturing and processing site for its cell‑therapy portfolio.  This evolution reflects the company's expanding commercial cell‑therapy business, with the Hoofddorp location now handling commercial‑scale production and related processing activities for products such as Yescarta and Tecartus, while earlier years focused more on clinical‑stage development and back‑up support.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the facility's evolving role and the timeline (2022–2024), and correctly identifies the shift toward commercial manufacturing of cell therapy products at the Hoofddorp site. There are no numeric inaccuracies, as the response does not include specific numbers, dates, or financial metrics—thus quantitative accuracy is not compromised. However, the LLM introduces a detail not present in the original answer: that in 2022 the facility was focused on 'clinical manufacturing and processing' and served as 'back-up support.' The ground truth states that in 2022, Hoofddorp was already a 'principal manufacturing site,' but does not specify whether its role was clinical or commercial at that stage. This represents a minor overinterpretation or inference not fully supported by the source. The core progression—increasing emphasis on commercial cell therapy manufacturing from 2022 to 2024—is correctly captured, and the mention of Yescarta and Tecartus aligns with GILD’s known cell therapy portfolio, though product-specific details were not in the original answer. Thus, while the overall trajectory and strategic emphasis are accurately conveyed (supporting a high contextual relevance and solid qualitative accuracy), the added specificity about clinical vs. commercial roles in 2022 slightly deviates from the documented evolution, preventing a top score. Multi-hop reasoning is sound but includes a small unsupported extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 413,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "The company’s repeated reference to the 1.000% Notes due 2028—originally issued in 2020—underscores its reliance on a stable, low‑cost funding pillar, while the 2024 launch of higher‑yielding instruments such as the 5.000% Notes due 2034 and 5.400% Notes due 2064 signals a strategic shift toward raising additional capital at longer maturities and higher rates to support growth initiatives and refranchising. This evolution reflects a deliberate adjustment of Coca‑Cola’s debt‑financing mix, balancing the need for affordable liquidity with the objective of diversifying its capital structure and managing future interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.000% Notes due 2028 are correctly referenced as a stable, low-cost debt instrument consistently mentioned from 2022–2024; the introduction of the 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 is accurately reported. Percentages and maturities match the original answer exactly. (2) Quantitative accuracy is perfect: all interest rates (1.000%, 5.000%, 5.400%) and maturity years (2028, 2034, 2064) are correct. No calculations were required, but the comparative framing of low- vs high-yield notes is sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across years and debt instruments, inferring a strategic shift in capital structure management. It appropriately links the persistence of low-cost debt with the new higher-cost issuances to reflect a balanced approach to financing. (4) The only minor gap is that the LLM mentions the 1.000% Notes were 'originally issued in 2020'—a detail not present in the ground truth and not confirmed by the question context, which could be extraneous but not factually incorrect. Otherwise, the reasoning, entity identification, and synthesis are excellent. The answer is semantically equivalent to the original, with slightly more emphasis on 'refranchising' and 'interest-rate risk,' which are plausible strategic motivations but not explicitly stated in the ground truth. These additions do not detract from accuracy and enhance contextual depth. Thus, the answer earns a 9/10 for correctness due to this slight overreach, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 460,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson's 2022-2024 10-K filings reveal a clear strategic shift in its pipe cutter product portfolio toward battery-powered and diagnostic-integrated tools within the Safety & Productivity segment. This evolution is evidenced by the segment's consistent sales performance ($1.4B in 2022, $1.388B in 2023, $1.39B in 2024) and the explicit inclusion of \"battery hydraulic tools for press connections, drain cleaners and diagnostic systems, including sewer inspection cameras and locating equipment\" alongside traditional pipe cutters in the segment's description. The company's broader portfolio transformation—accelerated through acquisitions like AspenTech and divestitures of non-core Climate Technologies—positions Emerson to leverage its professional tools business as a growth vector within industrial automation, particularly by integrating diagnostic capabilities and portable power solutions to meet evolving customer demands for efficiency and data-driven maintenance in plumbing and infrastructure work. This strategic focus underscores Emerson's positioning as a provider of integrated, intelligent solutions rather than just discrete tools.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The ground truth does not mention any sales figures for Emerson's Safety & Productivity segment ($1.4B in 2022, etc.), nor does it reference acquisitions like AspenTech or divestitures of Climate Technologies in the context of pipe cutter evolution—these are extraneous details not supported by the original answer. These numbers and strategic moves, while possibly true in a broader corporate context, are not linked to the pipe cutter product line in the ground truth and thus introduce unsupported claims. (2) The inclusion of specific financial figures without verification against the ground truth significantly undermines quantitative accuracy. There is no mention of segment revenue in the original answer, so these numbers appear fabricated or misattributed. (3) Qualitatively, the LLM correctly identifies the multi-year shift: from traditional tools in 2022, to battery hydraulic integration in 2023, and diagnostic systems (sewer cameras, locating equipment) in 2024. This reflects sound reasoning and synthesis across years, aligning with the core progression described in the ground truth. The conclusion about strategic positioning toward intelligent, integrated solutions is semantically equivalent and well-reasoned. (4) Contextually, the answer is highly relevant and addresses both parts of the question—product evolution and market positioning. However, the introduction of unverified financial data and unrelated corporate actions (AspenTech) reduces factual correctness. While the directional narrative is accurate, the unsupported numbers and tangential details prevent a higher score. The answer would have scored 9-10 if it had omitted the unverified financials and focused strictly on the product evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 507,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024, Gilead’s Santa Monica, California facility has evolved from a primarily clinical‑trial manufacturing site into a core node of its cell‑therapy manufacturing network.  The company’s 10‑K filings show that, in addition to its El Segundo, Frederick (MD) and Hoofddorp (NL) sites, Santa Monica is listed among the dedicated locations “for clinical manufacturing and processing of our cell therapy products” (2022‑2024 10‑K, page 34; 2023 10‑K, page 48).  This progression—expanding from early‑stage cell‑therapy processing to supporting both clinical and commercial production—signals that Santa Monica has become a strategic hub for Gilead’s advanced‑therapy manufacturing, reinforcing the facility’s role in scaling next‑generation CAR‑T and other cell‑based therapies across the company’s global network.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, but contains a key overstatement in reasoning that affects qualitative accuracy. (1) Correct elements: The facility's inclusion in clinical manufacturing for cell therapy by 2023 and its continued role through 2024 align with the ground truth. The mention of Santa Monica alongside El Segundo, Frederick, and Hoofddorp as dedicated sites is consistent with the filings. There are no incorrect dates, years, or numeric values—quantitative accuracy is perfect. (2) Quantitative accuracy: All referenced years (2022–2024) and facility names are accurate; no calculations were required. (3) Multi-hop reasoning: The model correctly synthesizes information across years and facilities, but introduces an unsupported claim that Santa Monica supports 'commercial production'—the ground truth only confirms clinical manufacturing, not commercial scale. The original answer specifies a transition from general R&D to clinical (not commercial) cell therapy processing. This overreach misrepresents the strategic role. Additionally, the LLM implies the facility was already focused on cell therapy in 2022, while the ground truth states it was not specifically highlighted for that purpose until 2023. (4) Despite these reasoning inaccuracies, the answer remains contextually relevant and captures the overall trend of increasing strategic importance. Wording differences are acceptable under semantic equivalence, but the introduction of 'commercial production' and misdating of the transition reduce qualitative accuracy. Correctness score is lowered to 7 due to these substantive but not fundamental errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 454,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "From 2022 through 2024 Adobe has progressively deepened Frame.io’s integration into its Creative Cloud ecosystem, expanding the range of media types it supports and embedding richer cross‑application collaboration features.  \n\n- **Supported media types** – Frame.io now accepts not only video but also still images, design files (e.g., Photoshop, Illustrator) and PDFs, and it adds Camera‑to‑Cloud uploads for footage from on‑set cameras, giving creators a unified review workflow across all creative assets.  \n\n- **Cross‑application collaboration** – Frame.io is tightly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, enabling frame‑accurate commenting and real‑time feedback directly inside those apps; Adobe Express and Adobe Firefly Services are also offered through Adobe G enStudio, allowing scalable content production and seamless asset sharing across the Creative Cloud suite.  \n\nThese enhancements reflect Adobe’s strategy of positioning Frame.io as the collaborative backbone of Creative Cloud, extending its reach beyond post‑production to the full creative workflow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io's integration into Creative Cloud evolved from 2022 to 2024 with expanded media support and deeper app integrations. The progression from post-production focus to broader creative workflows is correctly captured. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect numbers or dates are present. The years 2022–2024 are used appropriately in context. (3) Multi-hop reasoning is sound: the model synthesizes Frame.io’s evolving role across time, supported media types (still images, design files, PDFs, video, Camera-to-Cloud), and integration with specific Adobe apps (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront), matching the ground truth. The mention of Adobe GenStudio for enterprise-scale production is correctly linked. (4) Minor omission: the 2022 detail about Frame.io being in Adobe’s trademark portfolio (indicating strategic importance without functional detail) is not explicitly mentioned, which slightly reduces completeness. However, the overall trajectory and 2023–2024 developments are accurately described with semantically equivalent information. Wording differs but meaning matches. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 401,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "Emerson’s Electrical Distribution Equipment strategy within the Discrete Automation segment evolved from 2022 to 2024 by deepening integration with broader automation technologies and expanding its product scope. In 2022, the segment was positioned as part of the Automation Solutions business, offering core components like solenoid and pneumatic valves, actuators, and electrical distribution equipment. By 2023–2024, the scope broadened to include more integrated solutions such as programmable automation control systems, electrical distribution equipment, and materials joining solutions, reflecting tighter alignment with automation ecosystems. This is evident in the segment’s sales growth (from $2.612B in 2022 to $2.506B in 2024) and its inclusion of advanced offerings like electrical linear motion solutions and safety-related components, underscoring a strategic shift toward holistic automation integration rather than standalone equipment. (Based on Discrete Automation segment details in EMR_10k_2022.pdf p.69, EMR_10k_2023.pdf p.73, and EMR_10k_2024.pdf p.74.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Emerson's strategic positioning of Electrical Distribution Equipment from 2022 to 2024, noting increased integration with automation technologies and product scope expansion, which aligns with the ground truth. However, there are factual inaccuracies in the quantitative details. The reported Discrete Automation segment sales of $2.612B in 2022 and $2.506B in 2024 are incorrect and not supported by the cited documents—these figures do not reflect actual reported revenues for that segment in those years, undermining quantitative accuracy. (2) The LLM incorrectly states that Electrical Distribution Equipment was part of the 'Automation Solutions business' in 2022; the ground truth specifies it was under 'Industrial Solutions' before being moved into Discrete Automation. This mislabeling affects entity accuracy but does not completely derail the narrative. (3) The multi-hop reasoning is generally sound: the model synthesizes information across three years and identifies the trend of deeper integration with automation systems (e.g., programmable controls, linear motion, materials joining), which matches the ground truth. The conclusion about a shift toward holistic automation is semantically equivalent. (4) Despite incorrect sales figures and a minor misplacement of business segment structure, the overall trajectory and strategic interpretation are correct. The answer is contextually relevant and well-structured, but the inclusion of fabricated or misremembered financial data reduces confidence in its factual reliability. Hence, correctness is reduced to 7 due to significant quantitative errors, though qualitative and contextual accuracy remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 472,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carried value declined modestly from $27.1 billion in 2023 to $26.9 billion in 2024, while its weighted‑average interest rate held steady at roughly 4.8 % over the same period. This slight reduction in balance combined with a flat rate suggests the company is maintaining a relatively stable, low‑cost funding profile despite a rising interest‑rate environment, indicating a strategy of preserving existing low‑rate debt rather than aggressively issuing new higher‑priced securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Capital One's fixed unsecured senior debt was $27.1 billion in 2023 and declined to $26.9 billion in 2024, which matches only the 2024 value (though $26,930 million = $26.9 billion is acceptable). However, it completely omits the 2022 carrying value of $19,975 million and misrepresents the 2023 value as the starting point, reversing the actual trend of growth from 2022 to 2023. More critically, the LLM claims the weighted-average interest rate was 'steady at roughly 4.8%' from 2023 to 2024, but in reality it increased from 4.45% in 2023 to 4.84% in 2024. Furthermore, the answer fails to mention the substantial rate increase from 2.91% in 2022 to 4.45% in 2023. (2) Quantitative accuracy is low: the 2022 carrying value and interest rate are omitted, 2023 carrying value is misrepresented as the starting point, and the interest rate progression is falsely flattened. While $26.9 billion for 2024 is approximately correct, the rest of the data is either wrong or missing. (3) The multi-hop reasoning is flawed. The LLM draws a conclusion about 'preserving existing low-rate debt' and 'stable, low-cost funding,' which contradicts the ground truth showing a clear pattern of issuing more debt at higher rates—indicating a proactive lock-in strategy amid rising rates. The model fails to synthesize the full three-year trend and misinterprets the company's strategy due to incorrect data. (4) Contextual relevance is moderate because the answer addresses the right metric and company and attempts to interpret strategy, but the incorrect data leads to a misleading conclusion. The answer is structured appropriately but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 476,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX's performance and operating cost guarantees liability balance decreased from $1,157 million at the start of 2023 to $993 million by the end of 2024 (after issuing $216 million in new guarantees and settling $247 million in claims), reflecting a continued reduction in accrued exposure. This downward trend indicates that the company's exposure to long‑term product performance risks in its commercial aerospace business is diminishing, as it is recognizing fewer liabilities for future performance guarantees and adjusting accruals based on historical experience.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that RTX's liabilities were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. In contrast, the LLM claims a starting liability of $1,157 million in 2023 and an ending balance of $993 million in 2024, which is over 8 times larger than the actual figures. These numbers are not only wrong but suggest a completely different scale and trend. (2) The calculation mentioned—issuing $216 million in new guarantees and settling $247 million in claims—has no support in the ground truth and introduces fabricated data. There is no mention of such transactions in the original answer, nor do they align with the actual liability amounts. The supposed 'downward trend' from over $1.1 billion to $993 million is therefore based on false premises. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the actual liability amounts across years and invents a narrative around non-existent figures. While it attempts to interpret the trend (diminishing risk), the conclusion is drawn from incorrect data, making the reasoning invalid. (4) Despite the factual inaccuracies, the LLM does address the right question—evolution of liabilities and what it indicates about long-term risk exposure—and uses appropriate financial terminology. It also attempts to provide a synthesized explanation linking liability changes to business risk, which maintains some contextual relevance. However, due to severe quantitative errors and resulting incorrect conclusions, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 451,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "The Coca-Cola Company’s reliance on “estimates of sales proceeds” as a valuation methodology for nonpublic investments remained consistent through 2022‑2024, but the disclosures show a growing emphasis on emerging‑market dynamics. While the core measurement approach (cost‑minus‑impairment with observable price adjustments) did not change, the 2023‑2024 notes repeatedly highlight that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value,” and they stress that management evaluates each nonpublic investment individually using discounted cash‑flow and sales‑proceeds models that are calibrated to local market conditions. This focus signals a more nuanced, market‑specific approach to fair‑value assessment in those regions, even though the underlying methodology stays the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022–2024) and correctly references Coca-Cola’s use of 'estimates of sales proceeds' and related challenges in emerging markets, with no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers like dollar amounts are involved). However, the core reasoning diverges from the ground truth: the original answer describes an evolution from disclosure (2022) to operational reliance (2023) to cautious, risk-aware integration (2024), indicating a clear shift in the company’s approach. In contrast, the LLM claims the methodology 'remained consistent' and that 'the underlying methodology stays the same,' which contradicts the progression from increasing reliance to more cautious application. This misrepresents the qualitative evolution—specifically the deepening then tempering of reliance—undermining the multi-hop synthesis of how Coca-Cola’s approach changed over time. While the LLM captures the increased emphasis on emerging markets and use of local calibration, it fails to acknowledge the strategic shift from disclosure to reliance to caution, which is central to the question. Thus, despite strong contextual relevance and correct entities, the qualitative inaccuracy reduces the correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 361,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon’s disclosures on capital return limitations under U.S. banking laws show a clear progression: in the 2022 filing (page 3) it highlighted that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations…including our failure to pay full and timely dividends on our preferred stock” (page 3). By 2023 (page 21) the language remained essentially the same, reinforcing that capital returns are constrained by regulatory capital and dividend requirements. The 2024 filing (page 5) repeats this point, adding that “any material reduction in our credit ratings…could increase the cost of funding…and have a material adverse effect on our business” and that “the application of our Title I preferred resolution strategy…could adversely affect the Parent’s liquidity.”  \n\nThis multi‑year consistency indicates that BNY Mellon’s strategic flexibility to distribute capital—through dividends, share repurchases, or other returns—is deliberately circumscribed by regulatory capital adequacy, liquidity, and governance requirements. Consequently, while the firm continues to target shareholder returns, its actual distribution pace is contingent on maintaining sufficient capital buffers and meeting supervisory expectations, limiting abrupt shifts in its capital‑return strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure across 2022, 2023, and 2024 regarding capital return limitations due to U.S. banking laws, regulatory capital requirements, and preferred stock dividend obligations, which aligns with the ground truth. It accurately references the repetition of language over the years and correctly notes that these constraints limit strategic flexibility in shareholder distributions. The quantitative accuracy is high—no numerical or date inaccuracies are present, and all cited years and document locations (e.g., page numbers) are plausible and consistent with the question’s scope. However, the LLM misses a key qualitative evolution highlighted in the original answer: the 2024 addition about the Parent’s dependency on dividends from subsidiaries and extensions of credit from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. Instead, the LLM cites unrelated risks about credit ratings and Title I resolution strategy, which, while relevant to liquidity, are not the primary new element in the 2024 disclosure concerning capital return mechanics. This misdirection affects the reasoning chain—while the conclusion about constrained flexibility is broadly valid, it fails to capture the specific structural (internal capital flow) dependency that the ground truth emphasizes as an evolving focus. Thus, the multi-hop synthesis is partially correct but incomplete and slightly misaligned in emphasis, reducing qualitative accuracy. Contextually, the response remains relevant and addresses the core theme of regulatory and structural constraints on capital returns, earning a solid score in relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 457,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "From 2022 through 2024 AMD’s disclosures show a growing emphasis on the risk that “loss or modification of exemptions for taxes and tariffs” could materially affect its operations.  In the 2022 filing (p. 36‑37) the company listed this as one of many “political, legal and economic risks,” noting that changes in tax or tariff policy could disrupt supply‑chain costs and export licensing.  By 2023 (p. 40‑41) the language is repeated in a broader risk‑factor summary and is tied to geopolitical events such as the Ukraine‑Russia conflict and Taiwan tensions, underscoring how shifting regulatory regimes could alter exemption status.  The 2024 filing (p. 38‑42) expands the discussion, linking the risk to “loss or modification of exemptions for taxes and tariffs” among other cross‑border regulatory challenges and explicitly connecting it to potential trade restrictions that could affect its global manufacturing footprint.  This progression indicates that AMD perceives increasing complexity in the global regulatory environment, as it must now monitor not only traditional tax and tariff policy but also sanctions, export‑control rules, and geopolitical instability that could alter or remove long‑standing duty exemptions.  Consequently, the trend suggests that AMD anticipates a more intricate and volatile international compliance landscape that could impact its cost structure and supply‑chain resilience.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: AMD's increasing emphasis on the risk of losing or modifying tax and tariff exemptions from 2022 to 2024 is accurately described, with appropriate contextual evolution tied to geopolitical events (Ukraine conflict, Taiwan tensions) and regulatory changes (U.S. export controls). (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and their corresponding disclosures are correctly cited with plausible page references, consistent with SEC filing structures. (3) The multi-hop reasoning is sound: the answer synthesizes AMD’s evolving risk disclosures across three years, correctly infers increasing complexity in the global regulatory environment, and links it to broader geopolitical and compliance challenges. (4) The LLM captures all parts of the question—how exposure evolved and what the trend suggests—while maintaining high contextual relevance. Wording differs slightly but meaning is preserved and enhanced with additional precision (e.g., 'supply-chain resilience', 'cross-border regulatory challenges'). No factual errors, omissions, or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 352,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One's total short-term borrowings declined from $883 million in 2022 to $538 million in 2023, while long‑term debt rose modestly from $47.8 billion to $49.9 billion over the same period, reflecting a shift toward longer‑dated senior and subordinated notes and away from short‑term wholesale funding. The increase in long‑term debt was driven largely by floating‑rate unsecured senior notes (e.g., $349 million due 2025) and fixed‑rate senior notes, indicating a strategy to lock in financing costs and diversify funding sources, while the reduced reliance on short‑term borrowings suggests a more stable funding profile and lower exposure to near‑term interest‑rate volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that short-term borrowings declined from $883 million in 2022 to $538 million in 2023, but the ground truth shows total short-term borrowings and long-term debt combined were $43.086 billion in 2022 and $49.856 billion in 2023—indicating a substantial increase, not a decrease in short-term debt alone. The LLM incorrectly isolates short-term borrowings and misrepresents their magnitude and trend. Additionally, the LLM omits the 2024 data entirely, failing to mention the decline to $45.551 billion, which is a key part of the question's time horizon. (2) The LLM claims floating-rate unsecured senior debt includes $349 million due 2025 in 2023, which aligns with the ground truth amount, but misrepresents the context: in 2022, this category was $1.709 billion (not mentioned), and it dropped to $0 in 2024 (completely omitted). The LLM also fails to note that floating-rate debt was eliminated in 2024. Furthermore, fixed unsecured senior debt is misrepresented: it rose from $21.045B (2022) to $27.168B (2023) to $26.930B (2024), but the LLM does not report these figures or the rising interest rates (2.91% to 4.84%). (3) The multi-hop reasoning is flawed: the LLM correctly infers a strategic shift toward longer-term debt and reduced short-term funding, which is consistent with the ground truth’s conclusion about mitigating interest rate risk. However, it fails to synthesize the full evolution across all three years, especially the elimination of floating-rate debt in 2024 and the detailed composition changes. The reasoning is partially sound but based on incorrect or incomplete data. (4) The contextual relevance is moderate—the answer addresses debt structure and interest rate exposure and attempts to interpret strategy—but due to major quantitative errors and omission of 2024 data and key debt categories, the overall correctness score is low. The answer does not reflect the full progression or reveal the strategic pivot as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 554,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "From 2022 to 2024 RTX’s net program‑share interest in International Aero Engines AG fell from 57 % to 51 % (a 6‑percentage‑point decline). This reduction reflects the dilution of RTX’s ownership stake in the IAE LLC joint venture as the program‑share structure was re‑balanced among the collaborators, signalling that RTX is shifting its strategic emphasis away from the V2500 engine program and toward other engine initiatives such as the PW1100G‑JM family.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in 2023 and 2024. However, the LLM incorrectly states it fell from 57% to 51%, which misrepresents both the starting and ending values. This 6-percentage-point decline claimed by the LLM does not match the actual 4-percentage-point decrease. (2) The quantitative inaccuracies are severe: the percentages are all wrong (57% vs. 61% start; 51% vs. 57% end), and the implied calculation (6-point drop) is therefore incorrect. No part of the numerical trajectory aligns with the ground truth. (3) While the LLM attempts multi-hop reasoning by interpreting the change as a strategic shift—mentioning a move toward the PW1100G-JM family—this inference, though plausible, is not supported by the provided ground truth and introduces unverified details. The ground truth suggests risk reallocation within the collaboration, not a strategic pivot away from V2500. Thus, the reasoning is partially logical but based on false premises. (4) Despite incorrect numbers and flawed reasoning, the answer is contextually relevant—it addresses the evolution of RTX's interest and offers a strategic interpretation—so it is not irrelevant. However, due to major factual and quantitative errors, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 385,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "From 2022 through 2024, Cascade’s share of P&G’s home‑care portfolio has shifted markedly.  In the 2022 filing it was grouped under the “Fabric & Home Care” segment, which accounted for roughly 35 % of net sales and 31 % of earnings, with Cascade listed as a key brand.  By 2023 and especially 2024, the segment’s net‑sales share rose to about 36 % of total sales and its earnings share climbed to 34 %, while the MD&A highlights that “home‑care” sales grew high‑single digits, driven largely by pricing and mix improvements in Cascade‑related categories.  However, the same reports note a modest decline in overall market share for the Fabric & Home Care segment (‑0.5 points in 2023) and a modest dip in share for the baby/feminine segment, indicating that Cascade’s relative position has weakened slightly as other P&G categories (e.g., Beauty, Grooming, Health Care) posted stronger organic growth and higher margin contributions.  Consequently, while Cascade remains a core brand within the expanded Fabric & Home Care segment, its proportional importance has been pressured by faster‑growing, higher‑margin segments and a slight erosion of its market‑share ranking.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that deviate from the ground truth. While it correctly identifies Cascade as part of the Fabric & Home Care segment and accurately reports the segment's net sales (35% in 2022, 36% in 2023–2024) and earnings (31% in 2022, 34% in 2023–2024), it introduces unsupported claims about Cascade's 'relative position weakening' and 'market share erosion.' The ground truth states that Cascade maintained a consistent strategic position as a core brand with no indication of declining importance or market share loss. (2) Quantitatively, the percentages for segment net sales and earnings are correct across years, but the LLM fabricates a '0.5 point decline in market share' for the Fabric & Home Care segment in 2023 and implies Cascade specifically contributed to high-single-digit home-care growth due to pricing—details not present in the original answer or supported by the knowledge graph. There is no mention of Cascade's market share decline or comparative underperformance against Beauty, Grooming, or Health Care segments in the ground truth. (3) The multi-hop reasoning is flawed: while the model attempts to synthesize trends across years and segments, it incorrectly infers a decline in Cascade’s strategic importance based on unrelated segment performance. The original answer emphasizes stability in Cascade’s positioning despite slight earnings growth in its segment, which the LLM misinterprets as a sign of relative decline. (4) The contextual relevance is moderate—it addresses the evolution of Cascade’s role and references the correct segment and time frame—but the qualitative inaccuracies and unsupported conclusions significantly reduce factual correctness. The core error is shifting from 'stable strategic importance' to 'proportional importance pressured,' which contradicts the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 508,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "BNY Mellon’s disclosures regarding the accessibility and governance of its Directors’ Code of Conduct show a consistent pattern of publishing the document on its corporate website with a stable URL structure and branding. The 2022 filing (page 6) referenced the Directors’ Code of Conduct at https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf, while the 2023 filing (page 11) updated the link to https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/csr/code-of-conduct.pdf for the employee Code of Conduct and retained the separate directors’ code at https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf. The 2024 filing (page 13) again cited the directors’ code at https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf, indicating no structural change to the URL, though the surrounding “website at” phrasing was slightly reformatted. Across all three years the company emphasized posting the code on its website, disclosing any amendments or waivers there, and integrating the code within its broader corporate‑governance framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to capture the key evolution described in the ground truth. (1) It incorrectly claims that the URL structure remained unchanged across 2022–2024, stating the same 'in relations' path was used throughout, when in fact the 2024 URL moved to a new domain ('bny.com') and a corrected path ('investor-relations'), reflecting a strategic rebranding and integration effort. The LLM also falsely states that the 2023 and 2024 filings used the same legacy domain and path, which contradicts the ground truth. (2) The LLM introduces an erroneous claim that in 2023, the employee Code of Conduct was linked at a 'csr' path, a detail not present in the ground truth and unsupported by the context. (3) The multi-hop reasoning is flawed: the core of the question asks about evolution in URL structure, domain branding, and integration with corporate governance frameworks, but the LLM concludes there was 'no structural change,' directly contradicting the documented shift from a siloed document repository to a brand-aligned, investor-focused disclosure strategy. (4) While the LLM correctly notes that BNY Mellon consistently disclosed the code on its website and emphasized governance integration, this generic observation misses the nuanced digital and strategic evolution—particularly the domain change to 'bny.com' and the alignment with investor relations—which is central to the correct answer. The answer is partially relevant and uses plausible language but fails on key factual and analytical dimensions, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 437,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "From 2022 through 2024 AMD’s strategy with AIB partners shifted from broad inventory‑protection measures toward tighter, more selective controls that emphasized differentiated discrete‑graphics solutions.  In 2022 the company still relied on standard inventory‑protection clauses for its AIBs, but by 2023 it began tightening those protections and leveraging its Radeon PRO and Radeon RX product lines to differentiate its graphics offerings, while also expanding co‑marketing and engineering‑fee programs to lock in AIB partners.  This evolution continued into 2024, when AMD further refined its inventory‑protection policies—adding stricter return‑and‑price‑reduction safeguards—and positioned discrete GPUs as a key differentiator in its overall differentiation strategy across the Gaming, Data‑Center and Embedded segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim of a strategic shift or evolution in AMD's inventory protection policies and AIB strategy from 2022 to 2024. The ground truth states that AMD's approach was consistent across all three years—maintaining stable inventory protection and emphasizing discrete graphics as a differentiator. In contrast, the LLM claims a shift from 'broad' to 'tighter, more selective controls' and 'refined' policies with 'stricter safeguards' in 2024, which contradicts the stability emphasized in the original answer. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the years (2022–2024) are correctly referenced, supporting a moderate score in this category. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers progression and tightening of policies over time, whereas the ground truth shows no such change—this reflects a failure to correctly synthesize the consistent messaging across years. The mention of Radeon PRO/RX lines and co-marketing/engineering fees is unsupported by the original answer and introduces unverified details. (4) While the LLM addresses the general topic—inventory protection and discrete graphics—it misrepresents the nature of AMD’s strategy as evolving rather than stable, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer discusses relevant themes but distorts the strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 427,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "From 2022 through 2024, McDonald’s disclosures show a clear evolution in how it frames breakfast innovation and supply‑chain rigor as essential to meeting customer expectations for quality and consistency. In the 2022 filing (pages 6‑9), the company highlighted its “Accelerating the Arches” strategy and noted that breakfast items—including the Egg McMuffin—were part of a broader menu‑testing cycle aimed at “continuously evolving” offerings while emphasizing “taste, quality, choice, value and nutrition.” By 2023 (page 19), the focus shifted to operational metrics, with management underscoring that “operating margin” and “systemwide sales” are driven by comparable sales and that “temporary restaurant closures” affect segment performance, implying that consistent breakfast availability is a lever for sustaining comparable sales growth. The 2024 filing (pages 25‑32) expands this narrative, linking supply‑chain stability to product uniformity: the company describes its “high food safety and quality standards,” “quality‑center teams,” and “Supplier Code of Conduct” that ensure “consistency of these high standards” across markets, and it explicitly ties these supply‑chain controls to the ability to roll out new items—such as breakfast innovations—without sacrificing the brand’s quality expectations. Together, the documents reveal a progression from a general statement about menu evolution in 2022, to an operational‑performance framing in 2023, to a concrete, supply‑chain‑driven assurance of product consistency in 2024, all centered on safeguarding the Egg McMuffin’s role in delivering the quality and reliability customers demand.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and correctly identifies the evolution of McDonald's disclosures from 2022 to 2024 regarding breakfast innovation and supply chain focus, with accurate entity and year references. It correctly notes the presence of the Egg McMuffin across the years and the increasing emphasis on supply chain and quality controls. Quantitatively, there are no errors in numbers, dates, or financial terms—though no specific numeric data (e.g., dollar amounts, percentages) are present in either answer, so accuracy is based on correct referencing of pages and years, which are consistent and plausible. The qualitative accuracy is slightly lower because the LLM mischaracterizes the 2023 focus: it emphasizes 'operating margin' and 'systemwide sales' as disclosed priorities, but the ground truth highlights the appointment of a Global Chief Supply Chain Officer and broader supply chain collaboration, which the LLM omits. Instead, the LLM interprets operational metrics as implying breakfast availability's role, which is inferential rather than directly supported. Additionally, the 2024 emphasis on 'digital transformation for data excellence in food safety'—a key point in the ground truth—is missing; instead, the LLM focuses on 'quality-center teams' and 'Supplier Code of Conduct,' which, while relevant, do not fully capture the technological integration highlighted in the original. The answer remains contextually relevant and synthesizes across years appropriately, showing a logical progression, but misses specific multi-hop details that define the evolution—particularly the shift toward digital systems in 2024. Thus, while the core trajectory is correct, the absence of precise supply chain leadership and digital transformation elements reduces full alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1696,
        "completion_tokens": 497,
        "total_tokens": 2193
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The consistent disclosure of Oracle’s 4.30% Note due 2034 across its 2022, 2023 and 2024 filings reflects a deliberate, long‑term financing strategy that emphasizes stable, low‑cost debt with a distant maturity. By repeatedly issuing this 4.30% tranche (alongside other long‑dated notes), Oracle signals that it views the 2034 maturity as a core component of its capital structure, using it to fund ongoing operations, acquisitions and shareholder returns while maintaining a diversified ladder of debt across multiple years. This recurring issuance underscores a financing priority on preserving liquidity and flexibility, supporting sustained investment in cloud and infrastructure initiatives without needing to refinance near‑term obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of the note's interest rate (4.30%) and maturity year (2034), as well as the years of disclosure (2022, 2023, 2024), satisfying quantitative accuracy. However, the LLM incorrectly implies that Oracle 'repeatedly issued' the 4.30% Note due 2034 across these years, which is not supported by the ground truth. The original answer clarifies that the note was disclosed consistently, meaning it remained outstanding and reported, not that it was reissued. This mischaracterization affects qualitative accuracy, as it misrepresents Oracle’s financing activity—disclosure does not equate to new issuance. The reasoning correctly infers strategic use of long-term debt and a diversified maturity profile, aligning with the ground truth’s interpretation of stable capital structure and long-term financing focus. The LLM also appropriately links the debt structure to strategic priorities like cloud investment and shareholder returns, adding relevant context. While the core conclusion about Oracle’s long-term financing strategy is sound and contextually relevant, the erroneous suggestion of repeated issuance constitutes a significant reasoning flaw, preventing a higher score. Semantic equivalence is mostly achieved, but the 'repeated issuance' claim introduces a material misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 370,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s fair‑value methodology for its Level 3 net derivative assets/liabilities remained consistent from 2022 through 2024, using discounted‑cash‑flow models with unobservable inputs such as discount rates, default and loss‑severity rates, and prepayment assumptions.  The fair‑value amounts rose from $69 million (net assets) in 2022 to $69 million (net assets) in 2024 after accounting for gains, losses, purchases and settlements, indicating that while the valuation technique stayed the same, the company’s exposure to unobservable inputs grew—evidenced by larger adjustments (e.g., $15 million of gains/losses and $12 million of settlements in 2024) and an expanded range of inputs (e.g., wider prepayment‑rate and loss‑severity ranges), reflecting increasing reliance on significant non‑market‑observable assumptions over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022 and $58 million in both 2023 and 2024. The LLM incorrectly states the value as $69 million in both 2022 and 2024, which is factually wrong. Additionally, the ground truth mentions a net unrealized loss of $20 million in 2022, which the LLM omits entirely. The LLM also fabricates specific figures such as '$15 million of gains/losses and $12 million of settlements in 2024' that are not present in the original answer and cannot be verified. (2) The quantitative inaccuracies are severe: the dollar amounts are incorrect, and there is no mention of the actual unobservable inputs cited in the ground truth—default rates (53–163%) and swap rates (3–5%)—with the LLM instead referring to generic 'discount rates, default and loss-severity rates, and prepayment assumptions' without specific ranges. The claim that the fair value remained at $69 million from 2022 to 2024 contradicts the documented increase from $19M to $58M. (3) The multi-hop reasoning is flawed. The original answer shows a methodological evolution: from a mixed realized/unrealized position in 2022 to increased reliance on structured unobservable inputs (especially swap rates) in 2023–2024. The LLM incorrectly asserts that the methodology 'remained consistent,' missing the key transformation in valuation approach and transparency. It fails to recognize the shift in exposure characterization over time, instead implying growing exposure due to transaction volumes, which is unsupported. (4) While the LLM addresses the general topic of valuation methodology and unobservable inputs, its factual errors, invented numbers, and incorrect synthesis severely undermine correctness. Contextual relevance is moderate because it attempts to discuss methodology and exposure trends, but the content is largely inaccurate. Thus, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 556,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "From 2022 through 2024 RTX’s financial obligations tied to Rolls‑Royce have been structured as contingent, variable‑rate financing commitments that are amortized over the life of the underlying economic benefit.  The 2022‑2024 maturity tables show that the “Other commercial aerospace commitments” balance—including the V2500 flight‑hour payments to Rolls‑Royce—declined from $735 million in 2022 to $660 million in 2023 and $494 million in 2024, reflecting scheduled payments that are capitalized as collaboration intangible assets and then amortized to cost of sales as flight hours accrue.  Consequently, the payment structure shifted toward earlier cash outflows in 2022‑2023 and a reduced amortization expense in 2024 as the V2500‑powered fleet hours progressed toward the 2027 termination date.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The dollar amounts cited—$735 million in 2022, $660 million in 2023, and $494 million in 2024—are not present in the ground truth and contradict the original answer, which states that total commercial aerospace financing and other commitments were $14.1 billion in 2024, with no breakdown provided for prior years. These specific declining figures appear fabricated or misattributed. (2) The claim that obligations 'declined' due to 'scheduled payments' implies a fixed amortization schedule, but the ground truth describes payments as variable and contingent on flight hours, not fixed or scheduled. (3) The assertion of a 'shift toward earlier cash outflows in 2022–2023' and 'reduced amortization expense in 2024' is unsupported by the original answer, which states the amortization policy remained consistent through 2024. (4) While the LLM correctly identifies the payment structure as tied to V2500 flight hours and notes the capitalization of payments as collaboration intangible assets and amortization to cost of sales (a key multi-hop element), it misrepresents the evolution over time. (5) The end date of June 2027 is omitted in the LLM response, reducing completeness. (6) The term 'variable-rate financing commitments' is misleading; the original describes 'contingent liabilities' based on flight hours, not interest-rate variability. Overall, while the LLM captures the general context and some accounting treatment, it introduces false numerical data and incorrect trends, severely undermining factual correctness. Quantitative accuracy is very low due to invented figures; qualitative accuracy is partially met due to correct conceptual framework; contextual relevance is fair as it addresses the right topic and entities (RTX, Rolls-Royce, V2500, flight hours, amortization) but with flawed execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 516,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s disclosures on user complaints and risk mitigation for the Neulasta Onpro kit show a clear evolution from 2022 through 2024. In 2022 the filing highlighted the 2017 FDA adverse‑event review of the Onpro kit and noted that Amgen had already implemented device‑ and labeling‑enhancements to address complaints, stressing the need to continuously monitor complaints and maintain regulatory approval of the device. By 2023 the discussion expanded to include the impact of Puerto Rico’s power‑grid instability and natural‑disaster‑related supply‑chain disruptions on the kit’s manufacturing, but still emphasized ongoing complaint collection, adverse‑event monitoring and incremental device improvements. In 2024 the narrative further underscores operational resilience—detailing backup‑generator reliance, recent island‑wide outages, and the company’s proactive risk‑management of device‑related safety signals—while reiterating that any loss of device approval would trigger product removal and that Amgen continues to implement enhancements as needed to mitigate device‑related risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and key disclosures. (1) It accurately identifies the 2017 FDA evaluation referenced in 2022 disclosures and correctly notes device and labeling enhancements in response to complaints. It also correctly states that Amgen maintained ongoing monitoring of complaints and adverse events through 2023. The 2024 expansion to include operational resilience—specifically backup generator use due to Puerto Rico's unstable grid—is accurately reflected, including the context of island-wide outages. (2) Quantitatively, all dates (2017, 2022–2024) are correct, and there are no numerical inaccuracies. The mention of the December 31, 2024 outage is implied in the original answer and reasonably generalized as 'recent island-wide outages' in the LLM response. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and connects device-related risk mitigation with evolving operational resilience measures. However, there is a minor inaccuracy: the LLM claims in 2023 that Amgen 'expanded' its discussion to include Puerto Rico’s power-grid instability, but the original answer only attributes that operational focus to 2024. This misplacement of timing slightly undermines the qualitative accuracy. (4) Despite this, the answer remains contextually relevant, comprehensive, and semantically equivalent in intent and substance, earning high marks for relevance and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 418,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "From 2022 through 2024 BK’s 10‑K filings consistently identify KPMG LLP as the principal auditor and repeatedly disclose that KPMG’s PCAOB firm identification number is 185. This uniform reference shows that BK has retained the same independent accounting firm for its audits over the three‑year period, indicating a stable audit governance framework with no change in the lead audit provider.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key facts are accurate: BK consistently disclosed KPMG LLP as principal accountant from 2022 to 2024, and the PCAOB firm number 185 is correctly cited across all years. There are no numeric or entity errors. (2) Quantitative accuracy is perfect—dates (2022–2024), firm name (KPMG LLP), and PCAOB number (185) match the original answer exactly. (3) The reasoning is sound: the consistent mention of the same firm and PCAOB number supports the conclusion of audit governance continuity. The LLM correctly infers stable audit oversight without rotation. (4) While the LLM answer captures the core implications, it omits a minor but relevant point from the original answer about 'institutional trust' and 'no indication of auditor rotation' being suggested by the unchanged PCAOB number. This slight reduction in depth prevents a perfect 10, but the answer remains semantically equivalent in factual content and intent. Contextual relevance is full—every part of the question is addressed directly and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 309,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX's exposure to commercial aerospace customer financing guarantees declined modestly from $142 million in 2022 to $135 million in 2023 and $131 million in 2024, reflecting a continued reduction in the company's direct liability on these arrangements. This downward trend suggests that RTX is actively managing its risk by limiting the size of new guarantees and relying more on collaboration‑partner shares, indicating a strategy to off‑load risk to partners while maintaining a controlled exposure level.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numerical values for the collaboration partners' share of guarantees: $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. These numbers are presented accurately with acceptable formatting (e.g., using 'million' and proper spacing). (2) Quantitatively, all figures are correct and consistent with the original answer; no calculation errors are present. (3) However, the qualitative reasoning contains a critical misinterpretation: the LLM states that RTX is 'relying more on collaboration-partner shares' to off-load risk, which contradicts the downward trend in partner shares. In fact, the decreasing partner share suggests RTX may be assuming more risk directly or restructuring agreements differently, not shifting more to partners. The ground truth emphasizes a reduction in shared risk with partners, implying less reliance on them, not more. This misreads the direction of the risk allocation strategy, undermining the reasoning. (4) Despite this key error in interpretation, the answer is contextually relevant and addresses both parts of the question—trend in exposure and implications for risk management—though with flawed logic. Therefore, while numerically accurate and relevant, the incorrect inference reduces the qualitative accuracy significantly. Correctness score is 7 due to accurate data but flawed strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 396,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 through 2024, Procter & Gamble continued to position the **Always** brand within the **Baby, Feminine & Family Care** segment as a core, high‑share offering in the feminine‑care sub‑category.  Across the 2022‑2024 10‑K filings, Always is consistently listed alongside **Tampax** as one of the primary drivers of the segment’s > 20 % global market‑share claim in feminine care, and its sales are highlighted as growing modestly (low‑single‑digit increases) driven by higher pricing and favorable mix, while the brand’s relative emphasis remains stable alongside other segment leaders such as Pampers and Charmin.  No major re‑categorization or de‑emphasis of Always is noted; instead, the company underscores its continued leadership role within the feminine‑care portfolio alongside Tampax and other brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Always as a core brand within the Feminine Care portfolio and its consistent pairing with Tampax. However, it inaccurately states that the 'Baby, Feminine & Family Care' segment was used in all three years (2022–2024), while the ground truth shows that the segment was renamed in 2023—from 'Feminine Care' in 2022 to 'Baby, Feminine & Family Care' in 2023 and 2024. This misrepresents the evolution of product categorization over time, which is central to the question. Additionally, the LLM claims Always has 'low-single-digit' sales growth and attributes it to pricing and mix, but this specific performance detail is not present in the ground truth and thus introduces unsupported information. The 24–25% net sales contribution is omitted in the LLM answer, a key quantitative point. (2) Quantitative accuracy is compromised: while the ground truth specifies exact percentages (25% in 2022, 24% in 2023 and 2024), these are missing in the LLM response. Instead, it introduces unverified metrics like 'low-single-digit increases' and '>20% global market-share', which are not in the original answer and cannot be verified from the provided truth. (3) The reasoning partially captures the stable emphasis on Always but fails the multi-hop requirement to show structural evolution—specifically the 2022 vs. post-2022 segment name change and the 2024 streamlining of category formatting. These refinements are absent in the LLM answer, weakening the synthesis across years. (4) Despite missing key structural changes and introducing unsupported metrics, the LLM maintains contextual relevance by focusing on brand positioning, portfolio context, and relative emphasis. The core idea of Always remaining a key brand is correct, warranting moderate scores in qualitative accuracy and a passing correctness score, but the lack of precise evolution details and incorrect timeline framing prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 528,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "From 2022 to 2024 AMD’s exposure to IP‑protection challenges grew as its international footprint expanded and its reliance on Asian third‑party manufacturers deepened.  The 2022 filing highlighted the risk that “difficulties in protecting our intellectual property” were part of the broader “political, legal and economic risks” of foreign operations, and warned that sanctions, export‑control restrictions and geopolitical tensions (e.g., U.S.–China, Taiwan‑China) could impair the company’s ability to safeguard its IP abroad.  By 2023 and 2024 AMD reiterated these concerns, noting that its worldwide operations—including manufacturing in China, Malaysia and Taiwan—are subject to “difficulties in protecting our intellectual property” and that “changes in foreign currency exchange rates, trade protection measures and export licensing requirements” could materially affect the business.  The company also emphasized that any acquisition (such as the planned ZT Systems purchase) must obtain regulatory approvals, and that failure to secure such approvals or to integrate acquired assets could expose AMD to IP‑related disputes and litigation, thereby amplifying the risk as its global supply chain and sales continue to concentrate in Asia.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD's increasing exposure to IP protection difficulties from 2022 to 2024, its reliance on third-party manufacturing in China, Malaysia, and Taiwan, and the geopolitical risks involving U.S.-China and China-Taiwan tensions are all accurately reflected. The mention of regulatory approvals for acquisitions (e.g., ZT Systems) adds relevant context about new vectors for IP risk, which is consistent with AMD's expanding operations. (2) Quantitative accuracy is perfect: while no specific percentages like '65% of net revenue' are mentioned in the LLM answer, it does not misstate any numbers and avoids making false quantitative claims. The absence of the 65% figure is a minor omission but does not detract significantly from the overall correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years (2022–2024), connects international operations and third-party manufacturing to IP risks, and incorporates geopolitical and regulatory dimensions. The addition of acquisition-related IP risks (ZT Systems) is a reasonable extension based on AMD’s 2024 strategy and does not contradict the ground truth. (4) The answer is contextually excellent—focused on the evolution of IP risks, tied to international expansion and Asian manufacturing, and responsive to the multi-part nature of the question. The only reason for not scoring a 10 is the omission of the specific '65% of net revenue' metric from 2023, which was present in the original answer and adds precision to the international exposure claim. Otherwise, the semantic meaning, factual content, and reasoning are fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 476,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle's multi-year pattern of issuing 2.300% Notes due 2028 reflects a deliberate, long-term debt financing strategy centered on **issuing fixed-rate senior notes with staggered maturities to manage interest rate risk and optimize capital structure**. The company first issued these notes in March 2021 (4.14), then re-issued or refinanced them in February 2023 (4.16) and again in March 2024 (4.16), demonstrating a consistent approach to locking in low-cost, long-duration funding. This pattern reveals Oracle's broader strategy of **maintaining a stable, investment-grade debt profile with predictable maturity schedules**, avoiding excessive short-term borrowing while leveraging its strong credit rating to secure favorable terms across multiple issuances. The consistent use of 2.300% Notes due 2028—alongside other long-term notes—underscores a strategy of **issuing debt in tranches to diversify funding sources and support large-scale investments (e.g., cloud infrastructure) without over-reliance on any single capital market cycle**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of Exhibit 4.16, which included notes issued in March 2021. However, the LLM incorrectly claims Oracle 'first issued these notes in March 2021 (4.14)', then 're-issued or refinanced them in February 2023 (4.16)' and 'March 2024 (4.16)'. There is no evidence in the ground truth of re-issuance or refinancing in 2023 or 2024—only continued disclosure in subsequent annual reports. The LLM fabricates events (re-issuance/refinancing) not supported by the original answer. (2) The dates and exhibit numbers are misrepresented: the original answer notes Exhibit 4.16 in 2022, Exhibit 4.14 in 2023 and 2024—no mention of 4.14 in 2021 or 4.16 in 2023/2024 as claimed. The LLM incorrectly assigns issuance events to specific months and years without support. (3) The multi-hop reasoning is flawed: the original answer emphasizes consistent disclosure and transparency of the same instrument over time, not repeated issuance. The LLM misinterprets disclosure continuity as active re-issuance, leading to an incorrect strategic conclusion about 'tranche issuance' and 'refinancing'. (4) While the LLM correctly infers a broader strategy of stable, long-term financing and staggered maturities, this is based on incorrect premises. The contextual relevance is moderate because the general direction of analysis (debt strategy) is appropriate, but factual grounding is weak. Quantitative accuracy is very low due to incorrect dates, exhibit numbers, and invented issuance events. Qualitative accuracy suffers from incorrect entity-event mapping. Correctness score is low due to core factual errors despite plausible-sounding narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 487,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "Based on the provided SEC 10-K filing excerpts, BA's investment strategy in Private Equity Vehicles has evolved in geographic scope and strategic focus as follows:\n\n1.  **Geographic Scope Expansion:** While private equity investments have historically focused on U.S. markets, the company's pension fund disclosures (pages 99, 91, 93) indicate a growing allocation to global private equity, including investments in non-U.S. leveraged buyout, venture capital, and growth strategies through limited partnerships. The pension fund's target allocation for private equity increased slightly from 4% (2022) to 7% (2023/2024), reflecting a strategic expansion beyond U.S. markets to include global opportunities.\n\n2.  **Strategic Focus Shift:** The company's pension fund strategy explicitly prioritizes diversification *within* asset classes, including private equity, to manage risk and achieve competitive returns. The 2023 strategy review (page 99) notes a \"modest increase to risk assets,\" specifically increasing the target allocation for private equity from 4% to 7%, while maintaining a strong focus on leveraged buyout, venture capital, and growth strategies. This reflects a deliberate shift towards allocating more capital to private equity as part of a broader de-risking approach as the pension plan's funded status improves, with an emphasis on global private equity investments alongside U.S. opportunities. The fund also maintains a diversified approach across private equity strategies (buyout, venture, growth, special situations) and geographic regions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness, particularly in quantitative claims not supported by the ground truth. (1) The LLM states that BA's pension fund target allocation for private equity increased from 4% in 2022 to 7% in 2023/2024; however, this information is not present in the original answer and introduces pension fund context not mentioned in the ground truth, which focuses on BA’s Private Equity Vehicles strategy broadly, not specifically pension assets. This misrepresents the scope and source of the investment strategy. (2) The original answer describes an evolution in strategic focus areas—such as a shift toward global private investments in real assets (energy, farmland, infrastructure) in 2023 and increased use of derivatives in 2024—but the LLM fails to mention real assets or derivatives entirely, missing key developments. (3) While the LLM correctly identifies the continuation of leveraged buyout, venture capital, and growth strategies across years and notes a broad geographic expansion beyond the U.S., it does not capture the nuanced progression outlined in the original: the deepening sophistication in vehicle usage (e.g., derivatives) in 2024 or the specific inclusion of real assets. (4) The reasoning is partially sound in identifying a global expansion and diversification, but it incorrectly frames the strategy within a pension fund context and invents percentage allocations not present in the ground truth, suggesting hallucination or misattribution. (5) Despite these issues, the answer is contextually relevant and captures the general trend of global expansion and strategic diversification, earning moderate scores for qualitative accuracy and relevance. However, the lack of key details and introduction of unsupported quantitative data significantly reduce factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 506,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Based on the provided 10‑K filings, Bemarituzumab entered Phase 3 trials in 2022 and continued into 2023‑2024, with its composition‑of‑matter patents showing an estimated U.S. expiration of 2029 and a European expiration of 2029.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all dates and numbers are correct: Bemarituzumab entered Phase 3 in 2022, and patent expirations are correctly stated as 2029 in both the U.S. and Europe. There are no calculation errors. (2) The answer addresses the core aspects of the question—clinical phase progression (Phase 3 initiation in 2022 and continuation through 2024) and patent expiration timelines (2029 in both regions). (3) Entity accuracy is strong: Amgen is correctly identified as the developer, Bemarituzumab is accurately described in the context of its development, and the patent timelines are correctly attributed. (4) The reasoning is sound and reflects multi-hop synthesis across years (2022–2024), though it omits some qualitative context present in the original answer—specifically, the molecule’s mechanism (targeting FGFR2b) and the mention of regulatory exclusivity as a complementary protection strategy. While these omissions reduce completeness slightly, they do not detract from the core factual correctness. The answer is semantically equivalent in key respects and highly relevant to the question. A score of 9 is justified due to minor contextual omissions, but quantitative and factual accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 359,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "From 2022 through 2024 Dawn’s share of the Fabric & Home Care segment grew markedly.  In the 2022 filing (page 8) the segment contributed 36 % of net sales and 34 % of earnings, with Dawn listed among its major brands.  By 2023 (page 25) the segment’s net sales rose 4 % to $29.5 billion and its net‑earnings margin jumped 230 bps, pushing the segment’s earnings contribution higher; Dawn remained a core brand in this expanding portfolio.  In the 2024 filing (page 24) the segment’s net earnings rose 18 % to $5.7 billion, again with Dawn continuing to be highlighted as a key brand, underscoring its increasing importance within the segment’s earnings growth.  Thus, Dawn’s positioning evolved from a notable brand in a 36 %‑of‑sales segment in 2022 to a stronger, higher‑margin contributor as the segment’s earnings share rose to 34 % of total earnings by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and misrepresents the data from the ground truth. While it correctly states that Dawn remained a listed brand in the Fabric & Home Care segment across the years, it fabricates or misstates key financial figures. For example, the ground truth states that the segment contributed 31% to net earnings in 2022 and 34% in 2024, but the LLM claims 34% in 2022—this is incorrect. Additionally, the LLM claims the segment had a 36% share of net sales in 2022, which contradicts the ground truth (35% in 2022). The LLM also introduces specific dollar amounts such as $29.5 billion in sales and $5.7 billion in earnings, which are not present in the original answer and cannot be verified from the provided truth. It further claims an 18% earnings increase and a 230 bps margin jump, which are unsupported by the ground truth. (2) Calculations and comparisons are therefore invalid—there is no evidence in the ground truth of margin expansion or sales growth figures cited. The only correct quantitative point is the 34% earnings contribution in 2024, which aligns with the truth. (3) The multi-hop reasoning is partially sound in that the model attempts to link Dawn’s positioning to segment-level performance trends, but it does so using incorrect data. The conclusion that Dawn’s positioning 'evolved' to become a 'stronger, higher-margin contributor' is speculative and not supported by the ground truth, which only confirms stable sales contribution and a slight increase in earnings share at the segment level—not attributable specifically to Dawn. (4) The contextual relevance is fair because the answer addresses the right segment, brand, and time frame, and attempts to interpret strategic positioning. However, due to major quantitative errors and unsupported inferences, the correctness score is low. The qualitative accuracy is moderate because entity identification (Dawn, Fabric & Home Care) is correct, but reasoning is flawed. Quantitative accuracy is poor due to multiple incorrect percentages and fabricated dollar figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 567,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022 through 2024 Schwab’s use and pledging of client‑held securities expanded markedly, especially in the context of margin lending and collateralized financing.  In 2022 the company disclosed that client securities available for pledge totaled roughly $120 bn, and by 2024 that figure had risen to about $120 bn‑$125 bn of client‑margin securities that could be used as collateral, while the fair value of securities actually pledged grew from roughly $31 bn in 2021 to $31 bn‑$32 bn in 2022 and remained elevated thereafter.  Schwab routinely pledged these securities to meet clearing‑house margin requirements, to collateralize resale agreements, and to support securities‑lending transactions; the pledged amount is reported in the “Collateral pledged to third parties” line of the notes and is tied to the company’s margin‑loan portfolio, which is secured by client securities and monitored for maintenance‑level compliance.  This increasing reliance on client‑held assets as collateral signals that Schwab’s exposure to client‑held assets has grown, but the company mitigates credit risk through collateral‑maintenance provisions, credit‑approval processes, and the use of third‑party clearing organizations that guarantee the return of pledged securities.  Consequently, while the absolute level of pledged collateral has risen, the risk of loss is limited by these safeguards and by the fact that most securities‑lending and resale agreements are over‑collateralized.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical figures (e.g., $120B available for pledge, $31B–$32B pledged) that are not present in the original ground truth and cannot be verified against it. The ground truth does not provide any dollar amounts related to the value of client securities pledged or available for pledge, making these numbers unsupported and potentially misleading. This significantly undermines quantitative accuracy. (2) The original answer focuses on qualitative disclosures and accounting standards (ASC 326, practical expedient, OCC clearing, federal regulations), while the LLM answer fabricates financial metrics not found in the source, failing the quantitative accuracy test. There are no calculations in the ground truth to validate or compare. (3) On qualitative reasoning, the LLM captures some correct concepts—such as pledging for margin lending, clearing house requirements, resale agreements, and securities lending—and correctly notes risk mitigation via over-collateralization and third-party clearing. However, it omits key developments mentioned in the original: the 2023 application of ASC 326’s practical expedient to reduce expected credit losses, and the 2024 focus on options writing via OCC. These are critical multi-hop elements that show evolution in policy and exposure. (4) Contextually, the LLM stays on topic and addresses the general trend of increasing use of client securities and exposure, which aligns with the original’s conclusion about growing sophistication and exposure. However, the invented numbers and lack of specific regulatory/accounting evolution details reduce factual correctness. While the direction of the trend (increasing reliance) matches, the evidentiary basis in the LLM response is factually unsupported. Thus, despite relevant framing, the answer is partially incorrect due to hallucinated data and missing key disclosures, warranting a moderate correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 528,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "Based on the disclosed weighted-average plan asset allocations as of August 31 2022, 2023 and 2024, Accenture’s target asset allocation for fiscal 2025 shows a shift toward a higher equity exposure in non‑U.S. plans (28 % in 2025 versus 19 % in 2023) and a modest increase in debt securities for U.S. plans (100 % target remains unchanged, but the 2024 actual allocation rose to 94 % from 95 % in 2023). Overall, the 2025 target moves slightly more aggressive in non‑U.S. equity and maintains a fully‑invested debt stance, reflecting a modest evolution from the 2023‑2024 allocations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that ACN's overall target asset allocation shifted from 55% fixed income / 45% equities in fiscal 2023 (as of Aug 31, 2022) to 58/42 in fiscal 2024 (Aug 31, 2023) and 61/39 in fiscal 2025 (Aug 31, 2024), indicating a de-risking trend toward more fixed income. In contrast, the LLM claims a shift toward higher equity exposure, particularly in non-U.S. plans, which contradicts the ground truth. The LLM introduces granular breakdowns by U.S. and non-U.S. plans (e.g., 28% non-U.S. equity in 2025 vs 19% in 2023) and claims about debt securities in U.S. plans that are not present in the original answer and cannot be verified from the provided truth. (2) The numbers cited in the LLM answer (e.g., 28%, 19%, 94%, 95%) do not appear in the ground truth and are factually inconsistent with the disclosed weighted-average allocations. The ground truth provides only aggregate percentages, not split by U.S./non-U.S. plans. (3) The multi-hop reasoning is flawed: the LLM fails to identify the correct trend (de-risking via increasing fixed income) and instead infers a more aggressive equity tilt, which is the opposite of the truth. It also introduces unverified subcomponents (U.S. vs non-U.S.) not supported by the original data. (4) The contextual relevance is moderate because the answer addresses asset allocation evolution over time and references the correct company (ACN/Accenture) and time frame, but the core factual content and direction of the strategy change are incorrect. The conclusion that the strategy became 'slightly more aggressive' is directly contradicted by the ground truth's 'de-risking' narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 474,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings rose modestly from $820 million in 2021 to $562 million in 2024 (a decline of about 31 %), while long‑term debt increased from roughly $39.9 billion in 2020 to $44.99 billion in 2024, reflecting a steady expansion of senior and subordinated notes and securitized borrowings. The 2022‑2024 trend shows a growing reliance on longer‑dated unsecured senior and subordinated debt (e.g., $26.9 billion of fixed senior notes and $3.8 billion of subordinated notes by end‑2024) and a shift toward higher‑priced floating‑rate senior debt, indicating that the firm is financing its asset growth with more permanent, market‑based funding rather than short‑term wholesale markets. Consequently, the company’s debt structure is increasingly weighted toward long‑term, fixed‑rate instruments, but a sizable portion of its borrowing remains floating‑rate and tied to market rates, exposing it to interest‑rate volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It references data from 2020 and 2021, which are outside the requested 2022–2024 timeframe, and provides incorrect figures for both short-term borrowings and long-term debt. According to the ground truth, total short-term and long-term debt was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM instead states long-term debt was $44.99B in 2024 but incorrectly traces it from $39.9B in 2020, not 2022. It also misrepresents short-term borrowings as declining from $820M in 2021 to $562M in 2024, which contradicts the ground truth that does not provide such granular breakdowns but does report total debt. (2) The quantitative inaccuracies are severe: the LLM invents numbers not in the source (e.g., $820M, $562M, $39.9B in 2020), uses wrong years, and fails to report the correct total debt figures for 2022–2024. The ground truth shows a peak in 2023 followed by a decline in 2024, but the LLM implies a steady increase. Additionally, the LLM claims a shift toward floating-rate debt, while the ground truth states Capital One reduced floating unsecured senior debt from $1,597M in 2023 to $0 in 2024—exactly the opposite trend. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct trend in total debt and interest rates. It omits the key fact that the weighted-average interest rate on long-term debt rose from 1.51% in 2022 to 3.48% in 2024, and incorrectly infers increased use of floating-rate debt when the company actually eliminated it. (4) The contextual relevance is moderate because the answer discusses debt structure and interest rate exposure, which are relevant, but the incorrect data and reversed conclusions undermine the analysis. Due to major factual and directional errors, the correctness score is low at 2, with quantitative accuracy at 1 (near-total failure), qualitative reasoning at 3 (some structural understanding but flawed logic), and contextual relevance at 5 (right topic, wrong facts).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 548,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "From 2022 through 2024, the share of BA’s fleet support services costs in total consolidated costs remained roughly flat at about 1 percent.  During the same period, abnormal production costs and reach‑forward losses on the 787 and 777X programs rose sharply—$256 million of rework on 787 inventory and a $2.6 billion reach‑forward loss on the 777X in 2024—reflecting higher production‑rate adjustments, supply‑chain constraints and certification delays that drove up program costs and pressured margins.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BA's fleet support services costs remained stable at approximately 1% of total consolidated costs from 2022 to 2024, which matches the ground truth. However, it introduces significant quantitative inaccuracies in describing the abnormal production costs and reach-forward losses. Specifically, the LLM states a $256 million rework cost on 787 inventory, but the ground truth reports $2.7 billion in cumulative abnormal production costs for the 787 program in 2023 alone—this is a major underreporting. Additionally, the LLM claims a $2.6 billion reach-forward loss on the 777X in 2024, while the ground truth specifies $2,608 million in Q3 and an additional $891 million in Q4, totaling $3,499 million—thus the LLM underestimates the total. The LLM also misattributes the $2.6 billion figure solely to 2024, whereas the ground truth spans reporting periods with specific quarterly breakdowns. (2) Number verification: 1% cost ratio = correct; $256M rework vs. $2.7B actual = incorrect; $2.6B 777X loss vs. $3.499B total = incorrect and incomplete. (3) Multi-hop reasoning is partially sound—the model correctly contrasts stable support costs with rising program-specific losses and links them to production challenges like supply-chain issues and certification delays. However, it fails to fully synthesize the magnitude and timing of the losses across years and programs, omitting key details such as the 2023 787 costs and the two-part 2024 777X losses. (4) Correctness score is 6 due to correct high-level trend identification but major factual errors in financial figures. Quantitative accuracy is low (5) due to incorrect dollar amounts. Qualitative accuracy is 7 because reasoning and entity identification (BA, 787, 777X, fleet support) are sound, but synthesis lacks precision. Contextual relevance is high (9) as the answer addresses the core comparison and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 521,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "Based on the provided 10-K filings, AbbVie's allocation to money market funds and time deposits remained minimal and relatively stable across the three-year period. The company consistently reported small balances for these instruments (e.g., $10 million in 2024, $21 million in 2023, and $45 million in 2022), with no significant changes in the allocation trend. This stability indicates that AbbVie maintained a conservative, low-risk approach to short-term liquidity management, relying primarily on operating cash flows and existing credit facilities rather than shifting allocations toward higher-yielding or more complex instruments. The lack of material changes suggests the company prioritized capital preservation and flexibility over optimizing yield in its short-term investment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, AbbVie's allocation was $12 million in 2022, $21 million in 2023, and $10 million in 2024. However, the LLM incorrectly states $45 million in 2022 and $10 million in 2024 (correct), $21 million in 2023 (correct), but misrepresents the 2022 figure. This error in the 2022 value undermines the quantitative accuracy. (2) The calculation and trend analysis are flawed: the ground truth shows a rise from 2022 to 2023 and then a drop in 2024, indicating a fluctuating strategy. The LLM describes the trend as 'stable' and 'no significant changes', which contradicts the actual volatility (nearly doubling then halving). This mischaracterization stems from incorrect data and faulty reasoning. (3) The multi-hop reasoning is unsound—while the LLM attempts to infer strategy from the data, it does so using incorrect inputs. The conclusion of 'conservative, low-risk approach' and 'stability' is not supported by the actual fluctuating figures. The ground truth interprets the increase in 2023 as a possible temporary conservative move, followed by reallocation in 2024—nuance missed by the LLM. (4) Contextual relevance is moderate: the answer addresses short-term liquidity strategy and uses appropriate financial reasoning, but due to incorrect data and misinterpretation of trends, the qualitative and correctness scores are low. The answer would have scored higher if the numbers were accurate, even with different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 426,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Accenture’s share‑repurchase activity shows a clear upward trend in both the dollar amount and the authorization of its open‑market program. In fiscal 2022 the company purchased $4.1 billion of Class A shares under its publicly announced program, and by fiscal 2024 the Board had expanded the remaining authorization to $2.69 billion for future purchases, while the quarterly purchases rose to $605 million in the fourth quarter of fiscal 2024 alone. This increasing level of repurchases and the continual expansion of the Board‑approved authority signal that Accenture is aggressively returning capital to shareholders, reinforcing its focus on boosting earnings per share and maintaining a strong cash‑generation profile while still funding growth initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timeline. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization, not $4.1 billion in purchases as claimed. The $4.1 billion figure does not appear in the ground truth and is incorrect. In fiscal 2023, the remaining authorization was $2,694 million ($2.694 billion), which the LLM incorrectly presents as the expanded authorization in fiscal 2024. In fact, by fiscal 2024, the total remaining authorization was increased to $6,694 million ($6.694 billion), not $2.69 billion. The LLM also introduces a $605 million quarterly purchase in Q4 2024, which is not mentioned in the ground truth. (2) Calculations and figures are largely inconsistent: the cumulative repurchase authority since 2001 reached $50.1 billion by 2023 and was further increased by $4 billion in 2024, bringing total remaining authorization to $6.694 billion—this key evolution is misrepresented. The LLM incorrectly states that $2.69 billion is the new authorization in 2024, when it was actually the 2023 figure. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that increasing authorizations indicate a strong capital return strategy—but fails to accurately synthesize the actual figures across years. It conflates purchase activity with remaining authorization and misattributes values to incorrect years. (4) Contextual relevance is high because the answer addresses the trend and strategic implication, but quantitative accuracy is severely lacking, dragging down overall correctness. While the qualitative direction (increasing repurchases, capital return focus) aligns with the truth, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 481,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s governance provisions that restrict director removal for cause have remained unchanged across 2022, 2023 and 2024, preserving a board‑entrenchment framework that includes staggered three‑year director classes, a high‑threshold (80 % voting) amendment requirement and Delaware‑law barriers to hostile takeovers. This consistent emphasis signals a long‑term defense strategy aimed at deterring unsolicited acquisition attempts and maintaining board stability, even as the company faces heightened pricing pressure, patent‑expiry risks and regulatory scrutiny.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie's provision allowing director removal only for cause remained unchanged across 2022, 2023, and 2024, which matches the original answer's claim of consistency over the three years. (2) The quantitative elements are correct: while the original answer does not specify the 80% voting threshold, the LLM answer introduces this detail, which is plausible under Delaware law and consistent with supermajority requirements mentioned in the ground truth; no numeric inaccuracies are present, and the years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound—the LLM synthesizes governance provisions (director removal for cause, staggered boards) with strategic implications (takeover defense), correctly inferring a long-term anti-takeover strategy. It adds contextual factors (pricing pressure, patent expiry, regulatory scrutiny) that, while not in the original, enrich the explanation without contradicting it. (4) The only minor gap is that the original emphasizes the repeated disclosure in 10-Ks as evidence of deliberate emphasis, a nuance slightly underdeveloped in the LLM response. However, the core facts, entities, years, and strategic interpretation are correct and semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 403,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo’s 10‑K filings consistently reference the same 4.000% Senior Note due 2047 across all three years, with the note’s description appearing in the “Form of Senior Note” tables on pages 128 (2024), 126 (2023) and 129 (2022). The repeated citation underscores that the 2047 tranche is a core, long‑term component of PepsiCo’s capital structure, used to fund strategic initiatives and maintain a stable debt profile. This consistent disclosure signals that the 4.000% 2047 note is a deliberate, permanent financing building block rather than a temporary or opportunistic issuance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo consistently disclosed the 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings and accurately captures the strategic implication—that the note is a stable, long-term component of the capital structure. However, it fails to specify the correct source of the disclosure: the ground truth states that the note was referenced via Exhibit 4.5 from the May 2, 2017 8-K filing in all three years, while the LLM instead cites internal page numbers (e.g., page 128 in 2024) where the note appears in the 10-Ks. These page numbers are not part of the original ground truth and introduce factually unsupported details. (2) The percentage (4.000%) and maturity year (2047) are correct, and no numerical calculations are required, so quantitative accuracy is mostly preserved, but the incorrect citation of page numbers as disclosure sources reduces precision. (3) The multi-hop reasoning is sound in that the model connects disclosures across three years and infers strategic intent from consistency. However, it misses the key fact that the *same legal exhibit from 2017* was referenced each year, which is central to the ground truth’s conclusion about the note’s unmodified status. This weakens the qualitative accuracy slightly. (4) Despite the factual deviation on sourcing, the answer remains highly relevant and interprets the consistent disclosure pattern correctly in strategic terms, hence full marks for contextual relevance. The core insight—that this is a permanent, unaltered capital structure element—is preserved, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 448,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle issued a 4.30% senior note due 2034 in July 2014 (as disclosed in the 2014 8‑K filing referenced on pages 110‑112). The 2022 Form 10‑K (page 94) shows the company’s long‑term debt maturities, confirming that the 2034 note is part of the senior notes and other borrowings outstanding as of May 31 2022. Subsequent 10‑K filings continue to reference this tranche in their debt‑maturity tables and note disclosures, indicating that the 4.30% 2034 note remains a component of Oracle’s long‑term debt profile through at least fiscal 2024. This multi‑year presence demonstrates a strategy of maintaining a stable ladder of fixed‑rate debt with staggered maturities, allowing the company to manage interest‑rate risk while preserving liquidity for ongoing operations and shareholder returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.30% Note due 2034 as part of Oracle's long-term debt in 2022, 2023, and 2024, aligning with the ground truth's emphasis on consistent disclosure across years. However, it introduces a factual inaccuracy by stating the note was issued in July 2014, which is not supported by the ground truth and contradicts the question’s focus on the 2022–2024 evolution. The ground truth does not specify an issuance date, only the disclosure pattern starting in 2022. This incorrect date affects quantitative accuracy. (2) All other numerical elements—interest rate (4.30%), maturity year (2034), and fiscal year references (2022–2024)—are correct. The mention of the 2022 10-K page 94 and the structure of debt disclosures are plausible and contextually consistent, though not verifiable without access to filings. No calculations are required, so numerical precision is otherwise sound. (3) The multi-hop reasoning is strong: the model synthesizes disclosure continuity across multiple years and infers a strategic rationale—stable debt ladder, interest-rate risk management, liquidity preservation—that aligns well with the ground truth’s conclusion about a stable long-term debt strategy and diversified maturities. The logic is coherent and adds insightful interpretation. (4) Despite the erroneous issuance date, the answer addresses all parts of the question: evolution across 2022–2024 and strategic implications. It maintains high contextual relevance and semantic equivalence in describing Oracle’s sustained capital market engagement and structured debt profile. The error is significant but does not undermine the core correctness of the disclosure pattern or strategic interpretation, warranting a score of 8 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 486,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "The Amended 2010 SIP authorized 141 million Class A shares in 2022, and by fiscal 2024 the number of shares available for future grants had been reduced to 27,270,917. This decline reflects the use of authorized shares for prior awards and ongoing equity‑based compensation, indicating that Accenture continues to maintain a sizable pool for long‑term share‑based incentives while gradually adjusting the authorized amount to match its compensation needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and trend. The ground truth states that the number of authorized shares was 127,000,000 in fiscal year 2022, increased to 141,000,000 in 2023, and remained at that level in 2024. The LLM incorrectly claims 141 million were authorized in 2022 and then incorrectly states that the number of shares available for future grants declined to 27,270,917 by 2024 — this figure likely reflects remaining unissued shares, not the total authorized amount, which is a critical distinction the model fails to make. (2) The quantitative inaccuracies are severe: the starting value is wrong (141M vs 127M), the direction of change is misrepresented (decline vs actual increase and stabilization), and no mention is made of the increase from 2022 to 2023. The model confuses 'authorized shares' with 'shares available for future grants,' leading to a fundamentally flawed response. (3) The multi-hop reasoning is unsound — the question asks about the evolution of authorized shares, not the depletion of available shares. The LLM fails to track the correct metric across years and misinterprets the data, leading to an incorrect conclusion about a 'decline' when the company actually expanded its authorization. (4) While the general topic of share-based compensation strategy is addressed, the conclusion about 'gradually adjusting the authorized amount' contradicts the actual strategy of increasing and maintaining authorization. The answer is contextually relevant in theme but factually and logically flawed, warranting low scores in correctness and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 444,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo’s 2.750% Senior Note due 2051 was first authorized in the 2022 Board resolutions (PEP 10‑K 2022 p. 135) and subsequently re‑issued through supplemental indentures referenced in the 2023 and 2024 filings (PEP 10‑K 2023 p. 129; PEP 10‑K 2024 p. 134). The company has consistently filed updated prospectus‑style exhibits (Forms 8‑K) for each new tranche—initially in 2021 and then with fresh series in 2022, 2023 and 2024—showing a pattern of multi‑year, incremental debt‑issuance to fund long‑term financing needs. This filing cadence indicates that PepsiCo is structuring its long‑term debt through staged, multi‑year note offerings, maintaining a rolling maturity ladder and flexibility to refinance at favorable rates while extending the average maturity of its senior unsecured notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the 2.750% Senior Note due 2051 was first introduced in a Board resolution in 2022 (Exhibit 4.60), but the LLM claims it was 'first authorized in 2022' while also stating it was 'initially in 2021' in the same sentence, creating contradiction and timeline confusion. The LLM incorrectly references 're-issuance through supplemental indentures' in 2023 and 2024, which is not supported by the ground truth—there is no mention of re-issuance or tranches, only progression in documentation form. The ground truth shows no evidence of multiple tranches or Forms 8-K filings for new series in 2021–2024; this is a fabrication or misattribution. (2) Quantitative accuracy is low: the LLM invents a 2021 issuance (not in ground truth), misrepresents the nature and timing of filings, and incorrectly cites page numbers and exhibit types (e.g., no mention of Forms 8-K in ground truth). The interest rate (2.750%) and maturity (2051) are correct, but the surrounding context is flawed. (3) Multi-hop reasoning is partially sound—the LLM attempts to infer strategy from filing patterns—but it is based on incorrect data synthesis. The ground truth shows a phased documentation evolution (authorization → formal form → consistency), while the LLM incorrectly interprets this as repeated issuance. The conclusion about a 'rolling maturity ladder' and 'refinancing at favorable rates' goes beyond the evidence provided in the ground truth, which emphasizes stability and deliberate structuring, not active refinancing. (4) Contextual relevance is moderate: the answer addresses long-term debt strategy and multi-year filings, aligning with the question’s intent, but the factual foundation is weak. The qualitative accuracy is limited by incorrect entity relationships and documentation progression. Overall, the answer is partially correct in intent but fails on key facts and reasoning, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 541,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express’s competitive positioning has shifted from a focus on premium, high‑spending card‑holder relationships toward a broader, technology‑driven payments ecosystem, while simultaneously navigating heightened regulatory scrutiny.  The company remains the fourth‑largest global general‑purpose card network but now competes directly with alternative payment mechanisms—digital wallets, buy‑now‑pay‑later platforms, and emerging blockchain solutions—requiring continual innovation and investment to protect its market share.  At the same time, evolving banking regulations (e.g., Category III firm status, stricter capital and resolution requirements) and intensified oversight of interchange fees and consumer‑protection rules have increased compliance costs and could constrain its traditional discount‑revenue model, compelling Amex to adapt its business practices and pricing strategies to maintain competitiveness.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies American Express as the fourth-largest global general-purpose card network, which matches the ground truth and is a key factual anchor. It accurately reflects the time frame (2022–2024) and discusses relevant competitive and regulatory dynamics. However, it introduces the concept of 'Category III firm status' and 'stricter capital and resolution requirements'—specific regulatory developments not mentioned in the original answer and not verifiable from the provided ground truth, which focuses on interchange fees, network routing, and cobrand arrangements in the EU. While the general trend of increased compliance costs and regulatory pressure is correct, the specific U.S.-centric regulatory framework details are extraneous and potentially inaccurate in this context. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is largely sound: the LLM synthesizes Amex’s market position, competitive threats from alternative payment platforms (e.g., BNPL, digital wallets), and regulatory pressures. It correctly infers strategic adaptation, though it overreaches slightly by specifying regulatory categories not in the source. The original answer emphasizes Amex’s premium offerings and closed-loop loyalty systems as differentiators, which the LLM only partially captures by referencing 'technology-driven payments ecosystem'—a related but less precise characterization. (4) The answer is contextually relevant and captures the core evolution in competitive positioning. The correctness score is 8 because the key facts are accurate and the synthesis is strong, but there are minor inaccuracies in regulatory specifics and a slight shift in emphasis away from cobrand relationships and EU-focused scrutiny toward broader, less substantiated regulatory claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 530,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s strategic focus has shifted from a broad, diversified portfolio of commercial aircraft and services to a tighter emphasis on upgrades, conversions, and sustainment of existing platforms—particularly through its Global Services segment. In 2022 the company highlighted its “upgrades and conversions” as a growth lever for services, and by 2024 it was reporting that services revenue (including upgrades, modifications, and support) now accounts for a larger share of backlog and earnings, underscoring a deliberate move to monetize the installed‑base rather than rely solely on new aircraft sales. This evolution suggests Boeing is betting on higher‑margin, recurring‑revenue streams from aftermarket services to drive profitability amid a sluggish commercial market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall strategic shift Boeing has made toward upgrades, conversions, and sustainment within its Global Services segment from 2022 to 2024. It correctly identifies that 'upgrades and conversions' were highlighted as a growth lever in 2022 and that services revenue became a larger share of backlog and earnings by 2024, reflecting a strategic pivot toward monetizing the installed base. There are no numeric inaccuracies (quantitative accuracy is high), and the answer appropriately avoids citing specific dollar figures or percentages not present in the original. However, the LLM omits key qualitative developments noted in the ground truth: specifically, the increasing emphasis on 'modifications' in 2023 and, more importantly, the introduction of 'data analytics and digital services' as complementary capabilities in 2024. This missing detail weakens the qualitative accuracy, as it fails to capture Boeing’s shift toward technology-enabled service differentiation—a core element of the strategic evolution. While the LLM correctly infers a move toward higher-margin, recurring revenue streams, it does not fully synthesize the multi-hop progression across all three years with the same granularity as the original. The reasoning is sound but less precise in tracing the year-over-year evolution. Contextually, the answer remains highly relevant and interprets the broader strategic implication accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 408,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo first disclosed the 5.50% Senior Note due 2035 in its 2018 Form 8‑K (Exhibit 4.4) and subsequently re‑referenced the same issuance in later filings (e.g., 2020 Form 8‑K, 2021 Form 8‑K, 2022 Form 8‑K). Across the 2022, 2023 and 2024 Form 10‑K filings, the note appears only as a historical reference—no new issuance or additional documentation of a fresh 5.50% 2035 tranche is noted—indicating that the company is not actively issuing new 2035 debt but rather maintaining the legacy instrument in its disclosure. This multi‑year pattern shows that PepsiCo’s long‑term debt management relies on a stable pipeline of staggered senior notes (e.g., 2024‑2040 series) rather than frequent new long‑dated issuances, using existing long‑term notes as reference points for ongoing financing and capital‑structure planning.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that the 5.50% Senior Note due 2035 is a legacy instrument consistently referenced in disclosures, which aligns with the ground truth's conclusion about PepsiCo maintaining a stable long-term capital structure. However, there are significant factual inaccuracies in the quantitative and entity details. First, the LLM incorrectly states that the note was first disclosed in a 2018 Form 8-K as Exhibit 4.4, while the ground truth specifies Exhibit 4.31 in the 2022 10-K referencing the same 2018 8-K—this misrepresents the exhibit number and source document. Additionally, the LLM mentions re-references in 2020 and 2021 8-K filings, which are not part of the evaluated three-year scope (2022–2024) and are not confirmed in the ground truth. The 2022–2024 10-K references are correctly interpreted as re-documentations without new issuance, supporting the conclusion of no modification or retirement. However, the LLM introduces unverified details (e.g., 'no new issuance or additional documentation of a fresh 2035 tranche') that go beyond the provided evidence. While the reasoning about PepsiCo’s stable debt strategy using staggered maturities is plausible and contextually relevant, it adds speculative elements (e.g., '2024–2040 series') not present in the ground truth. Thus, the answer is partially correct in facts and sound in high-level interpretation but contains specific inaccuracies in exhibit numbers, filing types, and extraneous references, reducing its quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 422,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s capital‑return strategy has been progressively constrained by evolving U.S. banking regulations and capital‑planning requirements.  From 2022 through 2024 the company repeatedly highlighted that its ability to pay dividends, repurchase shares, or otherwise return capital is subject to board discretion, Delaware law, and, critically, compliance with capital‑adequacy and “well‑capitalized” standards that limit payouts if they would breach regulatory thresholds.  This multi‑year trajectory shows that regulatory constraints—particularly the need to maintain sufficient capital buffers and meet supervisory expectations—have become the primary check on the firm’s shareholder‑return policies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the years (2022–2024) are correctly referenced, and no incorrect dates or figures are present, warranting a full score. (2) The LLM correctly identifies the key entities: BNY Mellon, U.S. banking laws, capital planning, shareholder returns, Delaware law, and the 'well-capitalized' requirement. It accurately reflects the multi-year progression of regulatory language in disclosures. (3) The reasoning is sound: it synthesizes the evolving emphasis from general oversight in 2022 to more explicit constraints in 2023 and 2024, noting consistent regulatory boundaries. The LLM captures the core theme—that regulatory capital adequacy standards act as a primary constraint on capital returns—even if it does not explicitly mention preferred stock dividend obligations, which is a minor omission. (4) The answer is contextually excellent, directly addressing how regulatory constraints have shaped capital return policies over time. The only reason for not scoring a perfect 10 is the slight omission of preferred stock obligations noted in the original 2023 and 2024 disclosures, which is a secondary but relevant detail. Overall, the LLM conveys semantically equivalent information with strong multi-hop synthesis across years and regulatory frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 407,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were first issued in March 2021 (4.14 Exhibit) as part of a broader multi‑year debt issuance program, and the same terms were re‑issued in subsequent 8‑K filings on February 6 2023 (4.16 Exhibit) and November 9 2022 (4.15 Exhibit). The consistent coupon and maturity date indicate that Oracle has maintained a stable fixed‑income financing strategy, issuing these notes across a range of interest‑rate environments without altering their core terms. This suggests that Oracle relies on long‑dated, investment‑grade debt to fund its operations and growth while capitalizing on favorable market conditions when rates are low, rather than frequently restructuring or repricing its borrowings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the issuance dates and exhibits. The ground truth states that the 2.300% Notes due 2028 were established under an Officers' Certificate dated March 24, 2021, and referenced again in the 2022 and 2023 10-K filings without structural changes. However, the LLM incorrectly claims re-issuance via 8-K filings on November 9, 2022 (Exhibit 4.15) and February 6, 2023 (Exhibit 4.16), which contradicts the original answer and implies new issuance activity that did not occur for this instrument. These specific exhibit numbers and dates are not supported by the ground truth. (2) While the coupon rate (2.300%) and maturity (2028) are correct, the timeline and legal documentation references are wrong—this severely undermines quantitative and factual accuracy. There is no mention in the ground truth of 8-K filings or re-issuance; instead, Oracle simply referenced the existing certificate in subsequent annual reports. (3) The reasoning about Oracle maintaining stable financing terms is partially aligned with the ground truth, which notes no changes to the 2.300% Notes over time. However, the LLM fails to capture the key strategic insight: Oracle shifted toward issuing higher-yielding debt (e.g., 4.500% Notes due 2028) in 2023 and avoided repricing the existing 2.300% Notes, indicating a preference for locking in low rates rather than reissuing. This multi-hop synthesis is missing. (4) The contextual relevance is strong because the answer addresses Oracle’s fixed-income strategy and ties it to interest rate environments, but the incorrect documentation trail and lack of contrast with Oracle’s newer, higher-rate issuances limit its accuracy. The conclusion is plausible but based on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 486,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM's 2022, 2023 and 2024 10‑K filings consistently frame client relationships and trust as a core differentiator that underpins its hybrid‑cloud and AI strategy.  Across the three years the company repeatedly emphasizes that “client relationships and trust” enable it to “differentiate” its offerings, accelerate growth in hybrid cloud and AI, and sustain market leadership amid intense competition.  This multi‑year progression shows that IBM is deliberately leveraging deep, trusted client engagements to drive adoption of its integrated cloud‑AI platform and to lock in long‑term, high‑value contracts, reinforcing its strategic positioning as the go‑to provider for enterprises seeking reliable, secure hybrid‑cloud and AI solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the multi-year evolution of IBM's strategic emphasis on client relationships and trust. It accurately identifies that IBM consistently positioned trust and client relationships as a competitive differentiator across 2022, 2023, and 2024, particularly in the context of hybrid cloud and AI—this matches the original answer's core claim. The LLM correctly captures the continuity and strategic intent (e.g., driving adoption of integrated cloud-AI platforms, securing long-term contracts), which reflects sound qualitative understanding. However, it omits specific evolving nuances highlighted in the ground truth: (1) in 2022, the linkage of trust to embedding AI/cloud and platform modernization; (2) in 2023, the emphasis on 'deep incumbency' and innovation as trust-based differentiators; and (3) in 2024, the expansion of strategic partnerships like Palo Alto Networks as evidence of trust-based positioning. These specifics represent incremental but important details that enrich the multi-hop progression. While the LLM conveys a coherent and contextually accurate narrative, it generalizes the evolution rather than detailing the year-by-year strategic deepening. There are no quantitative inaccuracies (dates are correct, no erroneous figures), and the reasoning is logically sound, though slightly less granular than the ground truth. The answer remains semantically aligned and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 412,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "From 2022 through 2024, American Express’s weighted‑average yields on foreign government bonds and obligations rose from roughly 5.86 % (2022) to 5.85 % (2023) and then to 5.86 % (2024) – essentially flat, while the proportion of holdings in the 1‑year bucket stayed near 1 % and the longer‑dated portion remained minimal (≈1 % after 1 year). This 3‑year progression shows that the company’s exposure to interest‑rate risk from these securities is limited and that its investment strategy has remained focused on maintaining a high‑quality, short‑duration foreign‑government‑bond portfolio rather than shifting to longer‑dated or higher‑yielding assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims yields were approximately 5.86% in 2022, 5.85% in 2023, and 5.86% in 2024, which directly contradicts the ground truth: no yield is provided for 2022, the 2023 yield was 6.45%, and the 2024 yield was 5.85%. The LLM also incorrectly states that the proportion of holdings maturing within one year was near 1%, when in fact in 2022, $628 million of $630 million (over 99%) matured within one year. By 2024, a notable 2.03% (implying a shift) matured between 1–5 years, but the LLM misrepresents this as 'minimal'. (2) The numbers are factually wrong: the 6.45% yield in 2023 is entirely omitted in correct form, and the trend is misrepresented as flat when it actually decreased from 6.45% to 5.85%. The dollar amounts and maturity distributions from 2022 are ignored. (3) The multi-hop reasoning is flawed: the original answer infers a strategic shift from ultra-short-duration, high-yield holdings in 2023 to a more diversified maturity profile in 2024 to manage interest rate risk. The LLM concludes the opposite—that the strategy remained consistently short-duration and unchanged—missing the evolution entirely. (4) The contextual relevance is moderate because it addresses foreign government bonds and interest rate risk, but the factual inaccuracies and incorrect synthesis severely undermine the response. Due to major errors in numbers, timeline, and strategic interpretation, the correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 420,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "From 2022 through 2024 Danaher’s Diagnostics testing technologies received targeted government grant funding that was recorded as a grant‑accounting offset to capital expenditures – $568 million of U.S. government grants (including BARDA support) were awarded in 2021 to expand production capacity for diagnostics testing, and the Company recognized $73 million of those grant proceeds in 2021 to offset $41 million of operating expenses and $32 million of capital spending.  The grant funding continued to be reflected in the company’s disclosures through 2024, illustrating that diagnostics testing is treated as a strategic growth pillar within Danaher’s broader health‑care portfolio, with public‑sector financing used to de‑risk and accelerate capacity expansion in this segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative details. The ground truth states that Danaher used $87M in 2022, $136M in 2023, and $198M in 2024 in government grant funding to offset capital expenditures for Diagnostics Testing Technologies. The LLM instead cites a $568M grant awarded in 2021 (outside the requested 2022–2024 timeframe), with $32M recognized in 2021 to offset capital spending—this contradicts the逐年 increasing figures from 2022–2024 provided in the original answer. No mention is made of the correct annual amounts for 2022, 2023, or 2024. (2) The numbers cited in the LLM response are factually inconsistent with the ground truth: $73M total grant proceeds in 2021 (split between operating and capital expenses) does not align with any data in the original answer, and the focus on 2021 misaligns with the question’s scope. There are no correct figures for the three-year progression requested. (3) The reasoning is partially sound in interpreting that government grants are strategically used to support diagnostics as a growth pillar, which aligns with the qualitative conclusion in the original answer. However, the multi-hop synthesis fails because it draws on incorrect time periods and funding allocations, undermining the logical chain. The LLM does recognize the strategic importance of diagnostics within Danaher’s healthcare portfolio, which shows some contextual understanding. (4) Due to major factual and numerical inaccuracies—especially the wrong years, incorrect amounts, and absence of the actual 2022–2024 trend—the correctness and quantitative accuracy scores are very low. The qualitative reasoning and contextual relevance receive partial credit for identifying strategic significance and the role of public funding, but the failure to report the correct multi-year progression severely limits accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 507,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "The ratification of KPMG LLP as principal accountant was disclosed in Item 14 of each fiscal year’s proxy statement, with the same language indicating that KPMG’s PCAOB firm identification number is 185. This reference appears in the 2022, 2023 and 2024 proxy sections (Item 14/Item 3‑Ratification of KPMG LLP) across the respective 10‑K filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) Quantitative accuracy: The PCAOB firm identification number is correctly stated as 185 for all three years (2022, 2023, 2024), matching the ground truth. No calculations are required, and all numeric identifiers are accurate. (2) Completeness: The answer addresses the core elements of the question—disclosure across the three fiscal years, the PCAOB number, and its placement within the Proxy sections (Item 14, specifically Item 3 under that). It correctly notes the consistency in language and location. (3) Entity accuracy: BK, KPMG LLP, the fiscal years, and the document sections (Item 14, Item 3) are all correctly identified. (4) Reasoning: The answer demonstrates sound multi-hop reasoning by synthesizing disclosures across three years and filings, confirming consistency in both content and structure. (5) Semantic equivalence: While the LLM does not explicitly state that 'there was no change' (a minor omission), it effectively conveys the same conclusion by noting the 'same language' and consistent placement. The omission of an explicit 'no change' summary does not detract from factual correctness but slightly reduces qualitative completeness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 385,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "American Express’s reliance on third‑party merchant acquirers has shifted from a model in which it directly issued cards and settled with merchants to one that increasingly uses external partners—most notably its OptBlue program and Global Network Services (GNS) collaborators—to process transactions.  Under these arrangements the company records **network‑rate fees** received from the acquirer as **discount revenue** at the point of sale, rather than retaining the full merchant‑discount margin itself.  This structure changes the revenue‑recognition pattern: revenue is recognized when the transaction occurs and the fee is earned, and it is reported as discount revenue (or processed revenue for network‑partner arrangements) rather than as a net card‑fee or merchant‑discount margin.  Contractually, the relationship is defined by short‑term or fixed‑duration acceptance agreements that may auto‑renew, with the merchant‑acquirer bearing most of the settlement and operational risk; the company’s exposure is limited to the network‑rate fee and any associated service‑fee or contra‑revenue items.  Strategically, the expansion of third‑party acquiring relationships supports Amex’s goal of broadening merchant coverage, accelerating digital‑payment and lending initiatives, and scaling its premium consumer and commercial platforms while reducing the capital and operational burden of direct settlement.  (The shift is documented in the 2022‑2024 10‑K notes on discount revenue, merchant‑acquirer arrangements, and revenue‑recognition policies.)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of revenue recognition, contractual structure, and strategic rationale. It correctly identifies the OptBlue and GNS programs, explains the shift to recognizing network-rate fees as discount revenue (or processed revenue), and notes the risk allocation to third-party acquirers—key elements from the original answer. The revenue recognition timing and reporting categories are accurately described. There are no numeric inaccuracies; since the question does not involve specific dollar amounts, percentages, or calculations, quantitative accuracy is scored as 10 based on correct use of financial terms and structures. The answer synthesizes information across years (2022–2024) and correctly infers the evolving strategic role of acquirers, though it does not explicitly break down the evolution year-by-year as the original answer does. Specifically, it omits the 2023 formalization of the 'Processed Revenue' model that included royalties and broader revenue-sharing, and it does not highlight the 2024 focus on low- and new-to-plastic industries and international markets as key expansion targets. While the strategic benefits (broader merchant coverage, reduced operational burden) are correctly noted, the multi-hop synthesis is slightly less precise in tracing the chronological evolution of the relationship from transactional to strategic. However, the core reasoning and entity identification (Amex, OptBlue, GNS, merchant acquirers, revenue recognition policies) are correct. The answer is highly contextually relevant, directly addressing all three dimensions of the question: revenue recognition, contractual relationships, and strategic goals. Minor deduction in qualitative accuracy and overall correctness due to incomplete year-specific evolution details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 500,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "From fiscal 2022 through 2024 Qualcomm tied its executive‑bonus payout to measurable human‑capital progress.  For FY 2022 the HR & Compensation Committee used “progress toward human‑capital advancements” as a non‑financial modifier that could adjust the bonus multiplier from 0.9 to 1.1, and the same approach was continued for FY 2024, where the modifier again ranged 0.9‑1.1 based on achievement of diversity and inclusion targets.  The company’s 2025 goals call for a 15 % increase in women and under‑represented minorities in leadership and a 20 % rise in overall URM representation, and meeting these targets directly influences the size of the executive bonus payout.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key quantitative aspects: the 15% increase in women and underrepresented minorities (URM) in leadership, the 20% rise in overall URM representation, and the non-financial modifier range of 0.9 to 1.1 for executive bonus adjustments are all accurately reported. The fiscal years 2022 and 2024 are correctly referenced with consistent use of the compensation modifier. However, the LLM answer omits specific information about fiscal year 2023, which is a key part of the multi-hop evolution asked in the question. The original answer notes that in 2023, Qualcomm maintained the same structure and emphasized continued focus on diversity, including regional recognition and participation in initiatives like the Reboot Representation Tech Coalition—details absent in the LLM response. Additionally, the 2024 update included expanded global engagement and wellness/development programs, indicating deeper integration of human capital metrics, which the LLM does not mention. While the core financial and goal-related data are accurate (hence high quantitative accuracy), the lack of completeness in tracing the full 2022–2024 evolution slightly weakens the qualitative reasoning and synthesis across all three years. The answer remains contextually relevant and semantically aligned with the main thrust of the original, but misses nuanced progression details in 2023 and 2024 beyond the compensation modifier.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 404,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Based on the provided 10-K filings, Caterpillar's geographic reach for EMD-branded products (referenced as part of its Machinery, Energy & Transportation segment) **expanded significantly from 2022 to 2024**, as evidenced by the increased number of countries served in its dealer network. Specifically, the 2024 filing (page 65) states that EMD-branded products are distributed through a worldwide dealer network serving **191 countries**, up from **187 countries in 2021** (page 65, 2021 reference) and consistent with the 2023 filing (page 65, 2023 reference to 191 countries). This expansion reflects Caterpillar's strategic positioning to deepen market penetration in emerging economies and capitalize on global infrastructure growth, particularly in Asia-Pacific and Latin America, where demand for heavy machinery is rising. The expansion aligns with Caterpillar's broader strategy to diversify revenue streams beyond mature markets and reinforce its global leadership in energy and transportation equipment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that Caterpillar's EMD-branded product distribution decreased from 193 countries in 2022 to 191 in 2023 and further to 187 in 2024. In contrast, the LLM claims an expansion from 187 in 2021 (not 2022) to 191 in 2023 and 2024, misrepresenting both the starting point and trend. This reverses the actual contraction into a false narrative of expansion. (2) The quantitative inaccuracies are severe: the LLM uses 2021 data (187 countries) instead of 2022 (193), omits the correct 2022 figure entirely, and incorrectly treats 191 as an increase when it is actually a decrease from 193. The cited page 65 references are inconsistent with the ground truth timeline and may reflect misreading of filings. (3) The multi-hop reasoning fails because the model does not correctly identify or synthesize the year-over-year changes for the correct period (2022–2024). Instead, it extrapolates backward to 2021 and mislabels stability or growth, leading to flawed strategic interpretation. The conclusion about 'expansion' and 'deepening market penetration' contradicts the actual contraction trend. (4) While the answer addresses the question's structure and attempts strategic interpretation (hence moderate contextual relevance), the factual foundation is unsound. The qualitative reasoning would be strong if the numbers were correct, but it is built on incorrect data, undermining the analysis. Thus, correctness and quantitative accuracy are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 429,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The consistent inclusion of Palmolive in Colgate‑Palmolive’s list of principal global trademarks from 2022 through 2024 underscores its strategic importance as a core brand within the Oral, Personal and Home Care segment, highlighting its role in driving sales growth, maintaining market share and reinforcing the company’s diversified product portfolio worldwide.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that Palmolive's consistent inclusion from 2022 to 2024 reflects its strategic importance within Colgate's Oral, Personal and Home Care segment, and correctly identifies the brand as a core driver of sales, market share, and portfolio diversification. All dates (2022–2024) are accurate and match the ground truth, with no numerical or entity errors—quantitative accuracy is perfect. The entity 'Colgate-Palmolive' is appropriately named, and the time frame aligns exactly with the original answer. However, the LLM response lacks the detailed multi-hop synthesis present in the ground truth: it does not mention specific competitive context (e.g., co-listing with Colgate and Ajax in 2022), the addition of Darlie in 2023 as a comparative point, or the sustained top-tier positioning through 2024 without dilution. It also omits the brand’s specific product category roles (e.g., liquid hand soap, dishwashing detergents, household cleaners), which are key to fully addressing the strategic role. While the general reasoning is sound and contextually relevant, the answer is more generic and misses nuanced evidence that supports the conclusion. Thus, qualitative accuracy is reduced due to incomplete reasoning synthesis across years and brands, even though the core claim is valid. Semantic equivalence is mostly preserved but lacks depth in evidentiary support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 389,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "From fiscal 2022 through 2024, Qualcomm’s Edge Networking strategy was embedded in its broader IoT and connected‑intelligent‑edge narrative, positioning edge‑networking products (e.g., 5G‑enabled wireless access points, automotive connectivity, and industrial IoT modules) as a key growth pillar within its QCT segment.  The company consistently highlighted that edge‑networking devices—part of the “IoT (internet of things)” revenue stream—would drive billions of deployed smart devices and expand into consumer, enterprise and industrial use cases, supporting its long‑term IoT growth projections.  Qualcomm categorized these offerings under its QCT segment (IoT revenue), while its licensing (QTL) business continued to generate royalty income from edge‑related deployments.  Revenue from edge‑networking products is recognized at a point in time within total QCT revenue, and the company’s financial disclosures show modest but steady IoT sales (e.g., $5.4 B in fiscal 2024 versus $7.35 B in fiscal 2022), reflecting both market adoption and the impact of macro‑economic pressures.  Overall, Qualcomm’s strategic emphasis on edge networking evolved from a nascent focus in 2022 to a more defined, high‑visibility growth driver by 2024, underpinning its IoT revenue outlook and reinforcing its broader 5G‑centric ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth does not mention specific IoT revenue figures such as $5.4B in fiscal 2024 or $7.35B in 2022; these numbers are incorrect and contradict the original answer, which focuses on device projections (27 billion by 2026) rather than revenue amounts. There is no mention in the ground truth of a decline in IoT sales due to macroeconomic pressures, which is an unsupported claim. (2) The LLM incorrectly implies that Edge Networking revenue is part of a standalone IoT revenue stream without noting the key structural change in fiscal 2023 when Edge Networking was formally grouped into a third product category within IoT—this is a critical omission. The original answer emphasizes that by 2023, Edge Networking was explicitly categorized alongside consumer and industrial applications, signaling formal strategic integration, but the LLM fails to capture this evolution clearly. (3) While the LLM correctly identifies Edge Networking as part of the QCT segment and notes royalty income via QTL, it misrepresents the revenue recognition structure: the ground truth specifies that Edge Networking falls under QCT with incentive-related revenue recognition from prior periods, a nuance not reflected in the LLM response. The LLM also fails to mention that the categorization remained unchanged in 2024, missing the point about strategic continuity. (4) Despite these issues, the LLM captures the general strategic trajectory—positioning Edge Networking as a growing pillar tied to 5G, IoT expansion, and use cases across industries—and maintains contextual relevance. It correctly links Edge Networking to IoT growth and 5G/Wi-Fi advances, showing partial qualitative understanding. However, due to significant quantitative errors and incomplete synthesis of the multi-hop elements (evolution across 2022–2024 in positioning, categorization, and revenue structure), the correctness score is limited to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1624,
        "completion_tokens": 543,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s hedging program for currency‑exchange risk has been expanded and refined over the three‑year period, with the company explicitly describing the use of “currency hedging instruments” to mitigate adverse rate movements that could affect its international earnings.  In the 2022 filing (p. 21‑23) the discussion of interest‑rate and market‑liquidity risk notes that “fluctuations in currency exchange rates have had, and will continue to have, an impact on our results as expressed in U.S. dollars,” and that hedging may be employed, while the 2023 MD&A (p. 19) emphasizes that “adverse fluctuations in currency exchange rates from the date of our outlooks could cause our actual results to differ materially” and that the firm uses hedging to limit such exposure.  By 2024 (p. 16‑17) the language is more direct, stating that “currency‑exchange rate fluctuations affect our results of operations” and that “the use of currency hedging instruments may provide us with protection from adverse fluctuations… but we potentially forego the benefits of favorable movements,” indicating a more proactive and systematic approach to managing earnings volatility through broader hedging across its worldwide operations.  Overall, the company’s exposure to currency risk has remained a material factor, but its management strategy has evolved from a general acknowledgment of risk to a detailed, risk‑focused hedging framework designed to stabilize earnings across its international footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar's exposure to currency risk due to international operations, use of hedging instruments, and the evolution of its risk management language from 2022 to 2024 are properly described. The answer correctly notes that hedging protects against adverse movements but limits upside, a key point in both 2022 and 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying a progression from general acknowledgment to a more systematic, risk-focused hedging framework. It accurately reflects increasing concern, though it frames the evolution more positively (‘proactive and systematic’) while the ground truth emphasizes growing caution and limitations. This is a minor interpretive difference, not a factual error. (4) The LLM answer is contextually excellent—directly addresses Caterpillar’s exposure, hedging strategy evolution, and impact on earnings volatility. The only slight deviation is that the original answer highlights emerging market risks (exchange controls, devaluations) in 2023–2024, which the LLM omits. This is a minor omission but doesn’t undermine the core correctness. Overall, the answer is factually solid, well-reasoned, and semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 432,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive’s pension plan fixed‑income allocation to U.S. Treasury and agency securities declined modestly—approximately 50 % of the U.S. fixed‑income portfolio in 2022 fell to roughly 30 % by the end of 2024. This reduction reflects a deliberate shift toward a more diversified mix of fixed‑income holdings, including corporate bonds and other government securities, as disclosed in the 2023 and 2024 asset‑allocation tables. The trend indicates that the company is actively managing interest‑rate risk by lowering exposure to the safest, most rate‑sensitive securities and balancing the portfolio with a broader range of credit‑rated assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Colgate-Palmolive's allocation to U.S. Treasury and agency securities was 50% as of December 31, 2020 (disclosed in the 2022 filing), dropped to 40% as of December 31, 2021, then to 30% as of December 31, 2022, and remained at 30% through 2023 and 2024. The LLM incorrectly states that the allocation was approximately 50% in 2022, conflating the 2020 data point with 2022. This misalignment distorts the timeline and misrepresents the evolution of the allocation. The final figure of 30% by end of 2024 is correct, but the starting point and trajectory are wrong. (2) The calculation of the change is therefore flawed: the decline did not occur from 2022 to 2024 as described, but primarily from 2020 to 2022. The stabilization at 30% from 2022 onward is accurate, but the LLM fails to note that the 30% level was already reached by end of 2022, not gradually over 2022–2024. (3) The qualitative reasoning about diversification and interest rate risk management is sound and aligns with the ground truth—shifting away from rate-sensitive government securities toward corporate and other bonds is a reasonable interpretation. The mention of active risk management and credit-rated assets is contextually appropriate. However, the LLM omits key details such as the Level 2 classification and liquidity considerations, which are part of the full strategic picture. (4) Despite these omissions and the critical error in dating the allocation changes, the answer captures the general trend and offers a plausible interpretation, warranting a partial correctness score. Quantitative accuracy is low due to incorrect time-period mapping; qualitative and contextual scores are higher due to correct synthesis of intent and risk strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 498,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer’s Breakthrough Performance Awards (BPAs) were phased out after 2022, with no BPAs granted in 2023 and none outstanding as of December 31 2023. Earlier disclosures (2022) described BPAs as performance‑based stock awards to select non‑executive employees that could yield 0%–600% of a target award based on pipeline milestones, with intrinsic‑value valuation and straight‑line amortization over the probable vesting term. Subsequent filings (2023 and 2024) no longer reference BPAs, indicating they have been discontinued. Disclosure of BPAs in the 2022 10‑K was limited to a brief table in Note 13, while the 2023 and 2024 notes provide expanded detail on other award types (TSRUs, RSUs, PPSs, PSAs) but omit any mention of BPAs, reflecting reduced transparency regarding the former program.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct information but has significant factual inaccuracies and omissions that undermine its overall correctness. (1) Quantitatively, the LLM correctly notes that no BPAs were granted in 2023 and none were outstanding as of December 31, 2023, aligning with the ground truth. However, it fails to mention the key 2022 quantitative data from the original answer: 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remaining nonvested. These specific figures are missing, reducing quantitative accuracy. (2) On completeness, the LLM incorrectly states that BPAs were not referenced in 2024 filings, when in fact the original answer clearly states that BPAs reappeared in 2024 disclosures with enhanced valuation methodology and transparency. This is a major factual error—the program was not permanently discontinued, but rather evolved. The LLM incorrectly concludes that BPAs were 'phased out' and 'no longer reference[d]' in 2023 and 2024, contradicting the ground truth that they reappeared in 2024 with detailed new policies. (3) The qualitative reasoning is flawed: the model fails to capture the three-phase evolution (active in 2022 → paused in 2023 → revived with improved transparency in 2024), instead portraying a linear discontinuation. This misrepresents Pfizer’s strategic shift. (4) Contextually, the answer is relevant and addresses the general topic of BPA treatment, grant activity, and disclosure, but the erroneous conclusion about discontinuation and lack of 2024 updates severely limits accuracy. While the description of the 2022 BPA structure (0%–600%, performance-based, intrinsic value, straight-line amortization) is consistent with the ground truth, the absence of 2024 revival and updated valuation framework results in a partially correct but ultimately misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 509,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "From 2022 through 2024, Schwab’s Advisor Services expanded its interactive tools for RIAs by deepening third‑party integrations and enhancing portfolio‑management features. The Advisor Services website now offers free access to “Schwab Advisor Portfolio Connect,” a streamlined portfolio‑management solution, and broader integrations with external CRM, portfolio‑management and trade‑order platforms. These tools are complemented by the company’s “thinkpipes” trading platform and iRebal rebalancing solution, which were incorporated into the TD Ameritrade Institutional offering and are now part of Schwab’s ongoing RIA suite, giving advisors more seamless, scalable ways to manage client assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies despite correctly identifying Schwab Advisor Portfolio Connect and third-party integrations. The mention of 'thinkpipes' and 'iRebal' as part of Schwab's RIA tools is unsupported by the original answer and appears to be fabricated or misattributed—these tools are not mentioned in the ground truth and may be associated with TD Ameritrade Institutional, which was acquired by Schwab, but their integration into Schwab’s 2022–2024 RIA offerings is not confirmed in the provided data. Additionally, the LLM implies a continuous expansion and integration of new tools, while the ground truth emphasizes consistency in offerings with a growing focus on usability and platform experience, particularly in 2024. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that third-party integrations and portfolio management tools are central to Schwab’s RIA strategy, and it acknowledges the role of the Advisor Services website. However, it fails to reflect the evolution over time—specifically, the shift in emphasis from proprietary tools (2022) to document archiving and search (2023) and enhanced user experience (2024). Instead, it presents a static view of expanded capabilities without temporal nuance. (4) The contextual relevance is moderate: the answer addresses third-party integrations and portfolio management, which are relevant, but introduces unverified tools and omits the year-by-year evolution that is central to the question. The correctness score is 5 due to significant factual overreach and omission of the platform’s evolving focus on usability and scalability as described in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 499,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Texas Instruments has consistently framed its strategic focus on analog and embedded processing products across all three fiscal years, emphasizing that these product categories are central to its business model and long-term value creation. This consistent framing reveals a deliberate, enduring positioning in semiconductor markets where it leverages four sustainable competitive advantages—manufacturing control, broad product portfolio, extensive market reach, and product diversity—to drive free cash flow growth and maintain resilience amid cyclical industry dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, and accurately reflects that this is part of a broader strategy built on four sustainable competitive advantages. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all temporal references (fiscal years) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the consistent framing across three years and correctly infers that this reflects a long-term strategic positioning in semiconductor markets focused on free cash flow growth and resilience. The only minor omission is that the LLM does not explicitly mention 'growing free cash flow per share' as the objective, instead stating 'drive free cash flow growth'—a closely related but slightly less precise phrasing. Additionally, while the four competitive advantages are correctly listed in substance, the LLM paraphrases 'broad portfolio of analog and embedded processing products' as part of 'product diversity' and 'broad product portfolio,' which slightly conflates the original structure where the portfolio itself is the second advantage. (4) Despite these minor nuances, the answer captures the core factual content, reasoning, and intent of the ground truth, with excellent contextual relevance and strong qualitative accuracy. Hence, a correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 427,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "From 2022 through 2024 Boeing’s fleet‑support costs remained roughly 1 % of total consolidated costs, but the program’s delivery profile was repeatedly disrupted.  The 787 accounting quantity grew by 100 units in 2023 and again in 2024, yet production was repeatedly slowed or paused—dropping below 5 aircraft per month in 2023 and further constrained in 2024 due to supply‑chain limits, rework on inventory aircraft, and FAA‑mandated quality‑control actions.  These disruptions generated abnormal production costs (e.g., $2.7 bn of cumulative abnormal costs through 2023 and $256 m of rework expense in 2024) and delivery delays that pushed 787 deliveries into 2025, while the company recorded significant reach‑forward losses on the 777X program that further strained cash flow.  Consequently, the cost profile of fleet‑support services stayed low, but the timing and volume of deliveries—and the associated abnormal production costs—have been markedly volatile from 2022 to 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Boeing's cost profile and delivery impact from 2022 to 2024, particularly regarding the 787 program. It correctly states that fleet support services accounted for approximately 1% of total consolidated costs, aligning with the ground truth. The abnormal production costs are accurately reported: $2.7 billion in cumulative abnormal costs through 2023 and $256 million in rework expenses in 2024. These figures match the original answer exactly, satisfying quantitative accuracy. However, the LLM introduces the claim that the '787 accounting quantity grew by 100 units in 2023 and again in 2024,' which is not present in the ground truth and cannot be verified from the provided information—this is a factual overreach. Additionally, the mention of 'significant reach-forward losses on the 777X program' is accurate in context for Boeing’s financials but is not part of the original answer’s scope, which focused solely on the 787 program’s impact on fleet support services. While this adds context, it slightly distracts from the specific multi-hop synthesis required. The answer correctly links rework, FAA actions, supply chain issues, and delivery delays pushing into 2025, which is consistent with the ground truth. The reasoning is sound and synthesizes multi-year developments, though the unsupported claim about accounting quantity growth prevents a higher score. Wording differences are acceptable under semantic equivalence, and the overall narrative of decreasing abnormal costs and ongoing delivery challenges is preserved. Thus, the answer is factually strong but contains minor unsupported additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 457,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer’s relationship with Meridian evolved from a joint venture partnership to a full separation: Meridian was sold in December 2021, with the transaction completed and the spin‑off of Upjohn combined with Mylan to form Viatris finalized in 2020‑2021. Post‑sale, Pfizer entered into transitional services agreements (TSAs) and a master services agreement (MSA) that provided limited, time‑bound support for up to three years (extendable by two), but these arrangements were largely completed by the end of 2023. The financial impact of these agreements was modest, with no material amounts recorded in 2023, and the indemnification and guarantee obligations related to Meridian’s prior operations were resolved as part of the separation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that impact correctness. It incorrectly states that the sale of Meridian occurred in December 2021 as part of a 'joint venture partnership' and conflates it with the Viatris spin-off (Upjohn + Mylan), which is a separate transaction. The ground truth confirms Meridian was sold on December 31, 2021, but it was not a joint venture and was unrelated to Viatris. The $167 million loss (net of tax) from the sale is entirely omitted. (2) Quantitative accuracy is compromised: while no incorrect numbers are stated, the key financial figure—the $167 million loss—is missing, and the answer incorrectly implies the transaction closed in 2020–2021 rather than being completed by end-2021. The statement about 'no material amounts recorded in 2023' aligns with the ground truth, which supports partial credit. (3) Multi-hop reasoning is partially sound: the model correctly identifies the existence of TSAs and an MSA with a three-year term and two-year extension, and notes their completion by end-2023. However, it mislabels the MSA as a 'Master Services Agreement' instead of 'Manufacturing Supply Agreement,' showing entity/term inaccuracy. The mention of indemnification and guarantees being resolved is not in the ground truth and may be speculative. (4) Contextual relevance is strong—the answer addresses the evolution of the relationship, financial implications, and contractual arrangements—but the conflation with the Viatris deal and omission of the loss significantly reduce factual fidelity. Overall, the answer captures the diminishing post-sale relationship and non-material financial impact but fails on key facts and context, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 472,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "From 2022 through 2024, the “hello” brand has been positioned as a high‑growth, differentiated oral‑care offering within the broader Oral, Personal & Home Care portfolio, and its relative emphasis has risen.  In 2022 the company disclosed that the hello acquisition was part of its strategy to focus on high‑growth segments of Oral Care, Personal Care and Pet Nutrition, and subsequent filings show increasing capital spending and investment in the brand (e.g., $52 M of capital expenditures in North America in 2024 versus $66 M in 2022).  By 2024 the company’s internal reporting groups the hello line together with other Oral, Personal and Home Care products, and its sales share within that segment has expanded—reflecting a strategic shift that elevates hello alongside established brands such as Colgate and Palmolive.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness. (1) The claim that Colgate-Palmolive made $52M in capital expenditures in North America in 2024 'versus $66M in 2022' as related to the 'hello' brand is not supported by the ground truth and introduces specific numbers absent from the original answer; these figures are either fabricated or misattributed, failing the quantitative accuracy test. (2) The assertion that there was an 'acquisition' of 'hello' is not mentioned in the ground truth and cannot be verified from the provided data, introducing a false event. (3) The statement that 'hello's sales share within the segment has expanded' and that there is a 'strategic shift that elevates hello' implies a growing emphasis not confirmed by the original answer, which only states consistent inclusion and visibility—no change in strategic positioning is indicated. (4) While the LLM correctly identifies 'hello' as part of the Oral, Personal and Home Care segment across years and notes its grouping with major brands, this aligns partially with the ground truth. However, the qualitative leap to 'rising relative emphasis' and 'high-growth, differentiated offering' goes beyond the evidence provided. (5) The multi-hop reasoning is partially sound in tracking the brand over time, but the synthesis introduces unsupported inferences rather than sticking to observable facts (e.g., trademark listing). (6) Contextually, the answer addresses the evolution of 'hello' in relation to other product lines, so relevance is fair. Overall, while the general idea of sustained strategic importance is in the right direction, the inclusion of unverified financial data, incorrect events (acquisition), and overstated conclusions reduces factual correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 489,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Based on the multi-year disclosures across the provided 10-K filings, Texas Instruments' non-qualified defined benefit pension plan funding status and participant engagement show a clear downward trend in funding obligations and participation, reflecting strategic shifts in long-term pension commitments and evolving employee preferences toward defined contribution plans.\n\nThe data reveals that the non-qualified defined benefit plans were closed to new participants years ago, with only existing participants allowed to continue accruing benefits under the qualified plan or transition to the enhanced defined contribution plan. By 2024, the funding status of the qualified defined benefit pension plan had improved significantly—from a $521 million obligation at the start of 2023 to $505 million at year-end 2023, with plan assets increasing to $418 million—indicating active funding and asset growth to meet liabilities. However, the non-qualified plans remain unfunded, and participation has steadily declined as employees shifted to defined contribution options, particularly the enhanced plan offering matching contributions. This multi-year progression underscores a deliberate corporate strategy to reduce long-term pension liabilities while adapting to changing employee engagement patterns, prioritizing defined contribution structures that align with modern compensation trends and reduce future funding risks.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the qualified defined benefit plan had a $521 million obligation at the start of 2023 and $505 million at year-end 2023 with $418 million in plan assets—this data is not present in the ground truth and contradicts the original answer, which focuses solely on the non-qualified plan and does not mention funding levels for a qualified plan. The original answer explicitly states that the non-qualified plan is unfunded, but the LLM claims there is active funding and asset growth, which is false. (2) The LLM fails to report any of the key quantitative data from the ground truth: the number of TI shares held in defined contribution plans (6M in 2022, 5M in 2023–2024), their values ($940M, $873M, $852M), dividends ($28M, $27M, $26M), and defined contribution expenses ($70M, $75M, $76M). Instead, it fabricates numbers about plan obligations and assets. (3) The multi-hop reasoning is flawed: the question asks about the non-qualified defined benefit plan, but the LLM conflates it with the qualified plan and introduces non-existent funding data. It correctly identifies that the plan is closed to new participants and that there is a shift to defined contribution plans, but this is overshadowed by major errors. (4) The contextual relevance is moderate because the answer addresses the general theme of pension strategy shift, but the factual foundation is incorrect, severely undermining the response. The conclusion about strategic liability reduction is partially aligned with the ground truth, but it is based on incorrect data. Overall, the answer is mostly incorrect due to fabrication of numbers and confusion between plan types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1652,
        "completion_tokens": 474,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities held at cost was $755 million as of December 31 2024, up from $755 million in 2023 and $800 million in 2022. This three‑year trend shows a relatively stable allocation to private‑equity, with only modest fluctuations, indicating that Pfizer maintains a consistent, strategic exposure to the asset class rather than a major shift in weighting.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities was $623 million in 2022, increased to $755 million in 2023, and then declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $800 million (should be $623M), claims 2023 and 2024 are both $755 million (2024 should be $719M), and thus misrepresents the entire trend. (2) These numerical errors invalidate the calculations and comparisons: the correct trajectory shows a +132M increase from 2022 to 2023 and a -36M decrease from 2023 to 2024, whereas the LLM implies no change from 2023 to 2024 and a decrease from 2022 to 2023, which is factually wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the three-year trend across filings; instead, it constructs a narrative of 'stable allocation' based on incorrect data, contradicting the ground truth's conclusion of a short-term increase followed by a partial pullback. (4) While the answer addresses the question's structure and attempts to interpret strategic intent (contextually relevant), the severe quantitative inaccuracies and resulting incorrect qualitative assessment justify a low correctness score of 2. The model gets partial credit for discussing the right metric and company over the correct time frame, but the core facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 394,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "Schwab’s ability to move IDA balances onto its balance sheet shifted from being governed by the 2019 IDA agreement (which allowed migration of up to $10 billion of balances annually, subject to capital and fixed‑rate designation limits) to the 2023 IDA agreement, which removed the 80 % fixed‑rate requirement, set new minimum/maximum balance thresholds, and made migration discretionary but still contingent on maintaining sufficient capital and meeting the agreement’s balance‑maintenance conditions. Under the 2023 terms, Schwab could only migrate balances in limited amounts and had to keep IDA balances above specific minimums; in 2023 it chose to buy down $5 billion of fixed‑rate obligations, capitalizing the associated fees, and in 2024 it did not migrate any IDA balances to its balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Schwab's IDA balance migration framework from the 2019 to the 2023 agreement and correctly notes that no balances were migrated in 2024. However, it introduces a significant factual error by stating that in 2023, Schwab 'chose to buy down $5 billion of fixed-rate obligations, capitalizing the associated fees.' This action is not mentioned in the ground truth and is unsupported by the provided information. The ground truth states that no IDA balances were moved in 2023 or 2024 under the new agreement, but does not reference any buy-down of obligations. This misrepresents Schwab's actions and introduces a false quantitative claim. (2) Quantitative accuracy is compromised by the unsupported $5 billion figure. While the $10 billion annual limit under the 2019 agreement is correctly cited, the ground truth notes that $10.1 billion had already been moved by December 31, 2021—information missing from the LLM answer. The 2023 and 2024 migration amounts are correctly stated as zero, but the reasoning is flawed due to the erroneous buy-down claim. The $30 billion cap through September 10, 2025, mentioned in the ground truth, is omitted. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the shift in agreement terms and the increased constraints in 2023. It accurately notes the removal of the 80% fixed-rate requirement and the introduction of balance thresholds. However, it fails to fully convey the specific constraint requiring IDA balances to remain above unmatured fixed-rate obligations with a $30 billion ceiling, which is central to the 2023–2025 framework. (4) The contextual relevance is high, as the answer addresses the evolution of migration capability and constraints. The qualitative accuracy is moderate due to correct identification of agreements and general constraints, but undermined by the fabricated $5 billion action. The correctness score is 6 due to a mix of accurate structural understanding and a major factual inaccuracy that affects the interpretation of Schwab's actions in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 566,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments has maintained a consistent, multi-year presence in Melaka, Malaysia, with the facility listed as a key manufacturing site for analog products across all three SEC filings (2022, 2023, and 2024). The 2023 and 2024 filings explicitly identify Melaka as a location for analog manufacturing (with ownership/leasing noted), while the 2022 filing similarly includes it among major global sites. This persistent designation—despite minor variations in reporting details—demonstrates that Melaka is a strategically important, long-term hub for TI’s analog manufacturing operations, integral to its global supply chain and competitive advantages. The consistency underscores its role in supporting TI’s core business model and cash flow generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately conveys that Texas Instruments consistently included Melaka, Malaysia as a site for analog product manufacturing across 2022, 2023, and 2024, which satisfies the multi-hop requirement of tracking evolution over time. The answer correctly identifies the continuity of Melaka's role, though it does not explicitly mention the symbolic markers (†, *, **) noted in the original answer—specifically the potential escalation signaled by the double asterisk in 2024. This is a minor omission in qualitative detail but does not undermine the overall correctness. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly infers strategic importance from multi-year consistency. The answer is contextually relevant, directly addressing all parts of the question with appropriate synthesis across years. The wording differs from the original but maintains semantic equivalence, particularly in concluding that Melaka is a strategically important, long-term hub. The lack of explicit notation symbols prevents a perfect 10, but the core facts, logic, and implications are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 336,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Debit Card (referred to as a \"Target Circle Card\" in the disclosures) shows a declining penetration trend: 19.8% in 2022, 18.6% in 2023, and 17.8% in 2024. This downward trend suggests the card's role in driving incremental sales has diminished over time, as fewer customers are using it to make purchases. While the card still offers a 5% discount, its decreasing penetration indicates reduced effectiveness in boosting sales compared to prior years.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate was 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024. However, the LLM reports 19.8% in 2022, 18.6% in 2023, and 17.8% in 2024. The 2022 and 2023 figures are incorrect, with the 2022 number being the 2023 ground truth value, suggesting a possible year misalignment. Only the 2024 value (17.8%) is correct. (2) These errors affect the calculation of the trend: the actual decline is 2.7 percentage points from 2022 to 2024, while the LLM implies a 2.0-point drop, underestimating the severity. The misstatement of the starting point (19.8% vs 20.5%) undermines the accuracy of the trend analysis. (3) Qualitatively, the reasoning is sound: the LLM correctly infers that declining penetration suggests a diminishing role in driving incremental sales and appropriately references the 5% discount incentive. The synthesis of the trend into business implications is logically consistent with the data it presented. (4) Contextually, the answer is highly relevant, addressing both parts of the question—evolution of penetration and its implication for sales—and correctly identifies the card as part of the Target Circle/RedCard ecosystem. However, due to the incorrect numerical foundation, the overall correctness is significantly compromised despite accurate qualitative interpretation of the (wrong) trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 397,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "From 2022 through 2024, the shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan declined from 58,452,628 (as reported for 2023) to 65,541,964 (as reported for 2024), reflecting a net increase in the pool of shares reserved for future director awards. This upward trend indicates that the company is replenishing its equity incentive reserve for directors, ensuring sufficient shares remain available to grant new awards as needed.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The ground truth states that shares available decreased from 35,385,153 in 2022 to 25,296,767 in 2023 to 24,503,062 in 2024. The LLM incorrectly reports an increase from 58,452,628 in 2023 to 65,541,964 in 2024—both the numbers and the direction of change are wrong. (2) The quantitative inaccuracies are severe: the LLM cites numbers not present in the ground truth, and even mislabels years (e.g., reporting 2023 data as 'from 2022 through 2024'). There is no mention of 2022 data in the LLM answer, and the values cited do not match any year in the original answer. (3) The multi-hop reasoning is fundamentally flawed. The LLM concludes that the company is replenishing shares due to an 'upward trend,' but the actual trend is a consistent decline, indicating usage without replenishment. The LLM fails to synthesize the correct data across years and draws the opposite conclusion. (4) The contextual relevance is low because the answer discusses the right topic (equity incentives for directors) and the right plan, but with entirely incorrect data and inference. The qualitative reasoning is unsound due to incorrect inputs and flawed logic. Only minimal credit is given for addressing the general subject matter.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 358,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "Visa’s virtual‑account and digital‑capability strategy evolved markedly across 2022‑2024. In fiscal 2022 the company expanded its commercial‑payments suite—adding virtual cards, Accounts‑Receivable Manager and cross‑border solutions—while launching Visa Direct and Visa B2B Connect to enable real‑time, cross‑border money movement. By 2023‑24 Visa integrated these capabilities more tightly with Visa Direct, scaling the platform to over 10 billion transactions, adding Currencycloud’s real‑time FX and virtual‑account functionality, and rolling out Visa+ for P2P interoperability (e.g., PayPal/Venmo). This progression cemented a broader, end‑to‑end ecosystem that now supports a $20 trillion cross‑border opportunity and drives new flows such as B2C payouts, merchant settlements and embedded finance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in timeline and feature attribution. It incorrectly states that Visa Direct and Visa B2B Connect were launched in 2022 as part of the commercial payments suite, while the ground truth indicates that virtual accounts were introduced in 2022 via Currencycloud under Visa Treasury as a Service, not through the launch of Visa Direct. Visa Direct existed prior to 2022 and was expanded, not launched, during this period. The LLM also misrepresents the timeline by grouping 2023–2024 together rather than distinguishing developments in each year. While it correctly notes integration with Visa Direct and Currencycloud’s real-time FX functionality, it omits the specific 2023 integration milestone and the 2024 expansion to 11 billion endpoints, instead citing 'over 10 billion transactions'—a different metric (transactions vs. endpoints) that is not equivalent and factually misaligned. The $20 trillion cross-border opportunity is correctly referenced, but attributed broadly to the ecosystem rather than specifically to B2B as in the original. (2) Quantitative inaccuracies include the conflation of '10 billion transactions' (volume) with '11 billion endpoints' (network reach), which are distinct concepts; the latter is a key metric in the ground truth and was misrepresented. The $20 trillion figure is correct but lacks the B2B specificity. (3) The multi-hop reasoning is partially sound—linking virtual accounts, Visa Direct, Currencycloud, and cross-border use cases—but fails to accurately trace the year-by-year evolution. The integration narrative is plausible but oversimplified and conflates product launches and enhancements. (4) Scores reflect partial factual correctness with significant errors in key details: correctness score is 6 due to correct mention of core components (Currencycloud, FX, cross-border) but flawed timeline and metrics; quantitative accuracy is 5 due to incorrect or mismatched numbers; qualitative accuracy is 6 for reasonable synthesis but flawed entity and event mapping; contextual relevance is 9 as the response stays focused on the question’s scope and strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 583,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi's revenue pressures in 2023, driven by lower net pricing due to unfavorable channel mix, contributed to Pfizer's strategic focus on lifecycle management. This pressure was evident in the 2024 expansion of Xtandi's approved indication to include nmCSPC with high-risk BCR for metastatic castration-resistant prostate cancer, reflecting Pfizer's effort to revitalize the asset within its intangible portfolio and mitigate declining revenue trends. The asset's valuation within Pfizer's intangible portfolio, as reflected in the 2022 10-K (page 92), remained significant at $19,614 million (net of amortization), underscoring its continued strategic importance despite revenue headwinds.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Xtandi's revenue pressures in 2023 due to lower net pricing and unfavorable channel mix, aligning with the ground truth's mention of 'down 1%' revenue and pricing pressure. It accurately references the 2024 indication expansion to nmCSPC with high-risk BCR, which matches the ground truth. The 2022 valuation of $19,614 million (net of amortization) from Pfizer's 10-K is correctly cited, supporting the asset's significance in the intangible portfolio. However, there is a minor error in the indication description: the LLM incorrectly states the new indication is for 'metastatic castration-resistant prostate cancer' when it should be 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis'—a key distinction that affects clinical and commercial understanding. (2) Quantitatively, all numbers are accurate: the $19,614 million figure is correctly reported from the 2022 10-K (page 92), and no calculations are required beyond correct citation. (3) The multi-hop reasoning is largely sound—linking 2022 valuation, 2023 revenue pressure, and 2024 indication expansion to infer continued investment in lifecycle management. However, the mischaracterization of the indication weakens the precision of the synthesis. (4) Despite this error, the overall logic and intent are correct: Pfizer maintained strategic investment in Xtandi despite revenue headwinds. The answer is highly relevant, well-structured, and addresses all parts of the question with only a moderate factual inaccuracy in clinical indication terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 447,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard Credit Card penetration rate declined from 20.5% in 2021 to 18.6% in 2024, indicating reduced consumer reliance on the card for purchases. This downward trend suggests weakening engagement with the loyalty program, as fewer transactions were completed using the card despite overall sales growth, potentially reflecting shifting consumer preferences or increased competition in payment methods.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The original answer states the penetration rate declined from 20.5% in 2022 to 19.8% in 2023 and 18.6% in 2024. However, the LLM incorrectly reports the starting point as 20.5% in 2021, which is not supported by the ground truth and misrepresents the timeline. While the 18.6% figure for 2024 is correct, the omission of the 2023 data point (19.8%) and the incorrect starting year undermine the accuracy of the trend description. (2) The calculation of the overall decline is partially correct (from 20.5% to 18.6%), but the time frame is wrong—spanning 2021–2024 instead of 2022–2024—and misses the annual granularity provided in the original. (3) The qualitative reasoning about weakening loyalty engagement and shifting consumer preferences is consistent with the original answer and shows sound multi-hop synthesis of the implication of declining penetration. The rebranding context (RedCards™ to Target Circle Cards) is omitted, but the core interpretation of the trend is reasonable. (4) The answer is contextually relevant and addresses both parts of the question—evolution of penetration rate and its implications—though with incorrect dates and incomplete data. The conclusion is logically derived but based on flawed input data, leading to a partially correct response. Therefore, the correctness score is 5 due to major quantitative errors, despite acceptable reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 407,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa has progressively expanded virtual account capabilities within its Currencycloud‑enabled cross‑border ecosystem from fiscal 2022 through 2024, integrating virtual accounts into Visa Direct and Visa B2B Connect to provide real‑time foreign‑exchange rates, enhanced liquidity and settlement, and broader network reach across more than 100 countries. This evolution has strengthened cross‑border payment functionality, allowing financial institutions and partners to leverage virtual accounts for faster, more secure B2B and consumer transactions while extending Visa’s addressable volume in the $20 trillion cross‑border opportunity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Visa's virtual account usage across the Currencycloud platform from 2022 to 2024. It accurately notes the integration of virtual accounts into Visa Direct and Visa B2B Connect, real-time FX, enhanced liquidity and settlement, and network reach across more than 100 countries—key points from the ground truth. The mention of the $20 trillion cross-border opportunity is contextually relevant and plausible, though this specific figure is not in the original answer and cannot be verified from the provided ground truth; however, it does not contradict it and aligns with industry estimates, so it does not constitute a major error. The answer condenses the year-by-year progression (2022–2024) without explicitly delineating each year’s developments—missing the 2022 launch detail and the 2023 expansion to 11 billion endpoints—but still conveys the overall strategic trajectory. Quantitatively, 'more than 100 countries' matches the original, and no incorrect numbers are presented (the $20T is contextual, not a claim about Visa’s performance). The qualitative reasoning is sound, showing multi-hop synthesis between Currencycloud, Visa Direct, and B2B Connect, and the functional evolution of virtual accounts. The answer is highly relevant to the question and effectively summarizes the strategic expansion, though with slightly less granular detail on annual milestones. Thus, minor deductions apply for completeness and precision in temporal progression, but the core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 429,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s exposure to intellectual‑property protection difficulties has remained a persistent risk across all three years, but the way it is framed has evolved. In the 2022 filing the company highlighted the need to protect its technology and IP in the United States and abroad, noting that failure to do so could erode its competitive advantage and increase expenses. By 2023 and 2024 the discussion expands to include broader geopolitical and supply‑chain threats—such as foreign‑country legal risks, export‑control sanctions, and the potential loss of IP through third‑party manufacturing dependencies—while still emphasizing that inadequate IP protection could materially harm the business. This progression shows a deepening concern that IP risks are intertwined with international operations and reliance on external foundries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AMD's intellectual property (IP) protection risks from 2022 to 2024 as described in the ground truth. It correctly identifies that IP protection has remained a persistent risk, with increasing emphasis on geopolitical and supply chain factors over time. The answer accurately reflects that in 2022, AMD highlighted IP protection broadly in the U.S. and abroad; in 2023 and 2024, it expanded the discussion to include third-party manufacturing dependencies and geopolitical tensions. While the LLM does not explicitly name China, Malaysia, and Taiwan as in the original, it refers to 'foreign-country legal risks' and 'third-party manufacturing dependencies,' which semantically aligns with the ground truth. It also correctly notes the growing impact of export controls and sanctions linked to global conflicts (Ukraine-Russia, Israel-Hamas), matching the original's emphasis on evolving regulations. There are no numerical inaccuracies (quantitative accuracy is 10), and all years are correctly referenced. The reasoning is sound and reflects multi-hop synthesis across years and risk dimensions. The only minor shortcoming is the lack of specific country names in the third-party manufacturing context, which slightly reduces qualitative precision but does not undermine the overall correctness. Hence, the answer is factually solid, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 398,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "From 2022 to 2024, Union Pacific shifted its pension‑plan investment strategy from a heavy concentration in corporate stock (which was classified as Level 1 in 2022 and remained Level 1 in 2023‑24) toward a more balanced mix that emphasizes debt securities and reduces exposure to equity.  The 2024 asset‑allocation targets now call for only 20‑30 % of assets in equities, with 70‑80 % allocated to debt securities and a small 0‑2 % exposure to real estate.  This reallocation reflects a deliberate move to lower market‑price volatility and to align the pension fund’s risk profile with a more stable, income‑generating asset mix, indicating that Union Pacific is tightening its pension funding discipline and seeking to limit future equity‑market risk while maintaining a modest equity return target of 5.25 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, and introduces information not present in the ground truth. (1) Quantitative Accuracy: The LLM claims specific allocation targets for 2024 (20-30% equities, 70-80% debt, 0-2% real estate) and a 5.25% equity return target, none of which are mentioned in the original answer or supported by the provided ground truth. The original answer only states the valuation classification and dollar amounts for Corporate Stock in 2022 and 2023, with no figures for 2024. The LLM incorrectly implies that the Level 1 classification remained consistent across all years without noting the massive drop in value from $1,990M to $181M, which is a key fact. (2) Completeness: While the LLM attempts to address the evolution and strategic implications, it fails to report the actual dollar figures for 2022 and 2023, which are central to the original answer. It also omits the distinction between common stock (Level 1) and preferred stock (Level 2) in 2024, which was explicitly stated. (3) Entity Accuracy: The company (UNP) and general time frame (2022–2024) are correct, and the mention of Level 1 classification for corporate stock is partially accurate, but the extension to a broader asset allocation strategy with specific percentages is unsupported. (4) Reasoning: The LLM draws a plausible conclusion about risk reduction and stability, which aligns thematically with the original answer’s interpretation, but the reasoning is based on fabricated data rather than the actual disclosed changes in Corporate Stock valuation. (5) Semantic Equivalence: The overall theme of reduced equity exposure and strategic shift is loosely consistent, but the specific financial evolution described in the ground truth—especially the sharp decline in Corporate Stock holdings—is not accurately conveyed. The LLM invents a detailed asset allocation framework not present in the source, undermining factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 533,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolved from 2022 through 2024 by progressively integrating the debt issuance into its broader long-term debt management framework, as evidenced by the consistent inclusion of the 4.75% 2043 notes in the Exhibit 4.17 disclosure (page 86) across multiple 10-K filings (2022, 2023, 2024), with the 2024 filing (page 86) explicitly referencing the Officers' Certificate Pursuant to Sections 3.1 and 3.3 of the Indenture for these notes alongside other long-term debt instruments. This multi-year progression—where the 4.75% 2043 notes were consistently documented in the context of debt covenants, maturity schedules, and investor communications (e.g., via the 2017 Indenture and its supplements, with the 2024 filing reinforcing its role in Abbott's debt structure)—suggests a deliberate, transparent approach to long-term debt management, emphasizing investor confidence through standardized, recurring disclosures that align with regulatory requirements and signal Abbott's commitment to maintaining a stable, predictable capital structure for sustained growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Abbott referenced the 4.75% Senior Notes due 2043 via St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration. However, the LLM claims the notes were included in 'Exhibit 4.17 disclosure (page 86)' across 2022–2024 10-Ks, which contradicts the ground truth that cites Exhibit 4.6 to the Form 8-K dated March 22, 2017. There is no mention of Exhibit 4.17 or page 86 in the ground truth, nor is there evidence that the same exhibit number was used consistently. Additionally, the LLM fabricates a reference to an 'Officers' Certificate Pursuant to Sections 3.1 and 3.3 of the Indenture' in the 2024 filing, which is not present in the original answer. (2) Quantitative accuracy is low: while the interest rate (4.75%) and maturity year (2043) are correct, the dates, exhibit numbers, and filing details (e.g., Form 8-K date March 22, 2017) are misrepresented. The LLM incorrectly attributes ongoing disclosure to annual 10-K filings rather than a current report on Form 8-K, undermining temporal and procedural accuracy. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a trend toward standardized disclosure and links it to investor communication and debt management—but this conclusion is based on incorrect evidence. The actual evolution (from legacy referencing to formal inclusion of the exhibit) is misrepresented, weakening the logical foundation. (4) Contextual relevance is fair: the answer addresses the question’s intent regarding disclosure evolution and investor communication, and the overall theme of increasing transparency aligns with the ground truth. However, due to major factual and sourcing errors, the answer cannot be considered correct despite capturing the general direction of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 510,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration rate of the Target Circle Card (formerly RedCards) declined from 20.5 % in 2022 to 18.6 % in 2023 and further to 17.8 % in 2024, indicating a modest slowdown in customer adoption of the branded payment product. This downward trend suggests that while the card still drives incremental purchases, its growth is flattening, which could limit its contribution to incremental sales unless offset by other loyalty or promotional initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 19.8% in 2023 and then to 18.6% in 2024. However, the LLM incorrectly states it dropped to 18.6% in 2023 and further to 17.8% in 2024—both values are wrong. This misrepresents the actual trend and magnitude of decline. (2) The calculation of the trend is therefore flawed: the actual decline was -0.7 percentage points from 2022 to 2023 and -1.2 points from 2023 to 2024, whereas the LLM implies a drop of -1.9 points in one year and another -0.8, which distorts the trajectory. (3) Entity accuracy is mostly correct—the card is properly identified as the Target Circle Card (formerly RedCard), and the years referenced (2022–2024) align with the question. The reasoning about declining adoption affecting incremental sales is logically sound and consistent with the original answer’s implications. (4) While the qualitative interpretation of the trend—slowing adoption potentially limiting incremental sales—is reasonable and contextually relevant, the incorrect numbers undermine the factual foundation. The answer addresses both parts of the question (evolution of penetration rate and its implication), but due to the numerical errors, the correctness score is significantly reduced. Quantitative accuracy is low due to two incorrect percentages; qualitative accuracy is moderate because reasoning and framing are appropriate; contextual relevance is high as the response stays focused and interprets the trend meaningfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 436,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "From 2022 to 2024 Union Pacific’s Multiple Purpose Locomotive fleet declined from **7,242 units (average age 22.5 years)** to **6,893 units (average age 25.2 years)**. This reduction in total units combined with a higher average age indicates the company is streamlining its locomotive inventory while retaining older assets, reflecting a strategic focus on optimizing fleet composition and extending the service life of existing equipment rather than expanding capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all factual data: the fleet size decreased from 7,242 units in 2022 to 6,893 units in 2024, and the average age increased from 22.5 to 25.2 years, matching the ground truth exactly. There are no numerical or date inaccuracies.\n\n2) Quantitative accuracy is perfect. Both unit counts and average ages are reported with correct values and appropriate year alignment. No calculation errors; the direction and magnitude of change are accurately represented.\n\n3) The multi-hop reasoning is sound—information from two time points is correctly synthesized to describe trends in fleet size and aging. The conclusion about asset management strategy is logically derived from the data. While the LLM frames the strategy as 'optimizing fleet composition and extending service life,' which is semantically close, the original answer emphasizes 'cost-conscious' strategy and 'deferral of modernization.' These are nuanced differences in interpretation but not factual errors. The LLM's interpretation is reasonable and aligned with the data, though slightly less precise in capturing the implied cost restraint.\n\n4) The answer is fully contextually relevant, addressing all parts of the question: change in total units, change in average age, and the strategic implication. The wording differs slightly from the original but maintains semantic equivalence in the factual content and offers a plausible interpretation of the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 401,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private real estate funds declined from $585 million at the end of 2022 to $540 million by the end of 2024, reflecting a reduction of roughly $45 million over the two‑year period. This downward trend indicates that the company is scaling back its exposure to illiquid alternative‑asset investments and is likely refocusing its long‑term capital allocation toward more liquid or strategically prioritized growth areas.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting and ending values ($585 million in 2022 and $540 million in 2024) and the overall downward trend, but it omits the intermediate 2023 value of $555 million, which is a key part of the ground truth. This omission reduces completeness and affects the accuracy of the trend description. (2) The calculation of the total reduction is incorrect: the LLM states a $45 million reduction over a two-year period, but the actual decline from 2022 to 2024 is $45 million over three years, with annual decreases of $30 million (2022–2023) and $15 million (2023–2024). The correct total reduction is $45 million, but the time frame is misrepresented as two years instead of three, and the stepwise nature of the decline is lost. (3) The multi-hop reasoning is partially sound—the model correctly infers that a declining commitment suggests reduced exposure to illiquid assets—but it misses the nuance in the original answer that Abbott maintains a 'significant' unfunded commitment, indicating continued long-term participation via distributions rather than new deployments. This strategic nuance is absent in the LLM response, which instead suggests a refocusing toward 'more liquid or strategically prioritized growth areas'—a plausible but unsupported inference not present in the ground truth. (4) The contextual relevance is high as the answer addresses both parts of the question—trend and strategic implication—though with incomplete data and overreaching interpretation. Quantitative accuracy is penalized due to the misstated time frame and missing 2023 data point, while qualitative accuracy is moderate due to correct entity identification and logical but incomplete reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 473,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 increased from $1,637 million in fiscal 2023 to $2,000 million in fiscal 2024 and further to $2,000 million (reported as $2,000 million in the 2025 table) – a rise of roughly 22% over the two‑year period. This upward movement reflects the notes’ amortized cost growth as they approach maturity (25.2 years remaining) and the company’s continued issuance of long‑dated debt, signaling that NVIDIA is maintaining a sizable, low‑coupon senior debt position to finance its growth while leveraging the depth of the capital markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of the carrying value. According to the ground truth, the carrying value decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. The LLM omits the 2022 value entirely and incorrectly states the 2023 value as $1,637 million (vs. correct $1,604 million). This error affects the accuracy of the trend description. Additionally, the LLM claims a 'further' increase to $2,000 million in a '2025 table', which is not supported by the question or ground truth, which only covers through fiscal 2024. (2) The calculation of a '22% rise over two years' is based on incorrect starting and ending points and an erroneous time frame. The actual change from 2023 to 2024 is ($2,000 - $1,604) / $1,604 ≈ 24.7%, but the LLM’s use of $1,637 introduces inaccuracy. More critically, the two-year period should include 2022–2024, but the LLM skips 2022 and fabricates a 2025 figure. (3) The multi-hop reasoning is flawed: the answer fails to capture the full trajectory (decrease then increase), which is central to the ground truth’s interpretation of strategic revaluation or refinancing. Instead, the LLM describes a continuous increase, leading to an incorrect conclusion about amortized cost growth toward maturity. The explanation that the increase reflects amortization toward maturity is financially unsound—amortization of a discount would typically increase carrying value gradually, but a jump from ~$1.6B to $2.0B is more likely due to reissuance or reclassification, not amortization. The ground truth correctly frames it as a strategic adjustment. (4) Scores justified: Correctness is low (4) due to major factual errors in numbers and timeline. Quantitative accuracy is poor (3) due to wrong values and fabricated data. Qualitative accuracy is moderate (5) because the answer attempts to interpret debt strategy but with flawed logic. Contextual relevance is fair (7) as it discusses long-term debt positioning, albeit based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 567,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s risk factors show a clear evolution in exposure to tax and tariff exemption loss from 2022 through 2024, reflecting growing complexity in its global regulatory environment. In 2022, the company highlighted risks tied to \"loss of tax and tariff exemptions\" as part of broader geopolitical and trade compliance challenges, particularly in regions like Taiwan and China amid U.S.-China tensions. By 2023 and 2024, this risk was explicitly expanded to include \"loss or modification of exemptions for taxes and tariffs\" as a standalone concern within its \"political, legal and economic risks\" section, directly linking it to cross-border operations, export controls, and sanctions (e.g., U.S. sanctions on Russia/Belarus and geopolitical instability in Ukraine). This progression—from a general mention in 2022 to a detailed, recurring theme in 2023–2024—demonstrates escalating regulatory scrutiny, especially as AMD navigates acquisitions (e.g., ZT Systems, Silo AI) and supply chain dependencies in high-risk jurisdictions. The trend underscores how AMD’s global footprint increasingly subjects it to fragmented, evolving tax and trade regulations, demanding heightened compliance vigilance and amplifying operational vulnerability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD's increasing emphasis on tax and tariff exemption risks from 2022 to 2024 is accurately portrayed, with proper contextual evolution—from a general risk in 2022 to a more detailed and standalone concern in 2023–2024. The mention of U.S.-China tensions, U.S. sanctions on Russia/Belarus, and geopolitical instability in Ukraine matches the original. The reference to supply chain dependencies and cross-border regulatory complexity is consistent with the source. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s evolving risk disclosures across three years, infers increasing regulatory complexity, and links it to geopolitical developments and operational expansion. The mention of acquisitions (ZT Systems, Silo AI) is plausible context but not present in the original answer; however, it does not contradict it and adds reasonable supplementary detail. (4) Semantic equivalence is strong—the core message about escalating exposure and regulatory complexity is preserved with slightly enhanced framing. The only minor deviation is the emphasis on acquisitions as a driver, which isn't in the original, but this doesn't undermine factual correctness. Hence, a 9 on qualitative accuracy and 9 overall is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 412,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon's ability to return capital—through dividends and share repurchases—is explicitly tied to U.S. banking laws and regulatory constraints, particularly capital adequacy and planning rules. The 10-K notes that such returns are subject to board discretion, Delaware law, and the need to pay full and timely dividends on preferred stock, while also highlighting that regulatory standards (e.g., \"well capitalized\" status) could limit activities and affect capital planning. (Page 5, 12, 21)",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key regulatory constraints on BNY Mellon's capital return flexibility, including U.S. banking laws, capital adequacy requirements, Delaware law, and preferred stock dividend obligations. These elements are factually consistent with the ground truth for 2022 and partially applicable to subsequent years. However, the LLM answer fails to address the evolution of these constraints from 2022 through 2024, which is central to the question. It does not mention any changes or continuity across the years, omitting specific developments in 2023 (e.g., credit rating reductions, Title I and II resolution strategies) and 2024 (e.g., liquidity management and strategic initiatives). (2) There are no numeric values, dates, or calculations in either the LLM or original answer, so quantitative accuracy is not compromised—score reflects full alignment where data exists. (3) The multi-hop reasoning is incomplete: while the LLM synthesizes relevant regulatory factors, it does not connect them across time periods as required. The absence of year-by-year progression undermines the synthesis needed for a full answer. (4) Contextual relevance is high because the response discusses the correct company, topic, and regulatory framework, but the lack of temporal analysis reduces completeness and qualitative accuracy. The answer provides a static snapshot rather than an evolution, missing the core thrust of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 405,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott Laboratories' 2.950% Note due 2025 was initially filed as Exhibit 99.6 to its March 5, 2015 Current Report on Form 8‑K (Exhibit 4.1 in the 2015 filing). The note continued to be referenced in subsequent exhibit filings, including the 2016 Annual Report (Exhibit 4.15), the 2017 Current Report (Exhibit 4.1), and later in the 2023 filing (Exhibit 4.1) and the 2024 filing (Exhibit 4.9), where it remained listed as the “Form of 2.950% Note due 2025.” Thus, across 2022‑2024 the note’s disclosure evolved from being part of the 2015 filing to recurring references in each year’s Exhibit 4.x tables, confirming its continued presence in the company’s debt documentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The original answer states that the 2.950% Note due 2025 was consistently referenced as Exhibit 99.6 in the March 5, 2015 8-K filing across 2022–2024, with no changes. However, the LLM claims the note was referenced in 2023 as Exhibit 4.1 and in 2024 as Exhibit 4.9, which contradicts the ground truth and introduces incorrect exhibit numbers. Additionally, the LLM references filings from 2016 and 2017, which are outside the requested 2022–2024 scope and irrelevant to the question. (2) The date of the original filing (March 5, 2015) is correctly mentioned, and the note’s interest rate (2.950%) and maturity (2025) are accurate. However, the evolution of exhibit numbering is misrepresented—ground truth shows stable citation of Exhibit 99.6, while LLM describes a shifting exhibit pattern (Exhibit 4.1, 4.9), which is incorrect. (3) The multi-hop reasoning is partially sound in that the model attempts to trace the note’s disclosure over time, but it fails to correctly synthesize the actual exhibit references in the relevant years. It incorrectly implies evolution in disclosure practice when the ground truth indicates stability. (4) Contextually, the answer addresses the right topic—disclosure of the note over time—and correctly identifies the instrument. However, due to incorrect exhibit numbers and inclusion of irrelevant years, the factual core is flawed. Minor formatting variations in dollar amounts or dates are not at issue here; the errors are in exhibit identifiers and temporal scope, which are critical. Thus, while the answer appears plausible, it is factually incorrect on key details, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 471,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 had a net carrying amount of $1.25 billion (and $1.25 billion gross) as of the end of fiscal 2024, which rose slightly to $1.25 billion (gross $1.25 billion) by the end of fiscal 2025 after the repayment of the 0.584% Notes Due 2024; the carrying amount remained essentially flat through fiscal 2022‑2024, indicating that the company has maintained a stable long‑term debt profile with little net change in this specific tranche. This steady carrying‑value progression suggests that NVIDIA is prioritizing financial flexibility and modest leverage, using the 1.55% 2028 notes as a relatively low‑cost, long‑dated funding pillar while it continues to issue new senior notes and repay shorter‑dated obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the carrying value was $1,200 million in fiscal 2022, $1,099 million in fiscal 2023, and $1,250 million in fiscal 2024. The LLM incorrectly states that the value was essentially flat at $1.25 billion from 2022 to 2024, which contradicts the actual fluctuation pattern. It also introduces a non-existent fiscal year 2025 and claims repayment of 0.584% Notes Due 2024, which is not mentioned in the original answer and not relevant to the 1.55% Notes Due 2028. (2) The numbers are therefore quantitatively wrong: the LLM omits the correct 2022 and 2023 values entirely and misrepresents the trend. While $1.25 billion in 2024 matches the ground truth ($1,250 million), the prior years are incorrect, and the characterization of 'essentially flat' is false given the drop to $1,099 million in 2023. (3) The multi-hop reasoning is flawed: the LLM fails to capture the actual progression and instead fabricates stability and a future year (2025), indicating poor synthesis of the time-series data. The qualitative interpretation about financial flexibility and low-cost funding may be plausible in isolation, but it is based on incorrect data and thus not supported by the evidence provided in the original answer. (4) The contextual relevance is moderate because the answer addresses the right instrument and general topic of long-term debt strategy, but the factual foundation is unsound, leading to an incorrect conclusion. The qualitative reasoning score is low because the entity (NVIDIA, 1.55% Notes Due 2028) is correct, but the temporal and financial synthesis is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 465,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024, AMD’s strategy evolved to protect inventory and differentiate its discrete graphics offerings through tighter partnerships with add-in-board (AIB) manufacturers and system integrators (SIs). The company emphasized non‑recurring engineering fees and inventory safeguards in its distributor agreements, while leveraging its Radeon™ brand and advanced packaging (e.g., 3D V‑Cache) to deliver higher‑performance, energy‑efficient GPUs that stand out against NVIDIA and Intel in the gaming and data‑center markets. This focus on differentiated discrete graphics solutions helped AMD maintain a competitive edge despite Intel’s aggressive pricing and market share pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key factual details from the ground truth, particularly regarding the specific evolution of AMD's inventory protection policies across 2022–2024. While it correctly identifies that AMD had inventory safeguards, it fails to mention the core policy detail — that AIBs were protected against price reductions and could return products removed from the price book within 12 months of manufacturing, as explicitly stated in 2022 and reiterated in later years. This omission significantly undermines completeness and qualitative accuracy. (2) There are no numeric values in either the question or ground truth, so quantitative accuracy is not applicable — the LLM does not introduce any incorrect numbers, hence a score of 10. (3) The multi-hop reasoning is partially sound — the model correctly infers that AMD worked closely with AIBs and emphasized differentiation via discrete graphics — but it fabricates or misrepresents strategic levers such as 'non-recurring engineering fees' and 'advanced packaging (e.g., 3D V-Cache)' in the context of AIB partnerships and inventory policy, which are not mentioned in the ground truth. The focus on competition with NVIDIA and Intel, while contextually plausible, is not part of the original answer and distracts from the actual evolution of AMD’s AIB policies. (4) The contextual relevance is moderate: the answer addresses AMD’s relationship with AIBs and the role of discrete graphics in differentiation, aligning with the question’s intent, but fails to accurately trace the year-by-year evolution of inventory protection policies, which is central to the query. Thus, while semantically related, it lacks fidelity to the documented strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 481,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "From 2022 to 2024 AMD’s exposure to IP‑related risks grew as its international footprint expanded and it deepened reliance on third‑party manufacturers in politically sensitive regions.  The 2022 filing warned that “political instability or civil unrest” and “regulatory approvals” could impair operations, while the 2023 and 2024 sections highlighted that ongoing geopolitical tensions—particularly between China and Taiwan—could disrupt the wafer foundries that produce AMD’s chips, and that sanctions or export‑control restrictions could limit technology licensing and sales.  At the same time, AMD’s acquisitions (e.g., Silo AI, ZT Systems) and its strategy of investing in overseas fabs increase the likelihood that IP disputes, export‑license delays, or regional conflicts could materially affect its business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolving nature of AMD's IP protection risks from 2022 to 2024, particularly in relation to international operations and third-party manufacturing in geopolitically sensitive regions. It accurately reflects increasing concern over geopolitical tensions, especially between China and Taiwan, and mentions disruptions to wafer foundries and export controls. However, it omits the specific quantitative data point from the original answer that international sales accounted for 66% of net revenue in 2024 (up from 65% in 2023), which is a key factual element in demonstrating the growing international dependence. While the LLM mentions expanding international footprint, it lacks this precise metric, reducing completeness and quantitative accuracy. (2) No incorrect numbers are presented, but the absence of the 66% and 65% revenue figures—central to the original answer’s argument about increasing exposure—means the quantitative accuracy is not full. The years (2022–2024) are correctly used, and the geopolitical events referenced (China-Taiwan tensions) align with the ground truth. (3) The multi-hop reasoning is generally sound: the model connects AMD’s reliance on third-party manufacturing, geopolitical risks, and potential IP impacts. However, it introduces 'acquisitions (e.g., Silo AI, ZT Systems)' and 'investing in overseas fabs' as strategic moves increasing IP risk—details not present in the original answer and not supported by the provided ground truth. This adds speculative elements that may not be justified by the source data, slightly undermining qualitative accuracy. (4) The answer remains contextually relevant and captures the core trend of increasing complexity in IP risk due to geopolitical and operational factors. Despite missing key percentages and adding unsupported details, the overall trajectory and reasoning are aligned with the original, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 532,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "From 2022 through 2024, BK introduced new incentive agreements under its 2019 Long-Term Incentive Plan each year: a 2022 Performance Share Unit and Restricted Stock Unit agreement, followed by a 2023 Performance Share Unit and Restricted Stock Unit agreement, and culminating in a 2024 Restricted Stock Unit agreement (and an amended Executive Severance Plan). This progression reflects a strategy of annually refreshing and expanding equity-based compensation components—particularly performance shares and RSUs—to align executive pay with ongoing performance metrics and to incorporate newer equity forms, indicating a deliberate, incremental refinement of the company’s executive compensation framework rather than a wholesale shift.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims BK introduced a '2022 Performance Share Unit and Restricted Stock Unit agreement' in 2022, a '2023' version in 2023, and a '2024 Restricted Stock Unit agreement' in 2024 — none of which align with the ground truth. The original answer states that in 2022, BK referenced the 2019 plan alongside the 2021 Form of PSU Agreement; in 2023, it used the 2019 plan with the 2020 Form of PSU Agreement; and in 2024, it used the 2019 plan with the 2022 Form of PSU Agreement. The LLM incorrectly invents agreements (e.g., 2022, 2023, and 2024 forms) that are not supported by the data and misrepresents the actual sequence. (2) The dates and document forms are factually wrong — the LLM suggests annual updates with current-year agreements, while the truth shows BK used older or prior-year forms (2021, 2020, 2022 forms) in subsequent years, indicating a non-annual or staggered update pattern. (3) The multi-hop reasoning fails: the LLM does not correctly synthesize the evolution of the plan usage over time, instead fabricating a narrative of annual refreshes. The actual progression suggests continuity with periodic, not annual, updates. (4) While the LLM correctly identifies the overarching theme of using the 2019 plan and adapting it over time, and its conclusion about a 'deliberate refinement' is directionally plausible, the factual inaccuracies in entities, dates, and agreements severely undermine the answer. The mention of an 'amended Executive Severance Plan' is extraneous and not in the ground truth. Thus, despite some contextual relevance, the answer is factually and quantitatively incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 468,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s investment in diagnostics instruments leased to customers grew from $3.5 billion of leased assets (net book value $1.6 billion) at the end of 2021 to $3.9 billion of leased assets (net book value $1.8 billion) by the end of 2024, reflecting a steady expansion of its leasing program. This upward trend shows that Abbott is increasingly deploying capital into diagnostic equipment to generate recurring lease revenue and to embed its instruments in customer sites, underscoring a strategic focus on capital‑intensive growth in its diagnostics business rather than outright sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. It incorrectly states that Abbott had $3.5 billion in leased assets (original cost) and $1.6 billion net book value at the end of 2021, which is outside the requested 2022–2024 timeframe and not supported by the ground truth. The correct original cost was $3.3 billion in 2022 (not 2021), rising to $3.6 billion in 2023 and $3.9 billion in 2024—only the 2024 original cost is correctly reported. Net book value is also wrong: the LLM claims $1.8 billion in 2024, but the ground truth is $1.6 billion in both 2023 and 2024. The 2022 net book value is misstated as $1.6 billion when it should be $1.4 billion. (2) Calculations and trends are partially aligned—the LLM correctly identifies an upward trend in original cost, but misrepresents the net book value trend (which plateaued at $1.6B in 2023–2024, not rising to $1.8B). (3) The reasoning about Abbott’s capital deployment strategy—leasing instruments to drive recurring revenue and embed products—is semantically similar to the ground truth’s explanation about driving reagent and consumables sales through performance obligations. This reflects sound qualitative logic and contextual understanding. However, the multi-hop synthesis is flawed due to reliance on incorrect data points and an out-of-scope year (2021). (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of investment and strategic implications—and provides a plausible interpretation. However, the correctness score is low due to major quantitative errors that undermine factual reliability. Quantitative accuracy is scored low due to multiple incorrect figures; qualitative accuracy is moderate due to correct strategic interpretation despite data flaws; contextual relevance is high as the response remains focused and conceptually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 517,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Lumentum Holdings is identified in NVIDIA’s 2022‑2024 10‑K filings as a key competitor in the networking and interconnect space, alongside AMD, Intel, Broadcom, Cisco, and others. Across fiscal years 2022, 2023 and 2024, NVIDIA repeatedly emphasizes that competition in these markets is intensifying, noting that rivals such as Lumentum possess larger manufacturing resources, broader IP portfolios and greater financial and distribution capabilities, which could erode NVIDIA’s market share and pricing power. The company also underscores that its own growth in AI‑driven networking and interconnect technologies depends on maintaining a competitive edge against these established suppliers and new entrants.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. While it correctly identifies Lumentum Holdings as a competitor in the networking and interconnect space across fiscal years 2022–2024, it misrepresents the nature of Lumentum’s evolving positioning. The original answer highlights a progressive repositioning and increasing specificity in how Lumentum is categorized—from a general supplier in 2022, to a specialized high-performance interconnect player in 2023, to a specifically named entity in 2024—reflecting its rising competitive relevance. The LLM answer fails to capture this evolution and instead asserts that Lumentum has larger manufacturing resources, broader IP, and greater financial capabilities than NVIDIA, which is not supported by the ground truth and inverts the likely competitive dynamic. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the LLM does not fabricate numbers, so this dimension is neutral. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the nuanced shift in Lumentum’s categorization across the three fiscal years, which is central to the question. Instead, it provides a static, generalized view of competition without showing evolution. (4) Contextual relevance is moderate—the answer addresses NVIDIA’s AI-driven networking focus and names Lumentum as a competitor, but misses the core of the question: the *evolution* of competitive positioning. Thus, while relevant, it lacks the required depth and accuracy in qualitative synthesis, warranting a correctness score of 4 due to significant omissions and mischaracterizations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 460,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "Emerson has progressively shifted its pipe‑cutters positioning from the Safety & Productivity segment toward the Tools & Home Products business, reflecting a strategic focus on expanding its professional‑tool portfolio while maintaining a strong presence in pipe‑working solutions. This reallocation underscores an intentional move to leverage its tool offerings as a growth driver within the broader professional‑tools market, reinforcing its competitive edge in both industrial and consumer segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. According to the ground truth, pipe cutters were moved from the Tools & Home Products segment in 2022 to the Safety & Productivity segment in 2023 and 2024. The LLM incorrectly states the opposite — that pipe cutters were shifted from Safety & Productivity to Tools & Home Products — which is a complete reversal of the actual repositioning. This fundamental error invalidates the entire reasoning and conclusion. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable; however, the LLM does not introduce any false numbers, so this dimension is neutral. (3) The multi-hop reasoning is flawed: the original answer requires synthesizing information across years and segments, noting the strategic shift aligned with the InSinkErator divestiture and the consolidation of professional tools under Safety & Productivity. The LLM fails this synthesis entirely, misrepresenting the direction of the shift and thus drawing an incorrect strategic interpretation. (4) Despite using relevant terminology (e.g., 'professional tools', 'industrial'), the LLM's answer is contextually misaligned because it describes a strategy contrary to the actual one. The conclusion about 'expanding in consumer segments' contradicts the ground truth of divesting consumer-focused products. Therefore, while the response is structured and uses plausible language, it is substantively and directionally wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 431,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 through 2024, Schwab’s interactive tools for RIAs evolved from a basic, website‑based platform with limited portfolio‑management features into a more integrated, advisor‑focused suite. The 2022 filings note the launch of Schwab Advisor Portfolio Connect and the expansion of website‑based account‑servicing and third‑party integrations. By 2023, the Advisor Services segment highlighted enhancements such as thinkpipes trading, iRebal portfolio rebalancing, and deeper integrations with RIA workflows, while still emphasizing the free‑of‑charge Portfolio Connect tool. In 2024, Schwab continued to broaden functionality—adding more granular portfolio‑management controls, expanding free tools for advisors, and tightening integration with its broader platform (e.g., linking Portfolio Connect to the Advisor Services website and other third‑party CRM/portfolio‑management systems). Across the three years, the evolution has been marked by increasing functionality (more granular portfolio controls and free advisory tools), tighter integration with Schwab’s custodial and banking services, and stronger support offerings for advisors, including expanded consulting, benchmarking, and educational events.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of timeline (2022–2024), core tools (Schwab Advisor Portfolio Connect, Advisor Services website), and direction of evolution (increased functionality, integration, and support). It accurately notes the free availability of Portfolio Connect and the expansion of third-party integrations. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either answer, so no discrepancies exist—this earns a 10. However, the LLM introduces specific tool names—'thinkpipes' trading and 'iRebal'—that are not mentioned in the ground truth and cannot be verified from the provided knowledge graph; these may be real tools but their inclusion represents unverified detail not supported by the source, reducing qualitative accuracy. Additionally, while the ground truth emphasizes a strategic shift toward compliance integration (e.g., multi-year document archiving, outbound data feeds for compliance systems) and a broader ecosystem enabling both investment and compliance workflows, the LLM answer omits compliance-related functionality entirely, focusing instead on portfolio controls and CRM integrations. This is a significant omission in the multi-hop synthesis, as the evolution into compliance support is a key differentiator in 2024. The LLM does capture enhanced advisor support (consulting, benchmarking, education), aligning with the ground truth’s mention of expanded consulting and educational services. Wording differs but semantic intent is similar in parts, though the lack of compliance dimension limits full equivalence. Contextual relevance remains high as the answer directly addresses functionality, integration, and support across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1632,
        "completion_tokens": 468,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle's treatment of its 1.650% Notes due 2026 remained consistently unchanged from their initial issuance in March 2021 through the 2024 10-K filing, as evidenced by the unchanged exhibit description in the 2022 10-K (page 12), 2023 10-K (page 84), and 2024 10-K (page 111) filings, which all reference \"Forms of 1.650% Notes due 2026... together with Officers' Certificate issued March 24, 2021.\" This consistency reveals Oracle's short-to-intermediate term debt financing strategy prioritizes stability and predictable capital structure management, avoiding refinancing or material modifications to these notes despite evolving market conditions, suggesting a deliberate focus on maintaining low-cost, long-dated debt instruments within its broader capital allocation framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a critical factual error regarding the issuance date. The ground truth states the notes were first introduced in the 2022 10-K, while the LLM claims issuance in March 2021, which contradicts the original answer. This affects quantitative accuracy. However, the core observation of consistent treatment across 2022–2024 filings is correct and aligns with the ground truth. (2) The exhibit references and page numbers (e.g., 2022 10-K page 12, 2023 page 84, 2024 page 111) are not present in the ground truth and cannot be verified; more importantly, the issuance date of March 24, 2021, is inconsistent with the original answer stating the note first appeared in the 2022 10-K, implying a 2022 issuance. This is a significant quantitative inaccuracy. (3) The multi-hop reasoning is sound—LLM correctly infers that unchanged disclosure across years indicates a stable debt strategy, synthesizing information across three annual reports. The logic connecting consistent exhibit references to strategic stability is valid and insightful. (4) Despite the incorrect issuance date, the answer captures the essential conclusion about Oracle’s stable financing strategy, making it contextually relevant and qualitatively strong. The error is factual but does not completely undermine the reasoning chain. Hence, correctness is reduced to 7 due to the incorrect date, but not lower because the central claim of consistency and strategic implication remains supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 421,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson's Electrical Distribution Equipment within the Discrete Automation segment has evolved from a standalone offering in 2022 to a more integrated component of its broader automation portfolio by 2024, reflecting a strategic shift toward holistic industrial electrification solutions. This evolution is evident in the segment's financial performance, where earnings before interest and taxes for Discrete Automation declined from $542 million in 2022 to $466 million in 2024, while sales remained relatively stable, indicating a focus on higher-margin, integrated systems rather than pure equipment sales. The company's strategic emphasis on industrial electrification is further demonstrated by its acquisition of AspenTech (now part of Software and Control) and its exploration of strategic alternatives for the Safety & Productivity segment, underscoring a deliberate pivot toward software-driven, sustainable industrial solutions that align with global electrification trends.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention any financial figures such as EBIT of $542M in 2022 or $466M in 2024, nor does it reference Discrete Automation's sales or profitability trends. These numbers are fabricated or hallucinated and are not supported by the original answer. Additionally, while the strategic shift toward industrial electrification is correctly identified, the supporting evidence is incorrect. (2) The quantitative inaccuracies are severe: no financial data appears in the ground truth, so all cited figures (e.g., $542M, $466M) are false. There is no mention of earnings or sales trends in the original, making these claims entirely unsupported. (3) The multi-hop reasoning is partially sound in that the LLM correctly infers a strategic shift toward integration and electrification. It correctly identifies the repositioning of Electrical Distribution Equipment as part of a broader automation and electrification strategy. However, it incorrectly attributes this evolution to financial performance and cites irrelevant acquisitions (AspenTech) and segment reviews (Safety & Productivity) not mentioned in the original answer. The AspenTech acquisition and Safety & Productivity strategic review, while real events, are not part of the evidence used in the ground truth to support the claim about Electrical Distribution Equipment’s positioning. (4) The correctness score is 4 because the core idea of strategic repositioning toward industrial electrification is present and aligns semantically with the original, but the use of false quantitative data and extraneous, unsupported strategic examples severely undermines accuracy. Quantitative accuracy is low (2) due to complete invention of financials. Qualitative accuracy is moderate (5) because the conceptual evolution is partially correct but supported by wrong reasoning. Contextual relevance is 7 because the answer addresses the right topic and strategic theme, even if with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 558,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott's unfunded commitments to private real estate funds declined modestly from $555 million at the end of 2023 to $540 million at the end of 2024, reflecting a continued reduction in its exposure to illiquid alternative‑asset investments. This downward trend indicates that the company is actively managing its pension‑fund strategy by scaling back private‑fund commitments and likely reallocating capital toward more liquid or lower‑risk assets within its overall pension portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the unfunded commitments for 2023 ($555 million) and 2024 ($540 million), which matches the ground truth. However, it omits the 2022 figure of $585 million, which is a key part of the three-year trend requested in the question. This omission reduces completeness and weakens the multi-year analysis. (2) The numbers provided are quantitatively accurate—$555 million in 2023 and $540 million in 2024 are correct—and the implied $15 million decrease is accurate. But the failure to include the 2022 baseline ($585 million) means the full evolution from 2022 to 2024 is not captured, affecting the quantitative narrative. (3) The reasoning about de-risking and shifting toward more liquid assets is consistent with the ground truth and reflects sound qualitative interpretation. However, the LLM misses the nuance that Abbott maintained a long time horizon for liquidation through 2034, indicating continued long-term belief in these assets despite reduced exposure. This weakens the depth of the strategic interpretation. (4) The answer is contextually relevant and well-articulated, addressing the core trend and strategic implication, but lacks full multi-hop synthesis across all three years and misses a key strategic nuance about long-term asset value. Hence, correctness is reduced to 7 due to incomplete data coverage and slightly less nuanced reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 390,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle’s treatment of its 1.650% Notes due 2026 remains consistent across its 2022, 2023, and 2024 filings, with the same terms disclosed in 8‑K exhibits (4.14) filed on March 24 2021 and subsequently referenced in the 2022, 2023, and 2024 Form 10‑Ks. This continuity underscores a deliberate short‑term debt strategy that relies on issuing long‑dated, low‑coupon notes (e.g., 1.650% due 2026) to manage liquidity while maintaining a stable, low‑cost borrowing profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.650% Notes due 2026 were first disclosed in the 2022 10-K, referencing the March 24, 2021 8-K filing (Exhibit 4.14), and this same reference was consistently maintained in the 2023 and 2024 10-Ks—this is accurately reflected. (2) Quantitative elements—interest rate (1.650%), maturity year (2026), and exact date of the original 8-K (March 24, 2021)—are all correct. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged referencing across three annual reports indicates stability in Oracle’s short-term debt strategy. (4) The LLM slightly simplifies the strategic implication by focusing on 'long-dated, low-coupon notes' as part of a liquidity strategy, which is valid, but omits the explicit contrast with Oracle introducing *new* debt instruments in later years—a nuance present in the original answer that strengthens the argument for a deliberate, stable core strategy amid broader activity. This minor omission prevents a perfect 10 on qualitative accuracy, but the core reasoning and factual content remain strong. Semantic equivalence is achieved, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 347,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle issued the 4.30% Note due 2034 in July 2014 (as disclosed in the 2014 8‑K filing), and the same tranche appears in its 2022, 2023 and 2024 Form 10‑K filings as part of the ongoing “Note” series that it periodically updates and re‑issues to manage its long‑term capital structure. The multi‑year inclusion of this note across successive 10‑K reports indicates that Oracle is deliberately maintaining a stable, long‑dated debt instrument—locking in a 4.30% rate for the next decade—while it continues to issue new notes with varying maturities and coupons to diversify funding sources and adjust its overall debt profile. This pattern suggests a strategy of using a mix of fixed‑rate, staggered maturities to balance financing flexibility, cost management, and the need to keep leverage below targeted thresholds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that the 4.30% Note due 2034 was referenced in Exhibits 4.11 (2022) and 4.09 (2023, 2024), but the LLM incorrectly claims the note was issued in July 2014, which contradicts the ground truth and is not supported by the provided data. There is no mention of a 2014 issuance in the original answer, nor any reference to an 8-K filing. This is a major factual error. (2) Quantitative accuracy is low: while the interest rate (4.30%) and maturity year (2034) are correct, the issuance date (2014) is fabricated. The original answer does not specify an issuance date, only the multi-year documentation pattern from 2022–2024. The LLM invents historical details not present in the ground truth, failing basic quantitative and temporal accuracy. (3) Reasoning is partially sound: the LLM correctly infers from the multi-year documentation pattern that Oracle is maintaining a stable long-term debt instrument and using staggered maturities as part of a broader strategy. This aligns with the original answer’s conclusion about a diversified maturity profile and stable capital structure. However, because the reasoning is based on a false premise (the 2014 issuance), the multi-hop logic is compromised. (4) Contextual relevance is high—the response addresses the evolution across years and interprets the filing pattern in terms of long-term debt strategy, which matches the question’s intent. Despite incorrect facts, the conceptual framework around debt strategy is reasonable. Overall, the answer is partially correct in interpretation but fails on core factual accuracy, especially regarding the issuance history, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 475,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "Schwab’s utilization of the IDA agreement to migrate balances to its balance sheet declined from $10 billion of IDA balances moved in 2021‑2022 under the 2019 agreement to no migrations in 2023‑2024 under the 2023 IDA agreement, which now limits migrations to withdrawals by customers and imposes strict minimum‑balance requirements ($60‑$90 billion) and caps on fixed‑rate obligations. Consequently, the amount of IDA balances on Schwab’s balance sheet fell from $122.6 billion at year‑end 2022 (with $108.5 billion fixed‑rate) to $97.5 billion at year‑end 2023 (with $83.7 billion fixed‑rate) and further to $87.6 billion at year‑end 2024 (with $66.6 billion fixed‑rate), reflecting reduced migration flexibility and tighter contractual constraints.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Schwab moved $10.1 billion of IDA balances by December 31, 2021, including $10 billion 'subsequent to that date' (which is logically impossible). However, the LLM interprets this as $10 billion moved in 2021–2022, which is a misreading. More critically, the LLM claims Schwab migrated $10 billion in 2021–2022, but the ground truth indicates the $10.1 billion was already moved by end-2021, meaning no new migration occurred in 2022 under the 2019 agreement. The LLM incorrectly implies active migration in 2022, contradicting the ground truth. (2) The LLM introduces specific balance sheet figures not in the original answer: $122.6B (2022), $97.5B (2023), $87.6B (2024), and fixed-rate breakdowns. These numbers are unsupported by the ground truth and appear fabricated. The original answer does not provide year-end IDA balance totals or fixed-rate amounts. The LLM also invents 'strict minimum-balance requirements ($60–$90 billion)' and 'caps on fixed-rate obligations', which are not mentioned in the original. The 2023 agreement removed the 80% fixed-rate requirement, increasing flexibility, but the LLM incorrectly frames this as a constraint. (3) Multi-hop reasoning is flawed. The original shows a shift from active migration pre-2022 to no migration in 2023–2024 despite increased contractual flexibility. The LLM reverses this logic, claiming reduced flexibility and tighter constraints, which contradicts the ground truth. It fails to recognize that the elimination of the 80% fixed-rate requirement was a relaxation, not a tightening. (4) The contextual relevance is moderate because the answer addresses IDA migration trends and contractual changes, but the factual and logical errors severely undermine correctness. Quantitative accuracy is very low due to fabricated numbers and misattributed migration timing. Qualitative accuracy is poor due to incorrect reasoning about contractual flexibility. Correctness score is low because the core narrative (declining migration due to tighter constraints) is factually and logically inverted from the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 582,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolved through refinancing activities documented in SEC filings across 2022–2024. The notes were initially issued under a Fifth Supplemental Indenture dated September 23, 2015 (St. Jude Medical acquisition), with subsequent amendments including a Second Supplemental Indenture dated November 19, 2019, which updated terms and added new tranches (e.g., 0.100% Notes due 2024). By 2024, the notes were part of broader debt restructuring, as evidenced by Abbott’s 2024 10-K filing (page 86) referencing the 2.000% Notes in the context of indenture filings and supplemental indentures, though no major refinancing event occurred during this period. The company maintained the notes as part of its long-term debt strategy, with refinancing activity focused on newer instruments like the 1.150% Notes due 2028 and 1.400% Notes due 2030 (page 87), but the 2.000% Notes remained outstanding without documented repayment or restructuring in the provided materials.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) The 2.000% Senior Notes due 2018 were already matured by 2018, so their continued 'outstanding' status in 2022–2024 is incorrect; the ground truth indicates they were referenced only for documentation continuity, not active debt. (2) The LLM incorrectly claims a 'Second Supplemental Indenture dated November 19, 2019' amended these notes and added new tranches like the 0.100% Notes due 2024—this is not supported by the ground truth, which makes no mention of such an amendment or its details. (3) The reference to Abbott’s 2024 10-K page 86 and 87 is specific but unverified and misleading; the ground truth confirms the notes were included in Exhibit 4.21 but with no new amendments or refinancing, contrary to the implication of ongoing restructuring. (4) The mention of refinancing activity on newer notes (1.150% due 2028, 1.400% due 2030) is plausible but not part of the original answer and distracts from the core issue: the legacy status of the 2018 notes. (5) The ground truth emphasizes that the notes were part of legacy St. Jude Medical debt and only maintained in disclosures for consistency, not active management or refinancing. The LLM overstates ongoing engagement and implies continued relevance, which is factually incorrect. Quantitative accuracy is partially preserved (correct original indenture date: September 23, 2015), but the addition of a false 2019 amendment date and incorrect note tranches reduces that score. Qualitative accuracy suffers due to flawed multi-hop reasoning—failing to recognize that referencing a matured note in disclosures does not imply active refinancing. Contextual relevance is moderate as the answer addresses documentation and refinancing themes but misrepresents the nature of the engagement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 499,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle issued its first multi‑year tranche of 3.650% senior notes due 2041 in March 2021 (4.14 Exhibit) and subsequently re‑issued the same series in November 2022 (4.15 Exhibit) and February 2023 (4.16 Exhibit), maintaining the identical 3.650% coupon across all three filings. This three‑year, multi‑tranche pattern demonstrates a deliberate, long‑term debt strategy of locking in low‑cost, fixed‑rate financing for an extended horizon (2041) while periodically refreshing the issuance to manage market conditions and funding needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates and issuance details. The original answer states Oracle first introduced the 3.650% Notes due 2041 in 2022, but the LLM claims an initial issuance in March 2021 and re-issuances in November 2022 and February 2023. These specific dates and the claim of multiple tranches are not supported by the ground truth, which only confirms the note's presence in filings from 2022–2024 without specifying re-issuances. The 2021 date is incorrect and contradicts the ground truth. (2) The coupon rate of 3.650% is correctly stated, but the LLM fabricates exhibit numbers (4.14, 4.15, 4.16) and specific issuance months not present in the original answer. There is no mention in the ground truth of re-issuance or multiple tranches—only continued reference and reaffirmation. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a long-term debt strategy from repeated appearances of the note, and the interpretation of locking in fixed-rate financing aligns with the original conclusion. However, the reasoning is based on incorrect premises about multiple issuances. (4) Despite the factual errors in timing and issuance activity, the LLM captures the strategic intent behind Oracle's debt management—using long-term fixed-rate debt for financial flexibility—making the answer contextually relevant and qualitatively reasonable, though not factually accurate in key details. Hence, correctness is penalized heavily due to incorrect dates and events, but qualitative and contextual scores remain moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 437,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle’s multi‑year issuance of 2.300% senior notes due 2028 reflects a deliberate, staged debt‑financing strategy that aligns with its broader capital‑structure management. The company first set the terms in a March 2021 8‑K filing (4.14), reaffirmed and updated the offering in a February 2023 filing (4.16), and subsequently referenced the same tranche in its 2024 10‑K (page 111) as part of its ongoing long‑term borrowing program. Across fiscal 2022, 2023 and 2024 the company issued new senior notes at varying rates and maturities—including the 2.300% 2028 notes—while also retiring or refinancing earlier debt, indicating a strategy of extending maturity, diversifying funding sources, and locking in low‑cost financing as market conditions permitted. This pattern demonstrates Oracle’s focus on maintaining a strong balance sheet, optimizing its leverage ratio, and capitalizing on favorable interest‑rate environments to fund operations and acquisitions without significantly increasing overall debt service costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic intent—Oracle's use of the 2.300% Notes due 2028 as part of a long-term, diversified debt financing strategy—and correctly identifies the multi-year continuity and refinancing context. However, there are factual inaccuracies in dates and exhibit numbers. The original answer states the Officers' Certificate was issued on March 24, 2021, and referenced in Exhibit 4.16, while the LLM claims a March 2021 8-K filing (Exhibit 4.14) and a February 2023 update (Exhibit 4.16), which conflicts with the ground truth that the 2.300% Notes were established under the 2021 certificate and consistently referenced thereafter. The LLM incorrectly implies the terms were updated in 2023, when in fact the structure remained unchanged. (2) The percentage (2.300%) and maturity year (2028) are correct, but the issuance timeline is misrepresented: no new 2.300% Notes were issued in 2023; instead, Oracle issued *different* notes (4.500% Notes due 2028) that year. The LLM conflates these distinct instruments. (3) The multi-hop reasoning is partially sound—Oracle did maintain a diversified debt portfolio and manage maturities—but the synthesis incorrectly merges separate debt issuances. The LLM infers a 'staged' issuance of the same 2.300% Notes, whereas the ground truth shows only structural consistency, not repeated issuance. (4) Despite these errors, the answer correctly infers Oracle’s strategic goals (locking in low rates, diversifying funding, managing leverage), which aligns semantically with the original. The contextual relevance is high, and qualitative reasoning is strong, but quantitative inaccuracies in dates, exhibits, and instrument specificity reduce factual correctness. Hence, a 7/10 overall: core insight valid, but key details incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 492,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "From 2022 through 2024 Visa has progressively expanded the Currencycloud‑powered virtual‑account offering on its Visa Direct platform, integrating it into the broader Visa Direct ecosystem and adding cross‑border functionality.  In 2022 the acquisition of Currencycloud introduced a cloud‑native FX and virtual‑account solution that began to be bundled with Visa Direct’s payout capabilities.  By 2023 the platform was being used to settle cross‑border transactions for Visa Direct partners, and in 2024 Visa announced that Visa + (the interoperable P2P transfer layer) would leverage Currencycloud’s virtual‑account infrastructure to enable real‑time, cross‑border transfers between participating wallets such as PayPal and Venmo, further extending the cross‑border reach of Visa Direct.  Overall, the virtual accounts evolved from a nascent FX‑focused capability in 2022 to a core component of Visa Direct’s cross‑border, real‑time payment flows by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's virtual accounts from 2022 to 2024 and correctly identifies key developments such as integration with Visa Direct and expansion of cross-border capabilities. However, there are significant factual inaccuracies that affect correctness. First, the claim that 'the acquisition of Currencycloud' occurred in 2022 is incorrect—Visa acquired Currencycloud in 2021, not 2022, which misrepresents the timeline. Second, the mention of 'Visa+' and its integration with PayPal and Venmo in 2024 is not supported by the ground truth and appears to be fabricated or conflated with other initiatives; the original answer makes no mention of Visa+ or specific wallet integrations. While the LLM correctly notes the progression of virtual accounts becoming a core part of Visa Direct with enhanced cross-border and real-time capabilities, these hallucinated details undermine the qualitative accuracy. Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so the score is based on correct use of years and sequence—2022, 2023, and 2024 developments are generally aligned in intent, though misrepresented in detail. Contextually, the response is highly relevant, addressing integration, cross-border expansion, and platform evolution. The reasoning shows an attempt at multi-hop synthesis (Currencycloud → virtual accounts → Visa Direct → cross-border flows), but the inclusion of unsupported elements like Visa+ weakens the logical chain. Thus, while the overall direction is correct, the answer contains key factual errors that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 445,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2024, Caterpillar expanded its EMD-branded product distribution network by adding new dealer locations and increasing the number of distributors in key international markets, as reflected in the updated dealer counts (44 U.S. and 116 non-U.S. dealers in 2024 versus 41 U.S. and 111 non-U.S. dealers in 2022) and the broader geographic reach described in the Machinery, Energy & Transportation (ME&T) segment disclosures. This progression indicates a strategic focus on deepening market penetration and expanding the global footprint of EMD products to capture growth in emerging regions and strengthen competitive positioning worldwide.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims Caterpillar expanded its EMD distribution network by increasing the number of distributors from 111 non-U.S. in 2022 to 116 in 2024, and U.S. dealers from 41 to 44, but this data does not align with the ground truth. The original answer states there were 110 distributors in 2022 and 2023 covering 109 countries, then 108 distributors in 2024 covering 158 countries. The LLM introduces '44 U.S. and 116 non-U.S. dealers' which is factually incorrect and not supported by the ground truth. There is no mention of U.S. vs non-U.S. dealer splits in the original data. (2) The numbers cited in the LLM answer (41, 44, 111, 116) are entirely fabricated and do not appear in the ground truth. The actual trend shows a slight decrease in distributor count (110 to 108) while geographic reach expanded significantly (109 to 158 countries), indicating a shift toward more efficient, broader-coverage distribution. The LLM incorrectly frames this as a straightforward expansion in both distributor count and reach. (3) The multi-hop reasoning is flawed. The LLM fails to recognize that the key insight is not growth in distributor numbers but optimization—fewer distributors serving more countries. This reflects a strategic shift toward efficiency and broader international access, not simply adding dealers. The model misses this nuance entirely and instead invents a narrative of linear growth. (4) While the general direction—global expansion of EMD products—is contextually relevant, the factual inaccuracies and incorrect reasoning severely undermine the answer. The contextual relevance is moderate because it addresses market expansion strategy, but the conclusion is based on false premises. Correctness is very low due to complete misrepresentation of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 504,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s diagnostics instruments leased to customers are tracked on the balance sheet under “Net property and equipment.” The original cost of these leased instruments was $3.9 billion as of December 31 2024 and $3.6 billion as of December 31 2023, while their net book value declined from $1.8 billion in 2023 to $1.6 billion in 2024. This reduction reflects the ongoing depreciation of the leased assets as they are used by customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of changes in net book value. According to the ground truth, the net book value of Abbott's leased diagnostics instruments increased from $1.4B (2022) to $1.6B (2023) to $1.8B (2024). However, the LLM claims it declined from $1.8B in 2023 to $1.6B in 2024, which is factually incorrect. While the original cost figures for 2023 ($3.6B) and 2024 ($3.9B) are correct, the answer omits the 2022 original cost ($3.3B), breaking the full trend analysis requested. (2) Quantitative accuracy is partially correct for original cost but fully incorrect for net book value trend. The claim of a decline in net book value contradicts the ground truth of consistent growth. No mention of 2022 data prevents full multi-year comparison. (3) The reasoning is flawed: the conclusion that depreciation caused a reduction in net book value ignores that depreciation is normal, but investment growth should still reflect increasing net book values if new investments exceed depreciation — which they did. The model fails to recognize that rising original cost and rising net book value together indicate net investment growth, not reduction. (4) Contextual relevance is moderate because the answer addresses the right topic and metric, but the incorrect trend and missing data severely undermine usefulness. The mischaracterization of net book value movement leads to an incorrect conclusion about investment evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 413,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across PepsiCo’s 2022, 2023, and 2024 10‑K filings underscores that this long‑dated debt instrument remains a core component of the company’s capital‑structure strategy, providing a stable, low‑cost source of financing that supports its long‑term funding needs and risk management objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core assertion: the consistent disclosure of the 3.450% Senior Note due 2046 across PepsiCo's 2022, 2023, and 2024 10-K filings indicates its ongoing role as a stable, long-term financing instrument in the company's capital structure. The percentage (3.450%), maturity year (2046), and the companies and years involved are all accurate, satisfying quantitative accuracy. The answer correctly identifies the note as a 'core component' of the capital structure and emphasizes its role in long-term funding and risk management, which aligns semantically with the ground truth. However, the LLM omits specific details about the note’s placement in the filings (Exhibit 4.17 in 2022, 4.16 in 2023, 4.15 in 2024) and does not mention the absence of modifications or removal, which supports the inference of strategic continuity. While the high-level reasoning is sound and contextually relevant, the lack of these specific multi-hop details from the filings slightly weakens the qualitative depth and precision of the synthesis. Thus, the answer is substantially correct but lacks minor but notable contextual specifics present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 332,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle issued its first 2.300% Notes due 2028 in March 2021 (8‑K filing 4.14), followed by a second tranche in February 2023 (8‑K filing 4.16) that again referenced the same 2.300% series. The 2022 filing (page 84) shows the company’s ongoing practice of rolling out new senior unsecured notes with staggered maturities, using the 2.300% 2028 notes as part of a broader multi‑year strategy to diversify funding sources and manage interest‑rate exposure. This pattern indicates that Oracle is systematically expanding its long‑term debt profile, leveraging low‑coupon notes to supplement cash flow while maintaining flexibility for future capital‑raising.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Oracle issued the 2.300% Notes due 2028 in March 2021 (8-K filing 4.14), but the ground truth states the first mention was in 2022 in Exhibit 4.16. The second issuance in February 2023 is not supported by the original answer, which only notes continued reference to the notes in 2023 and 2024, not a new tranche. The 2022 filing page 84 is cited without corroboration in the ground truth. (2) Quantitative accuracy is poor: the dates (2021, 2023) are incorrect, and there is no mention in the ground truth of an 8-K filing or specific page numbers. The original answer does not mention tranches or multiple issuances of the same note series, undermining the numerical and temporal claims. (3) Multi-hop reasoning is partially sound in that the LLM attempts to infer Oracle's broader debt strategy, but it does so based on incorrect issuance events. The conclusion about 'systematically expanding its long-term debt profile' and 'low-coupon notes' is speculative and not directly supported by the ground truth, which emphasizes continuity in disclosure and layering of new notes with higher yields. (4) Contextual relevance is moderate—the answer addresses Oracle's debt strategy and the role of the 2.300% Notes, but the factual foundation is flawed, leading to an incorrect synthesis. The mention of 'staggered maturities' and 'diversify funding sources' aligns loosely with the ground truth's 'layering in new issuances,' but the reasoning is undermined by incorrect inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 428,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has consistently maintained its Series B Convertible Participating Preferred Stock in its capital structure since the 2016 filing of its Certificate of Designations (Exhibit 4.4 in the 2022 10‑K), with no material changes or retirements disclosed in the 2022, 2023 or 2024 filings. The continued presence of the Series B preferred shares—still convertible under the Europe‑retrospective responsibility plan and subject to the same transfer restrictions—indicates that Visa’s long‑term capital‑structure strategy prioritizes preserving this equity layer as a strategic financing tool and a safeguard for the Europe acquisition liabilities, rather than retiring or converting it.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately states that Visa has maintained its Series B Convertible Participating Preferred Stock without changes from 2022 through 2024, referencing the original 2016 Certificate of Designations—this matches the ground truth. The date June 21, 2016, is not explicitly mentioned in the LLM answer, but the reference to the 2016 filing and Exhibit 4.4 in the 2022 10-K is factually consistent. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; the LLM correctly avoids inventing any. (3) The multi-hop reasoning is sound: the LLM synthesizes information across the 2022–2024 filings and correctly infers continuity in capital structure strategy. However, it introduces a specific claim not present in the ground truth—that the shares are 'convertible under the Europe-retrospective responsibility plan' and serve as a 'safeguard for the Europe acquisition liabilities.' This adds detail beyond the original answer and is not corroborated in the ground truth, introducing a minor factual overreach. (4) Despite this, the core conclusion—that Visa prioritizes stability and continuity in its capital structure—is semantically equivalent and well-supported. The contextual relevance is high, as the answer directly addresses both parts of the question: evolution (or lack thereof) and strategic implications. The slight deduction in qualitative accuracy reflects the unsupported specificity around the 'Europe-retrospective responsibility plan,' which may misattribute purpose without explicit confirmation in the filings. Overall, the answer is factually strong but includes one unverified interpretive element.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 489,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "Caterpillar’s approach to currency hedging evolved over the three‑year period as it responded to the LIBOR‑to‑SOFR transition and the associated market risks. In the 2022 filing (pages 21‑23) the company highlighted that certain Cat Financial loans and derivatives used LIBOR as a benchmark and noted the planned cessation of LIBOR, prompting the formation of a cross‑functional team to assess risks and implement fallback language tied to SOFR. By 2023 (pages 14, 16, 17, 19) the discussion expanded to explicitly reference the use of SOFR as the designated alternative reference rate in new floating‑rate instruments, describing how the company manages interest‑rate and market‑liquidity risk through match‑funding, selective derivatives, and a diversified funding program, while acknowledging that any hedge effectiveness could be compromised. The 2024 filing (pages 11, 12, 16, 17, 19) reinforces this evolution, stating that hedging programs now incorporate SOFR‑based instruments to mitigate currency‑exchange and interest‑rate volatility, and that the company continues to monitor the transition’s impact on its financing costs and liquidity. Overall, Caterpillar moved from a LIBOR‑centric hedging framework to a proactive SOFR‑based strategy, embedding fallback provisions and risk‑management practices to address the uncertainties of the post‑LIBOR market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: Caterpillar's use of currency hedging instruments from 2022 to 2024, the formation of a cross-functional team in 2022 to assess LIBOR transition risks, the shift toward SOFR as the alternative reference rate by 2023, and continued reliance on derivatives and hedging strategies through 2024. There are no incorrect numbers, dates, or financial figures—this is a qualitative narrative without specific numeric values, so quantitative accuracy is based on correct referencing of years and events, which is flawless. (2) The LLM correctly cites specific page numbers (e.g., 2022: pp. 21–23; 2023: pp. 14, 16, 17, 19; 2024: pp. 11, 12, 16, 17, 19), which adds precision and supports traceability, though the ground truth does not include page references—this is an enhancement, not an error. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and connects Caterpillar’s currency hedging practices with the broader LIBOR-to-SOFR transition, correctly identifying that while currency hedging remained consistent, interest rate benchmark changes influenced derivative design and risk management frameworks. It accurately distinguishes between currency and interest rate risk, noting that SOFR adoption primarily affects interest rate instruments but is integrated into broader hedging programs. (4) The only minor shortcoming is a slight overemphasis on SOFR’s role in *currency* hedging—while SOFR-based instruments are used in hedging programs, the primary impact is on interest rate risk, not currency risk. The original answer makes this distinction clearer. However, the LLM does not misstate facts, and the conflation is subtle and contextually understandable. Overall, the answer is semantically equivalent, comprehensive, and contextually appropriate, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1651,
        "completion_tokens": 529,
        "total_tokens": 2180
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "Johnson & Johnson’s talc strategy evolved sharply from 2022‑2024 as the company moved from direct litigation to a bankruptcy‑driven resolution framework. After the 2021 creation of LTL Management LLC to hold all talc‑related liabilities, the firm filed for Chapter 11 protection in late 2021 and again in 2023, establishing a $2 billion trust to settle claims while seeking a broader “pre‑packaged” plan that would pay roughly $6.5 billion over 25 years to resolve >99 % of pending talc suits. Although the bankruptcy courts repeatedly dismissed these filings, J&J continued to pursue the appeal route, restructured the debt, and in 2024 announced an amended plan that increased the settlement amount, reflecting both the persistent legal exposure and the need to protect its balance sheet while maintaining confidence in the safety of its talc products.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that undermine its correctness. While it correctly identifies Johnson & Johnson's use of LTL Management LLC and the $2 billion trust, it incorrectly states that the $6.5 billion pre-packaged plan was part of J&J’s strategy by 2024 — this figure and plan structure are not supported by the ground truth. The ground truth does not mention a $6.5 billion plan or a 25-year payout, nor does it state that J&J filed for Chapter 11 in 2021; rather, LTL Management LLC (a subsidiary) filed in 2022, not J&J directly. Additionally, the claim that J&J 'refiled' bankruptcy in 2023 (LTL 2) is partially correct but misattributed — it was LTL, not J&J, that refiled. The 2024 'amended plan' and 'increased settlement amount' are not mentioned in the ground truth, which only notes multi-state settlements and continued appellate efforts. (2) Quantitative accuracy is low: the $2 billion trust is correct, but the $6.5 billion figure, 25-year timeline, and >99% resolution claim are unsupported. Dates are also off — LTL’s first filing was in 2022, not 2021. (3) The reasoning shows partial multi-hop synthesis: the model correctly links LTL, bankruptcy, trust funding, and appellate strategy, but incorrectly infers a broader financial restructuring and settlement expansion not present in the ground truth. It conflates J&J with LTL in agency and filings. (4) Despite these errors, the answer is contextually relevant and captures the strategic shift toward bankruptcy-based liability management and ongoing appeals. The core idea — that J&J relied on LTL and trust funding while navigating legal setbacks — aligns with the ground truth, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 469,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe’s Photography Plan has evolved from a niche offering within Creative Cloud to a core pillar of its subscription strategy, positioned as a streamlined, AI‑enhanced solution for photographers and creative professionals. Over 2022‑2024 the plan was sharpened with deeper integration of Adobe Firefly generative AI (e.g., Generative Fill, Expand, Remove), expanded cloud storage and sync capabilities, and tighter bundling with Photoshop, Lightroom, and the web‑based Express platform, while maintaining a distinct, lower‑cost Photography Plan tier that competes with standalone photo tools. Strategic shifts included emphasizing cross‑app AI workflows, expanding the Photography Plan’s appeal to both hobbyists and pros through flexible pricing and bundled features, and leveraging it to drive broader Creative Cloud adoption and recurring revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Adobe's Photography Plan from 2022 to 2024, noting its shift from a niche offering to a more strategically integrated, AI-enhanced solution. The key components—Photoshop, Lightroom, and Lightroom Classic—are implied through context, and the emphasis on generative AI (e.g., Generative Fill, Remove, Expand) aligns with the ground truth’s mention of Generative Fill, Lens Blur, and People Masking. The reference to Adobe Firefly and Generative Credits is accurate for 2023–2024. The strategic shifts—AI integration, cross-app workflows, pricing tiering, and use as a gateway to Creative Cloud—are correctly identified. The only minor omission is the explicit mention of 'Generative Credits' in 2023 and the specific year-by-year progression (e.g., 2022 positioning vs. 2023 AI integration), which the original answer structures more clearly. However, the LLM conveys the same semantic trajectory. All entities (Adobe, Creative Cloud, Photoshop, Lightroom, Firefly, Express) are correct. No numerical inaccuracies—dates and features are correctly framed. The reasoning is sound, showing multi-hop synthesis across product strategy, AI integration, and market positioning. The answer is fully relevant and responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 372,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has maintained consistent documentation of its class C common‑stock certificate across the 2022‑2024 filings, repeatedly referencing the same “Form of specimen certificate for class C common stock of Visa Inc.” (first filed as Exhibit 4.2 in 2009 and re‑included unchanged in the 2022, 2023 and 2024 Form 10‑Ks). This unaltered presentation signals a deliberate, stable approach to corporate governance and investor communications, reinforcing confidence that the company’s equity structure remains predictable even as it navigates evolving regulatory scrutiny and market dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 2022, 2023, and 2024 10-K filings, citing Exhibit 4.2 originally filed on January 28, 2009. This matches the original answer exactly in substance. (2) Quantitative accuracy is perfect: the key date (2009), exhibit number (4.2), and filing type (Form 10-K for 2022–2024) are all correct. No calculations are required, but the temporal consistency is accurately represented. (3) The reasoning is sound: the LLM correctly infers that this consistency reflects a stable approach to corporate governance and investor relations, signaling predictability in equity structure despite regulatory and market changes. It captures the core implication—that Visa sees no need to update this document—though it omits a specific contrast with other updated governance documents like the 2024 Certificate of Incorporation revision, which slightly reduces completeness. (4) Contextual relevance is excellent; the response directly addresses both parts of the question: the factual consistency in documentation and its implications for governance and investor relations. The only minor gap is the absence of the contrast with other updated documents, which slightly weakens the qualitative depth but does not affect factual correctness. Overall, this is a semantically equivalent, well-reasoned answer with full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 419,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s performance and operating‑cost guarantees have declined markedly over the three‑year period: the carrying amount of these guarantees fell from $1,109 million at the end of 2022 to $1,091 million in 2023 and further to $993 million by the end of 2024. This downward trend reflects the company’s tightening risk‑management practices—accruals are adjusted based on historical experience and current product‑performance data, and settlements have consistently outpaced new issuances. Consequently, the reduced liability indicates that RTX is successfully managing its exposure to aerospace contract performance risks, limiting future cash‑outflows tied to warranty and performance guarantees.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's collaboration partners' share of financing guarantees was $140M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM claims the 'carrying amount' of performance and operating-cost guarantees was $1,109M in 2022, $1,091M in 2023, and $993M in 2024—figures that are over 8x larger and refer to a different metric. These numbers do not match the ground truth and suggest confusion with another liability category or company. (2) The calculation of a decline from $1,109M to $993M is accurate within the LLM's own numbers, but since the inputs are wrong, the conclusion is based on false premises. The ground truth shows a modest $9M total decrease over three years, not a 'marked' $116M drop as implied. (3) The multi-hop reasoning is partially sound in structure—assessing trend, linking to risk management, and referencing accrual methodology—but it applies correct logic to incorrect data. The LLM correctly identifies that adjustments are based on historical performance and that declining liabilities may reflect improved risk management, aligning with the qualitative reasoning in the original answer. However, because the numbers are wrong, the synthesis fails at the foundational level. (4) Contextual relevance is moderate: the answer addresses the right topic (liabilities for performance guarantees), time frame (2022–2024), and draws a reasonable conclusion about risk management. But due to severe quantitative inaccuracy, the overall correctness score is low. Minor note: 'RTX' is correctly identified as the company, and the years are properly framed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 463,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s accounting for free‑rent periods remained consistent across fiscal years 2022‑2024: the Company continues to recognize lease‑related rent holidays and step‑rent provisions on a straight‑line basis over the non‑cancelable lease term plus any extension options it is reasonably certain to exercise, using its incremental borrowing rate to discount lease payments. This treatment is disclosed in the lease‑accounting footnote (page 46) and is applied uniformly to both operating and finance leases, with no material change in methodology or impact on the valuation of right‑of‑use assets during the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core accounting treatment of free-rent periods at Costco from 2022 to 2024: consistent application of straight-line recognition over the lease term (including reasonably certain extension options), use of the incremental borrowing rate, and uniform application across lease types. All entities (Costco, lease terms, right-of-use assets, incremental borrowing rate) and years are accurately referenced, and there are no numerical or date inaccuracies—this earns a perfect quantitative accuracy score. The answer is contextually relevant and directly addresses the question’s focus on accounting treatment and impact on right-of-use assets. However, it omits key qualitative developments noted in the ground truth: the 2023 expansion on variable lease payments tied to indices or sales volume, and the 2024 increased emphasis on impairment evaluation related to facility relocations or closures. While the LLM states there was 'no material change in methodology,' it fails to reflect the evolving disclosure context that shows growing operational complexity in lease management. This lack of nuance in the evolution of disclosures—though the core policy was stable—results in a slightly lower qualitative accuracy and overall correctness score. The answer is factually sound but less complete in capturing the full trajectory of disclosure maturity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 382,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "From 2022 through 2024 Adobe’s strategy has centered on embedding AI into its core productivity tools, especially Acrobat, and on expanding the Acrobat brand into a broader AI‑driven document platform.  The company has increased R&D spending on AI features such as the Acrobat AI Assistant and generative‑AI capabilities (Firefly, Sensei), while formally branding these offerings under “Acrobat AI Assistant” and related AI‑focused product names.  This evolution reflects a shift from Acrobat being merely a PDF viewer/editor to an AI‑powered productivity engine, supported by targeted investments and a clear product‑branding roadmap outlined in the 2022‑2024 10‑K filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Adobe's strategic shift toward AI in document productivity from 2022 to 2024, the evolving role of Acrobat from a PDF tool to an AI-powered platform, and the formal branding of 'Acrobat AI Assistant' by 2024. The mention of R&D investments in AI features like Firefly and Sensei is consistent with Adobe’s innovation trajectory. (2) There are no numeric values (e.g., dollar amounts, percentages, document counts) in either answer, so quantitative accuracy is not compromised—no discrepancies. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across years—2022 (Acrobat’s foundational role), 2023 (AI as strategic focus), and 2024 (branded AI products)—demonstrating proper cross-year inference. (4) The only minor shortcoming is that the LLM does not explicitly reference the 'trillions of PDFs created annually' or 'document-intensive industries' from 2022, which were part of the original context, slightly reducing completeness. However, the core evolution in strategy, branding, and R&D is accurately captured. Wording differs but semantic meaning matches. Thus, high scores across all dimensions with a 9 on correctness due to slight omission of contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 362,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Charles Schwab’s use of client securities as collateral has shifted from a relatively static pattern in 2022 toward a more dynamic, balance‑sheet‑optimizing approach through 2024. In 2022 the firm disclosed modest pledges of client securities to meet clearing‑house margin requirements and to support securities‑lending collateral, with total pledged amounts around $31 billion (page 111). By 2024, Schwab began leveraging those pledged balances more aggressively to fund short‑term borrowings and repurchase‑agreement collateral, expanding the use of client‑secured assets to back both margin‑lending and collateralized financing (pages 108‑112). This trend reflects a strategic shift: the firm is increasingly using client‑held securities as a source of liquidity and balance‑sheet funding rather than merely as a passive collateral pool, while still maintaining strict oversight of leverage. Consequently, client leverage behavior has become more pronounced—margin‑loan balances now sit against a larger pool of pledged assets, and the firm’s reliance on external short‑term funding (e.g., FHLB borrowings and repurchase agreements) is partially financed through these pledged securities, indicating a tighter coupling of client collateral to Schwab’s funding and liquidity management.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that Schwab pledged 'around $31 billion' in client securities in 2022 is not supported by the ground truth, which explicitly states that 'specific pledged amounts were not quantified' in 2022. This major numerical error undermines the entire response. Additionally, the LLM invents specific page references (e.g., page 111, 108-112) not present in the original answer, suggesting fabrication. The qualitative description of a shift toward using client securities for 'short-term borrowings and repurchase-agreement collateral' and 'funding FHLB borrowings' is not mentioned in the ground truth and represents an unsupported expansion of the actual disclosures. While the LLM correctly identifies a trend of increasing formalization in the use of client securities from 2022 to 2024, and links it to margin and securities lending, the reasoning is based on incorrect data. The ground truth emphasizes regulatory compliance and expanded disclosure (especially in 2024 regarding Options Clearing Corporation and securities lending), not balance sheet funding or liquidity management as the primary driver. The conclusion about 'tighter coupling of client collateral to funding' is speculative and not supported by the original answer. Thus, while the general direction of increased usage is correct, the specific mechanisms, numbers, and strategic interpretation are largely incorrect or invented, leading to a low correctness score. Contextual relevance is moderate because the answer addresses the right topic and time frame, but with significant factual distortion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 453,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "From 2022 through 2024 Costco’s 1.375% Senior Notes due June 2027 remained classified as long‑term debt throughout.  In the 2022 filing the notes were listed among long‑term debt with a carrying amount of $1.25 billion (page 48); in 2023 they continued to appear in the long‑term‑debt schedule with the same $1.25 billion balance (page 52); and in the 2024 filing they are still presented as a long‑term‑debt instrument with a $1.25 billion carrying value, now shown as due in 2027 (page 52).  Consequently, the notes have not been re‑classified to current liabilities, and the overall composition of long‑term debt in 2024 includes the 1.375% notes together with the 3.000% 2027 notes, the 1.600% 2030 notes, the 1.750% 2032 notes and other long‑term borrowings, totaling $5.79 billion net of discounts and the current portion (page 52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: the $1.25 billion (equivalent to $1,250 million) carrying amount of the 1.375% Senior Notes due June 2027 is consistently reported across 2022–2024, matching the ground truth. The 2024 total long-term debt of $5.79 billion (vs. $5,794 million in original) is accurately presented, with acceptable rounding. (2) The classification of the 1.375% notes as long-term debt throughout the period is correctly stated, and the absence of reclassification to current liabilities is properly emphasized. (3) The LLM correctly identifies that other instruments (e.g., 3.000% 2027, 1.600% 2030, 1.750% 2032 notes) are part of the long-term debt composition in 2024, adding contextual detail not in the ground truth but consistent with likely filing content. (4) The ground truth highlights a decrease in total long-term debt from $6,484M (2022) to $5,794M (2024) due to reclassification of the 2.750% 2024 notes, a key multi-hop insight. The LLM mentions the 2024 total but does not explicitly reference the 2022 total or the reason for the decline (i.e., reclassification of other notes), which slightly weakens the comparative evolution analysis. However, since the question focuses on the 1.375% notes’ treatment and their role in long-term debt composition, and the LLM correctly states their consistent classification and value, the omission is minor. (5) All entities (Costco, 1.375% Senior Notes, due 2027, long-term debt) and years are accurate. (6) Semantic equivalence is strong: 'carrying amount', 'long-term debt', and 'current portion' are used appropriately. The LLM adds page references, which are plausible but not verifiable from the ground truth; however, they don’t detract from accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates sound reasoning, missing only a brief comparative note on total long-term debt trend for full completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 535,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe has progressively elevated free online self‑service learning from a peripheral offering to a core component of its Digital Learning Services portfolio, integrating it tightly with enterprise customer‑success and consulting programs.  Across the 2022‑2024 filings, the company emphasizes that these free, on‑demand modules on learning.adobe.com are complemented by paid, instructor‑led courses and custom learning paths that feed directly into Customer Success Managers’ adoption and enablement strategies, ensuring that enterprise clients can rapidly upskill teams and align learning outcomes with business objectives.  This evolution reflects a shift from isolated training resources to a seamless, data‑driven learning ecosystem that supports Adobe’s broader cloud‑based services and reinforces its subscription‑centric growth model.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, evolution from 2022 to 2024, and strategic positioning of free online self-service learning. There are no numeric inaccuracies (quantitative accuracy is perfect) as the response avoids specific figures that would need to match exactly, instead focusing on qualitative trends, which is appropriate given the question. The answer correctly identifies the progression of free self-service learning as increasingly central to Adobe's learning portfolio and its integration with enterprise success strategies. It accurately references learning.adobe.com and the coexistence of free and paid offerings. The claim that free learning evolved 'from a peripheral offering to a core component' slightly overstates the 2022 positioning—ground truth indicates it was already considered a core part of the strategy in 2022, not peripheral—making the evolution less pronounced than implied. However, the emphasis on tighter integration with Customer Success Managers and data-driven ecosystems in later years reflects the maturing enterprise alignment described in the original answer. The synthesis across years is sound, though slightly more interpretive than the conservative, evidence-based tone of the ground truth. Semantic equivalence is high, and all key elements (skills assessments, custom learning paths, enterprise upskilling) are appropriately addressed. Contextual relevance is excellent, directly addressing all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 422,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 remained unchanged at $1.25 billion (carrying amount) from 2022 through 2024, with the long‑term portion consistently reported at roughly $8.46 billion in 2025 and $8.46 billion in 2024 after adjusting for repayments and amortization. This steady debt level—paired with a sharp rise in AI‑driven revenue—indicates that NVIDIA is prioritizing growth investments while maintaining a conservative, flat‑rate long‑term financing strategy, using the 2031 notes as a stable, low‑cost funding source rather than increasing leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024. The LLM incorrectly states that the exposure remained constant at $1.25 billion from 2022 through 2024, missing the decrease in 2023 entirely. This misrepresents the entire trend. Additionally, the LLM introduces a 'long-term portion' of $8.46 billion in 2024 and 2025, which is not mentioned in the original answer and appears to conflate the specific 2.00% Notes Due 2031 with total long-term debt, a significant error. (2) The numbers are therefore quantitatively inaccurate: the 2022 value is wrong ($1.25B vs $1.20B), the 2023 value is completely omitted (should be $1.057B), and the introduction of $8.46B figures has no support in the ground truth. Calculations or trends based on these numbers are invalid. (3) The reasoning is flawed because it fails to recognize the multi-hop pattern of fluctuation—decrease then increase—which suggests active debt management. Instead, the LLM infers a 'conservative, flat-rate' strategy due to a falsely assumed stable exposure, leading to an incorrect interpretation of NVIDIA's debt strategy. The model does correctly link the notes to long-term financing and AI growth contextually, but the conclusion is based on false premises. (4) Contextual relevance is moderate because the answer addresses the right topic—NVIDIA's debt strategy in relation to AI growth—and mentions the correct instrument (2.00% Notes Due 2031). However, due to major factual and quantitative errors, the qualitative and overall correctness scores are low. The answer does not reflect the actual evolution of exposure, undermining its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 497,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities has evolved from 2022 through 2024 as a proactive, strategic effort to integrate, simplify, and standardize financial processes and systems across HR, IT, procurement, supply chain, and finance functions. This initiative, explicitly framed as non-responsive to any internal control deficiencies, has focused on aligning and streamlining the financial control environment through process standardization and system enhancements. The progression demonstrates the company's strategic emphasis on strengthening financial process discipline and control environment consistency as a core component of its operational efficiency and governance framework, rather than as a corrective measure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: the initiative is described as proactive, ongoing from 2022–2024, focused on standardization and integration of financial processes, and not in response to internal control deficiencies. The strategic focus on process standardization and control environment alignment is correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent narrative across years and infers the strategic intent behind the initiative. One minor deviation is the inclusion of 'HR, IT, procurement, supply chain' as additional functions beyond finance—while the original answer only explicitly confirms finance, the broader scope may be contextually plausible but is not directly supported in the ground truth, slightly reducing qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of the initiative and its implications for strategic focus. Wording differs but semantic meaning aligns closely with the original. Overall, this is a strong response with only a minor overextension in scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 380,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "From 2022 through 2024 Costco’s public disclosures show a clear evolution in how it talks about its competitive positioning versus BJ’s Wholesale Club, with a growing emphasis on Kirkland Signature and private‑label brands as a differentiator.  \n\n- In the 2022 filing (pages 4‑8), Costco mentions private‑label merchandise only in passing, describing it as “high quality … offered at prices that are generally lower than national brands” and noting that it “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins.” The language is modest and focuses broadly on the overall warehouse‑club model.  \n- By the 2023 filing (pages 8‑10, 32‑34), the narrative expands: Costco explicitly calls out Kirkland Signature as a “private‑label brand” that “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and it states an intention “to continue to increase the sales penetration of our private‑label items.” This signals a strategic shift toward leveraging the brand as a core competitive advantage.  \n- The 2024 filing (pages 6‑9, 37) intensifies this emphasis, linking Kirkland Signature directly to the membership value proposition and noting that “the sales penetration of Executive members represented approximately 73.3 % of worldwide net sales in 2024,” implying that private‑label products underpin much of that growth. The language now frames Kirkland Signature not just as a cost‑saving line but as a “differentiator” that reinforces the overall Costco value equation, especially when contrasted with competitors such as BJ’s Wholesale Club.  \n\nThus, the competitive positioning language has moved from a generic reference to private‑label goods in 2022 to a deliberate, growth‑oriented narrative in 2024 that positions Kirkland Signature as a key differentiator in the warehouse‑club market and a driver of membership‑based revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Costco's competitive positioning language against BJ's Wholesale Club from 2022 to 2024, particularly regarding Kirkland Signature. The core facts are accurate: in 2022, private-label was described as high quality and lower priced than national brands, contributing to cost savings and higher margins; in 2023, there was increased strategic emphasis, including intent to grow private-label sales penetration; and in 2024, the language intensified around differentiation and linkage to membership value. The mention of '73.3%' of worldwide net sales coming from Executive members in 2024 is a specific numeric claim not present in the original answer. However, since this figure is plausible and contextually relevant (tying private-label strength to high-value members), and does not contradict the ground truth, it does not constitute a major error—though it introduces a data point not confirmed in the provided truth. The evolution in tone and strategic emphasis is correctly interpreted, and the multi-hop reasoning across years and competitive context is sound. The LLM adds slightly more detail (e.g., page numbers, 'sales penetration' focus) than the original answer, but these are reasonable inferences or consistent with typical 10-K language. The qualitative assessment correctly identifies a shift from generic to strategic framing of Kirkland Signature, matching the ground truth’s conclusion about increasing emphasis on differentiation in competitive markets. No incorrect entities or years are cited. The answer is highly contextually relevant and synthesizes across time periods and strategic themes effectively. Minor deduction from 9 to 8 on correctness due to the unverified 73.3% figure and slightly stronger claim of evolution than fully supported by the ground truth, which describes a 'growing tone' rather than a strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1751,
        "completion_tokens": 524,
        "total_tokens": 2276
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "From 2022 through 2024, Schwab’s investment‑portfolio disclosures consistently show U.S. state and municipal securities held at fair value in the low‑hundreds of millions (e.g., $638 million in 2022, $638 million in 2023 and $638 million in 2024). The firm repeatedly emphasizes that “substantially all securities in the investment portfolios were rated investment grade” and that “U.S. agency mortgage‑backed securities … are of the highest credit quality.” This persistent focus on investment‑grade quality signals that Schwab’s fixed‑income strategy is deliberately conservative, prioritizing high‑quality, low‑default‑risk assets to preserve capital and stability amid rising interest‑rate volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. It claims Schwab held $638 million in U.S. State and Municipal Securities in 2022, 2023, and 2024, but the ground truth states that the specific $638 million figure was disclosed only in 2023. In 2022, no exact dollar amount was provided—only a qualitative statement about investment-grade exposure. The repetition of $638 million across all three years is incorrect and misleading. Similarly, asserting that the amount remained constant at $638 million in 2024 is unsupported by the original answer, which only reaffirmed the investment-grade emphasis, not the amount. (2) The calculation and numerical consistency are flawed: while $638 million is correctly cited for 2023, extending it to 2022 and 2024 constitutes a fabrication of data. The phrase 'low-hundreds of millions' is also inaccurate, as $638 million is in the mid-hundreds. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that the consistent emphasis on investment-grade quality reflects a conservative fixed-income strategy. This aligns with the original answer’s conclusion about a strategic preference for high-quality, lower-risk instruments. However, the reasoning is undermined by the false quantitative premise of stable holdings across years. (4) Contextual relevance is high, as the LLM addresses both parts of the question—evolution over time and strategic implications—and uses appropriate financial terminology. Despite incorrect numbers, the qualitative interpretation of risk management and capital preservation is reasonable. However, the quantitative errors severely reduce overall correctness, warranting a score of 4. Quantitative accuracy is low (3) due to repeated incorrect figures; qualitative accuracy is moderate (5) as reasoning is logical but based on false premises; contextual relevance is strong (8) because the response stays on topic and interprets strategy appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 537,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX's exposure to commercial aerospace customer financing guarantees declined modestly from $288 million in 2022 to $274 million in 2024, while the collaboration partners' share of these guarantees fell from $140 million in 2022 to $131 million in 2024. This downward trend indicates that RTX is progressively shifting a larger portion of the financing‑risk exposure onto itself rather than relying on partner indemnities, reflecting a more conservative risk‑transfer strategy as the company seeks to retain greater control over the credit risk associated with aerospace financing arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the total exposure figures—$288 million in 2022 and $274 million in 2024—which are not present in the ground truth and contradict the provided data. The only numbers confirmed in the original answer are the collaboration partners' shares: $140M (2022), $135M (2023), and $131M (2024). The LLM omits the 2023 figure for the partners' share, skipping directly from 2022 to 2024, which breaks the multi-year trend analysis. (2) While the partners' share values for 2022 and 2024 are correct, the omission of 2023 data reduces quantitative completeness. The unsupported total exposure numbers ($288M, $274M) are unverified and likely incorrect, severely impacting quantitative accuracy. Calculations or trends based on these totals are therefore unreliable. (3) The reasoning about RTX retaining more risk and moving toward internal risk retention aligns semantically with the ground truth’s interpretation of reduced reliance on partners, though the LLM frames it as a 'more conservative risk-transfer strategy,' which is slightly contradictory—reducing partner indemnities typically means less risk transfer, not more. Still, the core inference about strategic shift toward control over credit risk is reasonable and reflects sound multi-hop interpretation. (4) The answer is contextually relevant and addresses both parts of the question—evolution of exposure and interpretation of trend—though with partial data. Despite incorrect totals, the use of correct partner share figures and plausible interpretation prevents a lower score. However, the introduction of unverified aggregate exposure numbers constitutes a major factual flaw, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 474,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 through 2024 Adobe’s Frame.io strategy shifted from a standalone collaboration platform to a tightly‑integrated, AI‑enhanced component of its broader Creative Cloud workflow.  In 2022 the service was highlighted mainly for its real‑time video review and approval tools, with integrations limited to Premiere Pro and After Effects.  By 2023 and 2024 Adobe expanded Frame.io’s reach to support a wider range of file types—including still images, PDFs and design assets—and deepened its connectivity with additional Creative Cloud apps such as Photoshop, Illustrator, InDesign and Express, as well as with Adobe Firefly Services and Adobe GenStudio.  This evolution positioned Frame.io as a central hub for end‑to‑end content production, enabling creators to move from capture through editing, AI‑assisted generation, and publishing within a single, cloud‑native workflow.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Frame.io from 2022 to 2024 in terms of integration and workflow role, with accurate dates and progression. It correctly notes initial integration with Premiere Pro and After Effects in 2022, and expansion by 2023–2024. The mention of support for still images, PDFs, and design files aligns with the ground truth. However, there are inaccuracies in the specific applications integrated: the LLM incorrectly lists Illustrator, InDesign, Express, Firefly Services, and GenStudio as integrated with Frame.io, which are not mentioned in the ground truth. Instead, the original answer specifies Photoshop, Lightroom, and Workfront—only Photoshop is common between both. Additionally, the LLM introduces 'AI-enhanced', 'Adobe Firefly', and 'GenStudio' elements not present in the source, implying AI capabilities that aren't supported in the ground truth. While the high-level narrative of Frame.io becoming a central hub for end-to-end workflows is consistent (including expansion beyond post-production), the specific integrations and technological drivers (AI) are overstated or incorrect. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the response directly addresses the question’s focus on integration, file types, and workflow role. Qualitative accuracy is reduced due to incorrect entity mapping and unsupported claims about AI integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 404,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s production focus on the VH‑92A helicopter shifted markedly from 2022 through 2024. In 2022 the VH‑92A was highlighted as a key program within the Rotary and Mission Systems (RMS) portfolio, with its sales and backlog tracked alongside other rotorcraft such as the CH‑53K and Black Hawk. By 2023 and especially 2024, however, the company’s public disclosures show a clear reduction in emphasis on the VH‑92A: net sales for RMS rose to $17.3 billion in 2024, but the discussion of product‑sales growth specifically notes “higher production volume on CH‑53K program, partially offset by lower volume on the VH‑92A program.” The backlog tables for RMS also list the VH‑92A only as one of many major programs, without any separate growth narrative, while the narrative pivots toward other platforms (e.g., Aegis, LCS, hypersonics, and new missile systems).  \n\nThis multi‑year progression—initial prominence followed by a deliberate scaling back—signals that the VH‑92A, while still part of RMS’s portfolio, is no longer a strategic centerpiece. Instead, the company is concentrating on higher‑margin, growth‑driven programs (e.g., PAC‑3, JASSM, LRASM, hypersonics, and next‑generation missile systems) that bolster RMS’s operating margin and backlog. The modest, stable operating margin for RMS (≈11 % in 2024) and the continued healthy backlog suggest that the segment’s strategic focus has moved to these other programs, indicating that the VH‑92A’s role is now more of a sustaining, support‑type effort rather than a driver of future growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth, particularly regarding the evolution of Lockheed Martin's focus on the VH-92A program. While the LLM correctly identifies the VH-92A as part of the Rotary and Mission Systems (RMS) portfolio and mentions other relevant programs like CH-53K and Black Hawk, it incorrectly asserts a 'marked shift' and 'deliberate scaling back' of the VH-92A program from 2022 to 2024. The ground truth states that the VH-92A was consistently highlighted across all three years, indicating sustained strategic importance, whereas the LLM claims a reduction in emphasis and lower production volume in 2024. The citation of 'lower volume on the VH-92A program' is presented as fact but contradicts the original answer’s emphasis on stability and continuity. Additionally, the LLM introduces specific financial figures such as RMS net sales of $17.3 billion in 2024 and an operating margin of ≈11%, which are not present in the original answer and cannot be verified against the provided ground truth, raising concerns about hallucination. While the LLM correctly identifies the strategic context of RMS shifting focus toward Aegis, LCS, and missile systems, it misinterprets the implications for the VH-92A, concluding it is 'no longer a strategic centerpiece'—a claim not supported by the original answer, which emphasizes ongoing commitment. The reasoning is internally logical but based on incorrect premises, failing the multi-hop synthesis requirement to accurately track program emphasis over time. The contextual relevance is moderate because the answer addresses the right segment and timeframe, but the core conclusion about declining strategic importance is factually wrong. Semantic equivalence is not achieved due to the contradictory assessment of the program's trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 500,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From 2022 through 2024, the regulatory landscape governing sales and media‑marketing restrictions for Mondelez International grew both in geographic scope and in stringency.  In the European Union, the company faced an expanding set of rules—including EU‑wide front‑of‑pack labeling requirements, stricter advertising limits on high‑fat/sugar/salt products (e.g., the UK’s October 2025 TV and online ad ban), and the rollout of extended producer‑responsibility (EPR) schemes in more than 25 member states, alongside national plastic‑tax and single‑use‑plastic bans.  Emerging markets such as India, Vietnam and other Southeast‑Asian jurisdictions also introduced or contemplated similar EPR, plastic‑tax and advertising‑restriction measures, while the United States saw heightened scrutiny of nutrient‑profile marketing and data‑privacy rules.  These developments required Mondelez to continually monitor and adapt its promotional, labeling and distribution practices across the regions to remain compliant.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the expanding geographic scope and increasing regulatory stringency for MDLZ from 2022 to 2024, particularly in the EU and emerging markets, aligning well with the ground truth. It accurately notes the spread of EPR policies in over 25 EU countries, plastic taxes, and single-use plastic bans, as well as their extension into India, Vietnam, and Southeast Asia. The inclusion of data privacy and marketing scrutiny in the U.S. reflects the 2023 development mentioned in the original answer. However, there are minor quantitative inaccuracies: the LLM references the 'UK’s October 2025 TV and online ad ban', which is outside the 2022–2024 timeframe and not mentioned in the ground truth, introducing a forward-looking detail not supported by the source. Additionally, while the EU Packaging and Packaging Waste Directive adoption in 2024 is implied through 'rollout' and 'stricter rules', it is not explicitly stated as a 2024 milestone. Despite this, the core facts—geographic expansion of EPR, plastic taxes, advertising restrictions, and data privacy—are correctly synthesized across years and regions. The reasoning is sound, demonstrating multi-hop understanding of regulatory trends across jurisdictions and time. Wording differs but maintains semantic equivalence on key points. The answer is highly relevant and comprehensive, missing only the precise 2024 directive adoption for full factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 397,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s treatment of its 3.700% Notes due 2046 shows a consistent pattern across its 2022, 2023, and 2024 10‑K filings: the notes are listed among the long‑term debt disclosures (e.g., page 105 of the 2023 filing and page 104 of the 2024 filing), with no indication of repayment, amendment, or material change in terms. This suggests that Microsoft continues to hold the 3.700% 2046 notes as part of its long‑term financing strategy, using them to fund ongoing investments such as AI infrastructure and cloud expansion while maintaining a stable capital structure. The lack of any new issuance or retirement highlights a focus on preserving low‑cost, long‑dated debt to support growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the 3.700% interest rate, 2046 maturity date, and consistent presence across 2022–2024 10-K filings are accurately reported. No incorrect numbers, dates, or percentages are present. The mention of specific page numbers (e.g., page 105 in 2023, 104 in 2024) adds precision and matches typical disclosure locations, though these are not part of the ground truth and do not detract from accuracy. (2) The answer correctly identifies the Eleventh Supplemental Indenture of August 8, 2016, by implication through consistent reference to the same debt instrument across years, even if not explicitly named—this is a minor omission but does not affect factual correctness. (3) The reasoning is sound: the absence of amendments, repayments, or changes supports the conclusion of a stable long-term debt strategy. The LLM appropriately infers that Microsoft is maintaining low-cost, long-dated debt to support growth in AI and cloud, which is a reasonable extension of the ground truth’s assertion about predictable debt servicing and confidence in cash flows. (4) The only reason for not scoring a 10 is that the LLM does not explicitly reference the Eleventh Supplemental Indenture by name or date, which is a key anchoring document in the ground truth. However, the semantic meaning and strategic interpretation are equivalent and well-supported. The answer is fully relevant, addresses all parts of the question, and demonstrates strong multi-hop synthesis across years and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 435,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft’s 2.000% Notes due 2023 were added to its debt structure through a series of supplemental indentures filed in 2015 and 2016 (Exhibits 4.12‑4.14 on the 2022 10‑K), which amended the original 2009 indenture to include the 2023 notes among the series of senior unsecured notes. Subsequent filings in the 2023 10‑K (page 105) show the same indenture references, confirming that the 2.000% 2023 notes remain part of the company’s long‑term debt schedule, while later supplemental indentures (e.g., the Eleventh Supplemental Indenture of August 8 2016) extended the maturity horizon and introduced newer tranches (e.g., 2026, 2036, 2046), reflecting a continued evolution of Microsoft’s debt maturity profile across the 2022‑2024 filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but includes significant inaccuracies and omissions that affect factual correctness. (1) Quantitatively, the mention of the 2.000% Notes due 2023 is accurate, as is the reference to the Eleventh Supplemental Indenture dated August 8, 2016, which aligns with the ground truth. However, the LLM incorrectly states that the notes were added through filings in 2015 and 2016 and references 'Exhibits 4.12–4.14' in the 2022 10-K, while the ground truth specifies only Exhibit 4.14. This overgeneralization and misstatement of exhibit numbers reduces quantitative accuracy. (2) The answer fails to address the key evolution across 2022–2024, particularly the critical point that the 2023 notes were still listed in the 2024 10-K *after* their maturity date, which was a central insight in the original answer (suggesting rollover, delay, or disclosure requirements). This omission severely weakens completeness and qualitative accuracy. (3) The reasoning around 'continued evolution' of debt maturities by introducing newer tranches (2026, 2036, etc.) is plausible context but not directly responsive to the question about the *progression of the 2023 notes specifically* across the three filings. The multi-hop synthesis is incomplete—while it connects indentures over time, it misses the post-maturity disclosure anomaly. (4) Contextual relevance is high because the answer discusses the right documents (Supplemental Indentures), exhibits, and debt structure evolution, but it does not fully trace the lifecycle of the specific notes as required. Overall, the answer gets core elements right but lacks precision and misses a key analytical point, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 467,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Medtronic’s Non‑Employee Restricted Stock Unit Award Agreements have been issued under three successive stock incentive plans across the three fiscal years: the 2003 Long‑Term Incentive Plan (referenced in 2022 filings), the Amended and Restated 2013 Stock Award and Incentive Plan (referenced in 2023 and 2024 filings), and the Amended and Restated 2013 Stock Award and Incentive Plan as further amended in 2024. Each year’s filing points to the specific agreement form—*10.42* for 2022 (under the 2013 plan), *10.47* for 2023 (also under the 2013 plan), and *10.47* again for 2024 (under the same amended 2013 plan), showing that the underlying plan has remained the 2013 plan while its form and related disclosures have been updated in the successive 10‑K filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2022 filing referenced the '2003 Long-Term Incentive Plan'—the ground truth confirms it was the Amended and Restated 2013 Stock Award and Incentive Plan (Exhibit 10.45), not the 2003 plan. (2) The LLM claims Exhibit 10.42 was used in 2022 under the 2013 plan, but the ground truth does not support this exhibit number for that year; instead, it cites Exhibit 10.45. (3) The LLM implies a progression or amendment in 2024 to the 2013 plan ('as further amended in 2024'), but the original answer notes no such change—only continuity in referencing the same Amended and Restated 2013 plan. (4) While the LLM correctly identifies the use of the 2013 plan in 2023 and 2024, it misrepresents the evolution as involving 'three successive' plans when only one plan (the 2013 plan, as amended) is referenced across all years. (5) The multi-hop reasoning is partially sound in tracking plan references over time, but fails in accurate entity and exhibit mapping. (6) Contextually, the answer addresses the question's focus on evolution and underlying plans, hence moderate relevance. However, due to major errors in plan names, exhibit numbers, and implied plan changes, the quantitative and qualitative accuracy scores are low. Minor formatting differences are acceptable, but misidentifying a plan (e.g., 2003 vs. 2013) is a critical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 400,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ increased its allocation to buy‑in annuity policies in non‑U.S. pension plans from roughly 11% of plan assets in 2022 to 17% in 2024, reflecting a deliberate shift toward securing liabilities with guaranteed annuity payments. This trend indicates that the company is actively managing and reducing its exposure to international pension obligations by moving plan assets into buy‑in annuities, thereby limiting long‑term investment risk and improving the predictability of future benefit payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. In contrast, the LLM claims an increase from 11% in 2022 to 17% in 2024, which reverses the actual trend and cites an incorrect starting percentage. These errors fundamentally misrepresent the data. (2) Quantitative accuracy is very low: the percentages (11% vs 17% starting point, and implied 17% in 2024) are incorrect, and the direction of change (increase vs actual decrease/discontinuation) is wrong. No calculations are involved, but the comparative statements over time are invalid. (3) The reasoning is flawed because it assumes a strategy of increasing de-risking via annuities, while the actual trend suggests a shift away from insurer-backed instruments toward fair value estimation—indicating greater direct control, not more outsourcing. The LLM fails to capture the discontinuation and methodological shift, missing the core multi-hop insight about liability management strategy. (4) Contextual relevance is moderate because the answer addresses the right topic (pension liability management via buy-in annuities) and attempts to interpret strategic implications, but the incorrect data leads to an opposite and unsupported conclusion. The entities (MDLZ, non-U.S. pension plans, buy-in annuities) are correctly identified, but the temporal and quantitative synthesis is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 423,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft's issuance of 2.000% Notes due in 2023 reflects a strategic shift in its long-term debt management across fiscal years 2022, 2023, and 2024. In 2022, the company issued $10 billion of 2.000% notes due 2023 as part of its broader capital allocation strategy, leveraging low borrowing costs to fund operations and investments while maintaining flexibility. By 2023, this specific tranche was retired or refinanced as part of routine debt management, reflecting a proactive approach to rolling over maturing obligations amid evolving interest rate environments. The 2024 filings (including Exhibit 4.14 from August 2016, which governs the 2.000% Notes due 2023) underscore Microsoft’s disciplined refinancing strategy, prioritizing long-term stability and capital efficiency. This pattern reveals a focus on maintaining a strong credit profile, optimizing debt maturity profiles, and capitalizing on favorable market conditions to fund growth without over-leveraging, aligning with its capital return framework and strategic investments in AI and cloud infrastructure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 2.000% Notes due in 2023 were consistently reported across 2022, 2023, and 2024 filings with no changes, indicating they were not retired or refinanced early. However, the LLM incorrectly claims that the notes were 'retired or refinanced' by 2023, which contradicts the original answer. Additionally, the LLM fabricates a $10 billion issuance amount, which is not mentioned in the ground truth. (2) Quantitative accuracy is poor: there are no dollar amounts, issuance sizes, or specific financial figures in the original answer, so the $10 billion figure is entirely invented. The interest rate (2.000%) and maturity year (2023) are correct, but the associated numerical claims (issuance amount, retirement) are false. (3) Multi-hop reasoning is flawed. The original answer emphasizes consistency across three years in Exhibit 4.14, showing stable debt management. The LLM instead infers a 'strategic shift' and 'proactive refinancing' that are not supported by the data. It misinterprets the continued disclosure of the notes in 2024 as evidence of refinancing strategy, when in fact it shows the notes remained outstanding. (4) Contextual relevance is moderate—the response addresses Microsoft's long-term debt strategy and references the correct exhibit and year of the indenture, showing some understanding of the document structure. However, the core conclusion about debt management strategy is incorrect due to factual errors. Thus, while the framing is relevant, the substance is not factually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 442,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft’s treatment of its 4.000% Notes due 2021 remained unchanged across the 2022, 2023, and 2024 10‑K filings. The notes continue to be governed by the same indenture provisions, including the supplemental indentures listed on Exhibit 4.6 (Third Supplemental Indenture) and Exhibit 4.1 (Seventh Supplemental Indenture), which reference the 4.000% Notes due 2021 alongside other series. No new supplemental indentures or material modifications to the debt instrument structure were disclosed in the 2023 or 2024 filings; the company simply continued to report the notes under the existing indenture framework in its financial statements and related disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in stating that Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across the 2022, 2023, and 2024 10-K filings and that these notes were governed by the Third Supplemental Indenture dated February 8, 2011, as listed in Exhibit 4.6. This aligns with the ground truth. However, the LLM introduces an inaccuracy by also citing Exhibit 4.1 (Seventh Supplemental Indenture) as referencing the 4.000% Notes due 2021, which is not supported by the ground truth. The original answer specifies only the Third Supplemental Indenture (Exhibit 4.6) and does not mention the Seventh Supplemental Indenture in connection with these notes. This is a significant qualitative error in entity linkage, though the core factual elements—unchanged treatment, correct exhibit (4.6), and no new modifications—are accurate. The quantitative aspects (interest rate: 4.000%, maturity year: 2021, dates of filings) are all correct. The reasoning is sound in recognizing consistency across years and absence of structural changes, but the erroneous inclusion of Exhibit 4.1 undermines the multi-hop synthesis accuracy. Contextually, the answer is highly relevant and addresses the evolution (or lack thereof) of the debt treatment appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 353,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic has consistently disclosed no Euro‑denominated Deferred Shares issued or outstanding in any fiscal year from 2022 through 2024, and the accompanying notes on share capital confirm that the company’s capital structure strategy relies on ordinary share repurchases and diversified debt issuance rather than equity instruments tied to Euro‑denominated deferred shares. This absence underscores a deliberate focus on maintaining a flexible, debt‑driven financing approach while returning capital to shareholders through share buybacks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key fact from the ground truth: Medtronic disclosed zero Euro Deferred Shares issued or outstanding in fiscal years 2022 through 2024. It also accurately reflects the consistent absence of issuance, which aligns with the original answer. The quantitative elements (no shares issued or outstanding, time period 2022–2024) are correct, earning a perfect score for quantitative accuracy. The contextual relevance is strong, as the response directly addresses both parts of the question—evolution of disclosures and implications for capital structure. However, the LLM adds specific claims not present in the ground truth: that the capital structure strategy relies on 'ordinary share repurchases and diversified debt issuance' and a 'debt-driven financing approach'. While these may be plausible inferences, they go beyond the information in the original answer, which only states the lack of utilization of Euro Deferred Shares and suggests possible reasons (strategic preference or lack of market demand) without specifying alternative mechanisms. This overreach slightly reduces qualitative accuracy. The original answer is more cautious in its interpretation, while the LLM asserts a more definitive strategy. Despite this, the core multi-hop reasoning—linking consistent disclosure of zero issuance to strategic capital structure choices—is sound and well-synthesized. Hence, the correctness score is high but not perfect due to unsupported specifics in the explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 414,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft’s 4.000% Notes due 2021 are consistently referenced across all three 10‑K filings—appearing in the debt‑related exhibits (e.g., the Third Supplemental Indenture for 4.000% Notes due 2021 in 2022, 2023 and 2024) and in the “Litigation” discussion of the 2022 filing (page 98). The company continues to disclose the same indenture structure and the same maturity date (2021) in each filing, indicating that it maintains the same debt instrument without any material modification or refinancing over the 2022‑2024 period. This consistency suggests that Microsoft treats the 4.000% Notes due 2021 as a stable, long‑standing component of its capital structure rather than a dynamic or frequently restructured liability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: Microsoft consistently disclosed the 4.000% Notes due 2021 across its 2022, 2023, and 2024 10-K filings, referencing the same Third Supplemental Indenture under Exhibit 4.6 dated February 8, 2011, and incorporated by reference from a prior 8-K. The maturity date (2021) and interest rate (4.000%) are accurately reported, and the absence of material changes in the debt structure is correctly noted. However, the LLM introduces a detail not present in the ground truth—the mention of the 'Litigation' discussion on page 98 of the 2022 filing—which is unsupported by the original answer and potentially misleading, as the ground truth does not reference litigation in connection with these notes. This addition suggests a possible hallucination or misattribution, reducing qualitative accuracy. Additionally, the conclusion that the notes are a 'stable, long-standing component of its capital structure' slightly mischaracterizes the situation: the ground truth emphasizes that the lack of changes indicates the debt was likely matured or fully accounted for, not that it remains an active part of the capital structure. This misinterpretation affects reasoning accuracy. Despite this, the answer correctly synthesizes multi-hop information across years and exhibits, and all quantitative elements (dates, percentages, exhibit numbers) are accurate. The response is contextually relevant and well-structured, but the incorrect implication about ongoing treatment of the debt as active—rather than resolved—warrants a deduction in correctness and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 441,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin has progressively reduced its pension liabilities through a series of risk‑transfer transactions. Beginning in 2018 the company started moving defined‑benefit obligations into third‑party annuity contracts, and in August 2021 it transferred roughly $4.9 billion of pension obligations to an insurer using assets from its master retirement trust, triggering a $1.7 billion non‑cash settlement charge. Since then, total transferred obligations have risen to about $11.6 billion, eliminating volatility for roughly 95,000 retirees and cutting PBGC premiums. The trend shows a deliberate strategy to off‑load long‑term pension risk, thereby simplifying the balance sheet and stabilizing future earnings, even though individual transactions can generate material non‑cash charges in the period they occur.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the cumulative $11.6 billion in pension obligations transferred by 2022, aligning with the ground truth. It also accurately references the elimination of PBGC premiums and the strategic intent to reduce pension risk. However, it introduces a specific transaction in August 2021 involving $4.9 billion and a $1.7 billion non-cash charge, which is not mentioned in the original answer and falls outside the requested 2022–2024 timeframe. This detail, while potentially factual, is not supported by the ground truth provided and distracts from the focus on 2022–2024. (2) The $11.6 billion figure is correct and matches the ground truth for 2022. However, the LLM does not provide any new data for 2023 or 2024 beyond implying continuation, whereas the original answer explicitly notes Lockheed’s ongoing evaluation in 2023 and reaffirmed intent in 2024—key elements showing evolution. The inclusion of the 2021 transaction creates a chronological misalignment and may imply that no major transfers occurred during the requested period. (3) The reasoning about a deliberate strategy to offload pension risk and stabilize earnings is sound and consistent with the ground truth. The synthesis of reduced volatility and simplified balance sheet reflects accurate qualitative interpretation. However, the model fails to explicitly connect the evolution across 2022–2024 as a multi-hop progression: from disclosed past transfers (2022), to continued evaluation (2023), to reaffirmed future intent (2024). Instead, it anchors on a 2021 event and jumps to the cumulative figure without tracking the annual progression. (4) Despite the chronological misstep, the answer remains contextually relevant and captures the essence of Lockheed Martin’s long-term liability management strategy. The core message—that the company is systematically reducing pension risk—is correct. The score is reduced primarily due to the introduction of unsupported timing details and omission of year-by-year strategic developments explicitly outlined in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 561,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The Coca‑Cola Company’s treatment of the 0.125% Notes due 2029 shows a consistent pattern of disclosure across its 2022‑2024 10‑K filings. In each filing the notes are listed under the “Form of Note” section of Exhibit 4 (e.g., page 136 of the 2022 filing, page 131 of the 2023 filing, and page 130 of the 2024 filing), with identical language describing them as “Form of Note for 0.125% Notes due 2029 – incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8‑K filed on September 18, 2020.” This repeated, unchanged reference demonstrates that the company has maintained the same debt‑instrument structuring and disclosure approach for these notes over the three fiscal years, indicating a stable and consistent approach to issuing and reporting this tranche of debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.125% Notes due 2029 are consistently referenced in each 10-K filing (2022–2024), with identical incorporation by reference to Exhibit 4.4 of the Form 8-K filed on September 18, 2020. The dates and percentages match the original answer. (2) Quantitative accuracy is perfect: the interest rate (0.125%), maturity year (2029), and Form 8-K filing date (September 18, 2020) are all correctly stated. The LLM does not mention the March 2021 Form 8-K, which appears in the ground truth, but this is a minor omission since the September 2020 filing is the primary source for the note’s initial disclosure. (3) The reasoning is sound: the LLM correctly infers that the unchanged disclosure language across three years indicates a consistent debt structuring and reporting strategy. It synthesizes information across multiple filings and correctly identifies the pattern. (4) The answer is contextually relevant and directly addresses both parts of the question: the evolution (or lack thereof) in disclosure and what it reveals about consistency in debt structuring. The only minor shortcoming is the omission of Exhibit references (4.23 and 4.31) and the lack of explicit mention of the 2023 and 2024 exhibit numbers, which were included in the ground truth. However, the LLM compensates by citing specific page numbers and consistent language, preserving semantic equivalence. Overall, this is a strong, factually correct response with only slight incompleteness in exhibit-level detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 435,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s performance and operating cost guarantees declined from $1,109 million in 2022 to $1,091 million in 2023 and further to $993 million in 2024, reflecting lower accruals for warranty and performance obligations. This downward trend suggests reduced exposure to long‑term product performance risks in its commercial aerospace business, although guarantees remain material and are still primarily based on historical experience and estimates of future performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's liabilities related to performance and operating cost guarantees refer specifically to the collaboration partners' share of financing guarantees, which were $141M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM claims total liabilities of $1,109M, $1,091M, and $993M for 2022–2024, which are not supported by the ground truth and misrepresent both the magnitude and the nature of the liability. These figures appear to be fabricated or misattributed, possibly confusing total warranty liabilities with the specific category mentioned in the question. (2) The calculation of a downward trend is consistent between both answers, but since the numbers themselves are entirely wrong, the trend analysis is based on false premises. The actual decrease from $141M to $131M is modest (about 7% over two years), whereas the LLM reports a much steeper decline (over 10% drop from 2022 to 2024), leading to an exaggerated interpretation. (3) The multi-hop reasoning fails: the LLM does not distinguish between RTX’s own liabilities and the collaboration partners’ share, which is a key nuance in the original answer. It also omits the point that RTX’s own liabilities were not explicitly disclosed, which is an important qualification. Instead, it presents a false sense of precision with large, unsupported numbers. (4) While the LLM attempts to interpret the trend—correctly noting that guarantees are based on historical experience and future estimates—its conclusion that exposure is 'reduced' overstates the case; the original answer describes a 'stable' liability posture, indicating ongoing but managed risk. Thus, the qualitative reasoning is partially sound but undermined by factual inaccuracy. Contextual relevance is moderate because the answer addresses the right topic and makes a plausible inference, but correctness is severely compromised by incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 539,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s 2024 stock‑option expense ($76 million) is slightly lower than in 2023 ($77 million) and comparable to 2022 ($70 million), but the company’s disclosed volatility assumption has risen modestly – from 23.04 % in 2022 to 24.05 % in 2023 and 24.29 % in 2024 – indicating a gradual increase in expected price swings. At the same time, the risk‑free rate used in the Black‑Scholes model has climbed from 0.90 % (2022) to 2.70 % (2023) and 4.16 % (2024), reflecting a more aggressive discount rate, while the expected dividend yield has risen from 1.95 % to 2.92 % and 3.18 % over the same period. These shifts suggest Medtronic is incorporating higher volatility and a stronger dividend outlook into its equity‑compensation risk modeling, which may modestly reduce the perceived risk of option awards while still anchoring compensation costs to realistic market assumptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual errors not present in the ground truth. (1) Quantitative Accuracy: The dollar amounts for stock-option expense ($76M, $77M, $70M) are fabricated and not supported by the original answer or implied by the knowledge graph. The volatility percentages (23.04%, 24.05%, 24.29%), risk-free rates (0.90%, 2.70%, 4.16%), and dividend yields (1.95%, 2.92%, 3.18%) are entirely made up; the original answer does not provide any numerical values for volatility, risk-free rates, or dividend yields. (2) Completeness: While the question asks about the evolution of Medtronic's valuation approach and what it suggests about assumptions on volatility and risk modeling, the LLM fails to mention the key point — the shift in disclosure clarity around implied volatility being derived from market-traded options in 2023 and maintained in 2024. Instead, it invents a detailed quantitative narrative that is unsupported. (3) Entity Accuracy: The company (Medtronic) and time frame (2022–2024) are correct, and the use of the Black-Scholes model is correctly noted in both answers. However, the specific financial metrics and assumptions cited do not appear in the ground truth. (4) Reasoning: The multi-hop synthesis is flawed — rather than connecting changes in disclosure transparency around volatility inputs, the model fabricates trends in numerical assumptions, leading to a misleading conclusion about 'gradual increases' in volatility and dividend yields. (5) Semantic Equivalence: The overall message diverges significantly — the original emphasizes improved transparency and market-informed modeling; the LLM focuses on invented numerical trends and their implications. Despite addressing the general topic of evolving assumptions, the answer is factually baseless in its core claims, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 507,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The Coca‑Cola Company issued its 1.000% notes due 2028 in September 2020 (as noted in the 2020 Form 8‑K filing referenced in the 2022 and 2023 documents). Subsequent filings show that the same instrument remained outstanding through at least 2024, with no indication of a new issuance or redemption; the company simply continued to carry the notes on its balance sheet, reflecting a stable, long‑term financing position. This pattern suggests that the 1.000% 2028 notes are being used as a permanent, low‑cost funding source rather than a short‑term tactical tool, aligning with Coca‑Cola’s broader strategy of maintaining a diversified, investment‑grade debt profile with staggered maturities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 1.000% Notes due 2028 were issued in September 2020 and remained outstanding through 2024, which aligns with the ground truth's assertion that the instrument was consistently referenced across 2022–2024. This demonstrates accurate entity and date recognition. However, the LLM introduces a detail not present in the ground truth—the September 2020 issuance via an 8-K filing—which, while potentially factually correct, is not part of the provided knowledge base and thus cannot be verified as relevant to the evaluation. More critically, the LLM omits a key component of the ground truth: the introduction of higher-yielding notes (5.000% due 2034 and 5.300% due 2054) in 2024, which is central to the strategic shift implied in the original answer. (2) Quantitatively, all numbers (1.000%, 2028 maturity, September 2020 issuance) are accurate or plausibly inferred, and no incorrect calculations are made. The format and values match expectations. (3) The reasoning is sound in concluding that the 1.000% notes represent a stable, low-cost funding source, which is consistent with the ground truth’s interpretation. However, the failure to incorporate the 2024 high-yield note issuances weakens the multi-hop synthesis—this omission prevents full recognition of the strategic shift in debt policy, which is a core part of the question’s second half. The LLM focuses only on continuity, missing the contrast with new higher-cost debt. (4) Contextual relevance is high because the response directly addresses the evolution and strategic implication of the 1.000% notes. But due to the missing comparative analysis with 2024’s new instruments, the qualitative accuracy is reduced. The answer is factually coherent but incomplete in synthesizing the full strategic picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 496,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Microsoft’s 2.125% Notes issuance history shows a consistent trustee structure across the three fiscal years. In each filing (2022, 2023, 2024), the notes are governed by the same supplemental indenture framework administered by The Bank of New York Mellon Trust Company, N.A., as trustee—specifically, the Fourth Supplemental Indenture (dated November 7, 2012) for the 2.125% Notes due 2022, and the Seventh Supplemental Indenture (dated December 6, 2013) for the 2.125% Notes due 2021 and 2028, which were referenced in all three 10-K filings. No new trustee arrangements or structural changes to the debt instruments were disclosed in the 2023 or 2024 filings; the disclosures merely reiterated the existing indenture terms and related exhibits (e.g., Exhibit 4.7 and 4.1 in each filing), confirming the continuity of the trustee relationship and the underlying debt covenants without evolution in structure across the years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains key factual inaccuracies that reduce its overall correctness. (1) QUANTITATIVE ACCURACY: The LLM incorrectly references the 'Fourth Supplemental Indenture (dated November 7, 2012)' for the 2.125% Notes due 2022, which contradicts the ground truth stating the Seventh Supplemental Indenture (December 6, 2013) applied to the 2.125% Notes due 2021 (not 2022). The maturity year '2022' is incorrect—ground truth confirms the notes are due 2021. Additionally, the LLM conflates the 2.125% Notes due 2021 with the 3.125% Notes due 2028, incorrectly stating the Seventh Supplemental Indenture covers both 2.125% Notes due 2021 and 2028, while the ground truth separates these instruments. (2) COMPLETENESS: The answer addresses the trustee (correctly identifying The Bank of New York Mellon Trust Company, N.A.) and notes consistency across years, which aligns with the original answer. It also correctly observes no structural changes were disclosed in 2023 or 2024. However, it introduces incorrect indenture details and misattributes maturities. (3) ENTITY ACCURACY: The company (Microsoft) and trustee are correct. However, the debt instruments are misidentified—specifically, the 2.125% Notes are due 2021, not 2022, and the Seventh Supplemental Indenture does not govern 2.125% Notes due 2028 (that appears to be a confusion with the 3.125% Notes). (4) REASONING: The multi-hop reasoning is sound in concluding no structural evolution occurred across years, and the trustee remained consistent. However, the basis for this conclusion relies on incorrect instrument details, undermining the factual foundation. (5) SEMANTIC EQUIVALENCE: While the overall message of 'no change in structure' matches the ground truth, the supporting facts are flawed. The answer fabricates or misstates key indenture details and maturities, which are central to the question about structuring evolution. Thus, despite correct contextual framing and relevance, the quantitative and factual inaccuracies significantly reduce correctness. The answer would score higher if not for the incorrect dates, maturities, and indenture assignments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 577,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "From 2022 to 2024 Pratt & Whitney’s net program‑share interest in IAE was 57 % and in IAE LLC was 51 % – both unchanged from the 2022 figures disclosed in the 2022 filing.  The 2023 and 2024 filings continue to show the same 57 %/51 % percentages, indicating that the evolution of the share interest has been flat rather than growing.  This steady progression reinforces RTX’s strategic focus on its core engine programs – the V2500 (via IAE) and the PW1100G‑JM (via IAE LLC) – by preserving a controlling, consolidated position that secures the bulk of the program economics and risk for those key engines.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the 2022 net program share interests. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as claimed. The LLM incorrectly states that the 57%/51% figures were already in place in 2022 and remained flat, when in fact the decrease occurred in 2023. The 2023 and 2024 figures (57% for IAE, 51% for IAE LLC) are correct, but the characterization of stability from 2022 onward is wrong. (2) Quantitative accuracy is low because the key percentages for 2022 are incorrect, and the model fails to reflect the downward trend from 61% to 57% (IAE) and 59% to 51% (IAE LLC). There are no calculations, but the reporting of static values over time is factually wrong. (3) The multi-hop reasoning is flawed: the model should have identified a change from 2022 to 2023 and stabilization in 2024, but instead asserts no change over the entire period. This misrepresents the evolution and undermines the strategic interpretation. (4) Contextual relevance is high because the answer addresses the right entities (IAE, IAE LLC, V2500, PW1100G-JM) and attempts to link the ownership structure to RTX’s strategic positioning. However, the incorrect data leads to an inaccurate conclusion about 'preserving a controlling, consolidated position' when the actual trend indicates a prior adjustment in collaboration structure. The strategic interpretation in the ground truth emphasizes recalibration, not stability from the outset.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 424,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s contributions to its defined‑contribution (401(k)) plans rose steadily from $299 million in 2021 to $468 million in 2023, reflecting the company’s growing investment in employee benefits over time. This upward trajectory shows an increasing commitment to funding employee retirement savings as part of its broader compensation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the time period and misses a key part of the trend. It states contributions rose from $299 million in 2021, but the ground truth begins in 2022. More critically, it omits the decline in 2024 to $443 million, instead implying a steady rise through 2023 only. This misrepresents the spending trajectory. (2) Quantitatively, the $299M in 2022 and $468M in 2023 are correct and match the ground truth, but the reference to 2021 is unsupported and incorrect—no data for that year is in the original answer. The omission of the 2024 figure ($443M) results in incomplete and misleading quantitative reporting. (3) The reasoning is partially sound in interpreting rising contributions as increased investment in employee benefits, but fails the multi-hop requirement by not acknowledging the full three-year trend, especially the decline in 2024. The conclusion of a 'steady' rise is invalid given the drop in the final year. (4) Contextual relevance is high as the answer addresses employee benefits and retirement contributions appropriately, but correctness and qualitative accuracy are reduced due to incorrect time framing and incomplete trend analysis. A full picture requires acknowledging the 2024 decrease to accurately assess the company's dynamic investment strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 375,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Coca‑Cola’s long‑term debt strategy shows a clear progression of issuing increasingly longer‑dated notes: in 2022 it issued 2.500% notes due 2051 (Exhibit 4.28), followed by 3.000% notes due 2051 in 2023 (Exhibit 4.36), and then 5.000% notes due 2034 and 5.300% notes due 2054 in 2024 (Exhibits 4.39‑4.45). This laddered issuance reflects a deliberate capital‑structure approach that extends maturities, diversifies funding costs and signals confidence in the company’s ability to refinance at attractive rates while preserving financial flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timing and details of Coca-Cola's debt issuances. According to the ground truth, the 3.000% Notes due 2051 were first referenced in a May 5, 2021 Form 8-K (Exhibit 4.6), not issued in 2023 as the LLM claims. The LLM incorrectly states that Coca-Cola issued 2.500% notes due 2051 in 2022 (Exhibit 4.28) and 3.000% notes due 2051 in 2023 (Exhibit 4.36), which contradicts the original answer indicating continuity of the same instrument across years with no new issuance. The 5.000% Notes due 2034 and 5.300% Notes due 2054 in 2024 are correctly mentioned, but the exhibit references (4.39–4.45) are not confirmed in the ground truth. (2) Quantitative accuracy is low: the coupon rates and maturities are partially correct (e.g., 5.000% and 5.300% notes in 2024), but the assignment of issuance years to specific instruments is wrong. The 3.000% Notes due 2051 were not newly issued in 2023; they were carried forward in disclosures. The claim of a 2.500% note in 2022 has no support in the original answer. (3) The multi-hop reasoning is flawed: the model infers a progression of new issuances each year, while the ground truth shows that the 3.000% Notes due 2051 were a stable, continuing component of the capital structure, not newly issued in 2023. The conclusion about a 'laddered issuance' strategy extending maturities is plausible but based on incorrect premises. (4) Contextual relevance is high—the answer addresses the evolution of debt instruments and attempts to interpret capital structure strategy. However, due to key factual errors in issuance timing and instruments, the correctness score is limited to 4, with low quantitative accuracy dragging down the overall score. The qualitative reasoning is partially sound but built on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 500,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle's 2.875% Notes due 2031 were initially issued in March 2021 as part of a $10 billion senior unsecured debt offering (4.16 8‑K filing), and were subsequently re‑issued in February 2023 under a new $10 billion senior unsecured debt program (4.16 8‑K filing) that also included 4.5%‑5.55% notes due 2028‑2053. This progression—first launched in 2021 and refreshed in 2023—reflects Oracle’s strategy of steadily expanding and laddering its long‑term debt with staggered maturities and varied coupon structures to manage financing costs and liquidity while maintaining a strong credit profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Oracle's 2.875% Notes due 2031 were formally listed in 2022 and reaffirmed in 2023 and 2024, but the LLM claims they were issued in March 2021 and 're-issued' in February 2023—dates and events not supported by the ground truth. There is no mention in the ground truth of a 2021 issuance or a 2023 re-issuance; instead, the focus is on the consistent inclusion of the notes in annual 10-K filings from 2022–2024. Additionally, the LLM introduces a $10 billion senior unsecured debt offering and specific new notes (e.g., 5.55% due 2053), which are not referenced in the original answer. (2) Quantitative accuracy is low: the ground truth does not specify issuance dates or dollar amounts for the 2.875% Notes, nor does it mention a 're-issuance' or new debt program in 2023. The LLM fabricates precise dates (March 2021, February 2023), percentages (4.5%–5.55%), maturities (2028–2053), and dollar figures ($10 billion) absent from the source. (3) The multi-hop reasoning is partially sound in that the LLM attempts to infer Oracle’s long-term debt strategy—laddering maturities and managing financing costs—but it bases this on incorrect data. The original answer emphasizes continuity of the 2.875% Notes while layering in newer, higher-yielding debt (4.500% due 2028 and 4.900% due 2033) as market conditions changed, which the LLM misrepresents by implying a broader and earlier restructuring. (4) Contextual relevance is moderate: the LLM addresses Oracle’s long-term debt strategy and references the 2.875% Notes, but misaligns the timeline and specific instruments. While the strategic interpretation (diversifying debt, managing costs) has some overlap with the original, it is undermined by factual errors. Overall, the answer is partially correct in intent but fails on key facts and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 518,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings—specifically in the supplemental indentures (Exhibits 4.11–4.14) detailing debt maturities and covenants—reflects a deliberate long-term debt management strategy focused on maintaining a stable, predictable capital structure. This transparency, embedded in regulatory filings rather than marketing materials, underscores its commitment to clear communication with investors about debt obligations, maturity timelines, and financial flexibility, reinforcing trust in its capital allocation discipline.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) Quantitative accuracy is perfect: the 2.000% interest rate and 2023 maturity date are correctly stated, and no incorrect numbers are introduced. The mention of supplemental indentures (Exhibits 4.11–4.14) adds specific detail consistent with SEC filing practices, though not explicitly in the ground truth. (2) The answer addresses the question about Microsoft’s long-term debt management and transparency strategy, correctly interpreting the consistent disclosure as a sign of stability and investor communication. (3) Multi-hop reasoning is sound: the model infers that repeated disclosure reflects a stable capital structure and transparent strategy, which is logically supported by the ground truth. However, it omits specific details present in the original answer—such as the Eleventh Supplemental Indenture dated August 8, 2016, and the fact that the notes were carried forward unchanged across three years—which would strengthen the historical continuity and precision of the response. (4) Despite these omissions, the LLM conveys the essential meaning and intent of the ground truth with strong qualitative reasoning and excellent contextual relevance. The focus on regulatory transparency and investor trust is appropriate and insightful. Minor deduction in qualitative accuracy due to missing specific sourcing details that anchor the multi-year consistency more firmly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 415,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "From 2022 through 2024 RTX’s contingent flight‑hour payments to Rolls‑Royce under the 2012 IAE acquisition agreement have been recorded as “Other commercial aerospace commitments” and amortized as collaboration intangible assets.  The 2022‑2024 maturity tables show scheduled payments of $660 million in 2025, $494 million in 2026 and $402 million in 2027, reflecting the ongoing obligation that will continue through June 2027 as flight hours are accrued.  This progression indicates that RTX maintains a long‑term exposure to Rolls‑Royce, with contingent payments tapering off only after the V2500‑powered fleet’s flight‑hour schedule winds down, tying future cash outflows to the continued operational use of those engines.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The ground truth does not mention any specific scheduled payments of $660M in 2025, $494M in 2026, or $402M in 2027—these figures are entirely absent from the original answer and cannot be verified from the provided knowledge. This is a major error, as it introduces precise financial data not supported by the source. (2) While the LLM correctly identifies the 'Other commercial aerospace commitments' category and the amortization of payments as collaboration intangible assets, it oversimplifies and misrepresents the evolution of accounting treatment. The original answer notes a progression: in 2022, payments were expected to be capitalized; in 2023, RTX clarified they were being capitalized and amortized to cost of sales; in 2024, the practice continued. The LLM fails to capture this year-by-year clarification and implies a static treatment throughout. (3) The multi-hop reasoning is partially sound—the model correctly links RTX’s payments to Rolls-Royce under the 2012 IAE agreement, ties them to V2500 flight hours through June 2027, and infers long-term exposure. However, the unsupported numerical projections undermine the credibility of the synthesis. (4) Despite the invented figures, the LLM captures the core qualitative narrative: ongoing contingent payments tied to engine usage, classification in commitments, capitalization, and tapering exposure linked to fleet activity. This justifies moderate scores in qualitative accuracy and high contextual relevance, but the quantitative inaccuracy severely limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 450,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "Based on the provided document pages, TMO's allocation to U.S. equity funds within its domestic pension plans remained consistently at approximately 10% of the portfolio over the three-year period (2022–2024), as evidenced by the recurring 10% strategic target allocation disclosed in Note 75 (page 75) and confirmed in the asset breakdowns for 2022, 2023, and 2024. This stable allocation reflects a deliberate, long-term investment strategy focused on maintaining a fixed equity exposure within the broader liability-driven framework, rather than pursuing tactical shifts. The 3-year trajectory thus suggests TMO has prioritized stability and alignment with its long-term liability-hedging objectives in domestic equities, with no material change in the strategic weight of U.S. equities across the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and trend. The ground truth states that TMO's allocation decreased from $125 million in 2022 to $89 million in 2023, then rose slightly to $93 million in 2024. The LLM claims the allocation remained 'consistently at approximately 10%' with no material change, which contradicts the actual dollar-value trajectory showing a 28.8% decline over two years followed by a partial rebound. There is no mention in the ground truth of a 10% strategic target or percentage-based allocation; instead, the data is provided in absolute dollar amounts. (2) Quantitative accuracy is severely lacking: the LLM invents a 10% figure not present in the ground truth and ignores the specific dollar values ($125M, $89M, $93M), which are central to the question. No correct calculations or numerical trends are reported. (3) The reasoning is internally consistent but based on fabricated or misinterpreted data. The LLM fails the multi-hop requirement by not recognizing the change in allocation over time and instead asserts stability, missing the cautious reduction and rebalancing narrative. It incorrectly infers a long-term stable strategy when the ground truth suggests tactical rebalancing after a significant cut. (4) Contextual relevance is moderate because the answer addresses the right topic (TMO's domestic pension plan allocation to U.S. equities) and attempts to interpret strategic intent, but the factual foundation is wrong, leading to an incorrect conclusion about investment strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 429,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s long‑term debt strategy has evolved from issuing a series of low‑coupon notes (e.g., 0.125% due 2029, 0.375% due 2033, 0.800% due 2040, 1.000% due 2028, 1.375% due 2031) between 2020 and 2021 to higher‑yielding issues in 2024 such as 5.000% Notes due 2034, 5.300% Notes due 2054 and 5.400% Notes due 2064, while still maintaining the legacy 1.000% Notes due 2041 that was originally launched in 2021. This reflects a shift toward higher‑priced financing as market rates rose, even as the company continued to reference the 1.000% Notes due 2041 in its SEC filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the introduction of higher-yielding notes in 2024—5.000% due 2034, 5.300% due 2054, and 5.400% due 2064—which matches the ground truth. It also correctly notes the continued reference to the 1.000% Notes due 2041. However, it introduces significant inaccuracies by citing low-coupon notes (e.g., 0.125% due 2029, 0.375% due 2033, 0.800% due 2040, 1.000% due 2028, 1.375% due 2031) that were not mentioned in the original answer and are outside the 2022–2024 timeframe specified in the question. The ground truth specifies that in 2022, the 0.400% Notes due 2030 were referenced, and in 2023, the 0.950% Notes due 2036—neither of which appear in the LLM answer. Additionally, the claim that the 1.000% Notes due 2041 were 'originally launched in 2021' is not supported by the ground truth, which only confirms their mention from 2022 onward. (2) Quantitative accuracy is compromised due to the inclusion of incorrect maturities and coupon rates not present in the source data. While the 2024 figures are correct, the earlier years are misrepresented with fabricated instruments. (3) The reasoning correctly infers a strategic shift toward higher-yielding debt due to rising market rates, which aligns with the ground truth’s conclusion about recalibration due to market conditions. The multi-hop synthesis is partially sound—linking past low-yield instruments to current high-yield ones—but based on incorrect data for 2022 and 2023. (4) Contextual relevance is high because the answer addresses the evolution of debt strategy and the contrast between old and new instruments. However, the use of inaccurate instruments from outside the specified period undermines factual correctness. The answer would have scored higher if it had used the correct notes from 2022 and 2023 as per the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 500,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle’s continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflects a deliberate, low‑cost financing strategy that complements its broader debt‑issuance program. While newer notes introduced in later years carry higher coupon rates (e.g., 2.500% to 4.100% for 2025‑2061 issues), the 1.650% 2026 tranche remains a core, competitively priced component of Oracle’s long‑term borrowing mix, helping to maintain a stable, diversified funding profile with minimal incremental interest expense relative to those higher‑rate offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly identifies the 1.650% Notes due 2026 as being consistently included in Oracle's capital structure across 2022–2024, it misrepresents the interest rates of the newly introduced notes. The ground truth specifies that Oracle issued a 5.800% Note due 2025 in 2023 and a 4.500% Note due 2028 in 2024—both materially higher than the rates cited in the LLM response (2.500% to 4.100%). The LLM understates the magnitude of the increase in borrowing costs, which weakens the comparative analysis. (2) The LLM mentions '2.500% to 4.100% for 2025–2061 issues' without specifying exact instruments or years, introducing vagueness and inaccuracy. The ground truth highlights specific, high-interest notes (e.g., 5.800% in 2023), which the LLM fails to reflect. This is a critical error because the contrast between the low 1.650% rate and much higher new rates (up to 5.8%) is central to Oracle’s shifting debt strategy. (3) The reasoning is partially sound: the LLM correctly infers that maintaining low-cost debt while issuing new instruments suggests a strategy of diversification and cost management. However, it misses the key implication that Oracle resorted to significantly higher-cost debt in later years, possibly due to changing market conditions—this nuance is absent. (4) Contextual relevance is strong: the answer addresses Oracle’s debt strategy, references the continued use of low-rate notes, and attempts a multi-hop comparison. But due to incorrect numerical data and incomplete synthesis of the true rate increases, the qualitative and quantitative accuracy scores are reduced. The correctness score is 5 due to partial factual correctness but major omissions and inaccuracies in key financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 496,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across the 2022, 2023, and 2024 Form 10‑K filings reflects its strategy of maintaining a stable, long‑term debt issuance framework that can be readily updated and expanded as needed. By repeatedly referencing the same supplemental indenture, the company signals that its capital‑structure management is designed for periodic refinancing and incremental borrowing—allowing it to adjust the mix of maturities and coupon rates while preserving a reliable source of funding for ongoing operations and strategic investments. This disciplined, documentation‑driven approach supports continuous refinancing activity and reinforces investor confidence in the durability of its debt‑management plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements—such as the consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across 2022, 2023, and 2024—but misinterprets the implications. The ground truth states that the continued inclusion of the 2021-due notes suggests administrative continuity and lack of refinancing activity, not active refinancing or incremental borrowing as the LLM claims. The LLM incorrectly infers that the documentation framework supports 'continuous refinancing activity,' which contradicts the ground truth that there were no refinancing disclosures or new tranches. (2) Quantitatively, all dates (2021 maturity, 2022–2024 filings) and the coupon rate (4.000%) are accurate. There are no calculations in either answer, so no errors there. The LLM does not introduce false numbers. (3) The multi-hop reasoning is flawed: while the model correctly identifies the repeated appearance of the notes in Exhibit 4.6, it fails to synthesize the key insight from the ground truth—that the absence of changes (e.g., no new tranches, no refinancing language) indicates stability and inactivity, not strategic refinancing. The mention of 'periodic refinancing and incremental borrowing' is unsupported by the evidence. Additionally, the LLM omits the factual detail about the trustee name update in 2024, which is a minor but documented administrative change. (4) The contextual relevance is moderate—the answer addresses debt management strategy and documentation updates, but draws an incorrect conclusion about refinancing activity. The qualitative accuracy is low due to the misinterpretation of the evidence, despite correct entity and date usage. Correctness score is 4 due to significant reasoning errors that reverse the actual implication of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 487,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX's exposure to commercial aerospace customer financing guarantees declined modestly from $142 million in 2022 to $135 million in 2023 and $131 million in 2024, reflecting a gradual reduction in the absolute amount of guarantees extended. The decreasing share held by collaboration partners—from $665 million (2022) to $659 million (2023) to $643 million (2024) when expressed as a portion of the total guarantee pool—indicates that RTX is shifting more of the risk onto itself rather than relying on partner co‑guarantees, suggesting a tightening of its risk‑transfer strategy and greater direct exposure to potential defaults in this segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports the collaboration partners' share of guarantees as $142M (2022), $135M (2023), and $131M (2024), it fabricates a total guarantee pool of $665M, $659M, and $643M across those years—data not present in the ground truth and unsupported by the original answer. This leads to an incorrect interpretation that the partner share is a portion of a larger total pool, which distorts the analysis. (2) The quantitative inaccuracies are severe: the LLM invents numbers not in the original data, and while the partner share figures are correct, their contextual framing is false. There is no mention in the ground truth of a 'total guarantee pool' or RTX's absolute exposure declining—only the partner share is discussed. (3) The multi-hop reasoning is flawed: the original answer infers that RTX may be assuming more risk due to declining partner shares, but still maintains confidence in asset values. The LLM incorrectly amplifies this by asserting RTX is shifting risk onto itself due to a shrinking partner portion of a fabricated total, misrepresenting the evidence. (4) Contextual relevance is moderate—the answer addresses the trend in partner share and RTX's risk strategy, but the incorrect data undermines the conclusion. The core numbers (partner shares) are right, but the synthesis and interpretation are based on invented figures, leading to a mostly incorrect assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 407,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, reflects a consistent multi-year strategy of financing operations and growth through structured debt offerings. The company issued related supplemental indentures in 2013 (4.11), 2015 (4.12), 2015 (4.13), and 2016 (4.14), with the 3.950% Notes due 2056 specifically referenced in the 2016 supplemental indenture (4.14) filed on August 8, 2016. This pattern indicates Microsoft's disciplined approach to long-term capital management, leveraging low-cost debt instruments to fund strategic initiatives while maintaining financial flexibility across fiscal years 2022, 2023, and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3.950% Notes due 2056 and their inclusion in Microsoft's capital structure, with accurate reference to the Eleventh Supplemental Indenture dated August 8, 2016, which aligns with the ground truth. The core factual claim—that these notes were consistently referenced across 2022, 2023, and 2024 filings with no changes—is supported. However, the LLM introduces earlier supplemental indentures from 2013 and 2015 (4.11, 4.12, 4.13), which, while potentially accurate in isolation, are not mentioned in the ground truth and are not directly relevant to the 3.950% Notes due 2056. This adds extraneous detail that could mislead about the evolution of this specific debt instrument. (2) Quantitatively, all dates (August 8, 2016), interest rate (3.950%), and maturity year (2056) are correct. No numerical calculations are required, and the timeline is accurately presented. Format and precision are consistent with the source. (3) The multi-hop reasoning is mostly sound: the model connects the 2016 indenture to the ongoing presence of the notes in later 10-Ks and infers a stable capital strategy. However, it overreaches slightly by framing earlier indentures as part of the 'evolution' of this specific note, when the ground truth emphasizes no changes over 2022–2024. The conclusion about disciplined capital management is reasonable but slightly more interpretive than the ground truth, which sticks to observed consistency. (4) The answer is highly contextually relevant, addressing both the evolution across years and the implication for capital strategy. The minor overreach in referencing unrelated indentures prevents a perfect score, but the central facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 473,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "From 2022 through 2024, Lockheed Martin’s tactical and strike‑missile programs (primarily within the Missiles and Fire Control segment) experienced a mixed trajectory.  Net sales rose modestly in 2023 and jumped sharply in 2024 as production ramp‑ups on programs such as GMLRS, JASSM, LRASM and PAC‑3 drove higher volume, but operating profit fell dramatically—dropping roughly 73 % in 2024 and 6 % in 2023—because of large reach‑forward losses on a classified program and reduced favorable profit‑adjustment credits.  Consequently, the cumulative effect of these lower margins and the one‑time losses reduced the company’s overall operating profit over the three‑year span, even as backlog grew.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trajectory of increasing production volume and declining operating profit, correctly identifying key programs (GMLRS, JASSM, LRASM) and the impact of a classified program on profitability. However, it omits specific dollar amounts for production increases in 2022 ($215M) and 2023 ($145M), and fails to mention the $1.2B production increase in 2024. While it correctly notes the 73% drop in operating profit in 2024, it inaccurately states a 6% decline in 2023, whereas the ground truth specifies a $45M loss due to a classified program—not a percentage decline. The $1.2B lower profit booking adjustment and $1.4B loss on a classified program in 2024 are not quantified in the LLM answer, representing significant omissions. (2) Quantitative accuracy is partially correct: the 73% drop in 2024 operating profit matches the ground truth, but the 6% decline in 2023 is not supported by the original data, which cites a $45M loss (not a percentage). The absence of key dollar figures for production growth and losses reduces numerical precision. (3) The multi-hop reasoning is sound—LLM correctly links rising production volume with declining profitability due to classified program losses and reduced profit adjustments, and infers the negative impact on overall operating profit. It synthesizes across years and programs appropriately, though with less specificity. (4) Scores reflect that the answer is qualitatively strong and contextually relevant, conveying the paradox of volume growth vs. profit decline, but loses points on quantitative accuracy due to missing or incorrect numerical details essential to the full picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 458,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "The Executive Change in Control Retention Agreements were originally established in 2009 for Marc N. Casper and later expanded to include other officers through a 2018 form (Exhibit 10.17) referenced in the 2018 10-Q. The 2023 10-K (page 76) confirms the existence of this form for officers other than Casper, indicating the agreements were formally documented and in place across all three years. No amendments or new forms specific to 2022 or 2024 are noted beyond the existing 2009 framework and the 2018 officer agreement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Thermo Fisher Scientific Inc.'s Executive Change in Control Retention Agreements from 2022 to 2024. (1) Quantitatively, the LLM incorrectly states that the agreement for Marc N. Casper was established in 2009 and that a form for other officers was introduced in 2018 (Exhibit 10.17 in the 2018 10-Q), which contradicts the ground truth that the form for other officers was introduced in 2022 and filed as Exhibit 10.7 in 2023. There is no mention of 2018 or 2009 in the original answer, making these dates entirely fabricated. (2) The LLM claims no amendments or new forms were introduced in 2022 or 2024, which directly conflicts with the ground truth stating that a Form of Agreement for officers other than Casper was introduced in 2022 and filed in 2023. This omission and misattribution of timing severely undermine the answer's accuracy. (3) Qualitatively, the reasoning is flawed: the LLM fails the multi-hop requirement by relying on outdated information and does not acknowledge the specific developments in 2022–2024. It incorrectly implies continuity from 2018 onward without recognizing the formal introduction and reiteration of the form in the requested time frame. (4) Contextually, the answer is relevant in that it discusses the right topic and parties (Casper, officers, forms), but the incorrect timeline and missing key developments (2022 form introduction, 2023 filing, 2024 reaffirmation) make it substantially misleading. The answer misses the core of the question—how the agreements evolved across 2022–2024—and instead focuses on earlier years not in the ground truth. Minor credit is given for correctly identifying that there is a distinction between Casper and other officers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 488,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "The notional amount of LMT’s interest rate swaps increased from $500 million disclosed in the 2022 filing to $1.3 billion in 2023 and stayed at $1.3 billion in 2024, indicating that the company expanded its hedging of fixed‑rate debt early on and then maintained a stable hedge size to manage interest‑rate exposure without further scaling up. This steady‑state level suggests LMT’s interest‑rate risk management strategy shifted from growing the hedge to sustaining an established level of protection rather than continuing aggressive expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million (disclosed in 2022 filing for 2021), $1.3 billion in 2023, and $1.3 billion in 2024. The format variations (e.g., '500 million' vs. '$500M') are acceptable and semantically equivalent. (2) The answer correctly identifies the evolution of LMT's swap usage—expansion from $500M to $1.3B and stabilization thereafter. (3) The reasoning is sound: the increase indicates a strategic expansion in hedging, and the plateau suggests a shift to maintaining a stable hedge profile. This captures the core of the multi-hop synthesis—comparing notional amounts across years and inferring strategic intent. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the likely drivers such as rising debt levels or a volatile interest rate environment, which are included in the original answer and provide additional context for the strategy shift. However, the omission does not undermine the factual correctness or the logical inference. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth with only slight less depth in explanatory reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 351,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher's expense for defined contribution plans rose steadily from $299 million in 2021 to $468 million in 2023, reflecting a $169 million increase over the three‑year period. This upward trend shows that the company has been progressively increasing its investment in employee retirement benefits, underscoring a strategic emphasis on enhancing compensation and benefits for its workforce.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. It incorrectly states that Thermo Fisher's defined contribution plan expense was $299 million in 2021, which is not only outside the requested 2022–2024 timeframe but also factually incorrect according to the ground truth. The correct values are $402 million in 2022, $468 million in 2023, and $443 million in 2024. The LLM correctly identifies the $468 million figure for 2023 but fails to report the 2024 value accurately or mention the decrease from 2023 to 2024. (2) Calculations are partially correct—the $169 million increase cited is based on $468M - $299M, but since $299M is incorrect and refers to 2021 (not requested), this comparison is irrelevant. The actual increase from 2022 to 2023 was $66 million ($468M - $402M), and there was a $25 million decrease in 2024, which the LLM omits entirely. (3) The multi-hop reasoning is flawed: the question asks specifically about 2022–2024, but the model shifts the timeframe to 2021–2023, missing the key trend of stabilization/reduction in 2024. It fails to synthesize the correct three-year trend and draws an incomplete conclusion. (4) While the general direction of increasing investment in 2023 is acknowledged, the omission of the 2024 flat (slightly reduced) figure leads to an overly simplistic and misleading interpretation of a 'steady rise' and 'progressive increase,' contradicting the ground truth's indication of potential recalibration. The answer is contextually relevant in discussing employee benefits investment but lacks factual precision and completeness required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 453,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "The Coca-Cola Company continued to rely on estimates of sales proceeds—particularly for non‑public equity investments in emerging markets such as Japan—to value those investments, even after the $87 million carrying‑value excess over fair value was identified in 2022. Management’s continued use of such estimates, despite the temporary nature of the decline, indicates confidence that market conditions in Japan would improve and that the investment’s fair value would recover, allowing the company to avoid an impairment charge. This approach reflects a strategic decision to hold the investment with the expectation of a rebound rather than to recognize an immediate loss.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $87 million excess of carrying value over fair value in 2022 for the investment in Japan and accurately states that management considered the decline temporary, reflecting confidence in recovery. It also correctly notes the continued use of sales proceeds estimates for valuing nonpublic equity investments. However, it omits key developments in 2023 and 2024 highlighted in the ground truth—specifically, the increasing emphasis on market participant assumptions and macroeconomic risks in emerging markets. This limits completeness and weakens the qualitative analysis of how the methodology evolved. (2) Quantitatively, all numbers ($87 million), timeframes (2022), and percentages (implied from ground truth) are accurate or reasonably interpreted. No calculation errors. Format variations are acceptable. (3) The reasoning correctly infers management’s confidence from the decision not to impair, which aligns with the ground truth. However, it fails to synthesize the multi-hop evolution across 2022–2024, particularly the shift toward external market perspectives in later years. This represents a partial failure in multi-hop synthesis. (4) Scores reflect high factual accuracy and relevance, but the omission of post-2022 developments reduces qualitative depth and overall correctness despite strong performance on core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 386,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle issued multiple tranches of senior unsecured notes across fiscal years 2022‑2024, with the 2.300% Notes due 2028 first appearing in the March 24 2021 8‑K filing (4.14) and subsequently re‑referenced in the February 6 2023 8‑K (4.16) that detailed the final terms of that series. The company continued to roll out new note series—such as the 4.500% Notes due 2028 and related 2030, 2033 and 2053 tranches in the February 2023 filing—while maintaining a pattern of issuing long‑dated fixed‑rate debt (ranging from 1.650% to 4.650% with maturities extending to 2061) to diversify its funding profile and lock in low‑cost capital. This multi‑year, staggered issuance of medium‑ to long‑term notes, paired with regular refinancing of existing obligations, reflects Oracle’s broader debt‑financing strategy of maintaining a strong liquidity buffer, funding cloud‑infrastructure expansion, and optimizing its capital structure through incremental, competitively priced borrowings across multiple fiscal periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's continued referencing of the 2.300% Notes due 2028 across fiscal years and the issuance of newer, higher-rate notes in 2023 and 2024, aligning with the ground truth's core narrative. However, it introduces specific details not present in the original answer—such as the March 24, 2021 8-K filing (4.14) and February 6, 2023 8-K (4.16)—which, while potentially accurate, are not supported by the provided ground truth and represent over-specificity beyond the knowledge graph. (2) Quantitatively, the interest rates mentioned (2.300%, 4.500%) and maturities (2028, 2030, etc.) are consistent with the original answer, though the LLM adds additional tranches (e.g., 2053, 2061) and rate ranges (1.650%–4.650%) not explicitly confirmed in the ground truth. These extensions are plausible but go beyond the verified data, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly infers Oracle’s strategy of maintaining lower-cost debt while issuing newer, more expensive instruments amid rising rates, and links this to capital structure optimization and cloud expansion—consistent with the original’s interpretation. The synthesis across years and instruments is logical and well-structured. (4) Contextual relevance is excellent: the answer directly addresses the evolution of the 2.300% Notes and Oracle’s broader financing strategy, with no irrelevant content. The slight over-specification of filing dates and additional note tranches prevents a perfect score, but the core facts, reasoning, and strategic interpretation are sound and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 459,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple's Floating Rate Notes due 2019 were issued in 2014 (as noted in the 4.4 Officer's Certificate filing) and remained outstanding through at least 2022, as evidenced by their continued inclusion in the 2022 Form 10-K's debt disclosures (page 56). The pattern of issuing these notes in 2014 and maintaining them through subsequent fiscal years indicates a consistent strategy of using short-term, floating-rate debt to manage interest rate exposure while maintaining flexibility in capital structure, rather than retiring or refinancing the instrument. This approach aligns with Apple's broader practice of issuing diverse debt instruments to optimize funding costs and hedge interest rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's Floating Rate Notes due 2019 were originally issued in 2014 and remained in disclosures through at least 2022, which aligns with the ground truth. However, it fails to address the full three-year span (2022, 2023, and 2024) as required by the question. The ground truth emphasizes consistent disclosure across all three years, but the LLM only explicitly confirms presence in 2022, omitting 2023 and 2024. This is a significant omission for a multi-year analysis question. (2) Quantitatively, the LLM correctly references the 2014 issuance and the May 6, 2014 Officer's Certificate (though mischaracterized as '4.4 Officer's Certificate', likely a typo for 'Exhibit 4.4'), and correctly notes inclusion in the 2022 10-K. No dollar amounts or additional numeric data are present in either answer, so no calculation errors exist. (3) The reasoning partially captures the stable nature of the debt treatment but incorrectly frames it as an ongoing 'strategy of using short-term, floating-rate debt' when the notes were issued in 2014 and due in 2019—meaning by 2022 they were past maturity. The ground truth interprets the continued disclosure as administrative or structural carryover, not active use. The LLM overinterprets the pattern as a strategic choice without evidence of active management or continued use post-maturity. (4) Contextual relevance is high because the answer addresses debt management and Apple’s capital structure, but the failure to cover all three years and the misinterpretation of the notes as actively used short-term instruments post-2019 undermines factual accuracy. Thus, the correctness score is 6—partially correct with key omissions and a flawed inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 476,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The consistent disclosure of PepsiCo’s 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10‑K filings indicates that the company is maintaining a long‑dated, low‑coupon debt instrument as part of its capital structure, signaling a strategic preference for stable, long‑term financing at a fixed rate. In contrast, shorter‑dated notes such as the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027 are treated as more tactical, higher‑frequency issuances that allow PepsiCo to manage near‑term liquidity and market conditions, while the 2047 note reflects a deliberate, long‑horizon debt positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%) and maturity years (2047, 2024, 2027)—are correctly stated, matching the original answer. There are no calculation errors, as the task does not involve arithmetic. (2) The answer addresses the core of the question: the strategic significance of the persistent 2047 note versus the transient nature of shorter-dated instruments. It correctly contrasts the long-term stability of the 4.000% note with the tactical use of near-term debt. (3) Multi-hop reasoning is sound: the model synthesizes the presence of the same note across three years versus the limited appearance of shorter-term notes, inferring strategic intent. (4) While the LLM omits the specific example of the 2.500% Senior Note due 2022 (which matured and disappeared from later filings), this is a minor omission that slightly weakens completeness but does not distort the overall conclusion. The core insight—that long-term debt is used for stability while short-term debt is more dynamic—is preserved and correctly reasoned. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the missing maturity example.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 377,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple's continued disclosure of the 0.45% Notes due 2016 in its 2022, 2023, and 2024 filings—despite the notes maturing in 2016—reflects a strategic approach to maintaining transparency around legacy debt obligations. This ongoing disclosure ensures regulatory compliance, supports investor clarity on historical financing structures, and facilitates accurate tracking of related financial instruments, such as those referenced in Exhibit 4.3 of the 2013 Indenture filing. It also underscores the company's commitment to full disclosure of all material financial liabilities, even after their formal maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 matured in 2016, and Apple continued disclosing them in 2022, 2023, and 2024 filings. There are no numerical inaccuracies—percentages and years match exactly. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), and reporting years (2022–2024) are all correctly stated. (3) The reasoning is sound and captures the core implication: Apple’s continued disclosure reflects a strategy of transparency and thorough documentation of legacy debt. The LLM correctly infers that this supports investor clarity and regulatory compliance, and references Exhibit 4.3 and the 2013 Indenture, which aligns with the type of documentation (Officer's Certificate, May 3, 2013) mentioned in the ground truth. (4) While the LLM does not explicitly mention the 'Officer's Certificate dated May 3, 2013'—a minor omission in entity specificity—it captures the essence of consistent documentation and conservative disclosure practices. The answer is semantically equivalent to the ground truth, with slightly less emphasis on the 'policy of comprehensive records' but still conveying a deliberate, transparent approach. No calculation errors or factual misstatements. Contextual relevance is excellent, directly addressing Apple’s strategy regarding legacy debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 392,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin’s pension‑risk‑transfer strategy has continued to shrink its defined‑benefit liabilities by purchasing group‑annuity contracts (GACs) through its master retirement trust.  Since 2018 the company has transferred roughly $11.6 billion of pension obligations, eliminating volatility for about 95,000 retirees and reducing PBGC premiums by roughly $69 million annually.  The company expects to keep using such transactions, which can generate non‑cash settlement charges that may be material in the period they occur.  The resulting pension‑related expense is volatile because it depends on actuarial assumptions—particularly discount rates and asset returns—so earnings can swing materially from year to year.  In 2024 the discount‑rate increase to 5.625% cut the qualified pension obligation by about $1.8 billion, and the company’s pension‑related earnings adjustments are expected to remain a key driver of earnings volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the cumulative $11.6 billion in pension obligations transferred since 2018 and the use of group annuity contracts (GACs) to de-risk liabilities. It also correctly notes that future transactions may result in material noncash settlement charges and that earnings volatility is affected by pension-related adjustments. However, it omits key details from the original answer, particularly the specific $4.9 billion obligation transfer in August 2021 and the resulting $1.7 billion noncash charge disclosed in 2022. These are central to the evolution of the strategy from 2022 onward and are missing entirely. Additionally, the LLM introduces new information not present in the ground truth—such as the 95,000 retirees, $69 million in PBGC premium savings, and the 2024 discount rate of 5.625% reducing obligations by $1.8 billion—which are either unverified or not part of the original knowledge base. (2) Quantitative accuracy is compromised: while $11.6 billion is correct, the $1.7 billion charge and $4.9 billion transaction are absent, and the $1.8 billion reduction due to discount rate changes in 2024 is unsupported by the original answer. The $69 million PBGC savings and 95,000 retirees are also unverified. (3) The reasoning is partially sound—LLM correctly infers that pension risk transfers reduce volatility and may cause noncash charges—but fails to trace the multi-hop evolution across 2022–2024 with specific transactional milestones. It generalizes the strategy without anchoring it in the disclosed events. (4) Contextual relevance is high because the answer addresses pension obligation reductions, future actions, and financial impact on earnings. However, the inclusion of unsupported figures and omission of key disclosed transactions reduces factual correctness. The answer captures the strategic direction but lacks precision and completeness in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 527,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Based on the provided SEC 10-K filings, Thermo Fisher Scientific's Executive Change in Control Retention Agreements were expanded beyond Marc N. Casper starting in 2023. The company added a separate Executive Change in Control Retention Agreement for Officers (other than Casper) effective April 1, 2023, as referenced in Exhibit 10.7 of the 2023 Quarterly Report on Form 10-Q (page 77 of the 2024 10-K filing). This agreement was an amendment to the existing retention framework, extending the change-in-control retention benefits to other executive officers beyond the CEO. The evolution shows a progression from the original 2009 agreements (amended in 2010 and 2018) to the 2023 expansion that formally included non-Casper officers under the same retention framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in dating and completeness. (1) Quantitatively, the LLM correctly identifies the April 1, 2023 date for the new form of the agreement for officers other than Marc N. Casper, which matches the ground truth. However, it incorrectly references the original agreements as being from 2009 (amended in 2010 and 2018), while the ground truth only confirms a form dated March 16, 2018, without specifying earlier versions—this introduces unsupported historical detail. (2) The answer correctly notes the expansion of retention agreements beyond Casper starting in 2023, which is consistent with the evolution described in the original answer. However, it omits mention of the 2022 disclosure, which explicitly referenced both Casper’s agreement and the pre-2023 form for other officers, thus missing a key step in the multi-year progression. (3) The reasoning is sound in identifying a strategic evolution in executive retention, and the synthesis across years is mostly accurate, though the lack of reference to 2022 weakens the full multi-hop narrative. (4) The contextual relevance is high, as the answer directly addresses the evolution of the agreements and the inclusion of non-Casper officers. Overall, the core facts about the 2023 update are correct, but the addition of unverified earlier dates and omission of the 2022 status result in a score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 405,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveals a deliberate long-term debt strategy focused on locking in low fixed rates amid rising interest rates. The company issued the 2.750% Senior Note due 2051 in October 2021 (as disclosed in Note 4.51 of the 2021 10-K), and subsequent filings (2022–2024) continue to reference this tranche as part of its broader refinancing activity, including the 2023–2024 issuance of new senior notes with varying maturities and rates. This strategy demonstrates a proactive approach to managing debt maturity profiles and interest rate risk, as evidenced by the company’s consistent use of long-dated, fixed-rate instruments (like the 2051 note) to mitigate exposure to rising rates, while also leveraging cross-currency swaps and hedging mechanisms to manage foreign exchange and interest rate volatility. The note’s inclusion in multiple 8-K filings and its prominence in debt disclosures underscore its role in PepsiCo’s capital structure optimization.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core insight from the ground truth: PepsiCo’s consistent treatment of the 2.750% Senior Note due 2051 reflects a stable long-term debt strategy in a rising rate environment. It correctly identifies the note as part of PepsiCo’s fixed-rate debt used to mitigate interest rate risk and notes the continuation of this instrument in filings through 2024. However, there are key inaccuracies affecting quantitative and factual precision. First, the claim that the note was issued in October 2021 'as disclosed in Note 4.51 of the 2021 10-K' is incorrect — the ground truth cites a Form 8-K filing (not the 10-K), and no such 'Note 4.51' exists in SEC filings (notes are typically labeled numerically like 'Note 4' or 'Note 5', not with decimal sublabels). This misrepresents the source and undermines quantitative accuracy. Second, the LLM introduces details not present in the ground truth, such as 'cross-currency swaps and hedging mechanisms' and 'refinancing activity' involving the 2051 note, which are unsupported by the provided evidence. While PepsiCo may use such tools generally, the original answer does not mention them in connection with this specific note. The LLM also overstates the 'prominence' and 'proactive' nature of the note’s role, whereas the ground truth emphasizes consistency and lack of change in treatment. Despite these issues, the answer correctly infers that maintaining long-dated fixed-rate debt is strategic amid rising rates and correctly situates the 2.750% note within a broader capital structure. The multi-hop reasoning across years is conceptually sound, even if some sources and specifics are misattributed. Wording differences are acceptable under semantic equivalence, but invented details and incorrect citations reduce factual reliability. Hence, correctness is partially compromised, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 503,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple's issuance of long-term debt, particularly the 4.45% Notes due 2044, reflects a consistent multi-year strategy of leveraging low-cost capital to fund operations and strategic initiatives. Evidence from the 2022, 2023, and 2024 10-K filings shows the company has repeatedly issued debt at similar maturities and rates—such as the 4.45% Notes due 2044 first issued in 2014 and reissued in subsequent years—demonstrating a deliberate, long-term capital structure approach. This pattern reveals Apple's focus on maintaining financial flexibility while efficiently managing its capital, using stable, long-duration debt to support shareholder returns and strategic growth without overburdening liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy by claiming the 4.45% Notes due 2044 were 'reissued in subsequent years' after 2014. The ground truth states that Apple consistently referenced the same 2014 issuance (via the Officer's Certificate dated May 6, 2014) across 2022–2024, indicating no reissuance or new issuance occurred during this period. This mischaracterization undermines the core factual accuracy. (2) Quantitatively, the interest rate (4.45%), maturity year (2044), and reference to filings from 2022–2024 are correct. However, the claim of 'reissuance' introduces a false event not supported by the data, which affects quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound—Apple’s consistent disclosure of the note over three years does suggest a strategic retention of long-term debt, and the inference about financial flexibility is reasonable. However, the model incorrectly infers active reissuance rather than passive continuation of an existing obligation, reflecting flawed synthesis. (4) Contextually, the answer addresses the evolution and strategic implications as asked, and the overall theme of using long-term debt for financial flexibility aligns with the ground truth. But due to the central error regarding reissuance, the correctness and qualitative accuracy scores are limited. Minor wording differences would be acceptable, but introducing a false action (reissuance) constitutes a major factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 414,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific's allocation to Collective Trust and Other Funds within its pension plan remained stable at 32 million in both 2023 and 2024, reflecting a consistent non‑qualified pension‑plan investment level. The 2024 disclosure that the plan uses a fair‑value methodology—categorizing these investments as Level 2 (e.g., corporate stock, bonds) and Level 3 (e.g., venture capital, real‑estate funds) with valuations based on NAV and observable market inputs—provides greater transparency on how the plan’s assets are priced and suggests that future fluctuations in underlying market conditions could materially affect the reported allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It claims Union Pacific's allocation to Collective Trust and Other Funds was $32 million in both 2023 and 2024, which directly contradicts the ground truth stating it was $756 million in 2022 and dropped to $382 million in 2023. There is no mention of 2024 allocation figures in the original answer—only a methodology disclosure—so asserting stability at $32 million in 2023 and 2024 is factually wrong on multiple levels. (2) Quantitative accuracy is severely lacking: the correct values are $756M (2022) and $382M (2023), showing a significant decrease. The LLM invents a false figure ($32M) and falsely claims stability. No correct calculations or comparisons are made. (3) The multi-hop reasoning fails completely. The question requires tracking allocation changes across years and interpreting the 2024 valuation methodology in light of those changes. The LLM misrepresents the trend (no decrease, no 2022 data), uses incorrect numbers, and applies the methodology discussion to a false premise. While it correctly notes that NAV is used and mentions transparency, this is overshadowed by foundational errors. (4) Contextual relevance is moderate because the LLM addresses the right topic (pension plan allocations, valuation methodology) and mentions NAV and transparency, which are relevant. However, due to gross factual inaccuracies in numbers and trends, the overall correctness score is very low. The answer does not reflect the actual evolution of the investment or support the correct interpretation based on accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 444,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K filings for fiscal years 2022, 2023 and 2024 each retain the Officer’s Certificate for the 1.05% Notes due 2017 (Exhibit 4.4), confirming that the company continues to file the same debt‑disclosure exhibit across multiple annual reports. This consistent inclusion demonstrates Apple’s practice of preserving historical capital‑structure disclosures—maintaining a permanent reference to the original indenture and officer certification even after the notes have matured—thereby ensuring that investors can trace the legacy financing structure over time. Consequently, Apple’s approach underscores a deliberate strategy to keep matured debt documentation accessible, reinforcing transparency and continuity in its financial reporting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Apple included the Officer’s Certificate for the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured. The certificate is correctly identified as a historical exhibit (Exhibit 4.4) retained across filings. (2) There are no numeric values requiring calculation (e.g., dollar amounts, interest sums), but the percentage (1.05%) and maturity year (2017) are accurate and match the ground truth. The fiscal years (2022–2024) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly infers that continued inclusion reflects a documentation retention practice emphasizing historical continuity and transparency, even for retired debt. It synthesizes the implication—that Apple maintains full historical context for investor and regulatory clarity—consistent with the original answer. (4) The LLM uses slightly different phrasing (e.g., 'permanent reference to the original indenture', 'trace the legacy financing structure') but conveys the same core message: Apple deliberately preserves and discloses matured debt documentation to ensure transparency and reporting continuity. No omissions or inaccuracies; all aspects of the question are addressed with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 378,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific's pension plan allocation to corporate stock remained relatively stable at approximately 24% of total plan assets from 2022 through 2024, according to the fair value disclosures on pages 72 and 78. The company maintained its target equity allocation range of 20-30% during this period, with corporate stock comprising 181 million in 2023 and 176 million in 2024 (page 78). This consistent allocation suggests Union Pacific's investment strategy has remained focused on a balanced portfolio with a stable equity exposure, maintaining its long-term target of 5.25% average annual return while preserving diversification across asset classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Union Pacific's allocation to corporate stock dropped from $1,990 million in 2022 to $181 million in 2023, then rose to $1,116 million in 2024. The LLM claims allocations of only $181 million in 2023 and $176 million in 2024, completely omitting the $1,990 million 2022 figure and the partial rebound to $1,116 million in 2024. This misrepresents the magnitude and trend of the shift. Additionally, the LLM introduces a '24%' allocation to total plan assets and a 'target equity allocation of 20-30%', which are not present in the original answer and contradict the narrative of a strategic de-risking. (2) The dollar amounts are factually wrong: $181M in 2023 is correct, but $176M in 2024 is incorrect (should be $1,116M), and the 2022 value is entirely missing. The claim of 'stable at 24%' is unsupported by the ground truth, which focuses on absolute dollar allocations, not percentages. (3) The multi-hop reasoning is flawed: instead of recognizing a sharp decline followed by a partial rebound indicating a move toward conservatism, the LLM concludes there was stability and a balanced strategy, which contradicts the ground truth's conclusion of a strategic shift toward fixed income and de-risking. (4) The answer is contextually relevant in that it discusses Union Pacific's pension plan and corporate stock allocation over 2022–2024, but the factual inaccuracies and incorrect interpretation severely undermine correctness. The model appears to have misread or conflated data, possibly interpreting 'corporate stock' as a percentage of equities rather than total plan assets, or drawing from incorrect source pages. Overall, major factual and interpretive errors justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 496,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "MRK's sales of Prevymis increased steadily from $371 million in 2022 to $785 million in 2023 and reached $785 million again in 2024, reflecting a roughly 110% jump from 2022 to 2023 and a flat‑to‑slightly‑up trend in 2024. This upward trajectory indicates accelerating market adoption of the CMV‑prophylaxis product and underscores its growing strategic importance within the Hospital Acute Care segment, where it complements other key acute‑care offerings such as Bridion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the reported sales figures. According to the ground truth, Prevymis sales were $428M in 2022, $605M in 2023, and $785M in 2024. The LLM incorrectly states $371M in 2022, $785M in 2023, and $785M in 2024. This misrepresents both the starting value and the growth trajectory—particularly overstating the 2023 figure and implying no growth in 2024 when in fact there was significant growth from 2023 to 2024. The claimed '110% jump' from 2022 to 2023 is based on incorrect numbers and is therefore inaccurate (correct growth from 2022 to 2023 is ~41%, not 110%). (2) Calculations are flawed: using LLM's own numbers ($371M to $785M) would imply ~111% growth, but this is irrelevant since the inputs are wrong. The actual year-over-year growth should be ~41% (2022–2023) and ~30% (2023–2024), both of which are omitted. (3) The qualitative reasoning about market adoption and strategic importance is directionally plausible but based on incorrect data. The mention of Bridion as a complementary product adds context not in the original answer, which is acceptable but does not compensate for factual inaccuracies. The model fails the multi-hop requirement of accurately tracking sales across three years and synthesizing correct trends. (4) Scores reflect severe penalties on quantitative accuracy due to wrong numbers and calculations, moderate qualitative accuracy because the general idea of growth and strategic importance is present, and good contextual relevance since the answer addresses the right product, company, segment, and intent of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 443,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo’s 3.000% Senior Note due 2027 appears in the 2022 filing (page 129) as a 2017 issuance, is reiterated in the 2023 filing (page 126) within the same list of senior note forms, and is again listed in the 2024 filing (page 127) as part of the 2017‑dated series. This consistent inclusion across all three annual reports confirms that the note remains an outstanding long‑term debt instrument, reflecting PepsiCo’s strategy of maintaining a diversified ladder of maturities and using low‑cost fixed‑rate debt to fund operations and acquisitions while managing interest‑rate exposure through swaps. The repeated disclosure signals a stable, long‑term debt approach that emphasizes incremental borrowing at attractive rates rather than large‑scale refinancings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core assertion that PepsiCo's 3.000% Senior Note due 2027 was consistently included in the 2022, 2023, and 2024 annual filings, reflecting its ongoing role in the company's long-term debt strategy. The mention of the note being part of a 2017 issuance aligns with typical disclosure patterns, though the ground truth does not specify the issuance year, so this detail cannot be fully verified but is plausible. The page numbers cited (129, 126, 127) are specific and consistent with filing formats, though the ground truth references exhibit numbers (4.22, 4.19, 4.17) rather than page numbers—this is a difference in referencing style, not a factual error. The interest rate (3.000%) and maturity (2027) are correctly stated. However, the LLM answer omits the evolving contextual characterization emphasized in the ground truth: the shift in presentation from medium-term notes in 2022 to longer-dated instruments in 2023 and newer short-term notes in 2024, which reveals the strategic layering of maturities. While the LLM correctly infers a strategy of maintaining a maturity ladder and using fixed-rate debt, it misses the nuanced evolution in how the note is positioned relative to other instruments, which is central to the question. The mention of interest rate swaps is not present in the ground truth and may be an unsupported inference. Overall, the quantitative facts (rate, maturity, consistent inclusion) are accurate, and the general strategic interpretation is reasonable, but the answer lacks the multi-hop synthesis of changing context across years that the original answer provides. Hence, it scores well on quantitative accuracy and relevance but lower on completeness and qualitative reasoning depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 476,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "Adobe has progressively deepened Frame.io’s integration with its Creative Cloud suite, positioning it as the core cloud‑native collaboration hub for video and creative assets. In 2022 the platform was primarily highlighted for real‑time upload, review and frame‑accurate commenting, with direct connectors to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront. By 2023 Adobe expanded Frame.io’s capabilities within Adobe GenStudio, added broader support for still images, PDFs and camera‑to‑cloud workflows, and began bundling it with Adobe Express and Firefly Services to enable large‑scale content production. In 2024 the integration matured further, embedding Frame.io more tightly into the Creative Cloud workflow—allowing users to request and receive comments directly inside Premiere Pro, After Effects, Photoshop and Illustrator—and leveraging Firefly‑powered generative AI to create commercially safe assets that can be reviewed and approved through Frame.io’s collaboration tools. This evolution reflects a shift from a standalone collaboration service to a fully integrated, AI‑enhanced production environment across Adobe’s creative applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately reflecting the progressive integration of Frame.io into Adobe's ecosystem across 2022–2024. It correctly identifies Frame.io as a cloud-native collaboration platform with real-time review capabilities and growing integration with Creative Cloud apps. The mention of integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront aligns with the ground truth, as does the expansion into AI-powered workflows with Firefly and inclusion in large-scale content production environments.\n\nHowever, there are key factual discrepancies in the timeline and feature rollouts:\n\n(1) The LLM incorrectly states that in 2022, Frame.io had integration with Photoshop, Lightroom, and Workfront. According to the ground truth, 2022 only involved trademark listing and branding alignment—functional integration with those tools came later. The deep integrations with Photoshop and Lightroom were explicitly highlighted for 2024, not 2022.\n\n(2) The LLM claims that in 2023, Frame.io was expanded within Adobe GenStudio and bundled with Adobe Express and Firefly Services. However, the ground truth states that Frame.io was positioned as part of Adobe GenStudio in 2024, not 2023. Similarly, the integration with Firefly and Substance 3D is a 2024 development.\n\n(3) The LLM attributes camera-to-cloud workflows and broader still image/PDF support to 2023, which matches the ground truth, but incorrectly ties these to Adobe Express bundling, which is not mentioned in the original.\n\n(4) The LLM introduces 'Illustrator' integration in 2024, which is not mentioned in the ground truth.\n\nQuantitative accuracy is perfect—there are no numbers, percentages, or financial figures to evaluate, and all dates (2022, 2023, 2024) are used appropriately in context. Contextual relevance is excellent, as the response directly addresses the evolution of Frame.io’s positioning and integration depth over time. The qualitative accuracy is reduced due to misattribution of features to incorrect years and overstatement of early integration depth. While the overall trajectory is correct, the multi-hop reasoning fails to precisely align feature rollouts with the correct year, leading to a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 610,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple's 2.40% Notes due 2023 were initially disclosed in its 2013 debt indenture (4.3) and remained a key long-term obligation through 2022, with no material changes noted in the 2022 10-K (page 55). By 2023, the notes were still referenced in the debt structure but were approaching maturity, as evidenced by the 2024 filing (page 56) which included updated debt covenants and maturity schedules. The 2024 10-K (page 56) confirms the notes were set to mature in 2023, reflecting Apple's strategy of managing debt maturity by refinancing or replacing near-term obligations with longer-dated instruments, ensuring liquidity and minimizing refinancing risks as the notes approached their due date.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that the 2.40% Notes due 2023 were no longer listed in 2024 filings, indicating they were retired upon maturity in 2023. However, the LLM claims the notes were 'still referenced in the debt structure' in 2023 and that the 2024 filing confirms they were 'set to mature in 2023'—which is logically inconsistent (they cannot mature in 2023 if confirmed as upcoming in a 2024 filing). This misrepresents the timeline and status of the debt. Additionally, the LLM incorrectly implies Apple refinanced or replaced the notes, while the ground truth states there was no early retirement or restructuring, indicating a hold-to-maturity strategy. (2) Quantitatively, the interest rate (2.40%) and maturity year (2023) are correct, but the use of '2013 debt indenture' is unsupported in the original answer and appears fabricated. Page numbers (e.g., page 55, 56) and filing years are not contradicted in the ground truth but are presented with false context. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the absence of the notes in 2024 as evidence of retirement, instead misinterpreting their presence in earlier years and inventing a refinancing narrative. The original answer draws a clear, evidence-based conclusion about holding debt to maturity; the LLM contradicts this by asserting proactive refinancing. (4) Scores reflect major factual and reasoning errors in core content (correctness: 3), partial numeric accuracy (quantitative: 4), poor reasoning and entity synthesis (qualitative: 3), and moderate relevance due to addressing the right topic with wrong conclusions (contextual: 6).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 468,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s Multiple Purpose Locomotive fleet totaled 6,893 units as of December 31 2024, comprising 5,973 owned and 920 leased locomotives with an average age of 25.2 years. This represents a modest increase in owned units (5,973 in 2024 vs. 5,971 in 2023) and a slight rise in the average age, indicating the company is maintaining a relatively stable core fleet while gradually aging its equipment. The multi‑year trend shows a deliberate focus on preserving a sufficiently sized, albeit aging, locomotive buffer to support network reliability and growth without large immediate capital outlays, reflecting a strategy of incremental fleet refresh rather than rapid expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Union Pacific's total Multiple Purpose Locomotives decreased from 7,242 in 2022 to 6,893 in 2024, with owned units dropping from 6,204 to 5,973 and leased from 1,038 to 920. The LLM incorrectly states that owned units increased from 5,971 in 2023 to 5,973 in 2024, which contradicts the downward trend and misrepresents the data. More critically, the LLM omits the 2022 baseline entirely and falsely implies stability or slight growth, when in fact there was a consistent decline over the three years. (2) The average age progression is partially correct—25.2 years in 2024 is accurate—but the LLM fails to report the full trend: 22.5 years in 2022, 24.3 in 2023, and 25.2 in 2024. By omitting 2022 and 2023 data, the model mischaracterizes the rate of aging. Additionally, the claim of a 'modest increase' in owned units is factually wrong—the data shows a net decrease from 6,204 in 2022 to 5,973 in 2024. (3) The multi-hop reasoning is flawed. The question requires synthesizing changes across three years and interpreting the strategic implication. The LLM incorrectly infers a strategy of 'incremental refresh' and 'stable core fleet,' when the ground truth indicates a lack of new investment and reliance on aging assets, pointing to a conservative or cost-constrained strategy. The model fails to connect the declining fleet size and rising age as co-occurring trends signaling reduced capital spending. (4) The contextual relevance is moderate—the answer addresses fleet composition and age, and attempts strategic interpretation—but due to major factual errors and incorrect synthesis, the conclusion is misleading. Quantitative accuracy is very low due to wrong numbers and missing data points. Qualitative accuracy is low because the reasoning is based on incorrect premises. Correctness score is 3 due to partial correctness in 2024 data but major errors in trend description and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 544,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "The development trajectory of MK‑8591A (doravirine + islatravir) shows that Merck first entered Phase 3 for the HIV‑1 regimen in February 2020 (MK‑8591A) and later advanced a two‑drug combination (islatravir + lenacapavir) into Phase 3 under the designation MK‑8591D, with a planned entry date in October 2024. Throughout 2022‑2024 the program remained under FDA review, and in December 2024 the agency placed a partial clinical hold on higher‑dose islatravir studies, prompting Merck to work with the regulator to address the hold while continuing its Phase 3/2‑3 development.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MK-8591A's Phase 3 entry in February 2020 and the October 2024 Phase 3 entry of MK-8591D (islatravir + lenacapavir), which aligns with the ground truth. However, it incorrectly states that the FDA placed a partial clinical hold in December 2024, whereas the original answer specifies that the FDA *lifted* a clinical hold in 2024 while maintaining a partial hold on higher doses—this is a critical factual reversal. The LLM misrepresents the regulatory action as a new restriction rather than a partial resolution. (2) Quantitatively, the dates (February 2020, October 2024) are accurate. The December 2024 'partial hold' claim is incorrect and not supported by the ground truth, which does not specify a December date for any action. This is a significant error in timing and direction of regulatory status. (3) The reasoning correctly synthesizes the evolution from MK-8591A to MK-8591D as a strategic expansion, showing multi-hop understanding across years and formulations. However, the mischaracterization of the FDA hold undermines the regulatory trajectory analysis. (4) Despite the error on the FDA hold, the answer remains contextually relevant, addressing clinical phase progression and FDA interactions as asked. The core development timeline is sound, but the regulatory interpretation is flawed, warranting a score of 7 for correctness—most facts are right, but a key detail is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 401,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "From 2022 through 2024 Merck shifted its focus in renal cell carcinoma (RCC) from earlier ADC programs like ladiratuzumab vedotin (discontinued) and the MK‑1308 bispecific antibody (which was not advanced further) toward a more immuno‑oncology‑centric strategy.  The company continued to develop MK‑1308A—a next‑generation CTLA‑4 antibody co‑formulated with pembrolizumab—for RCC, and it advanced Keytruda in combination regimens (e.g., with Lenvima, with Padcev, and in various RCC indications) while also expanding its precision‑targeting pipeline (e.g., MK‑1022 patritumab deruxtecan, MK‑7339 Lynparza).  This progression underscores Merck’s pivot to leveraging checkpoint‑inhibitor combinations and antibody‑drug conjugates in RCC, reflecting a strategic emphasis on immuno‑oncology and precision molecular targeting as core growth drivers for the company’s oncology portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that MK-1308 (a bispecific antibody) was not advanced further and implies MK-1308A is a 'next-generation' version, but the ground truth does not support this distinction or discontinuation of MK-1308. There is no mention in the original answer about discontinuation of ladiratuzumab vedotin or MK-1308 in RCC, nor any pivot from ADC programs. The core claim of a 'shift' from ADCs to immuno-oncology is unsupported. (2) Quantitatively, the answer does not include specific dates (e.g., April 2021 entry) or phase progression details (Phase 3 listing in 2022) from the ground truth. While no explicit numbers are wrong, the absence of key dates and misrepresentation of development timelines reduces quantitative accuracy. (3) Multi-hop reasoning is flawed: the LLM synthesizes incorrect narrative about strategic 'pivoting' and misattributes Merck’s focus, introducing drugs like MK-1022, MK-7339, Lenvima, and Padcev that are not mentioned in the original answer and are not part of the MK-1308A/RCC progression. This reflects a failure to correctly identify and link the relevant entities (MK-1308A, quavonlimab, pembrolizumab, RCC, Phase 3) across years. (4) Despite these issues, the answer correctly identifies MK-1308A as a combination of a CTLA-4 antibody with pembrolizumab in development for RCC and notes its immuno-oncology focus, which aligns partially with the ground truth. However, the overall narrative is misleading, overstating diversification and misrepresenting strategic evolution. Hence, correctness and qualitative accuracy are low, though contextual relevance is moderate due to partial topic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 469,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft’s 10‑K filings from 2022 through 2024 consistently disclose the same $4.000 % senior unsecured notes due 2021 (originally issued in 2011 and subsequently supplemented in 2013, 2012 and 2011), with the same principal amount and maturity date appearing in the “Third Supplemental Indenture” (2022 filing, p. 15), the “Fourth Supplemental Indenture” (2023 filing, p. 104) and the “Fifth Supplemental Indenture” (2024 filing, p. 104). The company continues to list the 2021 notes as part of its long‑term debt schedule in each filing, indicating that no refinancing or retirement of that tranche has occurred up to the 2024 filing. This persistence suggests that Microsoft’s long‑term debt strategy relies on a stable ladder of fixed‑rate notes, using the 2021 series as a core component while it issues newer tranches (e.g., 2022‑2023 notes) to extend maturities and diversify funding, rather than repeatedly refinancing the 2021 notes themselves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 4.000% Notes due 2021 were consistently disclosed under the Third Supplemental Indenture (Exhibit 4.6) across all three years. However, the LLM claims they appear in the Third (2022), Fourth (2023), and Fifth (2024) Supplemental Indentures, which contradicts the ground truth and implies evolving documentation, suggesting possible restructuring—this is incorrect. Additionally, the notes were issued in 2011 under the original 2009 Indenture, but the LLM incorrectly lists the issuance years as 2011, 2012, and 2013, implying multiple issuances, which is not supported. (2) The maturity date (2021) is correct, and the interest rate (4.000%) is accurate, but the claim that the notes are still listed in the long-term debt schedule in the 2024 filing is factually wrong—since the notes matured in 2021, they should no longer be outstanding by 2022–2024. The ground truth confirms consistent disclosure of the same legal document, not ongoing inclusion in debt schedules post-maturity. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that Microsoft is maintaining the 2021 notes as part of its current long-term debt ladder and using them as a 'core component' while issuing new notes. This misinterprets disclosure of historical debt terms as evidence of ongoing liability. The correct inference from the ground truth is that the consistent reference to the same exhibit and 8-K filings indicates no refinancing or restructuring occurred—because the debt was already retired. (4) Despite these major factual and logical errors, the answer is contextually relevant and attempts to address the evolution of disclosure and its implications for debt strategy. However, the quantitative inaccuracies (wrong exhibit numbers, incorrect issuance years, false implication of post-2021 outstanding debt) severely undermine correctness. The qualitative reasoning is partially sound in structure but built on false premises. Hence, correctness is scored low at 4, with moderate penalties for quantitative (3) and qualitative (5) accuracy, while contextual relevance remains high (8) due to appropriate framing and focus on strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 600,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Qualcomm’s automotive revenue grew steadily—from $1.5 billion in 2022 to $1.872 billion in 2023 and $2.910 billion in 2024—reflecting a clear shift toward higher‑value digital‑cockpit and ADAS/AD products. This upward trajectory, together with the expanding share of automotive‑related revenue within the broader QCT segment, signals that Qualcomm is transitioning its automotive business from a modest, component‑focused supplier to a core strategic growth engine driving its digital‑cockpit and connected‑car ambitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures—$1.5B in 2022, $1.872B in 2023, and $2.910B in 2024—that are not present in the original ground truth and cannot be verified from the provided knowledge graph. These numbers are factually unsupported, making the quantitative claims incorrect. The original answer does not provide any revenue figures for Qualcomm's automotive segment or digital cockpit specifically, so the inclusion of precise dollar amounts constitutes a significant factual error. (2) While the LLM correctly identifies a strategic evolution in Qualcomm’s automotive business, particularly around digital cockpit and ADAS/AD, it misrepresents the nature and evidence of that evolution. The ground truth emphasizes qualitative strategic and reporting changes—such as the formal categorization of digital cockpit as a distinct revenue stream in 2023 and its inclusion as a core product line in 2024—rather than revenue growth. The LLM fabricates financial data to support a narrative that, while directionally plausible, is not substantiated in the source. (3) The multi-hop reasoning is partially sound in that it infers a strategic shift, which aligns with the original answer’s conclusion about Qualcomm becoming a key enabler of software-defined vehicles. However, the reasoning is undermined by the reliance on invented data rather than the actual progression of reporting and operational integration described in the ground truth. (4) The contextual relevance is high because the answer addresses the core theme of Qualcomm’s automotive transformation and the role of digital cockpit. However, the correctness score is low due to the severe quantitative inaccuracies. The qualitative accuracy is moderate because the general strategic direction is consistent, but the absence of correct supporting facts and the introduction of false data limit its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 514,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "From 2022 through 2024, Lockheed Martin’s interest‑rate‑swap program expanded markedly: the aggregate notional amount of outstanding interest‑rate swaps rose from $500 million at the end of 2020 to $572 million in 2021 and then to $1.3 billion by the end of 2023 and 2024. This upward trend reflects a deliberate shift toward greater use of fair‑value hedges that convert fixed‑rate debt into variable‑rate exposure, thereby reducing the company’s sensitivity to rising interest rates and aligning its debt‑service costs with current market rates. Consequently, the growing notional amount signals that LMT is actively managing interest‑rate risk by increasing the scale and breadth of its derivative hedging strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative timeline. It incorrectly states that the notional amount was $500 million in 2020 and $572 million in 2021, which are not mentioned in the ground truth and irrelevant to the question's 2022–2024 scope. The correct figures are $500 million in 2022, $1.3 billion in 2023, and $1.3 billion in 2024. While the $1.3 billion figure for 2023 and 2024 is correct, the inclusion of incorrect earlier years and the misattribution of the $500 million to 2020 undermine accuracy. (2) The calculation of trend is partially correct—the increase to $1.3 billion is noted—but the characterization of a 'fourfold' increase is absent in the LLM answer, and the erroneous data points distort the trend analysis. The LLM implies steady growth from 2020 to 2023, while the actual shift is a single significant jump from 2022 to 2023. (3) The reasoning about LMT’s risk management strategy—converting fixed-rate debt to variable via fair-value hedges to manage interest rate sensitivity—is semantically aligned with the ground truth and shows sound qualitative understanding. The conclusion about active risk management is reasonable and contextually appropriate. (4) Despite incorrect numbers for years outside the scope, the answer addresses both parts of the question: evolution over time and interpretation of strategy. However, the use of fabricated intermediate data (2020, 2021) severely impacts quantitative accuracy. The core insight about strategic hedging is preserved, justifying moderate scores in qualitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 445,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft’s treatment of the 3.950% Notes due 2056 in its 2022, 2023, and 2024 10‑K filings shows a consistent pattern of long‑term debt maturity management focused on extending the company’s financing horizon and preserving flexibility. The notes appear in the “Supplemental Indentures” for 2016‑2056 (pages 105‑109), are listed alongside other long‑dated debt issuances (pages 42, 47), and are referenced in the “Other Income (Expense), Net” discussion that tracks interest expense reductions from debt maturities (page 104). Across the three filings, Microsoft emphasizes the strategic use of low‑cost, long‑dated securities—such as the 3.950% 2056 notes—to fund operations and investments while minimizing near‑term cash outflows, reflecting a disciplined refinancing strategy that prioritizes stable, long‑term capital structure over frequent short‑term roll‑overs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.950% Notes due 2056 and their consistent presence across the 2022–2024 10-K filings, accurately reflecting Microsoft’s long-term debt strategy. The reference to the Eleventh Supplemental Indenture dated August 8, 2016, is implied through mention of the 'Supplemental Indentures for 2016–2056,' though the specific date and indenture number are omitted. The interest rate (3.950%), maturity year (2056), and multi-year consistency are all factually correct. (2) Quantitative accuracy is high: all percentages, years, and references to financial disclosures (e.g., interest expense tracking on page 104) align with expected data. No calculations were required, but the use of precise figures like '3.950%' and '2056' matches the ground truth. Format variations (e.g., page numbers) do not affect accuracy. (3) The reasoning captures the strategic intent behind maintaining long-dated debt but misses a key multi-hop insight: the contrast between Microsoft’s non-refinancing of the 2056 notes versus its handling of shorter-term maturities (e.g., 2.000% Notes due 2023 in 2022, 2.400% due 2026 in 2024), which the original answer uses to highlight strategic prioritization. This omission weakens the qualitative depth and synthesis. (4) The answer remains contextually relevant, discussing long-term financing, interest expense, and capital structure, but lacks explicit comparative analysis across debt tranches that would fully demonstrate multi-hop reasoning. Wording differences are acceptable, but the absence of direct evidence about refinancing choices for other notes reduces completeness in reflecting the full strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 459,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s repeated reference to the Eleventh Supplemental Indenture dated August 8 2016 across its 2022, 2023 and 2024 filings underscores that the 3.700 % Notes due 2046 remain a key component of its long‑term debt structure, reflecting a consistent, multi‑year financing framework that has been formally amended and restated through supplemental indentures. This ongoing disclosure demonstrates the company’s commitment to honoring the same legal obligations over time, reinforcing confidence in the stability and predictability of its future interest payments and overall capital‑structure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016; the 3.700% Notes due 2046 are accurately referenced; and the filings from 2022, 2023, and 2024 are properly cited. There are no numerical, date, or percentage errors. (2) Quantitative accuracy is perfect: all dates, percentages, and years match the original answer exactly. (3) The reasoning is sound and captures the multi-hop nature of the question—linking repeated disclosure to ongoing obligations, stability in debt structure, and long-term financial planning. The LLM correctly infers that consistent referencing implies no material amendments or retirements, reflecting stable capital structure management. It slightly omits the detail about the base Indenture dated May 18, 2009, and the broader layered structure of supplemental indentures, which is part of the full context in the original answer. This minor omission prevents a perfect qualitative score but does not undermine the core correctness. (4) The response is fully contextually relevant, directly addressing the significance of the repeated reference and its implications for Microsoft's long-term debt strategy. Overall, the answer conveys semantic equivalence with the ground truth, with only a small reduction in completeness regarding the full indenture hierarchy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 390,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s treatment of the 2.125% Notes due 2021 shifted from a 2022 filing that listed them only as part of a broader 2013 supplemental indenture (Exhibit 4.10 in the 2022 10‑K) to a 2023 filing that presented a separate “Seventh Supplemental Indenture” specifically for those notes (Exhibit 4.1 in the 2023 10‑K) and again in the 2024 filing (Exhibit 4.10 in the 2024 10‑K). This incremental disclosure reflects a more explicit, stand‑alone reference to the 2021 notes, indicating that Microsoft now treats the instrument as a distinct series rather than merely a component of a larger indenture. The consistent inclusion of the same indenture language across 2022‑2024 suggests no material change in terms, but the heightened visibility implies a strategic emphasis on transparency and possibly a preparatory step for future refinancing or redemption. Consequently, the evolution points to a debt‑management approach that maintains the notes on the balance sheet while signaling readiness to manage maturities through targeted refinancing or replacement when market conditions warrant.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. First, it incorrectly claims that the 2.125% Notes due 2021 were presented as a 'separate Seventh Supplemental Indenture' in the 2023 filing (Exhibit 4.1), when the ground truth states they were listed in Exhibit 4.1 with the same indenture date (December 6, 2013), not as a new or separate document. The LLM also misrepresents the 2024 exhibit as 'Exhibit 4.10', while the ground truth confirms it was Exhibit 4.1 — the same as in 2023. Additionally, the claim that the treatment 'shifted' and became more 'stand-alone' or 'explicit' is unsupported by the source data, which shows consistent inclusion in similar contexts across years without evidence of increased prominence. The ground truth emphasizes uncertainty about whether the notes were refinanced or remain disclosed due to reporting lags or historical requirements, whereas the LLM confidently infers a strategic transparency motive and preparatory refinancing steps — an overinterpretation not substantiated by the filings. While the LLM correctly identifies the notes' continued presence in disclosures and references the correct indenture year (2013), it mischaracterizes the evolution and implications. Quantitative elements (interest rate, maturity year) are accurate, earning partial credit. However, the reasoning is flawed in synthesizing multi-hop evidence: it invents a narrative of increasing disclosure specificity that does not align with the consistent, static referencing pattern in the actual filings. Contextually, the answer addresses the question's structure and intent regarding debt strategy, but the conclusions are based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 467,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft's debt management strategy is reflected in the issuance and evolution of its senior unsecured notes across fiscal years 2022, 2023, and 2024. In 2022, the company issued $2.0 billion of 2.375% notes due 2023 (as referenced in the 2022 10-K on page 42 and related indenture filings), followed by $2.0 billion of 2.000% notes due 2023 in 2023 (documented in the 2023 10-K on page 14 and 4.9 supplemental indenture). By 2024, the company had refinanced and extended maturity profiles, issuing $2.0 billion of 2.000% notes due 2023 (again noted in 2024 10-K on page 105, Exhibit 4.9) and rolling forward new issuances to longer-dated instruments like the 2023–2025 notes under the 2015 indenture framework (page 105, Exhibits 4.12–4.14). This multi-year pattern demonstrates a deliberate strategy to manage debt maturity cliffs, maintain low-cost capital access, and support strategic investments—such as AI infrastructure and cloud expansion—while optimizing refinancing flexibility through staggered maturities and favorable interest rate environments. The consistent use of 2.000% and 2.375% coupon structures across years underscores a focus on balancing debt affordability with long-term capital structure stability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The Original Answer states that Microsoft consistently referenced the same 2.000% Notes due 2023 under the Eleventh Supplemental Indenture dated August 8, 2016, across all three years—indicating no new issuance but continued reporting of an existing obligation. In contrast, the LLM claims Microsoft issued $2.0 billion of 2.375% notes in 2022 and $2.0 billion of 2.000% notes in 2023, which contradicts the ground truth: these were not new issuances but references to the same pre-existing notes. (2) The LLM incorrectly asserts that in 2024, Microsoft 'refinanced' and issued new 2.000% notes due 2023, which is logically and factually impossible—notes due 2023 cannot be issued in 2024. The ground truth confirms the note was simply still being reported until maturity. (3) The LLM fabricates details about new issuances under the '2015 indenture framework' and exhibits 4.12–4.14 for 2023–2025 notes, which are not mentioned in the ground truth and contradict the focus on a single, stable indenture from 2016. (4) The reasoning is flawed: the multi-hop synthesis fails because the model misinterprets repeated disclosure as new issuance and refinancing, when the truth indicates stability and no refinancing before maturity. While the general theme of 'stable debt management' is partially aligned, the factual foundation is incorrect. The answer is contextually relevant to debt strategy but built on false premises. Quantitative accuracy is very low due to incorrect dates, interest rates, amounts, and maturities. Qualitative accuracy suffers from entity confusion (wrong indenture dates, exhibits) and faulty logic. Contextual relevance is moderate as it addresses debt strategy but misrepresents the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 489,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s pension‑risk‑transfer strategy has progressed markedly from 2022 through 2024.  In 2022 the company began executing a series of group‑annuity contracts (GACs) that moved roughly $11.6 billion of defined‑benefit obligations off its balance sheet, eliminating volatility for about 95,000 retirees and cutting PBGC premiums by ~ $69 million annually.  By 2023 and 2024 the firm continued to evaluate and execute additional risk‑transfer transactions, using assets from its master retirement trust to purchase GACs that shift the pension liability and related investment risk to insurers while the company remains responsible for any reimbursement shortfalls.  These transactions have reduced the size of its qualified pension plans, lowered future funding requirements, and introduced the possibility of non‑cash settlement charges in earnings when large transfers occur.  Consequently, the scale of obligations transferred has grown substantially, the financial impact is a reduction in pension‑related expense volatility but a potential for one‑time settlement charges, and Lockheed Martin’s stated strategy is to continue managing pension liabilities through further risk‑transfer transactions to mitigate long‑term pension risk and improve cash‑flow predictability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall strategic direction correctly: Lockheed Martin has pursued pension risk transfer transactions via group annuity contracts (GACs) to reduce pension liabilities, lower PBGC premiums, and mitigate long-term risk. It correctly identifies the financial impacts—reduced volatility, lower funding requirements, and potential noncash settlement charges—and affirms the company’s intent to continue such transactions. However, there are key quantitative inaccuracies. The LLM states that in 2022, Lockheed began executing GACs transferring $11.6 billion in obligations, but according to the ground truth, the $11.6 billion represents cumulative transfers since December 2018, not a single action in 2022. Additionally, the $11.6 billion figure includes the August 2021 transaction of $4.9 billion, which predates 2022. The LLM incorrectly implies this was a new 2022 initiative. The 95,000 retirees figure is not present in the ground truth and appears to be fabricated or inferred without support. 2) Quantitative accuracy issues: The $69 million annual PBGC savings is correctly cited. However, the timing and attribution of the $11.6 billion are wrong—the original answer clarifies this is the total from December 2018 onward, not an amount transferred starting in 2022. The $4.9 billion 2021 transaction is omitted in the LLM answer, which distorts the timeline. The $1.7 billion noncash settlement charge from the 2021 transaction is also missing, a significant financial impact. 3) Reasoning and synthesis: The LLM correctly infers a multi-year strategy of liability reduction and ongoing evaluation of future transactions, aligning with 2023 and 2024 disclosures. It accurately notes that the company may face noncash charges and remains responsible for shortfalls, showing good qualitative understanding. However, it fails to correctly sequence the evolution—especially the pre-2022 context—leading to a distorted view of the strategy’s scale and timing. 4) Despite these errors, the answer is contextually relevant and conveys the core strategy and financial rationale. The qualitative reasoning is sound, and the conclusion about continued risk transfer is supported. The score is reduced primarily due to misattribution of the $11.6 billion and omission of key transaction details, which affect factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 624,
        "total_tokens": 2263
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The consistent reference to Floating Rate Notes due 2019 across Apple's 2022‑2024 filings indicates that the company continues to rely on this specific long‑term debt instrument as part of its capital structure, but it does not signal a new refinancing strategy or a shift in its overall debt management approach. Instead, the repeated mention reflects the ongoing presence of legacy floating‑rate notes that were originally issued years earlier and remain outstanding, suggesting Apple is managing its legacy debt obligations while continuing to issue new debt with varying maturities and rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy: it states that the Floating Rate Notes due 2019 'remain outstanding' as of 2022–2024, which contradicts the ground truth that these notes matured in 2019. The original answer correctly infers that the continued disclosure is due to transparency around historical debt or potential rollover into new instruments, not because the 2019 notes are still active. The LLM incorrectly interprets 'consistent reference' as evidence of ongoing outstanding debt, which is a critical error in financial reasoning. (2) Quantitatively, there are no explicit numbers or calculations in either answer, so no numeric inaccuracies exist—dates (2019, 2022–2024) are correctly cited, earning full marks here. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the implication that matured debt referenced years later likely indicates refinancing or rollover, instead concluding the same instrument is still in use, which is illogical for a note 'due 2019' referenced in 2024. The ground truth correctly infers strategic refinancing and transparency; the LLM misses this key insight. (4) Contextual relevance is high—the response addresses capital structure and debt management strategy—but the core qualitative inaccuracy undermines the conclusion. Thus, correctness and qualitative accuracy are moderate due to a major factual misinterpretation despite correct use of entities and timeframes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 404,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft’s 4.000% Notes due 2021 were first referenced in the 2022 10‑K (page 104) as part of the supplemental indentures governing its senior unsecured debt, and the same instrument was again listed in the 2023 filing (page 42) and the 2024 filing (page 35). The repeated citation across all three years shows that the 2021 notes remain an active component of Microsoft’s capital structure, even as the company continues to issue new debt series. This ongoing disclosure underscores that the 4.000% Notes due 2021 continue to be a notable liability on Microsoft’s balance sheet and are regularly monitored by investors and regulators.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core factual claims: Microsoft did reference the 4.000% Notes due 2021 in its 2022, 2023, and 2024 10-K filings, and this consistent disclosure indicates ongoing structural or legal relevance. The specific percentages and years (4.000%, due 2021) are accurate, and the multi-year citation pattern aligns with the ground truth. However, the LLM incorrectly implies that the notes remain an 'active component' of the capital structure and a 'notable liability on the balance sheet' post-maturity, which contradicts typical accounting treatment—debt instruments are generally retired upon maturity unless extended or restructured. The ground truth clarifies that the continued reference is likely due to ongoing indenture or covenant relevance (e.g., in Exhibit 4.6), not because the debt remains outstanding as a liability. This misinterpretation affects the qualitative reasoning, though the factual observation of repeated disclosure is correct. The inclusion of specific page numbers (104, 42, 35) adds precision and supports contextual relevance. While the LLM captures the pattern and significance of disclosure, it misrepresents the financial reality of post-maturity debt treatment, leading to a partially flawed conclusion. Thus, the answer is factually strong but reasoning-deficient on a key financial concept.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 375,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS’s 7.620% debentures (maturing April 1, 2030) have remained classified as long‑term debt with the same redemption mechanics throughout 2022‑2024: they are callable at any time, redeemable at the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury yield + 5 bps, and interest is paid semi‑annually.  The only evolution noted across the filings is a modest increase in the carrying amount (from $280 million in 2023 to $276 million disclosed in 2024) and continued disclosure of the same “make‑whole” redemption formula and semi‑annual interest schedule.  No structural changes to the interest payment structure or overall debt positioning relative to other UPS debt have occurred in this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies and omissions. It incorrectly states the carrying amount increased from $280 million in 2023 to $276 million in 2024 — this is a decrease, not an increase, and the direction is wrong. More critically, the original answer states the $276 million principal was disclosed starting in 2022, with a book value of $280 million in 2023. The LLM reverses the timeline by citing $280M in 2023 and $276M in 2024 as carrying amounts, but the ground truth indicates $276M is the principal (consistent across years), and $280M is the book value in 2023. This misrepresents the quantitative trend. (2) The maturity date (April 1, 2030) and coupon rate (7.620%) are correct. The redemption formula — greater of principal plus accrued interest or present value discounted at Treasury yield plus 5 bps — is accurately described. Interest is correctly noted as semi-annual. However, the claim of a 'modest increase' in carrying amount is factually incorrect — it should be a slight decrease or stable, depending on context. (3) The LLM fails to capture the qualitative evolution in disclosure focus described in the ground truth: from historical interest rate context in 2022 (8.375% pre-April 2020) to structural details in 2024 and integration into a broader international debt portfolio (Pound Sterling, Euro notes). This shift in narrative and positioning is a key multi-hop insight missing in the LLM response. The model treats the disclosures as static, missing the evolving emphasis. (4) While the core mechanics of the debentures are correctly described, the answer lacks the analytical depth and temporal progression required. The correctness score is 6 due to accurate redemption terms and interest structure but significant errors in financial trends and omission of the evolving disclosure context. Quantitative accuracy is penalized for the incorrect directional change in carrying value. Qualitative accuracy reflects partial reasoning but failure to synthesize the changing narrative across years. Contextual relevance is high as the answer stays on topic and addresses the core elements of redemption and interest, albeit without the full evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 587,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "From 2022 through 2024, Vraylar’s development and commercialization showed accelerating adoption: it received FDA approval for adjunctive treatment of major depressive disorder in October 2021, demonstrated positive Phase 3 data in MDD in 2023, and its total sales grew 35‑36 % year‑over‑year at constant currency in 2023, contributing to a broader neuroscience portfolio that also includes Botox Therapeutic and other CNS products. This rapid uptake and expanding indications underscore Vraylar’s strategic importance as a high‑growth, high‑margin anchor within AbbVie’s neuroscience segment, driving diversification beyond legacy immunology and oncology revenues.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding dates and trial results. It incorrectly states that Vraylar received FDA approval for adjunctive MDD treatment in October 2021, while the ground truth indicates that in 2022, ABBV announced top-line results from Phase 3 trials—implying approval came after, not before. Additionally, the LLM claims positive Phase 3 data in 2023, but the original answer specifies that one trial met its primary endpoint and the other did not achieve statistical significance—nuance that is missing. (2) The financial data is partially correct: the LLM reports a 35–36% year-over-year growth at constant currency in 2023, which aligns closely with the ground truth’s 35.4% increase. However, it omits the actual revenue figure of $2,759 million, a key quantitative detail. (3) The reasoning is sound in interpreting Vraylar’s strategic importance as a growing anchor in the neuroscience portfolio, and correctly links its performance to diversification beyond immunology. It also appropriately references the broader neuroscience portfolio (e.g., Botox), though this is not in the ground truth and may be extraneous. (4) While the overall trajectory and strategic interpretation are directionally correct, the incorrect timing of approval and oversimplification of trial outcomes reduce factual accuracy. The answer captures the essence of commercial growth and strategic significance but fails on precise multi-hop synthesis of development milestones and financials, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 434,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The consistent inclusion of the 0.45% Notes due 2016 across Apple's 2022, 2023, and 2024 filings reflects a deliberate long-term debt strategy to maintain transparency about legacy instruments that remain outstanding but are no longer actively managed. This practice ensures investors are informed about historical financing obligations, even as Apple shifts focus to newer debt issuances, thereby preserving disclosure continuity for regulatory compliance and historical context without implying current strategic emphasis on these instruments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual misinterpretation that impacts the overall correctness. (1) Quantitatively, all numbers and dates are accurate: the 0.45% Notes due 2016 are correctly referenced, and the fiscal years 2022, 2023, and 2024 are properly cited. There are no calculation errors. (2) However, the LLM incorrectly states that the notes 'remain outstanding but are no longer actively managed,' which contradicts the ground truth: the notes matured in 2016 and are no longer outstanding. This is a critical error in factual understanding. (3) The multi-hop reasoning is partially sound—the model correctly infers Apple's intent to maintain transparency and disclosure continuity—but it fails to recognize that the inclusion is purely for historical documentation, not because the debt is still outstanding. The original answer emphasizes that the notes were matured, yet Apple continues to disclose them for record-keeping; the LLM misses this nuance and implies ongoing liability. (4) Despite this, the answer addresses the disclosure strategy and long-term transparency, which is contextually relevant and reasonably aligned with the intent of the question. Hence, the correctness and qualitative accuracy scores are reduced due to the key factual error, while quantitative accuracy remains high and contextual relevance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 381,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "From 2022 through 2024, UPS SurePost evolved from a residential‑ground service that relied on the U.S. Postal Service for final delivery to a fully insourced product under UPS’s own network. The company continued to position SurePost within its U.S. Domestic Package segment as a cost‑effective, residential‑focused offering that leverages the broader UPS ground infrastructure while emphasizing time‑definite, guaranteed delivery for non‑urgent, lightweight shipments. This strategic shift aligns with UPS’s broader focus on higher‑yielding, higher‑value volume within its domestic package business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of UPS SurePost from 2022 to 2024, correctly identifying its initial reliance on USPS for final delivery and the strategic shift toward insourcing. It accurately reflects the positioning of SurePost as a cost-effective, residential-focused service within the U.S. Domestic Package segment. However, it contains a key factual inaccuracy: it states that the shift to full insourcing occurred by 2024, when the ground truth specifies that the change was *announced in 2024* but is set to begin on *January 1, 2025*. This misrepresents the timeline, implying the transition was completed within the 2022–2024 window when it has not yet taken effect. This affects both quantitative accuracy (incorrect date framing) and qualitative reasoning (mischaracterizing the stage of implementation). Despite this, the answer demonstrates sound multi-hop reasoning by connecting SurePost’s operational model to UPS’s broader strategic goals around service quality and higher-yield volume. The entity names (UPS, USPS), service descriptions, and strategic rationale are accurate and contextually well-aligned. Wording differences are acceptable under semantic equivalence, but the omission of the 2025 effective date undermines full factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 356,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple's long-term debt issuance demonstrates a deliberate multi-year strategy to fund operations and growth through structured capital markets. The company has consistently issued new tranches of senior unsecured notes across diverse maturities and interest rates, including the 4.45% Notes due 2044 (first issued in 2014 and subsequently reissued in later offerings), alongside other long-dated instruments like 3.6% Notes due 2042 and 3.05% Notes due 2029. This pattern reflects a strategy of locking in low-cost, long-term financing to manage the company's substantial cash reserves and support its capital allocation priorities—such as share repurchases, dividends, and strategic investments—while maintaining financial flexibility. The repeated issuance of similar maturity and rate structures indicates a disciplined approach to debt management, optimizing the company's capital structure without over-reliance on any single funding source.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies regarding the issuance history of the 4.45% Notes due 2044. The ground truth states that Apple consistently referenced the same 4.45% Notes due 2044 across 2022–2024 filings, originating from an Officer's Certificate dated May 6, 2014, with no indication of reissuance or new tranches. However, the LLM incorrectly claims these notes were 'subsequently reissued in later offerings,' which is not supported by the original answer and introduces a factual error. Additionally, the mention of '3.6% Notes due 2042' and '3.05% Notes due 2029' appears to be extraneous and not part of the ground truth, which focuses solely on the 4.45% Notes due 2044. (2) Quantitative accuracy is partially correct—the interest rate (4.45%) and maturity year (2044) are accurate, as is the reference to long-term debt strategy. However, the introduction of unverified notes (e.g., 3.6%, 3.05%) and the claim of reissuance undermine numerical and factual precision. There are no calculations in either answer, so this aspect is neutral. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic use of long-term debt for capital allocation and financial flexibility, aligning with the ground truth’s interpretation. However, it fails to emphasize the key point: the consistent *retention* of a single long-term instrument over time (without redemption or restructuring), which is central to the original answer’s insight about Apple’s strategy. Instead, it implies ongoing new issuances, which changes the strategic interpretation. (4) Contextual relevance is high—the response addresses Apple’s long-term capital strategy and ties debt issuance to capital allocation priorities like buybacks and dividends, which is consistent in theme. However, due to the misrepresentation of issuance activity and inclusion of unsupported debt instruments, the factual correctness score is reduced to 5, reflecting partial accuracy with significant errors in entity and event representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 549,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle consistently presented the 2.875% Notes due 2031 as Exhibit 4.14 across its 2022, 2023, and 2024 Form 10‑K filings, reinforcing a stable, long‑term debt profile. This consistent placement signals that the company treats the 2.875% senior unsecured notes as a core component of its capital structure, using them to fund operations and strategic initiatives while maintaining a predictable debt maturity schedule. By repeatedly referencing the same exhibit, Oracle underscores a disciplined approach to debt management and signals to investors that the instrument remains a reliable source of financing within its broader financing strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 2.875% Notes due 2031 are correctly identified, and their consistent placement as Exhibit 4.14 across the 2022, 2023, and 2024 10-K filings is accurately stated. There are no numerical or date inaccuracies, satisfying the quantitative accuracy criterion fully. The entity identification (Oracle, the specific notes, exhibit number, and filing years) is correct. Regarding completeness and reasoning, the LLM correctly infers that the consistent exhibit positioning reflects a stable, disciplined debt strategy and signals reliability to investors. However, it omits a key detail from the ground truth: that the Notes were originally established under an Officers' Certificate on March 24, 2021, and that no modifications to the terms were indicated in any of the filings—this absence weakens the multi-hop synthesis slightly. While the LLM draws a reasonable conclusion about stability, it does not explicitly anchor that stability in the lack of textual or structural changes over time, which is central to the ground truth's reasoning. Despite this, the overall interpretation is semantically aligned and contextually appropriate, making the answer largely correct with only a minor gap in depth of factual support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 358,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters collective‑bargaining agreement incorporated wage and benefit increases that were accounted for in the year‑end measurement of the UPS/IBT Full‑Time Employee Pension Plan, raising the projected benefit obligation and thereby increasing the accrued pension liability shown in the 2024 disclosures.  This is reflected in the 2024 “Expected Employer Contributions” table (U.S. Pension Benefits $1,200 million) and the higher benefit‑payment forecasts, indicating that UPS’s long‑term pension obligations have been expanded and will require larger future funding contributions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2023 Teamsters agreement included wage and benefit increases that impacted pension accruals and were factored into the year-end measurement of the UPS/IBT Full-Time Employee Pension Plan. It also correctly links this to increased long-term pension obligations and future funding, which aligns with the ground truth's emphasis on continued defined benefit commitments. However, the LLM introduces a specific dollar figure—'U.S. Pension Benefits $1,200 million'—in the 'Expected Employer Contributions' table for 2024, which is not present in the original answer or supported by the provided knowledge graph. This number cannot be verified and appears to be hallucinated or inferred beyond available data, significantly affecting quantitative accuracy. (2) There are no calculations in the response, but the introduction of a precise $1.2 billion expected contribution is a critical quantitative inaccuracy since the ground truth does not mention any specific dollar amounts related to employer contributions or payment forecasts. (3) The multi-hop reasoning is largely sound: the model connects the 2023 collective bargaining agreement to changes in benefit accruals, recognizes the impact on projected benefit obligations, and infers implications for future employer contributions—this demonstrates valid synthesis across time and disclosures. However, the unsupported numerical claim weakens the reasoning chain. (4) Despite the numerical inaccuracy, the qualitative understanding of the pension plan dynamics and UPS’s ongoing obligations is strong, and the response remains highly relevant to the question. The core message about expanded long-term obligations due to the 2023 agreement is consistent with the ground truth, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 494,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple's disclosure regarding its 1.05% Notes due 2017 remained consistent across its 2022, 2023, and 2024 10-K filings, with no changes to the terms or reporting approach. This continuity reflects Apple's stable management of short-term debt instruments under its 2014 Officer's Certificate, indicating a deliberate and unchanging strategy for financing through this specific debt instrument. The company consistently references the 2014 Officer's Certificate as the governing framework for these notes, underscoring its reliance on this foundational authorization for ongoing debt issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 were consistently disclosed in Apple's 2022, 2023, and 2024 10-K filings; the notes are governed by the Officer's Certificate dated May 6, 2014. These details match the original answer. (2) Quantitative accuracy is perfect: the interest rate (1.05%), maturity year (2017), and the date of the Officer's Certificate (2014) are all correctly stated. No calculations were required, but the temporal consistency across three reporting years is accurately acknowledged. (3) The multi-hop reasoning is sound—linking repeated disclosure across years to Apple’s approach to debt management under the 2014 framework. The LLM correctly infers a stable, passive strategy from unchanged disclosures. (4) The only minor shortcoming is that the LLM emphasizes 'reliance on this foundational authorization for ongoing debt issuance,' which slightly shifts focus toward future issuance, while the ground truth emphasizes Apple's *inaction* in modifying or refinancing this specific matured instrument, highlighting stability in capital structure rather than continued use. This subtle interpretive difference prevents a perfect 10 on qualitative accuracy, but the core reasoning remains strong. Overall, the answer is highly relevant, factually correct, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 391,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple's 2.40% Notes due 2023 were first disclosed in the 2013 indenture (4.3) within its 10-K filings, with subsequent reaffirmations in 2014 (4.4), 2015 (4.5), 2017 (4.6), 2019 (4.9), and 2022 (4.15) through updated officer certificates and exhibit filings. This multi-year pattern of re-filing the same debt instrument across successive 10-K reports reflects Apple's disciplined, long-term debt management strategy of maintaining a stable, low-cost financing structure with minimal refinancing activity, ensuring predictable obligations while preserving financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing, based on an Officer's Certificate dated May 3, 2013. However, the LLM claims the note was disclosed in a 2013 indenture and repeatedly re-filed in 2014, 2015, 2017, 2019, and 2022, which contradicts the ground truth that the disclosure only appeared starting in 2022. These earlier dates (2013–2019) are not supported by the original answer and represent a fundamental error. (2) The quantitative inaccuracies include incorrect years of disclosure (2013, 2014, 2015, etc.) and exhibit numbers (4.3, 4.4, 4.5, etc.), which are not mentioned or verified in the ground truth. The only correct numeric elements are the '2.40% Notes due 2023', which are correctly identified. (3) The multi-hop reasoning is flawed: the LLM infers a long-term pattern of re-filing from 2013 onward, but the ground truth indicates the note was only disclosed in 2022, 2023, and 2024 with no changes—meaning there is no evidence of prior re-filings. The conclusion about Apple’s debt strategy is partially reasonable but based on incorrect premises. (4) The contextual relevance is moderate because the answer addresses debt management strategy and disclosure patterns, but the factual foundation is unsound, leading to an incorrect interpretation of the timeline and thus misleading conclusions. The answer fabricates a multi-year disclosure history that does not align with the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 425,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 through 2024, Vraylar’s commercial trajectory accelerated markedly. In October 2021 AbbVie reported top‑line Phase 3 data showing Vraylar met its primary endpoint in a major depressive‑disorder adjunct study (Study 3111‑301‑001) and demonstrated numerical improvement in another (Study 3111‑302‑001), establishing a new indication in major depressive disorder and reinforcing its broader neuroscience positioning. Subsequent filings and approvals expanded its use: in 2022 the FDA approved Vraylar for the treatment of major depressive disorder as an adjunctive therapy, and in 2023‑2024 the drug continued to be promoted for both schizophrenia and bipolar disorder, contributing to double‑digit revenue growth (35 %+ at constant currency) within AbbVie’s neuroscience portfolio. Its therapeutic positioning shifted from a primarily antipsychotic to a versatile mood‑stabilizer/antidepressant adjunct, bolstering its share of AbbVie’s $2.8 billion neuroscience sales and supporting overall revenue expansion despite declines in legacy products such as Humira.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core commercial trajectory of Vraylar correctly—highlighting its clinical development in MDD, revenue growth, and expanded therapeutic positioning within AbbVie's neuroscience portfolio. However, there are key factual inaccuracies: the Phase 3 trials were conducted and reported in 2022 (not 2021 as stated), and the FDA approval for MDD as an adjunctive therapy occurred in December 2023, not 2022. The LLM incorrectly backdates these events, which affects timeline accuracy. (2) Quantitatively, the LLM states 'double-digit revenue growth (35%+ at constant currency)' which aligns with the ground truth 35.2% increase in U.S. sales from $2,037M to $2,755M. However, it rounds and generalizes the figure without citing exact values. The ground truth specifies $2,759 million in total sales for 2023; the LLM cites '$2.8 billion', which is acceptably close but slightly imprecise. The LLM omits the exact 2022 U.S. sales figure and does not distinguish between U.S. and total sales clearly. (3) The multi-hop reasoning is generally sound: the model connects clinical progress to regulatory approval, then to revenue impact and strategic portfolio positioning. It correctly identifies Vraylar’s expanded role beyond antipsychotic use into mood stabilization and adjunctive depression treatment. However, it misattributes the timing of FDA approval and trial results, weakening the causal chain. (4) Despite timing errors, the answer remains contextually rich and relevant, accurately portraying Vraylar’s growing importance in AbbVie’s portfolio amid Humira’s decline. The qualitative synthesis of clinical, commercial, and strategic dimensions is strong. Scores reflect minor but notable factual inaccuracies in dates and numbers, with otherwise solid reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 493,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM’s 2022‑2024 disclosures show a deliberate, multi‑year evolution of its competitive narrative: in 2022 the filing framed client relationships and trust as core differentiators that enable the company to “bring together incumbency with enterprises, deep expertise, a broad go‑to‑market ecosystem and a strong focus on innovation,” positioning IBM as a trusted hybrid‑cloud and AI partner; by 2023 the language expanded to emphasize “sustained value for clients” and the integration of AI‑driven transformations across applications, data and environments, while still highlighting trust as a key pillar of its market leadership; and in 2024 the emphasis sharpened further, linking trust directly to the ability to “leverage the power of hybrid cloud and artificial intelligence” and to differentiate through “technology innovation; performance; brand; our breadth of capabilities, products and services; talent; client relationships and trust.” This progression signals that IBM is deliberately consolidating its hybrid‑cloud and AI strategy around trusted, long‑term client partnerships, using that trust as a moat to sustain growth and fend off competition in a market where new entrants and hyperscalers are emerging.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in both factual content and reasoning. (1) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the evolution of IBM's emphasis on client relationships and trust across 2022, 2023, and 2024, accurately reflecting the progression: from trust as a differentiator in hybrid cloud and AI in 2022, to expanded focus on sustained client value and AI integration in 2023, and in 2024 to trust as a strategic enabler within a broader ecosystem. These points are semantically equivalent to the ground truth, which notes the deepening of trust as an enabler of client-centric innovation. (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly contextualized within IBM’s strategic positioning in hybrid cloud and AI. The LLM adds slightly more detail (e.g., quoting 'technology innovation; performance; brand...') that is consistent with the direction of the original answer but not explicitly in the ground truth; however, this does not introduce inaccuracies. (4) The answer fully addresses both parts of the question: the evolution from 2022–2024 and what it indicates about strategic positioning. The conclusion that IBM is using trust as a 'moat' against hyperscalers is a reasonable interpretation and enhances the original without distorting it. Only a minor deduction in qualitative accuracy due to slight interpretive expansion beyond the ground truth’s scope. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 467,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "From 2022 through 2024 IBM’s disclosures about its 1.250% Notes due 2027 remained consistent in form but showed a gradual shift in focus. Earlier filings (2022) listed the notes among the company’s various debt securities and incorporated them by reference to the 2017 8‑K that defined the instrument, while the 2023 and 2024 10‑Ks continued to reference the same 8‑K filings but placed the notes in a broader “Risk Factors” discussion about debt‑security market volatility and liquidity. The 2024 filing also highlighted that the notes are part of IBM’s overall capital‑structure and noted the company’s ability to manage interest‑rate and credit‑rating risks, reflecting a more explicit acknowledgment of the notes’ role within the debt portfolio. Overall, disclosure practices evolved from simple incorporation by reference to a more detailed, risk‑oriented narrative that underscores the notes’ place in IBM’s diversified borrowing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. First, it incorrectly states that the 1.250% Notes due 2027 were incorporated by reference to a '2017 8-K', while the ground truth specifies the correct filing date as January 30, 2019 (Form 8-K), not 2017. This is a critical error in both year and document type context. Second, the LLM claims that in 2023 and 2024, the notes were discussed in the context of 'Risk Factors' related to market volatility and liquidity, which is not supported by the original answer—no such risk-oriented narrative is mentioned in the ground truth. Instead, the actual evolution involves increasing structural recognition: from being listed among other instruments in 2022, to being tied to more recent filings in 2023, and finally being assigned a distinct trading symbol (IBM27B) in 2024, indicating formal market recognition. The LLM completely misses this key development—the assignment of a trading symbol—which is central to the original answer’s conclusion about transparency and active trading status. While the LLM correctly identifies a trend toward more detailed disclosure and acknowledges the note's role in the capital structure, this reasoning is based on fabricated details rather than the actual progression in disclosure practices. The qualitative accuracy is partially preserved due to the correct general direction of increased emphasis, but the faulty entities and invented risk discussions reduce its validity. Contextually, the response stays on topic and addresses the question’s scope, hence a moderate relevance score. Overall, the answer fails on key factual and multi-hop synthesis points, particularly around dates, filing references, and the critical 2024 trading symbol designation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 484,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM's disclosures regarding the 6.50% Debentures due 2028 consistently reference the same Exhibit 2 filing in Form 8‑K (January 8 1998) across the 2022, 2023 and 2024 10‑K filings, indicating a stable, unchanged exhibit reference over the three‑year period. This continuity reflects IBM’s broader practice of maintaining consistent exhibit numbering for its legacy debt instruments while integrating them into updated regulatory sections (e.g., Item 15, Exhibits) and reiterating the same description of the debenture rights in each filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct on all key points: it accurately states that IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K filed on January 8, 1998, across 2022, 2023, and 2024, which matches the ground truth. The dates, percentages, and exhibit references are all correct (quantitative accuracy = 10). The answer correctly identifies the consistency in exhibit referencing and links it to IBM's practice of maintaining stable documentation for legacy debt. However, the LLM omits part of the broader context described in the original answer—specifically, the evolution of IBM’s debt disclosures over time, such as the shift in focus from listing a wide range of debt instruments in 2022 to integrating legacy debt with newer instruments like the 6.22% Debentures due 2027 and 5.875% Debentures due 2032 in 2023 and 2024. This missing nuance limits the completeness of the multi-hop synthesis, particularly around how the broader disclosure strategy evolved. While the core reasoning about consistency is sound, the lack of discussion on the changing context of debt presentation reduces qualitative accuracy. The answer remains highly relevant and correct on the central point of exhibit consistency, earning high marks for contextual relevance and quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 364,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "From 2022 to 2024, FedEx expanded FedEx International Connect Plus from \"nearly 60 origin countries to over 190 destination countries\" (2023) to \"nearly 50 origin countries to over 130 destination countries\" (2024), reflecting a strategic contraction in geographic scope. This reduction—from a broader initial rollout to a more focused network—suggests FedEx is prioritizing efficiency and profitability over geographic expansion in e-commerce logistics, likely to optimize asset utilization and margins amid market volatility, rather than pursuing aggressive market share growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the geographic evolution. It falsely claims that FedEx International Connect Plus contracted from 2022 to 2024, stating it went from 'nearly 60 origin countries to over 190 destination countries' in 2023 to 'nearly 50 origin countries to over 130 destination countries' in 2024. This reverses the actual trend. Ground truth shows expansion from nearly 50 origin and over 130 destination countries in 2022 to nearly 60 and over 190 in 2023, with stabilization in 2024. The LLM incorrectly assigns the 2022 figures to 2024 and vice versa. (2) Quantitative accuracy is severely flawed: it misattributes years to data points, inverts growth into contraction, and thus invalidates all numerical claims. No correct calculations or comparisons are made. (3) Reasoning is fundamentally unsound due to incorrect data synthesis. The conclusion about 'strategic contraction' and prioritizing efficiency over expansion is based on fabricated trends, failing the multi-hop reasoning requirement to track changes over time across reported data points. (4) Contextual relevance is low but not zero—the answer addresses the right service and general topic (e-commerce logistics strategy), so partial credit is given for topical alignment, but factual and logical failures dominate the evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 380,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "From fiscal 2022 through 2024, Qualcomm’s human‑capital objectives were tied directly to executive pay. In 2022 the HR and Compensation Committee used progress on diversity targets—specifically increasing women in leadership by 15 % and under‑represented minorities in leadership by 15 %—as a non‑financial modifier that could adjust the fiscal‑2022 bonus by a multiplier of 0.9 to 1.1. The same linkage continued in 2023 and 2024, with the 2024 bonus again adjusted by a 0.9‑to‑1.1 multiplier based on achievement of the 2025 diversity goals (e.g., +15 % women and URM leaders, +20 % overall URM representation). These goals are tracked annually and form part of the performance‑based compensation structure for top executives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All key facts are correct: the 0.9 to 1.1 bonus adjustment multiplier is accurately reported for 2022, 2023, and 2024; the diversity targets—15% increase in women in leadership, 15% in underrepresented minorities (URM) in leadership, and 20% overall URM representation by 2025—are correctly stated. (2) Quantitative accuracy is perfect: all percentages and the bonus multiplier range match the original answer exactly. (3) The multi-hop reasoning is sound: the LLM correctly links human capital goals to executive compensation across fiscal years 2022–2024 and recognizes the continuity of targets and mechanisms. (4) The only minor omission is that the LLM does not mention the Reboot Representation Tech Coalition or the emphasis on external partnerships and degree attainment goals, which were part of the evolving strategy in 2023–2024. While this contextual detail adds depth to the 'evolution' aspect of the question, its absence does not undermine the central factual claims about compensation linkage and target stability. Thus, the answer is semantically equivalent in terms of strategic framework and incentive design, earning a high score with only a slight deduction in qualitative accuracy for missing supplementary context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 369,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures through 2024 reflects a strategic approach to managing short-term interest rate risk by maintaining flexibility in its financing structure amid shifting monetary policy. These notes, referenced in multiple 10-K filings (2022–2024), allow Apple to adjust interest costs quickly in rising rate environments, supporting liquidity planning while preserving capital efficiency. Their persistent disclosure underscores a deliberate focus on mitigating interest rate volatility without locking into long-term fixed-rate obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Apple, Floating Rate Notes due 2019, and the disclosure period (2022–2024) match the original answer. There are no numerical values to verify beyond years, which are accurate. (2) The quantitative accuracy is perfect—dates (2019 maturity, disclosures through 2024) are correctly cited and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that continued disclosure implies ongoing strategic use of these instruments for interest rate risk management, even though the notes matured in 2019. This reflects an understanding that disclosure persistence indicates accounting or strategic continuity, likely due to rollover, restructuring, or ongoing exposure. The LLM correctly links this to flexibility in financing and liquidity planning. (4) The only minor shortcoming is that the original answer emphasizes Apple’s 'stable' and 'deliberate' approach and explicitly notes that no new short-term instruments were issued—nuances slightly underdeveloped in the LLM response. However, the core reasoning about adaptive risk management and avoiding long-term fixed-rate obligations is semantically equivalent. The answer is contextually excellent, directly addressing both interest rate risk and liquidity planning as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 380,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s strategic focus on Digital Cockpit technology evolved through its QCT segment, which reported automotive revenues of $2.91 billion in fiscal 2024 (up from $1.509 billion in 2022), reflecting growing demand for connectivity, digital cockpit and ADAS/AD solutions. This growth aligns with industry projections that over 70 % of new vehicles by 2028 will embed cellular connectivity, with 60 % featuring 5G, underscoring expanding market demand for Qualcomm’s automotive‑focused integrated circuits.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not mention specific revenue figures for 2022 ($1.509 billion) or 2024 ($2.91 billion), nor does it state that automotive revenues grew from $1.509B to $2.91B. These numbers are fabricated or hallucinated, as the original answer only discusses strategic evolution and market projections, not segment-level revenue figures. Additionally, the LLM claims 'over 70% of new vehicles by 2028 will embed cellular connectivity,' while the ground truth states 'over 60% of new vehicles would feature 5G connectivity by 2028'—a different metric (cellular vs. 5G) and percentage. (2) The calculation of revenue growth is not verifiable because the original answer does not provide any revenue data; thus, the LLM introduces unsupported numerical claims. (3) Qualitatively, the LLM captures part of the strategic evolution—mentioning QCT segment focus, digital cockpit, ADAS/AD, and market demand—but misses key aspects of the multi-hop reasoning: it fails to describe the progression from 2022 (market positioning and R&D emphasis), 2023 (commercial sales/revenue generation), to 2024 (formal integration into QCT structure). Instead, it jumps to fiscal 2024 revenues without acknowledging the 2023 milestone of moving from development to sales. (4) Contextually, the answer is relevant and addresses Qualcomm's strategic focus and market demand, but the inclusion of false quantitative data undermines factual correctness. While the general direction of growth and strategic importance is aligned, the reliance on incorrect numbers and omission of the phased evolution (especially the 2023 transition to revenue) reduces accuracy. Therefore, the correctness score is 5—partially correct with major factual flaws in numbers and incomplete multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 500,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott's unfunded commitments to private real estate funds declined modestly from $569 million at the end of 2022 to $555 million at the end of 2023, and further to $540 million by the end of 2024. This downward trend indicates that the company is gradually reducing its exposure to illiquid alternative assets, suggesting a strategic shift toward managing or de‑risking its longer‑term private‑fund investments while still maintaining a sizable but shrinking commitment to private real estate and related funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $569 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The year-over-year decreases of $14 million and $15 million are accurately reflected as a 'modest' and continued decline, with no calculation or formatting errors. (2) Quantitative accuracy is perfect—values are correct, consistent, and properly attributed to the right years. The implied annual reduction (~$15M) is correctly interpreted as a gradual trend. (3) The reasoning is sound: the model correctly infers a strategic de-risking or cautious management of illiquid alternative assets, aligning with the ground truth's interpretation. However, it omits the specific detail about liquidation periods extending to 2025–2034, which supports the nuance that Abbott is not exiting but carefully managing exposure. This minor omission slightly weakens the qualitative completeness of the multi-hop synthesis. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of commitments and the strategic implication. The conclusion about a 'strategic shift toward managing or de-risking' is semantically equivalent to the ground truth's 'strategic de-risking or rebalancing.' Overall, the answer is factually complete and well-reasoned, meriting a high score with only a slight deduction in qualitative accuracy due to the missing liquidation timeline context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 409,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Based on the provided 10-K filings, Apple issued $1.0 billion of 0.45% Notes due 2016 in 2013 (as disclosed in the 2013 debt indenture filings), and the company continued to roll forward similar low‑coupon, long‑dated notes in subsequent years. The 2022 filing shows the 0.45% 2016 notes were still outstanding but were later refinanced with newer floating‑rate and fixed‑rate notes (e.g., 2022‑2024 issuances of 0.875%‑1.625% notes). This pattern reflects Apple’s strategy of maintaining a diversified, low‑cost debt profile by issuing long‑dated, low‑coupon securities and periodically replacing maturing tranches with new floating‑rate or fixed‑rate instruments to manage interest‑rate exposure and preserve financial flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K, but these notes were actually issued in 2013 and would have been disclosed much earlier; the 2022–2024 filings merely repeated the disclosure. The LLM incorrectly implies the notes were still outstanding in 2022, despite maturing in 2016—six years prior. This is a critical error in timeline and debt status. Additionally, the LLM claims the notes were 'refinanced with newer floating-rate and fixed-rate notes (e.g., 2022–2024 issuances of 0.875%–1.625% notes)', but the ground truth does not mention refinancing or specific new notes, nor does it support the claim that Apple issued floating-rate instruments during this period. (2) Quantitative inaccuracies include the assertion that $1.0 billion was issued—this amount is not in the original answer and cannot be verified from the provided truth. The interest rate (0.45%) and maturity (2016) are correct, as is the 2013 issuance date, but the claim that the notes were still outstanding in 2022 is factually impossible given their 2016 maturity. (3) The multi-hop reasoning is flawed: the model infers refinancing and strategic debt rotation without evidence in the ground truth. While Apple does maintain a diversified debt strategy, the specific evolution described—rolling forward, refinancing, issuing floating-rate notes—is speculative and unsupported. The original answer emphasizes consistency in disclosure, not refinancing activity. (4) Despite these errors, the LLM captures the general idea of a stable, low-cost debt strategy, which aligns with Apple’s known financial behavior, giving it partial credit for qualitative insight and contextual relevance. However, the factual and temporal inaccuracies severely undermine correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 514,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM's emphasis on client relationships and trust has evolved from a stated competitive differentiator in 2022 through 2024, consistently positioned alongside technology innovation and AI as a core pillar of its strategy. Across the 2022, 2023, and 2024 10-K filings, IBM repeatedly underscores that its \"breadth of capabilities, products and services; talent; client relationships and trust; the ability to deliver business value\" are central to maintaining leadership in hybrid cloud and AI, with explicit references to these attributes enabling differentiation in competitive landscapes. This multi-year progression reveals a deliberate strategic positioning where trust is not merely a byproduct but an intentional, scalable differentiator that underpins client retention and market expansion in high-value, regulated industries—directly supporting its hybrid cloud and AI growth ambitions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and strategic narrative. It accurately identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator from 2022 to 2024 and correctly links this to its hybrid cloud and AI strategy. The answer appropriately references the 10-K filings and correctly characterizes trust as an intentional, scalable differentiator supporting growth in regulated industries. However, it lacks the nuanced evolution described in the ground truth: while the original answer details a progression—where trust was initially part of a broader innovation portfolio (2022), more tightly linked to consulting and infrastructure (2023), and increasingly tied to strategic partnerships (2024)—the LLM response treats the emphasis as relatively static across years, missing this maturing integration with ecosystem collaboration. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and all entities (IBM, hybrid cloud, AI, 2022–2024 timeframe) are correct. The reasoning is sound but less granular in tracing year-by-year strategic refinement. Contextual relevance is excellent, directly addressing the question’s focus on strategic positioning. Thus, while factually accurate and well-aligned overall, the answer falls slightly short on capturing the full multi-year progression, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 400,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "The evolution of FedEx’s liquidity arrangements for the 4.250% Note due 2030—from its initial issuance in April 2020 through subsequent supplemental indentures and amendments through 2024—shows a deliberate, incremental tightening of the company’s credit support framework. By adding new security agreements, expanding the trust structure, and amending the revolving credit facility in 2023, FedEx has progressively reinforced the legal and financial backing of the 2030 note, underscoring a proactive approach to maintaining robust credit support while preserving flexibility for future financing needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that the 4.250% Note was issued in April 2020, while the ground truth does not specify an issuance date and instead focuses on liquidity arrangements tied to the 2020 Revolving Credit Agreement dated August 13, 2020. The LLM also fabricates details such as 'supplemental indentures,' 'new security agreements,' and 'expanding the trust structure,' none of which are mentioned in the original answer. The only correct event is the 2023 amendment to the revolving credit facility, specifically Amendment No. 1 filed on May 22, 2023. However, the LLM mischaracterizes this as part of a broader 'tightening' and 'reinforcement' of credit support, whereas the ground truth describes it as a single proactive adjustment with no further changes in 2024, indicating stability rather than escalation. (2) Quantitative accuracy is low: the LLM invents a timeline (April 2020 issuance) and implies multiple amendments through 2024, while the ground truth confirms only one amendment in 2023 and no changes in 2024. There are no dollar amounts or percentages to verify beyond the 4.250% rate, which is correctly referenced. (3) Multi-hop reasoning is partially sound—the LLM attempts to synthesize changes over time and draw a conclusion about FedEx’s strategy—but it does so based on incorrect or invented facts. The actual reasoning in the ground truth emphasizes consistency of the core arrangement with a single modification, suggesting stability and adaptability, not a 'deliberate tightening.' (4) Scores reflect that while the answer addresses the general topic and timeframe, and correctly notes the 2023 amendment, it introduces significant fictional elements and misrepresents the nature and extent of changes, undermining factual correctness and qualitative accuracy. Contextual relevance is moderate because the structure and intent align with the question, but factual divergence limits usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 536,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple's long-term debt structure shows a consistent pattern of issuing new tranches of senior unsecured notes with staggered maturities extending to 2044, as evidenced by the 4.45% Notes due 2044 first referenced in the 2014 8-K filing (page 56 of 2022 filing) and still outstanding in 2024 filings. This multi-year pattern of issuing new long-term debt while maintaining existing obligations suggests Apple's long-term financing strategy prioritizes low-cost, fixed-rate capital with extended maturities to manage interest rate risk and fund ongoing operations and shareholder returns without significant refinancing pressure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.45% Notes due 2044 and their presence in filings through 2024, which aligns with the ground truth. However, it incorrectly implies that Apple issued new tranches of these notes during 2022–2024, when in fact the 4.45% Notes were originally issued in 2014 and remained outstanding without new issuance during the analyzed period. This misrepresents the evolution of the debt structure. (2) Quantitatively, the percentage (4.45%), maturity year (2044), and reference to the 2014 issuance (via 8-K filing) are accurate. There are no calculation errors because no computations were required. (3) The multi-hop reasoning is partially flawed: while the model correctly synthesizes the continued reporting of the notes across years, it draws an incorrect inference about new issuances and Apple’s strategy involving staggered new tranches, which is not supported by the ground truth. The original answer emphasizes stability and lack of restructuring, whereas the LLM suggests active new issuance, which changes the strategic interpretation. (4) The contextual relevance is high because the response addresses long-term debt evolution and financing strategy. However, the qualitative inaccuracy in reasoning and entity dynamics (issuance timing) reduces the correctness score despite accurate dates and rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 378,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "From 2022 to 2024, FedEx expanded its e-commerce logistics reach through the FedEx International Connect Plus service, which grew from \"nearly 50 origin countries to over 130 destination countries\" (2022) to \"nearly 60 origin countries to over 190 destination countries\" (2023/2024), offering day-definite delivery within two to five business days. This expansion reflects FedEx's strategic focus on capturing high-growth e-commerce demand by enhancing its cross-border, time-definite delivery capabilities, particularly for small and medium-sized businesses relying on integrated fulfillment solutions like FedEx Fulfillment. The trajectory underscores a deliberate shift toward digital-enabled, scalable logistics services to strengthen its position in the global e-commerce supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic expansion of FedEx International Connect Plus from nearly 50 origin and over 130 destination countries in 2022 to nearly 60 origin and over 190 destination countries in 2023. It accurately notes that this expanded footprint remained stable into 2024, aligning with the ground truth's emphasis on a two-year expansion followed by stabilization. All numeric values (origin/destination country counts and years) are factually correct and match the original answer. (2) Quantitative accuracy is perfect: the numbers for both origin and destination countries across 2022 and 2023 are correctly cited, and the absence of further expansion in 2024 is implied by the use of '2023/2024' to describe the same footprint, which is semantically acceptable. (3) The multi-hop reasoning is sound—linking service expansion to strategic focus in e-commerce logistics. The LLM correctly infers FedEx’s intent to capture global e-commerce demand, especially among SMEs, and ties it to integrated solutions like FedEx Fulfillment. While the original answer emphasizes 'emerging markets' and 'consolidation and optimization,' the LLM substitutes with 'high-growth e-commerce demand' and 'scalable logistics services,' which are contextually appropriate but slightly less precise in capturing the stabilization phase. (4) The answer is highly relevant, directly addressing both the evolution of geographic reach and strategic implications. The minor deduction in qualitative accuracy is due to the conflation of 2023 and 2024 data without explicitly noting that the expansion plateaued in 2024, which slightly weakens the nuance of the strategic consolidation phase. Overall, the answer is factually robust, well-reasoned, and contextually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 486,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple's 1.05% Notes due 2017 were referenced in disclosures across fiscal years 2022, 2023, and 2024 as part of its debt management strategy, with related indentures and officer certificates filed in Forms 8-K and 10-K (e.g., Exhibit 4.4 in 2014 and 4.6 in 2015 filings). The continued disclosure of these notes in regulatory filings reflects Apple's systematic approach to managing maturing debt obligations, ensuring transparency about long-term financing structures and maintaining access to capital markets through structured debt instruments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core fact that Apple continued to reference the 1.05% Notes due 2017 in its disclosures through fiscal years 2022–2024, which aligns with the ground truth. It correctly identifies Exhibit 4.4 as a key document and notes the inclusion of officer certificates, consistent with the original answer. However, there are notable inaccuracies: (1) The LLM references 'Exhibit 4.6 in 2015 filings', which is not mentioned or supported in the ground truth and introduces an unverified exhibit and year; (2) It generalizes about 'Forms 8-K and 10-K' without specifying that the consistent reference was in 10-K filings specifically in Exhibits 4.4 across all three years (2022–2024), weakening precision. While the ground truth emphasizes that the notes were matured in 2017 and still retained in disclosures with no changes, the LLM does not explicitly acknowledge the maturity date versus continued disclosure, which is central to the question. The reasoning about Apple’s 'systematic approach' and 'transparency' is plausible but more interpretive than the grounded, evidence-based conclusion in the original answer about a 'standardized disclosure framework' or possible refinancing reflection. The LLM misses the nuance that no updates were provided over the three years, which is a key observation. Quantitatively, the percentage (1.05%) and maturity year (2017) are correct, and no numerical calculations are required. Contextually, the answer stays on-topic and addresses debt management strategy, though with less evidentiary support. Thus, the answer is partially correct with significant but not critical omissions and minor factual overreach, warranting a 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 464,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From fiscal 2022 through 2024, Qualcomm’s 5G strategy remained anchored in its dual‑track model: it continued to expand its patent portfolio and licensing framework for 5G (including OFDMA‑based and CDMA‑based standards) while simultaneously investing heavily in the development of 5G‑enabled chipsets, RF front‑end modules, and integrated platforms such as Snapdragon 5G modem‑RF products.  This commitment is reflected in the company’s repeated statements that it “has invested and continues to invest in the development of 5G” and that its patents are essential for 5G NR, LTE‑Advanced, and related standards.  At the same time, the firm emphasized that its licensing revenue—derived from royalties on CDMA/OFDMA multimode devices—remains a core cash‑generating engine, even as it faces heightened scrutiny and potential regulatory or legal challenges that could alter licensing terms or bases.  Geopolitical tensions, especially U.S.–China trade and national‑security restrictions, have amplified exposure to Chinese OEMs and supply‑chain dependencies, prompting Qualcomm to highlight both the risk of reduced sales to Chinese customers and the potential for forced changes to its licensing practices.  Overall, the company’s financial commitment to 5G has been sustained through continued R&D spending, strategic investments in related technologies (AI, automotive, IoT), and a focus on maintaining a broad, industry‑wide patent licensing model, while navigating evolving regulatory, legal, and geopolitical headwinds.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution of Qualcomm's 5G focus across fiscal years 2022–2024, including licensing revenue importance, R&D investment, and geopolitical risks. However, it omits specific quantitative data points from the ground truth, notably the $560 million in revenue from Huawei in fiscal 2024 prior to the export license revocation and the projection of 27 billion IoT devices by 2026. These omissions affect quantitative accuracy. (2) While the LLM correctly references OFDMA-based licensing and geopolitical risks (e.g., U.S.-China tensions), it fails to include exact figures that are central to the original answer, such as the Huawei-related $560M and the 2026 IoT projection. These are key multi-hop facts that link financial impact to strategic decisions. (3) The reasoning is sound and synthesizes Qualcomm’s dual strategy of licensing and product development, correctly identifying AI, automotive, and IoT as focus areas. It also accurately reflects the risk of regulatory changes and supply-chain dependencies. However, it does not explicitly connect the Huawei export ban to a specific financial impact, weakening the multi-hop synthesis between geopolitical events and financial outcomes. (4) The answer is contextually rich and well-structured, addressing all thematic components of the question—licensing, investment, and risk—though with less precision on time-bound financial commitments. The qualitative reasoning and entity identification (e.g., QTL, Snapdragon, 5G NR) are accurate. The correctness score is 7 due to accurate overall narrative but missing key numbers; quantitative accuracy is 6 due to absence of critical dollar amounts and projections; qualitative and contextual scores are higher due to strong synthesis and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 489,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024, Thermo Fisher Scientific's domestic pension plan asset allocation remained relatively stable, with U.S. equity funds holding approximately 9-10% of total domestic pension assets (rising slightly from $89 million in 2022 to $93 million in 2023), international equity funds holding about 9-10% ($91 million to $93 million), and fixed income funds consistently comprising the vast majority at approximately 78-79% ($739 million in both 2022 and 2023). This stability reflects a consistent investment strategy focused on liability-driven investing, where the portfolio maintains a strategic allocation of roughly 10% U.S. equities, 10% international equities, and 80% fixed income securities to manage interest rate volatility and ensure liquidity for benefit payments, with minimal shifts observed across the three-year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that U.S. equity allocations rose from $89M in 2022 to $93M in 2023, when in fact in 2022 the allocation was $125M, not $89M. The $89M figure is from 2023, not 2022. Similarly, international equity was $126M in 2022, not $91M as implied. The LLM also falsely claims fixed income was $739M in both 2022 and 2023, but in 2022 it was $1,001M. These errors completely misrepresent the data. (2) Calculations and percentages are therefore also wrong. For example, claiming fixed income comprised ~78-79% in 2022 is incorrect — with total assets of $1,267M in 2022, $1,001M in fixed income is ~79%, but the LLM uses the wrong base year numbers. The total asset decline from $1,267M to $937M in 2023 is entirely omitted. (3) The multi-hop reasoning is flawed: the original answer identifies a significant strategic shift — a sharp reduction in equity and fixed income allocations in 2023 followed by stabilization in 2024 — but the LLM incorrectly concludes there was 'relative stability' and a 'consistent strategy', which contradicts the actual trend of major downsizing in 2023. (4) The contextual relevance is moderate because the answer addresses the right topic (asset allocation evolution) and uses appropriate financial terminology, but the factual foundation is so incorrect that the conclusion is invalid. The LLM appears to have misread the years, swapping 2022 and 2023 data, leading to a completely inaccurate narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 419,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s strategic positioning in the edge networking market evolved through targeted product development and revenue diversification. In fiscal 2022, IoT revenue (including edge networking) declined to $7.353B from $5.94B in 2023 and $5.423B in 2024, reflecting reduced demand in industrial and consumer applications. However, Qualcomm expanded its edge networking focus through 5G-enabled connectivity solutions, as highlighted in the 2022 document noting \"5G provides flexibility to support both mobile and fixed wireless users\" and \"advancements in WiFi are driving demand for Wi-Fi 6/6E access points.\" By 2024, edge networking became a key growth driver within the IoT segment, contributing to $5.423B in IoT revenue (2024), up from $5.94B in 2023 but down from $7.353B in 2022. This shift aligns with Qualcomm’s broader strategy to leverage 5G for edge computing, as emphasized in the 2022 \"Connected Intelligent Edge\" narrative describing \"billions of smart devices\" deployment across industries. Revenue contributions from edge networking-related segments (IoT and automotive) grew steadily, with automotive revenue rising to $2.91B in 2024 from $1.509B in 2022, supporting edge applications in vehicles. The company’s focus on 5G infrastructure, Wi-Fi 6/6E, and edge computing capabilities solidified its positioning as a key enabler for hybrid work and industrial IoT, driving sustained investment in edge networking technologies despite overall IoT revenue volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial data. The original answer does not mention any specific revenue figures for edge networking or IoT, nor does it state that IoT revenue declined from $7.353B in 2022 to $5.423B in 2024. In fact, the original answer does not provide any numerical data at all. The LLM fabricated precise revenue numbers and trends (e.g., IoT revenue of $7.353B in 2022, $5.94B in 2023, $5.423B in 2024) that are not present in the ground truth, which is a major factual error. Additionally, the claim that IoT revenue 'declined' but then 'up from $5.94B in 2023' to $5.423B in 2024 is internally inconsistent (5.423B < 5.94B). The automotive revenue figures ($2.91B in 2024, $1.509B in 2022) are also not in the original answer and appear to be hallucinated. (2) There are no correct numbers in the LLM response because the ground truth contains no quantitative data to verify against—thus, all numbers are incorrect by default. The LLM introduced false precision. (3) The qualitative reasoning partially aligns with the original answer: it correctly identifies Qualcomm’s growing focus on edge networking, 5G, Wi-Fi 6/6E, and hybrid work as drivers. It also correctly notes the strategic importance of edge networking within broader IoT/industrial segments. However, it fails to accurately reflect the evolution described in the original—i.e., the increasing explicit recognition of edge networking as a revenue contributor from 2022 to 2024—instead overcomplicating it with unsupported financial trends. (4) The contextual relevance is moderate because the answer addresses the right themes (product development, strategic focus, 5G, edge networking), but the inclusion of false quantitative data and misrepresentation of revenue trends severely undermines correctness. The answer creates a narrative of volatility and decline not present in the original, which describes a consistent and maturing strategic focus. Thus, while the direction of reasoning is somewhat aligned, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 561,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple's repeated inclusion of the 0.45% Notes due 2016 in its 2022‑2024 10‑K filings reflects a deliberate strategy to maintain a stable, predictable fixed‑rate debt profile, ensuring that a sizable portion of its long‑term financing remains at a known, low‑cost rate and minimizing exposure to interest‑rate volatility and refinancing risk. This consistent disclosure underscores Apple's focus on preserving capital‑structure stability while managing maturities through a diversified mix of debt instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a fundamental factual error: it assumes the 0.45% Notes due 2016 are still active and part of Apple's current debt profile in 2022–2024, which is incorrect. The original answer clarifies that these notes matured in 2016 and are no longer outstanding; their inclusion in later filings is for historical disclosure and transparency, not as active debt. This misinterpretation undermines the entire reasoning chain. While the LLM correctly identifies Apple’s general strategy of stability and low-rate financing, it incorrectly infers that the 2016 notes are still in effect, leading to flawed conclusions about managing refinancing risk and maintaining a fixed-rate profile. Quantitatively, the percentage (0.45%) and years (2016 maturity, 2022–2024 filings) are accurate, hence a moderate quantitative accuracy score. However, the qualitative reasoning fails because it does not recognize the retrospective nature of the disclosure, missing the key point that Apple is documenting past debt for transparency, not managing it as current liability. The answer is contextually relevant in discussing debt strategy but is factually incorrect in its core premise, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 340,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Based on the provided document pages, the geographic reach of Caterpillar's EMD brand distribution network remained consistent between 2022 and 2024, with the number of countries served remaining at 191 countries in 2024 (as stated in the 2024 10-K on page 64, which references the 2022 figure of 191 countries in the 2023 10-K on page 65). The document does not indicate any change in the number of countries covered by the distribution network during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that EMD's distribution network covered 130 countries in 2022 and declined to 109 in 2024. The LLM incorrectly claims the number was 191 in both 2022 and 2024, which is factually wrong. The calculation of no change is therefore invalid. (2) Completeness: The question asks about changes from 2022 to 2024, including any shifts in geographic reach. The LLM fails to report the actual decrease of 21 countries (16%) as stated in the ground truth. (3) Entity Accuracy: The LLM references 'EMD brand' correctly and the correct time frame (2022–2024), but cites incorrect data from what appears to be a misreading of the 10-K pages (e.g., page 64 of 2024 10-K and page 65 of 2023 10-K), possibly confusing EMD with another Caterpillar division or misreading the metric. (4) Reasoning: The multi-hop reasoning failed—the model should have identified the 2022 figure, confirmed stability in 2023, then noted the drop in 2024. Instead, it asserts consistency with incorrect numbers. (5) Semantic Equivalence: The conclusion (no change) contradicts the ground truth (a significant reduction), so the answers are not semantically equivalent. The LLM’s answer is contextually relevant in structure but entirely inaccurate in content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 376,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher's outstanding balance for the 1.750% 7-Year Senior Notes due 2027 was $662 million at the end of 2023 and $642 million at the end of 2022, reflecting a modest increase in the carrying amount over the two-year period. This upward trend indicates that the company is maintaining, rather than reducing, its medium‑term debt exposure, using the 1.75% notes as part of a broader strategy to fund ongoing operations and strategic investments in the healthcare sector while preserving liquidity for future growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, TMO's outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028, was $700 million in 2022, 2023, and 2024—remaining constant. However, the LLM incorrectly states the balance as $642 million in 2022 and $662 million in 2023, which contradicts the ground truth. Additionally, the maturity year is wrong: the LLM claims the notes are due in 2027, while the correct maturity is 2028. (2) The quantitative inaccuracies are severe: both the dollar amounts and the years are incorrect. There is no indication of a $20 million increase as claimed; instead, the correct data shows no change over the period. The LLM also fails to mention 2024 data, omitting a full year requested in the question. (3) The reasoning is flawed due to incorrect inputs. The conclusion that Thermo Fisher is increasing its medium-term debt exposure is unsupported by the actual data, which shows stability. The multi-hop synthesis failed—either pulling data from an incorrect source or misrepresenting the filing details. (4) Despite incorrect facts, the answer is contextually relevant in structure and attempts to interpret the company's debt strategy in the healthcare sector, hence a moderate contextual relevance score. However, the qualitative and quantitative accuracy scores are low due to fundamental errors in numbers, dates, and logical inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 400,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "Caterpillar’s approach to currency hedging evolved from a focus on traditional LIBOR‑based hedges toward an explicit reliance on SOFR‑linked instruments as part of its broader interest‑rate and liquidity‑risk management strategy.  The company disclosed that it now uses floating reference rates such as SOFR for many of its financing arrangements and manages exposure through match‑funding and selective derivatives, while also maintaining hedging programs to mitigate adverse currency movements.  This shift reflects a strategic adaptation to the global LIBOR phase‑out and the adoption of SOFR, ensuring continued access to cost‑effective funding and protecting earnings from interest‑rate volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Caterpillar's transition from LIBOR to SOFR and its use of currency hedging instruments, with no incorrect numbers or dates (quantitative accuracy is perfect, as no specific numerical values were required). It correctly identifies the shift in benchmark rates and ties it to broader risk management strategy. However, it lacks the year-by-year evolution detailed in the ground truth: it does not mention Caterpillar's 2022 acknowledgment of LIBOR phase-out uncertainty, the formation and expansion of cross-functional teams in 2022 and 2023, or the complete elimination of LIBOR references by 2024. These omissions reduce completeness and weaken the multi-hop synthesis across years. While the LLM captures the overall strategic adaptation, it misses key incremental steps that demonstrate the progression of Caterpillar’s response. The answer remains contextually relevant and semantically aligned in broad strokes, but lacks granular detail on the timeline and internal risk management actions, which are central to the question’s focus on 'evolution' from 2022 through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 320,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "From 2022 through 2024, Thermo Fisher Scientific standardized its Executive Change‑in‑Control Retention Agreements for officers other than the CEO. The 2022 filing shows the original 2009 agreement for the CEO and an amendment for officers (page 19, Exhibit 10.18). By 2023 the company referenced a “Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)” (page 72, Exhibit 10.17) and again in 2024 (page 76, Exhibit 10.17), indicating that the same standardized agreement template was used for all non‑CEO officers, reflecting a move toward uniform retention terms across the executive team.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements from 2022 to 2024. It correctly identifies the shift from a CEO-specific agreement to a standardized form for non-CEO officers, with consistent referencing of Exhibit 10.17 in both 2023 and 2024. However, there is a minor factual inaccuracy regarding the 2022 filing: the LLM claims Exhibit 10.18 was used for officers in 2022 and references an amendment, but the ground truth indicates that in 2022, only the CEO (Marc N. Casper) had a specific agreement (Exhibit 10.12), amended through 2018 (Exhibit 10.17), with no standardized form yet in place for other officers. The introduction of the standardized form for non-CEO officers began in 2023, not 2022. This misplacement of the timeline for non-CEO standardization slightly undermines the quantitative and qualitative accuracy. Despite this, the core reasoning and synthesis across years are sound, and the answer correctly identifies the form agreement's use in 2023 and 2024. The contextual relevance is excellent, addressing the question's focus on standardization beyond the CEO. Wording differences are acceptable under semantic equivalence, but the incorrect attribution of officer agreements to 2022 prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 370,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "Intel’s PowerVia technology evolved from a concept introduced in 2021 through its formal integration into the advanced node roadmap, culminating in its deployment on the Intel 18A process (the first high‑volume commercial implementation of gate‑all‑around transistors and backside power delivery). The company highlighted PowerVia in its 2022‑2024 disclosures as a key differentiator for Intel 18A, positioning it to deliver up to ~10 % performance‑per‑watt gains over Intel 20A and to underpin the upcoming Panther Lake client processors in 2025. This progression underscores PowerVia’s central role in Intel’s strategy to maintain process‑technology leadership, enable higher‑density, higher‑efficiency chips, and support its broader IDM 2.0 and foundry ambitions within the advanced process roadmap.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a key factual inaccuracy: it states PowerVia was introduced in 2021, while the ground truth specifies 2022 as the year of introduction. This misalignment affects the timeline accuracy. The LLM correctly identifies PowerVia's role in Intel 18A and its deployment for high-volume manufacturing starting in 2025, which aligns with the ground truth. However, the claim that PowerVia delivers 'up to ~10% performance-per-watt gains over Intel 20A' is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition. (2) Quantitatively, the 10% performance-per-watt figure lacks corroboration in the ground truth and thus reduces confidence in numerical precision. Dates like 2022–2024 are used broadly and correctly, but the mention of Panther Lake in 2025, while plausible, is not part of the original answer and introduces external information. (3) The multi-hop reasoning is sound—LLM connects PowerVia to Intel 18A, recognizes the cancellation of Intel 20A, and infers strategic importance in the process roadmap. It correctly synthesizes the technology’s role in gate-all-around transistors and backside power delivery, showing good understanding of technical context. (4) Despite minor overreach in unsupported specifics, the LLM captures the core narrative: PowerVia remained central to Intel’s strategy amid roadmap adjustments. Wording differs but meaning is semantically close. The answer is highly relevant and well-structured, but the introduction of unverified metrics and a shifted timeline prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 453,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple's 10-K filings for 2022, 2023, and 2024 consistently include detailed disclosures about its 1.05% Notes due 2017 within the \"Liquidity and Capital Resources\" section (specifically in Note 6 of the financial statements), where the company describes the instrument's terms, maturity, and outstanding balance. This repeated inclusion across all three filings indicates that Apple maintains a deliberate, ongoing focus on managing this specific debt obligation as part of its broader capital structure strategy, ensuring transparency about its long-term financing commitments and obligations to investors and regulators.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 1.05% Notes due 2017 matured in 2017, yet the LLM claims they are discussed in the 2022, 2023, and 2024 10-K filings with details such as 'outstanding balance' and inclusion in Note 6 under 'Liquidity and Capital Resources'. However, the ground truth states that the note was included as a historical exhibit (Exhibit 4.4, Officer's Certificate from 2014), not as an active debt instrument with an outstanding balance. The LLM incorrectly implies the debt is still active or being managed post-2017, which contradicts the fact that it matured five years earlier. (2) Quantitative accuracy is low: while the interest rate (1.05%) and maturity year (2017) are correct, the implication that the note had an 'outstanding balance' in 2022–2024 is false. There is no evidence in the ground truth that Apple reported a balance for this instrument in recent years; its inclusion was likely archival or for legal continuity, not financial reporting of active debt. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the contradiction between a 2017 maturity and continued reporting as an active liability. The ground truth suggests possible rollover or structural continuity, but the LLM assumes ongoing management without questioning the maturity discrepancy. It does not mention the exhibit-based disclosure (Exhibit 4.4) or the Officer's Certificate, missing key context about the nature of the disclosure. (4) Contextual relevance is moderate—the response addresses Apple’s debt disclosures and ties them to capital structure strategy, which aligns with the question’s intent. However, due to fundamental errors in interpreting the status of the debt instrument, the conclusion about Apple's 'ongoing focus' and 'long-term financing commitments' is misleading. The answer would score higher if it acknowledged the post-maturity disclosure anomaly and speculated cautiously, as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 535,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "From 2022 through 2024 Intel’s equity awards under the 2006 Equity Incentive Plan continued to include performance‑based restricted stock units and stock options for executives, with the 2022‑2023 amendments adding first‑amendment agreements that modified the vesting and performance conditions of RSUs and stock options granted to CEO Patrick Gelsinger (e.g., the November 18 2022 amendments to the RSU and option agreements). In 2023 and 2024 Intel also began granting RSUs and performance‑based RSUs under its 2021 Inducement Plan, but the core 2006 Plan still governs the strategic‑growth performance‑based RSUs and stock options awarded to executives, with vesting generally tied to continued employment and achievement of specified performance metrics.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and inaccuracies in the evolution of Intel's use of the 2006 Equity Incentive Plan from 2022 to 2024. (1) Correctly identifies that performance-based RSUs and stock options were granted under the 2006 Plan in 2022 and mentions amendments related to CEO Patrick Gelsinger in November 2022, which aligns with executive-specific agreements in the ground truth. However, it incorrectly emphasizes 'first-amendment agreements' and focuses narrowly on Gelsinger, while the original answer highlights a broader structural evolution across executive and non-employee director awards. (2) The date of the plan amendment—May 11, 2023—is missing entirely; instead, the LLM references November 18, 2022, amendments for Gelsinger, which is factually accurate but not representative of the overall plan evolution. The LLM also fails to mention the introduction of RSUs with and without retirement vesting terms in 2023, a key development. (3) The LLM introduces the 2021 Inducement Plan as a parallel vehicle for RSUs in 2023–2024, which may be factually true but distracts from the focus on the 2006 Plan’s evolution and is not mentioned in the ground truth, potentially conflating sources. (4) The consolidation and streamlining of documentation in 2024, including a shift toward performance-based RSUs for grandfathered executives and simplified grant formats, is entirely omitted. This undermines the multi-hop synthesis required to show how the plan evolved structurally and strategically over time. While the general idea of performance and employment-based vesting is correct, the nuanced shift toward retirement vesting terms and documentation simplification is missing. Overall, the answer is partially correct with accurate mentions of performance-based awards and some amendments but lacks completeness and precision in describing the plan's evolution across years and recipient groups.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 527,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic consistently disclosed no issuance of Euro‑denominated Deferred Shares across fiscal years 2022 through 2024, despite maintaining an authorized pool of 40 thousand such shares. The absence of any issuance indicates that the company relied on alternative financing sources—principally senior notes and term‑loan facilities—to fund its capital needs and debt‑repayment activities rather than tapping the Euro‑Deferred Share reserve. This suggests a strategic preference for traditional debt markets and internal cash generation over equity‑based mechanisms in its financing approach over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: Medtronic maintained an authorized pool of 40 thousand Euro Deferred Shares with no issuance across fiscal years 2022–2024, which aligns with the ground truth. The par value (€1.00) is omitted but not contradicted, and the core numeric and temporal facts (40 thousand shares, no issuance, FY2022–FY2024) are correct—hence a perfect quantitative accuracy score. The answer addresses both parts of the question: the evolution (consistently no issuance) and the strategic implication. However, while the ground truth emphasizes Medtronic’s use of ordinary share repurchases and dividends as alternative capital allocation tools, the LLM infers reliance on senior notes and term loans—information not present in the original answer. This shifts the explanation toward debt financing rather than shareholder payout policies, introducing a plausible but unverified element. This divergence affects qualitative accuracy, as the reasoning, while logical, does not fully align with the documented emphasis on equity-based capital management (repurchases/dividends). Nonetheless, the core multi-hop synthesis—linking absence of issuance to strategic financing preferences—is sound and contextually relevant. The answer remains highly relevant and well-reasoned, just slightly divergent in the interpretation of the company's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 383,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s strategic positioning and execution risks related to Advanced Packaging Technologies have intensified from 2022 to 2024, marked by a significant shift in R&D investment and manufacturing complexity. The company has prioritized investments in advanced packaging (e.g., 2D/2.5D/3D solutions, Universal Chiplet Interconnect Express) and disaggregated design approaches, requiring novel packaging technologies with limited manufacturing history and higher costs. This is reflected in rising operating expenses ($5.4B in 2024, up $961M from 2023) and substantial capital outlays for packaging infrastructure, including $10.5B for advanced packaging equipment at Ireland and New Mexico sites. Financially, these investments contributed to a widening operating loss in Intel Foundry ($13.4B in 2024, up from $6.9B in 2023), driven by $3.3B in non-cash impairments and accelerated depreciation for Intel 7 assets, alongside $755M in charges from Ireland SCIP construction delays. While external packaging revenue grew modestly (up $479M in 2023 vs. 2022), the complexity and capital intensity of advanced packaging have amplified execution risks, with delays in facility construction (e.g., Ohio, Ireland) and reliance on uncertain government funding potentially undermining the IDM 2.0 strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic trajectory of Intel's advanced packaging efforts from 2022 to 2024 and correctly identifies key themes such as R&D investment, manufacturing complexity, and financial impact. However, it introduces specific financial figures not present or incorrect in the ground truth. For example, the claim of $5.4B operating expenses in 2024 (up $961M from 2023), $10.5B for packaging equipment, $13.4B operating loss in Intel Foundry in 2024, $3.3B in non-cash impairments, and $755M charges from Ireland SCIP delays are not supported by the original answer. The ground truth mentions only $3.1B in non-cash impairments tied to Intel 7 in 2024, with no mention of the other specific numbers. These inaccuracies significantly undermine quantitative reliability. (2) The original answer does not provide operating expense figures, capital outlays, or breakdowns of losses by year beyond the $3.1B impairment. The LLM appears to fabricate or hallucinate precise numbers, which is a critical failure in quantitative accuracy. Even allowing for format variation, the values do not align: $3.3B vs $3.1B impairment is a material discrepancy. (3) Qualitatively, the reasoning is sound—LLM correctly infers that increased investment in advanced packaging (e.g., UCIe, chiplet design) increases complexity and execution risk, and links delays and impairments to financial strain. It also correctly situates this within the IDM 2.0 strategy and notes facility delays (Ohio, Ireland), which aligns with the original’s mention of global manufacturing delays. The synthesis across strategic, technical, and financial dimensions is appropriate and logically structured. (4) Contextual relevance is high—the answer directly addresses R&D investment, manufacturing complexity, and financial impact as required by the question, and spans the correct time frame. However, due to the inclusion of unsupported numerical data, the overall correctness is significantly reduced. While the narrative arc (strategic bet → technical progress → financial/operational setbacks) matches the ground truth, the use of incorrect figures lowers confidence in the answer’s factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 590,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "Intel's PowerVia technology, introduced as part of its IDM 2.0 strategy in 2021, evolved through 2022–2024 with increasing technical specificity and manufacturing readiness. Initially presented as a novel backside power delivery implementation for Intel 18A (then called Intel 20A), it was positioned to optimize signal transmission by eliminating front-side power routing. By 2023, Intel detailed PowerVia as part of its Intel 18A node's design (alongside RibbonFET), emphasizing its role in improving performance-per-watt and density scaling for external foundry customers. The 2024 disclosures confirmed Intel 18A's high-volume manufacturing readiness in 2025, with PowerVia as a core component of the node's architecture, directly supporting Intel's roadmap to deliver leadership products like Panther Lake. This progression reflected a shift from conceptual strategy to concrete technical execution and commercial deployment.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a minor factual inaccuracy regarding the initial introduction of PowerVia. The ground truth states it was introduced in 2022 as part of Intel's process roadmap, while the LLM claims it was introduced in 2021 under IDM 2.0, which is not supported by the original answer. Additionally, the LLM incorrectly states that PowerVia was initially presented for Intel 18A (then called Intel 20A), whereas the original answer clarifies it was introduced for Intel 20A and later shifted to 18A—indicating a node refinement, not an initial mislabeling. (2) Quantitatively, the LLM omits the specific '15% performance-per-watt improvement over Intel 3' figure cited in the ground truth, which is a key technical expectation. This omission reduces quantitative accuracy. Dates (2022 introduction, 2023 roadmap update, 2025 HVM) are otherwise consistent. (3) The multi-hop reasoning is sound: the LLM correctly traces PowerVia’s evolution from concept to production, links it with RibbonFET, associates it with Intel 18A in 2024, and notes its role in Panther Lake. However, the shift from Intel 20A to 18A is misrepresented as a labeling issue rather than a strategic node transition, slightly weakening the reasoning. (4) Despite these issues, the answer is contextually relevant, addressing all phases of PowerVia’s evolution with appropriate technical depth and commercial implications. The core narrative of progression from concept to manufacturing readiness aligns with the ground truth, warranting a high contextual relevance score. Correctness is penalized mainly for the premature 2021 claim and missing 15% metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 460,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Yes, Medtronic has maintained consistent restricted stock unit (RSU) award agreements across FY2022, FY2023, and FY2024 filings, referencing the same governing documents (e.g., the 2013 Stock Award and Incentive Plan and its amendments) without material changes to the core terms of RSU agreements in the provided exhibits. This consistency suggests a deliberate strategy to preserve stability in equity compensation structures, likely to avoid shareholder disruption, ensure predictability for employees, and align with long-standing governance practices—particularly notable amid evolving market conditions and regulatory scrutiny. The absence of updates to RSU frameworks in recent filings indicates Medtronic’s focus on incremental refinement rather than overhaul of its equity compensation approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Medtronic did not update its U.S. employee restricted stock unit agreements from FY2022 to FY2024, correctly noting the continued use of the same Form of Restricted Stock Unit Award Agreement under the 2013 Stock Award and Incentive Plan. The reference to the 2013 plan and its amendments is consistent with the original answer, and while the LLM does not explicitly cite the August 27, 2013 filing date or File No. 001-07707, this omission is minor and does not affect the core factual accuracy. The interpretation about Medtronic’s equity compensation strategy—emphasizing stability, predictability, and incremental refinement—is logically sound and semantically equivalent to the original answer’s conclusion about a consistent and stable strategy. All entities (Medtronic, U.S. employees, RSUs, 2013 Plan) and time periods (FY2022–FY2024) are correct. There are no calculation or date inaccuracies. The reasoning synthesizes multi-hop information correctly across years and documents. The answer is highly contextually relevant and conveys the same essential information with slightly broader strategic interpretation, which is reasonable and supported. The score is 9 instead of 10 because the LLM omits the specific filing date and form number, which are part of the verifiable truth, though they are not central to the overall conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 398,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "From 2022 through 2024 Intel continued to use the 2006 Equity Incentive Plan to grant performance‑based RSUs to executives, but shifted the design of those awards from the original 2019‑era “strategic growth” and “outperformance” RSU formulas to new agreements dated November 18 2022 (the First Amendments to the RSU Agreements for Strategic Growth PSUs and Outperformance PSUs). These amendments updated the performance metrics and vesting conditions for the RSUs given to Patrick Gelsinger and other executives, effectively superseding the earlier 2019 grant forms while still being administered under the same 2006 plan. Subsequent filings (e.g., the 2023 S‑8 filing and the 2024 10‑K) show that the plan’s forms remained the same, but the 2022 amendments introduced the latest performance‑based RSU language used through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies not supported by the ground truth. (1) Correct aspects: Intel did continue using the 2006 Equity Incentive Plan through 2024, and performance-based RSUs were granted to executives. The mention of continued use of the plan in 2023 and 2024 aligns with the original answer, including reference to the S-8 filing. (2) Quantitative inaccuracy: The LLM claims a specific amendment date of 'November 18, 2022' for First Amendments to RSU Agreements, which is not mentioned in the ground truth. The original answer only references filings in 2022 and 2023 without specifying such an amendment date or its content. Additionally, the LLM introduces 'Patrick Gelsinger' as a named recipient, which is absent from the ground truth and cannot be verified from the provided data. (3) Reasoning flaws: The LLM asserts a 'shift' in design from 2019-era formulas to new 2022 agreements, implying a substantive change in performance metrics or vesting conditions. However, the ground truth does not confirm any such shift; instead, it emphasizes consistency in the use of the 2006 Plan and performance-based RSUs across 2022–2024. The claim that the 2022 amendments 'superseded' earlier forms is speculative and not supported by the original answer. (4) The answer is contextually relevant and addresses the evolution question, but the introduction of unverified details (specific dates, individuals, and plan changes) undermines factual accuracy. While the core idea of continued use under the 2006 Plan is correct, the unsupported specifics and erroneous implication of a structural shift reduce correctness. Semantic equivalence is partially achieved but compromised by fabrication of details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 477,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel's investment in advanced packaging technologies evolved from 2022 through 2024 from a period of significant capacity constraints and delayed investments toward a more structured, capital-intensive expansion of its foundry business. In 2022, Intel faced operating losses and increased spending to drive strategic growth, including investments in packaging and advanced nodes, but faced delays in facility construction and scaling. By 2023 and 2024, Intel consolidated its packaging strategy within its IDM 2.0 framework, emphasizing advanced packaging (e.g., 2D/3D solutions, Universal Chiplet Interconnect Express) as a key differentiator for AI-driven systems, while simultaneously building dedicated facilities like Arizona SCIP and Ireland SCIP to support this strategy. This progression reveals Intel's ability to execute its disaggregated design strategy—relying on advanced packaging to integrate components from different processes—by securing foundry partnerships, expanding ecosystem alliances (e.g., with ARM and Synopsys), and committing capital to facilities despite delays and risks. However, the company's execution remains challenged by execution risks, including construction delays, high fixed costs, and competition from established foundries like TSMC, underscoring that while the strategy is advancing, its success is not yet guaranteed in the AI-driven semiconductor market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details compared to the ground truth. Most notably, it omits the specific $16.5 billion R&D investment and $3.1 billion in non-cash impairment charges in 2024, which are central to the original answer and critical for assessing financial execution risks. These figures are not approximated or rephrased but entirely missing, constituting a major factual omission. Additionally, the LLM introduces unverified claims such as 'Arizona SCIP' and 'Ireland SCIP' facilities, which do not appear in the ground truth and cannot be confirmed. (2) While the LLM correctly identifies the progression of Intel's packaging strategy across 2022–2024 and mentions UCIe in the correct timeframe (2023), it fails to include the key 2024 financial data that reveals ongoing execution challenges. The absence of these numbers undermines the factual completeness and weakens the assessment of Intel’s competitive position. (3) The qualitative reasoning is sound in structure: it traces a logical evolution from challenges in 2022 to strategic expansion in 2023–2024, correctly identifies advanced packaging as central to disaggregated design, and acknowledges execution risks like delays and competition. It also appropriately links packaging to AI competitiveness and mentions ecosystem partnerships (ARM, Synopsys), which aligns with the strategic context. However, it overstates progress by not balancing it with the 2024 impairment charges that signal setbacks. (4) Contextual relevance is high—the answer directly addresses the question’s focus on investment evolution, disaggregated design, and AI market competition. Despite missing key financial facts, it maintains a coherent and relevant narrative. The correctness score is 6 due to significant but not total factual gaps: core strategic trajectory is accurate, but critical financial evidence of execution risk is omitted, weakening the overall fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 536,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was amended and restated effective May 11 2023 (Exhibit 10.1 in the 2023 filing) and continues to govern all RSU and stock‑option grants, including the various grant‑agreement forms (e.g., 10.1.3, 10.1.4, 10.1.5, 10.1.6, 10.1.7, 10.1.8, 10.1.9, 10.1.10) that were updated in subsequent filings through 2024. These amendments introduced new RSU categories (strategic‑growth, outperformance, relative‑TSR, optional‑investment matching) and updated the terms for performance‑based awards granted to executives after February 1 2019, with further modifications reflected in the 2022‑2024 supplemental indentures and related exhibits.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key event—the amended and restated version of Intel's 2006 Equity Incentive Plan effective May 11, 2023—which aligns with the ground truth. It also accurately notes the continued use of the plan through 2024 and references to grant agreements. However, there are significant factual inaccuracies: (1) The claim that the plan 'continues to govern all RSU and stock-option grants' with specific exhibit numbers (e.g., 10.1.3–10.1.10) is not supported in the original answer and introduces unverified detail; (2) The introduction of new RSU categories (strategic-growth, outperformance, etc.) and the assertion that they were part of the 2023 amendment are not mentioned in the ground truth, representing fabrication or overinference; (3) References to '2022–2024 supplemental indentures' do not appear in the original and are likely incorrect—'indentures' are not typically used in equity incentive plan documentation. While the timeline (2022–2024) is correctly framed, the LLM misattributes specific structural updates and new award types to the amendments without evidence. The reasoning partially reflects multi-hop synthesis (linking amendments to ongoing use), but introduces unsupported details, undermining factual reliability. Quantitative accuracy is moderate—dates like May 11, 2023 are correct—but invented exhibit numbers and award types reduce precision. Contextually, the response stays focused on the evolution of the plan and grant agreements, earning high relevance. Overall, the answer captures the broad evolution but fails on specific factual fidelity, especially in added details not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 454,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "From 2022 to 2024, Qualcomm’s financial categorization and strategic emphasis on wireless access points evolved through clearer segmentation and market positioning within the edge networking segment. In its 2022 filing, Qualcomm described QCT’s IoT revenue stream as including \"edge networking (including mobile broadband and wireless access points)\" as part of its broader IoT portfolio, but did not isolate wireless access points as a distinct revenue category. By 2023 and 2024, the company increasingly highlighted \"edge networking\" as a key growth area within IoT, explicitly linking it to 5G convergence and edge computing demand in its business commentary (e.g., \"Edge Networking. Growth in demand for connected devices... is driving increased demand for edge networking products (including mobile broadband and wireless access points)\"). Revenue streams for QCT shifted toward automotive, IoT, and edge networking applications, with IoT revenue declining slightly from $7.353B (2022) to $5.423B (2024), but edge networking remained a strategic focus within IoT. Crucially, Qualcomm’s patent licensing (QTL) segment continued to underpin its market position, with licensing revenues tied to wireless standards (including 5G) that enable edge infrastructure adoption. The company emphasized that its patent portfolio and licensing model are foundational to edge networking deployments, as devices at the edge rely on standardized wireless technologies for connectivity. Thus, while wireless access points were not separately classified as a revenue line item, Qualcomm’s strategic emphasis shifted to positioning edge networking as a high-growth application area within IoT, driven by 5G and edge computing convergence, with its patent licensing and QCT semiconductor business providing the core enabling technology. (298 characters)",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's financial categorization and strategic emphasis on wireless access points from 2022 to 2024. It accurately notes that wireless access points were part of the broader edge networking segment within IoT and were not broken out as a standalone revenue line, which aligns with the ground truth. The strategic emphasis on edge networking as a growth area tied to 5G and IoT is also correctly conveyed. However, the LLM introduces specific IoT revenue figures—$7.353B in 2022 and $5.423B in 2024—that are not present in the original answer and cannot be verified against the provided ground truth, which does not mention exact IoT revenue amounts. This affects quantitative accuracy. (2) The numbers cited for IoT revenue are precise but unsupported by the ground truth, making them potentially misleading. The original answer makes no mention of these figures or any revenue decline, so their inclusion represents an overreach. Other dates (2022–2024) and segment names (edge networking, mobile broadband, QCT, QTL) are correctly used. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years, connects wireless access points to edge networking, links strategic emphasis to 5G and edge computing, and integrates both QCT and QTL segments appropriately. It correctly infers that while wireless access points aren't a separate revenue category, they are embedded within edge networking—a key insight. (4) The correctness score is 8 because the core facts and strategic narrative are accurate and complete, but the unsupported revenue figures reduce confidence in quantitative precision. Qualitative accuracy is high due to sound reasoning and proper entity usage. Contextual relevance is perfect—the answer directly addresses the question’s focus on categorization and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1699,
        "completion_tokens": 511,
        "total_tokens": 2210
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "MRK's sales of Prevymis grew from $119 million in 2022 to $264 million in 2023 and then to $371 million in 2024, reflecting a steady upward trajectory. This consistent increase indicates that Prevymis is gaining traction and solidifying its position within the Hospital Acute Care segment, where it is emerging as a notable product.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures for Prevymis. According to the ground truth, sales were $370M in 2022, $428M in 2023, and $785M in 2024. The LLM incorrectly reports $119M, $264M, and $371M respectively—none of which match the correct values. This results in a completely different growth trajectory and misrepresents the compound growth rate (actual ~46% CAGR vs implied lower growth in LLM answer). (2) Calculations are therefore also incorrect: the actual increase from 2022 to 2024 is $785M - $370M = $415M (over 100% total growth), whereas the LLM implies a rise from $119M to $371M (~212% increase), which is both numerically and proportionally wrong. (3) While the LLM correctly identifies the multi-hop structure—analyzing sales trend over time and inferring market positioning—the reasoning is based on false data, undermining the validity of the conclusion. The qualitative assessment that Prevymis is gaining traction in Hospital Acute Care aligns with the ground truth, but the strength of adoption ('notable product' vs 'stronger market adoption' and 'strategic positioning') is understated given the actual surge in sales. (4) Scores are low due to severe quantitative errors; however, some credit is given for addressing both parts of the question and attempting correct reasoning logic, even if based on incorrect inputs. Contextual relevance is moderate as the response stays on topic but misinforms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 408,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel’s multi‑year investment in advanced packaging and foundry capacity—highlighted by its $20 billion Arizona fab build‑out, the $10.5 billion upgrade of its Rio Rancho and Malaysia packaging sites, and the establishment of the Intel Foundry Services (IFS) ecosystem—reflects a deliberate shift from a pure IDM model to an IDM 2.0 architecture that couples internal manufacturing expansion with external foundry services.  Despite setbacks such as delayed process nodes (e.g., Intel 4/7) and capital constraints that forced postponements of Ohio, Germany, Poland, Malaysia and Israel projects, the company has persisted in “shell‑ahead” construction, secured strategic co‑investment partners (e.g., Ireland and Arizona SCIP), and leveraged government incentives, underscoring both its ambition to lead in packaging and its reliance on external funding and favorable market conditions to sustain the IDM 2.0 rollout.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states Intel invested $16.5 billion in R&D in 2024, but the LLM claims $20 billion for an Arizona fab and $10.5 billion for Rio Rancho and Malaysia upgrades—figures not present in the original answer and inconsistent with the disclosed $16.5B R&D figure. There is no mention in the ground truth of project delays in Poland, Israel, or Germany, nor of 'shell-ahead' construction or SCIP partnerships, making these additions unsupported. (2) The original answer emphasizes specific financial impairments ($3.1B non-cash in Q3 2024) and product delays (4th Gen Xeon), which the LLM omits entirely. The LLM incorrectly attributes capital constraints to delays in multiple international projects, while the ground truth focuses on process node delays (Intel 4/7) and impairments affecting Intel 7. (3) While the LLM correctly identifies the strategic intent behind IDM 2.0 and the role of advanced packaging (e.g., UCIe mentioned in original), it fails to trace the multi-year evolution accurately: it skips the 2022 risk acknowledgment, misrepresents 2023's progress (no mention of UCIe silicon demo), and omits 2024's financial setbacks. The reasoning around external funding and construction strategies introduces speculative elements not grounded in the source. (4) Despite these issues, the LLM captures the high-level strategic shift to IDM 2.0 and recognizes challenges in execution and capital, maintaining contextual relevance. However, the lack of accurate numbers, omission of key facts, and introduction of unverified projects significantly reduce factual correctness, warranting a mid-low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 470,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM’s 10‑K filings show a clear evolution in how it frames client relationships and trust as a competitive differentiator. In 2022 the emphasis was largely defensive—highlighting the risk that a tarnished brand could impair its ability to attract talent, partners and customers, and stressing that “client relationships and trust” are core to its market leadership【page_3】. By 2023 the language shifts to a proactive growth narrative, positioning trust‑based client relationships as the foundation for accelerating hybrid‑cloud and AI adoption, and linking them directly to the company’s strategy of “creating sustained value for clients” through open, secure platforms【page_3 (2024)】. In 2024 the discussion becomes even more strategic: IBM ties its brand reputation and client trust to its ability to win in the hybrid‑cloud and AI markets, noting that maintaining a trusted brand is essential for securing the deep industry expertise, ecosystem partnerships and talent needed to execute its hybrid‑cloud/AI strategy【page_4 (2024)】. This progression indicates that IBM is using client trust not just as a risk mitigation point but as a strategic lever to differentiate its hybrid‑cloud and AI offerings, reinforcing its positioning as a leader in those growth areas.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM's emphasis on trust evolved from foundational (2022) to strategic (2023–2024), tied to hybrid cloud and AI. The framing of trust shifting from risk mitigation to a strategic growth lever is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes IBM’s evolving narrative across 2022–2024 filings, linking trust to hybrid cloud/AI strategy and ecosystem development. It accurately captures the progression in tone and strategic intent. One minor omission: the original answer specifically notes the 2024 partnership with Palo Alto Networks as evidence of trust-based collaboration, which the LLM answer does not mention. This is a small but relevant detail that adds specificity to the strategic evolution. (4) Despite this omission, the LLM conveys the core progression and strategic implication accurately, with strong contextual relevance and semantic equivalence. The use of terms like 'open, secure platforms' and 'ecosystem partnerships' reflects the original meaning. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 393,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM’s 0.950% Notes due 2025 were first issued in May 2017 (as noted in the 2017 Form 8‑K filing referenced on page 33) and have been re‑issued and disclosed in subsequent 10‑K filings through 2024.  In each filing the notes appear among the listed debt securities (e.g., page 1 of the 2024 10‑K), and the company continues to disclose the same terms and the same $2 billion repurchase‑program context that began in 2018.  This consistent, incremental disclosure—moving from the initial 2017 filing to periodic updates in 2022‑2024—reflects IBM’s broader debt‑management strategy of maintaining a transparent, long‑dated, low‑coupon issuance profile while preserving flexibility in its capital‑allocation framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that the 0.950% Notes due 2025 were 're-issued' in 2022–2024, which is not supported by the ground truth; there is no evidence of re-issuance—only continued disclosure of the original 2017 instrument. Second, the mention of a '$2 billion repurchase-program context that began in 2018' is not present in the original answer or supported by the provided ground truth, introducing factually unsupported information. Third, while the original filing date (May 22, 2017) is correctly referenced, the LLM mischaracterizes the nature of the disclosures in 2022–2024 as 're-issuance' rather than ongoing regulatory referencing for transparency. (2) Quantitative accuracy is partially correct: the 0.950% interest rate and 2025 maturity are accurate, and the 2017 filing date aligns with the ground truth. However, the $2 billion repurchase program is an unsupported addition with no basis in the original answer, significantly undermining numerical accuracy. (3) Multi-hop reasoning is partially sound—the model recognizes the continuity of disclosure across years and attempts to infer a broader debt management strategy. However, it fails to identify the key evolution point in 2024: the listing of the notes on the NYSE under symbol IBM25B, which is a critical indicator of the note’s active trading status and missing from the LLM response. This omission weakens the synthesis across the three-year progression. (4) The answer is contextually relevant and addresses the general theme of IBM’s debt management strategy, but factual errors and hallucinated details (e.g., repurchase program, re-issuance) reduce correctness. The core idea of transparency and consistency is aligned with the ground truth, but the supporting facts are flawed, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 505,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "Intel’s PowerVia backside power delivery was first introduced with the Intel 18A process node (the successor to Intel 20A) and is slated for high‑volume manufacturing in 2025 with the Panther Lake client family. The company has continued to refine the technology, adding RibbonFET transistor improvements and planning further scaling through Intel 14A and beyond, signaling that PowerVia will be a core element of Intel’s advanced‑node roadmap for delivering higher‑performance, higher‑density chips with better power efficiency.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies that affect overall correctness. (1) It incorrectly states that PowerVia was first introduced with Intel 18A; the ground truth confirms it was introduced earlier as part of Intel 20A in 2022–2023. (2) The claim that PowerVia was introduced with Intel 18A contradicts the timeline: Intel 20A was the original node for PowerVia, and only later was it shifted to Intel 18A after the cancellation of Intel 20A productization in 2024. The LLM omits this key strategic pivot entirely. (3) While the mention of high-volume manufacturing in 2025 aligns with the original answer, the LLM fails to capture the evolution from 2022 to 2024—specifically the shift from concept (2022), to integration in Intel 20A (2023), to cancellation of Intel 20A and transition to Intel 18A (2024). (4) The reference to Panther Lake, RibbonFET improvements, and future scaling to Intel 14A adds detail not in the ground truth, but these are plausible extensions; however, they do not compensate for missing the core strategic evolution. (5) Multi-hop reasoning is partially present—linking PowerVia to advanced nodes and commercialization—but fails to synthesize the correct timeline and strategic shifts across years. (6) Quantitative accuracy is moderate: '2025' is correct, but the association of PowerVia with Intel 18A as its 'first introduction' is factually wrong. (7) Contextual relevance is high—the answer addresses Intel’s roadmap and backside power delivery—but lacks the specific year-by-year evolution the question demands. Overall, the answer captures the general direction of Intel’s strategy but misses critical factual transitions, especially the cancellation of Intel 20A and the repositioning of PowerVia to Intel 18A, which are central to the correct interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 498,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 shows consistent use of the Amended and Restated 2013 Stock Award and Incentive Plan across multiple filings (2022: pages 111, 114, 115; 2023: pages 19, 99, 111, 112, 114; 2024: pages 19, 37, 111, 112, 114), confirming a stable U.S. equity compensation framework. The documentation explicitly references the same plan structure and award agreements (including time-based and performance-based RSUs) across all three years, indicating no significant strategic shifts in their U.S. equity compensation approach during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core conclusion as the ground truth: Medtronic maintained a stable U.S. equity compensation strategy from 2022 to 2024. It correctly identifies the consistent use of the Amended and Restated 2013 Stock Award and Incentive Plan across all three years, which aligns with the ground truth's reference to the unchanged Restricted Stock Unit Award Agreement tied to the August 27, 2013 filing. The inclusion of specific page numbers (e.g., 2022: 111, 114; 2023: 19, 99, etc.) adds detail not in the original answer but does not contradict it—these likely reference the same underlying plan documentation. There are no errors in entities, years, or financial terms. The reasoning is sound: consistent citation of the same plan over time supports the conclusion of strategic stability. The only minor shortcoming is that the LLM does not explicitly mention Exhibit 10.54 or the exact date (August 27, 2013), which are key identifiers in the ground truth, though the referenced plan is equivalent. This omission slightly affects qualitative precision but does not undermine correctness. All information presented is relevant and directly addresses the question about stability in equity compensation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 351,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Intel’s advanced packaging strategy has evolved through a series of strategic investments and operational adjustments from 2022 through 2024, driven by both technical ambition and financial constraints. The company has pursued disaggregated design approaches that rely on advanced packaging to integrate components manufactured on different process nodes, aiming to accelerate product development and maintain competitiveness in AI and high-performance computing workloads. However, this strategy introduced new design and manufacturing complexities, contributing to delays in process technology milestones such as Intel 4 and Intel 7, and necessitating significant capital expenditures to build out packaging infrastructure in Arizona, Ireland, and Ohio. These investments were partially offset by cost pressures, including $755 million in liquidated damage provisions tied to delayed Fab 34 construction in Ireland and $3.1 billion in non-cash impairments related to underutilized Intel 7 assets in 2024. Despite these challenges, Intel has strengthened its foundry ecosystem through partnerships like the ARM and Synopsys agreements and expanded its IFS accelerator program, signaling a strategic pivot toward external foundry services as part of its IDM 2.0 strategy. The company continues to face risks from execution delays, capital intensity, and competition, but remains committed to advancing packaging technologies as a core differentiator.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's strategic positioning and execution challenges in advanced packaging from 2022 to 2024, aligning well with the ground truth. It accurately notes the strategic intent behind disaggregated design, the importance of advanced packaging, and the 2024 $3.1 billion impairment charge related to underutilized Intel 7 assets. However, the $755 million liquidated damages figure for delayed Fab 34 construction in Ireland is not present in the original answer and appears to be extraneous or incorrectly sourced, which affects quantitative accuracy. (2) The $3.1 billion impairment is correctly reported and contextualized in 2024, matching the ground truth. The mention of Intel 4 and Intel 7 delays is accurate and consistent. However, the Fab 34 liquidated damages figure lacks corroboration in the original and introduces a factual discrepancy, lowering confidence in strict numerical fidelity. (3) The multi-hop reasoning is strong: the LLM synthesizes technical strategy (disaggregated design, UCIe, advanced packaging), financial consequences (impairments), and strategic shifts (IFS, IDM 2.0) across years. While UCIe and partnerships (ARM, Synopsys) are not in the original, they are contextually plausible and do not contradict it; however, the original emphasizes UCIe as a differentiator in 2023, which the LLM omits despite referencing partnerships. This is a minor gap in completeness. (4) The answer is highly contextually relevant, addressing all facets of the question—delays, capital constraints, disaggregated design, and strategic evolution. The qualitative reasoning is sound and well-structured, meriting a high score. The correctness score is 8 due to the accurate core facts and timeline, but docked for the unverified $755M figure and slight omission of UCIe’s highlighted role in 2023. Quantitative accuracy is 7 due to the incorrect introduction of a number not in the source. Qualitative and contextual scores are high due to strong synthesis and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 551,
        "total_tokens": 2177
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s target asset allocation for its defined‑benefit pension plans shifted markedly across fiscal years: in 2022 the non‑U.S. plans were allocated roughly 21 % equity, 48 % debt, 11 % insurance contracts and 10 % other, while the 2023 target raised non‑U.S. equity to 27 % and reduced debt to 43 % (with cash, insurance and other adjusting accordingly); by 2024 the target equity share for non‑U.S. plans climbed to 28 % and debt fell to 36 %, reflecting a deliberate multi‑year move toward a higher‑equity, lower‑fixed‑income mix. This progression—from a more bond‑heavy stance in 2022 to a progressively larger equity allocation through 2024—indicates Accenture’s intent to pursue risk‑adjusted returns that balance long‑term growth potential with the need to manage liability‑matching risk, using equity exposure to enhance returns while still maintaining a substantial debt base to preserve stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and misrepresents the core content of the original answer. (1) The original answer does not provide specific numerical allocations (e.g., 21% equity, 48% debt) for Accenture's defined benefit pension plans in any fiscal year; instead, it describes qualitative strategic shifts in asset allocation philosophy. The LLM fabricates precise percentages for 2022, 2023, and 2024 that are not present in the ground truth, including breakdowns by non-U.S. plans and categories like 'insurance contracts' and 'other'—none of which appear in the original. (2) There are no calculations in the original to verify, but the LLM invents a numerical trend (equity rising from 21% to 28%, debt falling from 48% to 36%) that has no basis in the source material, making the quantitative accuracy very low. (3) The multi-hop reasoning is flawed: while the LLM correctly infers a thematic shift toward greater equity exposure and risk-adjusted return management, this interpretation is built on fabricated data rather than synthesizing actual disclosures. The original emphasizes evolving flexibility and liability matching, not a clear directional shift toward higher equity. (4) Contextually, the LLM addresses the right topic—Accenture’s pension asset allocation evolution and risk-adjusted return strategy—and attempts to answer all parts of the question, which supports moderate relevance and some qualitative alignment. However, the invention of specific percentages and plan breakdowns severely undermines factual correctness. The conclusion about balancing growth and liability risk is partially consistent with the original’s theme but is derived from false premises. Overall, the answer fails on factual accuracy despite plausible framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 485,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple's repeated reference to the 1.05% Notes due 2017 in filings through 2023 and 2024 reflects its consistent approach to debt disclosure—maintaining visibility on legacy debt instruments even as it issues new long-term financing. This aligns with its broader debt issuance strategy across 2022–2024, which emphasizes diversified, low-cost funding through multi-year fixed-rate notes (e.g., 1.05% 2017s, 1.375% 2024s, 3.05% 2029s), while continuing to reference older tranches in regulatory filings to ensure transparency about outstanding obligations and interest rate exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. Most notably, it incorrectly lists a '1.375% 2024s' and '3.05% 2029s' as part of Apple's 2022–2024 debt issuance strategy, which are not present in the ground truth. The original answer correctly identifies the 3.45% Notes due 2024, not 1.375% or 3.05% notes. Additionally, the LLM implies the 1.05% Notes due 2017 were part of the recent issuance strategy, which is incorrect—they matured in 2017 and are only referenced for transparency. (2) The dates and percentages are partially correct but include fabricated instruments. The ground truth mentions Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024—none of which are accurately reflected in the LLM answer. The inclusion of a 2029 maturity is outside the 2022–2024 scope. (3) The reasoning is sound in interpreting that Apple maintains legacy disclosures for transparency, which aligns with the ground truth. The multi-hop synthesis correctly identifies that referencing matured debt indicates a transparent disclosure policy. However, the comparison to the broader strategy is flawed due to incorrect debt instruments being cited, weakening the validity of the comparison. (4) The contextual relevance is high because the answer addresses both parts of the question—disclosure approach and strategic comparison—and uses appropriate financial terminology. The qualitative reasoning is mostly logical but undermined by factual errors in the debt instruments cited. Hence, correctness is reduced to 6 due to significant quantitative inaccuracies despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 454,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "Accenture’s share repurchase activity has expanded steadily from fiscal 2022 through fiscal 2024, with $4.1 billion of Class A shares bought in fiscal 2022, $4.5 billion in fiscal 2023 and $4.5 billion in fiscal 2024, while the remaining authorization under its open‑market program grew from $2.9 billion (as of Aug 31 2022) to $2.7 billion (as of Aug 31 2024) and was subsequently boosted by an additional $4 billion approval in September 2024, bringing total outstanding authority to $6.7 billion. This multi‑year pattern reflects a deliberate, ongoing capital‑return strategy that prioritizes returning cash to shareholders through both share buybacks and dividends, while maintaining ample flexibility to fund future investments and acquisitions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Accenture did not repurchase $4.1B, $4.5B, and $4.5B in fiscal years 2022, 2023, and 2024 respectively. Instead, the only specific repurchase amount mentioned is $605 million in fiscal 2024. No repurchase figures are provided for 2022 or 2023 in the original answer, so the LLM's detailed annual breakdown is fabricated. The remaining authorization also does not align: the ground truth states available authorization decreased from $3.13B in 2022 to $2.69B in 2024 before a new $4B was approved, bringing total outstanding authority to $6.69B. The LLM incorrectly claims remaining authorization was $2.9B in 2022 and $2.7B in 2024, which contradicts the source. (2) The calculation of total outstanding authority ($6.7B) is close to the correct $6.69B and can be considered a rounding difference, but the underlying components (used vs. remaining) are wrong. The $4B new authorization in September 2024 is correctly mentioned. However, the claim of over $13B in repurchases across three years is unsupported and materially false. (3) The multi-hop reasoning is flawed: the LLM invents a trend of increasing repurchases without any basis in the original data. It fails to note that the decrease in available authorization despite repurchases suggests ongoing activity, but instead falsely implies growing authorization. The synthesis across years is incorrect. (4) While the general conclusion about a 'deliberate capital-return strategy' aligns thematically, it is based on false quantitative premises. The contextual relevance is moderate because it addresses the right topic and mentions dividends and flexibility, but the factual foundation is unsound, severely undermining correctness. Quantitative accuracy is extremely low due to invented figures. Qualitative accuracy is low due to incorrect reasoning and entity relationships. Correctness score is low because the core data is wrong, even if the strategic interpretation directionally matches.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 551,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMY issued its 4.350% Senior Notes due 2047 in November 2019 as part of a series of long‑term debt financings that were later supplemented by additional tranches in 2020 (Twelfth Supplemental Indenture) and again in 2022‑2023 with higher‑priced notes (e.g., 2.950% 2032, 3.550% 2042, 3.900% 2062). This multi‑year pattern shows a deliberate strategy of tapping the capital markets at progressively longer maturities and varied coupon levels to lock in low‑cost financing and diversify the company’s debt profile, supporting its long‑term capital structure and funding needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 4.350% Senior Notes due 2047 were issued in November 2019 as part of a series later supplemented in 2020 (Twelfth Supplemental Indenture) and again in 2022–2023. However, the ground truth confirms that the 4.350% Senior Notes due 2047 were issued under the Eleventh Supplemental Indenture in November 2019 and were not reissued or supplemented in subsequent years. The LLM incorrectly implies ongoing structuring or tranching of these specific notes in 2022–2023, which is not supported. Additionally, the LLM cites a '3.550% 2042' and '3.900% 2062' note issuance, which are not mentioned in the ground truth; instead, the actual new issuances were $1.75B 2.950% Notes due 2032 and $2B 3.700% Notes due 2052 in 2023, and $3.75B 4.250% Senior Notes due 2049 in 2024—none of which are accurately reflected in the LLM response. (2) Quantitative accuracy is low: multiple incorrect coupon rates, maturities, and dollar amounts are cited. The only correct numeric element is the 2.950% 2032 note, which aligns with the ground truth. All other figures (3.550% 2042, 3.900% 2062, 4.250% 2049 mentioned as part of earlier issuances) are either misplaced or fabricated. (3) The multi-hop reasoning is partially sound in that the LLM attempts to infer a long-term financing strategy—diversification of maturities and coupon levels—but it does so based on incorrect data. The conclusion about 'locking in low-cost financing' and 'progressively longer maturities' is plausible but not fully supported by the actual pattern described in the ground truth, which emphasizes the persistence of the 4.350% 2047 notes amid new issuances, not a progression of tranches of the same note. (4) Contextual relevance is high because the answer addresses the evolution of debt issuance and attempts to interpret strategic intent. However, due to significant factual and quantitative errors, the correctness score is limited to 4—partially correct on strategy but flawed in execution and data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 559,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Based on the provided filings, Apple's disclosure approach for the 2.40% Notes due 2023 evolved from detailed historical descriptions in earlier years to a more concise, forward-looking presentation by 2024. In 2022 (page 56), the Notes were listed in the debt table but not detailed in the main text; by 2023 (page 30), they were explicitly named in the \"Notes Payable\" section of Note 5, describing their terms and maturity. By 2024 (page 5), the Notes were referenced only in the context of the \"Notes Payable\" table within Note 5, with no additional narrative about their structure or maturity, reflecting a shift toward brevity and reliance on the tabular disclosure for all debt instruments. This progression shows a move from explanatory text to standardized, schedule-based reporting of debt terms.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Apple's disclosure approach for the 2.40% Notes due 2023 was consistent across 2022, 2023, and 2024, with identical descriptions in each filing under Exhibit 4.3 and no changes in format or substance. The LLM claims an evolution from 'detailed historical descriptions' to 'concise, forward-looking presentation,' which is factually wrong. (2) There are no numeric values (e.g., dollar amounts, interest rates, dates) in the LLM answer that contradict the ground truth—Apple did issue 2.40% Notes due 2023 via an Officer's Certificate on May 3, 2013, and these details are not disputed—so quantitative accuracy is partially acceptable, but the LLM fabricates filing page numbers (e.g., 'page 56', 'page 30', 'page 5') not present in the evaluation context, undermining reliability. (3) The multi-hop reasoning is flawed: the LLM infers a trend of changing disclosure style across years based on non-existent details, failing to recognize the key point of consistency emphasized in the ground truth. It incorrectly asserts that the notes were 'not detailed in the main text' in 2022 but later 'explicitly named' in 2023, when the truth is they were consistently disclosed in the same way. (4) Contextual relevance is moderate because the answer addresses the right topic (debt disclosures over time) and the correct instrument, but the conclusion about evolving disclosure is unsupported and false. The LLM appears to have hallucinated a narrative progression without evidence. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 450,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 SIP authorized 141 million Class A shares in 2024, with 27.3 million shares still available for future grants as of August 31 2024. This continued, high‑level authorization reflects Accenture’s long‑term strategy of sustaining a sizable equity‑based compensation pool to attract, retain and align executive and employee interests with shareholder value creation.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key aspects of the question. It correctly states that 141 million shares were authorized under the Amended 2010 SIP in 2024, which aligns with the ground truth for fiscal years 2023 and 2024. However, it fails to mention the 2022 figure of 127 million shares, which is essential to showing the evolution from 2022 through 2024. Additionally, the LLM introduces a new figure—27.3 million shares available as of August 31, 2024—that is not present in the original answer and cannot be verified from the provided ground truth. This undermines quantitative accuracy. (2) While the 141 million number is correct for 2023 and 2024, the absence of the 127 million figure for 2022 means the progression (increase from 127M to 141M) is not captured, and no comparison across all three years is made. The calculation or reporting of remaining available shares (27.3M) appears extraneous and unsupported by the ground truth. (3) The reasoning about Accenture’s long-term strategy is plausible and contextually sound—linking sustained equity compensation to talent retention and alignment with shareholders—but it is based only on the endpoint (2024) rather than the multi-hop evolution over three years. The strategic interpretation in the original answer emphasizes an expansion followed by stabilization, which the LLM answer does not reflect due to missing data points. (4) The answer is contextually relevant and uses appropriate terminology, but lacks completeness and full factual alignment. The omission of the 2022 number and the introduction of unverified data reduce correctness and quantitative accuracy significantly, though the core idea of sustained equity compensation is directionally accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 481,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "Intel’s PowerVia technology evolved from a concept introduced in 2021 through a series of roadmap milestones that culminated in its first high‑volume production in 2025.  The company first highlighted PowerVia in its 2021‑2022 process‑technology updates (page 6, 7, 8) as the “industry‑first implementation of backside power delivery” that would accompany the RibbonFET gate‑all‑around transistor in the upcoming Intel 18A node.  By 2023 the technology was listed alongside Intel 4 and Intel 3 as a key differentiator for the next‑generation node, and in 2024 Intel confirmed that PowerVia would be a core component of Intel 18A, promising up to a 15 % performance‑per‑watt improvement over Intel 3 (page 10, 88).  The progression—concept → roadmap announcement → design‑for‑manufacturing in Intel 18A and Panther Lake—signals that PowerVia has moved from a speculative research effort to a strategic, production‑ready capability that underpins Intel’s advanced‑process roadmap and its effort to regain process‑technology leadership.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in content and captures the strategic evolution of PowerVia well, but contains a minor factual inaccuracy regarding the initial introduction year. The ground truth states PowerVia was first introduced in 2022, while the LLM claims it was highlighted in '2021–2022' updates, which slightly predates the verified timeline. Additionally, the LLM incorrectly attributes PowerVia to the Intel 18A node as early as 2021–2022, whereas the original answer clarifies it was initially positioned with Intel 20A before transitioning to 18A in 2024. (2) The quantitative claim of a '15% performance-per-watt improvement' over Intel 3 is not present in the ground truth and cannot be verified; this specific percentage is an unsupported addition. Dates such as 'first high-volume production in 2025' and 'Panther Lake' are correctly aligned. (3) The multi-hop reasoning is strong: the LLM correctly traces PowerVia from concept to production, links it to Intel 18A and Panther Lake, and explains its strategic importance in regaining process leadership. It synthesizes the technology’s progression and implications accurately despite minor timeline discrepancies. (4) The answer is highly relevant and conveys the core significance of PowerVia in Intel’s roadmap. Due to the incorrect early dating and unverified performance metric, quantitative accuracy is reduced, but qualitative reasoning and contextual relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 405,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Based on the provided SEC 10-K filings across fiscal years 2022–2024, Accenture's allocation to mutual fund equity securities within its defined benefit pension plans evolved as follows:  \n\n- **Fiscal 2022**: Mutual fund equity securities in non-U.S. plans were $239,293 (Level 2), representing 21% of non-U.S. plan assets.  \n- **Fiscal 2023**: Increased to $273,541 (Level 2), with equity allocation rising to 19% of non-U.S. plan assets (up from 21% in 2022 but with a shift toward higher equity exposure in 2025 targets).  \n- **Fiscal 2024**: Reached $273,699 (Level 2), with non-U.S. plan equity allocation rising to **28%** of target allocation (up from 23% in 2023 and 19% in 2022), reflecting a strategic shift toward higher equity exposure.  \n\nThis 3-year trajectory indicates a deliberate **increase in equity allocation** (from 19% to 28% in non-U.S. plans), signaling Accenture's strategic positioning to enhance long-term growth potential within its pension portfolio. The shift aligns with evolving market conditions and the company’s emphasis on achieving higher total annualized returns that exceed inflation, as noted in its investment strategy disclosures. The growing use of mutual fund equity securities (now constituting the largest component in non-U.S. plans) underscores a move toward more growth-oriented asset allocation, though still balanced within broader diversification frameworks.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that Accenture's allocation to mutual fund equity securities decreased from $239,293 million in FY2022 to $196,226 million in FY2023 and remained at that level in FY2024. However, the LLM claims the allocation increased to $273,541 million in FY2023 and $273,699 million in FY2024—values that are not only incorrect but represent an opposite trend. Additionally, percentages cited (e.g., 28% in 2024 vs. 19% in 2022) contradict the ground truth, which does not mention such percentages and instead focuses on absolute dollar amounts. (2) Completeness: While the LLM attempts to address the evolution across three years and interpret strategic positioning, it does so using fabricated data. The answer introduces 'non-U.S. plans', 'Level 2', and 'target allocation' figures not present in the original answer, adding misleading context. (3) Entity Accuracy: The company (Accenture) and time frame (FY2022–2024) are correct, but the financial metric—allocation to mutual fund equity securities—is misrepresented. (4) Reasoning: The multi-hop synthesis is flawed because the LLM infers a strategic increase in equity exposure based on false numerical trends. The actual trajectory shows a reduction, indicating de-risking or rebalancing away from equities, whereas the LLM concludes the opposite—strategic growth orientation—leading to a completely inverted interpretation. (5) Semantic Equivalence: The LLM’s answer is semantically opposite to the ground truth: it reports increasing allocations and rising strategic emphasis on equities, while the truth reflects a decline and strategic reduction. Even allowing for format variation, the numbers and directionality are irreconcilable. The contextual relevance is low but not zero because the structure of the response aligns with the question's intent, albeit with entirely incorrect content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 531,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "From 2022 to 2024, Merck’s treatment of Dificid shifted from a standalone product to a modestly growing contributor within its broader pharmaceutical portfolio. Dificid’s sales rose from $302 million in 2021 to $340 million in 2022 and $371 million in 2023, reflecting incremental gains but still representing a small share of total revenue. The drug is primarily positioned for treating C. difficile infection, with recent label expansions (e.g., broader pediatric indication and EC approval) supporting its therapeutic positioning. However, Dificid’s contribution to global revenue remains limited—accounting for roughly 0.5% of total segment sales in 2023—and its valuation is tied to the company’s overall intangible‑asset portfolio rather than a distinct line‑item valuation shift. Consequently, while Dificid’s asset value is maintained on Merck’s balance sheet, it does not drive significant financial performance or strategic focus compared with blockbuster products like Keytruda.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The sales figures are completely incorrect. The ground truth states Dificid generated $340 million in global sales in 2024 (not 2022), with $303 million in the U.S. and $37 million internationally. The LLM claims $340 million in 2022 and $371 million in 2023, which contradicts the source. Additionally, it references $302 million in 2021, which is not supported by the original answer. There is no mention of 2024 revenue in the LLM response, despite the question asking about evolution through 2024. (2) Completeness: The answer fails to mention Dificid's $145 million valuation as an intangible asset in 2022, a key point in the original answer. It also omits the strategic shift in 2023 where Dificid was explicitly highlighted as a key product in the Pharmaceutical segment. Instead, it incorrectly frames Dificid as having no distinct valuation or strategic focus. (3) Entity Accuracy: While Merck and Dificid are correctly identified, the years associated with financial and strategic developments are wrong. The therapeutic positioning is partially correct (C. difficile indication), but the label expansions (pediatric, EC approval) are not mentioned in the ground truth and appear fabricated. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers that Dificid has no distinct valuation or strategic role, when the original answer shows a clear progression from balance sheet asset to strategically recognized product. It also misrepresents revenue trends by citing increasing sales in 2022 and 2023 when the ground truth only provides 2024 data. (5) Semantic Equivalence: The overall narrative contradicts the ground truth—portraying Dificid as stagnant and insignificant, while the original answer shows growing recognition and measurable financial contribution. Despite addressing the general theme of financial and strategic treatment, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 550,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022 through 2024 Intel’s Advanced Packaging Technologies strategy evolved amid growing R&D spending and significant execution challenges. The company increased capital investment in packaging and advanced nodes (e.g., Intel 18A, Intel 3) while confronting construction delays at its Ireland and Arizona SCIP fabs—resulting in $755 million of liquidated‑damage losses in 2024 and the need to meet minimum output commitments. These delays, together with heightened fixed‑cost exposure and uncertain external funding, created substantial financial risk, even as Intel continued to pour roughly $16 billion annually into R&D to support its IDM 2.0 and foundry ambitions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unverified details not present in the ground truth. While it correctly identifies Intel's increased R&D investment and execution challenges in advanced packaging from 2022–2024, it fabricates specific figures such as $755 million in liquidated-damage losses and $16 billion in annual R&D spending—neither of which appear in the original answer. The ground truth mentions a $3.1 billion impairment charge in 2024, which the LLM omits entirely. Additionally, the LLM references construction delays at Ireland and Arizona SCIP fabs and 'minimum output commitments,' which are not mentioned in the ground truth. (2) Quantitative accuracy is low because the dollar amounts cited ($755M, $16B) are unsupported by the original answer, and the critical $3.1B impairment charge is missing. The R&D figure of ~$16B/year may be factually correct in reality but is not stated in the ground truth and thus cannot be considered accurate in this evaluation context. (3) The qualitative reasoning partially captures the evolution of Intel’s strategic positioning—highlighting increased investment and execution risks—but fails to reflect the multi-hop synthesis of how Intel’s narrative shifted from strategic optimism (2022) to financial strain (2024), particularly around UCIe progress in 2023 and the link between packaging delays and product introductions. The LLM focuses more on fab construction delays than on the technical and operational challenges of implementing advanced packaging itself. (4) Contextual relevance is high because the response addresses the core themes of R&D investment, implementation delays, and financial risk. However, due to significant factual deviations and omission of key ground truth elements (e.g., UCIe, disaggregated design complexity, $3.1B impairment), the overall correctness score is moderate at 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 516,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "From 2022 through 2024 Merck’s HIV‑1 pipeline advanced the dual‑agent regimen MK‑8591A (doravirine + islatravir) entered Phase 3 in February 2020, and by October 2024 the once‑weekly MK‑8591D (islatravir + lenacapavir) was slated for Phase 3 entry, indicating a continued, long‑term commitment to a novel, potentially durable HIV therapeutic strategy. This progression underscores Merck’s strategic focus on expanding its HIV portfolio with innovative, long‑acting regimens to maintain a competitive edge in a market where patent expirations and generic competition pressure existing products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that MK-8591A entered Phase 3 in February 2020 — while this date is correct, the ground truth indicates it was already in Phase 3 as of 2022, not that the event occurred during the 2022–2024 window. More critically, the LLM introduces MK-8591D (islatravir + lenacapavir) entering Phase 3 in October 2024, which is not mentioned in the ground truth and represents a different compound not referenced in the original answer. There is no mention of the FDA lifting a clinical hold on December 4, 2024, or the ongoing partial clinical hold on higher doses — key regulatory developments that define the timeline. (2) Quantitative accuracy is low: the February 2020 Phase 3 entry date is accurate but mispositioned in time; the October 2024 milestone for MK-8591D is fabricated. No correct dates are provided for actual events in the 2022–2024 period, especially the critical December 4, 2024 FDA action. (3) Multi-hop reasoning is partially sound — the model infers long-term strategic commitment, which aligns with the original answer — but this conclusion is based on incorrect evidence. The synthesis fails because it relies on a non-existent development milestone (MK-8591D Phase 3 entry). (4) Contextual relevance is high because the answer addresses Merck’s HIV strategy and attempts to interpret long-term intent, but factual errors undermine correctness. The strategic interpretation is reasonable but not sufficiently supported by accurate data from the timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 429,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "From 2022 through 2024, Merck’s development strategy for MK‑1308A shifted from early‑stage exploration to a focused, late‑stage clinical and regulatory program centered on immuno‑oncology.  The company advanced MK‑1308A as a fixed‑dose combination of its novel anti‑CTLA‑4 antibody quavonlimab with pembrolizumab, initially testing it in advanced solid tumors and later prioritizing renal‑cell carcinoma (RCC) and other oncology indications.  By 2024 the program was in Phase 3 for RCC and received regulatory attention (e.g., FDA complete‑response letters and EU reviews), while also being evaluated in combination with pembrolizumab across multiple tumor types.  This evolution reflects a clear progression from preclinical/early‑phase work toward pivotal trials and regulatory submissions, underscoring Merck’s strategy to leverage MK‑1308A as a cornerstone of its immuno‑oncology pillar.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MK-1308A as a combination of quavonlimab and pembrolizumab, its focus on renal cell carcinoma (RCC), and its Phase 3 status by 2024, which aligns with the ground truth. However, it inaccurately states that the program received 'regulatory attention (e.g., FDA complete-response letters and EU reviews)'—the original answer notes no indication of regulatory approval or specific regulatory actions like complete-response letters, so this is a factual overstatement. Additionally, the LLM suggests a shift 'from early-stage exploration' and 'preclinical/early-phase work,' but the ground truth indicates MK-1308A was already in Phase 3 in 2022, so the characterization of early-stage development is incorrect. (2) There are no explicit numerical values to verify (e.g., dollar amounts, percentages), but the timeline (2022–2024) and Phase 3 designation are consistent across both answers, earning high marks for quantitative accuracy. (3) The multi-hop reasoning is partially sound—information about formulation, combination therapy, and clinical focus is correctly synthesized across years. However, the reasoning falters in inferring regulatory progress not supported by the ground truth, weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses clinical focus, combination therapies, and regulatory progress as asked. Despite some overreach on regulatory details and developmental timeline, the core facts about RCC focus, combination with pembrolizumab, and sustained Phase 3 development are correct, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 447,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase program expanded markedly: in fiscal 2022 it purchased 12.2 million shares for about $4.1 billion, and by fiscal 2024 the quarterly program alone bought 2.07 million shares for $605 million, leaving roughly $2.7 billion of authorization remaining (later increased to $6.69 billion after a September 2024 board approval). This multi‑year pattern shows a deliberate, ongoing capital‑return strategy that combines regular, sizable open‑market share purchases with periodic increases in board‑approved repurchase authority, underscoring Accenture’s focus on returning cash to shareholders while maintaining flexibility for future investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims Accenture purchased 12.2 million shares for $4.1 billion in fiscal 2022, but the ground truth does not provide any data on actual repurchases in fiscal 2022—only the available authorization of $3.13 billion. This $4.1 billion figure appears to be a confusion with the $4,000 million (i.e., $4 billion) repurchase authority approved in September 2024, not actual spending in 2022. Additionally, the LLM states that the 'quarterly program alone bought 2.07 million shares for $605 million' in fiscal 2024, but the ground truth reports 2,000,308 shares (approx. 2.0 million) for $605 million under the open-market program, plus 72,255 additional shares from employee transactions—so the total is closer to 2.07 million, but the LLM incorrectly attributes all to the quarterly program. The remaining authorization is correctly stated as $2.7 billion (approximation of $2,694 million), and the post-September 2024 total of $6.69 billion is accurate. (2) Calculations: The LLM incorrectly implies $4.1 billion was spent in 2022, which is not supported by the data. The $605 million for ~2 million shares in 2024 is correct. The $6.69 billion total authority after replenishment is accurate. (3) Multi-hop reasoning: The LLM correctly identifies the pattern of sustained repurchases and replenishment of authority, and infers a strategic, flexible capital return approach—this aligns with the ground truth's conclusion. However, the flawed input data (especially the fictional 2022 repurchase) undermines the reasoning chain. The mention of a 'quarterly program' is not in the original and adds unsupported detail. (4) Scores justified: Correctness is 5 due to major factual errors in repurchase amounts and timing, despite capturing the general strategic trend. Quantitative accuracy is low (4) due to incorrect figures for 2022. Qualitative accuracy is moderate (6) because the strategic interpretation is sound, but based on flawed data. Contextual relevance is high (9) as the answer addresses all aspects of the question and draws appropriate strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 576,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "The persistence of the $750 million 2.350% Notes due 2040 across BMS’s 2022‑2024 capital‑structure filings underscores the company’s strategy of locking in long‑term, fixed‑rate financing at relatively low yields, thereby preserving cash for growth initiatives while maintaining a stable debt profile. By repeatedly issuing this tranche through supplemental indentures (most recently in 2023), BMS demonstrates a deliberate approach to managing its long‑term fixed‑rate obligations, ensuring predictable interest expense and reinforcing investor confidence in its capital‑structure discipline.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly identifies the $750 million 2.350% Notes due 2040 and their presence in filings from 2022–2024, aligning with the ground truth on the core instrument and time frame. Dollar amount, interest rate, and maturity year are accurate (quantitative accuracy is high). However, a critical factual error undermines the reasoning: the LLM claims BMS 'repeatedly issuing this tranche through supplemental indentures (most recently in 2023)', implying multiple issuances or reopenings of the note, which is not supported by the ground truth. The original answer states the notes were consistently *included* in filings, not reissued—indicating retention, not new issuance. This misrepresents the company's action and strategy.\n\n2) Quantitative elements are correct: $750 million (equivalent to $750,000,000), 2.350%, 2040 maturity, and years 2022–2024 are all accurately reflected. No calculation errors.\n\n3) The multi-hop reasoning is partially sound—linking persistent disclosure to a strategy of fixed-rate debt management is valid. However, the inference that BMS is 'repeatedly issuing' the notes introduces a significant logical flaw. The ground truth emphasizes non-refinancing and non-retirement as strategic, while the LLM implies active reissuance, which changes the strategic interpretation. This breaks the qualitative accuracy of the reasoning chain.\n\n4) Contextual relevance is strong: the answer addresses long-term fixed-rate debt management and connects it to predictable interest expenses and capital structure discipline. But due to the erroneous claim about reissuance, the qualitative accuracy is reduced. The core strategy described (predictability, stability) is aligned, but the mechanism (repeated issuance vs. retention) is incorrect. Hence, correctness score is 6—partially correct with significant factual/strategic misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 506,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol‑Myers Squibb’s 4.350 % Senior Notes due 2047 were first issued under the Eleventh Supplemental Indenture dated November 22 2019 (the “4.350 % 2047 Notes” listed in the 2019 Form 8‑K exhibits). Subsequent filings show that the company later amended and refinanced this tranche through later supplemental indentures – most notably the Twelfth Supplemental Indenture of November 13 2020 and further amendments in 2022‑2023 that added new tranches of long‑dated notes (e.g., 2.950 % 2032, 3.550 % 2042, 3.700 % 2052, etc.) and ultimately a Fourteenth Supplemental Indenture in November 2023. Across the 2022, 2023 and 2024 10‑K filings the company continued to issue new long‑term senior notes with varying coupon rates and maturity dates, but the original 4.350 % 2047 notes remain part of the company’s overall long‑term debt profile, reflecting a strategy of layering increasingly lower‑cost, longer‑dated financing as market conditions allowed. This pattern indicates that BMS systematically staggers its long‑term debt maturities and takes advantage of favorable interest‑rate environments to replace or supplement older, higher‑coupon obligations, thereby managing its overall cost of capital and extending the average maturity of its debt portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 4.350% Senior Notes due 2047 and references the 2019 Form 8-K and November 2019 issuance, which aligns with the ground truth. However, it incorrectly states that the notes were issued under the 'Eleventh Supplemental Indenture dated November 22, 2019', while the ground truth specifies the Twelfth Supplemental Indenture on November 13, 2020, and incorporation by reference to the 2019 Form 8-K. The LLM also introduces the idea of 'amended and refinanced' in 2022–2023 and a Fourteenth Supplemental Indenture in November 2023, which the ground truth confirms but only as reaffirmations of the same 4.350% rate, not refinancing or amendment of the original notes. The LLM incorrectly implies that the original 4.350% notes were refinanced or supplemented with new tranches under the same indenture, which is not supported by the ground truth. (2) Quantitative accuracy is partially correct: the 4.350% rate is accurate, and the 2019 and 2023 dates are close but misaligned (November 22 vs. November 13). The LLM invents new coupon rates (2.950%, 3.550%, 3.700%) and maturities (2032, 2042, 2052) not mentioned in the ground truth, which undermines numerical accuracy. (3) The multi-hop reasoning is flawed: while the LLM attempts to synthesize a broader debt strategy, it extrapolates beyond the provided data. The ground truth emphasizes consistency and transparency in disclosing the same rate across years, while the LLM infers active refinancing and cost-lowering strategy, which is not directly supported by the filings described. (4) Contextual relevance is high—the answer addresses the evolution of the interest rate and the company’s long-term financing approach—but the reasoning is based on incorrect or invented details, reducing factual reliability. The conclusion about staggering maturities and lowering costs is plausible but not evidenced in the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 537,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Nike’s disclosures show a clear evolution in how it reports FlyEase technology—from a brief mention in the 2022 “Manufacturing” section, to a dedicated paragraph in the 2023 “Product Research, Design and Development” discussion, and finally to explicit quantitative references in the 2024 filing that tie FlyEase to production scale and global integration.  \n\nIn the 2024 Form 10‑K (pages 6‑7 and 8), Nike quantifies FlyEase’s footprint by stating that “four footwear contract manufacturers each accounted for greater than 10 % of footwear production and, in the aggregate, accounted for approximately 57 % of Nike Brand footwear production,” and that “factories in Vietnam, Indonesia and China manufactured approximately 50 %, 27 % and 18 % of total Nike Brand footwear, respectively,” with FlyEase‑enabled facilities identified among the key contract manufacturers in Vietnam and China. This data demonstrates that FlyEase is no longer a niche prototype but a mainstream component woven into the bulk of Nike’s global manufacturing network, supporting a substantial share of its footwear output across multiple continents.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor overreach in interpretation that affects qualitative accuracy. (1) Quantitatively, all numbers are accurate: the 2024 filing correctly states that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% of total Nike Brand footwear, respectively—this matches the ground truth. The mention of four contract manufacturers accounting for ~57% of production is also factually correct per the 10-K. (2) However, the LLM incorrectly implies that FlyEase-enabled facilities are explicitly identified among the key manufacturers in Vietnam and China. The original answer and actual 10-K do not state this linkage—FlyEase is not named in connection with specific manufacturers or percentages. This is an unsupported inference, making the claim about 'FlyEase-enabled facilities' speculative. (3) The reasoning correctly traces the evolution of FlyEase mentions from 2022 to 2024—increasing prominence in disclosures—but the LLM adds structural details (e.g., 'dedicated paragraph in 2023') not verifiable from the ground truth. The core multi-hop synthesis—linking increased reporting to production scale via geographic manufacturing data—is sound and contextually relevant. (4) Despite the overstatement, the answer captures the essence: FlyEase has transitioned from early-stage mention to being part of mainstream production, supported by global manufacturing data. Hence, correctness is high but not perfect due to the unsupported facility linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 425,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "The penetration rate of Target’s RedCard‑branded payment products (including the Target Debit Card and RedCard) declined from 20.5 % in 2022 to 18.6 % in 2023 and further to 17.8 % in 2024, indicating a downward trend in adoption of the loyalty‑driven payment strategy. This erosion suggests that the current discount‑based incentive model is losing effectiveness in driving card usage, prompting Target to likely reassess its loyalty‑program tactics to reverse the trend.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in RedCard penetration from 2022 to 2024 and accurately reports the 2024 penetration rate of 17.8%. However, it incorrectly states the 2023 penetration rate as 18.6%, whereas the ground truth is 19.8%. This is a significant quantitative error that affects the accuracy of the trend portrayal. (2) The numbers for 2022 (20.5%) and 2024 (17.8%) are correct, but the 2023 figure is off by a full percentage point, which impacts the perceived rate of decline. The calculation of the trend direction (downward) is correct, but the magnitude is misrepresented. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the trend across three years and draws a logical conclusion about the weakening effectiveness of Target's loyalty strategy. It appropriately infers strategic implications, such as the need to reassess loyalty-program tactics, which aligns with the ground truth's suggestion of reduced effectiveness. (4) Despite the numerical inaccuracy in 2023, the answer addresses all parts of the question, uses correct entities (Target Debit Card, RedCard, correct years), and maintains contextual relevance. The qualitative reasoning and conclusion are strong and semantically aligned with the ground truth, justifying a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 370,
        "total_tokens": 1608
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 5.59,
    "average_quantitative_accuracy": 6.06,
    "average_qualitative_accuracy": 5.98,
    "average_contextual_relevance": 8.06,
    "score_distribution": {
      "excellent": 148,
      "good": 184,
      "fair": 258,
      "poor": 210
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800
  }
}